data_2phe_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2phe _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 110.364 -0.235 . . . . 10.0 110.364 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 41.2 ttm -135.83 110.09 8.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.032 0.444 . . . . 10.0 110.643 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -100.37 169.49 9.07 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.426 -0.583 . . . . 10.0 109.426 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -132.35 132.55 43.02 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.899 -0.321 . . . . 10.0 110.92 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 22.7 pt -117.79 -2.09 9.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.977 0.418 . . . . 10.0 110.999 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 176.99 173.91 42.96 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.838 -0.696 . . . . 10.0 111.724 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -63.91 126.99 29.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.837 0.319 . . . . 10.0 110.225 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 87.1 mmm 64.16 17.65 10.8 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.794 -0.639 . . . . 10.0 111.326 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -128.93 109.17 11.01 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 109.948 -0.39 . . . . 10.0 109.948 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -121.76 160.23 25.01 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.789 -178.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 40.9 t -111.69 114.64 47.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.968 -0.56 . . . . 10.0 110.126 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.94 119.4 27.11 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.765 -0.652 . . . . 10.0 110.523 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 74.7 t -132.6 106.77 11.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.682 -0.488 . . . . 10.0 109.682 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.3 ptt180 -155.53 169.83 23.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.661 0.267 . . . . 10.0 111.014 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.72 132.46 45.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.045 -0.525 . . . . 10.0 109.94 178.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -145.17 117.41 8.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.632 -0.258 . . . . 10.0 110.731 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 74.7 mttt 61.8 -86.75 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.804 -0.635 . . . . 10.0 111.176 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -148.39 31.03 1.28 Allowed Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 111.439 -0.664 . . . . 10.0 111.439 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.9 ttmt -158.17 169.48 24.43 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.563 -0.532 . . . . 10.0 109.563 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 58.8 t -86.36 119.42 34.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.014 0.435 . . . . 10.0 110.034 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.1 tp -84.06 101.82 12.06 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.836 -0.62 . . . . 10.0 110.675 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 15.1 mt -108.46 98.23 6.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.586 -0.894 . . . . 10.0 108.586 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -118.9 121.83 40.88 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.552 0.575 . . . . 10.0 112.552 -177.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 56.7 mt -100.71 103.58 15.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.115 -1.068 . . . . 10.0 108.115 177.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 8.8 ttm-85 -145.98 160.46 41.82 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.931 0.396 . . . . 10.0 111.318 -177.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -63.75 141.44 58.77 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.648 -0.871 . . . . 10.0 108.648 177.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -113.6 120.54 41.28 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.105 0.479 . . . . 10.0 111.757 -178.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -102.51 155.17 18.45 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.296 -0.865 . . . . 10.0 108.899 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 25.2 ttt -82.42 139.16 34.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.385 0.612 . . . . 10.0 111.733 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -83.33 144.61 46.87 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 114.922 -1.036 . . . . 10.0 109.154 178.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -47.57 -33.47 18.08 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.862 2.375 . . . . 10.0 112.91 178.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -75.76 -59.38 2.78 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.338 -0.392 . . . . 10.0 110.72 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 169.44 -11.51 0.05 OUTLIER Glycine 0 CA--C 1.521 0.462 0 C-N-CA 120.107 -1.044 . . . . 10.0 114.029 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -79.33 -175.08 4.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 117.22 0.51 . . . . 10.0 111.31 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 57.2 mmm -134.62 141.92 46.75 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.277 -0.638 . . . . 10.0 109.277 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.2 mmtp -146.79 156.29 48.1 Favored Pre-proline 0 N--CA 1.464 0.238 0 CA-C-O 120.639 0.256 . . . . 10.0 111.281 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -63.4 153.7 72.91 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.289 2.659 . . . . 10.0 114.258 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -102.4 -110.41 3.4 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.057 -0.974 . . . . 10.0 112.28 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -122.59 -46.49 2.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.015 0.408 . . . . 10.0 111.874 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 16.1 mttp -71.15 104.79 3.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.702 0.287 . . . . 10.0 110.517 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 174.42 165.91 31.63 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.862 -0.685 . . . . 10.0 112.378 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 20.2 tt -146.63 142.03 20.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.99 0.424 . . . . 10.0 110.551 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.3 m -85.83 136.62 33.24 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.021 -0.536 . . . . 10.0 110.201 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 71.4 mt -93.12 105.23 17.35 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.272 -0.422 . . . . 10.0 110.886 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -62.38 141.43 96.41 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.363 -0.606 . . . . 10.0 109.363 178.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -47.12 -38.08 24.25 Favored 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 122.617 2.211 . . . . 10.0 112.474 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -77.61 -37.28 50.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.125 -0.488 . . . . 10.0 110.295 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -68.05 -31.43 71.08 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.711 -0.677 . . . . 10.0 110.612 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 54.2 t-105 -55.36 -45.63 76.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.88 -0.6 . . . . 10.0 110.797 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.8 t -69.12 -51.81 34.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.383 -0.372 . . . . 10.0 110.395 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -55.51 -42.87 75.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.004 -0.544 . . . . 10.0 111.534 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.6 tp -61.35 -47.85 84.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.644 0.259 . . . . 10.0 110.816 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -60.54 -37.72 82.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.005 0.431 . . . . 10.0 111.338 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -73.83 -31.62 63.3 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.061 -0.518 . . . . 10.0 111.39 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -81.07 -15.33 56.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.487 -0.324 . . . . 10.0 111.15 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.4 mt -49.77 -43.5 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 112.215 0.45 . . . . 10.0 112.215 -179.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.4 m -56.97 -37.43 71.58 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.763 0.316 . . . . 10.0 111.643 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -83.6 -39.77 19.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.012 0.434 . . . . 10.0 110.616 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 92.2 mt -60.19 -50.44 80.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.777 -0.647 . . . . 10.0 110.242 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -59.59 -37.14 77.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.392 -0.822 . . . . 10.0 110.559 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -66.21 -35.72 81.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.312 -0.858 . . . . 10.0 110.814 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -70.83 -33.5 70.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.885 -0.598 . . . . 10.0 110.559 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 60.5 t -62.24 -40.55 88.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.347 0.594 . . . . 10.0 110.118 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.8 mtm105 -74.35 -13.16 60.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.529 -0.759 . . . . 10.0 111.275 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 38.7 mttp -90.46 -2.62 57.94 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.911 0.386 . . . . 10.0 110.827 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 84.0 mt . . . . . 0 C--N 1.325 -0.458 0 CA-C-N 116.249 -0.432 . . . . 10.0 110.861 -179.948 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 121.067 0.46 . . . . 10.0 110.35 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 88.0 mmm -99.7 102.8 14.38 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.565 -0.743 . . . . 10.0 109.779 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -108.03 115.68 30.56 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.387 -0.369 . . . . 10.0 111.223 -179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -71.34 125.0 25.82 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.171 -0.468 . . . . 10.0 110.378 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 19.1 pt -116.6 2.85 7.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.005 -0.543 . . . . 10.0 110.286 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 170.66 -162.45 35.49 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.993 -0.622 . . . . 10.0 111.969 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.33 117.83 25.38 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 110.199 -0.297 . . . . 10.0 110.199 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' MET . . . . . . . . . . . . . 19.9 mmt 68.33 8.91 6.92 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.545 -0.752 . . . . 10.0 111.566 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -120.8 119.26 32.21 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.499 -0.556 . . . . 10.0 109.499 179.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -135.18 138.32 43.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.884 0.373 . . . . 10.0 111.2 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 75.5 t -89.94 117.78 33.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 108.631 -0.877 . . . . 10.0 108.631 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 24.5 t -111.48 109.87 20.03 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.036 0.446 . . . . 10.0 111.289 -178.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 20.4 t -92.73 94.86 4.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.193 -0.669 . . . . 10.0 109.193 178.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 26.5 ptt-85 -122.05 149.18 43.9 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.118 0.485 . . . . 10.0 111.546 -178.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -87.54 115.99 25.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.51 -0.768 . . . . 10.0 109.262 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -110.14 105.81 15.04 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.445 -0.343 . . . . 10.0 111.222 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 33.2 mttm 57.61 30.78 19.34 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.703 -0.68 . . . . 10.0 112.785 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 92.67 30.84 9.24 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.509 -0.853 . . . . 10.0 112.23 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 18.4 mmtm -144.22 108.13 4.71 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 122.367 0.267 . . . . 10.0 110.45 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 16.1 t -69.49 106.18 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.387 -0.597 . . . . 10.0 109.387 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 94.5 mt -111.02 128.88 56.0 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.027 0.441 . . . . 10.0 111.665 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 82' ' ' ILE . . . . . . . . . . . . . 5.2 mp -90.75 86.45 2.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 107.499 -1.297 . . . . 10.0 107.499 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -85.78 107.61 17.71 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.744 -0.662 . . . . 10.0 112.02 -177.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 63.4 mt -92.63 95.84 5.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 107.5 -1.296 . . . . 10.0 107.5 177.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 19.7 ttm-85 -132.84 168.84 17.66 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.504 0.669 . . . . 10.0 111.973 -177.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -89.25 154.95 19.71 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.214 -0.903 . . . . 10.0 109.348 178.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 87' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -131.47 118.8 20.69 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.909 -0.404 . . . . 10.0 109.909 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 88' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -108.28 136.61 47.64 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.976 -0.556 . . . . 10.0 109.798 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 52.4 ttm -75.55 130.99 39.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.072 0.463 . . . . 10.0 111.41 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 90' ' ' ASP . . . . . . . . . . . . . 35.0 p30 -84.79 172.23 9.37 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.579 -0.737 . . . . 10.0 109.774 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.89 -13.08 28.83 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.695 2.263 . . . . 10.0 112.863 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -84.72 -43.81 13.95 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.968 0.413 . . . . 10.0 110.254 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 129.57 16.26 1.88 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.945 -0.645 . . . . 10.0 112.317 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -109.74 147.02 33.94 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.725 0.298 . . . . 10.0 110.279 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 95' ' ' MET . . . . . . . . . . . . . 84.3 mmm -88.7 115.84 26.52 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 110.047 -0.353 . . . . 10.0 110.047 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -104.12 140.78 21.4 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 116.347 -0.388 . . . . 10.0 110.053 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.13 129.04 20.78 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.438 2.092 . . . . 10.0 112.159 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . -76.17 -173.63 36.17 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.107 -0.568 . . . . 10.0 112.199 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -88.3 -23.28 23.5 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.894 0.378 . . . . 10.0 111.202 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 7.0 mtmp? -88.08 113.81 24.09 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.282 0.563 . . . . 10.0 110.851 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . 169.13 175.67 38.6 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 110.894 -0.882 . . . . 10.0 110.894 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 21.1 tt -143.56 138.44 25.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 117.299 0.549 . . . . 10.0 111.425 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 1.5 m -98.33 107.71 20.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.781 -0.645 . . . . 10.0 109.986 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 46.3 mt -99.39 135.56 40.62 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.466 -0.334 . . . . 10.0 110.741 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -88.18 164.23 34.01 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 108.836 -0.802 . . . . 10.0 108.836 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -49.43 -32.26 26.04 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.179 2.586 . . . . 10.0 113.305 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -64.22 -57.95 8.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.266 -0.424 . . . . 10.0 110.69 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -66.88 -30.85 71.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.094 0.473 . . . . 10.0 109.949 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 109' ' ' TRP . . . . . . . . . . . . . 48.7 t-105 -59.54 -42.33 92.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.543 -0.753 . . . . 10.0 110.04 179.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 29.9 t -63.9 -47.61 79.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 10.0 109.784 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -61.05 -38.95 87.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.816 -0.629 . . . . 10.0 111.073 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 49.6 tp -58.6 -45.93 88.09 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.801 0.334 . . . . 10.0 110.373 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -66.25 -36.06 82.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.172 0.51 . . . . 10.0 110.984 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -74.06 -32.54 63.33 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.104 -0.498 . . . . 10.0 111.274 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -75.76 -11.86 60.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.194 -0.457 . . . . 10.0 111.213 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 58.0 mt -55.18 -39.65 52.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.501 -0.318 . . . . 10.0 111.26 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 4.9 m -59.36 -24.08 63.09 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.876 0.369 . . . . 10.0 111.523 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.02 -44.38 7.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.915 0.388 . . . . 10.0 110.752 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 61.5 mt -63.78 -46.82 93.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.997 -0.547 . . . . 10.0 111.397 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -57.63 -33.08 67.89 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.36 -0.382 . . . . 10.0 111.14 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -63.27 -42.55 99.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.291 -0.413 . . . . 10.0 110.912 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.2 -30.73 66.74 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.839 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 45.1 t -75.81 -38.09 36.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 10.0 110.968 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -78.72 -6.29 55.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 10.0 111.235 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 65.7 mttt . . . . . 0 C--N 1.327 -0.401 0 CA-C-O 120.971 0.415 . . . . 10.0 110.273 179.775 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.846 0 CA-C-O 120.899 0.38 . . . . 10.0 110.78 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 62.1 mtt -112.11 97.53 6.72 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.708 -0.478 . . . . 10.0 109.708 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -91.02 135.71 33.57 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.36 -0.382 . . . . 10.0 110.599 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -89.14 128.67 35.79 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.761 0.315 . . . . 10.0 110.41 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.9 pt -117.1 9.02 7.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.175 0.512 . . . . 10.0 110.497 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 159.88 173.27 28.16 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.719 -0.753 . . . . 10.0 111.945 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -61.92 117.59 6.12 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.648 0.261 . . . . 10.0 110.71 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 67.2 mmm 70.41 15.55 7.28 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.389 -0.823 . . . . 10.0 111.557 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -121.72 120.87 35.93 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 122.242 -0.286 . . . . 10.0 110.269 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -132.95 143.84 49.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.398 0.618 . . . . 10.0 111.916 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.2 t -108.83 111.14 34.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 108.312 -0.995 . . . . 10.0 108.312 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.9 m -101.92 116.39 32.6 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.249 0.547 . . . . 10.0 112.151 -178.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.9 t -103.94 110.73 31.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.409 -0.814 . . . . 10.0 109.581 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -157.8 179.71 8.95 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.101 0.477 . . . . 10.0 111.134 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -112.21 133.21 54.47 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.297 -0.865 . . . . 10.0 109.613 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -136.49 118.33 15.16 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.567 -0.288 . . . . 10.0 110.269 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 97.4 mttt 57.67 43.92 21.46 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 123.499 0.5 . . . . 10.0 111.596 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.25 40.99 94.97 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.707 -0.759 . . . . 10.0 111.51 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? -151.08 102.55 2.96 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.913 0.387 . . . . 10.0 110.121 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.5 t -77.93 121.85 31.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.403 -0.591 . . . . 10.0 109.403 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 24.1 mt -139.12 144.75 38.81 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.621 0.724 . . . . 10.0 112.176 -178.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.0 mt -104.12 98.98 7.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 114.591 -1.186 . . . . 10.0 108.004 178.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -94.19 121.35 35.6 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.554 0.576 . . . . 10.0 112.554 -177.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 22.8 mt -98.74 108.19 21.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 107.181 -1.415 . . . . 10.0 107.181 177.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.2 ttm180 -144.63 163.23 34.55 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.573 0.701 . . . . 10.0 112.864 -176.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -89.9 142.09 28.03 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.864 -1.062 . . . . 10.0 109.124 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -114.43 135.92 53.57 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.528 -0.306 . . . . 10.0 110.341 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 45.7 t90 -108.67 134.77 50.95 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.72 -0.474 . . . . 10.0 109.72 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 25.2 ttt -84.4 117.67 23.77 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.87 -0.419 . . . . 10.0 109.87 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.24 164.21 55.19 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.932 -0.576 . . . . 10.0 110.868 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -53.39 -33.13 65.23 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.088 2.525 . . . . 10.0 113.318 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -69.74 -57.38 5.19 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.009 -0.367 . . . . 10.0 110.009 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 146.12 21.1 0.12 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.461 -0.876 . . . . 10.0 112.775 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -106.95 149.15 27.8 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.803 0.335 . . . . 10.0 110.306 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 98.4 mmm -88.77 117.67 27.91 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.293 -0.412 . . . . 10.0 110.013 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -108.34 133.86 20.42 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.211 -0.449 . . . . 10.0 110.672 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.67 136.31 30.29 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.493 2.129 . . . . 10.0 112.157 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -85.15 -158.43 29.61 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.595 -0.812 . . . . 10.0 112.799 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.0 mtm180 -103.46 -22.38 13.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.869 0.366 . . . . 10.0 110.973 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 19.6 ttmt -82.65 82.96 7.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.239 -0.437 . . . . 10.0 110.478 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -152.9 165.77 31.22 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.604 -0.599 . . . . 10.0 111.604 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 12.0 tt -147.73 124.28 2.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.111 0.481 . . . . 10.0 111.226 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.3 m -94.62 125.69 39.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.801 -0.636 . . . . 10.0 110.387 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 76.6 mt -121.54 135.3 55.02 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.945 -0.391 . . . . 10.0 109.945 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -81.98 163.22 54.31 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 109.818 -0.438 . . . . 10.0 109.818 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -42.06 -38.98 5.49 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.614 2.876 . . . . 10.0 114.286 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.84 -49.25 77.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.533 -0.303 . . . . 10.0 110.865 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -67.96 -37.84 82.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.317 0.579 . . . . 10.0 109.687 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 23.5 t-105 -58.08 -43.29 86.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.272 -0.876 . . . . 10.0 110.709 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.7 t -65.32 -43.98 89.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.045 -0.525 . . . . 10.0 110.617 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -65.32 -36.12 83.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.431 -0.349 . . . . 10.0 110.841 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 48.6 tp -59.63 -41.14 89.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.429 . . . . 10.0 110.405 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -65.42 -31.08 71.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.997 -0.547 . . . . 10.0 111.394 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -77.43 -28.57 52.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.0 0.429 . . . . 10.0 111.367 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -85.06 -8.47 58.67 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.246 -0.434 . . . . 10.0 111.582 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 61.7 mt -53.99 -43.21 57.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 112.016 0.376 . . . . 10.0 112.016 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.14 -30.03 64.08 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.2 0.444 . . . . 10.0 112.2 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -89.79 -41.75 11.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.783 0.325 . . . . 10.0 110.539 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 72.1 mt -62.93 -48.4 88.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.938 -0.574 . . . . 10.0 111.054 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -63.59 -34.04 76.93 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.008 -0.542 . . . . 10.0 110.563 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -69.17 -41.09 77.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.637 -0.71 . . . . 10.0 109.855 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.65 -37.94 83.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.727 -0.67 . . . . 10.0 110.224 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 92.6 t -60.33 -42.01 89.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 121.228 0.537 . . . . 10.0 109.96 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.8 mtm105 -71.44 -37.12 71.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.606 -0.725 . . . . 10.0 110.786 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 30.3 mttp -65.67 -42.77 90.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.422 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 72.5 mt . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.041 -0.527 . . . . 10.0 110.74 179.488 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.191 0 CA-C-O 121.27 0.557 . . . . 10.0 110.599 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 82.6 mmm -92.49 96.55 10.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.83 -0.623 . . . . 10.0 109.759 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -79.62 113.59 17.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.207 -0.451 . . . . 10.0 110.805 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -98.22 128.11 44.51 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.851 -0.426 . . . . 10.0 109.851 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 20.5 pt -116.8 16.0 7.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.671 0.272 . . . . 10.0 111.706 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 158.11 -161.54 31.64 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.155 -1.021 . . . . 10.0 112.726 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 5.2 mtmp? -67.56 103.86 1.45 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.448 -0.376 . . . . 10.0 111.841 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' MET . . . . . . . . . . . . . 67.4 mmm 64.86 6.47 3.37 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.246 0.832 . . . . 10.0 113.246 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -100.39 121.49 41.6 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 121.783 -0.573 . . . . 10.0 110.696 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -122.67 149.25 44.29 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.706 -0.679 . . . . 10.0 110.45 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 96.0 t -98.61 103.08 14.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.257 -0.645 . . . . 10.0 109.257 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 10.2 t -88.39 88.11 7.51 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.819 -0.628 . . . . 10.0 111.18 -178.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 3.2 t -84.66 92.35 3.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.694 -0.854 . . . . 10.0 108.694 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 23.4 ptt-85 -126.28 147.93 49.61 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.272 0.558 . . . . 10.0 111.474 -178.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -79.89 115.62 19.58 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.286 -0.87 . . . . 10.0 110.436 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -86.72 61.68 6.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.176 -0.466 . . . . 10.0 110.889 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 30.0 mttm 62.53 58.6 1.64 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.85 -0.614 . . . . 10.0 111.051 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.56 21.29 37.79 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.839 -0.696 . . . . 10.0 111.682 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 62.2 mmtt -145.04 89.49 1.96 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.569 0.223 . . . . 10.0 110.531 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 20.2 t -66.44 105.67 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.636 -0.505 . . . . 10.0 109.636 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 79.7 mt -115.42 142.04 47.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.344 0.592 . . . . 10.0 111.456 -178.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 82' ' ' ILE . . . . . . . . . . . . . 5.3 mp -92.07 88.87 2.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.516 -0.92 . . . . 10.0 108.516 178.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -87.97 94.64 9.85 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.876 -0.602 . . . . 10.0 110.833 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 26.8 mt -81.65 95.25 2.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.255 -1.016 . . . . 10.0 108.255 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 17.4 ttm-85 -123.6 145.71 48.71 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.862 -0.608 . . . . 10.0 111.724 -177.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -76.06 128.39 34.9 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.531 -0.759 . . . . 10.0 109.109 178.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 87' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -98.96 101.38 12.75 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.072 0.463 . . . . 10.0 110.464 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 88' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -84.75 -176.55 6.27 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.561 -0.745 . . . . 10.0 109.789 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 41.6 ttm -133.43 135.11 44.39 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 110.014 -0.365 . . . . 10.0 110.014 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 90' ' ' ASP . . . . . . . . . . . . . 29.0 p30 -92.19 171.77 7.24 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 109.899 -0.408 . . . . 10.0 109.899 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -61.9 -18.9 63.66 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.448 2.098 . . . . 10.0 112.704 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -77.03 -40.6 45.85 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.225 0.535 . . . . 10.0 110.275 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 120.67 21.04 3.36 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.95 -0.643 . . . . 10.0 112.245 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -100.88 147.32 26.25 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.774 0.321 . . . . 10.0 110.7 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 95' ' ' MET . . . . . . . . . . . . . 82.9 mmm -88.54 96.18 10.52 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.321 -0.622 . . . . 10.0 109.321 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -94.52 128.87 38.42 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.887 -0.597 . . . . 10.0 111.631 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -66.16 128.33 19.33 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.578 2.185 . . . . 10.0 111.339 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . -74.11 -176.32 34.51 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 121.046 -0.597 . . . . 10.0 113.294 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 14.5 mmt180 -87.89 -32.88 18.74 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.959 0.409 . . . . 10.0 110.201 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 4.3 mtmp? -77.87 99.1 5.84 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.458 -0.792 . . . . 10.0 110.551 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -178.44 159.79 25.35 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 110.667 -0.973 . . . . 10.0 110.667 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 18.4 tt -131.12 142.41 43.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 117.196 0.498 . . . . 10.0 111.579 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.5 105.3 15.82 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.831 -0.622 . . . . 10.0 109.776 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 96.1 mt -93.33 142.27 27.51 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.792 0.329 . . . . 10.0 111.376 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 41.4 p-10 -93.01 164.71 20.61 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 108.633 -0.877 . . . . 10.0 108.633 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.93 -30.73 31.52 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.489 2.126 . . . . 10.0 112.669 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -66.71 -59.27 3.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.921 -0.581 . . . . 10.0 110.861 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -67.08 -29.83 69.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.488 -0.324 . . . . 10.0 110.639 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 109' ' ' TRP . . . . . . . . . . . . . 31.0 t-105 -60.56 -42.25 96.21 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.63 -0.507 . . . . 10.0 109.63 178.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 9.7 t -67.81 -45.4 74.83 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.505 -0.554 . . . . 10.0 109.505 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -57.97 -40.65 81.14 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.015 -0.539 . . . . 10.0 110.54 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 33.1 tp -59.64 -47.19 86.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.92 -0.582 . . . . 10.0 110.665 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -62.95 -34.63 77.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.101 0.477 . . . . 10.0 110.666 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -74.17 -30.17 62.12 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.801 -0.636 . . . . 10.0 110.787 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -82.51 -10.49 58.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.435 . . . . 10.0 111.71 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 55.8 mt -55.2 -34.82 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 120.708 0.29 . . . . 10.0 111.15 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 1.5 m -60.66 -21.4 62.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.265 -0.425 . . . . 10.0 111.601 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -106.17 -42.42 5.08 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.616 0.246 . . . . 10.0 110.663 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 60.6 mt -61.64 -52.03 65.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.885 0.374 . . . . 10.0 110.924 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -62.35 -38.12 88.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.873 -0.603 . . . . 10.0 111.083 -179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -62.03 -37.67 85.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.705 -0.679 . . . . 10.0 111.23 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.32 -20.4 57.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.266 -0.425 . . . . 10.0 111.864 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 78.1 t -58.21 -36.39 57.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.891 0.377 . . . . 10.0 111.416 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 6.6 ptp85 -102.68 14.4 32.04 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.359 -0.382 . . . . 10.0 111.141 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 98.8 mttt . . . . . 0 C--N 1.326 -0.447 0 CA-C-O 121.017 0.437 . . . . 10.0 110.206 179.961 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 120.943 0.401 . . . . 10.0 110.224 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 50.8 ttm -144.81 118.22 9.06 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.283 -0.417 . . . . 10.0 110.646 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -95.37 171.15 8.88 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.21 -0.45 . . . . 10.0 110.162 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -131.99 134.39 45.53 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.199 -0.297 . . . . 10.0 110.199 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 11.6 pt -122.08 12.19 5.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.106 0.479 . . . . 10.0 110.569 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 156.0 174.54 25.93 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.814 -0.708 . . . . 10.0 111.945 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -57.24 116.62 3.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.622 0.249 . . . . 10.0 111.376 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 2.5 mmt 69.46 11.7 8.09 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.356 -0.838 . . . . 10.0 112.45 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -111.71 104.13 12.46 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.415 -0.587 . . . . 10.0 109.415 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -120.43 145.72 46.93 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.355 0.597 . . . . 10.0 112.406 -178.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 36.6 t -99.16 105.99 18.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.001 -1.0 . . . . 10.0 108.92 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.6 m -88.39 113.4 23.96 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.885 0.374 . . . . 10.0 111.099 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 38.2 t -106.18 92.89 2.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.066 -0.515 . . . . 10.0 109.846 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -123.63 -171.15 2.26 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.086 -0.506 . . . . 10.0 109.985 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -102.51 160.17 14.79 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.626 0.251 . . . . 10.0 110.343 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -119.07 45.63 2.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.049 0.452 . . . . 10.0 110.522 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 11.2 mptt 55.65 41.5 30.45 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.274 0.559 . . . . 10.0 110.673 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 136.15 -42.41 1.33 Allowed Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 111.057 -0.817 . . . . 10.0 111.057 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -100.83 -167.36 1.42 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.703 -0.48 . . . . 10.0 109.703 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.0 m -105.72 142.53 18.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.738 0.304 . . . . 10.0 110.663 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.53 78.94 1.31 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.105 -0.498 . . . . 10.0 109.894 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 27.6 mt -101.46 88.27 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.062 -0.718 . . . . 10.0 109.062 178.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -113.28 135.9 53.34 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.347 0.594 . . . . 10.0 111.458 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 45.7 mt -108.19 96.07 4.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 108.407 -0.96 . . . . 10.0 108.407 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 -118.47 154.82 31.86 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.951 -0.568 . . . . 10.0 111.433 -178.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -73.98 124.37 26.09 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.728 -0.842 . . . . 10.0 108.728 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -103.99 121.54 43.37 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.931 0.396 . . . . 10.0 110.759 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -108.25 137.5 46.12 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.912 -0.585 . . . . 10.0 109.926 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 6.5 ttt -74.94 126.92 32.02 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.301 -0.409 . . . . 10.0 110.202 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 44.8 p30 -87.83 171.56 9.38 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 116.154 -0.476 . . . . 10.0 110.605 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -57.78 -24.95 66.38 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.855 2.37 . . . . 10.0 113.393 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -76.24 -30.87 58.07 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.961 0.41 . . . . 10.0 110.54 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 112.37 22.04 5.97 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.83 -0.7 . . . . 10.0 112.151 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -110.22 164.4 12.69 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.95 0.405 . . . . 10.0 110.369 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 94.2 mmm -96.9 114.23 25.84 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.062 -0.517 . . . . 10.0 109.809 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 13.7 mmtp -113.81 131.69 22.97 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.226 -0.443 . . . . 10.0 110.493 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.06 133.84 34.73 Favored 'Trans proline' 0 C--O 1.233 0.264 0 C-N-CA 122.554 2.169 . . . . 10.0 112.408 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -81.81 -128.38 1.03 Allowed Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.984 -0.627 . . . . 10.0 113.202 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -110.07 -34.28 6.44 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.648 0.261 . . . . 10.0 111.556 -178.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.1 mtmt -86.87 117.07 25.36 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.188 0.518 . . . . 10.0 111.741 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -166.8 155.17 26.15 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.716 -0.953 . . . . 10.0 110.716 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 7.9 tp -134.82 130.6 52.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 117.494 0.647 . . . . 10.0 111.9 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.8 m -92.26 116.01 28.59 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.146 -0.934 . . . . 10.0 109.661 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 82.3 mt -109.56 113.05 25.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.032 0.444 . . . . 10.0 110.958 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -81.99 169.3 19.04 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.989 -0.55 . . . . 10.0 110.091 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -44.41 -47.88 10.54 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 123.064 2.509 . . . . 10.0 113.855 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.0 tp10 -67.35 -50.94 57.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.488 0.185 . . . . 10.0 110.767 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -55.53 -46.65 77.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.316 -0.402 . . . . 10.0 111.193 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 56.0 t-105 -62.25 -42.87 99.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.908 0.385 . . . . 10.0 110.586 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 50.0 m -64.3 -46.71 82.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 10.0 110.757 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -65.6 -37.74 87.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.478 -0.328 . . . . 10.0 110.557 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.6 tp -57.72 -43.42 85.27 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.279 -0.418 . . . . 10.0 110.81 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -62.23 -36.98 83.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.293 -0.412 . . . . 10.0 110.89 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -81.77 -17.07 48.97 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.106 0.479 . . . . 10.0 111.044 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -85.53 -18.67 32.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.197 -0.456 . . . . 10.0 110.283 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 86.0 mt -54.12 -40.39 46.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.133 -0.485 . . . . 10.0 111.311 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.28 -25.04 61.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 10.0 111.758 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.42 -35.52 9.54 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.872 0.368 . . . . 10.0 110.763 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 83.9 mt -64.75 -47.59 88.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.922 -0.581 . . . . 10.0 110.86 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.14 -32.33 73.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 10.0 110.813 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -64.48 -41.4 96.49 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.815 -0.629 . . . . 10.0 110.124 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.96 -35.66 80.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.997 -0.547 . . . . 10.0 110.32 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 88.4 t -62.91 -37.85 80.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.943 -0.571 . . . . 10.0 110.215 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 16.5 mtm105 -75.2 -25.28 58.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.977 -0.556 . . . . 10.0 111.012 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -78.53 -20.14 51.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.331 -0.395 . . . . 10.0 111.352 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 12.6 mt . . . . . 0 C--N 1.321 -0.659 0 CA-C-N 116.586 -0.279 . . . . 10.0 110.437 179.971 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.094 0 CA-C-O 121.181 0.515 . . . . 10.0 110.683 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 59.1 mtm -103.3 128.3 50.39 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.903 -0.589 . . . . 10.0 109.874 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -114.21 128.12 56.21 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.156 -0.474 . . . . 10.0 110.161 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -79.68 134.09 36.4 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.093 0.473 . . . . 10.0 111.316 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 6.4 pt -112.42 -26.08 3.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.707 -0.679 . . . . 10.0 110.398 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -167.84 -174.53 36.86 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.771 -0.932 . . . . 10.0 110.771 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 14.8 mttp -70.8 127.64 33.33 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.069 0.462 . . . . 10.0 111.057 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' MET . . . . . . . . . . . . . 39.2 mmm 64.26 25.88 13.63 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.057 -0.974 . . . . 10.0 111.703 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -140.11 115.25 9.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.484 -0.325 . . . . 10.0 110.233 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -126.61 133.15 51.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.045 -0.525 . . . . 10.0 110.758 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 86.6 t -88.75 115.21 28.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.048 -0.523 . . . . 10.0 109.611 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 8.1 m -90.68 101.25 14.0 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.946 0.403 . . . . 10.0 111.076 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 8.9 t -97.58 99.34 8.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.168 -0.469 . . . . 10.0 110.003 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -160.03 166.43 29.97 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.258 -0.428 . . . . 10.0 110.211 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.87 145.32 26.62 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.203 0.525 . . . . 10.0 110.333 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -126.98 100.71 6.25 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 109.132 -0.692 . . . . 10.0 109.132 178.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 66.6 mttm 67.33 33.78 5.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.402 -0.817 . . . . 10.0 111.009 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 96.39 -9.94 67.13 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.734 -0.745 . . . . 10.0 112.971 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 32.2 mmtt -109.25 113.71 26.78 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.66 0.23 . . . . 10.0 110.919 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 14.3 t -64.33 117.76 5.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.612 -0.514 . . . . 10.0 109.612 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 97.8 mt -125.73 129.3 49.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.174 0.511 . . . . 10.0 111.699 -178.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 82' ' ' ILE . . . . . . . . . . . . . 5.2 mp -93.25 95.82 5.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 108.08 -1.081 . . . . 10.0 108.08 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -85.73 107.31 17.54 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.939 -0.573 . . . . 10.0 111.991 -177.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 12.0 mt -99.23 83.91 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.071 -1.085 . . . . 10.0 108.071 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 6.1 ttm180 -123.89 162.75 22.67 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.711 -0.677 . . . . 10.0 111.089 -177.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -70.19 153.06 43.56 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.48 -0.933 . . . . 10.0 108.48 177.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 87' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -140.46 111.16 6.85 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.184 0.516 . . . . 10.0 110.783 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 88' ' ' TRP . . . . . . . . . . . . . 20.6 m0 -108.64 -170.81 1.73 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.513 -0.767 . . . . 10.0 109.356 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 33.3 ttm -127.82 142.66 51.23 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 110.146 -0.316 . . . . 10.0 110.146 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 90' ' ' ASP . . . . . . . . . . . . . 36.9 p30 -99.83 169.94 7.4 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 116.17 -0.468 . . . . 10.0 110.522 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -59.93 -20.58 60.68 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.713 2.276 . . . . 10.0 112.362 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -73.76 -43.34 59.28 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.994 0.426 . . . . 10.0 110.007 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 118.79 26.54 2.53 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.955 -0.64 . . . . 10.0 112.244 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -113.33 152.22 30.2 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.841 0.353 . . . . 10.0 110.625 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 95' ' ' MET . . . . . . . . . . . . . 95.6 mmm -82.78 105.15 13.56 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.073 -0.714 . . . . 10.0 109.073 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -103.37 145.93 31.51 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.765 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.02 146.94 94.82 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.576 2.184 . . . . 10.0 111.849 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . -73.89 -140.72 0.56 Allowed Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.728 -0.669 . . . . 10.0 112.617 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 2.4 mtp-105 -102.64 -32.76 9.73 Favored 'General case' 0 C--N 1.32 -0.714 0 O-C-N 122.382 -0.481 . . . . 10.0 111.109 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -127.7 157.1 41.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.243 0.545 . . . . 10.0 111.396 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . 171.15 160.86 20.71 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 110.507 -1.037 . . . . 10.0 110.507 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 20.5 tt -133.1 140.8 46.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 117.95 0.875 . . . . 10.0 111.544 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -101.62 112.19 24.68 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.054 -0.521 . . . . 10.0 110.013 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 52.1 mt -97.72 134.86 40.32 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.822 0.344 . . . . 10.0 110.615 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -88.97 168.98 14.13 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 108.915 -0.772 . . . . 10.0 108.915 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -48.8 -38.73 38.28 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.608 2.205 . . . . 10.0 113.414 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -67.01 -54.7 19.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.63 -0.259 . . . . 10.0 111.172 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -61.74 -35.69 78.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.442 -0.345 . . . . 10.0 110.509 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 109' ' ' TRP . . . . . . . . . . . . . 65.7 t-105 -61.87 -41.23 97.6 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.106 -0.497 . . . . 10.0 109.699 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 25.3 t -63.62 -46.61 84.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.489 . . . . 10.0 109.719 178.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -58.37 -40.17 81.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.881 -0.6 . . . . 10.0 110.815 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 53.5 tp -60.94 -41.4 96.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 10.0 110.461 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -68.85 -36.09 77.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.15 0.5 . . . . 10.0 110.737 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -73.79 -25.15 59.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.828 -0.624 . . . . 10.0 111.332 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -86.78 -4.89 59.23 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.302 -0.408 . . . . 10.0 111.397 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 61.7 mt -57.27 -41.38 78.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 120.778 0.323 . . . . 10.0 110.881 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 5.7 m -64.83 -11.95 42.85 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.146 -0.479 . . . . 10.0 112.21 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.25 -47.21 3.57 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.83 0.348 . . . . 10.0 110.447 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 61.9 mt -66.35 -45.95 88.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.102 -0.499 . . . . 10.0 111.817 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -62.13 -36.23 81.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.728 0.299 . . . . 10.0 111.236 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -67.87 -34.89 77.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.983 0.421 . . . . 10.0 110.26 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.48 -37.53 80.22 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.718 -0.475 . . . . 10.0 109.718 178.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 83.9 t -64.81 -42.36 94.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.896 -0.593 . . . . 10.0 110.58 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -75.65 -5.9 47.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.795 0.331 . . . . 10.0 110.91 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 43.2 mttp . . . . . 0 C--N 1.327 -0.389 0 CA-C-N 116.377 -0.374 . . . . 10.0 110.572 179.614 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 120.563 0.22 . . . . 10.0 110.516 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 29.6 mtm -142.97 130.45 21.17 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.965 -0.383 . . . . 10.0 109.965 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -122.15 147.33 46.29 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.13 -0.486 . . . . 10.0 109.97 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -98.07 116.76 30.95 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.408 -0.36 . . . . 10.0 110.43 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 24.6 pt -105.06 10.28 9.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.12 0.486 . . . . 10.0 110.776 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 164.29 173.59 33.12 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.78 -0.724 . . . . 10.0 111.645 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 44.8 tttp -62.28 120.69 11.47 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.47 0.176 . . . . 10.0 110.765 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 24.8 mmt 64.07 28.26 14.22 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 123.732 0.645 . . . . 10.0 111.888 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -131.08 112.26 12.73 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.967 -0.382 . . . . 10.0 109.967 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -120.0 140.98 50.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.095 0.474 . . . . 10.0 111.444 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.2 t -94.58 110.55 23.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.779 -0.646 . . . . 10.0 109.448 178.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.39 83.38 6.23 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.992 -0.549 . . . . 10.0 110.697 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.0 t -89.7 86.15 2.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.914 -0.773 . . . . 10.0 108.914 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -151.35 172.21 16.27 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.701 -0.681 . . . . 10.0 110.597 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -106.01 138.0 42.95 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.808 -0.633 . . . . 10.0 109.814 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -126.4 95.48 4.38 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.396 -0.365 . . . . 10.0 110.318 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.3 36.86 25.91 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.667 -0.697 . . . . 10.0 111.892 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 103.05 -17.64 51.67 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.516 -0.85 . . . . 10.0 112.18 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -89.18 94.93 10.1 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.994 0.426 . . . . 10.0 110.293 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.1 t -100.71 93.63 3.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.878 -0.601 . . . . 10.0 109.684 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.94 157.12 42.51 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.096 -0.502 . . . . 10.0 110.949 -179.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 5.3 mp -81.42 90.32 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.573 -0.899 . . . . 10.0 108.573 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -82.17 102.41 11.08 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.831 -0.622 . . . . 10.0 111.955 -177.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.3 mt -84.51 109.41 17.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 107.727 -1.212 . . . . 10.0 107.727 178.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 10.9 ttm-85 -128.98 149.15 50.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.446 0.641 . . . . 10.0 112.544 -177.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -91.62 149.92 21.42 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.504 -0.924 . . . . 10.0 108.504 178.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -120.26 152.37 37.86 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.051 0.453 . . . . 10.0 111.539 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 12.6 t90 -145.03 154.33 42.41 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.926 -0.768 . . . . 10.0 108.926 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.4 ttm -88.03 134.74 33.67 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.909 0.385 . . . . 10.0 110.76 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 51.2 p-10 -85.68 175.52 4.44 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.787 -0.642 . . . . 10.0 110.534 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -61.72 -17.81 56.89 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.568 2.178 . . . . 10.0 112.911 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.79 -41.71 20.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.826 0.346 . . . . 10.0 110.773 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 122.52 18.48 3.32 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.834 -0.698 . . . . 10.0 111.994 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -104.14 163.49 12.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.927 0.394 . . . . 10.0 110.882 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 78.5 mmm -88.06 111.33 21.43 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.916 -0.583 . . . . 10.0 109.479 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.7 mmmt -109.03 129.97 23.28 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.804 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.43 133.63 19.4 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.234 1.956 . . . . 10.0 111.513 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.7 160.15 37.78 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.916 -0.659 . . . . 10.0 112.12 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -77.87 -7.91 57.35 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.161 0.505 . . . . 10.0 110.397 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -104.19 127.49 51.8 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.647 -0.706 . . . . 10.0 109.828 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -166.5 -173.53 34.96 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 111.206 -0.757 . . . . 10.0 111.206 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.9 tp -152.51 113.23 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.208 0.528 . . . . 10.0 110.582 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -92.5 90.61 7.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.165 -0.47 . . . . 10.0 111.36 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.8 mp -65.97 131.25 45.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.559 -0.291 . . . . 10.0 111.011 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -78.98 166.47 41.97 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 110.396 -0.224 . . . . 10.0 110.396 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -47.45 -41.15 29.4 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.222 2.615 . . . . 10.0 114.004 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -69.51 -45.14 69.58 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.828 -0.349 . . . . 10.0 110.838 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -57.97 -39.83 79.12 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.964 0.411 . . . . 10.0 110.17 178.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 66.2 t-105 -59.09 -44.4 91.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.782 -0.644 . . . . 10.0 110.564 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.8 t -67.36 -48.28 67.92 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.025 -0.534 . . . . 10.0 110.486 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -60.06 -38.8 83.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.94 -0.573 . . . . 10.0 111.08 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 27.9 tp -60.98 -49.53 77.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.465 -0.334 . . . . 10.0 110.594 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -60.54 -38.49 84.64 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.301 -0.409 . . . . 10.0 111.192 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -71.99 -26.5 62.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.962 -0.563 . . . . 10.0 111.831 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -93.42 -9.45 38.56 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.671 0.249 . . . . 10.0 111.671 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 16.4 mt -51.55 -44.05 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 112.224 0.453 . . . . 10.0 112.224 -179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.3 m -60.46 -34.55 74.16 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.871 0.367 . . . . 10.0 111.773 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.08 -41.04 21.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.953 0.406 . . . . 10.0 110.325 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 82.3 mt -65.38 -48.62 82.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.805 -0.634 . . . . 10.0 111.224 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -59.42 -37.69 78.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.098 -0.501 . . . . 10.0 110.774 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.66 -39.3 94.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.019 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.89 -33.78 76.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.927 -0.579 . . . . 10.0 110.613 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 63.1 t -64.36 -37.52 80.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.235 0.54 . . . . 10.0 109.855 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 19.9 mtm105 -78.84 -27.18 44.16 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.565 -0.743 . . . . 10.0 110.509 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -69.6 -36.07 75.86 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.99 -0.55 . . . . 10.0 110.566 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 47.2 mt . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 115.855 -0.612 . . . . 10.0 111.322 -179.49 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.219 0 CA-C-O 121.082 0.468 . . . . 10.0 110.665 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 5.6 mmm -97.99 95.92 7.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.773 -0.649 . . . . 10.0 109.708 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -90.83 126.28 35.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.067 -0.515 . . . . 10.0 111.166 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -87.73 103.74 15.9 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.199 -0.455 . . . . 10.0 109.823 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 5.6 pt -100.39 5.2 10.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.304 0.573 . . . . 10.0 110.351 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 179.43 158.88 22.49 Favored Glycine 0 N--CA 1.438 -1.179 0 N-CA-C 110.988 -0.845 . . . . 10.0 110.988 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 29.9 mttp -64.26 114.95 4.58 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.761 -0.459 . . . . 10.0 109.761 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' MET . . . . . . . . . . . . . 70.3 mmm 78.91 3.97 2.42 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.313 -0.858 . . . . 10.0 111.128 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -115.57 124.59 51.4 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.722 -0.473 . . . . 10.0 109.722 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -131.12 145.32 51.94 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.228 0.537 . . . . 10.0 111.558 -178.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.99 96.03 4.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 108.399 -0.963 . . . . 10.0 108.399 177.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.71 96.65 10.51 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.028 -0.533 . . . . 10.0 110.8 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 28.4 t -84.66 115.01 25.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.369 -0.604 . . . . 10.0 109.369 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.64 161.45 42.58 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.983 0.42 . . . . 10.0 111.02 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -85.55 118.63 25.18 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.467 -0.788 . . . . 10.0 110.097 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -109.05 89.15 2.91 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.496 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 61.4 mttm 60.8 44.86 10.51 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.525 -0.762 . . . . 10.0 112.185 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.42 38.24 12.94 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.601 -0.809 . . . . 10.0 111.527 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -151.53 106.44 3.27 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 122.733 0.413 . . . . 10.0 110.138 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 24.4 t -73.2 99.06 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 108.563 -0.903 . . . . 10.0 108.563 178.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 96.2 mt -105.82 132.08 52.37 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.511 0.672 . . . . 10.0 112.599 -177.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 82' ' ' ILE . . . . . . . . . . . . . 4.8 mp -93.35 94.09 4.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 107.322 -1.362 . . . . 10.0 107.322 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -89.0 106.06 18.19 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.962 -0.563 . . . . 10.0 112.223 -177.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 37.7 mt -93.39 99.29 9.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 107.84 -1.17 . . . . 10.0 107.84 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 20.2 ttm-85 -140.97 165.63 27.01 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.223 0.535 . . . . 10.0 112.112 -177.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.11 144.13 25.76 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.51 -0.922 . . . . 10.0 108.51 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 87' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -125.92 125.93 43.57 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.289 0.566 . . . . 10.0 111.047 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 88' ' ' TRP . . . . . . . . . . . . . 66.2 t90 -104.85 136.25 44.7 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.404 -0.817 . . . . 10.0 110.105 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 50.3 ttm -78.97 115.95 18.97 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.034 0.445 . . . . 10.0 110.745 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 90' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.69 161.97 59.53 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.659 -0.7 . . . . 10.0 110.356 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -53.23 -27.03 36.26 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.191 2.594 . . . . 10.0 113.993 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.7 -17.26 59.21 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 122.235 -0.29 . . . . 10.0 110.776 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 103.65 11.6 32.56 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.936 -0.65 . . . . 10.0 113.712 178.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -103.38 156.76 17.5 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 117.062 0.431 . . . . 10.0 110.696 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 95' ' ' MET . . . . . . . . . . . . . 87.7 mmm -94.25 103.0 15.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.252 -0.431 . . . . 10.0 110.024 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt -93.28 147.29 33.47 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.082 -0.508 . . . . 10.0 110.47 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.13 145.57 98.17 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 122.29 1.994 . . . . 10.0 111.789 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . -75.94 -112.78 0.12 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.871 -0.68 . . . . 10.0 112.849 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 71.7 mtp85 -138.51 -22.06 1.01 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.968 0.413 . . . . 10.0 110.934 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 39.2 mttt -100.4 -146.22 0.34 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.993 -0.548 . . . . 10.0 109.915 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.72 153.95 30.6 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.612 -0.804 . . . . 10.0 112.751 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 15.4 tt -145.99 134.31 16.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.951 0.405 . . . . 10.0 110.545 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 4.0 m -92.25 116.14 28.7 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.062 -0.517 . . . . 10.0 109.701 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 96.0 mt -111.67 138.24 48.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.208 -0.451 . . . . 10.0 110.411 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 33.3 p30 -88.93 170.43 11.03 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.39 -0.596 . . . . 10.0 109.39 179.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -51.47 -35.06 53.96 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.527 2.151 . . . . 10.0 113.121 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -62.89 -53.85 47.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.305 -0.407 . . . . 10.0 110.342 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -67.41 -34.9 78.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.058 -0.519 . . . . 10.0 110.206 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 109' ' ' TRP . . . . . . . . . . . . . 35.1 t-105 -61.12 -45.52 94.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.898 -0.592 . . . . 10.0 109.955 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 13.3 t -64.03 -43.87 94.27 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.697 -0.482 . . . . 10.0 109.697 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -61.16 -39.57 90.59 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 116.061 -0.518 . . . . 10.0 110.744 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 34.5 tp -60.2 -43.3 96.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.876 0.369 . . . . 10.0 110.204 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -66.49 -39.85 88.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.035 -0.53 . . . . 10.0 110.567 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -74.42 -16.25 60.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.822 -0.626 . . . . 10.0 111.372 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -90.12 -4.63 57.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.52 -0.309 . . . . 10.0 111.193 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 75.3 mt -58.78 -35.42 55.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.69 0.281 . . . . 10.0 110.722 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.25 -12.25 39.33 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.27 -0.423 . . . . 10.0 111.725 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -111.9 -49.65 2.97 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.884 0.373 . . . . 10.0 110.606 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 43.4 mt -65.42 -53.44 39.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 10.0 111.568 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -62.54 -31.28 72.04 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.799 0.333 . . . . 10.0 110.627 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -62.03 -47.4 84.89 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.927 -0.579 . . . . 10.0 110.19 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.81 -39.16 80.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.026 -0.534 . . . . 10.0 110.529 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 53.3 t -64.47 -37.23 79.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.818 -0.628 . . . . 10.0 111.207 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 8.7 ptp85 -81.77 -6.57 59.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.851 0.358 . . . . 10.0 110.999 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 74.5 mttt . . . . . 0 C--N 1.327 -0.405 0 CA-C-O 121.049 0.452 . . . . 10.0 110.435 179.289 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.861 0 CA-C-O 120.854 0.359 . . . . 10.0 110.123 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 54.2 ttm -115.73 117.65 30.84 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.16 -0.473 . . . . 10.0 110.584 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -107.47 179.28 4.29 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.911 -0.586 . . . . 10.0 109.51 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -135.32 138.29 43.27 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 121.006 -0.278 . . . . 10.0 110.923 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.6 pt -117.56 -9.77 11.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.16 -0.473 . . . . 10.0 111.23 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 176.11 -178.92 47.46 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.482 -0.866 . . . . 10.0 112.336 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 43.3 tttp -58.03 118.15 5.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.688 0.28 . . . . 10.0 111.043 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 66.8 mmm 67.28 8.03 5.93 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.442 -0.799 . . . . 10.0 112.165 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -113.35 113.02 24.66 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 120.917 0.389 . . . . 10.0 110.078 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -121.17 163.85 17.81 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.894 -0.593 . . . . 10.0 110.879 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.3 t -121.28 102.45 12.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.369 -0.832 . . . . 10.0 108.999 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.1 m -97.65 98.92 10.29 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.094 0.405 . . . . 10.0 112.094 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 19.5 t -81.54 82.38 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 108.209 -1.034 . . . . 10.0 108.209 177.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -115.97 167.5 10.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.876 -0.602 . . . . 10.0 111.496 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.93 141.2 47.03 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.734 -0.666 . . . . 10.0 110.17 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -126.4 101.84 6.88 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.03 -0.532 . . . . 10.0 111.171 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 78.0 mttt 61.32 34.07 18.67 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.004 -0.543 . . . . 10.0 112.018 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.94 18.54 43.27 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.554 -0.831 . . . . 10.0 111.762 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.0 mtpt -127.75 99.25 5.47 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.327 -0.249 . . . . 10.0 110.327 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 96.7 t -69.62 111.88 3.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.844 -0.428 . . . . 10.0 109.844 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 79.3 mt -122.97 119.17 29.61 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.22 -0.445 . . . . 10.0 110.663 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 75.6 mt -75.79 101.48 2.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 108.955 -0.757 . . . . 10.0 108.955 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -72.9 100.68 2.98 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.722 -0.672 . . . . 10.0 112.258 -178.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 34.8 mt -100.44 91.81 2.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 107.874 -1.158 . . . . 10.0 107.874 177.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.25 160.52 32.74 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.046 -0.525 . . . . 10.0 111.278 -177.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -78.39 147.81 33.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.252 0.548 . . . . 10.0 110.788 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -126.34 125.31 42.05 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.62 -0.718 . . . . 10.0 109.685 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -105.66 167.76 9.55 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.333 -0.394 . . . . 10.0 110.108 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 27.8 ttt -106.01 131.11 53.7 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.691 0.281 . . . . 10.0 110.339 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -87.11 171.16 10.43 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 116.013 -0.539 . . . . 10.0 110.314 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.64 -10.29 28.64 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.829 2.353 . . . . 10.0 113.257 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -85.08 -43.06 14.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.167 0.508 . . . . 10.0 109.801 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 126.98 19.18 2.01 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.614 -0.721 . . . . 10.0 112.223 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -105.94 178.41 4.57 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.985 0.421 . . . . 10.0 110.981 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 18.7 ttm -105.43 112.43 25.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.757 -0.656 . . . . 10.0 110.005 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.3 mmpp? -102.02 123.11 44.73 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.187 -0.46 . . . . 10.0 111.62 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -80.42 128.19 6.93 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.614 2.209 . . . . 10.0 111.824 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -68.17 156.58 52.89 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.68 -0.772 . . . . 10.0 111.636 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.15 -38.43 83.13 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.03 0.443 . . . . 10.0 110.415 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.0 96.67 3.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.608 -0.723 . . . . 10.0 110.385 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -164.97 136.19 4.08 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.772 -0.728 . . . . 10.0 111.922 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 19.0 tt -116.69 124.18 72.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.533 0.682 . . . . 10.0 110.707 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.3 m -102.35 110.95 23.04 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.618 -0.719 . . . . 10.0 109.818 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 79.4 mt -97.39 131.61 43.89 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.903 -0.589 . . . . 10.0 111.244 -178.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -84.06 167.14 29.52 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.828 -0.624 . . . . 10.0 109.601 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -43.14 -41.67 9.6 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.317 2.678 . . . . 10.0 113.71 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.36 -46.53 89.63 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.879 0.371 . . . . 10.0 110.781 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -69.91 -39.45 76.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.018 -0.537 . . . . 10.0 109.734 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 68.3 t-105 -56.99 -43.63 81.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.408 -0.815 . . . . 10.0 110.652 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.2 t -61.68 -52.41 64.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.306 -0.406 . . . . 10.0 109.925 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -58.5 -41.71 85.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.911 -0.586 . . . . 10.0 110.709 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 21.5 tp -55.47 -51.42 67.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.031 -0.531 . . . . 10.0 110.967 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -63.35 -38.34 90.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.311 -0.404 . . . . 10.0 111.441 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -67.49 -36.22 80.68 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.019 -0.537 . . . . 10.0 111.553 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -82.18 -17.56 45.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.647 -0.251 . . . . 10.0 111.33 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 18.7 mt -49.94 -37.05 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 111.991 0.367 . . . . 10.0 111.991 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.33 -35.68 72.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.42 -0.354 . . . . 10.0 111.414 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.3 -33.48 15.31 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.94 0.4 . . . . 10.0 110.501 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 91.8 mt -60.93 -47.61 92.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.002 -0.545 . . . . 10.0 110.462 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -62.9 -33.59 75.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.812 -0.631 . . . . 10.0 110.569 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -65.83 -33.18 75.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.806 -0.633 . . . . 10.0 110.026 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -70.54 -31.34 68.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.995 -0.548 . . . . 10.0 110.306 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 51.5 t -63.57 -39.02 83.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.999 -0.546 . . . . 10.0 109.789 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.6 ttm105 -70.42 -23.6 62.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.813 -0.63 . . . . 10.0 110.458 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 16.9 mttp -79.26 -23.53 43.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.823 -0.626 . . . . 10.0 110.557 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 C--N 1.323 -0.544 0 CA-C-N 116.208 -0.451 . . . . 10.0 111.422 -179.989 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.176 0 CA-C-O 121.047 0.451 . . . . 10.0 110.84 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 98.1 mmm -93.82 90.08 6.39 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.436 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -67.8 126.06 28.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.878 -0.601 . . . . 10.0 110.345 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -96.29 130.47 43.38 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.806 0.336 . . . . 10.0 110.768 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 21.8 pt -121.38 8.17 6.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.894 -0.593 . . . . 10.0 110.438 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 171.1 178.03 41.34 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.043 -0.823 . . . . 10.0 111.043 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 28.2 mtmm -67.74 106.13 2.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 117.04 0.42 . . . . 10.0 109.987 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' MET . . . . . . . . . . . . . 45.6 mtm 78.08 -0.59 2.63 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 124.093 0.87 . . . . 10.0 111.482 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? -99.12 122.17 41.97 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.771 -0.455 . . . . 10.0 109.771 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -128.84 168.32 16.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.342 0.592 . . . . 10.0 111.806 -178.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 58.4 t -107.27 102.67 14.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 108.103 -1.073 . . . . 10.0 108.103 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 1.4 t -84.94 88.05 7.4 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.493 0.553 . . . . 10.0 112.493 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 44.6 t -89.03 100.14 10.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 107.851 -1.166 . . . . 10.0 107.851 177.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 15.1 ptt-85 -131.91 162.7 30.02 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.195 0.522 . . . . 10.0 111.827 -177.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -95.51 108.49 20.73 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.514 -0.766 . . . . 10.0 109.135 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -93.13 84.63 4.87 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.459 -0.337 . . . . 10.0 110.56 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 72.6 mttt 59.51 45.42 13.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.613 -0.722 . . . . 10.0 111.759 179.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.0 5.37 70.82 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.804 -0.713 . . . . 10.0 112.377 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -118.47 101.88 8.49 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.135 -0.32 . . . . 10.0 110.135 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 12.9 t -65.31 115.29 3.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.654 -0.499 . . . . 10.0 109.654 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 78.9 mt -124.48 132.36 53.49 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.114 0.483 . . . . 10.0 111.602 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 82' ' ' ILE . . . . . . . . . . . . . 5.1 mp -94.88 91.14 2.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 107.647 -1.242 . . . . 10.0 107.647 177.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -89.3 103.19 15.84 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.388 -0.824 . . . . 10.0 111.74 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 60.2 mt -80.49 107.75 13.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 107.585 -1.265 . . . . 10.0 107.585 177.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 27.0 ttm-85 -152.85 154.07 34.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.02 0.438 . . . . 10.0 111.744 -176.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -93.74 150.06 20.71 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.047 -0.524 . . . . 10.0 109.781 178.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 87' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -119.54 127.54 53.11 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.195 -0.457 . . . . 10.0 110.43 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 88' ' ' TRP . . . . . . . . . . . . . 2.2 m0 -108.83 136.34 48.55 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.578 -0.527 . . . . 10.0 109.578 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 42.8 ttm -74.66 126.37 30.7 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.976 0.417 . . . . 10.0 110.341 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 90' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.0 171.62 6.38 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.804 -0.634 . . . . 10.0 110.976 -179.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -52.71 -32.1 53.67 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 123.163 2.575 . . . . 10.0 113.392 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.05 -28.95 65.86 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.944 0.402 . . . . 10.0 110.269 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 106.84 16.06 14.94 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.826 -0.702 . . . . 10.0 112.214 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -106.8 147.74 29.33 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.921 -0.4 . . . . 10.0 109.921 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 95' ' ' MET . . . . . . . . . . . . . 89.7 mmm -82.69 105.89 14.09 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.427 -0.583 . . . . 10.0 109.427 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -88.06 126.69 60.14 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.964 -0.562 . . . . 10.0 111.164 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -65.4 123.97 12.23 Favored 'Trans proline' 0 C--O 1.237 0.452 0 C-N-CA 122.584 2.189 . . . . 10.0 111.459 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . -60.45 164.45 15.48 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.818 -0.628 . . . . 10.0 113.537 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 52.4 mtm180 -77.11 -4.03 42.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.985 0.422 . . . . 10.0 111.005 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 38.1 mttm -114.64 115.07 26.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.171 -0.468 . . . . 10.0 110.722 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -175.93 174.41 46.89 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.681 -0.968 . . . . 10.0 110.681 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 16.3 tt -141.84 122.16 11.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.229 0.537 . . . . 10.0 111.354 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 1.2 m -93.07 102.67 15.0 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.879 -0.6 . . . . 10.0 110.173 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 95.2 mt -96.12 132.35 41.61 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.137 -0.483 . . . . 10.0 111.272 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -84.08 163.61 47.47 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 108.586 -0.894 . . . . 10.0 108.586 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -49.38 -32.83 27.39 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.734 2.289 . . . . 10.0 112.542 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -61.75 -57.94 9.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.762 -0.654 . . . . 10.0 111.059 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -74.05 -28.47 61.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.807 0.337 . . . . 10.0 110.619 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 109' ' ' TRP . . . . . . . . . . . . . 28.8 t-105 -60.26 -43.16 96.39 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.506 -0.553 . . . . 10.0 109.506 178.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 37.3 t -63.51 -44.96 92.77 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.505 -0.554 . . . . 10.0 109.505 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -58.36 -40.04 81.18 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.68 -0.691 . . . . 10.0 110.613 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 20.8 tp -59.93 -45.31 93.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 10.0 110.191 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -63.86 -33.6 76.06 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.853 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -74.36 -45.61 45.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.998 -0.546 . . . . 10.0 110.648 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -62.93 -18.25 62.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.589 -0.732 . . . . 10.0 112.181 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 67.8 mt -53.38 -38.25 31.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.778 0.323 . . . . 10.0 110.605 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.19 -28.86 67.03 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.815 -0.63 . . . . 10.0 111.826 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -98.96 -40.13 8.22 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.715 0.293 . . . . 10.0 111.412 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 83.0 mt -62.79 -48.2 89.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 10.0 110.69 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -63.01 -31.46 72.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.225 0.536 . . . . 10.0 110.377 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -63.96 -36.59 84.47 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.436 -0.802 . . . . 10.0 110.048 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -77.52 -40.53 42.38 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.853 -0.612 . . . . 10.0 110.821 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 94.1 t -61.48 -43.14 96.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.069 -0.514 . . . . 10.0 111.52 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -70.55 -10.77 60.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.684 0.278 . . . . 10.0 111.602 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 85.1 mttt . . . . . 0 C--N 1.326 -0.414 0 CA-C-O 120.751 0.31 . . . . 10.0 110.933 179.963 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.889 0 CA-C-O 120.681 0.276 . . . . 10.0 110.506 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 24.0 mmt -123.23 92.78 3.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.239 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -96.34 121.09 37.75 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.734 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -87.13 120.11 28.06 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.796 0.332 . . . . 10.0 110.174 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.3 pt -110.23 0.13 9.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.064 0.459 . . . . 10.0 111.063 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 170.19 -178.64 42.86 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.583 -0.818 . . . . 10.0 111.964 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -65.9 114.25 4.98 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.457 0.17 . . . . 10.0 110.92 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 71.5 mmm 69.15 18.78 8.15 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 123.917 0.761 . . . . 10.0 111.663 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -121.83 112.6 18.55 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.934 -0.395 . . . . 10.0 109.934 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -124.91 144.08 50.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.392 0.615 . . . . 10.0 111.671 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 48.0 t -104.0 107.22 21.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.177 -0.92 . . . . 10.0 109.037 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.5 p -102.5 92.48 4.68 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.168 0.508 . . . . 10.0 112.059 -178.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 16.9 t -83.47 100.54 7.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.085 -0.507 . . . . 10.0 110.003 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.65 156.72 38.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.393 -0.367 . . . . 10.0 110.363 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -83.49 136.07 34.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.145 -0.479 . . . . 10.0 110.86 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -135.24 98.73 4.05 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.075 -0.511 . . . . 10.0 110.672 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 84.3 mttt 59.91 42.3 16.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.632 -0.713 . . . . 10.0 111.004 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.32 51.82 3.99 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.634 -0.793 . . . . 10.0 111.556 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.02 89.81 2.43 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.058 -0.349 . . . . 10.0 110.058 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.3 t -95.49 91.55 2.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.641 -0.503 . . . . 10.0 109.641 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -157.14 174.06 16.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.9 -0.591 . . . . 10.0 111.181 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 69.7 mt -88.65 88.87 3.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.267 -0.642 . . . . 10.0 109.267 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -84.39 117.59 23.72 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.86 -0.609 . . . . 10.0 111.806 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 58.4 mt -103.93 137.54 32.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.97 -0.559 . . . . 10.0 109.642 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 10.4 ttm180 -144.92 146.41 31.98 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.711 -0.477 . . . . 10.0 109.711 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -78.59 93.74 4.89 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.402 -0.592 . . . . 10.0 109.402 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -78.08 115.95 18.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.702 -0.681 . . . . 10.0 111.717 -178.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 35.1 m0 -99.19 -157.39 0.6 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.175 -0.676 . . . . 10.0 109.175 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 20.6 ttt -130.58 132.4 45.51 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.042 -0.355 . . . . 10.0 110.042 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -94.73 167.85 12.38 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 116.273 -0.421 . . . . 10.0 110.565 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -62.48 -14.92 42.28 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.124 2.549 . . . . 10.0 113.452 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -83.7 -39.88 19.6 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.12 0.486 . . . . 10.0 110.044 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 123.75 19.19 2.81 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.787 -0.72 . . . . 10.0 112.518 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -106.59 166.27 10.68 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.684 -0.487 . . . . 10.0 109.684 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 94.4 mmm -87.33 84.37 7.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.877 0.37 . . . . 10.0 110.484 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.07 108.16 24.24 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.153 -0.476 . . . . 10.0 110.05 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -73.95 152.72 46.73 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.251 1.967 . . . . 10.0 112.821 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -94.24 178.93 37.5 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 111.038 -0.825 . . . . 10.0 111.038 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -78.53 71.59 5.0 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.243 0.544 . . . . 10.0 110.345 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 24.7 ttmt -161.97 133.88 5.55 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.242 -0.89 . . . . 10.0 109.672 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 154.37 -169.47 32.74 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.958 -0.639 . . . . 10.0 111.652 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 20.4 tt -168.91 139.63 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.745 0.307 . . . . 10.0 110.42 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.01 145.01 25.8 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.506 -0.315 . . . . 10.0 110.268 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 45.6 mt -121.93 117.56 26.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.461 -0.336 . . . . 10.0 110.176 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -78.61 164.24 56.84 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 109.969 -0.382 . . . . 10.0 109.969 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -43.22 -45.68 9.66 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.732 2.954 . . . . 10.0 113.866 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -64.01 -42.56 97.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.493 0.187 . . . . 10.0 111.135 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -63.84 -43.6 95.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.991 0.424 . . . . 10.0 110.011 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 62.6 t-105 -59.27 -41.83 89.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.651 -0.704 . . . . 10.0 110.867 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.5 m -66.81 -43.9 82.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.851 -0.613 . . . . 10.0 111.115 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -68.35 -38.95 81.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.36 -0.382 . . . . 10.0 111.038 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.2 tp -59.08 -44.31 91.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.316 -0.402 . . . . 10.0 110.958 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -64.65 -32.54 74.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.272 -0.422 . . . . 10.0 111.1 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -75.45 -33.32 60.87 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.034 0.445 . . . . 10.0 110.888 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -77.81 -8.47 58.06 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.411 0.522 . . . . 10.0 112.411 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 74.7 mt -54.68 -44.46 70.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.674 0.273 . . . . 10.0 111.291 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.31 -19.78 62.17 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.147 -0.479 . . . . 10.0 111.911 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.26 -48.4 4.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.755 0.312 . . . . 10.0 110.718 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 87.6 mt -58.02 -51.43 70.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.893 -0.594 . . . . 10.0 110.931 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -60.04 -35.66 75.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.73 -0.668 . . . . 10.0 111.38 -178.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -66.12 -38.24 87.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.879 0.371 . . . . 10.0 110.259 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.54 -38.29 83.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.128 -0.487 . . . . 10.0 110.1 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 59.7 t -63.15 -39.56 85.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.879 -0.6 . . . . 10.0 110.1 179.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 25.2 mtm105 -72.92 -30.36 63.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.95 -0.568 . . . . 10.0 110.873 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 35.2 mttp -70.98 -35.06 71.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.262 -0.427 . . . . 10.0 110.905 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 26.6 mt . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 116.325 -0.398 . . . . 10.0 110.795 179.88 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.17 0 CA-C-O 121.183 0.516 . . . . 10.0 110.735 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 20.4 mmm -103.45 102.22 12.13 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.079 -0.712 . . . . 10.0 109.079 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -94.6 114.93 26.97 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.882 -0.599 . . . . 10.0 111.443 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -75.56 121.57 22.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.813 -0.631 . . . . 10.0 110.522 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 12.6 pt -116.05 13.23 7.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.248 -0.433 . . . . 10.0 110.856 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 167.7 -179.31 41.16 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.778 -0.646 . . . . 10.0 111.874 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.55 111.22 5.23 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.895 0.378 . . . . 10.0 110.06 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' MET . . . . . . . . . . . . . 49.2 mtp 73.17 8.75 5.31 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.2 -0.909 . . . . 10.0 111.175 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -105.1 118.95 37.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.496 -0.32 . . . . 10.0 110.213 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -132.74 124.09 27.47 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.881 0.372 . . . . 10.0 111.725 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 46.7 t -76.4 105.32 5.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.716 -0.846 . . . . 10.0 108.716 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 5.2 m -84.21 87.77 7.19 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.949 -0.569 . . . . 10.0 111.665 -178.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 67.5 t -93.87 120.14 42.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.31 -0.626 . . . . 10.0 109.31 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -164.43 172.9 12.77 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.217 -0.447 . . . . 10.0 110.45 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -94.11 118.29 31.32 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.047 -0.524 . . . . 10.0 109.91 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -108.36 92.69 4.16 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.307 -0.406 . . . . 10.0 110.306 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 93.5 mttt 60.72 33.44 20.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.357 -0.838 . . . . 10.0 111.824 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 102.78 -1.97 48.68 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.619 -0.801 . . . . 10.0 113.146 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -119.37 115.99 25.26 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 122.596 -0.355 . . . . 10.0 111.216 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 28.5 t -75.64 106.6 5.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.172 -0.677 . . . . 10.0 109.172 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 80.6 mt -107.68 127.85 54.03 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.188 0.518 . . . . 10.0 112.163 -178.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 82' ' ' ILE . . . . . . . . . . . . . 5.0 mp -92.47 95.62 5.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 107.503 -1.295 . . . . 10.0 107.503 177.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -91.07 117.42 29.58 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 112.677 0.621 . . . . 10.0 112.677 -177.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 77.9 mt -100.16 98.9 7.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 107.953 -1.129 . . . . 10.0 107.953 177.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 8.9 ttm-85 -147.64 166.35 27.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.227 -0.442 . . . . 10.0 111.238 -177.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.87 157.07 17.46 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.917 -0.771 . . . . 10.0 108.917 178.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 87' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -121.03 120.73 36.22 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.961 0.41 . . . . 10.0 110.513 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 88' ' ' TRP . . . . . . . . . . . . . 36.2 m95 -103.52 138.32 40.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.764 -0.653 . . . . 10.0 110.173 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 58.1 ttm -91.21 132.28 36.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.756 0.312 . . . . 10.0 110.668 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 90' ' ' ASP . . . . . . . . . . . . . 8.7 p30 -91.97 173.14 5.52 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 116.298 -0.41 . . . . 10.0 110.144 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -59.45 -26.28 81.43 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.482 2.121 . . . . 10.0 112.489 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -71.36 -26.43 62.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.004 0.431 . . . . 10.0 110.147 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 104.85 16.71 16.29 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.986 -0.626 . . . . 10.0 112.643 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -98.22 155.23 17.28 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.893 0.378 . . . . 10.0 110.749 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 95' ' ' MET . . . . . . . . . . . . . 98.8 mmm -101.62 100.46 10.86 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.66 -0.496 . . . . 10.0 109.66 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -97.75 140.14 21.77 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 116.164 -0.471 . . . . 10.0 110.895 -178.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -60.31 143.16 99.49 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 122.569 2.179 . . . . 10.0 111.337 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.47 168.62 21.24 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 116.1 -0.5 . . . . 10.0 112.923 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 8.1 mmt180 -79.85 -3.76 49.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.076 0.465 . . . . 10.0 111.136 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 3.9 pttp -117.79 -160.35 0.78 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.984 -0.746 . . . . 10.0 108.984 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . 108.53 168.24 21.05 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.655 -0.783 . . . . 10.0 112.386 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 20.9 tt -144.82 139.99 23.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.942 0.401 . . . . 10.0 110.869 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 3.8 m -102.69 110.3 22.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.006 -0.543 . . . . 10.0 110.003 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 92.9 mt -104.06 135.18 46.05 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.053 0.454 . . . . 10.0 111.24 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 34.1 p-10 -93.1 165.77 17.78 Favored Pre-proline 0 C--N 1.317 -0.83 0 N-CA-C 108.698 -0.853 . . . . 10.0 108.698 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -50.39 -32.43 33.83 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.505 2.137 . . . . 10.0 112.51 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -63.29 -53.51 51.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.607 -0.724 . . . . 10.0 110.948 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -75.01 -30.49 61.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.925 0.393 . . . . 10.0 110.307 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 109' ' ' TRP . . . . . . . . . . . . . 46.7 t-105 -59.55 -41.26 89.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.771 -0.649 . . . . 10.0 109.777 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 22.9 t -63.32 -49.32 74.44 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.609 -0.515 . . . . 10.0 109.609 178.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -58.6 -40.6 83.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.683 -0.689 . . . . 10.0 110.96 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 63.5 tp -58.28 -44.68 88.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.557 -0.292 . . . . 10.0 110.214 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -62.98 -41.64 99.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.109 -0.496 . . . . 10.0 110.529 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -68.81 -35.52 77.09 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.72 -0.673 . . . . 10.0 111.41 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 13.6 mm-40 -75.27 -14.75 60.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.254 -0.43 . . . . 10.0 111.398 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 56.3 mt -57.99 -37.76 63.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 120.705 0.288 . . . . 10.0 110.6 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 1.1 m -65.0 -7.26 10.96 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.066 -0.516 . . . . 10.0 111.706 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -116.7 -47.11 2.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.056 0.455 . . . . 10.0 110.424 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 65.9 mt -64.66 -49.33 80.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.809 -0.632 . . . . 10.0 111.821 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -58.1 -40.03 80.12 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.922 0.391 . . . . 10.0 111.106 -178.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -64.66 -36.99 86.06 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.829 -0.623 . . . . 10.0 110.513 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.42 -24.85 60.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.942 -0.572 . . . . 10.0 111.599 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 89.3 t -58.53 -37.63 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 121.04 0.448 . . . . 10.0 110.847 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -100.6 16.42 24.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.309 -0.405 . . . . 10.0 110.809 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 92.4 mttt . . . . . 0 C--N 1.327 -0.407 0 CA-C-N 116.172 -0.467 . . . . 10.0 110.247 179.715 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 109.827 -0.434 . . . . 10.0 109.827 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 41.7 ttm -112.29 103.04 11.16 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.107 0.479 . . . . 10.0 111.316 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -89.42 173.95 8.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.903 -0.59 . . . . 10.0 109.577 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -127.42 126.55 42.6 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.615 0.245 . . . . 10.0 110.64 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.7 pt -117.39 15.44 7.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.321 -0.4 . . . . 10.0 110.885 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 154.07 175.75 25.66 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.312 -0.947 . . . . 10.0 112.595 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 42.0 tttp -60.12 113.48 2.37 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 122.698 0.399 . . . . 10.0 110.91 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 66.8 mmm 69.87 17.68 7.51 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 123.784 0.678 . . . . 10.0 111.644 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? -119.94 107.29 12.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.088 0.471 . . . . 10.0 109.936 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -115.3 152.0 33.55 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.728 -0.669 . . . . 10.0 110.838 -178.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.4 t -102.05 111.59 32.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.421 -0.809 . . . . 10.0 110.203 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.14 87.75 7.41 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.027 0.441 . . . . 10.0 111.43 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 16.5 t -86.98 108.21 17.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.589 -0.893 . . . . 10.0 108.589 178.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -153.77 -179.64 8.01 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.306 0.574 . . . . 10.0 111.998 -178.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -120.53 123.02 41.88 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.814 -1.085 . . . . 10.0 109.075 178.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -115.67 86.11 2.41 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.014 0.435 . . . . 10.0 110.929 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt 57.35 41.49 26.38 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.257 -0.883 . . . . 10.0 111.348 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 112.38 -24.5 13.81 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.511 -0.852 . . . . 10.0 112.346 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -84.3 82.72 8.26 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.887 0.375 . . . . 10.0 110.554 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.8 t -90.37 103.37 14.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 108.958 -0.756 . . . . 10.0 108.958 178.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -157.97 174.19 15.63 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.952 0.406 . . . . 10.0 111.369 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 38.7 pt -92.64 172.39 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.993 -0.549 . . . . 10.0 110.194 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -151.01 147.49 27.2 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.617 0.246 . . . . 10.0 111.216 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 60.7 mt -121.22 106.83 19.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.326 -0.62 . . . . 10.0 109.326 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 60.2 mtm180 -129.72 151.89 49.82 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.949 0.404 . . . . 10.0 111.451 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -83.11 97.73 8.95 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.382 -0.97 . . . . 10.0 108.382 178.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -81.32 142.68 32.84 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.434 -0.803 . . . . 10.0 112.693 -177.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 13.8 m0 -128.6 177.25 7.16 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.489 -0.93 . . . . 10.0 108.489 178.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 1.1 ttt -103.97 127.51 51.51 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 110.059 -0.349 . . . . 10.0 110.059 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -85.02 167.21 27.43 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.636 -0.256 . . . . 10.0 110.359 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -61.63 -19.25 64.23 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.904 2.403 . . . . 10.0 113.403 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -77.68 -46.79 20.88 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.077 0.465 . . . . 10.0 110.006 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 133.36 15.79 1.25 Allowed Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.982 -0.628 . . . . 10.0 112.5 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -106.94 179.18 4.34 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.858 0.361 . . . . 10.0 110.386 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 85.7 mmm -106.55 109.93 21.99 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.205 -0.452 . . . . 10.0 110.737 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 48.5 mmtt -125.37 128.67 24.66 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.828 -0.623 . . . . 10.0 109.577 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -82.63 177.28 7.07 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.078 2.519 . . . . 10.0 113.129 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -100.82 -169.27 28.59 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.794 -0.639 . . . . 10.0 111.884 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -80.09 55.98 2.29 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.839 0.352 . . . . 10.0 111.282 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -160.6 132.98 6.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.261 -0.427 . . . . 10.0 110.231 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 172.19 -170.95 43.91 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.066 -0.588 . . . . 10.0 111.754 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 8.9 tt -165.85 127.56 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.945 0.402 . . . . 10.0 110.897 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 51.7 m -105.56 145.05 31.47 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.235 -0.654 . . . . 10.0 109.235 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -131.59 129.68 41.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.028 0.442 . . . . 10.0 110.351 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -75.25 164.0 64.08 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.36 -0.837 . . . . 10.0 111.263 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -48.27 -38.37 33.52 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.619 2.88 . . . . 10.0 114.224 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -65.31 -42.22 93.23 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.042 -0.355 . . . . 10.0 110.042 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -65.48 -45.37 83.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.136 0.493 . . . . 10.0 109.801 178.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 56.2 t-105 -56.79 -42.43 79.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.281 -0.872 . . . . 10.0 110.462 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.4 m -65.49 -46.42 79.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.269 -0.423 . . . . 10.0 110.605 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -61.5 -42.74 99.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.494 . . . . 10.0 110.847 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 53.8 tp -57.85 -45.75 85.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.901 -0.591 . . . . 10.0 111.314 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -59.0 -42.47 90.15 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.328 -0.396 . . . . 10.0 111.322 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -74.04 -16.99 61.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.184 -0.462 . . . . 10.0 111.758 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -93.14 -10.6 35.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.745 0.307 . . . . 10.0 110.989 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 70.7 mt -56.71 -37.53 53.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.571 -0.286 . . . . 10.0 111.45 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.14 -23.58 64.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.904 0.383 . . . . 10.0 111.397 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -97.73 -44.4 6.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.138 0.494 . . . . 10.0 110.088 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 67.1 mt -60.25 -52.43 61.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.876 -0.602 . . . . 10.0 111.2 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -61.51 -33.82 74.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.995 -0.548 . . . . 10.0 110.268 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -66.41 -35.62 80.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.533 -0.758 . . . . 10.0 110.259 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.52 -37.42 63.09 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.932 -0.576 . . . . 10.0 110.767 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 99.4 t -61.78 -34.54 62.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 10.0 110.805 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 13.9 mtm105 -78.05 -13.72 59.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.131 -0.486 . . . . 10.0 111.417 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -95.37 -31.48 13.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.862 0.363 . . . . 10.0 111.139 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 75.4 mt . . . . . 0 C--N 1.325 -0.48 0 CA-C-N 116.473 -0.33 . . . . 10.0 110.518 179.709 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.18 0 CA-C-O 121.019 0.438 . . . . 10.0 111.021 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 97.3 mmm -108.12 89.89 3.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.991 -0.55 . . . . 10.0 109.621 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -98.49 133.03 43.43 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.161 -0.472 . . . . 10.0 110.669 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -92.17 132.37 36.69 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.814 0.34 . . . . 10.0 110.746 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 30.5 pt -125.73 16.86 4.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.188 0.518 . . . . 10.0 110.174 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 167.78 165.28 24.92 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.041 -0.824 . . . . 10.0 111.041 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 15.6 mttp -64.07 116.6 6.07 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.944 0.372 . . . . 10.0 110.126 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' MET . . . . . . . . . . . . . 17.5 mmt 69.64 15.73 8.1 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.868 -0.605 . . . . 10.0 110.824 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -119.17 109.81 16.31 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.436 -0.579 . . . . 10.0 109.436 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -122.33 142.36 50.58 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.353 0.597 . . . . 10.0 112.078 -178.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 70.8 t -94.48 93.67 4.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 107.809 -1.182 . . . . 10.0 107.809 177.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 8.5 t -84.15 95.87 8.77 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.889 -0.596 . . . . 10.0 111.551 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 17.4 t -90.07 87.92 2.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.533 -0.914 . . . . 10.0 108.533 178.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 10.4 ptt-85 -118.09 172.97 7.05 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.146 -0.479 . . . . 10.0 111.207 -178.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -105.54 128.87 53.83 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.811 -0.631 . . . . 10.0 110.67 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -108.8 78.0 1.11 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.302 -0.408 . . . . 10.0 109.93 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 35.5 mttm 60.56 50.97 5.36 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.713 -0.676 . . . . 10.0 111.768 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.18 4.61 71.29 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.683 -0.77 . . . . 10.0 112.356 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -118.29 99.3 6.76 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.65 0.262 . . . . 10.0 110.373 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 41.7 t -67.46 116.88 7.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.653 -0.499 . . . . 10.0 109.653 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 95.9 mt -123.53 132.03 53.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.232 0.539 . . . . 10.0 111.818 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 82' ' ' ILE . . . . . . . . . . . . . 5.2 mp -92.63 87.72 2.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 107.834 -1.173 . . . . 10.0 107.834 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -85.39 94.79 9.06 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.745 -0.662 . . . . 10.0 112.014 -178.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 50.9 mt -87.43 99.62 8.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 107.272 -1.381 . . . . 10.0 107.272 177.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 12.7 ttm-85 -138.33 154.97 48.98 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.28 0.562 . . . . 10.0 111.819 -177.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -82.25 148.82 28.17 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.362 -0.835 . . . . 10.0 109.56 178.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 87' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -132.65 121.63 23.45 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.594 -0.521 . . . . 10.0 109.594 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 88' ' ' TRP . . . . . . . . . . . . . 23.7 m0 -99.19 143.44 29.46 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.225 -0.443 . . . . 10.0 110.469 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 42.6 ttm -84.62 120.18 26.07 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.314 -0.403 . . . . 10.0 110.061 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 90' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.52 163.65 53.29 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.963 -0.562 . . . . 10.0 110.856 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -57.83 -32.34 94.69 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.233 2.622 . . . . 10.0 113.44 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.44 -49.57 66.27 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.888 0.375 . . . . 10.0 110.465 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 136.68 24.73 0.47 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.718 -0.754 . . . . 10.0 112.669 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -115.35 161.98 17.76 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.938 0.399 . . . . 10.0 110.606 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 95' ' ' MET . . . . . . . . . . . . . 96.9 mmm -101.55 106.24 17.3 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.871 -0.604 . . . . 10.0 109.387 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 35.4 mmtt -98.91 136.25 20.67 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 116.127 -0.488 . . . . 10.0 110.233 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -58.21 139.16 89.46 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.756 2.304 . . . . 10.0 112.194 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . -82.62 -140.13 3.53 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 121.061 -0.59 . . . . 10.0 112.455 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 60.8 mtp85 -117.32 -27.57 6.38 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.945 0.402 . . . . 10.0 110.645 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 4.3 mtmt -88.57 114.32 25.07 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.945 -0.571 . . . . 10.0 110.134 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . 166.01 156.81 9.63 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.522 -0.847 . . . . 10.0 112.727 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 18.8 tt -156.38 140.92 8.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.001 0.429 . . . . 10.0 110.402 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 3.4 m -88.56 108.23 19.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.209 -0.45 . . . . 10.0 110.29 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 68.5 mt -87.12 131.5 34.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.206 -0.452 . . . . 10.0 110.443 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -88.2 166.65 22.71 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 109.295 -0.631 . . . . 10.0 109.295 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -47.13 -32.44 13.65 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.005 2.47 . . . . 10.0 113.251 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -67.45 -56.12 10.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.291 -0.413 . . . . 10.0 110.46 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -63.33 -34.07 76.91 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.044 -0.525 . . . . 10.0 110.285 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 109' ' ' TRP . . . . . . . . . . . . . 52.0 t-105 -61.37 -43.06 99.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.857 -0.61 . . . . 10.0 109.908 178.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 1.6 t -66.29 -45.46 80.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.807 -0.633 . . . . 10.0 109.494 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -56.52 -47.97 78.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.51 -0.768 . . . . 10.0 111.014 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 56.4 tp -58.62 -43.8 89.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.257 -0.429 . . . . 10.0 110.753 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -63.13 -38.54 91.6 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.953 0.406 . . . . 10.0 111.193 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -80.72 -6.65 58.73 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.203 -0.453 . . . . 10.0 111.503 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 13.6 mm-40 -105.26 -6.01 20.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.664 0.269 . . . . 10.0 111.078 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 85.1 mt -52.49 -47.23 48.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 10.0 111.921 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.57 -40.94 72.63 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.227 0.454 . . . . 10.0 112.227 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -76.04 -47.36 25.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.358 -0.383 . . . . 10.0 111.537 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 70.5 mt -64.21 -42.35 95.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.729 0.299 . . . . 10.0 110.904 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -60.68 -37.37 81.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.118 0.485 . . . . 10.0 110.422 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -69.33 -31.44 69.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.695 -0.684 . . . . 10.0 110.55 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.04 -32.44 63.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.259 -0.428 . . . . 10.0 110.212 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 95.0 t -69.2 -41.79 81.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.987 -0.551 . . . . 10.0 110.769 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -75.27 -31.52 60.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.509 -0.314 . . . . 10.0 111.095 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 86.0 mttt . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 116.426 -0.352 . . . . 10.0 110.805 -179.257 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 110.412 -0.218 . . . . 10.0 110.412 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 54.0 ttm -107.44 115.46 30.2 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.968 -0.382 . . . . 10.0 109.968 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -98.83 149.75 22.58 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.413 -0.358 . . . . 10.0 110.482 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -102.83 124.35 48.18 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.699 0.285 . . . . 10.0 111.239 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 37.1 pt -116.38 0.31 8.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.368 -0.378 . . . . 10.0 110.859 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 168.45 -179.02 41.71 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.509 -0.853 . . . . 10.0 112.522 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 37.3 tttp -64.4 117.52 7.39 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.728 0.299 . . . . 10.0 110.92 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 39.9 mmm 65.3 7.95 4.58 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.434 -0.803 . . . . 10.0 112.033 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -113.54 112.11 23.01 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.733 -0.469 . . . . 10.0 109.733 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -125.55 157.05 38.06 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.08 -0.509 . . . . 10.0 111.342 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 86.3 t -117.78 101.0 11.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.048 -0.978 . . . . 10.0 109.344 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.9 m -89.42 98.72 11.93 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.109 -0.496 . . . . 10.0 110.987 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.1 t -86.64 117.64 31.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.066 -0.516 . . . . 10.0 110.213 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.1 ptt-85 -136.62 173.2 11.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.234 -0.439 . . . . 10.0 110.141 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -113.33 153.08 29.07 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.755 0.312 . . . . 10.0 110.351 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -161.16 119.34 2.41 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.085 -0.507 . . . . 10.0 109.842 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 30.4 mtmt 66.34 25.21 10.45 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.504 0.502 . . . . 10.0 110.264 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.41 1.89 90.52 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.706 -0.759 . . . . 10.0 111.399 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -102.12 -175.86 2.96 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.988 -0.375 . . . . 10.0 109.988 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 42.5 t -119.61 137.0 54.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.039 0.447 . . . . 10.0 111.267 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 73.6 mt -121.27 100.83 7.26 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.482 -0.781 . . . . 10.0 110.301 178.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 44.8 mt -89.17 95.49 5.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.303 -0.629 . . . . 10.0 109.303 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.34 109.97 14.18 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.464 0.542 . . . . 10.0 112.464 -177.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 35.3 mt -109.27 90.88 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.395 -0.965 . . . . 10.0 108.395 177.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.4 ttm-85 -137.35 168.07 20.36 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.969 -0.56 . . . . 10.0 111.678 -177.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -91.64 129.77 37.56 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.413 -0.958 . . . . 10.0 108.413 178.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -114.02 118.6 34.55 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.9 0.381 . . . . 10.0 110.068 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 81.6 m95 -102.43 146.23 28.39 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.896 -0.593 . . . . 10.0 110.726 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 34.2 ttm -68.35 128.63 37.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.144 -0.48 . . . . 10.0 111.474 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 34.5 p30 -97.46 171.79 5.61 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 115.61 -0.723 . . . . 10.0 110.845 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -78.39 32.0 0.45 Allowed 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.927 2.418 . . . . 10.0 111.711 178.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -123.0 -44.4 2.18 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.976 -0.749 . . . . 10.0 108.976 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 126.93 18.49 2.12 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 114.871 -1.059 . . . . 10.0 110.973 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -121.24 -177.68 3.58 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.806 -0.442 . . . . 10.0 109.806 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 61.0 mmm -117.57 115.16 24.56 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.791 -0.448 . . . . 10.0 109.791 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.3 mmpt? -95.36 139.58 22.05 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.138 -0.483 . . . . 10.0 110.572 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -69.36 118.8 5.9 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.941 2.427 . . . . 10.0 112.622 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -70.14 168.87 47.22 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 121.173 -0.537 . . . . 10.0 111.827 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -81.24 56.53 2.89 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.873 0.368 . . . . 10.0 111.8 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 13.2 ttmt -167.29 108.38 0.62 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.779 -0.646 . . . . 10.0 109.901 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 170.44 175.98 39.58 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.017 -1.087 . . . . 10.0 112.929 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 13.9 tt -155.21 157.65 4.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.313 -0.625 . . . . 10.0 109.313 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.1 p -112.24 173.92 6.13 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 121.069 -0.252 . . . . 10.0 110.861 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 37.7 mt -136.7 149.95 48.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.412 -0.358 . . . . 10.0 110.301 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 11.9 p-10 -117.95 167.37 11.4 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 109.538 -0.541 . . . . 10.0 109.538 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -47.27 -45.59 21.76 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.944 2.429 . . . . 10.0 113.389 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -56.48 -50.54 71.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.089 -0.505 . . . . 10.0 111.514 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -71.97 -36.75 69.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.432 -0.349 . . . . 10.0 110.701 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 69.0 t-105 -56.45 -45.21 80.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.916 -0.584 . . . . 10.0 111.029 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.0 t -61.6 -51.38 68.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.334 -0.393 . . . . 10.0 110.182 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -61.55 -37.23 83.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.082 -0.508 . . . . 10.0 111.508 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 66.5 tp -61.47 -45.11 95.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.921 0.391 . . . . 10.0 110.2 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -65.08 -36.26 83.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.267 0.556 . . . . 10.0 110.172 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -74.42 -9.21 58.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.476 -0.783 . . . . 10.0 111.48 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -112.01 1.71 16.52 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.706 -0.225 . . . . 10.0 111.53 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.5 mt -55.28 -53.29 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.659 -0.246 . . . . 10.0 111.344 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.85 -39.1 80.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 10.0 111.446 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -67.19 -51.39 54.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.131 -0.486 . . . . 10.0 111.566 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 62.6 mt -65.33 -45.05 94.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.351 -0.386 . . . . 10.0 111.182 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -60.32 -42.09 94.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.103 -0.499 . . . . 10.0 111.612 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -66.33 -36.87 84.02 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 120.836 0.35 . . . . 10.0 110.195 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.13 -41.95 97.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.936 -0.575 . . . . 10.0 109.974 178.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 97.3 t -65.52 -41.98 92.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.784 -0.644 . . . . 10.0 109.856 178.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 27.3 mtm105 -67.12 -22.62 65.79 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.746 -0.661 . . . . 10.0 111.144 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 35.6 mttp -78.63 -30.39 46.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 10.0 110.283 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 70.8 mt . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 115.993 -0.549 . . . . 10.0 110.679 179.993 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.162 0 CA-C-O 120.91 0.385 . . . . 10.0 110.756 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 86.5 mmm -95.09 84.64 4.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.058 0.456 . . . . 10.0 110.274 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -82.22 159.46 23.23 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.757 -0.656 . . . . 10.0 110.091 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -133.6 119.01 18.89 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.942 0.401 . . . . 10.0 110.972 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 3.0 pt -97.02 95.05 4.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.137 -0.69 . . . . 10.0 109.137 178.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.82 -93.06 1.78 Allowed Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 110.74 -0.944 . . . . 10.0 110.74 -178.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -165.37 151.92 10.11 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.652 -0.499 . . . . 10.0 109.652 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' MET . . . . . . . . . . . . . 1.2 mpt? 74.93 -50.76 0.67 Allowed 'General case' 0 N--CA 1.473 0.69 0 O-C-N 123.856 0.722 . . . . 10.0 111.67 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -75.7 110.51 10.17 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.752 0.311 . . . . 10.0 110.365 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -110.26 131.16 55.3 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.184 -0.462 . . . . 10.0 111.086 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 22.3 t -78.65 83.54 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.698 -0.853 . . . . 10.0 108.698 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 26.1 t -87.22 92.59 9.11 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.576 -0.738 . . . . 10.0 111.731 -178.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 3.8 t -86.0 73.69 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.657 -0.868 . . . . 10.0 108.657 177.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 35.0 ptt-85 -102.29 144.05 31.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.484 0.659 . . . . 10.0 112.093 -177.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -82.71 126.22 32.12 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.974 -1.012 . . . . 10.0 108.939 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -118.27 100.97 7.84 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.644 0.259 . . . . 10.0 110.674 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 63.7 mttm 58.78 35.46 24.33 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.8 -0.636 . . . . 10.0 111.872 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.19 8.27 61.59 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.613 -0.803 . . . . 10.0 112.265 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 42.0 mmtt -117.43 107.45 14.35 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-O 120.78 0.324 . . . . 10.0 110.681 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 21.9 t -74.42 105.26 3.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.529 -0.545 . . . . 10.0 109.529 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 98.5 mt -118.07 125.05 49.55 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.197 0.523 . . . . 10.0 111.364 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 82' ' ' ILE . . . . . . . . . . . . . 32.7 mt -85.87 82.84 2.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.16 -1.052 . . . . 10.0 108.16 178.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -93.65 100.71 12.9 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.395 -0.82 . . . . 10.0 111.086 -178.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 36.0 mt -84.24 94.93 3.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 108.353 -0.98 . . . . 10.0 108.353 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 5.6 ttm-85 -106.0 151.0 25.18 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.831 -0.622 . . . . 10.0 111.686 -177.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -83.56 116.07 22.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.716 -0.674 . . . . 10.0 110.24 178.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 87' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -96.03 106.74 18.95 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.942 -0.572 . . . . 10.0 109.855 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 88' ' ' TRP . . . . . . . . . . . . . 76.8 m95 -104.52 139.42 39.44 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.898 -0.592 . . . . 10.0 110.335 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 39.3 ttm -69.05 130.44 42.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.953 -0.567 . . . . 10.0 111.665 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 90' ' ' ASP . . . . . . . . . . . . . 49.0 p30 -90.35 173.88 5.23 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.477 -0.783 . . . . 10.0 109.724 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -61.55 -20.32 68.21 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.228 1.952 . . . . 10.0 112.56 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -74.66 -44.0 52.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.281 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 124.48 20.86 2.32 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.925 -0.655 . . . . 10.0 112.165 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -114.77 161.9 17.57 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.182 -0.303 . . . . 10.0 110.182 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 95' ' ' MET . . . . . . . . . . . . . 8.2 mmt -93.31 113.96 26.28 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.824 -0.435 . . . . 10.0 109.824 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 48.1 mmtt -105.97 126.05 31.62 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.042 -0.526 . . . . 10.0 111.119 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.98 118.36 5.53 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.591 2.194 . . . . 10.0 111.819 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . -83.46 -157.84 25.16 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.767 -0.73 . . . . 10.0 112.712 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -86.17 -20.74 28.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.868 0.366 . . . . 10.0 110.448 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 6.8 mtpm? -69.39 106.36 2.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.905 -0.588 . . . . 10.0 109.694 178.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . 161.83 157.11 8.7 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.727 -0.669 . . . . 10.0 111.464 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 6.5 tp -133.63 134.99 56.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.946 0.403 . . . . 10.0 110.731 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.21 108.49 21.23 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.826 -0.625 . . . . 10.0 110.481 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 80.4 mt -111.4 137.74 48.79 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.979 0.419 . . . . 10.0 110.835 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 36.5 p-10 -85.95 168.25 20.33 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.325 -0.398 . . . . 10.0 109.932 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -52.63 -27.33 32.77 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.775 2.317 . . . . 10.0 112.526 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -66.38 -51.38 57.7 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.936 -0.574 . . . . 10.0 109.942 178.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -65.63 -33.21 75.37 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.979 -0.555 . . . . 10.0 110.355 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 109' ' ' TRP . . . . . . . . . . . . . 45.9 t-105 -57.8 -41.91 83.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.126 -0.488 . . . . 10.0 110.699 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 13.6 t -68.04 -53.31 26.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.315 -0.402 . . . . 10.0 110.736 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -59.33 -36.59 75.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.481 . . . . 10.0 111.303 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 64.2 tp -60.12 -48.0 83.55 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.162 -0.31 . . . . 10.0 110.162 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -62.9 -39.11 93.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.142 -0.481 . . . . 10.0 110.881 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -68.29 -30.66 69.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.938 -0.574 . . . . 10.0 111.429 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -85.39 -8.3 58.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.676 -0.238 . . . . 10.0 111.265 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 27.3 mt -57.22 -37.4 56.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.676 -0.238 . . . . 10.0 111.513 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.12 -29.42 67.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.945 0.402 . . . . 10.0 111.282 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -91.2 -42.81 10.22 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.168 -0.469 . . . . 10.0 110.68 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 82.8 mt -64.05 -47.14 91.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.893 -0.594 . . . . 10.0 111.206 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -60.01 -38.96 84.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.565 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -63.85 -42.66 97.53 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.641 -0.709 . . . . 10.0 110.249 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.63 -33.96 77.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.971 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 71.3 t -60.4 -35.22 61.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-O 121.362 0.601 . . . . 10.0 110.708 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 7.3 ptt85 -102.99 21.22 16.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.803 -0.635 . . . . 10.0 110.613 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 17.4 ttmt . . . . . 0 C--N 1.325 -0.498 0 CA-C-O 121.412 0.625 . . . . 10.0 109.821 179.941 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 109.933 -0.395 . . . . 10.0 109.933 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 49.1 ttm -126.55 105.54 8.81 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.917 0.389 . . . . 10.0 110.618 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -96.37 126.47 41.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.004 -0.544 . . . . 10.0 110.407 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -85.74 131.48 34.32 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.009 -0.367 . . . . 10.0 110.009 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 26.9 pt -119.62 11.68 6.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.147 0.498 . . . . 10.0 110.807 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 161.39 174.71 31.6 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.401 -0.68 . . . . 10.0 111.401 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -61.85 120.32 10.51 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.058 0.456 . . . . 10.0 110.873 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 36.1 mmm 66.19 12.7 8.72 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.079 -0.964 . . . . 10.0 111.964 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -114.81 113.0 23.66 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.718 -0.475 . . . . 10.0 109.718 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -126.73 134.27 50.69 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.116 0.484 . . . . 10.0 111.71 -177.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 38.7 t -93.82 105.16 16.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 108.912 -0.773 . . . . 10.0 108.912 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.2 m -80.8 82.99 6.65 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.502 -0.772 . . . . 10.0 111.3 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.8 t -83.41 93.55 3.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.912 -0.773 . . . . 10.0 108.912 178.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -133.92 -175.37 3.82 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.816 -0.629 . . . . 10.0 111.029 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -117.07 142.45 46.96 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.873 -0.603 . . . . 10.0 110.033 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -145.38 96.53 2.85 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.018 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.8 mttp 68.48 29.15 5.77 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.016 -0.538 . . . . 10.0 111.057 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 84.37 54.15 3.06 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.545 -0.836 . . . . 10.0 111.834 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.8 mttp -146.41 130.52 17.39 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.783 -0.209 . . . . 10.0 110.472 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.3 t -80.2 84.69 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.54 -0.911 . . . . 10.0 108.54 178.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 30.5 mt -83.7 104.84 14.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.892 -0.595 . . . . 10.0 112.126 -178.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 16.6 mt -97.25 64.07 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 106.704 -1.591 . . . . 10.0 106.704 176.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -68.41 101.68 1.28 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.735 -1.12 . . . . 10.0 113.375 -176.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 63.0 mt -84.21 108.0 16.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 107.383 -1.34 . . . . 10.0 107.383 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -143.69 170.47 15.8 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.599 0.714 . . . . 10.0 112.335 -177.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -99.95 140.77 33.7 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.282 -0.872 . . . . 10.0 108.911 177.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -122.23 121.76 37.58 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.912 0.387 . . . . 10.0 110.462 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -114.49 153.57 29.76 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.763 -0.653 . . . . 10.0 109.943 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 2.3 ttm -83.02 122.14 27.93 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.836 -0.431 . . . . 10.0 109.836 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.47 170.76 13.66 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.824 -0.626 . . . . 10.0 110.726 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -54.19 -29.78 58.17 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 123.053 2.502 . . . . 10.0 113.458 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -73.75 -45.2 53.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.965 0.412 . . . . 10.0 110.608 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 124.51 30.18 1.01 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.63 -0.795 . . . . 10.0 112.0 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -116.33 167.76 10.74 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.78 0.324 . . . . 10.0 110.32 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 92.3 mmm -89.42 98.25 11.66 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.251 -0.648 . . . . 10.0 109.251 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -98.23 124.54 46.77 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.447 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -78.02 146.86 23.34 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.727 2.284 . . . . 10.0 112.891 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -85.08 -174.1 50.13 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.725 -0.75 . . . . 10.0 112.332 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -76.06 -26.92 56.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.98 0.419 . . . . 10.0 110.758 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -76.38 81.38 3.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.863 -0.608 . . . . 10.0 110.609 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -146.62 129.48 3.33 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.959 -0.564 . . . . 10.0 111.766 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 8.5 tt -127.29 113.86 33.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.201 0.524 . . . . 10.0 110.702 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.3 m -79.27 99.9 7.28 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.089 -0.505 . . . . 10.0 110.679 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.7 mt -76.53 171.66 14.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.153 0.501 . . . . 10.0 110.442 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -133.03 158.32 76.13 Favored Pre-proline 0 C--N 1.316 -0.87 0 N-CA-C 108.835 -0.802 . . . . 10.0 108.835 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -41.39 -45.3 5.91 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.825 3.017 . . . . 10.0 113.891 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -64.38 -49.69 70.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.709 0.29 . . . . 10.0 110.833 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -63.56 -40.74 97.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.266 -0.424 . . . . 10.0 110.586 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -59.47 -44.79 92.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.924 -0.58 . . . . 10.0 110.294 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 56.8 m -64.4 -41.02 96.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.226 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -63.98 -42.02 97.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.254 -0.43 . . . . 10.0 110.395 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 22.9 tp -59.36 -40.99 88.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.992 -0.549 . . . . 10.0 110.543 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -63.95 -33.49 75.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.856 -0.611 . . . . 10.0 111.121 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -76.82 -15.4 59.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.324 -0.398 . . . . 10.0 111.115 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -99.55 -5.18 29.61 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.547 -0.297 . . . . 10.0 110.879 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 56.7 mt -56.56 -39.73 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.396 -0.365 . . . . 10.0 111.489 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.14 -30.21 69.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.109 -0.496 . . . . 10.0 111.099 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -90.04 -39.93 12.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.756 -0.656 . . . . 10.0 110.571 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 92.8 mt -62.21 -51.22 75.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.323 -0.399 . . . . 10.0 110.628 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -62.05 -28.7 69.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.243 0.544 . . . . 10.0 110.329 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -63.64 -49.78 71.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.422 -0.808 . . . . 10.0 110.064 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.47 -34.18 77.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.778 -0.647 . . . . 10.0 110.969 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 72.5 t -61.44 -42.65 94.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.964 0.412 . . . . 10.0 110.678 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 24.1 mtm180 -75.03 -24.25 58.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.018 -0.537 . . . . 10.0 111.143 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -74.78 -46.34 37.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.021 0.439 . . . . 10.0 110.81 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 17.6 mt . . . . . 0 C--N 1.326 -0.452 0 CA-C-N 116.008 -0.542 . . . . 10.0 111.14 -179.724 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.163 0 CA-C-O 121.171 0.51 . . . . 10.0 110.471 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 86.5 mmm -109.14 111.01 22.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.7 -0.682 . . . . 10.0 109.914 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -107.87 157.65 17.99 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.268 -0.424 . . . . 10.0 110.462 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -117.38 135.07 54.13 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.486 -0.325 . . . . 10.0 110.284 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 21.2 pt -126.84 29.13 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.176 -0.465 . . . . 10.0 111.113 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 149.97 -172.1 29.89 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.929 -0.653 . . . . 10.0 111.616 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -69.24 105.87 2.67 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.555 0.178 . . . . 10.0 110.735 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER 76.01 -12.8 0.96 Allowed 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.71 0.633 . . . . 10.0 112.71 178.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -79.75 113.87 18.24 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.861 -0.422 . . . . 10.0 109.861 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -119.88 161.79 20.24 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.439 0.638 . . . . 10.0 112.15 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 95.2 t -119.84 114.5 44.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.0 -1.0 . . . . 10.0 108.361 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 4.9 t -104.04 106.59 17.15 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.0 0.428 . . . . 10.0 111.571 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 31.2 t -104.9 110.01 29.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.972 -0.751 . . . . 10.0 108.972 178.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 7.0 ptt-85 -151.73 163.02 40.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.941 0.4 . . . . 10.0 111.686 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -82.64 113.38 20.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.823 -0.626 . . . . 10.0 109.984 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -105.24 84.25 2.08 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.364 -0.38 . . . . 10.0 110.787 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 59.0 mttm 62.41 43.6 7.91 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.69 -0.686 . . . . 10.0 111.477 178.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 86.87 35.52 9.93 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.528 -0.844 . . . . 10.0 112.429 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 19.1 mmtm -150.84 115.71 5.26 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 122.196 0.198 . . . . 10.0 110.557 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 28.4 t -75.82 90.21 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.692 -0.855 . . . . 10.0 108.692 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 45.6 mt -95.21 130.99 41.74 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.358 0.599 . . . . 10.0 111.98 -178.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 82' ' ' ILE . . . . . . . . . . . . . 3.1 mp -103.13 91.06 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 107.799 -1.185 . . . . 10.0 107.799 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -89.85 104.46 17.02 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.588 -0.733 . . . . 10.0 111.69 -178.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 54.3 mt -87.28 97.56 6.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 107.501 -1.296 . . . . 10.0 107.501 177.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -132.0 150.28 52.2 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.886 -0.597 . . . . 10.0 112.127 -176.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -83.55 128.49 34.56 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.85 -0.796 . . . . 10.0 108.85 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 87' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -103.01 122.14 44.01 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.971 0.415 . . . . 10.0 110.546 -179.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 88' ' ' TRP . . . . . . . . . . . . . 22.4 m0 -99.92 136.88 39.16 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.859 -0.609 . . . . 10.0 109.851 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 44.2 ttm -73.33 141.02 47.11 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.109 0.481 . . . . 10.0 110.864 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 90' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.37 165.45 13.53 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 115.605 -0.725 . . . . 10.0 110.238 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -55.09 -29.71 66.89 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.113 2.542 . . . . 10.0 113.815 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.75 -35.24 72.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.966 0.412 . . . . 10.0 110.384 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 119.52 20.26 3.95 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.639 -0.791 . . . . 10.0 112.966 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -111.56 160.68 16.96 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.88 0.34 . . . . 10.0 110.366 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 95' ' ' MET . . . . . . . . . . . . . 84.6 mmm -98.11 111.2 23.6 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.73 -0.47 . . . . 10.0 109.73 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 49.8 mmtt -100.66 135.98 19.99 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.231 -0.44 . . . . 10.0 111.01 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -63.0 118.88 5.77 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.394 2.063 . . . . 10.0 111.845 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . -68.57 167.95 43.67 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.741 -0.743 . . . . 10.0 112.039 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 5.4 mtm180 -82.26 47.97 1.21 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.192 0.52 . . . . 10.0 110.98 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -161.78 104.87 1.21 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.689 -0.687 . . . . 10.0 110.418 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -173.93 161.13 31.37 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 110.805 -0.918 . . . . 10.0 110.805 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 7.5 tp -119.8 122.46 68.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.298 0.57 . . . . 10.0 111.244 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -94.37 104.84 16.81 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.825 -0.625 . . . . 10.0 110.254 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 83.9 mt -98.27 163.62 12.64 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.231 -0.441 . . . . 10.0 110.628 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 45.4 p30 -115.83 169.95 6.32 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 108.652 -0.87 . . . . 10.0 108.652 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -53.61 -30.38 54.94 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.283 1.988 . . . . 10.0 112.445 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -65.02 -56.53 12.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.601 -0.727 . . . . 10.0 110.799 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -72.49 -27.52 62.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.258 -0.428 . . . . 10.0 110.409 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 109' ' ' TRP . . . . . . . . . . . . . 34.9 t-105 -65.92 -36.78 84.33 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.962 -0.755 . . . . 10.0 108.962 177.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 29.2 t -64.35 -51.16 64.75 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.322 -0.854 . . . . 10.0 109.437 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -62.22 -36.1 80.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.757 -0.656 . . . . 10.0 111.076 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 52.7 tp -59.25 -44.24 92.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.92 0.39 . . . . 10.0 110.069 178.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -66.38 -30.54 70.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.926 -0.579 . . . . 10.0 110.751 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -79.75 -25.8 40.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.19 -0.459 . . . . 10.0 111.01 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -84.03 -10.44 57.87 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.337 -0.392 . . . . 10.0 111.217 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 73.0 mt -56.53 -43.29 77.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.375 -0.375 . . . . 10.0 111.787 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.23 -28.75 68.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.871 0.367 . . . . 10.0 111.695 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.79 -43.09 12.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.304 -0.407 . . . . 10.0 110.99 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 78.5 mt -67.26 -46.1 84.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.14 -0.482 . . . . 10.0 110.773 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.88 -43.84 77.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.019 -0.537 . . . . 10.0 110.828 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -61.32 -37.52 83.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.525 -0.761 . . . . 10.0 111.242 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.49 -41.64 54.87 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.354 -0.385 . . . . 10.0 111.15 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 77.1 t -62.9 -42.5 96.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.197 -0.456 . . . . 10.0 111.441 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 20.1 ptt180 -73.41 -6.77 48.37 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.801 0.297 . . . . 10.0 111.801 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 63.7 mttt . . . . . 0 C--N 1.327 -0.371 0 CA-C-O 121.025 0.441 . . . . 10.0 110.734 179.493 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 110.282 -0.266 . . . . 10.0 110.282 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.88 122.73 48.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.805 0.336 . . . . 10.0 111.162 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -117.95 144.13 45.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.106 -0.497 . . . . 10.0 110.122 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -84.2 125.25 32.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.928 0.394 . . . . 10.0 110.76 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.3 pt -115.88 16.36 7.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.198 -0.456 . . . . 10.0 110.478 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 154.75 176.24 26.77 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.594 -0.602 . . . . 10.0 111.594 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 51.8 tttp -65.61 120.17 12.45 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.688 0.28 . . . . 10.0 110.731 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 59.7 mmm 66.18 24.67 10.77 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.54 -0.755 . . . . 10.0 112.05 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -132.18 119.81 21.39 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.201 -0.296 . . . . 10.0 110.201 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -128.3 135.23 49.33 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.054 0.454 . . . . 10.0 111.751 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 41.4 t -90.05 107.33 18.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 108.696 -0.853 . . . . 10.0 108.696 178.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.8 m -94.9 90.35 5.97 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.943 0.401 . . . . 10.0 111.799 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 45.5 t -78.11 111.08 14.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.886 -0.783 . . . . 10.0 108.886 178.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.1 ptt180 -138.08 -167.01 2.08 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.106 -0.497 . . . . 10.0 110.596 -178.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -126.76 139.62 52.99 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.257 -0.428 . . . . 10.0 110.127 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -148.03 112.85 5.42 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.226 -0.443 . . . . 10.0 110.125 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.8 mtmp? 68.42 15.11 9.22 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.755 -0.657 . . . . 10.0 111.234 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 100.21 0.39 55.9 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.278 -0.963 . . . . 10.0 112.485 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.3 mtpt -109.38 132.51 54.06 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.214 -0.291 . . . . 10.0 110.214 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 43.8 t -70.74 107.32 2.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.204 -0.665 . . . . 10.0 109.204 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.7 mt -97.21 113.54 25.15 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.235 0.54 . . . . 10.0 112.376 -178.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 70.4 mt -89.1 89.38 3.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 107.322 -1.362 . . . . 10.0 107.322 177.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -79.2 101.9 8.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.499 -0.773 . . . . 10.0 112.655 -177.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.5 mt -94.34 81.25 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.537 -0.912 . . . . 10.0 108.537 178.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.9 ttm180 -117.07 155.19 29.68 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.675 -0.693 . . . . 10.0 110.961 -178.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -72.0 139.22 48.49 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.518 -0.549 . . . . 10.0 109.518 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -118.29 111.58 18.95 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.956 0.408 . . . . 10.0 110.229 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -103.02 145.65 29.56 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.761 -0.654 . . . . 10.0 109.897 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 40.8 ttm -87.62 137.74 32.08 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.112 -0.329 . . . . 10.0 110.112 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 53.0 p-10 -99.35 177.57 1.53 Allowed Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.071 -0.513 . . . . 10.0 110.275 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -63.95 -12.46 32.15 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.513 2.142 . . . . 10.0 113.018 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -88.16 -16.76 32.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.291 0.567 . . . . 10.0 110.073 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.11 14.75 55.65 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.637 -0.71 . . . . 10.0 111.745 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -94.51 157.73 15.86 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.052 0.453 . . . . 10.0 110.751 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 87.1 mmm -92.64 108.71 20.19 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.181 -0.674 . . . . 10.0 109.181 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.2 mmmm -108.62 128.91 24.68 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 116.154 -0.475 . . . . 10.0 111.099 -178.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.06 139.14 32.21 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.348 2.032 . . . . 10.0 112.283 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -84.16 -169.36 45.31 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.433 -0.667 . . . . 10.0 111.433 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.03 -7.72 51.09 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 117.3 0.55 . . . . 10.0 110.969 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 21.2 ttmt -100.25 113.9 26.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.173 -0.467 . . . . 10.0 110.108 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -175.7 168.66 41.11 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.85 -0.691 . . . . 10.0 111.8 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 17.2 tt -139.58 121.53 16.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.332 0.587 . . . . 10.0 111.006 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.77 113.0 24.68 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.952 -0.567 . . . . 10.0 109.704 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 25.2 mt -111.68 133.64 53.79 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.011 -0.54 . . . . 10.0 110.379 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.5 p30 -91.55 172.82 6.03 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 109.32 -0.622 . . . . 10.0 109.32 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -42.77 -37.91 6.22 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 123.505 2.803 . . . . 10.0 114.282 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -57.03 -49.56 75.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.645 0.26 . . . . 10.0 111.02 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.4 -33.54 63.04 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 110.032 -0.358 . . . . 10.0 110.032 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 69.1 t-105 -57.91 -53.66 55.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.878 -0.601 . . . . 10.0 110.911 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.7 m -61.95 -42.52 99.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.296 -0.411 . . . . 10.0 110.748 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -64.35 -41.47 96.73 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.306 -0.406 . . . . 10.0 110.731 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 61.2 tp -61.91 -43.89 97.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 10.0 110.615 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt -61.71 -27.83 68.98 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.925 0.393 . . . . 10.0 110.735 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -77.15 -38.19 52.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.096 0.475 . . . . 10.0 110.312 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -76.42 -18.88 58.6 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.74 -0.664 . . . . 10.0 111.541 -179.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 44.4 mt -51.62 -39.61 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 112.072 0.397 . . . . 10.0 112.072 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 18.1 m -65.31 -17.52 64.58 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.968 0.359 . . . . 10.0 111.968 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.08 -34.29 8.47 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.745 -0.465 . . . . 10.0 109.745 178.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 83.0 mt -64.68 -48.72 83.53 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-N 115.827 -0.624 . . . . 10.0 109.966 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -58.31 -38.47 77.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.448 -0.796 . . . . 10.0 110.326 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -65.87 -41.58 91.44 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.217 -0.902 . . . . 10.0 110.561 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.23 -37.95 89.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.87 -0.605 . . . . 10.0 110.874 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 95.6 t -62.41 -40.66 88.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 10.0 110.35 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.1 mtt85 -68.92 -30.43 68.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.831 -0.622 . . . . 10.0 110.872 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 16.9 mttp -71.21 -25.52 62.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.089 0.471 . . . . 10.0 110.762 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 62.3 mt . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 116.064 -0.516 . . . . 10.0 110.522 179.783 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.264 0 CA-C-O 121.143 0.497 . . . . 10.0 110.566 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 88.0 mmm -119.12 99.29 6.63 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.562 -0.745 . . . . 10.0 110.088 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -101.54 139.22 37.49 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.922 -0.581 . . . . 10.0 110.33 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -93.52 139.62 30.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.049 0.452 . . . . 10.0 111.708 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 5.8 pt -138.0 94.33 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.507 -0.769 . . . . 10.0 109.529 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.64 -135.98 12.45 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.669 -0.777 . . . . 10.0 111.387 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -117.63 120.96 39.63 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.369 -0.234 . . . . 10.0 110.369 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' MET . . . . . . . . . . . . . 96.4 mmm 65.26 2.11 1.8 Allowed 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.817 0.673 . . . . 10.0 112.817 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' ARG . . . . . . . . . . . . . 2.3 tpp180 -98.95 126.36 44.62 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.819 -0.438 . . . . 10.0 109.819 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -130.66 142.67 50.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.514 0.673 . . . . 10.0 112.3 -178.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 62.1 t -93.41 110.44 23.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.586 -0.894 . . . . 10.0 108.586 178.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 13.3 t -100.4 103.29 14.66 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.14 0.495 . . . . 10.0 111.919 -178.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 19.3 t -96.2 98.33 7.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 108.943 -0.762 . . . . 10.0 108.943 178.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 19.6 ptt-85 -131.51 155.07 48.06 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.221 0.534 . . . . 10.0 111.966 -178.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -95.79 113.43 25.07 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.288 -0.869 . . . . 10.0 109.871 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -92.77 78.6 4.78 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.379 -0.373 . . . . 10.0 110.526 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 90.1 mttt 56.53 57.53 4.79 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.743 -0.662 . . . . 10.0 111.092 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.27 29.56 33.21 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.636 -0.792 . . . . 10.0 112.02 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -142.21 88.97 2.13 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.744 0.307 . . . . 10.0 110.252 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 12.0 t -70.01 102.31 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.408 -0.589 . . . . 10.0 109.408 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 37.0 mt -117.98 132.34 56.4 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.014 0.435 . . . . 10.0 111.366 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 82' ' ' ILE . . . . . . . . . . . . . 4.1 mp -91.65 86.9 2.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 108.138 -1.06 . . . . 10.0 108.138 178.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -89.78 95.89 10.44 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.315 -0.857 . . . . 10.0 110.937 -178.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 21.7 mt -78.67 116.41 22.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 108.217 -1.031 . . . . 10.0 108.217 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 20.3 ttm-85 -142.38 151.42 41.85 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.296 0.57 . . . . 10.0 112.163 -177.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -89.8 162.88 15.29 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.669 -0.696 . . . . 10.0 109.373 178.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 87' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -111.79 129.81 56.01 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.056 0.455 . . . . 10.0 111.251 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 88' ' ' TRP . . . . . . . . . . . . . 24.3 m95 -117.03 145.89 43.41 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.394 -0.965 . . . . 10.0 108.394 178.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 30.1 ttm -108.65 137.71 46.15 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.549 -0.461 . . . . 10.0 110.469 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 90' ' ' ASP . . . . . . . . . . . . . 55.1 p30 -93.83 171.78 6.62 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.165 -0.471 . . . . 10.0 110.644 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -64.65 -13.3 38.21 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.619 2.213 . . . . 10.0 113.098 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -82.71 -41.64 19.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.893 0.378 . . . . 10.0 110.048 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 119.87 27.84 2.01 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 121.085 -0.579 . . . . 10.0 111.886 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.24 151.39 27.4 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.965 0.412 . . . . 10.0 110.341 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 95' ' ' MET . . . . . . . . . . . . . 82.4 mmm -90.01 112.05 23.34 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.854 -0.612 . . . . 10.0 109.99 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 61.2 mmtt -111.17 140.5 22.92 Favored Pre-proline 0 C--N 1.318 -0.786 0 CA-C-N 116.444 -0.344 . . . . 10.0 110.522 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -63.22 131.38 32.05 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 122.607 2.205 . . . . 10.0 111.843 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . -68.69 160.88 51.63 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 121.151 -0.547 . . . . 10.0 112.835 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -71.83 -23.5 61.55 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.878 0.371 . . . . 10.0 110.877 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -88.45 142.84 27.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.195 -0.457 . . . . 10.0 110.378 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . 138.98 163.47 9.52 Favored Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 111.503 -0.639 . . . . 10.0 111.503 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 20.0 tt -145.39 142.99 22.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.888 0.375 . . . . 10.0 110.97 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.11 110.87 23.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.911 -0.586 . . . . 10.0 110.194 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 94.8 mt -95.49 133.98 38.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.779 0.323 . . . . 10.0 110.914 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -88.54 168.85 14.91 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.471 -0.566 . . . . 10.0 109.471 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -45.69 -37.78 16.27 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.995 2.463 . . . . 10.0 113.836 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -68.14 -52.98 28.52 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.972 0.415 . . . . 10.0 110.314 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -62.58 -34.69 77.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.738 -0.664 . . . . 10.0 110.854 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 109' ' ' TRP . . . . . . . . . . . . . 34.7 t-105 -59.4 -43.74 92.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.114 -0.493 . . . . 10.0 110.143 178.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 19.3 t -67.97 -46.93 69.98 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.974 -0.557 . . . . 10.0 110.012 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -58.22 -41.71 84.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.949 -0.569 . . . . 10.0 110.841 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 43.2 tp -57.79 -46.93 83.92 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.926 0.393 . . . . 10.0 110.09 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -65.13 -33.91 77.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.902 -0.59 . . . . 10.0 110.882 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -74.4 -38.43 63.1 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.859 -0.61 . . . . 10.0 112.026 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -79.06 -5.37 53.84 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.8 0.296 . . . . 10.0 111.8 -179.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 25.7 mt -53.32 -41.26 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.784 -0.189 . . . . 10.0 111.396 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.26 -37.42 72.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.289 -0.414 . . . . 10.0 111.889 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.09 -45.29 16.7 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.864 0.364 . . . . 10.0 110.918 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 71.1 mt -59.82 -52.48 60.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.839 -0.619 . . . . 10.0 110.988 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -61.08 -39.06 88.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.925 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -58.54 -38.84 78.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.958 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -78.47 -38.55 40.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.268 -0.423 . . . . 10.0 111.054 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 89.1 t -66.93 -35.45 74.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.34 -0.391 . . . . 10.0 111.466 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -81.7 -6.33 58.94 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 111.875 0.324 . . . . 10.0 111.875 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 91.4 mttt . . . . . 0 C--N 1.326 -0.439 0 CA-C-O 121.103 0.478 . . . . 10.0 111.131 -179.565 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 110.364 -0.235 . . . . 10.0 110.364 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 41.2 ttm -135.83 110.09 8.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.032 0.444 . . . . 10.0 110.643 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -100.37 169.49 9.07 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.426 -0.583 . . . . 10.0 109.426 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -132.35 132.55 43.02 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.899 -0.321 . . . . 10.0 110.92 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 22.7 pt -117.79 -2.09 9.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.977 0.418 . . . . 10.0 110.999 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 176.99 173.91 42.96 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.838 -0.696 . . . . 10.0 111.724 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -63.91 126.99 29.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.837 0.319 . . . . 10.0 110.225 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 87.1 mmm 64.16 17.65 10.8 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.794 -0.639 . . . . 10.0 111.326 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -128.93 109.17 11.01 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 109.948 -0.39 . . . . 10.0 109.948 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -121.76 160.23 25.01 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.789 -178.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 40.9 t -111.69 114.64 47.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.968 -0.56 . . . . 10.0 110.126 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.94 119.4 27.11 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.765 -0.652 . . . . 10.0 110.523 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 74.7 t -132.6 106.77 11.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.682 -0.488 . . . . 10.0 109.682 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.3 ptt180 -155.53 169.83 23.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.661 0.267 . . . . 10.0 111.014 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.72 132.46 45.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.045 -0.525 . . . . 10.0 109.94 178.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -145.17 117.41 8.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.632 -0.258 . . . . 10.0 110.731 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 74.7 mttt 61.8 -86.75 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.804 -0.635 . . . . 10.0 111.176 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -148.39 31.03 1.28 Allowed Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 111.439 -0.664 . . . . 10.0 111.439 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.9 ttmt -158.17 169.48 24.43 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.563 -0.532 . . . . 10.0 109.563 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 58.8 t -86.36 119.42 34.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.014 0.435 . . . . 10.0 110.034 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.1 tp -84.06 101.82 12.06 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.836 -0.62 . . . . 10.0 110.675 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 15.1 mt -108.46 98.23 6.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.586 -0.894 . . . . 10.0 108.586 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -118.9 121.83 40.88 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.552 0.575 . . . . 10.0 112.552 -177.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 56.7 mt -100.71 103.58 15.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.115 -1.068 . . . . 10.0 108.115 177.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.408 ' NH2' ' SD ' ' C' ' 478' ' ' MET . 8.8 ttm-85 -145.98 160.46 41.82 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.931 0.396 . . . . 10.0 111.318 -177.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -63.75 141.44 58.77 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.648 -0.871 . . . . 10.0 108.648 177.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -113.6 120.54 41.28 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.105 0.479 . . . . 10.0 111.757 -178.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -102.51 155.17 18.45 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.296 -0.865 . . . . 10.0 108.899 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 25.2 ttt -82.42 139.16 34.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.385 0.612 . . . . 10.0 111.733 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -83.33 144.61 46.87 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 114.922 -1.036 . . . . 10.0 109.154 178.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -47.57 -33.47 18.08 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.862 2.375 . . . . 10.0 112.91 178.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -75.76 -59.38 2.78 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.338 -0.392 . . . . 10.0 110.72 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 169.44 -11.51 0.05 OUTLIER Glycine 0 CA--C 1.521 0.462 0 C-N-CA 120.107 -1.044 . . . . 10.0 114.029 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -79.33 -175.08 4.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 117.22 0.51 . . . . 10.0 111.31 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 57.2 mmm -134.62 141.92 46.75 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.277 -0.638 . . . . 10.0 109.277 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.2 mmtp -146.79 156.29 48.1 Favored Pre-proline 0 N--CA 1.464 0.238 0 CA-C-O 120.639 0.256 . . . . 10.0 111.281 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -63.4 153.7 72.91 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.289 2.659 . . . . 10.0 114.258 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -102.4 -110.41 3.4 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.057 -0.974 . . . . 10.0 112.28 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -122.59 -46.49 2.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.015 0.408 . . . . 10.0 111.874 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 16.1 mttp -71.15 104.79 3.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.702 0.287 . . . . 10.0 110.517 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 174.42 165.91 31.63 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.862 -0.685 . . . . 10.0 112.378 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 20.2 tt -146.63 142.03 20.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.99 0.424 . . . . 10.0 110.551 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.3 m -85.83 136.62 33.24 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.021 -0.536 . . . . 10.0 110.201 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 71.4 mt -93.12 105.23 17.35 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.272 -0.422 . . . . 10.0 110.886 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -62.38 141.43 96.41 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.363 -0.606 . . . . 10.0 109.363 178.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -47.12 -38.08 24.25 Favored 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 122.617 2.211 . . . . 10.0 112.474 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -77.61 -37.28 50.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.125 -0.488 . . . . 10.0 110.295 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -68.05 -31.43 71.08 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.711 -0.677 . . . . 10.0 110.612 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 54.2 t-105 -55.36 -45.63 76.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.88 -0.6 . . . . 10.0 110.797 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.8 t -69.12 -51.81 34.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.383 -0.372 . . . . 10.0 110.395 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -55.51 -42.87 75.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.004 -0.544 . . . . 10.0 111.534 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.6 tp -61.35 -47.85 84.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.644 0.259 . . . . 10.0 110.816 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -60.54 -37.72 82.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.005 0.431 . . . . 10.0 111.338 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -73.83 -31.62 63.3 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.061 -0.518 . . . . 10.0 111.39 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -81.07 -15.33 56.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.487 -0.324 . . . . 10.0 111.15 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.4 mt -49.77 -43.5 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 112.215 0.45 . . . . 10.0 112.215 -179.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.4 m -56.97 -37.43 71.58 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.763 0.316 . . . . 10.0 111.643 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -83.6 -39.77 19.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.012 0.434 . . . . 10.0 110.616 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 92.2 mt -60.19 -50.44 80.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.777 -0.647 . . . . 10.0 110.242 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -59.59 -37.14 77.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.392 -0.822 . . . . 10.0 110.559 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -66.21 -35.72 81.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.312 -0.858 . . . . 10.0 110.814 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -70.83 -33.5 70.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.885 -0.598 . . . . 10.0 110.559 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 60.5 t -62.24 -40.55 88.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.347 0.594 . . . . 10.0 110.118 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.8 mtm105 -74.35 -13.16 60.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.529 -0.759 . . . . 10.0 111.275 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 38.7 mttp -90.46 -2.62 57.94 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.911 0.386 . . . . 10.0 110.827 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 84.0 mt . . . . . 0 C--N 1.325 -0.458 0 CA-C-N 116.249 -0.432 . . . . 10.0 110.861 -179.948 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 121.067 0.46 . . . . 10.0 110.35 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 88.0 mmm -99.7 102.8 14.38 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.565 -0.743 . . . . 10.0 109.779 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -108.03 115.68 30.56 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.387 -0.369 . . . . 10.0 111.223 -179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -71.34 125.0 25.82 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.171 -0.468 . . . . 10.0 110.378 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 19.1 pt -116.6 2.85 7.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.005 -0.543 . . . . 10.0 110.286 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 170.66 -162.45 35.49 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.993 -0.622 . . . . 10.0 111.969 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.33 117.83 25.38 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 110.199 -0.297 . . . . 10.0 110.199 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' MET . . . . . . . . . . . . . 19.9 mmt 68.33 8.91 6.92 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.545 -0.752 . . . . 10.0 111.566 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -120.8 119.26 32.21 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.499 -0.556 . . . . 10.0 109.499 179.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -135.18 138.32 43.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.884 0.373 . . . . 10.0 111.2 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 75.5 t -89.94 117.78 33.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 108.631 -0.877 . . . . 10.0 108.631 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 24.5 t -111.48 109.87 20.03 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.036 0.446 . . . . 10.0 111.289 -178.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 20.4 t -92.73 94.86 4.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.193 -0.669 . . . . 10.0 109.193 178.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 26.5 ptt-85 -122.05 149.18 43.9 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.118 0.485 . . . . 10.0 111.546 -178.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -87.54 115.99 25.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.51 -0.768 . . . . 10.0 109.262 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -110.14 105.81 15.04 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.445 -0.343 . . . . 10.0 111.222 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 33.2 mttm 57.61 30.78 19.34 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.703 -0.68 . . . . 10.0 112.785 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 92.67 30.84 9.24 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.509 -0.853 . . . . 10.0 112.23 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 18.4 mmtm -144.22 108.13 4.71 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 122.367 0.267 . . . . 10.0 110.45 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 16.1 t -69.49 106.18 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.387 -0.597 . . . . 10.0 109.387 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 94.5 mt -111.02 128.88 56.0 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.027 0.441 . . . . 10.0 111.665 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' ILE . . . . . . . . . . . . . 5.2 mp -90.75 86.45 2.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 107.499 -1.297 . . . . 10.0 107.499 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -85.78 107.61 17.71 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.744 -0.662 . . . . 10.0 112.02 -177.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 63.4 mt -92.63 95.84 5.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 107.5 -1.296 . . . . 10.0 107.5 177.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 19.7 ttm-85 -132.84 168.84 17.66 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.504 0.669 . . . . 10.0 111.973 -177.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -89.25 154.95 19.71 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.214 -0.903 . . . . 10.0 109.348 178.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -131.47 118.8 20.69 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.909 -0.404 . . . . 10.0 109.909 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -108.28 136.61 47.64 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.976 -0.556 . . . . 10.0 109.798 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 52.4 ttm -75.55 130.99 39.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.072 0.463 . . . . 10.0 111.41 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' ASP . . . . . . . . . . . . . 35.0 p30 -84.79 172.23 9.37 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.579 -0.737 . . . . 10.0 109.774 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.89 -13.08 28.83 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.695 2.263 . . . . 10.0 112.863 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -84.72 -43.81 13.95 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.968 0.413 . . . . 10.0 110.254 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 129.57 16.26 1.88 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.945 -0.645 . . . . 10.0 112.317 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -109.74 147.02 33.94 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.725 0.298 . . . . 10.0 110.279 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' MET . . . . . . . . . . . . . 84.3 mmm -88.7 115.84 26.52 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 110.047 -0.353 . . . . 10.0 110.047 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -104.12 140.78 21.4 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 116.347 -0.388 . . . . 10.0 110.053 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.13 129.04 20.78 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.438 2.092 . . . . 10.0 112.159 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . -76.17 -173.63 36.17 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.107 -0.568 . . . . 10.0 112.199 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -88.3 -23.28 23.5 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.894 0.378 . . . . 10.0 111.202 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 7.0 mtmp? -88.08 113.81 24.09 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.282 0.563 . . . . 10.0 110.851 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . 169.13 175.67 38.6 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 110.894 -0.882 . . . . 10.0 110.894 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 21.1 tt -143.56 138.44 25.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 117.299 0.549 . . . . 10.0 111.425 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 1.5 m -98.33 107.71 20.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.781 -0.645 . . . . 10.0 109.986 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 46.3 mt -99.39 135.56 40.62 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.466 -0.334 . . . . 10.0 110.741 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -88.18 164.23 34.01 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 108.836 -0.802 . . . . 10.0 108.836 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -49.43 -32.26 26.04 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.179 2.586 . . . . 10.0 113.305 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -64.22 -57.95 8.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.266 -0.424 . . . . 10.0 110.69 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -66.88 -30.85 71.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.094 0.473 . . . . 10.0 109.949 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' TRP . . . . . . . . . . . . . 48.7 t-105 -59.54 -42.33 92.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.543 -0.753 . . . . 10.0 110.04 179.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 29.9 t -63.9 -47.61 79.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 10.0 109.784 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -61.05 -38.95 87.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.816 -0.629 . . . . 10.0 111.073 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 49.6 tp -58.6 -45.93 88.09 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.801 0.334 . . . . 10.0 110.373 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -66.25 -36.06 82.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.172 0.51 . . . . 10.0 110.984 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -74.06 -32.54 63.33 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.104 -0.498 . . . . 10.0 111.274 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -75.76 -11.86 60.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.194 -0.457 . . . . 10.0 111.213 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 58.0 mt -55.18 -39.65 52.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.501 -0.318 . . . . 10.0 111.26 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 4.9 m -59.36 -24.08 63.09 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.876 0.369 . . . . 10.0 111.523 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.02 -44.38 7.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.915 0.388 . . . . 10.0 110.752 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 61.5 mt -63.78 -46.82 93.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.997 -0.547 . . . . 10.0 111.397 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -57.63 -33.08 67.89 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.36 -0.382 . . . . 10.0 111.14 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -63.27 -42.55 99.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.291 -0.413 . . . . 10.0 110.912 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.2 -30.73 66.74 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.839 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 45.1 t -75.81 -38.09 36.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 10.0 110.968 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -78.72 -6.29 55.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 10.0 111.235 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 65.7 mttt -104.76 86.02 2.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.971 0.415 . . . . 10.0 110.273 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 66.4 mt . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.45 -0.786 . . . . 10.0 110.229 -179.956 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 465' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 . . . . . 0 N--CA 1.477 0.922 0 N-CA-C 110.437 -0.209 . . . . 10.0 110.437 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 466' ' ' GLY . . . . . . . . . . . . . . . -57.01 -44.98 92.8 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.251 -0.5 . . . . 10.0 112.685 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 467' ' ' ALA . . . . . . . . . . . . . . . -97.72 -26.14 14.84 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.644 -0.502 . . . . 10.0 109.644 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 468' ' ' LEU . . . . . . . . . . . . . 11.2 tp -57.22 -51.9 67.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.347 -0.842 . . . . 10.0 111.158 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 469' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -73.21 -34.87 66.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.123 0.487 . . . . 10.0 110.674 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 470' ' ' MET . . . . . . . . . . . . . 22.5 ttt -61.26 -50.68 72.07 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.628 -0.714 . . . . 10.0 110.464 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 471' ' ' ALA . . . . . . . . . . . . . . . -85.38 40.5 0.84 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.279 0.561 . . . . 10.0 110.605 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 472' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -133.28 -41.72 0.88 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.925 -0.769 . . . . 10.0 108.925 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 473' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -64.67 -30.71 71.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.378 -0.828 . . . . 10.0 110.017 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 474' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -84.45 0.5 49.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.781 -0.645 . . . . 10.0 111.701 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 475' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.2 -36.8 80.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.916 0.388 . . . . 10.0 110.849 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 476' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.39 -16.08 61.85 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.295 -0.412 . . . . 10.0 110.856 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 477' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -64.42 -39.05 93.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.89 -0.595 . . . . 10.0 110.012 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 478' ' ' MET . . . . . 0.408 ' SD ' ' NH2' ' A' ' 85' ' ' ARG . 1.5 ttt -98.46 -16.06 19.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.084 0.468 . . . . 10.0 109.938 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 479' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -67.71 -42.17 82.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.18 0.514 . . . . 10.0 109.741 178.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 480' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.16 19.5 5.78 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.895 -0.593 . . . . 10.0 110.539 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 481' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -129.64 -58.11 1.11 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.953 -0.567 . . . . 10.0 111.09 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 482' ' ' ALA . . . . . . . . . . . . . . . -93.35 -41.04 10.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.964 0.412 . . . . 10.0 110.763 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 483' ' ' LEU . . . . . . . . . . . . . 14.2 mt -82.99 9.38 10.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.99 -0.55 . . . . 10.0 110.921 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 484' ' ' GLY . . . . . . . . . . . . . . . -153.07 86.71 0.14 Allowed Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 110.941 -0.864 . . . . 10.0 110.941 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 485' ' ' ILE . . . . . . . . . . . . . 15.7 tt -174.9 -26.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.965 0.412 . . . . 10.0 111.138 -178.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 486' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.22 -24.79 37.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.81 0.338 . . . . 10.0 111.102 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 487' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.76 -0.33 53.36 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.641 -0.709 . . . . 10.0 109.894 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 488' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -73.52 -27.06 61.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.437 -0.801 . . . . 10.0 110.45 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 489' ' ' GLY . . . . . . . . . . . . . . . -179.98 128.28 1.2 Allowed Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 111.084 -0.807 . . . . 10.0 111.084 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.789 0 CA-C-O 118.321 -1.266 . . . . 10.0 111.377 -179.833 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.846 0 CA-C-O 120.899 0.38 . . . . 10.0 110.78 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 62.1 mtt -112.11 97.53 6.72 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.708 -0.478 . . . . 10.0 109.708 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -91.02 135.71 33.57 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.36 -0.382 . . . . 10.0 110.599 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -89.14 128.67 35.79 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.761 0.315 . . . . 10.0 110.41 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.9 pt -117.1 9.02 7.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.175 0.512 . . . . 10.0 110.497 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 159.88 173.27 28.16 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.719 -0.753 . . . . 10.0 111.945 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -61.92 117.59 6.12 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.648 0.261 . . . . 10.0 110.71 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 67.2 mmm 70.41 15.55 7.28 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.389 -0.823 . . . . 10.0 111.557 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -121.72 120.87 35.93 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 122.242 -0.286 . . . . 10.0 110.269 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -132.95 143.84 49.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.398 0.618 . . . . 10.0 111.916 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.2 t -108.83 111.14 34.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 108.312 -0.995 . . . . 10.0 108.312 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.9 m -101.92 116.39 32.6 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.249 0.547 . . . . 10.0 112.151 -178.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.9 t -103.94 110.73 31.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.409 -0.814 . . . . 10.0 109.581 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -157.8 179.71 8.95 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.101 0.477 . . . . 10.0 111.134 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -112.21 133.21 54.47 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.297 -0.865 . . . . 10.0 109.613 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -136.49 118.33 15.16 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.567 -0.288 . . . . 10.0 110.269 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 97.4 mttt 57.67 43.92 21.46 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 123.499 0.5 . . . . 10.0 111.596 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.25 40.99 94.97 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.707 -0.759 . . . . 10.0 111.51 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? -151.08 102.55 2.96 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.913 0.387 . . . . 10.0 110.121 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.5 t -77.93 121.85 31.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.403 -0.591 . . . . 10.0 109.403 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 24.1 mt -139.12 144.75 38.81 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.621 0.724 . . . . 10.0 112.176 -178.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.0 mt -104.12 98.98 7.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 114.591 -1.186 . . . . 10.0 108.004 178.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -94.19 121.35 35.6 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.554 0.576 . . . . 10.0 112.554 -177.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 22.8 mt -98.74 108.19 21.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 107.181 -1.415 . . . . 10.0 107.181 177.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.2 ttm180 -144.63 163.23 34.55 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.573 0.701 . . . . 10.0 112.864 -176.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -89.9 142.09 28.03 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.864 -1.062 . . . . 10.0 109.124 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -114.43 135.92 53.57 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.528 -0.306 . . . . 10.0 110.341 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 45.7 t90 -108.67 134.77 50.95 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.72 -0.474 . . . . 10.0 109.72 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 25.2 ttt -84.4 117.67 23.77 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.87 -0.419 . . . . 10.0 109.87 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.24 164.21 55.19 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.932 -0.576 . . . . 10.0 110.868 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -53.39 -33.13 65.23 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.088 2.525 . . . . 10.0 113.318 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -69.74 -57.38 5.19 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.009 -0.367 . . . . 10.0 110.009 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 146.12 21.1 0.12 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.461 -0.876 . . . . 10.0 112.775 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -106.95 149.15 27.8 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.803 0.335 . . . . 10.0 110.306 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 98.4 mmm -88.77 117.67 27.91 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.293 -0.412 . . . . 10.0 110.013 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -108.34 133.86 20.42 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.211 -0.449 . . . . 10.0 110.672 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.67 136.31 30.29 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.493 2.129 . . . . 10.0 112.157 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -85.15 -158.43 29.61 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.595 -0.812 . . . . 10.0 112.799 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.0 mtm180 -103.46 -22.38 13.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.869 0.366 . . . . 10.0 110.973 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 19.6 ttmt -82.65 82.96 7.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.239 -0.437 . . . . 10.0 110.478 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -152.9 165.77 31.22 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.604 -0.599 . . . . 10.0 111.604 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 12.0 tt -147.73 124.28 2.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.111 0.481 . . . . 10.0 111.226 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.3 m -94.62 125.69 39.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.801 -0.636 . . . . 10.0 110.387 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 76.6 mt -121.54 135.3 55.02 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.945 -0.391 . . . . 10.0 109.945 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -81.98 163.22 54.31 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 109.818 -0.438 . . . . 10.0 109.818 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -42.06 -38.98 5.49 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.614 2.876 . . . . 10.0 114.286 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.84 -49.25 77.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.533 -0.303 . . . . 10.0 110.865 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -67.96 -37.84 82.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.317 0.579 . . . . 10.0 109.687 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 23.5 t-105 -58.08 -43.29 86.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.272 -0.876 . . . . 10.0 110.709 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.7 t -65.32 -43.98 89.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.045 -0.525 . . . . 10.0 110.617 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -65.32 -36.12 83.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.431 -0.349 . . . . 10.0 110.841 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 48.6 tp -59.63 -41.14 89.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.429 . . . . 10.0 110.405 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -65.42 -31.08 71.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.997 -0.547 . . . . 10.0 111.394 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -77.43 -28.57 52.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.0 0.429 . . . . 10.0 111.367 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -85.06 -8.47 58.67 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.246 -0.434 . . . . 10.0 111.582 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 61.7 mt -53.99 -43.21 57.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 112.016 0.376 . . . . 10.0 112.016 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.14 -30.03 64.08 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.2 0.444 . . . . 10.0 112.2 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -89.79 -41.75 11.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.783 0.325 . . . . 10.0 110.539 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 72.1 mt -62.93 -48.4 88.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.938 -0.574 . . . . 10.0 111.054 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -63.59 -34.04 76.93 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.008 -0.542 . . . . 10.0 110.563 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -69.17 -41.09 77.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.637 -0.71 . . . . 10.0 109.855 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.65 -37.94 83.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.727 -0.67 . . . . 10.0 110.224 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 92.6 t -60.33 -42.01 89.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 121.228 0.537 . . . . 10.0 109.96 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.8 mtm105 -71.44 -37.12 71.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.606 -0.725 . . . . 10.0 110.786 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 30.3 mttp -65.67 -42.77 90.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.422 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 72.5 mt . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.041 -0.527 . . . . 10.0 110.74 179.488 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.191 0 CA-C-O 121.27 0.557 . . . . 10.0 110.599 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 82.6 mmm -92.49 96.55 10.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.83 -0.623 . . . . 10.0 109.759 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -79.62 113.59 17.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.207 -0.451 . . . . 10.0 110.805 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -98.22 128.11 44.51 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.851 -0.426 . . . . 10.0 109.851 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 20.5 pt -116.8 16.0 7.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.671 0.272 . . . . 10.0 111.706 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 158.11 -161.54 31.64 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.155 -1.021 . . . . 10.0 112.726 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 5.2 mtmp? -67.56 103.86 1.45 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.448 -0.376 . . . . 10.0 111.841 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' MET . . . . . . . . . . . . . 67.4 mmm 64.86 6.47 3.37 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.246 0.832 . . . . 10.0 113.246 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -100.39 121.49 41.6 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 121.783 -0.573 . . . . 10.0 110.696 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -122.67 149.25 44.29 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.706 -0.679 . . . . 10.0 110.45 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 96.0 t -98.61 103.08 14.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.257 -0.645 . . . . 10.0 109.257 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 10.2 t -88.39 88.11 7.51 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.819 -0.628 . . . . 10.0 111.18 -178.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 3.2 t -84.66 92.35 3.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.694 -0.854 . . . . 10.0 108.694 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 23.4 ptt-85 -126.28 147.93 49.61 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.272 0.558 . . . . 10.0 111.474 -178.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -79.89 115.62 19.58 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.286 -0.87 . . . . 10.0 110.436 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -86.72 61.68 6.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.176 -0.466 . . . . 10.0 110.889 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 30.0 mttm 62.53 58.6 1.64 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.85 -0.614 . . . . 10.0 111.051 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.56 21.29 37.79 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.839 -0.696 . . . . 10.0 111.682 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 62.2 mmtt -145.04 89.49 1.96 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.569 0.223 . . . . 10.0 110.531 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 20.2 t -66.44 105.67 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.636 -0.505 . . . . 10.0 109.636 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 79.7 mt -115.42 142.04 47.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.344 0.592 . . . . 10.0 111.456 -178.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' ILE . . . . . . . . . . . . . 5.3 mp -92.07 88.87 2.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.516 -0.92 . . . . 10.0 108.516 178.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -87.97 94.64 9.85 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.876 -0.602 . . . . 10.0 110.833 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 26.8 mt -81.65 95.25 2.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.255 -1.016 . . . . 10.0 108.255 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 17.4 ttm-85 -123.6 145.71 48.71 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.862 -0.608 . . . . 10.0 111.724 -177.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -76.06 128.39 34.9 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.531 -0.759 . . . . 10.0 109.109 178.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -98.96 101.38 12.75 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.072 0.463 . . . . 10.0 110.464 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -84.75 -176.55 6.27 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.561 -0.745 . . . . 10.0 109.789 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 41.6 ttm -133.43 135.11 44.39 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 110.014 -0.365 . . . . 10.0 110.014 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' ASP . . . . . . . . . . . . . 29.0 p30 -92.19 171.77 7.24 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 109.899 -0.408 . . . . 10.0 109.899 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -61.9 -18.9 63.66 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.448 2.098 . . . . 10.0 112.704 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -77.03 -40.6 45.85 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.225 0.535 . . . . 10.0 110.275 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 120.67 21.04 3.36 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.95 -0.643 . . . . 10.0 112.245 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -100.88 147.32 26.25 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.774 0.321 . . . . 10.0 110.7 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' MET . . . . . . . . . . . . . 82.9 mmm -88.54 96.18 10.52 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.321 -0.622 . . . . 10.0 109.321 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -94.52 128.87 38.42 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.887 -0.597 . . . . 10.0 111.631 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -66.16 128.33 19.33 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.578 2.185 . . . . 10.0 111.339 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . -74.11 -176.32 34.51 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 121.046 -0.597 . . . . 10.0 113.294 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 14.5 mmt180 -87.89 -32.88 18.74 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.959 0.409 . . . . 10.0 110.201 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 4.3 mtmp? -77.87 99.1 5.84 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.458 -0.792 . . . . 10.0 110.551 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -178.44 159.79 25.35 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 110.667 -0.973 . . . . 10.0 110.667 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 18.4 tt -131.12 142.41 43.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 117.196 0.498 . . . . 10.0 111.579 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.5 105.3 15.82 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.831 -0.622 . . . . 10.0 109.776 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 96.1 mt -93.33 142.27 27.51 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.792 0.329 . . . . 10.0 111.376 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 41.4 p-10 -93.01 164.71 20.61 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 108.633 -0.877 . . . . 10.0 108.633 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.93 -30.73 31.52 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.489 2.126 . . . . 10.0 112.669 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -66.71 -59.27 3.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.921 -0.581 . . . . 10.0 110.861 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -67.08 -29.83 69.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.488 -0.324 . . . . 10.0 110.639 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' TRP . . . . . . . . . . . . . 31.0 t-105 -60.56 -42.25 96.21 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.63 -0.507 . . . . 10.0 109.63 178.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 9.7 t -67.81 -45.4 74.83 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.505 -0.554 . . . . 10.0 109.505 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -57.97 -40.65 81.14 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.015 -0.539 . . . . 10.0 110.54 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 33.1 tp -59.64 -47.19 86.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.92 -0.582 . . . . 10.0 110.665 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -62.95 -34.63 77.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.101 0.477 . . . . 10.0 110.666 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -74.17 -30.17 62.12 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.801 -0.636 . . . . 10.0 110.787 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -82.51 -10.49 58.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.435 . . . . 10.0 111.71 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 55.8 mt -55.2 -34.82 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 120.708 0.29 . . . . 10.0 111.15 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 1.5 m -60.66 -21.4 62.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.265 -0.425 . . . . 10.0 111.601 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -106.17 -42.42 5.08 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.616 0.246 . . . . 10.0 110.663 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 60.6 mt -61.64 -52.03 65.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.885 0.374 . . . . 10.0 110.924 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -62.35 -38.12 88.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.873 -0.603 . . . . 10.0 111.083 -179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -62.03 -37.67 85.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.705 -0.679 . . . . 10.0 111.23 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.32 -20.4 57.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.266 -0.425 . . . . 10.0 111.864 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 78.1 t -58.21 -36.39 57.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.891 0.377 . . . . 10.0 111.416 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 6.6 ptp85 -102.68 14.4 32.04 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.359 -0.382 . . . . 10.0 111.141 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -127.42 56.73 1.53 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.017 0.437 . . . . 10.0 110.206 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 66.9 mt . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.698 -0.668 . . . . 10.0 110.459 -179.76 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 465' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.481 1.103 0 CA-C-O 120.666 0.27 . . . . 10.0 111.207 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 466' ' ' GLY . . . . . . . . . . . . . . . -67.38 -41.15 91.41 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.2 -0.524 . . . . 10.0 112.181 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 467' ' ' ALA . . . . . . . . . . . . . . . -108.59 -51.01 2.94 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.547 -0.538 . . . . 10.0 109.547 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 468' ' ' LEU . . . . . . . . . . . . . 86.8 mt -98.89 105.99 18.2 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.841 -0.618 . . . . 10.0 110.343 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 469' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -147.21 -55.94 0.24 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.03 -0.532 . . . . 10.0 110.283 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 470' ' ' MET . . . . . . . . . . . . . 45.9 ttm -74.0 -49.15 25.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 10.0 110.746 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 471' ' ' ALA . . . . . . . . . . . . . . . -67.57 -12.46 60.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.233 -0.439 . . . . 10.0 111.148 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 472' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.34 -23.09 66.3 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.907 -0.588 . . . . 10.0 110.948 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 473' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -68.49 -21.51 64.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.081 -0.509 . . . . 10.0 110.866 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 474' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -73.99 -23.27 59.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.989 0.424 . . . . 10.0 110.699 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 475' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -62.35 -27.95 69.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.703 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 476' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -70.0 -41.03 74.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.116 -0.493 . . . . 10.0 110.509 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 477' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -70.05 -36.93 75.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.338 0.589 . . . . 10.0 110.038 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 478' ' ' MET . . . . . . . . . . . . . 45.5 ttp -76.54 -12.22 59.99 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.013 -0.54 . . . . 10.0 110.458 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 479' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -91.76 -98.82 0.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 10.0 111.934 -178.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 480' ' ' THR . . . . . . . . . . . . . 2.8 m -73.59 -32.5 64.15 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.118 0.784 . . . . 10.0 113.118 -177.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 481' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -63.45 -47.23 82.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.777 0.322 . . . . 10.0 111.687 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 482' ' ' ALA . . . . . . . . . . . . . . . -60.75 -27.08 67.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.093 -0.503 . . . . 10.0 112.285 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 483' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.64 11.44 26.57 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.635 -0.257 . . . . 10.0 111.229 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 484' ' ' GLY . . . . . . . . . . . . . . . -110.19 -26.58 4.85 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.661 -0.781 . . . . 10.0 111.732 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 485' ' ' ILE . . . . . . . . . . . . . 19.1 tt -66.44 -31.76 55.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.773 0.321 . . . . 10.0 111.347 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 486' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -98.32 -36.69 9.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.641 -0.254 . . . . 10.0 110.716 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 487' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -61.17 -25.44 67.02 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.003 0.43 . . . . 10.0 110.267 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 488' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -53.89 -38.02 64.35 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 115.829 -0.623 . . . . 10.0 110.694 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 489' ' ' GLY . . . . . . . . . . . . . . . -108.23 -49.93 0.79 Allowed Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.641 -0.79 . . . . 10.0 112.388 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.868 0 CA-C-O 118.469 -1.184 . . . . 10.0 111.62 -179.7 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 120.943 0.401 . . . . 10.0 110.224 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 50.8 ttm -144.81 118.22 9.06 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.283 -0.417 . . . . 10.0 110.646 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -95.37 171.15 8.88 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.21 -0.45 . . . . 10.0 110.162 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -131.99 134.39 45.53 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.199 -0.297 . . . . 10.0 110.199 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 11.6 pt -122.08 12.19 5.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.106 0.479 . . . . 10.0 110.569 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 156.0 174.54 25.93 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.814 -0.708 . . . . 10.0 111.945 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -57.24 116.62 3.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.622 0.249 . . . . 10.0 111.376 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 2.5 mmt 69.46 11.7 8.09 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.356 -0.838 . . . . 10.0 112.45 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -111.71 104.13 12.46 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.415 -0.587 . . . . 10.0 109.415 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -120.43 145.72 46.93 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.355 0.597 . . . . 10.0 112.406 -178.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 36.6 t -99.16 105.99 18.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.001 -1.0 . . . . 10.0 108.92 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.6 m -88.39 113.4 23.96 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.885 0.374 . . . . 10.0 111.099 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 38.2 t -106.18 92.89 2.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.066 -0.515 . . . . 10.0 109.846 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -123.63 -171.15 2.26 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.086 -0.506 . . . . 10.0 109.985 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -102.51 160.17 14.79 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.626 0.251 . . . . 10.0 110.343 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -119.07 45.63 2.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.049 0.452 . . . . 10.0 110.522 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 11.2 mptt 55.65 41.5 30.45 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.274 0.559 . . . . 10.0 110.673 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 136.15 -42.41 1.33 Allowed Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 111.057 -0.817 . . . . 10.0 111.057 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -100.83 -167.36 1.42 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.703 -0.48 . . . . 10.0 109.703 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.0 m -105.72 142.53 18.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.738 0.304 . . . . 10.0 110.663 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.53 78.94 1.31 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.105 -0.498 . . . . 10.0 109.894 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 27.6 mt -101.46 88.27 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.062 -0.718 . . . . 10.0 109.062 178.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -113.28 135.9 53.34 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.347 0.594 . . . . 10.0 111.458 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 45.7 mt -108.19 96.07 4.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 108.407 -0.96 . . . . 10.0 108.407 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 -118.47 154.82 31.86 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.951 -0.568 . . . . 10.0 111.433 -178.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -73.98 124.37 26.09 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.728 -0.842 . . . . 10.0 108.728 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -103.99 121.54 43.37 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.931 0.396 . . . . 10.0 110.759 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -108.25 137.5 46.12 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.912 -0.585 . . . . 10.0 109.926 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 6.5 ttt -74.94 126.92 32.02 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.301 -0.409 . . . . 10.0 110.202 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 44.8 p30 -87.83 171.56 9.38 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 116.154 -0.476 . . . . 10.0 110.605 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -57.78 -24.95 66.38 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.855 2.37 . . . . 10.0 113.393 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -76.24 -30.87 58.07 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.961 0.41 . . . . 10.0 110.54 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 112.37 22.04 5.97 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.83 -0.7 . . . . 10.0 112.151 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -110.22 164.4 12.69 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.95 0.405 . . . . 10.0 110.369 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 94.2 mmm -96.9 114.23 25.84 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.062 -0.517 . . . . 10.0 109.809 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 13.7 mmtp -113.81 131.69 22.97 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.226 -0.443 . . . . 10.0 110.493 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.06 133.84 34.73 Favored 'Trans proline' 0 C--O 1.233 0.264 0 C-N-CA 122.554 2.169 . . . . 10.0 112.408 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -81.81 -128.38 1.03 Allowed Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.984 -0.627 . . . . 10.0 113.202 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -110.07 -34.28 6.44 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.648 0.261 . . . . 10.0 111.556 -178.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.1 mtmt -86.87 117.07 25.36 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.188 0.518 . . . . 10.0 111.741 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -166.8 155.17 26.15 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.716 -0.953 . . . . 10.0 110.716 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 7.9 tp -134.82 130.6 52.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 117.494 0.647 . . . . 10.0 111.9 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.8 m -92.26 116.01 28.59 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.146 -0.934 . . . . 10.0 109.661 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 82.3 mt -109.56 113.05 25.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.032 0.444 . . . . 10.0 110.958 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -81.99 169.3 19.04 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.989 -0.55 . . . . 10.0 110.091 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -44.41 -47.88 10.54 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 123.064 2.509 . . . . 10.0 113.855 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.0 tp10 -67.35 -50.94 57.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.488 0.185 . . . . 10.0 110.767 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -55.53 -46.65 77.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.316 -0.402 . . . . 10.0 111.193 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 56.0 t-105 -62.25 -42.87 99.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.908 0.385 . . . . 10.0 110.586 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 50.0 m -64.3 -46.71 82.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 10.0 110.757 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -65.6 -37.74 87.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.478 -0.328 . . . . 10.0 110.557 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.6 tp -57.72 -43.42 85.27 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.279 -0.418 . . . . 10.0 110.81 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -62.23 -36.98 83.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.293 -0.412 . . . . 10.0 110.89 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -81.77 -17.07 48.97 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.106 0.479 . . . . 10.0 111.044 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -85.53 -18.67 32.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.197 -0.456 . . . . 10.0 110.283 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 86.0 mt -54.12 -40.39 46.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.133 -0.485 . . . . 10.0 111.311 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.28 -25.04 61.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 10.0 111.758 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.42 -35.52 9.54 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.872 0.368 . . . . 10.0 110.763 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 83.9 mt -64.75 -47.59 88.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.922 -0.581 . . . . 10.0 110.86 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.14 -32.33 73.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 10.0 110.813 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -64.48 -41.4 96.49 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.815 -0.629 . . . . 10.0 110.124 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.96 -35.66 80.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.997 -0.547 . . . . 10.0 110.32 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 88.4 t -62.91 -37.85 80.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.943 -0.571 . . . . 10.0 110.215 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 16.5 mtm105 -75.2 -25.28 58.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.977 -0.556 . . . . 10.0 111.012 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -78.53 -20.14 51.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.331 -0.395 . . . . 10.0 111.352 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 12.6 mt . . . . . 0 C--N 1.321 -0.659 0 CA-C-N 116.586 -0.279 . . . . 10.0 110.437 179.971 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.094 0 CA-C-O 121.181 0.515 . . . . 10.0 110.683 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 59.1 mtm -103.3 128.3 50.39 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.903 -0.589 . . . . 10.0 109.874 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -114.21 128.12 56.21 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.156 -0.474 . . . . 10.0 110.161 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -79.68 134.09 36.4 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.093 0.473 . . . . 10.0 111.316 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 6.4 pt -112.42 -26.08 3.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.707 -0.679 . . . . 10.0 110.398 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -167.84 -174.53 36.86 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.771 -0.932 . . . . 10.0 110.771 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 14.8 mttp -70.8 127.64 33.33 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.069 0.462 . . . . 10.0 111.057 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' MET . . . . . . . . . . . . . 39.2 mmm 64.26 25.88 13.63 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.057 -0.974 . . . . 10.0 111.703 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -140.11 115.25 9.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.484 -0.325 . . . . 10.0 110.233 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -126.61 133.15 51.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.045 -0.525 . . . . 10.0 110.758 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 86.6 t -88.75 115.21 28.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.048 -0.523 . . . . 10.0 109.611 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 8.1 m -90.68 101.25 14.0 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.946 0.403 . . . . 10.0 111.076 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 8.9 t -97.58 99.34 8.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.168 -0.469 . . . . 10.0 110.003 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -160.03 166.43 29.97 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.258 -0.428 . . . . 10.0 110.211 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.87 145.32 26.62 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.203 0.525 . . . . 10.0 110.333 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -126.98 100.71 6.25 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 109.132 -0.692 . . . . 10.0 109.132 178.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 66.6 mttm 67.33 33.78 5.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.402 -0.817 . . . . 10.0 111.009 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 96.39 -9.94 67.13 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.734 -0.745 . . . . 10.0 112.971 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 32.2 mmtt -109.25 113.71 26.78 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.66 0.23 . . . . 10.0 110.919 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 14.3 t -64.33 117.76 5.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.612 -0.514 . . . . 10.0 109.612 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 97.8 mt -125.73 129.3 49.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.174 0.511 . . . . 10.0 111.699 -178.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' ILE . . . . . . . . . . . . . 5.2 mp -93.25 95.82 5.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 108.08 -1.081 . . . . 10.0 108.08 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -85.73 107.31 17.54 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.939 -0.573 . . . . 10.0 111.991 -177.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 12.0 mt -99.23 83.91 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.071 -1.085 . . . . 10.0 108.071 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 6.1 ttm180 -123.89 162.75 22.67 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.711 -0.677 . . . . 10.0 111.089 -177.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -70.19 153.06 43.56 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.48 -0.933 . . . . 10.0 108.48 177.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -140.46 111.16 6.85 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.184 0.516 . . . . 10.0 110.783 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' TRP . . . . . . . . . . . . . 20.6 m0 -108.64 -170.81 1.73 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.513 -0.767 . . . . 10.0 109.356 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 33.3 ttm -127.82 142.66 51.23 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 110.146 -0.316 . . . . 10.0 110.146 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' ASP . . . . . . . . . . . . . 36.9 p30 -99.83 169.94 7.4 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 116.17 -0.468 . . . . 10.0 110.522 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -59.93 -20.58 60.68 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.713 2.276 . . . . 10.0 112.362 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -73.76 -43.34 59.28 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.994 0.426 . . . . 10.0 110.007 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 118.79 26.54 2.53 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.955 -0.64 . . . . 10.0 112.244 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -113.33 152.22 30.2 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.841 0.353 . . . . 10.0 110.625 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' MET . . . . . . . . . . . . . 95.6 mmm -82.78 105.15 13.56 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.073 -0.714 . . . . 10.0 109.073 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -103.37 145.93 31.51 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.765 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.02 146.94 94.82 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.576 2.184 . . . . 10.0 111.849 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . -73.89 -140.72 0.56 Allowed Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.728 -0.669 . . . . 10.0 112.617 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 2.4 mtp-105 -102.64 -32.76 9.73 Favored 'General case' 0 C--N 1.32 -0.714 0 O-C-N 122.382 -0.481 . . . . 10.0 111.109 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -127.7 157.1 41.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.243 0.545 . . . . 10.0 111.396 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . 171.15 160.86 20.71 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 110.507 -1.037 . . . . 10.0 110.507 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 20.5 tt -133.1 140.8 46.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 117.95 0.875 . . . . 10.0 111.544 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -101.62 112.19 24.68 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.054 -0.521 . . . . 10.0 110.013 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 52.1 mt -97.72 134.86 40.32 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.822 0.344 . . . . 10.0 110.615 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -88.97 168.98 14.13 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 108.915 -0.772 . . . . 10.0 108.915 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -48.8 -38.73 38.28 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.608 2.205 . . . . 10.0 113.414 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -67.01 -54.7 19.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.63 -0.259 . . . . 10.0 111.172 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -61.74 -35.69 78.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.442 -0.345 . . . . 10.0 110.509 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' TRP . . . . . . . . . . . . . 65.7 t-105 -61.87 -41.23 97.6 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.106 -0.497 . . . . 10.0 109.699 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 25.3 t -63.62 -46.61 84.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.489 . . . . 10.0 109.719 178.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -58.37 -40.17 81.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.881 -0.6 . . . . 10.0 110.815 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 53.5 tp -60.94 -41.4 96.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 10.0 110.461 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -68.85 -36.09 77.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.15 0.5 . . . . 10.0 110.737 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -73.79 -25.15 59.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.828 -0.624 . . . . 10.0 111.332 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -86.78 -4.89 59.23 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.302 -0.408 . . . . 10.0 111.397 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 61.7 mt -57.27 -41.38 78.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 120.778 0.323 . . . . 10.0 110.881 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 5.7 m -64.83 -11.95 42.85 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.146 -0.479 . . . . 10.0 112.21 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.25 -47.21 3.57 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.83 0.348 . . . . 10.0 110.447 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 61.9 mt -66.35 -45.95 88.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.102 -0.499 . . . . 10.0 111.817 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -62.13 -36.23 81.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.728 0.299 . . . . 10.0 111.236 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -67.87 -34.89 77.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.983 0.421 . . . . 10.0 110.26 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.48 -37.53 80.22 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.718 -0.475 . . . . 10.0 109.718 178.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 83.9 t -64.81 -42.36 94.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.896 -0.593 . . . . 10.0 110.58 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -75.65 -5.9 47.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.795 0.331 . . . . 10.0 110.91 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 43.2 mttp -104.65 1.43 29.52 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.377 -0.374 . . . . 10.0 110.572 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 82.5 mt . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.73 -0.653 . . . . 10.0 109.813 179.713 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 465' ' ' TYR . . . . . . . . . . . . . 58.1 t80 . . . . . 0 N--CA 1.48 1.046 0 CA-C-O 120.282 0.087 . . . . 10.0 111.165 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 466' ' ' GLY . . . . . . . . . . . . . . . -54.5 -40.17 68.65 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 121.566 -0.349 . . . . 10.0 113.522 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 467' ' ' ALA . . . . . . . . . . . . . . . -60.05 -38.17 82.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.984 0.421 . . . . 10.0 110.956 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 468' ' ' LEU . . . . . . . . . . . . . 33.3 tp -80.43 -34.33 36.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.099 0.476 . . . . 10.0 110.461 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 469' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -62.23 -44.66 96.06 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.746 -0.661 . . . . 10.0 110.476 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 470' ' ' MET . . . . . . . . . . . . . 99.0 mmm -80.99 -14.16 58.21 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.814 -0.63 . . . . 10.0 110.988 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 471' ' ' ALA . . . . . . . . . . . . . . . -65.26 -44.39 88.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.871 0.367 . . . . 10.0 110.048 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 472' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -68.03 -33.08 73.91 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.369 -0.604 . . . . 10.0 109.369 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 473' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -64.36 -44.08 92.55 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 115.408 -0.814 . . . . 10.0 110.558 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 474' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.1 -19.63 64.86 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.918 0.389 . . . . 10.0 110.831 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 475' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -83.27 -51.4 7.49 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.032 -0.531 . . . . 10.0 109.848 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 476' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -69.39 -38.83 78.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.516 -0.765 . . . . 10.0 111.276 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 477' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.84 91.79 0.86 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.729 0.776 . . . . 10.0 109.939 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 478' ' ' MET . . . . . . . . . . . . . 20.2 ttt -176.8 -44.86 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.488 -1.233 . . . . 10.0 108.413 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 479' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -67.82 -16.95 64.35 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.523 -0.762 . . . . 10.0 110.818 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 480' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.84 -26.8 67.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.388 0.613 . . . . 10.0 110.172 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 481' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -111.35 -40.01 4.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.149 -0.932 . . . . 10.0 109.629 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 482' ' ' ALA . . . . . . . . . . . . . . . -79.55 28.72 0.25 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.822 -0.627 . . . . 10.0 112.55 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 483' ' ' LEU . . . . . . . . . . . . . 33.5 tp -171.76 -50.83 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 122.477 0.311 . . . . 10.0 110.199 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 484' ' ' GLY . . . . . . . . . . . . . . . -46.6 -42.9 14.79 Favored Glycine 0 C--N 1.335 0.478 0 O-C-N 123.899 0.749 . . . . 10.0 113.4 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 485' ' ' ILE . . . . . . . . . . . . . 23.2 pt -109.47 -4.59 10.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.715 0.293 . . . . 10.0 111.017 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 486' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -87.74 -29.49 21.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.522 -0.308 . . . . 10.0 111.35 -178.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 487' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -74.31 -13.43 60.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.095 0.474 . . . . 10.0 110.411 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 488' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -101.52 93.49 5.4 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.898 -0.592 . . . . 10.0 109.879 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 489' ' ' GLY . . . . . . . . . . . . . . . 99.58 177.26 31.19 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 121.056 -0.593 . . . . 10.0 111.996 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.091 0 CA-C-O 118.798 -1.001 . . . . 10.0 111.722 -179.901 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 120.563 0.22 . . . . 10.0 110.516 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 29.6 mtm -142.97 130.45 21.17 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.965 -0.383 . . . . 10.0 109.965 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -122.15 147.33 46.29 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.13 -0.486 . . . . 10.0 109.97 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -98.07 116.76 30.95 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.408 -0.36 . . . . 10.0 110.43 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 24.6 pt -105.06 10.28 9.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.12 0.486 . . . . 10.0 110.776 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 164.29 173.59 33.12 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.78 -0.724 . . . . 10.0 111.645 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 44.8 tttp -62.28 120.69 11.47 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.47 0.176 . . . . 10.0 110.765 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 24.8 mmt 64.07 28.26 14.22 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 123.732 0.645 . . . . 10.0 111.888 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -131.08 112.26 12.73 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.967 -0.382 . . . . 10.0 109.967 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -120.0 140.98 50.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.095 0.474 . . . . 10.0 111.444 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.2 t -94.58 110.55 23.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.779 -0.646 . . . . 10.0 109.448 178.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.39 83.38 6.23 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.992 -0.549 . . . . 10.0 110.697 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.0 t -89.7 86.15 2.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.914 -0.773 . . . . 10.0 108.914 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -151.35 172.21 16.27 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.701 -0.681 . . . . 10.0 110.597 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -106.01 138.0 42.95 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.808 -0.633 . . . . 10.0 109.814 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -126.4 95.48 4.38 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.396 -0.365 . . . . 10.0 110.318 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.3 36.86 25.91 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.667 -0.697 . . . . 10.0 111.892 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 103.05 -17.64 51.67 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.516 -0.85 . . . . 10.0 112.18 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -89.18 94.93 10.1 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.994 0.426 . . . . 10.0 110.293 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.1 t -100.71 93.63 3.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.878 -0.601 . . . . 10.0 109.684 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.94 157.12 42.51 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.096 -0.502 . . . . 10.0 110.949 -179.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 5.3 mp -81.42 90.32 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.573 -0.899 . . . . 10.0 108.573 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -82.17 102.41 11.08 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.831 -0.622 . . . . 10.0 111.955 -177.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.3 mt -84.51 109.41 17.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 107.727 -1.212 . . . . 10.0 107.727 178.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 10.9 ttm-85 -128.98 149.15 50.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.446 0.641 . . . . 10.0 112.544 -177.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -91.62 149.92 21.42 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.504 -0.924 . . . . 10.0 108.504 178.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -120.26 152.37 37.86 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.051 0.453 . . . . 10.0 111.539 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 12.6 t90 -145.03 154.33 42.41 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.926 -0.768 . . . . 10.0 108.926 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.4 ttm -88.03 134.74 33.67 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.909 0.385 . . . . 10.0 110.76 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 51.2 p-10 -85.68 175.52 4.44 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.787 -0.642 . . . . 10.0 110.534 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -61.72 -17.81 56.89 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.568 2.178 . . . . 10.0 112.911 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.79 -41.71 20.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.826 0.346 . . . . 10.0 110.773 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 122.52 18.48 3.32 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.834 -0.698 . . . . 10.0 111.994 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -104.14 163.49 12.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.927 0.394 . . . . 10.0 110.882 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 78.5 mmm -88.06 111.33 21.43 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.916 -0.583 . . . . 10.0 109.479 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.7 mmmt -109.03 129.97 23.28 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.804 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.43 133.63 19.4 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.234 1.956 . . . . 10.0 111.513 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.7 160.15 37.78 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.916 -0.659 . . . . 10.0 112.12 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -77.87 -7.91 57.35 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.161 0.505 . . . . 10.0 110.397 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -104.19 127.49 51.8 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.647 -0.706 . . . . 10.0 109.828 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -166.5 -173.53 34.96 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 111.206 -0.757 . . . . 10.0 111.206 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.9 tp -152.51 113.23 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.208 0.528 . . . . 10.0 110.582 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -92.5 90.61 7.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.165 -0.47 . . . . 10.0 111.36 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.8 mp -65.97 131.25 45.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.559 -0.291 . . . . 10.0 111.011 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -78.98 166.47 41.97 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 110.396 -0.224 . . . . 10.0 110.396 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -47.45 -41.15 29.4 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.222 2.615 . . . . 10.0 114.004 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -69.51 -45.14 69.58 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.828 -0.349 . . . . 10.0 110.838 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -57.97 -39.83 79.12 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.964 0.411 . . . . 10.0 110.17 178.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 66.2 t-105 -59.09 -44.4 91.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.782 -0.644 . . . . 10.0 110.564 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.8 t -67.36 -48.28 67.92 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.025 -0.534 . . . . 10.0 110.486 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -60.06 -38.8 83.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.94 -0.573 . . . . 10.0 111.08 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 27.9 tp -60.98 -49.53 77.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.465 -0.334 . . . . 10.0 110.594 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -60.54 -38.49 84.64 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.301 -0.409 . . . . 10.0 111.192 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -71.99 -26.5 62.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.962 -0.563 . . . . 10.0 111.831 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -93.42 -9.45 38.56 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.671 0.249 . . . . 10.0 111.671 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 16.4 mt -51.55 -44.05 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 112.224 0.453 . . . . 10.0 112.224 -179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.3 m -60.46 -34.55 74.16 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.871 0.367 . . . . 10.0 111.773 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.08 -41.04 21.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.953 0.406 . . . . 10.0 110.325 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 82.3 mt -65.38 -48.62 82.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.805 -0.634 . . . . 10.0 111.224 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -59.42 -37.69 78.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.098 -0.501 . . . . 10.0 110.774 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.66 -39.3 94.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.019 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.89 -33.78 76.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.927 -0.579 . . . . 10.0 110.613 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 63.1 t -64.36 -37.52 80.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.235 0.54 . . . . 10.0 109.855 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 19.9 mtm105 -78.84 -27.18 44.16 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.565 -0.743 . . . . 10.0 110.509 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -69.6 -36.07 75.86 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.99 -0.55 . . . . 10.0 110.566 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 47.2 mt . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 115.855 -0.612 . . . . 10.0 111.322 -179.49 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.219 0 CA-C-O 121.082 0.468 . . . . 10.0 110.665 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 5.6 mmm -97.99 95.92 7.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.773 -0.649 . . . . 10.0 109.708 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -90.83 126.28 35.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.067 -0.515 . . . . 10.0 111.166 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -87.73 103.74 15.9 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.199 -0.455 . . . . 10.0 109.823 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 5.6 pt -100.39 5.2 10.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.304 0.573 . . . . 10.0 110.351 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 179.43 158.88 22.49 Favored Glycine 0 N--CA 1.438 -1.179 0 N-CA-C 110.988 -0.845 . . . . 10.0 110.988 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 29.9 mttp -64.26 114.95 4.58 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.761 -0.459 . . . . 10.0 109.761 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' MET . . . . . . . . . . . . . 70.3 mmm 78.91 3.97 2.42 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.313 -0.858 . . . . 10.0 111.128 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -115.57 124.59 51.4 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.722 -0.473 . . . . 10.0 109.722 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -131.12 145.32 51.94 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.228 0.537 . . . . 10.0 111.558 -178.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.99 96.03 4.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 108.399 -0.963 . . . . 10.0 108.399 177.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.71 96.65 10.51 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.028 -0.533 . . . . 10.0 110.8 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 28.4 t -84.66 115.01 25.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.369 -0.604 . . . . 10.0 109.369 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.64 161.45 42.58 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.983 0.42 . . . . 10.0 111.02 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -85.55 118.63 25.18 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.467 -0.788 . . . . 10.0 110.097 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -109.05 89.15 2.91 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.496 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 61.4 mttm 60.8 44.86 10.51 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.525 -0.762 . . . . 10.0 112.185 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.42 38.24 12.94 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.601 -0.809 . . . . 10.0 111.527 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -151.53 106.44 3.27 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 122.733 0.413 . . . . 10.0 110.138 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 24.4 t -73.2 99.06 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 108.563 -0.903 . . . . 10.0 108.563 178.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 96.2 mt -105.82 132.08 52.37 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.511 0.672 . . . . 10.0 112.599 -177.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' ILE . . . . . . . . . . . . . 4.8 mp -93.35 94.09 4.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 107.322 -1.362 . . . . 10.0 107.322 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -89.0 106.06 18.19 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.962 -0.563 . . . . 10.0 112.223 -177.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 37.7 mt -93.39 99.29 9.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 107.84 -1.17 . . . . 10.0 107.84 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 20.2 ttm-85 -140.97 165.63 27.01 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.223 0.535 . . . . 10.0 112.112 -177.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.11 144.13 25.76 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.51 -0.922 . . . . 10.0 108.51 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -125.92 125.93 43.57 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.289 0.566 . . . . 10.0 111.047 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' TRP . . . . . . . . . . . . . 66.2 t90 -104.85 136.25 44.7 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.404 -0.817 . . . . 10.0 110.105 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 50.3 ttm -78.97 115.95 18.97 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.034 0.445 . . . . 10.0 110.745 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.69 161.97 59.53 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.659 -0.7 . . . . 10.0 110.356 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -53.23 -27.03 36.26 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.191 2.594 . . . . 10.0 113.993 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.7 -17.26 59.21 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 122.235 -0.29 . . . . 10.0 110.776 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 103.65 11.6 32.56 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.936 -0.65 . . . . 10.0 113.712 178.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -103.38 156.76 17.5 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 117.062 0.431 . . . . 10.0 110.696 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' MET . . . . . . . . . . . . . 87.7 mmm -94.25 103.0 15.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.252 -0.431 . . . . 10.0 110.024 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt -93.28 147.29 33.47 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.082 -0.508 . . . . 10.0 110.47 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.13 145.57 98.17 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 122.29 1.994 . . . . 10.0 111.789 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . -75.94 -112.78 0.12 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.871 -0.68 . . . . 10.0 112.849 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 71.7 mtp85 -138.51 -22.06 1.01 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.968 0.413 . . . . 10.0 110.934 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 39.2 mttt -100.4 -146.22 0.34 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.993 -0.548 . . . . 10.0 109.915 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.72 153.95 30.6 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.612 -0.804 . . . . 10.0 112.751 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 15.4 tt -145.99 134.31 16.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.951 0.405 . . . . 10.0 110.545 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 4.0 m -92.25 116.14 28.7 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.062 -0.517 . . . . 10.0 109.701 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 96.0 mt -111.67 138.24 48.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.208 -0.451 . . . . 10.0 110.411 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 33.3 p30 -88.93 170.43 11.03 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.39 -0.596 . . . . 10.0 109.39 179.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -51.47 -35.06 53.96 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.527 2.151 . . . . 10.0 113.121 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -62.89 -53.85 47.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.305 -0.407 . . . . 10.0 110.342 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -67.41 -34.9 78.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.058 -0.519 . . . . 10.0 110.206 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' TRP . . . . . . . . . . . . . 35.1 t-105 -61.12 -45.52 94.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.898 -0.592 . . . . 10.0 109.955 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 13.3 t -64.03 -43.87 94.27 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.697 -0.482 . . . . 10.0 109.697 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -61.16 -39.57 90.59 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 116.061 -0.518 . . . . 10.0 110.744 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 34.5 tp -60.2 -43.3 96.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.876 0.369 . . . . 10.0 110.204 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -66.49 -39.85 88.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.035 -0.53 . . . . 10.0 110.567 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -74.42 -16.25 60.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.822 -0.626 . . . . 10.0 111.372 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -90.12 -4.63 57.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.52 -0.309 . . . . 10.0 111.193 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 75.3 mt -58.78 -35.42 55.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.69 0.281 . . . . 10.0 110.722 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.25 -12.25 39.33 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.27 -0.423 . . . . 10.0 111.725 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -111.9 -49.65 2.97 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.884 0.373 . . . . 10.0 110.606 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 43.4 mt -65.42 -53.44 39.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 10.0 111.568 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -62.54 -31.28 72.04 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.799 0.333 . . . . 10.0 110.627 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -62.03 -47.4 84.89 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.927 -0.579 . . . . 10.0 110.19 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.81 -39.16 80.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.026 -0.534 . . . . 10.0 110.529 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 53.3 t -64.47 -37.23 79.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.818 -0.628 . . . . 10.0 111.207 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 8.7 ptp85 -81.77 -6.57 59.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.851 0.358 . . . . 10.0 110.999 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -96.5 5.95 49.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.049 0.452 . . . . 10.0 110.435 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 42.7 mt . . . . . 0 C--O 1.247 0.938 0 CA-C-O 118.3 -0.857 . . . . 10.0 109.995 179.455 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 465' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 . . . . . 0 N--CA 1.482 1.133 0 CA-C-O 120.41 0.148 . . . . 10.0 110.796 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 466' ' ' GLY . . . . . . . . . . . . . . . -55.33 -32.74 57.72 Favored Glycine 0 CA--C 1.52 0.344 0 CA-C-N 116.084 -0.507 . . . . 10.0 113.992 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 467' ' ' ALA . . . . . . . . . . . . . . . -67.49 -56.16 10.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.012 0.435 . . . . 10.0 110.805 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 468' ' ' LEU . . . . . . . . . . . . . 11.2 tp -65.77 -31.27 72.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.988 -0.551 . . . . 10.0 110.872 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 469' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -62.6 -21.03 65.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.615 -0.721 . . . . 10.0 111.884 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 470' ' ' MET . . . . . . . . . . . . . 92.7 mmm -111.13 -48.46 3.11 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.774 0.321 . . . . 10.0 111.834 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 471' ' ' ALA . . . . . . . . . . . . . . . -64.71 -59.52 4.15 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.679 0.622 . . . . 10.0 112.679 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 472' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -67.59 -28.55 67.85 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.868 0.321 . . . . 10.0 111.868 -178.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 473' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -57.65 -40.41 79.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.44 -0.346 . . . . 10.0 110.575 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 474' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -62.81 -44.82 95.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.146 -0.479 . . . . 10.0 109.882 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 475' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -62.36 -43.47 98.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.331 -0.395 . . . . 10.0 110.533 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 476' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.5 -39.91 77.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.925 -0.579 . . . . 10.0 110.57 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 477' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -79.34 -53.92 6.45 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.797 -0.638 . . . . 10.0 111.421 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 478' ' ' MET . . . . . . . . . . . . . 53.8 ttp -57.76 -44.24 86.01 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.861 0.689 . . . . 10.0 112.861 -177.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 479' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -68.01 -17.47 64.43 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 121.09 -0.244 . . . . 10.0 111.593 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 480' ' ' THR . . . . . . . . . . . . . 1.7 m -108.56 12.28 26.13 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.698 0.761 . . . . 10.0 109.403 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 481' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -119.81 -54.86 2.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.331 -0.85 . . . . 10.0 110.555 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 482' ' ' ALA . . . . . . . . . . . . . . . -78.28 -12.86 60.03 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.748 -0.66 . . . . 10.0 111.33 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 483' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.93 -41.3 77.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.255 -0.43 . . . . 10.0 111.05 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 484' ' ' GLY . . . . . . . . . . . . . . . -103.18 31.11 9.1 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.537 -0.839 . . . . 10.0 113.026 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 485' ' ' ILE . . . . . . . . . . . . . 15.6 tt -72.75 -35.68 50.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 117.21 0.505 . . . . 10.0 110.759 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 486' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -109.84 -0.45 18.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.969 0.414 . . . . 10.0 110.226 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 487' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -74.99 -21.06 59.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.765 -0.652 . . . . 10.0 110.096 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 488' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.2 -15.64 60.34 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.423 -0.808 . . . . 10.0 111.217 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 489' ' ' GLY . . . . . . . . . . . . . . . -90.0 -4.73 71.65 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.737 -0.744 . . . . 10.0 112.353 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.172 0 CA-C-O 118.931 -0.927 . . . . 10.0 112.383 -179.592 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.861 0 CA-C-O 120.854 0.359 . . . . 10.0 110.123 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 54.2 ttm -115.73 117.65 30.84 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.16 -0.473 . . . . 10.0 110.584 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -107.47 179.28 4.29 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.911 -0.586 . . . . 10.0 109.51 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -135.32 138.29 43.27 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 121.006 -0.278 . . . . 10.0 110.923 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.6 pt -117.56 -9.77 11.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.16 -0.473 . . . . 10.0 111.23 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 176.11 -178.92 47.46 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.482 -0.866 . . . . 10.0 112.336 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 43.3 tttp -58.03 118.15 5.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.688 0.28 . . . . 10.0 111.043 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 66.8 mmm 67.28 8.03 5.93 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.442 -0.799 . . . . 10.0 112.165 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -113.35 113.02 24.66 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 120.917 0.389 . . . . 10.0 110.078 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -121.17 163.85 17.81 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.894 -0.593 . . . . 10.0 110.879 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.3 t -121.28 102.45 12.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.369 -0.832 . . . . 10.0 108.999 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.1 m -97.65 98.92 10.29 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.094 0.405 . . . . 10.0 112.094 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 19.5 t -81.54 82.38 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 108.209 -1.034 . . . . 10.0 108.209 177.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -115.97 167.5 10.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.876 -0.602 . . . . 10.0 111.496 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.93 141.2 47.03 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.734 -0.666 . . . . 10.0 110.17 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -126.4 101.84 6.88 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.03 -0.532 . . . . 10.0 111.171 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 78.0 mttt 61.32 34.07 18.67 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.004 -0.543 . . . . 10.0 112.018 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.94 18.54 43.27 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.554 -0.831 . . . . 10.0 111.762 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.0 mtpt -127.75 99.25 5.47 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.327 -0.249 . . . . 10.0 110.327 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 96.7 t -69.62 111.88 3.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.844 -0.428 . . . . 10.0 109.844 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 79.3 mt -122.97 119.17 29.61 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.22 -0.445 . . . . 10.0 110.663 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 75.6 mt -75.79 101.48 2.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 108.955 -0.757 . . . . 10.0 108.955 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -72.9 100.68 2.98 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.722 -0.672 . . . . 10.0 112.258 -178.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 34.8 mt -100.44 91.81 2.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 107.874 -1.158 . . . . 10.0 107.874 177.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.25 160.52 32.74 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.046 -0.525 . . . . 10.0 111.278 -177.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -78.39 147.81 33.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.252 0.548 . . . . 10.0 110.788 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -126.34 125.31 42.05 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.62 -0.718 . . . . 10.0 109.685 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -105.66 167.76 9.55 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.333 -0.394 . . . . 10.0 110.108 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 27.8 ttt -106.01 131.11 53.7 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.691 0.281 . . . . 10.0 110.339 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -87.11 171.16 10.43 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 116.013 -0.539 . . . . 10.0 110.314 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.64 -10.29 28.64 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.829 2.353 . . . . 10.0 113.257 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -85.08 -43.06 14.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.167 0.508 . . . . 10.0 109.801 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 126.98 19.18 2.01 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.614 -0.721 . . . . 10.0 112.223 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -105.94 178.41 4.57 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.985 0.421 . . . . 10.0 110.981 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 18.7 ttm -105.43 112.43 25.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.757 -0.656 . . . . 10.0 110.005 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.3 mmpp? -102.02 123.11 44.73 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.187 -0.46 . . . . 10.0 111.62 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -80.42 128.19 6.93 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.614 2.209 . . . . 10.0 111.824 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -68.17 156.58 52.89 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.68 -0.772 . . . . 10.0 111.636 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.15 -38.43 83.13 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.03 0.443 . . . . 10.0 110.415 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.0 96.67 3.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.608 -0.723 . . . . 10.0 110.385 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -164.97 136.19 4.08 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.772 -0.728 . . . . 10.0 111.922 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 19.0 tt -116.69 124.18 72.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.533 0.682 . . . . 10.0 110.707 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.3 m -102.35 110.95 23.04 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.618 -0.719 . . . . 10.0 109.818 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 79.4 mt -97.39 131.61 43.89 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.903 -0.589 . . . . 10.0 111.244 -178.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -84.06 167.14 29.52 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.828 -0.624 . . . . 10.0 109.601 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -43.14 -41.67 9.6 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.317 2.678 . . . . 10.0 113.71 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.36 -46.53 89.63 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.879 0.371 . . . . 10.0 110.781 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -69.91 -39.45 76.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.018 -0.537 . . . . 10.0 109.734 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 68.3 t-105 -56.99 -43.63 81.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.408 -0.815 . . . . 10.0 110.652 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.2 t -61.68 -52.41 64.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.306 -0.406 . . . . 10.0 109.925 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -58.5 -41.71 85.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.911 -0.586 . . . . 10.0 110.709 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 21.5 tp -55.47 -51.42 67.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.031 -0.531 . . . . 10.0 110.967 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -63.35 -38.34 90.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.311 -0.404 . . . . 10.0 111.441 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -67.49 -36.22 80.68 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.019 -0.537 . . . . 10.0 111.553 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -82.18 -17.56 45.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.647 -0.251 . . . . 10.0 111.33 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 18.7 mt -49.94 -37.05 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 111.991 0.367 . . . . 10.0 111.991 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.33 -35.68 72.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.42 -0.354 . . . . 10.0 111.414 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.3 -33.48 15.31 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.94 0.4 . . . . 10.0 110.501 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 91.8 mt -60.93 -47.61 92.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.002 -0.545 . . . . 10.0 110.462 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -62.9 -33.59 75.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.812 -0.631 . . . . 10.0 110.569 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -65.83 -33.18 75.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.806 -0.633 . . . . 10.0 110.026 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -70.54 -31.34 68.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.995 -0.548 . . . . 10.0 110.306 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 51.5 t -63.57 -39.02 83.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.999 -0.546 . . . . 10.0 109.789 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.6 ttm105 -70.42 -23.6 62.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.813 -0.63 . . . . 10.0 110.458 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 16.9 mttp -79.26 -23.53 43.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.823 -0.626 . . . . 10.0 110.557 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 C--N 1.323 -0.544 0 CA-C-N 116.208 -0.451 . . . . 10.0 111.422 -179.989 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.176 0 CA-C-O 121.047 0.451 . . . . 10.0 110.84 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 98.1 mmm -93.82 90.08 6.39 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.436 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -67.8 126.06 28.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.878 -0.601 . . . . 10.0 110.345 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -96.29 130.47 43.38 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.806 0.336 . . . . 10.0 110.768 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 21.8 pt -121.38 8.17 6.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.894 -0.593 . . . . 10.0 110.438 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 171.1 178.03 41.34 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.043 -0.823 . . . . 10.0 111.043 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 28.2 mtmm -67.74 106.13 2.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 117.04 0.42 . . . . 10.0 109.987 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' MET . . . . . . . . . . . . . 45.6 mtm 78.08 -0.59 2.63 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 124.093 0.87 . . . . 10.0 111.482 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? -99.12 122.17 41.97 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.771 -0.455 . . . . 10.0 109.771 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -128.84 168.32 16.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.342 0.592 . . . . 10.0 111.806 -178.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 58.4 t -107.27 102.67 14.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 108.103 -1.073 . . . . 10.0 108.103 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 1.4 t -84.94 88.05 7.4 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.493 0.553 . . . . 10.0 112.493 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 44.6 t -89.03 100.14 10.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 107.851 -1.166 . . . . 10.0 107.851 177.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 15.1 ptt-85 -131.91 162.7 30.02 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.195 0.522 . . . . 10.0 111.827 -177.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -95.51 108.49 20.73 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.514 -0.766 . . . . 10.0 109.135 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -93.13 84.63 4.87 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.459 -0.337 . . . . 10.0 110.56 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 72.6 mttt 59.51 45.42 13.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.613 -0.722 . . . . 10.0 111.759 179.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.0 5.37 70.82 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.804 -0.713 . . . . 10.0 112.377 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -118.47 101.88 8.49 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.135 -0.32 . . . . 10.0 110.135 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 12.9 t -65.31 115.29 3.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.654 -0.499 . . . . 10.0 109.654 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 78.9 mt -124.48 132.36 53.49 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.114 0.483 . . . . 10.0 111.602 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' ILE . . . . . . . . . . . . . 5.1 mp -94.88 91.14 2.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 107.647 -1.242 . . . . 10.0 107.647 177.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -89.3 103.19 15.84 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.388 -0.824 . . . . 10.0 111.74 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 60.2 mt -80.49 107.75 13.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 107.585 -1.265 . . . . 10.0 107.585 177.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 27.0 ttm-85 -152.85 154.07 34.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.02 0.438 . . . . 10.0 111.744 -176.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -93.74 150.06 20.71 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.047 -0.524 . . . . 10.0 109.781 178.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -119.54 127.54 53.11 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.195 -0.457 . . . . 10.0 110.43 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' TRP . . . . . . . . . . . . . 2.2 m0 -108.83 136.34 48.55 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.578 -0.527 . . . . 10.0 109.578 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 42.8 ttm -74.66 126.37 30.7 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.976 0.417 . . . . 10.0 110.341 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.0 171.62 6.38 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.804 -0.634 . . . . 10.0 110.976 -179.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -52.71 -32.1 53.67 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 123.163 2.575 . . . . 10.0 113.392 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.05 -28.95 65.86 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.944 0.402 . . . . 10.0 110.269 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 106.84 16.06 14.94 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.826 -0.702 . . . . 10.0 112.214 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -106.8 147.74 29.33 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.921 -0.4 . . . . 10.0 109.921 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' MET . . . . . . . . . . . . . 89.7 mmm -82.69 105.89 14.09 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.427 -0.583 . . . . 10.0 109.427 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -88.06 126.69 60.14 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.964 -0.562 . . . . 10.0 111.164 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -65.4 123.97 12.23 Favored 'Trans proline' 0 C--O 1.237 0.452 0 C-N-CA 122.584 2.189 . . . . 10.0 111.459 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . -60.45 164.45 15.48 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.818 -0.628 . . . . 10.0 113.537 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 52.4 mtm180 -77.11 -4.03 42.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.985 0.422 . . . . 10.0 111.005 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 38.1 mttm -114.64 115.07 26.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.171 -0.468 . . . . 10.0 110.722 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -175.93 174.41 46.89 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.681 -0.968 . . . . 10.0 110.681 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 16.3 tt -141.84 122.16 11.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.229 0.537 . . . . 10.0 111.354 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 1.2 m -93.07 102.67 15.0 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.879 -0.6 . . . . 10.0 110.173 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 95.2 mt -96.12 132.35 41.61 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.137 -0.483 . . . . 10.0 111.272 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -84.08 163.61 47.47 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 108.586 -0.894 . . . . 10.0 108.586 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -49.38 -32.83 27.39 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.734 2.289 . . . . 10.0 112.542 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -61.75 -57.94 9.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.762 -0.654 . . . . 10.0 111.059 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -74.05 -28.47 61.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.807 0.337 . . . . 10.0 110.619 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' TRP . . . . . . . . . . . . . 28.8 t-105 -60.26 -43.16 96.39 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.506 -0.553 . . . . 10.0 109.506 178.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 37.3 t -63.51 -44.96 92.77 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.505 -0.554 . . . . 10.0 109.505 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -58.36 -40.04 81.18 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.68 -0.691 . . . . 10.0 110.613 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 20.8 tp -59.93 -45.31 93.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 10.0 110.191 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -63.86 -33.6 76.06 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.853 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -74.36 -45.61 45.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.998 -0.546 . . . . 10.0 110.648 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -62.93 -18.25 62.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.589 -0.732 . . . . 10.0 112.181 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 67.8 mt -53.38 -38.25 31.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.778 0.323 . . . . 10.0 110.605 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.19 -28.86 67.03 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.815 -0.63 . . . . 10.0 111.826 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -98.96 -40.13 8.22 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.715 0.293 . . . . 10.0 111.412 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 83.0 mt -62.79 -48.2 89.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 10.0 110.69 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -63.01 -31.46 72.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.225 0.536 . . . . 10.0 110.377 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -63.96 -36.59 84.47 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.436 -0.802 . . . . 10.0 110.048 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -77.52 -40.53 42.38 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.853 -0.612 . . . . 10.0 110.821 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 94.1 t -61.48 -43.14 96.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.069 -0.514 . . . . 10.0 111.52 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -70.55 -10.77 60.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.684 0.278 . . . . 10.0 111.602 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -104.12 2.57 32.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.751 0.31 . . . . 10.0 110.933 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 72.5 mt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.324 -0.846 . . . . 10.0 110.238 179.839 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 465' ' ' TYR . . . . . . . . . . . . . 31.3 t80 . . . . . 0 N--CA 1.48 1.059 0 CA-C-O 120.684 0.278 . . . . 10.0 110.939 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 466' ' ' GLY . . . . . . . . . . . . . . . -54.38 -31.78 51.35 Favored Glycine 0 C--N 1.334 0.437 0 CA-C-N 116.306 -0.406 . . . . 10.0 113.955 -179.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 467' ' ' ALA . . . . . . . . . . . . . . . -58.09 -40.12 80.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 117.024 0.412 . . . . 10.0 111.596 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 468' ' ' LEU . . . . . . . . . . . . . 40.4 tp -91.51 -33.75 15.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.996 0.427 . . . . 10.0 110.523 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 469' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -62.77 -46.88 85.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.697 -0.683 . . . . 10.0 111.476 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 470' ' ' MET . . . . . . . . . . . . . 49.8 ttm -60.14 -32.63 71.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.132 -0.485 . . . . 10.0 111.227 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 471' ' ' ALA . . . . . . . . . . . . . . . -62.29 -39.69 93.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.967 0.413 . . . . 10.0 110.859 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 472' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -80.14 -44.03 20.61 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.192 -0.458 . . . . 10.0 110.345 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 473' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -59.4 -42.04 90.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.77 -0.65 . . . . 10.0 111.054 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 474' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.49 -42.32 95.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.293 -0.412 . . . . 10.0 110.124 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 475' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -62.96 -47.79 81.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.974 -0.557 . . . . 10.0 110.287 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 476' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -62.04 -41.62 98.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.959 -0.564 . . . . 10.0 110.858 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 477' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -59.13 -44.92 92.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.377 -0.374 . . . . 10.0 110.462 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 478' ' ' MET . . . . . . . . . . . . . 13.8 tpp -70.04 -38.87 75.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 10.0 110.47 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 479' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.26 -29.06 70.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.389 0.614 . . . . 10.0 109.991 179.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 480' ' ' THR . . . . . . . . . . . . . 88.2 m -82.4 -43.21 17.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.333 -0.849 . . . . 10.0 110.121 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 481' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -59.59 -37.31 78.21 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.32 -0.855 . . . . 10.0 111.14 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 482' ' ' ALA . . . . . . . . . . . . . . . -98.01 17.18 18.93 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.125 -0.489 . . . . 10.0 111.76 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 483' ' ' LEU . . . . . . . . . . . . . 29.9 tp -81.38 -78.08 0.2 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.79 0.328 . . . . 10.0 110.547 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 484' ' ' GLY . . . . . . . . . . . . . . . -88.57 33.87 4.02 Favored Glycine 0 C--O 1.229 -0.168 0 C-N-CA 120.796 -0.716 . . . . 10.0 112.067 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 485' ' ' ILE . . . . . . . . . . . . . 12.9 tt -72.79 -31.11 35.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.797 0.332 . . . . 10.0 111.298 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 486' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -81.61 -20.5 39.63 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.477 -0.329 . . . . 10.0 111.412 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 487' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -92.97 -7.89 44.63 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.48 -0.327 . . . . 10.0 111.599 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 488' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -63.57 104.02 0.6 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.921 0.391 . . . . 10.0 110.499 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 489' ' ' GLY . . . . . . . . . . . . . . . 90.18 8.88 66.07 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.783 -0.722 . . . . 10.0 112.104 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.929 0 CA-C-O 118.715 -1.047 . . . . 10.0 111.972 179.757 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.889 0 CA-C-O 120.681 0.276 . . . . 10.0 110.506 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 24.0 mmt -123.23 92.78 3.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.239 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -96.34 121.09 37.75 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.734 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -87.13 120.11 28.06 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.796 0.332 . . . . 10.0 110.174 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.3 pt -110.23 0.13 9.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.064 0.459 . . . . 10.0 111.063 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 170.19 -178.64 42.86 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.583 -0.818 . . . . 10.0 111.964 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -65.9 114.25 4.98 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.457 0.17 . . . . 10.0 110.92 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 71.5 mmm 69.15 18.78 8.15 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 123.917 0.761 . . . . 10.0 111.663 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -121.83 112.6 18.55 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.934 -0.395 . . . . 10.0 109.934 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -124.91 144.08 50.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.392 0.615 . . . . 10.0 111.671 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 48.0 t -104.0 107.22 21.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.177 -0.92 . . . . 10.0 109.037 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.5 p -102.5 92.48 4.68 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.168 0.508 . . . . 10.0 112.059 -178.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 16.9 t -83.47 100.54 7.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.085 -0.507 . . . . 10.0 110.003 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.65 156.72 38.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.393 -0.367 . . . . 10.0 110.363 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -83.49 136.07 34.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.145 -0.479 . . . . 10.0 110.86 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -135.24 98.73 4.05 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.075 -0.511 . . . . 10.0 110.672 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 84.3 mttt 59.91 42.3 16.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.632 -0.713 . . . . 10.0 111.004 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.32 51.82 3.99 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.634 -0.793 . . . . 10.0 111.556 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.02 89.81 2.43 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.058 -0.349 . . . . 10.0 110.058 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.3 t -95.49 91.55 2.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.641 -0.503 . . . . 10.0 109.641 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -157.14 174.06 16.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.9 -0.591 . . . . 10.0 111.181 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 69.7 mt -88.65 88.87 3.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.267 -0.642 . . . . 10.0 109.267 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -84.39 117.59 23.72 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.86 -0.609 . . . . 10.0 111.806 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 58.4 mt -103.93 137.54 32.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.97 -0.559 . . . . 10.0 109.642 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 10.4 ttm180 -144.92 146.41 31.98 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.711 -0.477 . . . . 10.0 109.711 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -78.59 93.74 4.89 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.402 -0.592 . . . . 10.0 109.402 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -78.08 115.95 18.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.702 -0.681 . . . . 10.0 111.717 -178.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 35.1 m0 -99.19 -157.39 0.6 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.175 -0.676 . . . . 10.0 109.175 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 20.6 ttt -130.58 132.4 45.51 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.042 -0.355 . . . . 10.0 110.042 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -94.73 167.85 12.38 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 116.273 -0.421 . . . . 10.0 110.565 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -62.48 -14.92 42.28 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.124 2.549 . . . . 10.0 113.452 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -83.7 -39.88 19.6 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.12 0.486 . . . . 10.0 110.044 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 123.75 19.19 2.81 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.787 -0.72 . . . . 10.0 112.518 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -106.59 166.27 10.68 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.684 -0.487 . . . . 10.0 109.684 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 94.4 mmm -87.33 84.37 7.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.877 0.37 . . . . 10.0 110.484 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.07 108.16 24.24 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.153 -0.476 . . . . 10.0 110.05 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -73.95 152.72 46.73 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.251 1.967 . . . . 10.0 112.821 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -94.24 178.93 37.5 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 111.038 -0.825 . . . . 10.0 111.038 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -78.53 71.59 5.0 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.243 0.544 . . . . 10.0 110.345 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 24.7 ttmt -161.97 133.88 5.55 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.242 -0.89 . . . . 10.0 109.672 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 154.37 -169.47 32.74 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.958 -0.639 . . . . 10.0 111.652 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 20.4 tt -168.91 139.63 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.745 0.307 . . . . 10.0 110.42 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.01 145.01 25.8 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.506 -0.315 . . . . 10.0 110.268 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 45.6 mt -121.93 117.56 26.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.461 -0.336 . . . . 10.0 110.176 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -78.61 164.24 56.84 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 109.969 -0.382 . . . . 10.0 109.969 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -43.22 -45.68 9.66 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.732 2.954 . . . . 10.0 113.866 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -64.01 -42.56 97.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.493 0.187 . . . . 10.0 111.135 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -63.84 -43.6 95.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.991 0.424 . . . . 10.0 110.011 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 62.6 t-105 -59.27 -41.83 89.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.651 -0.704 . . . . 10.0 110.867 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.5 m -66.81 -43.9 82.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.851 -0.613 . . . . 10.0 111.115 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -68.35 -38.95 81.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.36 -0.382 . . . . 10.0 111.038 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.2 tp -59.08 -44.31 91.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.316 -0.402 . . . . 10.0 110.958 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -64.65 -32.54 74.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.272 -0.422 . . . . 10.0 111.1 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -75.45 -33.32 60.87 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.034 0.445 . . . . 10.0 110.888 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -77.81 -8.47 58.06 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.411 0.522 . . . . 10.0 112.411 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 74.7 mt -54.68 -44.46 70.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.674 0.273 . . . . 10.0 111.291 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.31 -19.78 62.17 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.147 -0.479 . . . . 10.0 111.911 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.26 -48.4 4.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.755 0.312 . . . . 10.0 110.718 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 87.6 mt -58.02 -51.43 70.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.893 -0.594 . . . . 10.0 110.931 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -60.04 -35.66 75.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.73 -0.668 . . . . 10.0 111.38 -178.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -66.12 -38.24 87.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.879 0.371 . . . . 10.0 110.259 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.54 -38.29 83.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.128 -0.487 . . . . 10.0 110.1 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 59.7 t -63.15 -39.56 85.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.879 -0.6 . . . . 10.0 110.1 179.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 25.2 mtm105 -72.92 -30.36 63.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.95 -0.568 . . . . 10.0 110.873 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 35.2 mttp -70.98 -35.06 71.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.262 -0.427 . . . . 10.0 110.905 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 26.6 mt . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 116.325 -0.398 . . . . 10.0 110.795 179.88 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.17 0 CA-C-O 121.183 0.516 . . . . 10.0 110.735 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 20.4 mmm -103.45 102.22 12.13 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.079 -0.712 . . . . 10.0 109.079 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -94.6 114.93 26.97 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.882 -0.599 . . . . 10.0 111.443 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -75.56 121.57 22.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.813 -0.631 . . . . 10.0 110.522 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 12.6 pt -116.05 13.23 7.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.248 -0.433 . . . . 10.0 110.856 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 167.7 -179.31 41.16 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.778 -0.646 . . . . 10.0 111.874 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.55 111.22 5.23 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.895 0.378 . . . . 10.0 110.06 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' MET . . . . . . . . . . . . . 49.2 mtp 73.17 8.75 5.31 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.2 -0.909 . . . . 10.0 111.175 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -105.1 118.95 37.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.496 -0.32 . . . . 10.0 110.213 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -132.74 124.09 27.47 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.881 0.372 . . . . 10.0 111.725 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 46.7 t -76.4 105.32 5.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.716 -0.846 . . . . 10.0 108.716 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 5.2 m -84.21 87.77 7.19 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.949 -0.569 . . . . 10.0 111.665 -178.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 67.5 t -93.87 120.14 42.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.31 -0.626 . . . . 10.0 109.31 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -164.43 172.9 12.77 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.217 -0.447 . . . . 10.0 110.45 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -94.11 118.29 31.32 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.047 -0.524 . . . . 10.0 109.91 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -108.36 92.69 4.16 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.307 -0.406 . . . . 10.0 110.306 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 93.5 mttt 60.72 33.44 20.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.357 -0.838 . . . . 10.0 111.824 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 102.78 -1.97 48.68 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.619 -0.801 . . . . 10.0 113.146 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -119.37 115.99 25.26 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 122.596 -0.355 . . . . 10.0 111.216 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 28.5 t -75.64 106.6 5.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.172 -0.677 . . . . 10.0 109.172 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 80.6 mt -107.68 127.85 54.03 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.188 0.518 . . . . 10.0 112.163 -178.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' ILE . . . . . . . . . . . . . 5.0 mp -92.47 95.62 5.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 107.503 -1.295 . . . . 10.0 107.503 177.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -91.07 117.42 29.58 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 112.677 0.621 . . . . 10.0 112.677 -177.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 77.9 mt -100.16 98.9 7.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 107.953 -1.129 . . . . 10.0 107.953 177.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 8.9 ttm-85 -147.64 166.35 27.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.227 -0.442 . . . . 10.0 111.238 -177.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.87 157.07 17.46 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.917 -0.771 . . . . 10.0 108.917 178.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -121.03 120.73 36.22 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.961 0.41 . . . . 10.0 110.513 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' TRP . . . . . . . . . . . . . 36.2 m95 -103.52 138.32 40.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.764 -0.653 . . . . 10.0 110.173 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 58.1 ttm -91.21 132.28 36.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.756 0.312 . . . . 10.0 110.668 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' ASP . . . . . . . . . . . . . 8.7 p30 -91.97 173.14 5.52 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 116.298 -0.41 . . . . 10.0 110.144 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -59.45 -26.28 81.43 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.482 2.121 . . . . 10.0 112.489 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -71.36 -26.43 62.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.004 0.431 . . . . 10.0 110.147 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 104.85 16.71 16.29 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.986 -0.626 . . . . 10.0 112.643 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -98.22 155.23 17.28 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.893 0.378 . . . . 10.0 110.749 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' MET . . . . . . . . . . . . . 98.8 mmm -101.62 100.46 10.86 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.66 -0.496 . . . . 10.0 109.66 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -97.75 140.14 21.77 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 116.164 -0.471 . . . . 10.0 110.895 -178.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -60.31 143.16 99.49 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 122.569 2.179 . . . . 10.0 111.337 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.47 168.62 21.24 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 116.1 -0.5 . . . . 10.0 112.923 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 8.1 mmt180 -79.85 -3.76 49.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.076 0.465 . . . . 10.0 111.136 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 3.9 pttp -117.79 -160.35 0.78 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.984 -0.746 . . . . 10.0 108.984 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . 108.53 168.24 21.05 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.655 -0.783 . . . . 10.0 112.386 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 20.9 tt -144.82 139.99 23.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.942 0.401 . . . . 10.0 110.869 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 3.8 m -102.69 110.3 22.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.006 -0.543 . . . . 10.0 110.003 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 92.9 mt -104.06 135.18 46.05 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.053 0.454 . . . . 10.0 111.24 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 34.1 p-10 -93.1 165.77 17.78 Favored Pre-proline 0 C--N 1.317 -0.83 0 N-CA-C 108.698 -0.853 . . . . 10.0 108.698 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -50.39 -32.43 33.83 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.505 2.137 . . . . 10.0 112.51 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -63.29 -53.51 51.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.607 -0.724 . . . . 10.0 110.948 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -75.01 -30.49 61.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.925 0.393 . . . . 10.0 110.307 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' TRP . . . . . . . . . . . . . 46.7 t-105 -59.55 -41.26 89.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.771 -0.649 . . . . 10.0 109.777 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 22.9 t -63.32 -49.32 74.44 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.609 -0.515 . . . . 10.0 109.609 178.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -58.6 -40.6 83.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.683 -0.689 . . . . 10.0 110.96 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 63.5 tp -58.28 -44.68 88.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.557 -0.292 . . . . 10.0 110.214 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -62.98 -41.64 99.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.109 -0.496 . . . . 10.0 110.529 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -68.81 -35.52 77.09 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.72 -0.673 . . . . 10.0 111.41 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 13.6 mm-40 -75.27 -14.75 60.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.254 -0.43 . . . . 10.0 111.398 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 56.3 mt -57.99 -37.76 63.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 120.705 0.288 . . . . 10.0 110.6 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 1.1 m -65.0 -7.26 10.96 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.066 -0.516 . . . . 10.0 111.706 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -116.7 -47.11 2.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.056 0.455 . . . . 10.0 110.424 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 65.9 mt -64.66 -49.33 80.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.809 -0.632 . . . . 10.0 111.821 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -58.1 -40.03 80.12 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.922 0.391 . . . . 10.0 111.106 -178.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -64.66 -36.99 86.06 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.829 -0.623 . . . . 10.0 110.513 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.42 -24.85 60.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.942 -0.572 . . . . 10.0 111.599 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 89.3 t -58.53 -37.63 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 121.04 0.448 . . . . 10.0 110.847 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -100.6 16.42 24.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.309 -0.405 . . . . 10.0 110.809 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -132.83 31.35 3.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.172 -0.467 . . . . 10.0 110.247 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 82.3 mt . . . . . 0 C--O 1.247 0.944 0 CA-C-O 118.607 -0.711 . . . . 10.0 110.32 179.826 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 465' ' ' TYR . . . . . . . . . . . . . 4.2 t80 . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 120.75 0.309 . . . . 10.0 110.811 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 466' ' ' GLY . . . . . . . . . . . . . . . -80.34 33.42 2.26 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 121.087 -0.577 . . . . 10.0 114.109 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 467' ' ' ALA . . . . . . . . . . . . . . . -85.03 -27.43 26.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.355 0.598 . . . . 10.0 110.136 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 468' ' ' LEU . . . . . . . . . . . . . 13.8 tp -85.88 72.67 10.47 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.599 -0.728 . . . . 10.0 110.054 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 469' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -139.59 -114.97 0.14 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.016 -0.538 . . . . 10.0 110.672 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 470' ' ' MET . . . . . . . . . . . . . 57.3 mmm -59.18 -31.09 68.68 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 111.825 0.305 . . . . 10.0 111.825 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 471' ' ' ALA . . . . . . . . . . . . . . . -60.04 -48.3 82.28 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.266 -0.424 . . . . 10.0 110.804 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 472' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -78.96 -30.62 44.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 10.0 110.386 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 473' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -50.95 -59.85 3.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.233 -0.894 . . . . 10.0 111.199 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 474' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -74.71 -26.44 59.81 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.492 -0.322 . . . . 10.0 110.817 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 475' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -57.73 -47.35 82.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.887 0.375 . . . . 10.0 111.243 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 476' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -78.61 -33.54 47.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.371 -0.377 . . . . 10.0 111.062 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 477' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -64.75 -56.27 14.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.436 -0.347 . . . . 10.0 110.829 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 478' ' ' MET . . . . . . . . . . . . . 21.2 ttt -59.27 -31.85 69.48 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.521 -0.763 . . . . 10.0 111.826 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 479' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -62.72 -37.3 85.98 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.517 -0.473 . . . . 10.0 110.525 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 480' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.81 -31.14 70.79 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.296 0.57 . . . . 10.0 109.841 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 481' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -66.69 -31.99 73.01 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-N 115.397 -0.819 . . . . 10.0 109.594 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 482' ' ' ALA . . . . . . . . . . . . . . . -85.57 -36.68 20.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.795 -0.639 . . . . 10.0 111.174 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 483' ' ' LEU . . . . . . . . . . . . . 11.9 mt -65.68 -47.36 75.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.342 -0.39 . . . . 10.0 110.778 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 484' ' ' GLY . . . . . . . . . . . . . . . -110.19 37.83 3.58 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.423 -0.894 . . . . 10.0 113.203 -179.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 485' ' ' ILE . . . . . . . . . . . . . 6.9 tt -76.73 -39.22 31.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.185 0.517 . . . . 10.0 110.647 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 486' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -104.16 4.92 34.59 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.024 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 487' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -71.64 -22.74 61.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.676 -0.693 . . . . 10.0 110.751 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 488' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -78.8 58.6 2.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.754 0.787 . . . . 10.0 109.681 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 489' ' ' GLY . . . . . . . . . . . . . . . 149.39 35.55 0.04 OUTLIER Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 114.748 -1.114 . . . . 10.0 110.611 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.647 0 CA-C-O 118.82 -0.989 . . . . 10.0 111.31 -179.81 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 109.827 -0.434 . . . . 10.0 109.827 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 41.7 ttm -112.29 103.04 11.16 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.107 0.479 . . . . 10.0 111.316 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -89.42 173.95 8.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.903 -0.59 . . . . 10.0 109.577 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -127.42 126.55 42.6 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.615 0.245 . . . . 10.0 110.64 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.7 pt -117.39 15.44 7.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.321 -0.4 . . . . 10.0 110.885 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 154.07 175.75 25.66 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.312 -0.947 . . . . 10.0 112.595 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 42.0 tttp -60.12 113.48 2.37 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 122.698 0.399 . . . . 10.0 110.91 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 66.8 mmm 69.87 17.68 7.51 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 123.784 0.678 . . . . 10.0 111.644 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? -119.94 107.29 12.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.088 0.471 . . . . 10.0 109.936 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -115.3 152.0 33.55 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.728 -0.669 . . . . 10.0 110.838 -178.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.4 t -102.05 111.59 32.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.421 -0.809 . . . . 10.0 110.203 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.14 87.75 7.41 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.027 0.441 . . . . 10.0 111.43 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 16.5 t -86.98 108.21 17.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.589 -0.893 . . . . 10.0 108.589 178.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -153.77 -179.64 8.01 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.306 0.574 . . . . 10.0 111.998 -178.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -120.53 123.02 41.88 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.814 -1.085 . . . . 10.0 109.075 178.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -115.67 86.11 2.41 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.014 0.435 . . . . 10.0 110.929 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt 57.35 41.49 26.38 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.257 -0.883 . . . . 10.0 111.348 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 112.38 -24.5 13.81 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.511 -0.852 . . . . 10.0 112.346 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -84.3 82.72 8.26 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.887 0.375 . . . . 10.0 110.554 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.8 t -90.37 103.37 14.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 108.958 -0.756 . . . . 10.0 108.958 178.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -157.97 174.19 15.63 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.952 0.406 . . . . 10.0 111.369 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 38.7 pt -92.64 172.39 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.993 -0.549 . . . . 10.0 110.194 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -151.01 147.49 27.2 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.617 0.246 . . . . 10.0 111.216 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 60.7 mt -121.22 106.83 19.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.326 -0.62 . . . . 10.0 109.326 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 60.2 mtm180 -129.72 151.89 49.82 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.949 0.404 . . . . 10.0 111.451 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -83.11 97.73 8.95 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.382 -0.97 . . . . 10.0 108.382 178.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -81.32 142.68 32.84 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.434 -0.803 . . . . 10.0 112.693 -177.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 13.8 m0 -128.6 177.25 7.16 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.489 -0.93 . . . . 10.0 108.489 178.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 1.1 ttt -103.97 127.51 51.51 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 110.059 -0.349 . . . . 10.0 110.059 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -85.02 167.21 27.43 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.636 -0.256 . . . . 10.0 110.359 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -61.63 -19.25 64.23 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.904 2.403 . . . . 10.0 113.403 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -77.68 -46.79 20.88 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.077 0.465 . . . . 10.0 110.006 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 133.36 15.79 1.25 Allowed Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.982 -0.628 . . . . 10.0 112.5 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -106.94 179.18 4.34 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.858 0.361 . . . . 10.0 110.386 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 85.7 mmm -106.55 109.93 21.99 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.205 -0.452 . . . . 10.0 110.737 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 48.5 mmtt -125.37 128.67 24.66 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.828 -0.623 . . . . 10.0 109.577 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -82.63 177.28 7.07 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.078 2.519 . . . . 10.0 113.129 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -100.82 -169.27 28.59 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.794 -0.639 . . . . 10.0 111.884 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -80.09 55.98 2.29 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.839 0.352 . . . . 10.0 111.282 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -160.6 132.98 6.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.261 -0.427 . . . . 10.0 110.231 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 172.19 -170.95 43.91 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.066 -0.588 . . . . 10.0 111.754 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 8.9 tt -165.85 127.56 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.945 0.402 . . . . 10.0 110.897 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 51.7 m -105.56 145.05 31.47 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.235 -0.654 . . . . 10.0 109.235 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -131.59 129.68 41.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.028 0.442 . . . . 10.0 110.351 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -75.25 164.0 64.08 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.36 -0.837 . . . . 10.0 111.263 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -48.27 -38.37 33.52 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.619 2.88 . . . . 10.0 114.224 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -65.31 -42.22 93.23 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.042 -0.355 . . . . 10.0 110.042 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -65.48 -45.37 83.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.136 0.493 . . . . 10.0 109.801 178.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 56.2 t-105 -56.79 -42.43 79.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.281 -0.872 . . . . 10.0 110.462 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.4 m -65.49 -46.42 79.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.269 -0.423 . . . . 10.0 110.605 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -61.5 -42.74 99.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.494 . . . . 10.0 110.847 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 53.8 tp -57.85 -45.75 85.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.901 -0.591 . . . . 10.0 111.314 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -59.0 -42.47 90.15 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.328 -0.396 . . . . 10.0 111.322 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -74.04 -16.99 61.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.184 -0.462 . . . . 10.0 111.758 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -93.14 -10.6 35.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.745 0.307 . . . . 10.0 110.989 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 70.7 mt -56.71 -37.53 53.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.571 -0.286 . . . . 10.0 111.45 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.14 -23.58 64.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.904 0.383 . . . . 10.0 111.397 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -97.73 -44.4 6.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.138 0.494 . . . . 10.0 110.088 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 67.1 mt -60.25 -52.43 61.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.876 -0.602 . . . . 10.0 111.2 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -61.51 -33.82 74.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.995 -0.548 . . . . 10.0 110.268 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -66.41 -35.62 80.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.533 -0.758 . . . . 10.0 110.259 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.52 -37.42 63.09 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.932 -0.576 . . . . 10.0 110.767 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 99.4 t -61.78 -34.54 62.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 10.0 110.805 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 13.9 mtm105 -78.05 -13.72 59.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.131 -0.486 . . . . 10.0 111.417 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -95.37 -31.48 13.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.862 0.363 . . . . 10.0 111.139 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 75.4 mt . . . . . 0 C--N 1.325 -0.48 0 CA-C-N 116.473 -0.33 . . . . 10.0 110.518 179.709 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.18 0 CA-C-O 121.019 0.438 . . . . 10.0 111.021 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 97.3 mmm -108.12 89.89 3.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.991 -0.55 . . . . 10.0 109.621 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -98.49 133.03 43.43 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.161 -0.472 . . . . 10.0 110.669 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -92.17 132.37 36.69 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.814 0.34 . . . . 10.0 110.746 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 30.5 pt -125.73 16.86 4.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.188 0.518 . . . . 10.0 110.174 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 167.78 165.28 24.92 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.041 -0.824 . . . . 10.0 111.041 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 15.6 mttp -64.07 116.6 6.07 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.944 0.372 . . . . 10.0 110.126 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' MET . . . . . . . . . . . . . 17.5 mmt 69.64 15.73 8.1 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.868 -0.605 . . . . 10.0 110.824 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -119.17 109.81 16.31 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.436 -0.579 . . . . 10.0 109.436 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -122.33 142.36 50.58 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.353 0.597 . . . . 10.0 112.078 -178.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 70.8 t -94.48 93.67 4.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 107.809 -1.182 . . . . 10.0 107.809 177.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 8.5 t -84.15 95.87 8.77 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.889 -0.596 . . . . 10.0 111.551 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 17.4 t -90.07 87.92 2.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.533 -0.914 . . . . 10.0 108.533 178.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 10.4 ptt-85 -118.09 172.97 7.05 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.146 -0.479 . . . . 10.0 111.207 -178.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -105.54 128.87 53.83 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.811 -0.631 . . . . 10.0 110.67 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -108.8 78.0 1.11 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.302 -0.408 . . . . 10.0 109.93 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 35.5 mttm 60.56 50.97 5.36 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.713 -0.676 . . . . 10.0 111.768 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.18 4.61 71.29 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.683 -0.77 . . . . 10.0 112.356 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -118.29 99.3 6.76 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.65 0.262 . . . . 10.0 110.373 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 41.7 t -67.46 116.88 7.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.653 -0.499 . . . . 10.0 109.653 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 95.9 mt -123.53 132.03 53.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.232 0.539 . . . . 10.0 111.818 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' ILE . . . . . . . . . . . . . 5.2 mp -92.63 87.72 2.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 107.834 -1.173 . . . . 10.0 107.834 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -85.39 94.79 9.06 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.745 -0.662 . . . . 10.0 112.014 -178.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 50.9 mt -87.43 99.62 8.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 107.272 -1.381 . . . . 10.0 107.272 177.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 12.7 ttm-85 -138.33 154.97 48.98 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.28 0.562 . . . . 10.0 111.819 -177.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -82.25 148.82 28.17 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.362 -0.835 . . . . 10.0 109.56 178.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -132.65 121.63 23.45 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.594 -0.521 . . . . 10.0 109.594 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' TRP . . . . . . . . . . . . . 23.7 m0 -99.19 143.44 29.46 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.225 -0.443 . . . . 10.0 110.469 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 42.6 ttm -84.62 120.18 26.07 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.314 -0.403 . . . . 10.0 110.061 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.52 163.65 53.29 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.963 -0.562 . . . . 10.0 110.856 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -57.83 -32.34 94.69 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.233 2.622 . . . . 10.0 113.44 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.44 -49.57 66.27 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.888 0.375 . . . . 10.0 110.465 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 136.68 24.73 0.47 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.718 -0.754 . . . . 10.0 112.669 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -115.35 161.98 17.76 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.938 0.399 . . . . 10.0 110.606 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' MET . . . . . . . . . . . . . 96.9 mmm -101.55 106.24 17.3 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.871 -0.604 . . . . 10.0 109.387 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 35.4 mmtt -98.91 136.25 20.67 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 116.127 -0.488 . . . . 10.0 110.233 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -58.21 139.16 89.46 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.756 2.304 . . . . 10.0 112.194 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . -82.62 -140.13 3.53 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 121.061 -0.59 . . . . 10.0 112.455 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 60.8 mtp85 -117.32 -27.57 6.38 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.945 0.402 . . . . 10.0 110.645 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 4.3 mtmt -88.57 114.32 25.07 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.945 -0.571 . . . . 10.0 110.134 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . 166.01 156.81 9.63 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.522 -0.847 . . . . 10.0 112.727 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 18.8 tt -156.38 140.92 8.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.001 0.429 . . . . 10.0 110.402 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 3.4 m -88.56 108.23 19.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.209 -0.45 . . . . 10.0 110.29 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 68.5 mt -87.12 131.5 34.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.206 -0.452 . . . . 10.0 110.443 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -88.2 166.65 22.71 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 109.295 -0.631 . . . . 10.0 109.295 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -47.13 -32.44 13.65 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.005 2.47 . . . . 10.0 113.251 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -67.45 -56.12 10.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.291 -0.413 . . . . 10.0 110.46 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -63.33 -34.07 76.91 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.044 -0.525 . . . . 10.0 110.285 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' TRP . . . . . . . . . . . . . 52.0 t-105 -61.37 -43.06 99.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.857 -0.61 . . . . 10.0 109.908 178.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 1.6 t -66.29 -45.46 80.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.807 -0.633 . . . . 10.0 109.494 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -56.52 -47.97 78.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.51 -0.768 . . . . 10.0 111.014 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 56.4 tp -58.62 -43.8 89.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.257 -0.429 . . . . 10.0 110.753 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -63.13 -38.54 91.6 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.953 0.406 . . . . 10.0 111.193 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -80.72 -6.65 58.73 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.203 -0.453 . . . . 10.0 111.503 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 13.6 mm-40 -105.26 -6.01 20.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.664 0.269 . . . . 10.0 111.078 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 85.1 mt -52.49 -47.23 48.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 10.0 111.921 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.57 -40.94 72.63 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.227 0.454 . . . . 10.0 112.227 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -76.04 -47.36 25.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.358 -0.383 . . . . 10.0 111.537 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 70.5 mt -64.21 -42.35 95.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.729 0.299 . . . . 10.0 110.904 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -60.68 -37.37 81.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.118 0.485 . . . . 10.0 110.422 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -69.33 -31.44 69.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.695 -0.684 . . . . 10.0 110.55 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.04 -32.44 63.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.259 -0.428 . . . . 10.0 110.212 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 95.0 t -69.2 -41.79 81.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.987 -0.551 . . . . 10.0 110.769 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -75.27 -31.52 60.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.509 -0.314 . . . . 10.0 111.095 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -107.79 78.09 1.17 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.426 -0.352 . . . . 10.0 110.805 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 94.6 mt . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.911 -0.566 . . . . 10.0 110.006 179.622 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 465' ' ' TYR . . . . . . . . . . . . . 28.5 t80 . . . . . 0 N--CA 1.48 1.048 0 CA-C-O 120.653 0.263 . . . . 10.0 110.488 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 466' ' ' GLY . . . . . . . . . . . . . . . -54.52 -42.07 74.9 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 121.297 -0.477 . . . . 10.0 112.513 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 467' ' ' ALA . . . . . . . . . . . . . . . -63.38 -38.15 90.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.047 0.451 . . . . 10.0 110.947 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 468' ' ' LEU . . . . . . . . . . . . . 65.2 tp -68.99 -40.92 78.49 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.996 -0.547 . . . . 10.0 110.539 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 469' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -65.91 -36.3 83.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.041 0.448 . . . . 10.0 110.723 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 470' ' ' MET . . . . . . . . . . . . . 90.1 mmm -71.49 -21.93 61.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.167 -0.47 . . . . 10.0 110.625 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 471' ' ' ALA . . . . . . . . . . . . . . . -69.38 -26.01 64.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.337 -0.392 . . . . 10.0 110.982 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 472' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -68.72 -24.94 64.53 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.024 0.44 . . . . 10.0 110.077 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 473' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -74.35 -3.95 33.42 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.899 -0.591 . . . . 10.0 110.392 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 474' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -101.33 -51.34 3.52 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.949 -0.76 . . . . 10.0 108.949 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 475' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -68.53 -63.74 1.0 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.67 -0.695 . . . . 10.0 111.158 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 476' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -81.62 49.86 1.4 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.104 0.478 . . . . 10.0 111.531 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 477' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -165.05 -46.78 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.94 -0.573 . . . . 10.0 110.204 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 478' ' ' MET . . . . . . . . . . . . . 27.8 ttp -95.19 -50.86 4.87 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.185 -0.462 . . . . 10.0 110.454 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 479' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -63.14 -51.74 65.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 10.0 111.159 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 480' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.38 -17.12 64.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.283 -0.417 . . . . 10.0 112.017 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 481' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -86.15 -47.5 9.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.003 0.43 . . . . 10.0 109.864 179.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 482' ' ' ALA . . . . . . . . . . . . . . . -63.67 -22.85 67.12 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.505 -0.771 . . . . 10.0 111.257 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 483' ' ' LEU . . . . . . . . . . . . . 29.6 mt -64.39 -23.98 67.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.318 -0.401 . . . . 10.0 111.291 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 484' ' ' GLY . . . . . . . . . . . . . . . -141.17 28.55 2.35 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.47 -0.871 . . . . 10.0 112.229 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 485' ' ' ILE . . . . . . . . . . . . . 12.9 tt -71.85 -39.96 68.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.835 0.35 . . . . 10.0 111.061 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 486' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -99.14 10.68 40.97 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.857 0.361 . . . . 10.0 110.752 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 487' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -63.79 -30.0 71.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.075 -0.512 . . . . 10.0 111.689 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 488' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -73.36 -3.03 24.68 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.952 0.406 . . . . 10.0 111.001 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 489' ' ' GLY . . . . . . . . . . . . . . . -117.48 13.63 13.47 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 121.07 -0.586 . . . . 10.0 111.787 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.785 0 CA-C-O 118.702 -1.054 . . . . 10.0 112.177 -179.898 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 110.412 -0.218 . . . . 10.0 110.412 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 54.0 ttm -107.44 115.46 30.2 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.968 -0.382 . . . . 10.0 109.968 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -98.83 149.75 22.58 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.413 -0.358 . . . . 10.0 110.482 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -102.83 124.35 48.18 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.699 0.285 . . . . 10.0 111.239 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 37.1 pt -116.38 0.31 8.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.368 -0.378 . . . . 10.0 110.859 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 168.45 -179.02 41.71 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.509 -0.853 . . . . 10.0 112.522 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 37.3 tttp -64.4 117.52 7.39 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.728 0.299 . . . . 10.0 110.92 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 39.9 mmm 65.3 7.95 4.58 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.434 -0.803 . . . . 10.0 112.033 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -113.54 112.11 23.01 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.733 -0.469 . . . . 10.0 109.733 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -125.55 157.05 38.06 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.08 -0.509 . . . . 10.0 111.342 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 86.3 t -117.78 101.0 11.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.048 -0.978 . . . . 10.0 109.344 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.9 m -89.42 98.72 11.93 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.109 -0.496 . . . . 10.0 110.987 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.1 t -86.64 117.64 31.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.066 -0.516 . . . . 10.0 110.213 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.1 ptt-85 -136.62 173.2 11.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.234 -0.439 . . . . 10.0 110.141 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -113.33 153.08 29.07 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.755 0.312 . . . . 10.0 110.351 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -161.16 119.34 2.41 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.085 -0.507 . . . . 10.0 109.842 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 30.4 mtmt 66.34 25.21 10.45 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.504 0.502 . . . . 10.0 110.264 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.41 1.89 90.52 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.706 -0.759 . . . . 10.0 111.399 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -102.12 -175.86 2.96 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.988 -0.375 . . . . 10.0 109.988 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 42.5 t -119.61 137.0 54.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.039 0.447 . . . . 10.0 111.267 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 73.6 mt -121.27 100.83 7.26 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.482 -0.781 . . . . 10.0 110.301 178.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 44.8 mt -89.17 95.49 5.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.303 -0.629 . . . . 10.0 109.303 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.34 109.97 14.18 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.464 0.542 . . . . 10.0 112.464 -177.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 35.3 mt -109.27 90.88 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.395 -0.965 . . . . 10.0 108.395 177.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.4 ttm-85 -137.35 168.07 20.36 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.969 -0.56 . . . . 10.0 111.678 -177.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -91.64 129.77 37.56 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.413 -0.958 . . . . 10.0 108.413 178.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -114.02 118.6 34.55 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.9 0.381 . . . . 10.0 110.068 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 81.6 m95 -102.43 146.23 28.39 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.896 -0.593 . . . . 10.0 110.726 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 34.2 ttm -68.35 128.63 37.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.144 -0.48 . . . . 10.0 111.474 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 34.5 p30 -97.46 171.79 5.61 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 115.61 -0.723 . . . . 10.0 110.845 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -78.39 32.0 0.45 Allowed 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.927 2.418 . . . . 10.0 111.711 178.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -123.0 -44.4 2.18 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.976 -0.749 . . . . 10.0 108.976 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 126.93 18.49 2.12 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 114.871 -1.059 . . . . 10.0 110.973 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -121.24 -177.68 3.58 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.806 -0.442 . . . . 10.0 109.806 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 61.0 mmm -117.57 115.16 24.56 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.791 -0.448 . . . . 10.0 109.791 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.3 mmpt? -95.36 139.58 22.05 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.138 -0.483 . . . . 10.0 110.572 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -69.36 118.8 5.9 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.941 2.427 . . . . 10.0 112.622 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -70.14 168.87 47.22 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 121.173 -0.537 . . . . 10.0 111.827 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -81.24 56.53 2.89 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.873 0.368 . . . . 10.0 111.8 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 13.2 ttmt -167.29 108.38 0.62 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.779 -0.646 . . . . 10.0 109.901 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 170.44 175.98 39.58 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.017 -1.087 . . . . 10.0 112.929 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 13.9 tt -155.21 157.65 4.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.313 -0.625 . . . . 10.0 109.313 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.1 p -112.24 173.92 6.13 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 121.069 -0.252 . . . . 10.0 110.861 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 37.7 mt -136.7 149.95 48.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.412 -0.358 . . . . 10.0 110.301 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 11.9 p-10 -117.95 167.37 11.4 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 109.538 -0.541 . . . . 10.0 109.538 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -47.27 -45.59 21.76 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.944 2.429 . . . . 10.0 113.389 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -56.48 -50.54 71.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.089 -0.505 . . . . 10.0 111.514 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -71.97 -36.75 69.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.432 -0.349 . . . . 10.0 110.701 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 69.0 t-105 -56.45 -45.21 80.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.916 -0.584 . . . . 10.0 111.029 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.0 t -61.6 -51.38 68.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.334 -0.393 . . . . 10.0 110.182 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -61.55 -37.23 83.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.082 -0.508 . . . . 10.0 111.508 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 66.5 tp -61.47 -45.11 95.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.921 0.391 . . . . 10.0 110.2 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -65.08 -36.26 83.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.267 0.556 . . . . 10.0 110.172 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -74.42 -9.21 58.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.476 -0.783 . . . . 10.0 111.48 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -112.01 1.71 16.52 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.706 -0.225 . . . . 10.0 111.53 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.5 mt -55.28 -53.29 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.659 -0.246 . . . . 10.0 111.344 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.85 -39.1 80.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 10.0 111.446 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -67.19 -51.39 54.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.131 -0.486 . . . . 10.0 111.566 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 62.6 mt -65.33 -45.05 94.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.351 -0.386 . . . . 10.0 111.182 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -60.32 -42.09 94.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.103 -0.499 . . . . 10.0 111.612 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -66.33 -36.87 84.02 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 120.836 0.35 . . . . 10.0 110.195 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.13 -41.95 97.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.936 -0.575 . . . . 10.0 109.974 178.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 97.3 t -65.52 -41.98 92.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.784 -0.644 . . . . 10.0 109.856 178.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 27.3 mtm105 -67.12 -22.62 65.79 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.746 -0.661 . . . . 10.0 111.144 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 35.6 mttp -78.63 -30.39 46.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 10.0 110.283 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 70.8 mt . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 115.993 -0.549 . . . . 10.0 110.679 179.993 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.162 0 CA-C-O 120.91 0.385 . . . . 10.0 110.756 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 86.5 mmm -95.09 84.64 4.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.058 0.456 . . . . 10.0 110.274 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -82.22 159.46 23.23 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.757 -0.656 . . . . 10.0 110.091 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -133.6 119.01 18.89 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.942 0.401 . . . . 10.0 110.972 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 3.0 pt -97.02 95.05 4.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.137 -0.69 . . . . 10.0 109.137 178.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.82 -93.06 1.78 Allowed Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 110.74 -0.944 . . . . 10.0 110.74 -178.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -165.37 151.92 10.11 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.652 -0.499 . . . . 10.0 109.652 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' MET . . . . . . . . . . . . . 1.2 mpt? 74.93 -50.76 0.67 Allowed 'General case' 0 N--CA 1.473 0.69 0 O-C-N 123.856 0.722 . . . . 10.0 111.67 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -75.7 110.51 10.17 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.752 0.311 . . . . 10.0 110.365 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -110.26 131.16 55.3 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.184 -0.462 . . . . 10.0 111.086 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 22.3 t -78.65 83.54 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.698 -0.853 . . . . 10.0 108.698 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 26.1 t -87.22 92.59 9.11 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.576 -0.738 . . . . 10.0 111.731 -178.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 3.8 t -86.0 73.69 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.657 -0.868 . . . . 10.0 108.657 177.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 35.0 ptt-85 -102.29 144.05 31.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.484 0.659 . . . . 10.0 112.093 -177.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -82.71 126.22 32.12 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.974 -1.012 . . . . 10.0 108.939 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -118.27 100.97 7.84 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.644 0.259 . . . . 10.0 110.674 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 63.7 mttm 58.78 35.46 24.33 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.8 -0.636 . . . . 10.0 111.872 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.19 8.27 61.59 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.613 -0.803 . . . . 10.0 112.265 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 42.0 mmtt -117.43 107.45 14.35 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-O 120.78 0.324 . . . . 10.0 110.681 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 21.9 t -74.42 105.26 3.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.529 -0.545 . . . . 10.0 109.529 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 98.5 mt -118.07 125.05 49.55 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.197 0.523 . . . . 10.0 111.364 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' ILE . . . . . . . . . . . . . 32.7 mt -85.87 82.84 2.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.16 -1.052 . . . . 10.0 108.16 178.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -93.65 100.71 12.9 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.395 -0.82 . . . . 10.0 111.086 -178.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 36.0 mt -84.24 94.93 3.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 108.353 -0.98 . . . . 10.0 108.353 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 5.6 ttm-85 -106.0 151.0 25.18 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.831 -0.622 . . . . 10.0 111.686 -177.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -83.56 116.07 22.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.716 -0.674 . . . . 10.0 110.24 178.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -96.03 106.74 18.95 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.942 -0.572 . . . . 10.0 109.855 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' TRP . . . . . . . . . . . . . 76.8 m95 -104.52 139.42 39.44 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.898 -0.592 . . . . 10.0 110.335 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 39.3 ttm -69.05 130.44 42.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.953 -0.567 . . . . 10.0 111.665 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' ASP . . . . . . . . . . . . . 49.0 p30 -90.35 173.88 5.23 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.477 -0.783 . . . . 10.0 109.724 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -61.55 -20.32 68.21 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.228 1.952 . . . . 10.0 112.56 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -74.66 -44.0 52.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.281 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 124.48 20.86 2.32 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.925 -0.655 . . . . 10.0 112.165 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -114.77 161.9 17.57 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.182 -0.303 . . . . 10.0 110.182 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' MET . . . . . . . . . . . . . 8.2 mmt -93.31 113.96 26.28 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.824 -0.435 . . . . 10.0 109.824 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 48.1 mmtt -105.97 126.05 31.62 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.042 -0.526 . . . . 10.0 111.119 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.98 118.36 5.53 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.591 2.194 . . . . 10.0 111.819 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . -83.46 -157.84 25.16 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.767 -0.73 . . . . 10.0 112.712 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -86.17 -20.74 28.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.868 0.366 . . . . 10.0 110.448 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 6.8 mtpm? -69.39 106.36 2.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.905 -0.588 . . . . 10.0 109.694 178.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . 161.83 157.11 8.7 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.727 -0.669 . . . . 10.0 111.464 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 6.5 tp -133.63 134.99 56.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.946 0.403 . . . . 10.0 110.731 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.21 108.49 21.23 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.826 -0.625 . . . . 10.0 110.481 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 80.4 mt -111.4 137.74 48.79 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.979 0.419 . . . . 10.0 110.835 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 36.5 p-10 -85.95 168.25 20.33 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.325 -0.398 . . . . 10.0 109.932 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -52.63 -27.33 32.77 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.775 2.317 . . . . 10.0 112.526 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -66.38 -51.38 57.7 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.936 -0.574 . . . . 10.0 109.942 178.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -65.63 -33.21 75.37 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.979 -0.555 . . . . 10.0 110.355 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' TRP . . . . . . . . . . . . . 45.9 t-105 -57.8 -41.91 83.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.126 -0.488 . . . . 10.0 110.699 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 13.6 t -68.04 -53.31 26.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.315 -0.402 . . . . 10.0 110.736 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -59.33 -36.59 75.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.481 . . . . 10.0 111.303 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 64.2 tp -60.12 -48.0 83.55 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.162 -0.31 . . . . 10.0 110.162 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -62.9 -39.11 93.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.142 -0.481 . . . . 10.0 110.881 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -68.29 -30.66 69.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.938 -0.574 . . . . 10.0 111.429 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -85.39 -8.3 58.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.676 -0.238 . . . . 10.0 111.265 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 27.3 mt -57.22 -37.4 56.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.676 -0.238 . . . . 10.0 111.513 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.12 -29.42 67.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.945 0.402 . . . . 10.0 111.282 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -91.2 -42.81 10.22 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.168 -0.469 . . . . 10.0 110.68 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 82.8 mt -64.05 -47.14 91.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.893 -0.594 . . . . 10.0 111.206 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -60.01 -38.96 84.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.565 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -63.85 -42.66 97.53 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.641 -0.709 . . . . 10.0 110.249 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.63 -33.96 77.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.971 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 71.3 t -60.4 -35.22 61.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-O 121.362 0.601 . . . . 10.0 110.708 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 7.3 ptt85 -102.99 21.22 16.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.803 -0.635 . . . . 10.0 110.613 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 17.4 ttmt -136.81 47.27 2.16 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.412 0.625 . . . . 10.0 109.821 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 58.5 mt . . . . . 0 C--O 1.245 0.856 0 CA-C-O 118.517 -0.754 . . . . 10.0 109.922 179.722 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 465' ' ' TYR . . . . . . . . . . . . . 11.1 p90 . . . . . 0 N--CA 1.476 0.869 0 CA-C-O 120.768 0.318 . . . . 10.0 110.896 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 466' ' ' GLY . . . . . . . . . . . . . . . 84.09 -2.9 87.14 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 121.068 -0.587 . . . . 10.0 114.062 178.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 467' ' ' ALA . . . . . . . . . . . . . . . -74.8 -32.76 62.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 117.401 0.601 . . . . 10.0 110.754 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 468' ' ' LEU . . . . . . . . . . . . . 69.9 tp -56.8 -35.84 69.2 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.596 -0.729 . . . . 10.0 111.785 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 469' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -64.65 -38.55 91.39 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.688 0.28 . . . . 10.0 111.281 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 470' ' ' MET . . . . . . . . . . . . . 1.2 tmm? -80.07 -25.8 39.92 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.941 0.4 . . . . 10.0 110.117 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 471' ' ' ALA . . . . . . . . . . . . . . . -59.36 -30.88 68.71 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.955 -0.566 . . . . 10.0 111.051 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 472' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -59.4 -34.97 73.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.745 -0.661 . . . . 10.0 110.978 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 473' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -96.44 -13.88 22.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.161 -0.472 . . . . 10.0 111.175 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 474' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.36 -39.27 78.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.932 0.396 . . . . 10.0 110.005 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 475' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -74.85 -21.62 59.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.896 -0.593 . . . . 10.0 111.214 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 476' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -63.51 -61.82 2.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.389 -0.369 . . . . 10.0 110.702 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 477' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -63.55 -27.93 69.59 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.991 0.424 . . . . 10.0 111.113 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 478' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -77.81 -5.6 51.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.156 -0.475 . . . . 10.0 111.057 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 479' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -113.44 -55.12 2.55 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.509 -0.314 . . . . 10.0 111.705 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 480' ' ' THR . . . . . . . . . . . . . 1.7 p -59.45 -51.99 67.54 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 112.287 0.477 . . . . 10.0 112.287 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 481' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -61.96 -45.42 93.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.055 -0.521 . . . . 10.0 110.87 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 482' ' ' ALA . . . . . . . . . . . . . . . -64.27 -47.28 80.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.889 -0.596 . . . . 10.0 112.263 -178.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 483' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.78 -46.74 84.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.45 -0.341 . . . . 10.0 111.135 -179.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 484' ' ' GLY . . . . . . . . . . . . . . . -70.32 -22.61 77.61 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.769 -0.729 . . . . 10.0 112.612 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 485' ' ' ILE . . . . . . . . . . . . . 1.3 mm -76.6 -44.63 34.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.821 0.344 . . . . 10.0 111.401 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 486' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.76 -45.59 20.73 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.345 -0.388 . . . . 10.0 111.996 -178.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 487' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.91 -42.81 94.43 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.51 0.559 . . . . 10.0 112.51 -178.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 488' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -135.59 72.4 1.44 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.974 0.416 . . . . 10.0 110.686 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 489' ' ' GLY . . . . . . . . . . . . . . . -98.18 -30.35 7.08 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.915 -0.659 . . . . 10.0 112.075 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.773 -1.015 . . . . 10.0 112.1 -179.804 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 109.933 -0.395 . . . . 10.0 109.933 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 49.1 ttm -126.55 105.54 8.81 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.917 0.389 . . . . 10.0 110.618 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -96.37 126.47 41.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.004 -0.544 . . . . 10.0 110.407 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -85.74 131.48 34.32 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.009 -0.367 . . . . 10.0 110.009 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 26.9 pt -119.62 11.68 6.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.147 0.498 . . . . 10.0 110.807 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 161.39 174.71 31.6 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.401 -0.68 . . . . 10.0 111.401 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -61.85 120.32 10.51 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.058 0.456 . . . . 10.0 110.873 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 36.1 mmm 66.19 12.7 8.72 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.079 -0.964 . . . . 10.0 111.964 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -114.81 113.0 23.66 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.718 -0.475 . . . . 10.0 109.718 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -126.73 134.27 50.69 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.116 0.484 . . . . 10.0 111.71 -177.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 38.7 t -93.82 105.16 16.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 108.912 -0.773 . . . . 10.0 108.912 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.2 m -80.8 82.99 6.65 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.502 -0.772 . . . . 10.0 111.3 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.8 t -83.41 93.55 3.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.912 -0.773 . . . . 10.0 108.912 178.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -133.92 -175.37 3.82 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.816 -0.629 . . . . 10.0 111.029 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -117.07 142.45 46.96 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.873 -0.603 . . . . 10.0 110.033 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -145.38 96.53 2.85 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.018 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.8 mttp 68.48 29.15 5.77 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.016 -0.538 . . . . 10.0 111.057 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 84.37 54.15 3.06 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.545 -0.836 . . . . 10.0 111.834 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.8 mttp -146.41 130.52 17.39 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.783 -0.209 . . . . 10.0 110.472 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.3 t -80.2 84.69 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.54 -0.911 . . . . 10.0 108.54 178.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 30.5 mt -83.7 104.84 14.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.892 -0.595 . . . . 10.0 112.126 -178.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 16.6 mt -97.25 64.07 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 106.704 -1.591 . . . . 10.0 106.704 176.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -68.41 101.68 1.28 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.735 -1.12 . . . . 10.0 113.375 -176.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 63.0 mt -84.21 108.0 16.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 107.383 -1.34 . . . . 10.0 107.383 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -143.69 170.47 15.8 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.599 0.714 . . . . 10.0 112.335 -177.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -99.95 140.77 33.7 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.282 -0.872 . . . . 10.0 108.911 177.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -122.23 121.76 37.58 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.912 0.387 . . . . 10.0 110.462 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -114.49 153.57 29.76 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.763 -0.653 . . . . 10.0 109.943 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 2.3 ttm -83.02 122.14 27.93 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.836 -0.431 . . . . 10.0 109.836 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.47 170.76 13.66 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.824 -0.626 . . . . 10.0 110.726 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -54.19 -29.78 58.17 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 123.053 2.502 . . . . 10.0 113.458 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -73.75 -45.2 53.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.965 0.412 . . . . 10.0 110.608 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 124.51 30.18 1.01 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.63 -0.795 . . . . 10.0 112.0 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -116.33 167.76 10.74 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.78 0.324 . . . . 10.0 110.32 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 92.3 mmm -89.42 98.25 11.66 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.251 -0.648 . . . . 10.0 109.251 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -98.23 124.54 46.77 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.447 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -78.02 146.86 23.34 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.727 2.284 . . . . 10.0 112.891 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -85.08 -174.1 50.13 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.725 -0.75 . . . . 10.0 112.332 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -76.06 -26.92 56.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.98 0.419 . . . . 10.0 110.758 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -76.38 81.38 3.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.863 -0.608 . . . . 10.0 110.609 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -146.62 129.48 3.33 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.959 -0.564 . . . . 10.0 111.766 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 8.5 tt -127.29 113.86 33.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.201 0.524 . . . . 10.0 110.702 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.3 m -79.27 99.9 7.28 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.089 -0.505 . . . . 10.0 110.679 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.7 mt -76.53 171.66 14.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.153 0.501 . . . . 10.0 110.442 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -133.03 158.32 76.13 Favored Pre-proline 0 C--N 1.316 -0.87 0 N-CA-C 108.835 -0.802 . . . . 10.0 108.835 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -41.39 -45.3 5.91 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.825 3.017 . . . . 10.0 113.891 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -64.38 -49.69 70.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.709 0.29 . . . . 10.0 110.833 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -63.56 -40.74 97.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.266 -0.424 . . . . 10.0 110.586 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -59.47 -44.79 92.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.924 -0.58 . . . . 10.0 110.294 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 56.8 m -64.4 -41.02 96.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.226 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -63.98 -42.02 97.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.254 -0.43 . . . . 10.0 110.395 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 22.9 tp -59.36 -40.99 88.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.992 -0.549 . . . . 10.0 110.543 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -63.95 -33.49 75.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.856 -0.611 . . . . 10.0 111.121 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -76.82 -15.4 59.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.324 -0.398 . . . . 10.0 111.115 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -99.55 -5.18 29.61 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.547 -0.297 . . . . 10.0 110.879 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 56.7 mt -56.56 -39.73 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.396 -0.365 . . . . 10.0 111.489 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.14 -30.21 69.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.109 -0.496 . . . . 10.0 111.099 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -90.04 -39.93 12.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.756 -0.656 . . . . 10.0 110.571 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 92.8 mt -62.21 -51.22 75.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.323 -0.399 . . . . 10.0 110.628 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -62.05 -28.7 69.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.243 0.544 . . . . 10.0 110.329 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -63.64 -49.78 71.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.422 -0.808 . . . . 10.0 110.064 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.47 -34.18 77.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.778 -0.647 . . . . 10.0 110.969 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 72.5 t -61.44 -42.65 94.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.964 0.412 . . . . 10.0 110.678 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 24.1 mtm180 -75.03 -24.25 58.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.018 -0.537 . . . . 10.0 111.143 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -74.78 -46.34 37.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.021 0.439 . . . . 10.0 110.81 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 17.6 mt . . . . . 0 C--N 1.326 -0.452 0 CA-C-N 116.008 -0.542 . . . . 10.0 111.14 -179.724 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.163 0 CA-C-O 121.171 0.51 . . . . 10.0 110.471 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 86.5 mmm -109.14 111.01 22.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.7 -0.682 . . . . 10.0 109.914 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -107.87 157.65 17.99 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.268 -0.424 . . . . 10.0 110.462 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -117.38 135.07 54.13 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.486 -0.325 . . . . 10.0 110.284 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 21.2 pt -126.84 29.13 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.176 -0.465 . . . . 10.0 111.113 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 149.97 -172.1 29.89 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.929 -0.653 . . . . 10.0 111.616 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -69.24 105.87 2.67 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.555 0.178 . . . . 10.0 110.735 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER 76.01 -12.8 0.96 Allowed 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.71 0.633 . . . . 10.0 112.71 178.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -79.75 113.87 18.24 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.861 -0.422 . . . . 10.0 109.861 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -119.88 161.79 20.24 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.439 0.638 . . . . 10.0 112.15 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 95.2 t -119.84 114.5 44.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.0 -1.0 . . . . 10.0 108.361 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 4.9 t -104.04 106.59 17.15 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.0 0.428 . . . . 10.0 111.571 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 31.2 t -104.9 110.01 29.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.972 -0.751 . . . . 10.0 108.972 178.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 7.0 ptt-85 -151.73 163.02 40.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.941 0.4 . . . . 10.0 111.686 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -82.64 113.38 20.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.823 -0.626 . . . . 10.0 109.984 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -105.24 84.25 2.08 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.364 -0.38 . . . . 10.0 110.787 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 59.0 mttm 62.41 43.6 7.91 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.69 -0.686 . . . . 10.0 111.477 178.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 86.87 35.52 9.93 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.528 -0.844 . . . . 10.0 112.429 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 19.1 mmtm -150.84 115.71 5.26 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 122.196 0.198 . . . . 10.0 110.557 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 28.4 t -75.82 90.21 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.692 -0.855 . . . . 10.0 108.692 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 45.6 mt -95.21 130.99 41.74 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.358 0.599 . . . . 10.0 111.98 -178.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' ILE . . . . . . . . . . . . . 3.1 mp -103.13 91.06 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 107.799 -1.185 . . . . 10.0 107.799 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -89.85 104.46 17.02 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.588 -0.733 . . . . 10.0 111.69 -178.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 54.3 mt -87.28 97.56 6.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 107.501 -1.296 . . . . 10.0 107.501 177.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -132.0 150.28 52.2 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.886 -0.597 . . . . 10.0 112.127 -176.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -83.55 128.49 34.56 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.85 -0.796 . . . . 10.0 108.85 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -103.01 122.14 44.01 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.971 0.415 . . . . 10.0 110.546 -179.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' TRP . . . . . . . . . . . . . 22.4 m0 -99.92 136.88 39.16 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.859 -0.609 . . . . 10.0 109.851 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 44.2 ttm -73.33 141.02 47.11 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.109 0.481 . . . . 10.0 110.864 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.37 165.45 13.53 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 115.605 -0.725 . . . . 10.0 110.238 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -55.09 -29.71 66.89 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.113 2.542 . . . . 10.0 113.815 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.75 -35.24 72.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.966 0.412 . . . . 10.0 110.384 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 119.52 20.26 3.95 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.639 -0.791 . . . . 10.0 112.966 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -111.56 160.68 16.96 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.88 0.34 . . . . 10.0 110.366 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' MET . . . . . . . . . . . . . 84.6 mmm -98.11 111.2 23.6 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.73 -0.47 . . . . 10.0 109.73 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 49.8 mmtt -100.66 135.98 19.99 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.231 -0.44 . . . . 10.0 111.01 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -63.0 118.88 5.77 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.394 2.063 . . . . 10.0 111.845 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . -68.57 167.95 43.67 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.741 -0.743 . . . . 10.0 112.039 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 5.4 mtm180 -82.26 47.97 1.21 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.192 0.52 . . . . 10.0 110.98 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -161.78 104.87 1.21 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.689 -0.687 . . . . 10.0 110.418 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -173.93 161.13 31.37 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 110.805 -0.918 . . . . 10.0 110.805 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 7.5 tp -119.8 122.46 68.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.298 0.57 . . . . 10.0 111.244 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -94.37 104.84 16.81 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.825 -0.625 . . . . 10.0 110.254 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 83.9 mt -98.27 163.62 12.64 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.231 -0.441 . . . . 10.0 110.628 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 45.4 p30 -115.83 169.95 6.32 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 108.652 -0.87 . . . . 10.0 108.652 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -53.61 -30.38 54.94 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.283 1.988 . . . . 10.0 112.445 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -65.02 -56.53 12.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.601 -0.727 . . . . 10.0 110.799 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -72.49 -27.52 62.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.258 -0.428 . . . . 10.0 110.409 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' TRP . . . . . . . . . . . . . 34.9 t-105 -65.92 -36.78 84.33 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.962 -0.755 . . . . 10.0 108.962 177.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 29.2 t -64.35 -51.16 64.75 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.322 -0.854 . . . . 10.0 109.437 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -62.22 -36.1 80.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.757 -0.656 . . . . 10.0 111.076 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 52.7 tp -59.25 -44.24 92.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.92 0.39 . . . . 10.0 110.069 178.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -66.38 -30.54 70.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.926 -0.579 . . . . 10.0 110.751 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -79.75 -25.8 40.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.19 -0.459 . . . . 10.0 111.01 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -84.03 -10.44 57.87 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.337 -0.392 . . . . 10.0 111.217 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 73.0 mt -56.53 -43.29 77.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.375 -0.375 . . . . 10.0 111.787 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.23 -28.75 68.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.871 0.367 . . . . 10.0 111.695 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.79 -43.09 12.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.304 -0.407 . . . . 10.0 110.99 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 78.5 mt -67.26 -46.1 84.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.14 -0.482 . . . . 10.0 110.773 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.88 -43.84 77.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.019 -0.537 . . . . 10.0 110.828 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -61.32 -37.52 83.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.525 -0.761 . . . . 10.0 111.242 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.49 -41.64 54.87 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.354 -0.385 . . . . 10.0 111.15 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 77.1 t -62.9 -42.5 96.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.197 -0.456 . . . . 10.0 111.441 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 20.1 ptt180 -73.41 -6.77 48.37 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.801 0.297 . . . . 10.0 111.801 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 63.7 mttt -90.51 -4.8 56.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.025 0.441 . . . . 10.0 110.734 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 49.8 tp . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.561 -0.733 . . . . 10.0 109.972 179.578 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 465' ' ' TYR . . . . . . . . . . . . . 25.5 t80 . . . . . 0 N--CA 1.478 0.925 0 CA-C-O 120.389 0.138 . . . . 10.0 110.965 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 466' ' ' GLY . . . . . . . . . . . . . . . -54.12 -30.21 46.35 Favored Glycine 0 CA--C 1.519 0.343 0 N-CA-C 114.245 0.458 . . . . 10.0 114.245 -178.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 467' ' ' ALA . . . . . . . . . . . . . . . -56.57 -47.59 79.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 117.209 0.505 . . . . 10.0 111.472 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 468' ' ' LEU . . . . . . . . . . . . . 28.9 tp -88.44 -31.93 18.55 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.005 0.431 . . . . 10.0 110.317 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 469' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -56.48 -48.61 76.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.487 -0.779 . . . . 10.0 111.653 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 470' ' ' MET . . . . . . . . . . . . . 1.8 mmm -63.03 -35.69 81.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.338 -0.392 . . . . 10.0 110.625 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 471' ' ' ALA . . . . . . . . . . . . . . . -68.95 -38.65 79.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.101 0.477 . . . . 10.0 110.148 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 472' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -67.81 -45.0 75.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.843 -0.617 . . . . 10.0 110.039 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 473' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -60.39 -42.94 96.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.686 -0.688 . . . . 10.0 109.778 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 474' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -65.64 -33.72 76.55 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.831 -0.622 . . . . 10.0 110.448 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 475' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -63.07 -47.37 83.21 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.811 -0.44 . . . . 10.0 109.811 178.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 476' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -65.98 -43.23 88.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.898 -0.592 . . . . 10.0 110.277 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 477' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -61.32 -38.49 87.06 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.558 -0.747 . . . . 10.0 110.948 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 478' ' ' MET . . . . . . . . . . . . . 31.3 tpp -74.46 -19.69 60.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.006 0.432 . . . . 10.0 111.2 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 479' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -70.59 -47.71 58.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.198 -0.456 . . . . 10.0 109.814 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 480' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.78 -4.73 58.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.844 -0.616 . . . . 10.0 111.152 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 481' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.39 -37.53 67.71 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.872 -0.603 . . . . 10.0 112.022 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 482' ' ' ALA . . . . . . . . . . . . . . . -99.02 16.91 21.08 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.111 0.412 . . . . 10.0 112.111 -178.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 483' ' ' LEU . . . . . . . . . . . . . 33.0 tp -87.15 -51.28 6.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.711 0.291 . . . . 10.0 111.518 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 484' ' ' GLY . . . . . . . . . . . . . . . -75.12 41.99 1.34 Allowed Glycine 0 CA--C 1.521 0.461 0 C-N-CA 121.391 -0.433 . . . . 10.0 113.858 -178.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 485' ' ' ILE . . . . . . . . . . . . . 6.3 tp -151.13 -16.05 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.784 0.326 . . . . 10.0 110.507 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 486' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -68.34 -35.38 77.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.949 0.404 . . . . 10.0 110.611 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 487' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -77.17 -2.87 36.64 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.355 -0.384 . . . . 10.0 110.964 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 488' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -79.7 -21.63 44.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.387 -0.37 . . . . 10.0 111.12 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 489' ' ' GLY . . . . . . . . . . . . . . . -171.98 170.8 43.74 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.717 -0.754 . . . . 10.0 112.271 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.873 0 CA-C-O 118.679 -1.067 . . . . 10.0 111.801 -179.756 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 110.282 -0.266 . . . . 10.0 110.282 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.88 122.73 48.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.805 0.336 . . . . 10.0 111.162 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -117.95 144.13 45.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.106 -0.497 . . . . 10.0 110.122 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -84.2 125.25 32.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.928 0.394 . . . . 10.0 110.76 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.3 pt -115.88 16.36 7.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.198 -0.456 . . . . 10.0 110.478 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 154.75 176.24 26.77 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.594 -0.602 . . . . 10.0 111.594 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 51.8 tttp -65.61 120.17 12.45 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.688 0.28 . . . . 10.0 110.731 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 59.7 mmm 66.18 24.67 10.77 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.54 -0.755 . . . . 10.0 112.05 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -132.18 119.81 21.39 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.201 -0.296 . . . . 10.0 110.201 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -128.3 135.23 49.33 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.054 0.454 . . . . 10.0 111.751 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 41.4 t -90.05 107.33 18.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 108.696 -0.853 . . . . 10.0 108.696 178.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.8 m -94.9 90.35 5.97 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.943 0.401 . . . . 10.0 111.799 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 45.5 t -78.11 111.08 14.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.886 -0.783 . . . . 10.0 108.886 178.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.1 ptt180 -138.08 -167.01 2.08 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.106 -0.497 . . . . 10.0 110.596 -178.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -126.76 139.62 52.99 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.257 -0.428 . . . . 10.0 110.127 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -148.03 112.85 5.42 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.226 -0.443 . . . . 10.0 110.125 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.8 mtmp? 68.42 15.11 9.22 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.755 -0.657 . . . . 10.0 111.234 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 100.21 0.39 55.9 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.278 -0.963 . . . . 10.0 112.485 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.3 mtpt -109.38 132.51 54.06 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.214 -0.291 . . . . 10.0 110.214 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 43.8 t -70.74 107.32 2.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.204 -0.665 . . . . 10.0 109.204 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.7 mt -97.21 113.54 25.15 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.235 0.54 . . . . 10.0 112.376 -178.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 70.4 mt -89.1 89.38 3.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 107.322 -1.362 . . . . 10.0 107.322 177.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -79.2 101.9 8.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.499 -0.773 . . . . 10.0 112.655 -177.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.5 mt -94.34 81.25 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.537 -0.912 . . . . 10.0 108.537 178.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.9 ttm180 -117.07 155.19 29.68 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.675 -0.693 . . . . 10.0 110.961 -178.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -72.0 139.22 48.49 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.518 -0.549 . . . . 10.0 109.518 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -118.29 111.58 18.95 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.956 0.408 . . . . 10.0 110.229 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -103.02 145.65 29.56 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.761 -0.654 . . . . 10.0 109.897 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 40.8 ttm -87.62 137.74 32.08 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.112 -0.329 . . . . 10.0 110.112 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 53.0 p-10 -99.35 177.57 1.53 Allowed Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.071 -0.513 . . . . 10.0 110.275 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -63.95 -12.46 32.15 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.513 2.142 . . . . 10.0 113.018 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -88.16 -16.76 32.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.291 0.567 . . . . 10.0 110.073 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.11 14.75 55.65 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.637 -0.71 . . . . 10.0 111.745 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -94.51 157.73 15.86 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.052 0.453 . . . . 10.0 110.751 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 87.1 mmm -92.64 108.71 20.19 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.181 -0.674 . . . . 10.0 109.181 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.2 mmmm -108.62 128.91 24.68 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 116.154 -0.475 . . . . 10.0 111.099 -178.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.06 139.14 32.21 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.348 2.032 . . . . 10.0 112.283 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -84.16 -169.36 45.31 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.433 -0.667 . . . . 10.0 111.433 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.03 -7.72 51.09 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 117.3 0.55 . . . . 10.0 110.969 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 21.2 ttmt -100.25 113.9 26.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.173 -0.467 . . . . 10.0 110.108 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -175.7 168.66 41.11 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.85 -0.691 . . . . 10.0 111.8 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 17.2 tt -139.58 121.53 16.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.332 0.587 . . . . 10.0 111.006 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.77 113.0 24.68 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.952 -0.567 . . . . 10.0 109.704 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 25.2 mt -111.68 133.64 53.79 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.011 -0.54 . . . . 10.0 110.379 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.5 p30 -91.55 172.82 6.03 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 109.32 -0.622 . . . . 10.0 109.32 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -42.77 -37.91 6.22 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 123.505 2.803 . . . . 10.0 114.282 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -57.03 -49.56 75.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.645 0.26 . . . . 10.0 111.02 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.4 -33.54 63.04 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 110.032 -0.358 . . . . 10.0 110.032 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 69.1 t-105 -57.91 -53.66 55.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.878 -0.601 . . . . 10.0 110.911 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.7 m -61.95 -42.52 99.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.296 -0.411 . . . . 10.0 110.748 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -64.35 -41.47 96.73 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.306 -0.406 . . . . 10.0 110.731 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 61.2 tp -61.91 -43.89 97.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 10.0 110.615 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt -61.71 -27.83 68.98 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.925 0.393 . . . . 10.0 110.735 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -77.15 -38.19 52.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.096 0.475 . . . . 10.0 110.312 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -76.42 -18.88 58.6 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.74 -0.664 . . . . 10.0 111.541 -179.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 44.4 mt -51.62 -39.61 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 112.072 0.397 . . . . 10.0 112.072 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 18.1 m -65.31 -17.52 64.58 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.968 0.359 . . . . 10.0 111.968 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.08 -34.29 8.47 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.745 -0.465 . . . . 10.0 109.745 178.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 83.0 mt -64.68 -48.72 83.53 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-N 115.827 -0.624 . . . . 10.0 109.966 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -58.31 -38.47 77.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.448 -0.796 . . . . 10.0 110.326 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -65.87 -41.58 91.44 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.217 -0.902 . . . . 10.0 110.561 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.23 -37.95 89.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.87 -0.605 . . . . 10.0 110.874 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 95.6 t -62.41 -40.66 88.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 10.0 110.35 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.1 mtt85 -68.92 -30.43 68.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.831 -0.622 . . . . 10.0 110.872 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 16.9 mttp -71.21 -25.52 62.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.089 0.471 . . . . 10.0 110.762 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 62.3 mt . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 116.064 -0.516 . . . . 10.0 110.522 179.783 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.264 0 CA-C-O 121.143 0.497 . . . . 10.0 110.566 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 88.0 mmm -119.12 99.29 6.63 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.562 -0.745 . . . . 10.0 110.088 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -101.54 139.22 37.49 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.922 -0.581 . . . . 10.0 110.33 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -93.52 139.62 30.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.049 0.452 . . . . 10.0 111.708 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 5.8 pt -138.0 94.33 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.507 -0.769 . . . . 10.0 109.529 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.64 -135.98 12.45 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.669 -0.777 . . . . 10.0 111.387 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -117.63 120.96 39.63 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.369 -0.234 . . . . 10.0 110.369 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' MET . . . . . . . . . . . . . 96.4 mmm 65.26 2.11 1.8 Allowed 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.817 0.673 . . . . 10.0 112.817 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' ARG . . . . . . . . . . . . . 2.3 tpp180 -98.95 126.36 44.62 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.819 -0.438 . . . . 10.0 109.819 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -130.66 142.67 50.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.514 0.673 . . . . 10.0 112.3 -178.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 62.1 t -93.41 110.44 23.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.586 -0.894 . . . . 10.0 108.586 178.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 13.3 t -100.4 103.29 14.66 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.14 0.495 . . . . 10.0 111.919 -178.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 19.3 t -96.2 98.33 7.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 108.943 -0.762 . . . . 10.0 108.943 178.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 19.6 ptt-85 -131.51 155.07 48.06 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.221 0.534 . . . . 10.0 111.966 -178.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -95.79 113.43 25.07 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.288 -0.869 . . . . 10.0 109.871 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -92.77 78.6 4.78 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.379 -0.373 . . . . 10.0 110.526 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 90.1 mttt 56.53 57.53 4.79 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.743 -0.662 . . . . 10.0 111.092 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.27 29.56 33.21 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.636 -0.792 . . . . 10.0 112.02 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -142.21 88.97 2.13 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.744 0.307 . . . . 10.0 110.252 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 12.0 t -70.01 102.31 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.408 -0.589 . . . . 10.0 109.408 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 37.0 mt -117.98 132.34 56.4 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.014 0.435 . . . . 10.0 111.366 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' ILE . . . . . . . . . . . . . 4.1 mp -91.65 86.9 2.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 108.138 -1.06 . . . . 10.0 108.138 178.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -89.78 95.89 10.44 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.315 -0.857 . . . . 10.0 110.937 -178.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 21.7 mt -78.67 116.41 22.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 108.217 -1.031 . . . . 10.0 108.217 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 20.3 ttm-85 -142.38 151.42 41.85 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.296 0.57 . . . . 10.0 112.163 -177.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -89.8 162.88 15.29 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.669 -0.696 . . . . 10.0 109.373 178.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -111.79 129.81 56.01 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.056 0.455 . . . . 10.0 111.251 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' TRP . . . . . . . . . . . . . 24.3 m95 -117.03 145.89 43.41 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.394 -0.965 . . . . 10.0 108.394 178.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 30.1 ttm -108.65 137.71 46.15 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.549 -0.461 . . . . 10.0 110.469 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' ASP . . . . . . . . . . . . . 55.1 p30 -93.83 171.78 6.62 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.165 -0.471 . . . . 10.0 110.644 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -64.65 -13.3 38.21 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.619 2.213 . . . . 10.0 113.098 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -82.71 -41.64 19.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.893 0.378 . . . . 10.0 110.048 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 119.87 27.84 2.01 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 121.085 -0.579 . . . . 10.0 111.886 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.24 151.39 27.4 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.965 0.412 . . . . 10.0 110.341 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' MET . . . . . . . . . . . . . 82.4 mmm -90.01 112.05 23.34 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.854 -0.612 . . . . 10.0 109.99 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 61.2 mmtt -111.17 140.5 22.92 Favored Pre-proline 0 C--N 1.318 -0.786 0 CA-C-N 116.444 -0.344 . . . . 10.0 110.522 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -63.22 131.38 32.05 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 122.607 2.205 . . . . 10.0 111.843 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . -68.69 160.88 51.63 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 121.151 -0.547 . . . . 10.0 112.835 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -71.83 -23.5 61.55 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.878 0.371 . . . . 10.0 110.877 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -88.45 142.84 27.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.195 -0.457 . . . . 10.0 110.378 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . 138.98 163.47 9.52 Favored Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 111.503 -0.639 . . . . 10.0 111.503 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 20.0 tt -145.39 142.99 22.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.888 0.375 . . . . 10.0 110.97 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.11 110.87 23.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.911 -0.586 . . . . 10.0 110.194 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 94.8 mt -95.49 133.98 38.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.779 0.323 . . . . 10.0 110.914 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -88.54 168.85 14.91 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.471 -0.566 . . . . 10.0 109.471 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -45.69 -37.78 16.27 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.995 2.463 . . . . 10.0 113.836 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -68.14 -52.98 28.52 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.972 0.415 . . . . 10.0 110.314 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -62.58 -34.69 77.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.738 -0.664 . . . . 10.0 110.854 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' TRP . . . . . . . . . . . . . 34.7 t-105 -59.4 -43.74 92.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.114 -0.493 . . . . 10.0 110.143 178.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 19.3 t -67.97 -46.93 69.98 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.974 -0.557 . . . . 10.0 110.012 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -58.22 -41.71 84.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.949 -0.569 . . . . 10.0 110.841 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 43.2 tp -57.79 -46.93 83.92 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.926 0.393 . . . . 10.0 110.09 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -65.13 -33.91 77.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.902 -0.59 . . . . 10.0 110.882 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -74.4 -38.43 63.1 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.859 -0.61 . . . . 10.0 112.026 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -79.06 -5.37 53.84 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.8 0.296 . . . . 10.0 111.8 -179.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 25.7 mt -53.32 -41.26 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.784 -0.189 . . . . 10.0 111.396 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.26 -37.42 72.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.289 -0.414 . . . . 10.0 111.889 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.09 -45.29 16.7 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.864 0.364 . . . . 10.0 110.918 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 71.1 mt -59.82 -52.48 60.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.839 -0.619 . . . . 10.0 110.988 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -61.08 -39.06 88.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.925 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -58.54 -38.84 78.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.958 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -78.47 -38.55 40.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.268 -0.423 . . . . 10.0 111.054 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 89.1 t -66.93 -35.45 74.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.34 -0.391 . . . . 10.0 111.466 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -81.7 -6.33 58.94 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 111.875 0.324 . . . . 10.0 111.875 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -119.95 83.48 2.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.103 0.478 . . . . 10.0 111.131 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 36.7 tp . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.306 -0.854 . . . . 10.0 109.728 179.627 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 465' ' ' TYR . . . . . . . . . . . . . 21.9 t80 . . . . . 0 N--CA 1.48 1.037 0 CA-C-O 120.416 0.151 . . . . 10.0 110.921 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 466' ' ' GLY . . . . . . . . . . . . . . . -58.11 -43.33 95.28 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.937 -0.649 . . . . 10.0 112.391 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 467' ' ' ALA . . . . . . . . . . . . . . . -77.25 23.84 0.19 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.354 0.597 . . . . 10.0 111.719 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 468' ' ' LEU . . . . . . . . . . . . . 69.8 tp -141.39 -53.91 0.46 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.652 -0.704 . . . . 10.0 109.205 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 469' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -59.22 -41.21 88.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.531 -0.759 . . . . 10.0 110.89 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 470' ' ' MET . . . . . . . . . . . . . 26.8 ttm -103.49 19.08 20.43 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.055 -0.521 . . . . 10.0 110.5 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 471' ' ' ALA . . . . . . . . . . . . . . . -117.34 -54.58 2.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.908 0.385 . . . . 10.0 110.892 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 472' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -59.61 -35.82 75.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.901 -0.59 . . . . 10.0 110.931 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 473' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -95.77 15.11 21.08 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.107 -0.497 . . . . 10.0 110.918 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 474' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -111.75 -30.19 7.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.0 0.428 . . . . 10.0 110.72 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 475' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -58.5 -39.95 81.46 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.973 -0.558 . . . . 10.0 110.955 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 476' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -78.85 8.9 4.77 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.833 0.679 . . . . 10.0 112.833 -178.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 477' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -73.01 -21.51 60.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.096 0.474 . . . . 10.0 109.878 179.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 478' ' ' MET . . . . . . . . . . . . . 3.9 ptp -145.01 -4.12 0.74 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.744 -0.662 . . . . 10.0 111.645 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 479' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -71.48 -83.27 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.788 -0.365 . . . . 10.0 111.328 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 480' ' ' THR . . . . . . . . . . . . . 13.0 p -65.41 -18.9 65.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.22 0.533 . . . . 10.0 110.774 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 481' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -67.31 -20.56 65.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.306 -0.861 . . . . 10.0 110.876 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 482' ' ' ALA . . . . . . . . . . . . . . . -65.56 -19.71 66.03 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.93 -0.577 . . . . 10.0 111.306 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 483' ' ' LEU . . . . . . . . . . . . . 22.4 tp -70.52 -58.61 3.51 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.442 -0.577 . . . . 10.0 109.442 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 484' ' ' GLY . . . . . . . . . . . . . . . -82.53 57.15 5.03 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.864 -0.607 . . . . 10.0 112.457 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 485' ' ' ILE . . . . . . . . . . . . . 17.9 tt -168.47 -31.82 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.394 -0.595 . . . . 10.0 109.394 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 486' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -89.34 -55.69 3.56 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.126 -0.488 . . . . 10.0 110.033 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 487' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -81.07 61.14 4.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.878 -0.601 . . . . 10.0 111.141 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 488' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -161.55 -52.73 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.567 -0.742 . . . . 10.0 109.745 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 489' ' ' GLY . . . . . . . . . . . . . . . -87.64 -5.61 78.16 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.45 -0.796 . . . . 10.0 112.898 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.796 0 CA-C-O 118.512 -1.16 . . . . 10.0 112.412 179.988 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 110.364 -0.235 . . . . 10.0 110.364 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 41.2 ttm -135.83 110.09 8.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.032 0.444 . . . . 10.0 110.643 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -100.37 169.49 9.07 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.426 -0.583 . . . . 10.0 109.426 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -132.35 132.55 43.02 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.899 -0.321 . . . . 10.0 110.92 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 22.7 pt -117.79 -2.09 9.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.977 0.418 . . . . 10.0 110.999 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 176.99 173.91 42.96 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.838 -0.696 . . . . 10.0 111.724 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.512 ' HG2' ' HG2' ' A' ' 68' ' ' MET . 64.4 tttp -63.91 126.99 29.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.837 0.319 . . . . 10.0 110.225 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.512 ' HG2' ' HG2' ' A' ' 67' ' ' LYS . 87.1 mmm 64.16 17.65 10.8 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.794 -0.639 . . . . 10.0 111.326 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.409 ' HD2' ' O ' ' A' ' 67' ' ' LYS . 0.4 OUTLIER -128.93 109.17 11.01 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 109.948 -0.39 . . . . 10.0 109.948 179.493 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.549 ' HD1' ' HB2' ' A' ' 87' ' ' TYR . 41.4 m-85 -121.76 160.23 25.01 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.789 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 40.9 t -111.69 114.64 47.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.968 -0.56 . . . . 10.0 110.126 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.94 119.4 27.11 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.765 -0.652 . . . . 10.0 110.523 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 81' ' ' LEU . 74.7 t -132.6 106.77 11.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.682 -0.488 . . . . 10.0 109.682 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.3 ptt180 -155.53 169.83 23.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.661 0.267 . . . . 10.0 111.014 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.72 132.46 45.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.045 -0.525 . . . . 10.0 109.94 178.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -145.17 117.41 8.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.632 -0.258 . . . . 10.0 110.731 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 74.7 mttt 61.8 -86.75 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.804 -0.635 . . . . 10.0 111.176 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -148.39 31.03 1.28 Allowed Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 111.439 -0.664 . . . . 10.0 111.439 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.425 ' HB2' ' HE3' ' A' ' 79' ' ' LYS . 20.9 ttmt -158.17 169.48 24.43 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.563 -0.532 . . . . 10.0 109.563 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 58.8 t -86.36 119.42 34.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.014 0.435 . . . . 10.0 110.034 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.503 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 1.1 tp -84.06 101.82 12.06 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.836 -0.62 . . . . 10.0 110.675 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.499 HG23 HG22 ' A' ' 73' ' ' VAL . 15.1 mt -108.46 98.23 6.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.586 -0.894 . . . . 10.0 108.586 178.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.475 ' HA ' ' HA ' ' A' ' 103' ' ' SER . 16.0 t70 -118.9 121.83 40.88 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.552 0.575 . . . . 10.0 112.552 -177.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 56.7 mt -100.71 103.58 15.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.115 -1.068 . . . . 10.0 108.115 177.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.679 ' HD2' ' HB2' ' A' ' 97' ' ' PRO . 8.8 ttm-85 -145.98 160.46 41.82 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.931 0.396 . . . . 10.0 111.318 -177.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.714 ' O ' ' HA ' ' A' ' 97' ' ' PRO . 13.2 pt-20 -63.75 141.44 58.77 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.648 -0.871 . . . . 10.0 108.648 177.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.549 ' HB2' ' HD1' ' A' ' 70' ' ' TYR . 1.7 m-85 -113.6 120.54 41.28 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.105 0.479 . . . . 10.0 111.757 -178.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -102.51 155.17 18.45 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.296 -0.865 . . . . 10.0 108.899 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 25.2 ttt -82.42 139.16 34.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.385 0.612 . . . . 10.0 111.733 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -83.33 144.61 46.87 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 114.922 -1.036 . . . . 10.0 109.154 178.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -47.57 -33.47 18.08 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.862 2.375 . . . . 10.0 112.91 178.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -75.76 -59.38 2.78 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.338 -0.392 . . . . 10.0 110.72 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 169.44 -11.51 0.05 OUTLIER Glycine 0 CA--C 1.521 0.462 0 C-N-CA 120.107 -1.044 . . . . 10.0 114.029 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -79.33 -175.08 4.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 117.22 0.51 . . . . 10.0 111.31 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 57.2 mmm -134.62 141.92 46.75 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.277 -0.638 . . . . 10.0 109.277 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.87 ' HD2' ' HD2' ' A' ' 97' ' ' PRO . 10.2 mmtp -146.79 156.29 48.1 Favored Pre-proline 0 N--CA 1.464 0.238 0 CA-C-O 120.639 0.256 . . . . 10.0 111.281 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.87 ' HD2' ' HD2' ' A' ' 96' ' ' LYS . 34.0 Cg_endo -63.4 153.7 72.91 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.289 2.659 . . . . 10.0 114.258 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -102.4 -110.41 3.4 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.057 -0.974 . . . . 10.0 112.28 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.412 ' HD3' ' HA ' ' A' ' 99' ' ' ARG . 18.8 mmt180 -122.59 -46.49 2.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.015 0.408 . . . . 10.0 111.874 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 16.1 mttp -71.15 104.79 3.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.702 0.287 . . . . 10.0 110.517 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.6 ' HA3' ' HG3' ' A' ' 85' ' ' ARG . . . 174.42 165.91 31.63 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.862 -0.685 . . . . 10.0 112.378 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.517 ' HB ' ' HA2' ' B' ' 101' ' ' GLY . 20.2 tt -146.63 142.03 20.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.99 0.424 . . . . 10.0 110.551 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 83' ' ' ASP . 1.3 m -85.83 136.62 33.24 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.021 -0.536 . . . . 10.0 110.201 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 71.4 mt -93.12 105.23 17.35 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.272 -0.422 . . . . 10.0 110.886 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -62.38 141.43 96.41 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.363 -0.606 . . . . 10.0 109.363 178.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -47.12 -38.08 24.25 Favored 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 122.617 2.211 . . . . 10.0 112.474 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -77.61 -37.28 50.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.125 -0.488 . . . . 10.0 110.295 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -68.05 -31.43 71.08 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.711 -0.677 . . . . 10.0 110.612 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 54.2 t-105 -55.36 -45.63 76.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.88 -0.6 . . . . 10.0 110.797 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.8 t -69.12 -51.81 34.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.383 -0.372 . . . . 10.0 110.395 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -55.51 -42.87 75.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.004 -0.544 . . . . 10.0 111.534 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.506 ' O ' HG13 ' A' ' 116' ' ' ILE . 62.6 tp -61.35 -47.85 84.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.644 0.259 . . . . 10.0 110.816 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.404 ' HA ' HD12 ' A' ' 116' ' ' ILE . 48.0 mtmt -60.54 -37.72 82.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.005 0.431 . . . . 10.0 111.338 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -73.83 -31.62 63.3 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.061 -0.518 . . . . 10.0 111.39 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -81.07 -15.33 56.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.487 -0.324 . . . . 10.0 111.15 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 112' ' ' LEU . 21.4 mt -49.77 -43.5 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 112.215 0.45 . . . . 10.0 112.215 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.4 m -56.97 -37.43 71.58 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.763 0.316 . . . . 10.0 111.643 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -83.6 -39.77 19.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.012 0.434 . . . . 10.0 110.616 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.475 ' O ' HG23 ' A' ' 123' ' ' VAL . 92.2 mt -60.19 -50.44 80.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.777 -0.647 . . . . 10.0 110.242 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -59.59 -37.14 77.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.392 -0.822 . . . . 10.0 110.559 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.416 ' HA ' ' CZ ' ' A' ' 124' ' ' ARG . 7.2 t70 -66.21 -35.72 81.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.312 -0.858 . . . . 10.0 110.814 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -70.83 -33.5 70.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.885 -0.598 . . . . 10.0 110.559 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 119' ' ' ILE . 60.5 t -62.24 -40.55 88.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.347 0.594 . . . . 10.0 110.118 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.416 ' CZ ' ' HA ' ' A' ' 121' ' ' ASP . 12.8 mtm105 -74.35 -13.16 60.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.529 -0.759 . . . . 10.0 111.275 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 38.7 mttp -90.46 -2.62 57.94 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.911 0.386 . . . . 10.0 110.827 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 84.0 mt . . . . . 0 C--N 1.325 -0.458 0 CA-C-N 116.249 -0.432 . . . . 10.0 110.861 -179.948 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 121.067 0.46 . . . . 10.0 110.35 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 88.0 mmm -99.7 102.8 14.38 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.565 -0.743 . . . . 10.0 109.779 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 63' ' ' PHE . . . . . 0.413 ' CD2' HG12 ' A' ' 119' ' ' ILE . 48.4 m-85 -108.03 115.68 30.56 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.387 -0.369 . . . . 10.0 111.223 -179.075 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 64' ' ' GLN . . . . . 0.46 ' HA ' ' HD1' ' B' ' 70' ' ' TYR . 55.1 tt0 -71.34 125.0 25.82 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.171 -0.468 . . . . 10.0 110.378 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 19.1 pt -116.6 2.85 7.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.005 -0.543 . . . . 10.0 110.286 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 170.66 -162.45 35.49 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.993 -0.622 . . . . 10.0 111.969 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.33 117.83 25.38 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 110.199 -0.297 . . . . 10.0 110.199 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 68' ' ' MET . . . . . . . . . . . . . 19.9 mmt 68.33 8.91 6.92 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.545 -0.752 . . . . 10.0 111.566 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 69' ' ' ARG . . . . . 0.544 ' HE ' ' HB3' ' B' ' 86' ' ' GLU . 0.7 OUTLIER -120.8 119.26 32.21 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.499 -0.556 . . . . 10.0 109.499 179.199 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 70' ' ' TYR . . . . . 0.46 ' HD1' ' HA ' ' B' ' 64' ' ' GLN . 38.8 m-85 -135.18 138.32 43.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.884 0.373 . . . . 10.0 111.2 -178.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.572 HG22 HG12 ' B' ' 84' ' ' ILE . 75.5 t -89.94 117.78 33.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 108.631 -0.877 . . . . 10.0 108.631 178.089 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 72' ' ' SER . . . . . 0.51 ' HB3' ' NH1' ' B' ' 74' ' ' ARG . 24.5 t -111.48 109.87 20.03 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.036 0.446 . . . . 10.0 111.289 -178.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 73' ' ' VAL . . . . . 0.431 ' CG2' HG23 ' A' ' 119' ' ' ILE . 20.4 t -92.73 94.86 4.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.193 -0.669 . . . . 10.0 109.193 178.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 74' ' ' ARG . . . . . 0.51 ' NH1' ' HB3' ' B' ' 72' ' ' SER . 26.5 ptt-85 -122.05 149.18 43.9 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.118 0.485 . . . . 10.0 111.546 -178.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -87.54 115.99 25.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.51 -0.768 . . . . 10.0 109.262 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -110.14 105.81 15.04 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.445 -0.343 . . . . 10.0 111.222 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 33.2 mttm 57.61 30.78 19.34 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.703 -0.68 . . . . 10.0 112.785 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 92.67 30.84 9.24 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.509 -0.853 . . . . 10.0 112.23 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 79' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' B' ' 79' ' ' LYS . 18.4 mmtm -144.22 108.13 4.71 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 122.367 0.267 . . . . 10.0 110.45 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 16.1 t -69.49 106.18 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.387 -0.597 . . . . 10.0 109.387 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 94.5 mt -111.02 128.88 56.0 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.027 0.441 . . . . 10.0 111.665 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 82' ' ' ILE . . . . . . . . . . . . . 5.2 mp -90.75 86.45 2.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 107.499 -1.297 . . . . 10.0 107.499 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 83' ' ' ASP . . . . . 0.501 ' HA ' ' HA ' ' B' ' 103' ' ' SER . 34.8 t70 -85.78 107.61 17.71 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.744 -0.662 . . . . 10.0 112.02 -177.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 84' ' ' ILE . . . . . 0.572 HG12 HG22 ' B' ' 71' ' ' VAL . 63.4 mt -92.63 95.84 5.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 107.5 -1.296 . . . . 10.0 107.5 177.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 85' ' ' ARG . . . . . 0.454 ' HG3' ' HA3' ' B' ' 101' ' ' GLY . 19.7 ttm-85 -132.84 168.84 17.66 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.504 0.669 . . . . 10.0 111.973 -177.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 86' ' ' GLU . . . . . 0.544 ' HB3' ' HE ' ' B' ' 69' ' ' ARG . 11.7 pt-20 -89.25 154.95 19.71 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.214 -0.903 . . . . 10.0 109.348 178.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 87' ' ' TYR . . . . . 0.624 ' HB3' ' HB3' ' B' ' 95' ' ' MET . 38.0 m-85 -131.47 118.8 20.69 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.909 -0.404 . . . . 10.0 109.909 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 88' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -108.28 136.61 47.64 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.976 -0.556 . . . . 10.0 109.798 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 52.4 ttm -75.55 130.99 39.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.072 0.463 . . . . 10.0 111.41 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 90' ' ' ASP . . . . . 0.491 ' OD2' ' HE2' ' B' ' 96' ' ' LYS . 35.0 p30 -84.79 172.23 9.37 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.579 -0.737 . . . . 10.0 109.774 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 91' ' ' PRO . . . . . 0.447 ' HD2' ' HB2' ' B' ' 90' ' ' ASP . 32.0 Cg_exo -61.89 -13.08 28.83 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.695 2.263 . . . . 10.0 112.863 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -84.72 -43.81 13.95 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.968 0.413 . . . . 10.0 110.254 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 129.57 16.26 1.88 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.945 -0.645 . . . . 10.0 112.317 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -109.74 147.02 33.94 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.725 0.298 . . . . 10.0 110.279 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 95' ' ' MET . . . . . 0.624 ' HB3' ' HB3' ' B' ' 87' ' ' TYR . 84.3 mmm -88.7 115.84 26.52 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 110.047 -0.353 . . . . 10.0 110.047 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 96' ' ' LYS . . . . . 0.491 ' HE2' ' OD2' ' B' ' 90' ' ' ASP . 72.0 mmtt -104.12 140.78 21.4 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 116.347 -0.388 . . . . 10.0 110.053 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.13 129.04 20.78 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.438 2.092 . . . . 10.0 112.159 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 98' ' ' GLY . . . . . 0.405 ' O ' ' HD3' ' B' ' 85' ' ' ARG . . . -76.17 -173.63 36.17 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.107 -0.568 . . . . 10.0 112.199 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -88.3 -23.28 23.5 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.894 0.378 . . . . 10.0 111.202 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 7.0 mtmp? -88.08 113.81 24.09 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.282 0.563 . . . . 10.0 110.851 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 101' ' ' GLY . . . . . 0.517 ' HA2' ' HB ' ' A' ' 102' ' ' ILE . . . 169.13 175.67 38.6 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 110.894 -0.882 . . . . 10.0 110.894 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 102' ' ' ILE . . . . . 0.592 ' HB ' ' HA2' ' A' ' 101' ' ' GLY . 21.1 tt -143.56 138.44 25.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 117.299 0.549 . . . . 10.0 111.425 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 103' ' ' SER . . . . . 0.501 ' HA ' ' HA ' ' B' ' 83' ' ' ASP . 1.5 m -98.33 107.71 20.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.781 -0.645 . . . . 10.0 109.986 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 46.3 mt -99.39 135.56 40.62 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.466 -0.334 . . . . 10.0 110.741 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 105' ' ' ASN . . . . . 0.542 ' HB2' ' HD2' ' B' ' 106' ' ' PRO . 8.7 p-10 -88.18 164.23 34.01 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 108.836 -0.802 . . . . 10.0 108.836 178.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 106' ' ' PRO . . . . . 0.542 ' HD2' ' HB2' ' B' ' 105' ' ' ASN . 7.6 Cg_endo -49.43 -32.26 26.04 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.179 2.586 . . . . 10.0 113.305 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -64.22 -57.95 8.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.266 -0.424 . . . . 10.0 110.69 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -66.88 -30.85 71.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.094 0.473 . . . . 10.0 109.949 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 109' ' ' TRP . . . . . 0.502 ' CH2' HG12 ' A' ' 116' ' ' ILE . 48.7 t-105 -59.54 -42.33 92.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.543 -0.753 . . . . 10.0 110.04 179.001 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 110' ' ' SER . . . . . 0.429 ' O ' ' HG3' ' B' ' 114' ' ' GLU . 29.9 t -63.9 -47.61 79.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 10.0 109.784 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -61.05 -38.95 87.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.816 -0.629 . . . . 10.0 111.073 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 112' ' ' LEU . . . . . 0.408 ' O ' HG13 ' B' ' 116' ' ' ILE . 49.6 tp -58.6 -45.93 88.09 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.801 0.334 . . . . 10.0 110.373 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 113' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' B' ' 109' ' ' TRP . 45.4 mtmt -66.25 -36.06 82.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.172 0.51 . . . . 10.0 110.984 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 114' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' B' ' 110' ' ' SER . 47.7 mt-10 -74.06 -32.54 63.33 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.104 -0.498 . . . . 10.0 111.274 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -75.76 -11.86 60.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.194 -0.457 . . . . 10.0 111.213 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 116' ' ' ILE . . . . . 0.408 HG13 ' O ' ' B' ' 112' ' ' LEU . 58.0 mt -55.18 -39.65 52.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.501 -0.318 . . . . 10.0 111.26 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 4.9 m -59.36 -24.08 63.09 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.876 0.369 . . . . 10.0 111.523 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.02 -44.38 7.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.915 0.388 . . . . 10.0 110.752 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 119' ' ' ILE . . . . . 0.504 ' O ' HG23 ' B' ' 123' ' ' VAL . 61.5 mt -63.78 -46.82 93.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.997 -0.547 . . . . 10.0 111.397 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -57.63 -33.08 67.89 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.36 -0.382 . . . . 10.0 111.14 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 121' ' ' ASP . . . . . 0.545 ' HA ' ' NE ' ' B' ' 124' ' ' ARG . 26.8 t70 -63.27 -42.55 99.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.291 -0.413 . . . . 10.0 110.912 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.2 -30.73 66.74 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.839 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 123' ' ' VAL . . . . . 0.504 HG23 ' O ' ' B' ' 119' ' ' ILE . 45.1 t -75.81 -38.09 36.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 10.0 110.968 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 124' ' ' ARG . . . . . 0.545 ' NE ' ' HA ' ' B' ' 121' ' ' ASP . 31.0 ptt180 -78.72 -6.29 55.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 10.0 111.235 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 65.7 mttt . . . . . 0 C--N 1.327 -0.401 0 CA-C-O 120.971 0.415 . . . . 10.0 110.273 179.775 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.846 0 CA-C-O 120.899 0.38 . . . . 10.0 110.78 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 62.1 mtt -112.11 97.53 6.72 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.708 -0.478 . . . . 10.0 109.708 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.512 ' CD2' HG12 ' B' ' 119' ' ' ILE . 40.4 m-85 -91.02 135.71 33.57 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.36 -0.382 . . . . 10.0 110.599 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.458 ' HG2' ' H ' ' A' ' 66' ' ' GLY . 22.3 tt0 -89.14 128.67 35.79 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.761 0.315 . . . . 10.0 110.41 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.9 pt -117.1 9.02 7.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.175 0.512 . . . . 10.0 110.497 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.458 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 159.88 173.27 28.16 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.719 -0.753 . . . . 10.0 111.945 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.596 ' HG2' ' HG2' ' A' ' 68' ' ' MET . 61.9 tttp -61.92 117.59 6.12 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.648 0.261 . . . . 10.0 110.71 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.596 ' HG2' ' HG2' ' A' ' 67' ' ' LYS . 67.2 mmm 70.41 15.55 7.28 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.389 -0.823 . . . . 10.0 111.557 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.479 ' HE ' ' HG2' ' A' ' 86' ' ' GLU . 5.0 mpt_? -121.72 120.87 35.93 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 122.242 -0.286 . . . . 10.0 110.269 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -132.95 143.84 49.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.398 0.618 . . . . 10.0 111.916 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.469 HG22 HG23 ' A' ' 84' ' ' ILE . 18.2 t -108.83 111.14 34.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 108.312 -0.995 . . . . 10.0 108.312 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.9 m -101.92 116.39 32.6 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.249 0.547 . . . . 10.0 112.151 -178.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.797 HG22 HG23 ' A' ' 82' ' ' ILE . 21.9 t -103.94 110.73 31.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.409 -0.814 . . . . 10.0 109.581 179.05 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -157.8 179.71 8.95 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.101 0.477 . . . . 10.0 111.134 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.661 ' HB2' HG22 ' A' ' 80' ' ' VAL . 1.6 t70 -112.21 133.21 54.47 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.297 -0.865 . . . . 10.0 109.613 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -136.49 118.33 15.16 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.567 -0.288 . . . . 10.0 110.269 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 97.4 mttt 57.67 43.92 21.46 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 123.499 0.5 . . . . 10.0 111.596 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.25 40.99 94.97 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.707 -0.759 . . . . 10.0 111.51 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? -151.08 102.55 2.96 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.913 0.387 . . . . 10.0 110.121 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.661 HG22 ' HB2' ' A' ' 75' ' ' ASP . 60.5 t -77.93 121.85 31.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.403 -0.591 . . . . 10.0 109.403 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.764 ' HB3' ' HB3' ' A' ' 103' ' ' SER . 24.1 mt -139.12 144.75 38.81 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.621 0.724 . . . . 10.0 112.176 -178.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.797 HG23 HG22 ' A' ' 73' ' ' VAL . 53.0 mt -104.12 98.98 7.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 114.591 -1.186 . . . . 10.0 108.004 178.085 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.603 ' HA ' ' HA ' ' A' ' 103' ' ' SER . 17.3 t70 -94.19 121.35 35.6 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.554 0.576 . . . . 10.0 112.554 -177.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.469 HG23 HG22 ' A' ' 71' ' ' VAL . 22.8 mt -98.74 108.19 21.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 107.181 -1.415 . . . . 10.0 107.181 177.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.515 ' HB2' ' OD2' ' A' ' 83' ' ' ASP . 11.2 ttm180 -144.63 163.23 34.55 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.573 0.701 . . . . 10.0 112.864 -176.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.479 ' HG2' ' HE ' ' A' ' 69' ' ' ARG . 16.3 mt-10 -89.9 142.09 28.03 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.864 -1.062 . . . . 10.0 109.124 177.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -114.43 135.92 53.57 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.528 -0.306 . . . . 10.0 110.341 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 45.7 t90 -108.67 134.77 50.95 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.72 -0.474 . . . . 10.0 109.72 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 25.2 ttt -84.4 117.67 23.77 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.87 -0.419 . . . . 10.0 109.87 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.24 164.21 55.19 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.932 -0.576 . . . . 10.0 110.868 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -53.39 -33.13 65.23 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.088 2.525 . . . . 10.0 113.318 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -69.74 -57.38 5.19 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.009 -0.367 . . . . 10.0 110.009 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 146.12 21.1 0.12 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.461 -0.876 . . . . 10.0 112.775 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.547 ' HB2' ' HE2' ' A' ' 96' ' ' LYS . 29.8 mt-10 -106.95 149.15 27.8 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.803 0.335 . . . . 10.0 110.306 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 98.4 mmm -88.77 117.67 27.91 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.293 -0.412 . . . . 10.0 110.013 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.547 ' HE2' ' HB2' ' A' ' 94' ' ' GLU . 69.4 mmtt -108.34 133.86 20.42 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.211 -0.449 . . . . 10.0 110.672 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.67 136.31 30.29 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.493 2.129 . . . . 10.0 112.157 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.485 ' O ' ' HD3' ' A' ' 85' ' ' ARG . . . -85.15 -158.43 29.61 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.595 -0.812 . . . . 10.0 112.799 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 99' ' ' ARG . 16.0 mtm180 -103.46 -22.38 13.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.869 0.366 . . . . 10.0 110.973 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 19.6 ttmt -82.65 82.96 7.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.239 -0.437 . . . . 10.0 110.478 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -152.9 165.77 31.22 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.604 -0.599 . . . . 10.0 111.604 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.559 ' HB ' ' HA2' ' B' ' 101' ' ' GLY . 12.0 tt -147.73 124.28 2.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.111 0.481 . . . . 10.0 111.226 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.764 ' HB3' ' HB3' ' A' ' 81' ' ' LEU . 5.3 m -94.62 125.69 39.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.801 -0.636 . . . . 10.0 110.387 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.478 ' HB3' ' HB2' ' A' ' 108' ' ' GLN . 76.6 mt -121.54 135.3 55.02 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.945 -0.391 . . . . 10.0 109.945 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -81.98 163.22 54.31 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 109.818 -0.438 . . . . 10.0 109.818 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -42.06 -38.98 5.49 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.614 2.876 . . . . 10.0 114.286 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.425 ' HG2' ' NE2' ' A' ' 111' ' ' GLN . 0.2 OUTLIER -61.84 -49.25 77.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.533 -0.303 . . . . 10.0 110.865 179.762 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.5 HE22 ' HD3' ' B' ' 69' ' ' ARG . 6.2 mt-30 -67.96 -37.84 82.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.317 0.579 . . . . 10.0 109.687 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.583 ' HZ2' ' HB2' ' B' ' 120' ' ' ASP . 23.5 t-105 -58.08 -43.29 86.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.272 -0.876 . . . . 10.0 110.709 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.7 t -65.32 -43.98 89.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.045 -0.525 . . . . 10.0 110.617 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.425 ' NE2' ' HG2' ' A' ' 107' ' ' GLU . 40.2 mt-30 -65.32 -36.12 83.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.431 -0.349 . . . . 10.0 110.841 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.427 HD13 HD13 ' B' ' 65' ' ' ILE . 48.6 tp -59.63 -41.14 89.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.429 . . . . 10.0 110.405 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -65.42 -31.08 71.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.997 -0.547 . . . . 10.0 111.394 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -77.43 -28.57 52.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.0 0.429 . . . . 10.0 111.367 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -85.06 -8.47 58.67 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.246 -0.434 . . . . 10.0 111.582 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 112' ' ' LEU . 61.7 mt -53.99 -43.21 57.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 112.016 0.376 . . . . 10.0 112.016 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.14 -30.03 64.08 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.2 0.444 . . . . 10.0 112.2 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -89.79 -41.75 11.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.783 0.325 . . . . 10.0 110.539 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.478 ' O ' HG23 ' A' ' 123' ' ' VAL . 72.1 mt -62.93 -48.4 88.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.938 -0.574 . . . . 10.0 111.054 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -63.59 -34.04 76.93 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.008 -0.542 . . . . 10.0 110.563 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -69.17 -41.09 77.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.637 -0.71 . . . . 10.0 109.855 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.65 -37.94 83.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.727 -0.67 . . . . 10.0 110.224 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 119' ' ' ILE . 92.6 t -60.33 -42.01 89.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 121.228 0.537 . . . . 10.0 109.96 179.031 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.8 mtm105 -71.44 -37.12 71.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.606 -0.725 . . . . 10.0 110.786 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 30.3 mttp -65.67 -42.77 90.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.422 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 72.5 mt . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.041 -0.527 . . . . 10.0 110.74 179.488 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.191 0 CA-C-O 121.27 0.557 . . . . 10.0 110.599 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 82.6 mmm -92.49 96.55 10.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.83 -0.623 . . . . 10.0 109.759 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 63' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -79.62 113.59 17.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.207 -0.451 . . . . 10.0 110.805 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -98.22 128.11 44.51 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.851 -0.426 . . . . 10.0 109.851 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 65' ' ' ILE . . . . . 0.427 HD13 HD13 ' A' ' 112' ' ' LEU . 20.5 pt -116.8 16.0 7.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.671 0.272 . . . . 10.0 111.706 -178.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 158.11 -161.54 31.64 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.155 -1.021 . . . . 10.0 112.726 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 67' ' ' LYS . . . . . 0.439 ' O ' ' HD2' ' B' ' 69' ' ' ARG . 5.2 mtmp? -67.56 103.86 1.45 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.448 -0.376 . . . . 10.0 111.841 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 68' ' ' MET . . . . . . . . . . . . . 67.4 mmm 64.86 6.47 3.37 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.246 0.832 . . . . 10.0 113.246 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 69' ' ' ARG . . . . . 0.5 ' HD3' HE22 ' A' ' 108' ' ' GLN . 3.0 mpt_? -100.39 121.49 41.6 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 121.783 -0.573 . . . . 10.0 110.696 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 70' ' ' TYR . . . . . 0.452 ' HB2' ' CD1' ' B' ' 87' ' ' TYR . 79.9 m-85 -122.67 149.25 44.29 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.706 -0.679 . . . . 10.0 110.45 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 96.0 t -98.61 103.08 14.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.257 -0.645 . . . . 10.0 109.257 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 10.2 t -88.39 88.11 7.51 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.819 -0.628 . . . . 10.0 111.18 -178.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 3.2 t -84.66 92.35 3.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.694 -0.854 . . . . 10.0 108.694 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 23.4 ptt-85 -126.28 147.93 49.61 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.272 0.558 . . . . 10.0 111.474 -178.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' B' ' 80' ' ' VAL . 12.8 t70 -79.89 115.62 19.58 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.286 -0.87 . . . . 10.0 110.436 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -86.72 61.68 6.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.176 -0.466 . . . . 10.0 110.889 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 30.0 mttm 62.53 58.6 1.64 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.85 -0.614 . . . . 10.0 111.051 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.56 21.29 37.79 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.839 -0.696 . . . . 10.0 111.682 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 62.2 mmtt -145.04 89.49 1.96 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.569 0.223 . . . . 10.0 110.531 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 80' ' ' VAL . . . . . 0.431 HG11 ' HA ' ' A' ' 123' ' ' VAL . 20.2 t -66.44 105.67 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.636 -0.505 . . . . 10.0 109.636 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 79.7 mt -115.42 142.04 47.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.344 0.592 . . . . 10.0 111.456 -178.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 82' ' ' ILE . . . . . 0.488 HD13 ' HB2' ' B' ' 109' ' ' TRP . 5.3 mp -92.07 88.87 2.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.516 -0.92 . . . . 10.0 108.516 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 83' ' ' ASP . . . . . 0.519 ' HA ' ' HA ' ' B' ' 103' ' ' SER . 34.9 t70 -87.97 94.64 9.85 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.876 -0.602 . . . . 10.0 110.833 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 26.8 mt -81.65 95.25 2.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.255 -1.016 . . . . 10.0 108.255 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 85' ' ' ARG . . . . . 0.411 ' HD3' ' O ' ' B' ' 98' ' ' GLY . 17.4 ttm-85 -123.6 145.71 48.71 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.862 -0.608 . . . . 10.0 111.724 -177.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 86' ' ' GLU . . . . . 0.485 ' H ' ' HG2' ' B' ' 86' ' ' GLU . 5.0 pt-20 -76.06 128.39 34.9 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.531 -0.759 . . . . 10.0 109.109 178.168 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 87' ' ' TYR . . . . . 0.452 ' CD1' ' HB2' ' B' ' 70' ' ' TYR . 23.0 m-85 -98.96 101.38 12.75 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.072 0.463 . . . . 10.0 110.464 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 88' ' ' TRP . . . . . 0.417 ' O ' ' HA ' ' B' ' 95' ' ' MET . 86.1 m95 -84.75 -176.55 6.27 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.561 -0.745 . . . . 10.0 109.789 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 41.6 ttm -133.43 135.11 44.39 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 110.014 -0.365 . . . . 10.0 110.014 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 90' ' ' ASP . . . . . 0.446 ' HB2' ' HD2' ' B' ' 91' ' ' PRO . 29.0 p30 -92.19 171.77 7.24 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 109.899 -0.408 . . . . 10.0 109.899 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 91' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' B' ' 90' ' ' ASP . 35.9 Cg_exo -61.9 -18.9 63.66 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.448 2.098 . . . . 10.0 112.704 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -77.03 -40.6 45.85 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.225 0.535 . . . . 10.0 110.275 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 120.67 21.04 3.36 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.95 -0.643 . . . . 10.0 112.245 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -100.88 147.32 26.25 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.774 0.321 . . . . 10.0 110.7 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 95' ' ' MET . . . . . 0.417 ' HA ' ' O ' ' B' ' 88' ' ' TRP . 82.9 mmm -88.54 96.18 10.52 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.321 -0.622 . . . . 10.0 109.321 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -94.52 128.87 38.42 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.887 -0.597 . . . . 10.0 111.631 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -66.16 128.33 19.33 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.578 2.185 . . . . 10.0 111.339 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 98' ' ' GLY . . . . . 0.411 ' O ' ' HD3' ' B' ' 85' ' ' ARG . . . -74.11 -176.32 34.51 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 121.046 -0.597 . . . . 10.0 113.294 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 14.5 mmt180 -87.89 -32.88 18.74 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.959 0.409 . . . . 10.0 110.201 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 4.3 mtmp? -77.87 99.1 5.84 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.458 -0.792 . . . . 10.0 110.551 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 101' ' ' GLY . . . . . 0.559 ' HA2' ' HB ' ' A' ' 102' ' ' ILE . . . -178.44 159.79 25.35 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 110.667 -0.973 . . . . 10.0 110.667 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 18.4 tt -131.12 142.41 43.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 117.196 0.498 . . . . 10.0 111.579 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 103' ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' B' ' 83' ' ' ASP . 0.7 OUTLIER -102.5 105.3 15.82 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.831 -0.622 . . . . 10.0 109.776 179.272 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 96.1 mt -93.33 142.27 27.51 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.792 0.329 . . . . 10.0 111.376 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 105' ' ' ASN . . . . . 0.403 ' ND2' ' HB3' ' B' ' 107' ' ' GLU . 41.4 p-10 -93.01 164.71 20.61 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 108.633 -0.877 . . . . 10.0 108.633 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.93 -30.73 31.52 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.489 2.126 . . . . 10.0 112.669 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 107' ' ' GLU . . . . . 0.403 ' HB3' ' ND2' ' B' ' 105' ' ' ASN . 9.2 tt0 -66.71 -59.27 3.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.921 -0.581 . . . . 10.0 110.861 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -67.08 -29.83 69.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.488 -0.324 . . . . 10.0 110.639 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 109' ' ' TRP . . . . . 0.488 ' HB2' HD13 ' B' ' 82' ' ' ILE . 31.0 t-105 -60.56 -42.25 96.21 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.63 -0.507 . . . . 10.0 109.63 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 9.7 t -67.81 -45.4 74.83 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.505 -0.554 . . . . 10.0 109.505 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -57.97 -40.65 81.14 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.015 -0.539 . . . . 10.0 110.54 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 112' ' ' LEU . . . . . 0.442 ' O ' HG13 ' B' ' 116' ' ' ILE . 33.1 tp -59.64 -47.19 86.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.92 -0.582 . . . . 10.0 110.665 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -62.95 -34.63 77.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.101 0.477 . . . . 10.0 110.666 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -74.17 -30.17 62.12 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.801 -0.636 . . . . 10.0 110.787 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 115' ' ' GLN . . . . . 0.401 ' O ' HG13 ' B' ' 119' ' ' ILE . 14.6 mm-40 -82.51 -10.49 58.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.435 . . . . 10.0 111.71 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 116' ' ' ILE . . . . . 0.442 HG13 ' O ' ' B' ' 112' ' ' LEU . 55.8 mt -55.2 -34.82 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 120.708 0.29 . . . . 10.0 111.15 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 1.5 m -60.66 -21.4 62.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.265 -0.425 . . . . 10.0 111.601 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -106.17 -42.42 5.08 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.616 0.246 . . . . 10.0 110.663 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 119' ' ' ILE . . . . . 0.512 HG12 ' CD2' ' A' ' 63' ' ' PHE . 60.6 mt -61.64 -52.03 65.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.885 0.374 . . . . 10.0 110.924 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 120' ' ' ASP . . . . . 0.583 ' HB2' ' HZ2' ' A' ' 109' ' ' TRP . 27.6 t70 -62.35 -38.12 88.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.873 -0.603 . . . . 10.0 111.083 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -62.03 -37.67 85.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.705 -0.679 . . . . 10.0 111.23 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.32 -20.4 57.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.266 -0.425 . . . . 10.0 111.864 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 123' ' ' VAL . . . . . 0.459 HG23 ' O ' ' B' ' 119' ' ' ILE . 78.1 t -58.21 -36.39 57.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.891 0.377 . . . . 10.0 111.416 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 6.6 ptp85 -102.68 14.4 32.04 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.359 -0.382 . . . . 10.0 111.141 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 98.8 mttt . . . . . 0 C--N 1.326 -0.447 0 CA-C-O 121.017 0.437 . . . . 10.0 110.206 179.961 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 120.943 0.401 . . . . 10.0 110.224 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.448 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 50.8 ttm -144.81 118.22 9.06 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.283 -0.417 . . . . 10.0 110.646 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.439 ' HB2' ' HB ' ' A' ' 71' ' ' VAL . 67.5 m-85 -95.37 171.15 8.88 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.21 -0.45 . . . . 10.0 110.162 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.55 ' HG2' ' H ' ' A' ' 66' ' ' GLY . 6.8 tt0 -131.99 134.39 45.53 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.199 -0.297 . . . . 10.0 110.199 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.524 HG13 ' HB3' ' A' ' 69' ' ' ARG . 11.6 pt -122.08 12.19 5.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.106 0.479 . . . . 10.0 110.569 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.55 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 156.0 174.54 25.93 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.814 -0.708 . . . . 10.0 111.945 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -57.24 116.62 3.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.622 0.249 . . . . 10.0 111.376 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 2.5 mmt 69.46 11.7 8.09 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.356 -0.838 . . . . 10.0 112.45 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.524 ' HB3' HG13 ' A' ' 65' ' ' ILE . 4.4 mpt_? -111.71 104.13 12.46 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.415 -0.587 . . . . 10.0 109.415 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.489 ' HD2' ' HB2' ' A' ' 87' ' ' TYR . 96.3 m-85 -120.43 145.72 46.93 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.355 0.597 . . . . 10.0 112.406 -178.015 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.534 HG13 HG12 ' A' ' 84' ' ' ILE . 36.6 t -99.16 105.99 18.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.001 -1.0 . . . . 10.0 108.92 178.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.6 m -88.39 113.4 23.96 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.885 0.374 . . . . 10.0 111.099 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 38.2 t -106.18 92.89 2.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.066 -0.515 . . . . 10.0 109.846 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.911 ' HG3' ' HB3' ' A' ' 81' ' ' LEU . 7.5 ptm180 -123.63 -171.15 2.26 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.086 -0.506 . . . . 10.0 109.985 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -102.51 160.17 14.79 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.626 0.251 . . . . 10.0 110.343 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.478 ' HB3' ' HB2' ' A' ' 79' ' ' LYS . 10.1 t80 -119.07 45.63 2.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.049 0.452 . . . . 10.0 110.522 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.425 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 11.2 mptt 55.65 41.5 30.45 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.274 0.559 . . . . 10.0 110.673 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 136.15 -42.41 1.33 Allowed Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 111.057 -0.817 . . . . 10.0 111.057 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.478 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 64.7 mttm -100.83 -167.36 1.42 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.703 -0.48 . . . . 10.0 109.703 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.0 m -105.72 142.53 18.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.738 0.304 . . . . 10.0 110.663 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.911 ' HB3' ' HG3' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -118.53 78.94 1.31 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.105 -0.498 . . . . 10.0 109.894 -179.716 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 27.6 mt -101.46 88.27 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.062 -0.718 . . . . 10.0 109.062 178.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.47 ' OD1' ' HB2' ' A' ' 85' ' ' ARG . 16.5 t70 -113.28 135.9 53.34 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.347 0.594 . . . . 10.0 111.458 -178.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.534 HG12 HG13 ' A' ' 71' ' ' VAL . 45.7 mt -108.19 96.07 4.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 108.407 -0.96 . . . . 10.0 108.407 178.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.602 ' HG3' ' HA3' ' A' ' 101' ' ' GLY . 6.7 ttm180 -118.47 154.82 31.86 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.951 -0.568 . . . . 10.0 111.433 -178.051 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -73.98 124.37 26.09 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.728 -0.842 . . . . 10.0 108.728 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.489 ' HB2' ' HD2' ' A' ' 70' ' ' TYR . 19.1 m-85 -103.99 121.54 43.37 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.931 0.396 . . . . 10.0 110.759 -179.075 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -108.25 137.5 46.12 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.912 -0.585 . . . . 10.0 109.926 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.429 ' HA ' ' O ' ' A' ' 94' ' ' GLU . 6.5 ttt -74.94 126.92 32.02 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.301 -0.409 . . . . 10.0 110.202 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.439 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 44.8 p30 -87.83 171.56 9.38 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 116.154 -0.476 . . . . 10.0 110.605 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.439 ' HD2' ' HB2' ' A' ' 90' ' ' ASP . 48.5 Cg_exo -57.78 -24.95 66.38 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.855 2.37 . . . . 10.0 113.393 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -76.24 -30.87 58.07 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.961 0.41 . . . . 10.0 110.54 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 112.37 22.04 5.97 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.83 -0.7 . . . . 10.0 112.151 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' A' ' 89' ' ' MET . 31.0 mt-10 -110.22 164.4 12.69 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.95 0.405 . . . . 10.0 110.369 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 94.2 mmm -96.9 114.23 25.84 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.062 -0.517 . . . . 10.0 109.809 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 13.7 mmtp -113.81 131.69 22.97 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.226 -0.443 . . . . 10.0 110.493 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.06 133.84 34.73 Favored 'Trans proline' 0 C--O 1.233 0.264 0 C-N-CA 122.554 2.169 . . . . 10.0 112.408 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -81.81 -128.38 1.03 Allowed Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.984 -0.627 . . . . 10.0 113.202 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -110.07 -34.28 6.44 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.648 0.261 . . . . 10.0 111.556 -178.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.1 mtmt -86.87 117.07 25.36 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.188 0.518 . . . . 10.0 111.741 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.602 ' HA3' ' HG3' ' A' ' 85' ' ' ARG . . . -166.8 155.17 26.15 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.716 -0.953 . . . . 10.0 110.716 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.501 HG12 HG22 ' B' ' 84' ' ' ILE . 7.9 tp -134.82 130.6 52.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 117.494 0.647 . . . . 10.0 111.9 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.8 m -92.26 116.01 28.59 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.146 -0.934 . . . . 10.0 109.661 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 82.3 mt -109.56 113.05 25.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.032 0.444 . . . . 10.0 110.958 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.603 ' HB2' ' HD2' ' A' ' 106' ' ' PRO . 19.8 p30 -81.99 169.3 19.04 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.989 -0.55 . . . . 10.0 110.091 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.603 ' HD2' ' HB2' ' A' ' 105' ' ' ASN . 92.2 Cg_exo -44.41 -47.88 10.54 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 123.064 2.509 . . . . 10.0 113.855 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.0 tp10 -67.35 -50.94 57.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.488 0.185 . . . . 10.0 110.767 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.464 HE22 ' HD3' ' B' ' 69' ' ' ARG . 63.5 mt-30 -55.53 -46.65 77.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.316 -0.402 . . . . 10.0 111.193 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 56.0 t-105 -62.25 -42.87 99.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.908 0.385 . . . . 10.0 110.586 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.474 ' HA ' ' HE2' ' A' ' 113' ' ' LYS . 50.0 m -64.3 -46.71 82.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 10.0 110.757 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -65.6 -37.74 87.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.478 -0.328 . . . . 10.0 110.557 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.518 ' O ' HG13 ' A' ' 116' ' ' ILE . 59.6 tp -57.72 -43.42 85.27 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.279 -0.418 . . . . 10.0 110.81 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.474 ' HE2' ' HA ' ' A' ' 110' ' ' SER . 52.0 mtmt -62.23 -36.98 83.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.293 -0.412 . . . . 10.0 110.89 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -81.77 -17.07 48.97 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.106 0.479 . . . . 10.0 111.044 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -85.53 -18.67 32.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.197 -0.456 . . . . 10.0 110.283 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.518 HG13 ' O ' ' A' ' 112' ' ' LEU . 86.0 mt -54.12 -40.39 46.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.133 -0.485 . . . . 10.0 111.311 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.28 -25.04 61.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 10.0 111.758 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.42 -35.52 9.54 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.872 0.368 . . . . 10.0 110.763 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 83.9 mt -64.75 -47.59 88.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.922 -0.581 . . . . 10.0 110.86 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.14 -32.33 73.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 10.0 110.813 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -64.48 -41.4 96.49 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.815 -0.629 . . . . 10.0 110.124 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.96 -35.66 80.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.997 -0.547 . . . . 10.0 110.32 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 88.4 t -62.91 -37.85 80.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.943 -0.571 . . . . 10.0 110.215 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 16.5 mtm105 -75.2 -25.28 58.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.977 -0.556 . . . . 10.0 111.012 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -78.53 -20.14 51.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.331 -0.395 . . . . 10.0 111.352 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 12.6 mt . . . . . 0 C--N 1.321 -0.659 0 CA-C-N 116.586 -0.279 . . . . 10.0 110.437 179.971 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.094 0 CA-C-O 121.181 0.515 . . . . 10.0 110.683 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 62' ' ' MET . . . . . 0.408 ' HG2' ' HA ' ' B' ' 72' ' ' SER . 59.1 mtm -103.3 128.3 50.39 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.903 -0.589 . . . . 10.0 109.874 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 63' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -114.21 128.12 56.21 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.156 -0.474 . . . . 10.0 110.161 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -79.68 134.09 36.4 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.093 0.473 . . . . 10.0 111.316 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 65' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 108' ' ' GLN . 6.4 pt -112.42 -26.08 3.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.707 -0.679 . . . . 10.0 110.398 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -167.84 -174.53 36.86 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.771 -0.932 . . . . 10.0 110.771 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 14.8 mttp -70.8 127.64 33.33 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.069 0.462 . . . . 10.0 111.057 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 68' ' ' MET . . . . . 0.513 ' HE3' ' HA ' ' B' ' 88' ' ' TRP . 39.2 mmm 64.26 25.88 13.63 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.057 -0.974 . . . . 10.0 111.703 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 69' ' ' ARG . . . . . 0.484 ' HE ' ' HG2' ' B' ' 86' ' ' GLU . 0.4 OUTLIER -140.11 115.25 9.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.484 -0.325 . . . . 10.0 110.233 179.116 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -126.61 133.15 51.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.045 -0.525 . . . . 10.0 110.758 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.466 HG22 HG23 ' B' ' 84' ' ' ILE . 86.6 t -88.75 115.21 28.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.048 -0.523 . . . . 10.0 109.611 179.095 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 72' ' ' SER . . . . . 0.408 ' HA ' ' HG2' ' B' ' 62' ' ' MET . 8.1 m -90.68 101.25 14.0 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.946 0.403 . . . . 10.0 111.076 -179.35 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 8.9 t -97.58 99.34 8.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.168 -0.469 . . . . 10.0 110.003 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -160.03 166.43 29.97 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.258 -0.428 . . . . 10.0 110.211 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.699 ' HA ' ' HA ' ' B' ' 80' ' ' VAL . 0.0 OUTLIER -86.87 145.32 26.62 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.203 0.525 . . . . 10.0 110.333 179.789 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -126.98 100.71 6.25 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 109.132 -0.692 . . . . 10.0 109.132 178.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 66.6 mttm 67.33 33.78 5.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.402 -0.817 . . . . 10.0 111.009 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 96.39 -9.94 67.13 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.734 -0.745 . . . . 10.0 112.971 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 79' ' ' LYS . . . . . 0.418 ' HD3' ' HA ' ' B' ' 79' ' ' LYS . 32.2 mmtt -109.25 113.71 26.78 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.66 0.23 . . . . 10.0 110.919 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 80' ' ' VAL . . . . . 0.699 ' HA ' ' HA ' ' B' ' 75' ' ' ASP . 14.3 t -64.33 117.76 5.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.612 -0.514 . . . . 10.0 109.612 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 97.8 mt -125.73 129.3 49.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.174 0.511 . . . . 10.0 111.699 -178.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 82' ' ' ILE . . . . . . . . . . . . . 5.2 mp -93.25 95.82 5.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 108.08 -1.081 . . . . 10.0 108.08 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 83' ' ' ASP . . . . . 0.4 ' HA ' ' HA ' ' B' ' 103' ' ' SER . 2.2 t70 -85.73 107.31 17.54 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.939 -0.573 . . . . 10.0 111.991 -177.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 84' ' ' ILE . . . . . 0.501 HG22 HG12 ' A' ' 102' ' ' ILE . 12.0 mt -99.23 83.91 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.071 -1.085 . . . . 10.0 108.071 178.114 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 85' ' ' ARG . . . . . 0.948 ' HG3' ' HA3' ' B' ' 101' ' ' GLY . 6.1 ttm180 -123.89 162.75 22.67 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.711 -0.677 . . . . 10.0 111.089 -177.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 86' ' ' GLU . . . . . 0.732 ' HB2' ' HA3' ' B' ' 98' ' ' GLY . 35.8 mt-10 -70.19 153.06 43.56 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.48 -0.933 . . . . 10.0 108.48 177.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 87' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -140.46 111.16 6.85 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.184 0.516 . . . . 10.0 110.783 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 88' ' ' TRP . . . . . 0.513 ' HA ' ' HE3' ' B' ' 68' ' ' MET . 20.6 m0 -108.64 -170.81 1.73 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.513 -0.767 . . . . 10.0 109.356 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 33.3 ttm -127.82 142.66 51.23 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 110.146 -0.316 . . . . 10.0 110.146 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 90' ' ' ASP . . . . . 0.446 ' HB2' ' HD2' ' B' ' 91' ' ' PRO . 36.9 p30 -99.83 169.94 7.4 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 116.17 -0.468 . . . . 10.0 110.522 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 91' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' B' ' 90' ' ' ASP . 34.8 Cg_exo -59.93 -20.58 60.68 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.713 2.276 . . . . 10.0 112.362 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -73.76 -43.34 59.28 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.994 0.426 . . . . 10.0 110.007 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 118.79 26.54 2.53 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.955 -0.64 . . . . 10.0 112.244 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -113.33 152.22 30.2 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.841 0.353 . . . . 10.0 110.625 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 95' ' ' MET . . . . . . . . . . . . . 95.6 mmm -82.78 105.15 13.56 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.073 -0.714 . . . . 10.0 109.073 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -103.37 145.93 31.51 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.765 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.02 146.94 94.82 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.576 2.184 . . . . 10.0 111.849 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 98' ' ' GLY . . . . . 0.732 ' HA3' ' HB2' ' B' ' 86' ' ' GLU . . . -73.89 -140.72 0.56 Allowed Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.728 -0.669 . . . . 10.0 112.617 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 99' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' B' ' 99' ' ' ARG . 2.4 mtp-105 -102.64 -32.76 9.73 Favored 'General case' 0 C--N 1.32 -0.714 0 O-C-N 122.382 -0.481 . . . . 10.0 111.109 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -127.7 157.1 41.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.243 0.545 . . . . 10.0 111.396 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 101' ' ' GLY . . . . . 0.948 ' HA3' ' HG3' ' B' ' 85' ' ' ARG . . . 171.15 160.86 20.71 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 110.507 -1.037 . . . . 10.0 110.507 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 20.5 tt -133.1 140.8 46.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 117.95 0.875 . . . . 10.0 111.544 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 103' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' B' ' 83' ' ' ASP . 0.9 OUTLIER -101.62 112.19 24.68 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.054 -0.521 . . . . 10.0 110.013 179.549 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 52.1 mt -97.72 134.86 40.32 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.822 0.344 . . . . 10.0 110.615 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -88.97 168.98 14.13 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 108.915 -0.772 . . . . 10.0 108.915 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 106' ' ' PRO . . . . . 0.521 ' HD3' ' O ' ' B' ' 80' ' ' VAL . 86.4 Cg_exo -48.8 -38.73 38.28 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.608 2.205 . . . . 10.0 113.414 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -67.01 -54.7 19.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.63 -0.259 . . . . 10.0 111.172 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -61.74 -35.69 78.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.442 -0.345 . . . . 10.0 110.509 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 109' ' ' TRP . . . . . 0.404 ' CZ2' HG12 ' A' ' 116' ' ' ILE . 65.7 t-105 -61.87 -41.23 97.6 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.106 -0.497 . . . . 10.0 109.699 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 110' ' ' SER . . . . . 0.411 ' O ' ' HG3' ' B' ' 114' ' ' GLU . 25.3 t -63.62 -46.61 84.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.489 . . . . 10.0 109.719 178.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -58.37 -40.17 81.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.881 -0.6 . . . . 10.0 110.815 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 53.5 tp -60.94 -41.4 96.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 10.0 110.461 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 113' ' ' LYS . . . . . 0.43 ' HG2' HD13 ' A' ' 116' ' ' ILE . 55.9 mtmt -68.85 -36.09 77.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.15 0.5 . . . . 10.0 110.737 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 114' ' ' GLU . . . . . 0.411 ' HG3' ' O ' ' B' ' 110' ' ' SER . 45.3 mt-10 -73.79 -25.15 59.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.828 -0.624 . . . . 10.0 111.332 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -86.78 -4.89 59.23 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.302 -0.408 . . . . 10.0 111.397 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 61.7 mt -57.27 -41.38 78.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 120.778 0.323 . . . . 10.0 110.881 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 5.7 m -64.83 -11.95 42.85 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.146 -0.479 . . . . 10.0 112.21 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.25 -47.21 3.57 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.83 0.348 . . . . 10.0 110.447 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 119' ' ' ILE . . . . . 0.473 ' O ' HG23 ' B' ' 123' ' ' VAL . 61.9 mt -66.35 -45.95 88.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.102 -0.499 . . . . 10.0 111.817 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -62.13 -36.23 81.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.728 0.299 . . . . 10.0 111.236 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 121' ' ' ASP . . . . . 0.466 ' O ' ' HG2' ' B' ' 124' ' ' ARG . 36.7 t70 -67.87 -34.89 77.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.983 0.421 . . . . 10.0 110.26 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.48 -37.53 80.22 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.718 -0.475 . . . . 10.0 109.718 178.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 123' ' ' VAL . . . . . 0.473 HG23 ' O ' ' B' ' 119' ' ' ILE . 83.9 t -64.81 -42.36 94.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.896 -0.593 . . . . 10.0 110.58 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 124' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' B' ' 121' ' ' ASP . 7.1 ptp180 -75.65 -5.9 47.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.795 0.331 . . . . 10.0 110.91 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 43.2 mttp . . . . . 0 C--N 1.327 -0.389 0 CA-C-N 116.377 -0.374 . . . . 10.0 110.572 179.614 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 120.563 0.22 . . . . 10.0 110.516 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.459 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 29.6 mtm -142.97 130.45 21.17 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.965 -0.383 . . . . 10.0 109.965 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.4 ' CE1' ' HB3' ' B' ' 118' ' ' ASP . 57.5 m-85 -122.15 147.33 46.29 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.13 -0.486 . . . . 10.0 109.97 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -98.07 116.76 30.95 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.408 -0.36 . . . . 10.0 110.43 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.538 HG22 ' HG3' ' B' ' 115' ' ' GLN . 24.6 pt -105.06 10.28 9.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.12 0.486 . . . . 10.0 110.776 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 164.29 173.59 33.12 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.78 -0.724 . . . . 10.0 111.645 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 44.8 tttp -62.28 120.69 11.47 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.47 0.176 . . . . 10.0 110.765 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.418 ' HB3' ' O ' ' A' ' 87' ' ' TYR . 24.8 mmt 64.07 28.26 14.22 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 123.732 0.645 . . . . 10.0 111.888 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -131.08 112.26 12.73 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.967 -0.382 . . . . 10.0 109.967 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.425 ' HB2' ' CE1' ' A' ' 87' ' ' TYR . 50.8 m-85 -120.0 140.98 50.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.095 0.474 . . . . 10.0 111.444 -179.008 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 62' ' ' MET . 21.2 t -94.58 110.55 23.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.779 -0.646 . . . . 10.0 109.448 178.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.795 ' HB3' ' HB3' ' A' ' 83' ' ' ASP . 0.7 OUTLIER -80.39 83.38 6.23 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.992 -0.549 . . . . 10.0 110.697 -179.209 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.0 t -89.7 86.15 2.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.914 -0.773 . . . . 10.0 108.914 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -151.35 172.21 16.27 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.701 -0.681 . . . . 10.0 110.597 -178.873 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.885 ' HB2' HG22 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -106.01 138.0 42.95 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.808 -0.633 . . . . 10.0 109.814 179.352 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -126.4 95.48 4.38 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.396 -0.365 . . . . 10.0 110.318 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.3 36.86 25.91 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.667 -0.697 . . . . 10.0 111.892 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 103.05 -17.64 51.67 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.516 -0.85 . . . . 10.0 112.18 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.488 ' HB3' HD11 ' A' ' 81' ' ' LEU . 48.7 mtmt -89.18 94.93 10.1 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.994 0.426 . . . . 10.0 110.293 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.885 HG22 ' HB2' ' A' ' 75' ' ' ASP . 2.1 t -100.71 93.63 3.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.878 -0.601 . . . . 10.0 109.684 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.488 HD11 ' HB3' ' A' ' 79' ' ' LYS . 0.9 OUTLIER -128.94 157.12 42.51 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.096 -0.502 . . . . 10.0 110.949 -179.075 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.549 HD13 ' HB2' ' A' ' 109' ' ' TRP . 5.3 mp -81.42 90.32 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.573 -0.899 . . . . 10.0 108.573 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.795 ' HB3' ' HB3' ' A' ' 72' ' ' SER . 20.5 t70 -82.17 102.41 11.08 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.831 -0.622 . . . . 10.0 111.955 -177.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.3 mt -84.51 109.41 17.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 107.727 -1.212 . . . . 10.0 107.727 178.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.467 ' HD3' ' O ' ' A' ' 98' ' ' GLY . 10.9 ttm-85 -128.98 149.15 50.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.446 0.641 . . . . 10.0 112.544 -177.191 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -91.62 149.92 21.42 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.504 -0.924 . . . . 10.0 108.504 178.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.425 ' CE1' ' HB2' ' A' ' 70' ' ' TYR . 8.0 m-85 -120.26 152.37 37.86 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.051 0.453 . . . . 10.0 111.539 -178.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 12.6 t90 -145.03 154.33 42.41 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.926 -0.768 . . . . 10.0 108.926 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.4 ttm -88.03 134.74 33.67 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.909 0.385 . . . . 10.0 110.76 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.877 ' HB3' ' HG3' ' A' ' 96' ' ' LYS . 51.2 p-10 -85.68 175.52 4.44 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.787 -0.642 . . . . 10.0 110.534 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.481 ' HD2' ' HB2' ' A' ' 90' ' ' ASP . 39.3 Cg_exo -61.72 -17.81 56.89 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.568 2.178 . . . . 10.0 112.911 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.79 -41.71 20.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.826 0.346 . . . . 10.0 110.773 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 122.52 18.48 3.32 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.834 -0.698 . . . . 10.0 111.994 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -104.14 163.49 12.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.927 0.394 . . . . 10.0 110.882 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 78.5 mmm -88.06 111.33 21.43 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.916 -0.583 . . . . 10.0 109.479 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.877 ' HG3' ' HB3' ' A' ' 90' ' ' ASP . 18.7 mmmt -109.03 129.97 23.28 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.804 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.43 133.63 19.4 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.234 1.956 . . . . 10.0 111.513 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.467 ' O ' ' HD3' ' A' ' 85' ' ' ARG . . . -63.7 160.15 37.78 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.916 -0.659 . . . . 10.0 112.12 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.429 ' HA ' ' HD3' ' A' ' 99' ' ' ARG . 25.1 mmt180 -77.87 -7.91 57.35 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.161 0.505 . . . . 10.0 110.397 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -104.19 127.49 51.8 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.647 -0.706 . . . . 10.0 109.828 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -166.5 -173.53 34.96 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 111.206 -0.757 . . . . 10.0 111.206 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.9 tp -152.51 113.23 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.208 0.528 . . . . 10.0 110.582 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.772 ' HA ' ' HA ' ' A' ' 83' ' ' ASP . 0.8 OUTLIER -92.5 90.61 7.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.165 -0.47 . . . . 10.0 111.36 -179.478 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.449 ' HG ' ' HB3' ' A' ' 108' ' ' GLN . 2.8 mp -65.97 131.25 45.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.559 -0.291 . . . . 10.0 111.011 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.493 ' HB2' ' HD2' ' A' ' 106' ' ' PRO . 20.2 p-10 -78.98 166.47 41.97 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 110.396 -0.224 . . . . 10.0 110.396 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.493 ' HD2' ' HB2' ' A' ' 105' ' ' ASN . 79.6 Cg_exo -47.45 -41.15 29.4 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.222 2.615 . . . . 10.0 114.004 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -69.51 -45.14 69.58 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.828 -0.349 . . . . 10.0 110.838 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.466 ' HG2' ' HA3' ' B' ' 66' ' ' GLY . 23.6 mt-30 -57.97 -39.83 79.12 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.964 0.411 . . . . 10.0 110.17 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.549 ' HB2' HD13 ' A' ' 82' ' ' ILE . 66.2 t-105 -59.09 -44.4 91.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.782 -0.644 . . . . 10.0 110.564 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.8 t -67.36 -48.28 67.92 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.025 -0.534 . . . . 10.0 110.486 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -60.06 -38.8 83.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.94 -0.573 . . . . 10.0 111.08 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.479 ' O ' HG13 ' A' ' 116' ' ' ILE . 27.9 tp -60.98 -49.53 77.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.465 -0.334 . . . . 10.0 110.594 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.46 ' HA ' HD12 ' A' ' 116' ' ' ILE . 48.6 mtmt -60.54 -38.49 84.64 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.301 -0.409 . . . . 10.0 111.192 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -71.99 -26.5 62.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.962 -0.563 . . . . 10.0 111.831 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -93.42 -9.45 38.56 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.671 0.249 . . . . 10.0 111.671 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 112' ' ' LEU . 16.4 mt -51.55 -44.05 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 112.224 0.453 . . . . 10.0 112.224 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.3 m -60.46 -34.55 74.16 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.871 0.367 . . . . 10.0 111.773 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.08 -41.04 21.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.953 0.406 . . . . 10.0 110.325 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.544 HG23 HG21 ' B' ' 73' ' ' VAL . 82.3 mt -65.38 -48.62 82.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.805 -0.634 . . . . 10.0 111.224 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -59.42 -37.69 78.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.098 -0.501 . . . . 10.0 110.774 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.66 -39.3 94.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.019 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.412 ' HA ' ' HD2' ' A' ' 125' ' ' LYS . . . -64.89 -33.78 76.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.927 -0.579 . . . . 10.0 110.613 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 119' ' ' ILE . 63.1 t -64.36 -37.52 80.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.235 0.54 . . . . 10.0 109.855 179.092 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 19.9 mtm105 -78.84 -27.18 44.16 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.565 -0.743 . . . . 10.0 110.509 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.412 ' HD2' ' HA ' ' A' ' 122' ' ' ALA . 13.7 mttt -69.6 -36.07 75.86 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.99 -0.55 . . . . 10.0 110.566 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 47.2 mt . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 115.855 -0.612 . . . . 10.0 111.322 -179.49 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.219 0 CA-C-O 121.082 0.468 . . . . 10.0 110.665 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 5.6 mmm -97.99 95.92 7.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.773 -0.649 . . . . 10.0 109.708 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 63' ' ' PHE . . . . . 0.477 ' CD2' HG12 ' A' ' 119' ' ' ILE . 38.8 m-85 -90.83 126.28 35.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.067 -0.515 . . . . 10.0 111.166 -179.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -87.73 103.74 15.9 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.199 -0.455 . . . . 10.0 109.823 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 65' ' ' ILE . . . . . 0.503 HG12 HG23 ' B' ' 71' ' ' VAL . 5.6 pt -100.39 5.2 10.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.304 0.573 . . . . 10.0 110.351 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 66' ' ' GLY . . . . . 0.466 ' HA3' ' HG2' ' A' ' 108' ' ' GLN . . . 179.43 158.88 22.49 Favored Glycine 0 N--CA 1.438 -1.179 0 N-CA-C 110.988 -0.845 . . . . 10.0 110.988 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 67' ' ' LYS . . . . . 0.484 ' O ' ' HB2' ' B' ' 68' ' ' MET . 29.9 mttp -64.26 114.95 4.58 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.761 -0.459 . . . . 10.0 109.761 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 68' ' ' MET . . . . . 0.484 ' HB2' ' O ' ' B' ' 67' ' ' LYS . 70.3 mmm 78.91 3.97 2.42 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.313 -0.858 . . . . 10.0 111.128 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 69' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -115.57 124.59 51.4 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.722 -0.473 . . . . 10.0 109.722 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 70' ' ' TYR . . . . . 0.575 ' HB2' ' CD2' ' B' ' 87' ' ' TYR . 95.7 m-85 -131.12 145.32 51.94 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.228 0.537 . . . . 10.0 111.558 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.503 HG23 HG12 ' B' ' 65' ' ' ILE . 65.6 t -103.99 96.03 4.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 108.399 -0.963 . . . . 10.0 108.399 177.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 72' ' ' SER . . . . . 0.458 ' O ' ' HD3' ' B' ' 74' ' ' ARG . 0.5 OUTLIER -87.71 96.65 10.51 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.028 -0.533 . . . . 10.0 110.8 -179.364 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 73' ' ' VAL . . . . . 0.544 HG21 HG23 ' A' ' 119' ' ' ILE . 28.4 t -84.66 115.01 25.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.369 -0.604 . . . . 10.0 109.369 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 74' ' ' ARG . . . . . 0.458 ' HD3' ' O ' ' B' ' 72' ' ' SER . 0.0 OUTLIER -150.64 161.45 42.58 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.983 0.42 . . . . 10.0 111.02 -179.528 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -85.55 118.63 25.18 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.467 -0.788 . . . . 10.0 110.097 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -109.05 89.15 2.91 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.496 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 61.4 mttm 60.8 44.86 10.51 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.525 -0.762 . . . . 10.0 112.185 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.42 38.24 12.94 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.601 -0.809 . . . . 10.0 111.527 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -151.53 106.44 3.27 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 122.733 0.413 . . . . 10.0 110.138 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 80' ' ' VAL . . . . . 0.492 ' O ' ' HD3' ' B' ' 106' ' ' PRO . 24.4 t -73.2 99.06 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 108.563 -0.903 . . . . 10.0 108.563 178.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 96.2 mt -105.82 132.08 52.37 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.511 0.672 . . . . 10.0 112.599 -177.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 82' ' ' ILE . . . . . . . . . . . . . 4.8 mp -93.35 94.09 4.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 107.322 -1.362 . . . . 10.0 107.322 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -89.0 106.06 18.19 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.962 -0.563 . . . . 10.0 112.223 -177.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 84' ' ' ILE . . . . . 0.421 ' O ' ' HA2' ' B' ' 101' ' ' GLY . 37.7 mt -93.39 99.29 9.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 107.84 -1.17 . . . . 10.0 107.84 177.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 85' ' ' ARG . . . . . 0.805 ' HG3' ' HA3' ' B' ' 101' ' ' GLY . 20.2 ttm-85 -140.97 165.63 27.01 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.223 0.535 . . . . 10.0 112.112 -177.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.11 144.13 25.76 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.51 -0.922 . . . . 10.0 108.51 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 87' ' ' TYR . . . . . 0.575 ' CD2' ' HB2' ' B' ' 70' ' ' TYR . 50.6 m-85 -125.92 125.93 43.57 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.289 0.566 . . . . 10.0 111.047 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 88' ' ' TRP . . . . . . . . . . . . . 66.2 t90 -104.85 136.25 44.7 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.404 -0.817 . . . . 10.0 110.105 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 50.3 ttm -78.97 115.95 18.97 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.034 0.445 . . . . 10.0 110.745 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 90' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.69 161.97 59.53 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.659 -0.7 . . . . 10.0 110.356 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -53.23 -27.03 36.26 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.191 2.594 . . . . 10.0 113.993 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.7 -17.26 59.21 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 122.235 -0.29 . . . . 10.0 110.776 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 103.65 11.6 32.56 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.936 -0.65 . . . . 10.0 113.712 178.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 94' ' ' GLU . . . . . 0.429 ' HB3' ' HE2' ' B' ' 96' ' ' LYS . 11.4 tt0 -103.38 156.76 17.5 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 117.062 0.431 . . . . 10.0 110.696 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 95' ' ' MET . . . . . 0.529 ' HB3' ' HB3' ' B' ' 87' ' ' TYR . 87.7 mmm -94.25 103.0 15.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.252 -0.431 . . . . 10.0 110.024 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 96' ' ' LYS . . . . . 0.429 ' HE2' ' HB3' ' B' ' 94' ' ' GLU . 67.0 mmtt -93.28 147.29 33.47 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.082 -0.508 . . . . 10.0 110.47 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.13 145.57 98.17 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 122.29 1.994 . . . . 10.0 111.789 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . -75.94 -112.78 0.12 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.871 -0.68 . . . . 10.0 112.849 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 71.7 mtp85 -138.51 -22.06 1.01 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.968 0.413 . . . . 10.0 110.934 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 39.2 mttt -100.4 -146.22 0.34 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.993 -0.548 . . . . 10.0 109.915 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 101' ' ' GLY . . . . . 0.805 ' HA3' ' HG3' ' B' ' 85' ' ' ARG . . . 94.72 153.95 30.6 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.612 -0.804 . . . . 10.0 112.751 179.164 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 15.4 tt -145.99 134.31 16.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.951 0.405 . . . . 10.0 110.545 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 4.0 m -92.25 116.14 28.7 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.062 -0.517 . . . . 10.0 109.701 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 96.0 mt -111.67 138.24 48.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.208 -0.451 . . . . 10.0 110.411 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 105' ' ' ASN . . . . . 0.545 ' HB2' ' HD2' ' B' ' 106' ' ' PRO . 33.3 p30 -88.93 170.43 11.03 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.39 -0.596 . . . . 10.0 109.39 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 106' ' ' PRO . . . . . 0.545 ' HD2' ' HB2' ' B' ' 105' ' ' ASN . 75.0 Cg_exo -51.47 -35.06 53.96 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.527 2.151 . . . . 10.0 113.121 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -62.89 -53.85 47.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.305 -0.407 . . . . 10.0 110.342 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -67.41 -34.9 78.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.058 -0.519 . . . . 10.0 110.206 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 109' ' ' TRP . . . . . . . . . . . . . 35.1 t-105 -61.12 -45.52 94.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.898 -0.592 . . . . 10.0 109.955 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 110' ' ' SER . . . . . 0.529 ' HA ' ' HE2' ' B' ' 113' ' ' LYS . 13.3 t -64.03 -43.87 94.27 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.697 -0.482 . . . . 10.0 109.697 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -61.16 -39.57 90.59 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 116.061 -0.518 . . . . 10.0 110.744 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 34.5 tp -60.2 -43.3 96.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.876 0.369 . . . . 10.0 110.204 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 113' ' ' LYS . . . . . 0.529 ' HE2' ' HA ' ' B' ' 110' ' ' SER . 41.5 mtmt -66.49 -39.85 88.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.035 -0.53 . . . . 10.0 110.567 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -74.42 -16.25 60.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.822 -0.626 . . . . 10.0 111.372 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 115' ' ' GLN . . . . . 0.538 ' HG3' HG22 ' A' ' 65' ' ' ILE . 14.7 mm-40 -90.12 -4.63 57.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.52 -0.309 . . . . 10.0 111.193 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 75.3 mt -58.78 -35.42 55.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.69 0.281 . . . . 10.0 110.722 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.25 -12.25 39.33 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.27 -0.423 . . . . 10.0 111.725 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 118' ' ' ASP . . . . . 0.4 ' HB3' ' CE1' ' A' ' 63' ' ' PHE . 1.4 m-20 -111.9 -49.65 2.97 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.884 0.373 . . . . 10.0 110.606 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 43.4 mt -65.42 -53.44 39.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 10.0 111.568 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 120' ' ' ASP . . . . . 0.401 ' HB2' ' HZ2' ' A' ' 109' ' ' TRP . 33.7 t70 -62.54 -31.28 72.04 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.799 0.333 . . . . 10.0 110.627 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -62.03 -47.4 84.89 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.927 -0.579 . . . . 10.0 110.19 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.81 -39.16 80.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.026 -0.534 . . . . 10.0 110.529 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 53.3 t -64.47 -37.23 79.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.818 -0.628 . . . . 10.0 111.207 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 124' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' B' ' 124' ' ' ARG . 8.7 ptp85 -81.77 -6.57 59.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.851 0.358 . . . . 10.0 110.999 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 74.5 mttt . . . . . 0 C--N 1.327 -0.405 0 CA-C-O 121.049 0.452 . . . . 10.0 110.435 179.289 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.861 0 CA-C-O 120.854 0.359 . . . . 10.0 110.123 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.431 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 54.2 ttm -115.73 117.65 30.84 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.16 -0.473 . . . . 10.0 110.584 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -107.47 179.28 4.29 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.911 -0.586 . . . . 10.0 109.51 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -135.32 138.29 43.27 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 121.006 -0.278 . . . . 10.0 110.923 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.6 pt -117.56 -9.77 11.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.16 -0.473 . . . . 10.0 111.23 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 176.11 -178.92 47.46 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.482 -0.866 . . . . 10.0 112.336 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.486 ' O ' ' HD2' ' A' ' 69' ' ' ARG . 43.3 tttp -58.03 118.15 5.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.688 0.28 . . . . 10.0 111.043 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 66.8 mmm 67.28 8.03 5.93 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.442 -0.799 . . . . 10.0 112.165 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.486 ' HD2' ' O ' ' A' ' 67' ' ' LYS . 2.4 mpt_? -113.35 113.02 24.66 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 120.917 0.389 . . . . 10.0 110.078 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.522 ' HB2' ' CD2' ' A' ' 87' ' ' TYR . 94.8 m-85 -121.17 163.85 17.81 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.894 -0.593 . . . . 10.0 110.879 -178.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 62' ' ' MET . 60.3 t -121.28 102.45 12.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.369 -0.832 . . . . 10.0 108.999 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.42 ' HB2' ' HB3' ' A' ' 83' ' ' ASP . 7.1 m -97.65 98.92 10.29 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.094 0.405 . . . . 10.0 112.094 -178.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.54 HG13 HG12 ' A' ' 82' ' ' ILE . 19.5 t -81.54 82.38 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 108.209 -1.034 . . . . 10.0 108.209 177.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -115.97 167.5 10.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.876 -0.602 . . . . 10.0 111.496 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.45 ' HA ' ' HA ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -112.93 141.2 47.03 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.734 -0.666 . . . . 10.0 110.17 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -126.4 101.84 6.88 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.03 -0.532 . . . . 10.0 111.171 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 78.0 mttt 61.32 34.07 18.67 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.004 -0.543 . . . . 10.0 112.018 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.94 18.54 43.27 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.554 -0.831 . . . . 10.0 111.762 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.437 ' HE2' ' HB2' ' A' ' 79' ' ' LYS . 8.0 mtpt -127.75 99.25 5.47 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.327 -0.249 . . . . 10.0 110.327 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 75' ' ' ASP . 96.7 t -69.62 111.88 3.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.844 -0.428 . . . . 10.0 109.844 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 79.3 mt -122.97 119.17 29.61 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.22 -0.445 . . . . 10.0 110.663 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.54 HG12 HG13 ' A' ' 73' ' ' VAL . 75.6 mt -75.79 101.48 2.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 108.955 -0.757 . . . . 10.0 108.955 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.42 ' HB3' ' HB2' ' A' ' 72' ' ' SER . 4.4 t70 -72.9 100.68 2.98 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.722 -0.672 . . . . 10.0 112.258 -178.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 34.8 mt -100.44 91.81 2.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 107.874 -1.158 . . . . 10.0 107.874 177.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.691 ' HG2' ' N ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -160.25 160.52 32.74 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.046 -0.525 . . . . 10.0 111.278 -177.252 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.691 ' N ' ' HG2' ' A' ' 85' ' ' ARG . 7.7 pt-20 -78.39 147.81 33.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.252 0.548 . . . . 10.0 110.788 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.673 ' HB3' ' HG2' ' A' ' 95' ' ' MET . 96.9 m-85 -126.34 125.31 42.05 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.62 -0.718 . . . . 10.0 109.685 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -105.66 167.76 9.55 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.333 -0.394 . . . . 10.0 110.108 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 27.8 ttt -106.01 131.11 53.7 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.691 0.281 . . . . 10.0 110.339 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.428 ' HB2' ' CD ' ' A' ' 91' ' ' PRO . 2.1 p30 -87.11 171.16 10.43 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 116.013 -0.539 . . . . 10.0 110.314 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.428 ' CD ' ' HB2' ' A' ' 90' ' ' ASP . 17.0 Cg_exo -68.64 -10.29 28.64 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.829 2.353 . . . . 10.0 113.257 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -85.08 -43.06 14.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.167 0.508 . . . . 10.0 109.801 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 126.98 19.18 2.01 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.614 -0.721 . . . . 10.0 112.223 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -105.94 178.41 4.57 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.985 0.421 . . . . 10.0 110.981 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.673 ' HG2' ' HB3' ' A' ' 87' ' ' TYR . 18.7 ttm -105.43 112.43 25.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.757 -0.656 . . . . 10.0 110.005 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.3 mmpp? -102.02 123.11 44.73 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.187 -0.46 . . . . 10.0 111.62 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.48 ' HB3' ' CE1' ' A' ' 87' ' ' TYR . 73.4 Cg_endo -80.42 128.19 6.93 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.614 2.209 . . . . 10.0 111.824 178.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.403 ' O ' ' HD3' ' A' ' 85' ' ' ARG . . . -68.17 156.58 52.89 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.68 -0.772 . . . . 10.0 111.636 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.15 -38.43 83.13 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.03 0.443 . . . . 10.0 110.415 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.52 ' H ' ' HG3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -76.0 96.67 3.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.608 -0.723 . . . . 10.0 110.385 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.411 ' CA ' ' HB2' ' A' ' 85' ' ' ARG . . . -164.97 136.19 4.08 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.772 -0.728 . . . . 10.0 111.922 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 19.0 tt -116.69 124.18 72.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.533 0.682 . . . . 10.0 110.707 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.3 m -102.35 110.95 23.04 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.618 -0.719 . . . . 10.0 109.818 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 79.4 mt -97.39 131.61 43.89 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.903 -0.589 . . . . 10.0 111.244 -178.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -84.06 167.14 29.52 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.828 -0.624 . . . . 10.0 109.601 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -43.14 -41.67 9.6 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.317 2.678 . . . . 10.0 113.71 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.36 -46.53 89.63 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.879 0.371 . . . . 10.0 110.781 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -69.91 -39.45 76.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.018 -0.537 . . . . 10.0 109.734 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 68.3 t-105 -56.99 -43.63 81.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.408 -0.815 . . . . 10.0 110.652 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.2 t -61.68 -52.41 64.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.306 -0.406 . . . . 10.0 109.925 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.45 ' O ' ' HG2' ' A' ' 115' ' ' GLN . 36.0 mt-30 -58.5 -41.71 85.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.911 -0.586 . . . . 10.0 110.709 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.614 ' O ' HG13 ' A' ' 116' ' ' ILE . 21.5 tp -55.47 -51.42 67.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.031 -0.531 . . . . 10.0 110.967 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.596 ' HA ' HD12 ' A' ' 116' ' ' ILE . 44.2 mtmt -63.35 -38.34 90.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.311 -0.404 . . . . 10.0 111.441 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -67.49 -36.22 80.68 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.019 -0.537 . . . . 10.0 111.553 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' A' ' 111' ' ' GLN . 14.1 mm-40 -82.18 -17.56 45.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.647 -0.251 . . . . 10.0 111.33 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.614 HG13 ' O ' ' A' ' 112' ' ' LEU . 18.7 mt -49.94 -37.05 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 111.991 0.367 . . . . 10.0 111.991 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.33 -35.68 72.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.42 -0.354 . . . . 10.0 111.414 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.3 -33.48 15.31 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.94 0.4 . . . . 10.0 110.501 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 91.8 mt -60.93 -47.61 92.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.002 -0.545 . . . . 10.0 110.462 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -62.9 -33.59 75.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.812 -0.631 . . . . 10.0 110.569 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -65.83 -33.18 75.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.806 -0.633 . . . . 10.0 110.026 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -70.54 -31.34 68.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.995 -0.548 . . . . 10.0 110.306 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 51.5 t -63.57 -39.02 83.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.999 -0.546 . . . . 10.0 109.789 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 124' ' ' ARG . 5.6 ttm105 -70.42 -23.6 62.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.813 -0.63 . . . . 10.0 110.458 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 16.9 mttp -79.26 -23.53 43.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.823 -0.626 . . . . 10.0 110.557 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 C--N 1.323 -0.544 0 CA-C-N 116.208 -0.451 . . . . 10.0 111.422 -179.989 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.176 0 CA-C-O 121.047 0.451 . . . . 10.0 110.84 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 98.1 mmm -93.82 90.08 6.39 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.436 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 63' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -67.8 126.06 28.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.878 -0.601 . . . . 10.0 110.345 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -96.29 130.47 43.38 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.806 0.336 . . . . 10.0 110.768 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 21.8 pt -121.38 8.17 6.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.894 -0.593 . . . . 10.0 110.438 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 171.1 178.03 41.34 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.043 -0.823 . . . . 10.0 111.043 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 67' ' ' LYS . . . . . 0.507 ' O ' ' HB2' ' B' ' 68' ' ' MET . 28.2 mtmm -67.74 106.13 2.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 117.04 0.42 . . . . 10.0 109.987 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 68' ' ' MET . . . . . 0.507 ' HB2' ' O ' ' B' ' 67' ' ' LYS . 45.6 mtm 78.08 -0.59 2.63 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 124.093 0.87 . . . . 10.0 111.482 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 69' ' ' ARG . . . . . 0.472 ' HG3' ' HB3' ' B' ' 86' ' ' GLU . 6.3 mpt_? -99.12 122.17 41.97 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.771 -0.455 . . . . 10.0 109.771 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -128.84 168.32 16.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.342 0.592 . . . . 10.0 111.806 -178.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 58.4 t -107.27 102.67 14.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 108.103 -1.073 . . . . 10.0 108.103 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 72' ' ' SER . . . . . 0.545 ' HB3' ' HB3' ' B' ' 83' ' ' ASP . 1.4 t -84.94 88.05 7.4 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.493 0.553 . . . . 10.0 112.493 -177.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 44.6 t -89.03 100.14 10.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 107.851 -1.166 . . . . 10.0 107.851 177.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 74' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' B' ' 74' ' ' ARG . 15.1 ptt-85 -131.91 162.7 30.02 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.195 0.522 . . . . 10.0 111.827 -177.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -95.51 108.49 20.73 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.514 -0.766 . . . . 10.0 109.135 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -93.13 84.63 4.87 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.459 -0.337 . . . . 10.0 110.56 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 72.6 mttt 59.51 45.42 13.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.613 -0.722 . . . . 10.0 111.759 179.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.0 5.37 70.82 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.804 -0.713 . . . . 10.0 112.377 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -118.47 101.88 8.49 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.135 -0.32 . . . . 10.0 110.135 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 80' ' ' VAL . . . . . 0.516 ' O ' ' HD3' ' B' ' 106' ' ' PRO . 12.9 t -65.31 115.29 3.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.654 -0.499 . . . . 10.0 109.654 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 78.9 mt -124.48 132.36 53.49 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.114 0.483 . . . . 10.0 111.602 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 82' ' ' ILE . . . . . . . . . . . . . 5.1 mp -94.88 91.14 2.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 107.647 -1.242 . . . . 10.0 107.647 177.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 83' ' ' ASP . . . . . 0.587 ' HA ' ' HA ' ' B' ' 103' ' ' SER . 38.7 t70 -89.3 103.19 15.84 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.388 -0.824 . . . . 10.0 111.74 -177.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 60.2 mt -80.49 107.75 13.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 107.585 -1.265 . . . . 10.0 107.585 177.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 85' ' ' ARG . . . . . 0.621 ' HD3' ' O ' ' B' ' 98' ' ' GLY . 27.0 ttm-85 -152.85 154.07 34.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.02 0.438 . . . . 10.0 111.744 -176.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 86' ' ' GLU . . . . . 0.472 ' HB3' ' HG3' ' B' ' 69' ' ' ARG . 4.1 pt-20 -93.74 150.06 20.71 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.047 -0.524 . . . . 10.0 109.781 178.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 87' ' ' TYR . . . . . 0.803 ' HB3' ' HB3' ' B' ' 95' ' ' MET . 15.7 m-85 -119.54 127.54 53.11 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.195 -0.457 . . . . 10.0 110.43 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 88' ' ' TRP . . . . . . . . . . . . . 2.2 m0 -108.83 136.34 48.55 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.578 -0.527 . . . . 10.0 109.578 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 42.8 ttm -74.66 126.37 30.7 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.976 0.417 . . . . 10.0 110.341 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 90' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.0 171.62 6.38 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.804 -0.634 . . . . 10.0 110.976 -179.042 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -52.71 -32.1 53.67 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 123.163 2.575 . . . . 10.0 113.392 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.05 -28.95 65.86 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.944 0.402 . . . . 10.0 110.269 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 106.84 16.06 14.94 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.826 -0.702 . . . . 10.0 112.214 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 94' ' ' GLU . . . . . 0.535 ' HB2' ' HE2' ' B' ' 96' ' ' LYS . 48.3 mt-10 -106.8 147.74 29.33 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.921 -0.4 . . . . 10.0 109.921 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 95' ' ' MET . . . . . 0.803 ' HB3' ' HB3' ' B' ' 87' ' ' TYR . 89.7 mmm -82.69 105.89 14.09 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.427 -0.583 . . . . 10.0 109.427 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 96' ' ' LYS . . . . . 0.535 ' HE2' ' HB2' ' B' ' 94' ' ' GLU . 73.5 mmtt -88.06 126.69 60.14 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.964 -0.562 . . . . 10.0 111.164 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -65.4 123.97 12.23 Favored 'Trans proline' 0 C--O 1.237 0.452 0 C-N-CA 122.584 2.189 . . . . 10.0 111.459 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 98' ' ' GLY . . . . . 0.621 ' O ' ' HD3' ' B' ' 85' ' ' ARG . . . -60.45 164.45 15.48 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.818 -0.628 . . . . 10.0 113.537 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 52.4 mtm180 -77.11 -4.03 42.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.985 0.422 . . . . 10.0 111.005 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 38.1 mttm -114.64 115.07 26.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.171 -0.468 . . . . 10.0 110.722 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -175.93 174.41 46.89 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.681 -0.968 . . . . 10.0 110.681 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 16.3 tt -141.84 122.16 11.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.229 0.537 . . . . 10.0 111.354 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 103' ' ' SER . . . . . 0.587 ' HA ' ' HA ' ' B' ' 83' ' ' ASP . 1.2 m -93.07 102.67 15.0 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.879 -0.6 . . . . 10.0 110.173 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 95.2 mt -96.12 132.35 41.61 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.137 -0.483 . . . . 10.0 111.272 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 105' ' ' ASN . . . . . 0.628 ' ND2' ' HB3' ' B' ' 107' ' ' GLU . 23.7 p-10 -84.08 163.61 47.47 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 108.586 -0.894 . . . . 10.0 108.586 178.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 106' ' ' PRO . . . . . 0.516 ' HD3' ' O ' ' B' ' 80' ' ' VAL . 72.4 Cg_exo -49.38 -32.83 27.39 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.734 2.289 . . . . 10.0 112.542 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 107' ' ' GLU . . . . . 0.628 ' HB3' ' ND2' ' B' ' 105' ' ' ASN . 13.4 tt0 -61.75 -57.94 9.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.762 -0.654 . . . . 10.0 111.059 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -74.05 -28.47 61.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.807 0.337 . . . . 10.0 110.619 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 109' ' ' TRP . . . . . 0.45 ' HH2' HG12 ' A' ' 116' ' ' ILE . 28.8 t-105 -60.26 -43.16 96.39 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.506 -0.553 . . . . 10.0 109.506 178.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 110' ' ' SER . . . . . 0.467 ' O ' ' HG3' ' B' ' 114' ' ' GLU . 37.3 t -63.51 -44.96 92.77 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.505 -0.554 . . . . 10.0 109.505 178.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -58.36 -40.04 81.18 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.68 -0.691 . . . . 10.0 110.613 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 112' ' ' LEU . . . . . 0.555 ' O ' HG13 ' B' ' 116' ' ' ILE . 20.8 tp -59.93 -45.31 93.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 10.0 110.191 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -63.86 -33.6 76.06 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.853 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 114' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' B' ' 110' ' ' SER . 35.9 mt-10 -74.36 -45.61 45.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.998 -0.546 . . . . 10.0 110.648 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -62.93 -18.25 62.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.589 -0.732 . . . . 10.0 112.181 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 116' ' ' ILE . . . . . 0.555 HG13 ' O ' ' B' ' 112' ' ' LEU . 67.8 mt -53.38 -38.25 31.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.778 0.323 . . . . 10.0 110.605 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.19 -28.86 67.03 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.815 -0.63 . . . . 10.0 111.826 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -98.96 -40.13 8.22 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.715 0.293 . . . . 10.0 111.412 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 119' ' ' ILE . . . . . 0.418 ' O ' HG23 ' B' ' 123' ' ' VAL . 83.0 mt -62.79 -48.2 89.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 10.0 110.69 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -63.01 -31.46 72.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.225 0.536 . . . . 10.0 110.377 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -63.96 -36.59 84.47 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.436 -0.802 . . . . 10.0 110.048 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -77.52 -40.53 42.38 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.853 -0.612 . . . . 10.0 110.821 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 123' ' ' VAL . . . . . 0.418 HG23 ' O ' ' B' ' 119' ' ' ILE . 94.1 t -61.48 -43.14 96.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.069 -0.514 . . . . 10.0 111.52 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -70.55 -10.77 60.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.684 0.278 . . . . 10.0 111.602 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 85.1 mttt . . . . . 0 C--N 1.326 -0.414 0 CA-C-O 120.751 0.31 . . . . 10.0 110.933 179.963 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.499 ' O ' ' HA ' ' A' ' 72' ' ' SER . . . . . . . . 0 N--CA 1.477 0.889 0 CA-C-O 120.681 0.276 . . . . 10.0 110.506 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 24.0 mmt -123.23 92.78 3.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.239 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.558 ' HB2' ' HB ' ' A' ' 71' ' ' VAL . 91.8 m-85 -96.34 121.09 37.75 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.734 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -87.13 120.11 28.06 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.796 0.332 . . . . 10.0 110.174 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.3 pt -110.23 0.13 9.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.064 0.459 . . . . 10.0 111.063 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.697 ' HA3' ' HG2' ' B' ' 108' ' ' GLN . . . 170.19 -178.64 42.86 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.583 -0.818 . . . . 10.0 111.964 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.449 ' HG2' ' HG2' ' A' ' 68' ' ' MET . 57.0 tttp -65.9 114.25 4.98 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.457 0.17 . . . . 10.0 110.92 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.449 ' HG2' ' HG2' ' A' ' 67' ' ' LYS . 71.5 mmm 69.15 18.78 8.15 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 123.917 0.761 . . . . 10.0 111.663 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -121.83 112.6 18.55 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.934 -0.395 . . . . 10.0 109.934 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -124.91 144.08 50.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.392 0.615 . . . . 10.0 111.671 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.558 ' HB ' ' HB2' ' A' ' 63' ' ' PHE . 48.0 t -104.0 107.22 21.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.177 -0.92 . . . . 10.0 109.037 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 61' ' ' ALA . 1.5 p -102.5 92.48 4.68 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.168 0.508 . . . . 10.0 112.059 -178.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.439 HG22 HG23 ' A' ' 82' ' ' ILE . 16.9 t -83.47 100.54 7.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.085 -0.507 . . . . 10.0 110.003 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.65 156.72 38.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.393 -0.367 . . . . 10.0 110.363 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.51 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 1.1 t70 -83.49 136.07 34.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.145 -0.479 . . . . 10.0 110.86 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -135.24 98.73 4.05 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.075 -0.511 . . . . 10.0 110.672 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 84.3 mttt 59.91 42.3 16.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.632 -0.713 . . . . 10.0 111.004 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.32 51.82 3.99 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.634 -0.793 . . . . 10.0 111.556 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -138.02 89.81 2.43 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.058 -0.349 . . . . 10.0 110.058 -179.626 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.3 t -95.49 91.55 2.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.641 -0.503 . . . . 10.0 109.641 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.734 HD13 ' HB3' ' A' ' 103' ' ' SER . 0.5 OUTLIER -157.14 174.06 16.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.9 -0.591 . . . . 10.0 111.181 -179.08 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.439 HG23 HG22 ' A' ' 73' ' ' VAL . 69.7 mt -88.65 88.87 3.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.267 -0.642 . . . . 10.0 109.267 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.488 ' HA ' ' HA ' ' A' ' 103' ' ' SER . 32.1 t70 -84.39 117.59 23.72 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.86 -0.609 . . . . 10.0 111.806 -178.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.422 HG12 HG13 ' A' ' 71' ' ' VAL . 58.4 mt -103.93 137.54 32.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.97 -0.559 . . . . 10.0 109.642 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.418 ' HB3' ' CE1' ' A' ' 87' ' ' TYR . 10.4 ttm180 -144.92 146.41 31.98 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.711 -0.477 . . . . 10.0 109.711 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -78.59 93.74 4.89 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.402 -0.592 . . . . 10.0 109.402 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 97' ' ' PRO . 16.4 m-85 -78.08 115.95 18.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.702 -0.681 . . . . 10.0 111.717 -178.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.417 ' CH2' ' HA3' ' A' ' 98' ' ' GLY . 35.1 m0 -99.19 -157.39 0.6 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.175 -0.676 . . . . 10.0 109.175 178.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 20.6 ttt -130.58 132.4 45.51 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.042 -0.355 . . . . 10.0 110.042 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.467 ' OD2' ' HB3' ' A' ' 94' ' ' GLU . 2.8 p30 -94.73 167.85 12.38 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 116.273 -0.421 . . . . 10.0 110.565 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -62.48 -14.92 42.28 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.124 2.549 . . . . 10.0 113.452 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.438 ' HA ' ' OE1' ' A' ' 92' ' ' GLU . 2.9 tp10 -83.7 -39.88 19.6 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.12 0.486 . . . . 10.0 110.044 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 123.75 19.19 2.81 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.787 -0.72 . . . . 10.0 112.518 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.467 ' HB3' ' OD2' ' A' ' 90' ' ' ASP . 21.5 tt0 -106.59 166.27 10.68 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.684 -0.487 . . . . 10.0 109.684 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 94.4 mmm -87.33 84.37 7.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.877 0.37 . . . . 10.0 110.484 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.657 ' HE2' ' HA ' ' A' ' 96' ' ' LYS . 0.3 OUTLIER -90.07 108.16 24.24 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.153 -0.476 . . . . 10.0 110.05 179.164 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.625 ' HD2' ' HE2' ' A' ' 96' ' ' LYS . 58.6 Cg_endo -73.95 152.72 46.73 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.251 1.967 . . . . 10.0 112.821 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.417 ' HA3' ' CH2' ' A' ' 88' ' ' TRP . . . -94.24 178.93 37.5 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 111.038 -0.825 . . . . 10.0 111.038 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -78.53 71.59 5.0 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.243 0.544 . . . . 10.0 110.345 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 24.7 ttmt -161.97 133.88 5.55 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.242 -0.89 . . . . 10.0 109.672 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 154.37 -169.47 32.74 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.958 -0.639 . . . . 10.0 111.652 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 20.4 tt -168.91 139.63 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.745 0.307 . . . . 10.0 110.42 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.734 ' HB3' HD13 ' A' ' 81' ' ' LEU . 0.7 OUTLIER -96.01 145.01 25.8 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.506 -0.315 . . . . 10.0 110.268 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 45.6 mt -121.93 117.56 26.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.461 -0.336 . . . . 10.0 110.176 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.545 ' HB2' ' HD2' ' A' ' 106' ' ' PRO . 2.7 p30 -78.61 164.24 56.84 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 109.969 -0.382 . . . . 10.0 109.969 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.545 ' HD2' ' HB2' ' A' ' 105' ' ' ASN . 1.7 Cg_endo -43.22 -45.68 9.66 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.732 2.954 . . . . 10.0 113.866 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -64.01 -42.56 97.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.493 0.187 . . . . 10.0 111.135 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -63.84 -43.6 95.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.991 0.424 . . . . 10.0 110.011 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.534 ' HZ2' ' HB2' ' B' ' 120' ' ' ASP . 62.6 t-105 -59.27 -41.83 89.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.651 -0.704 . . . . 10.0 110.867 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.5 m -66.81 -43.9 82.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.851 -0.613 . . . . 10.0 111.115 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -68.35 -38.95 81.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.36 -0.382 . . . . 10.0 111.038 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.2 tp -59.08 -44.31 91.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.316 -0.402 . . . . 10.0 110.958 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -64.65 -32.54 74.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.272 -0.422 . . . . 10.0 111.1 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -75.45 -33.32 60.87 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.034 0.445 . . . . 10.0 110.888 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -77.81 -8.47 58.06 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.411 0.522 . . . . 10.0 112.411 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 74.7 mt -54.68 -44.46 70.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.674 0.273 . . . . 10.0 111.291 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.31 -19.78 62.17 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.147 -0.479 . . . . 10.0 111.911 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.407 ' HB3' ' CE1' ' B' ' 63' ' ' PHE . 0.6 OUTLIER -101.26 -48.4 4.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.755 0.312 . . . . 10.0 110.718 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.653 HG23 HG21 ' B' ' 73' ' ' VAL . 87.6 mt -58.02 -51.43 70.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.893 -0.594 . . . . 10.0 110.931 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -60.04 -35.66 75.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.73 -0.668 . . . . 10.0 111.38 -178.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.461 ' HA ' ' CZ ' ' A' ' 124' ' ' ARG . 6.9 t70 -66.12 -38.24 87.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.879 0.371 . . . . 10.0 110.259 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.54 -38.29 83.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.128 -0.487 . . . . 10.0 110.1 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 119' ' ' ILE . 59.7 t -63.15 -39.56 85.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.879 -0.6 . . . . 10.0 110.1 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.461 ' CZ ' ' HA ' ' A' ' 121' ' ' ASP . 25.2 mtm105 -72.92 -30.36 63.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.95 -0.568 . . . . 10.0 110.873 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 35.2 mttp -70.98 -35.06 71.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.262 -0.427 . . . . 10.0 110.905 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 26.6 mt . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 116.325 -0.398 . . . . 10.0 110.795 179.88 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.17 0 CA-C-O 121.183 0.516 . . . . 10.0 110.735 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 20.4 mmm -103.45 102.22 12.13 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.079 -0.712 . . . . 10.0 109.079 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 63' ' ' PHE . . . . . 0.419 ' CE2' ' HA ' ' A' ' 119' ' ' ILE . 34.8 m-85 -94.6 114.93 26.97 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.882 -0.599 . . . . 10.0 111.443 -178.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -75.56 121.57 22.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.813 -0.631 . . . . 10.0 110.522 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 12.6 pt -116.05 13.23 7.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.248 -0.433 . . . . 10.0 110.856 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 167.7 -179.31 41.16 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.778 -0.646 . . . . 10.0 111.874 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 67' ' ' LYS . . . . . 0.507 ' O ' ' HD2' ' B' ' 69' ' ' ARG . 0.3 OUTLIER -69.55 111.22 5.23 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.895 0.378 . . . . 10.0 110.06 -179.758 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 68' ' ' MET . . . . . 0.459 ' HB2' ' O ' ' B' ' 67' ' ' LYS . 49.2 mtp 73.17 8.75 5.31 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.2 -0.909 . . . . 10.0 111.175 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 69' ' ' ARG . . . . . 0.507 ' HD2' ' O ' ' B' ' 67' ' ' LYS . 1.5 mpt_? -105.1 118.95 37.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.496 -0.32 . . . . 10.0 110.213 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -132.74 124.09 27.47 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.881 0.372 . . . . 10.0 111.725 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.457 HG12 HG23 ' B' ' 73' ' ' VAL . 46.7 t -76.4 105.32 5.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.716 -0.846 . . . . 10.0 108.716 178.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 5.2 m -84.21 87.77 7.19 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.949 -0.569 . . . . 10.0 111.665 -178.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 73' ' ' VAL . . . . . 0.653 HG21 HG23 ' A' ' 119' ' ' ILE . 67.5 t -93.87 120.14 42.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.31 -0.626 . . . . 10.0 109.31 178.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 74' ' ' ARG . . . . . 0.647 HH12 ' HB2' ' B' ' 83' ' ' ASP . 0.1 OUTLIER -164.43 172.9 12.77 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.217 -0.447 . . . . 10.0 110.45 -179.375 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -94.11 118.29 31.32 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.047 -0.524 . . . . 10.0 109.91 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -108.36 92.69 4.16 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.307 -0.406 . . . . 10.0 110.306 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 93.5 mttt 60.72 33.44 20.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.357 -0.838 . . . . 10.0 111.824 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 102.78 -1.97 48.68 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.619 -0.801 . . . . 10.0 113.146 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -119.37 115.99 25.26 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 122.596 -0.355 . . . . 10.0 111.216 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 80' ' ' VAL . . . . . 0.486 ' O ' ' HD3' ' B' ' 106' ' ' PRO . 28.5 t -75.64 106.6 5.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.172 -0.677 . . . . 10.0 109.172 178.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 80.6 mt -107.68 127.85 54.03 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.188 0.518 . . . . 10.0 112.163 -178.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 82' ' ' ILE . . . . . . . . . . . . . 5.0 mp -92.47 95.62 5.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 107.503 -1.295 . . . . 10.0 107.503 177.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 83' ' ' ASP . . . . . 0.647 ' HB2' HH12 ' B' ' 74' ' ' ARG . 3.4 t70 -91.07 117.42 29.58 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 112.677 0.621 . . . . 10.0 112.677 -177.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 77.9 mt -100.16 98.9 7.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 107.953 -1.129 . . . . 10.0 107.953 177.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 85' ' ' ARG . . . . . 0.54 ' HG3' ' HA3' ' B' ' 101' ' ' GLY . 8.9 ttm-85 -147.64 166.35 27.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.227 -0.442 . . . . 10.0 111.238 -177.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.87 157.07 17.46 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.917 -0.771 . . . . 10.0 108.917 178.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 87' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -121.03 120.73 36.22 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.961 0.41 . . . . 10.0 110.513 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 88' ' ' TRP . . . . . . . . . . . . . 36.2 m95 -103.52 138.32 40.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.764 -0.653 . . . . 10.0 110.173 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 89' ' ' MET . . . . . 0.503 ' HA ' ' O ' ' B' ' 94' ' ' GLU . 58.1 ttm -91.21 132.28 36.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.756 0.312 . . . . 10.0 110.668 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 90' ' ' ASP . . . . . 0.514 ' HB2' ' HD2' ' B' ' 91' ' ' PRO . 8.7 p30 -91.97 173.14 5.52 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 116.298 -0.41 . . . . 10.0 110.144 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 91' ' ' PRO . . . . . 0.514 ' HD2' ' HB2' ' B' ' 90' ' ' ASP . 39.5 Cg_exo -59.45 -26.28 81.43 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.482 2.121 . . . . 10.0 112.489 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -71.36 -26.43 62.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.004 0.431 . . . . 10.0 110.147 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 104.85 16.71 16.29 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.986 -0.626 . . . . 10.0 112.643 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 94' ' ' GLU . . . . . 0.503 ' O ' ' HA ' ' B' ' 89' ' ' MET . 16.3 mt-10 -98.22 155.23 17.28 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.893 0.378 . . . . 10.0 110.749 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 95' ' ' MET . . . . . . . . . . . . . 98.8 mmm -101.62 100.46 10.86 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.66 -0.496 . . . . 10.0 109.66 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 96' ' ' LYS . . . . . 0.414 ' HA ' ' HD3' ' B' ' 97' ' ' PRO . 71.8 mmtt -97.75 140.14 21.77 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 116.164 -0.471 . . . . 10.0 110.895 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 97' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' B' ' 96' ' ' LYS . 38.2 Cg_exo -60.31 143.16 99.49 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 122.569 2.179 . . . . 10.0 111.337 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.47 168.62 21.24 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 116.1 -0.5 . . . . 10.0 112.923 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 99' ' ' ARG . . . . . 0.441 HH11 ' HD2' ' B' ' 99' ' ' ARG . 8.1 mmt180 -79.85 -3.76 49.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.076 0.465 . . . . 10.0 111.136 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 100' ' ' LYS . . . . . 0.403 ' HB2' ' H ' ' B' ' 101' ' ' GLY . 3.9 pttp -117.79 -160.35 0.78 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.984 -0.746 . . . . 10.0 108.984 178.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 101' ' ' GLY . . . . . 0.54 ' HA3' ' HG3' ' B' ' 85' ' ' ARG . . . 108.53 168.24 21.05 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.655 -0.783 . . . . 10.0 112.386 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 20.9 tt -144.82 139.99 23.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.942 0.401 . . . . 10.0 110.869 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 3.8 m -102.69 110.3 22.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.006 -0.543 . . . . 10.0 110.003 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 92.9 mt -104.06 135.18 46.05 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.053 0.454 . . . . 10.0 111.24 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 105' ' ' ASN . . . . . 0.554 ' ND2' ' HB3' ' B' ' 107' ' ' GLU . 34.1 p-10 -93.1 165.77 17.78 Favored Pre-proline 0 C--N 1.317 -0.83 0 N-CA-C 108.698 -0.853 . . . . 10.0 108.698 178.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 106' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' B' ' 80' ' ' VAL . 73.7 Cg_exo -50.39 -32.43 33.83 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.505 2.137 . . . . 10.0 112.51 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 107' ' ' GLU . . . . . 0.554 ' HB3' ' ND2' ' B' ' 105' ' ' ASN . 6.4 tt0 -63.29 -53.51 51.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.607 -0.724 . . . . 10.0 110.948 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 108' ' ' GLN . . . . . 0.697 ' HG2' ' HA3' ' A' ' 66' ' ' GLY . 76.3 mt-30 -75.01 -30.49 61.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.925 0.393 . . . . 10.0 110.307 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 109' ' ' TRP . . . . . . . . . . . . . 46.7 t-105 -59.55 -41.26 89.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.771 -0.649 . . . . 10.0 109.777 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 110' ' ' SER . . . . . 0.627 ' HA ' ' HE3' ' B' ' 113' ' ' LYS . 22.9 t -63.32 -49.32 74.44 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.609 -0.515 . . . . 10.0 109.609 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -58.6 -40.6 83.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.683 -0.689 . . . . 10.0 110.96 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 112' ' ' LEU . . . . . 0.545 ' O ' HG13 ' B' ' 116' ' ' ILE . 63.5 tp -58.28 -44.68 88.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.557 -0.292 . . . . 10.0 110.214 178.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 113' ' ' LYS . . . . . 0.627 ' HE3' ' HA ' ' B' ' 110' ' ' SER . 51.2 mtmt -62.98 -41.64 99.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.109 -0.496 . . . . 10.0 110.529 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -68.81 -35.52 77.09 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.72 -0.673 . . . . 10.0 111.41 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 115' ' ' GLN . . . . . 0.426 ' HA ' ' OE1' ' B' ' 115' ' ' GLN . 13.6 mm-40 -75.27 -14.75 60.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.254 -0.43 . . . . 10.0 111.398 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 116' ' ' ILE . . . . . 0.545 HG13 ' O ' ' B' ' 112' ' ' LEU . 56.3 mt -57.99 -37.76 63.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 120.705 0.288 . . . . 10.0 110.6 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 1.1 m -65.0 -7.26 10.96 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.066 -0.516 . . . . 10.0 111.706 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -116.7 -47.11 2.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.056 0.455 . . . . 10.0 110.424 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 119' ' ' ILE . . . . . 0.529 ' O ' HG23 ' B' ' 123' ' ' VAL . 65.9 mt -64.66 -49.33 80.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.809 -0.632 . . . . 10.0 111.821 -179.2 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 120' ' ' ASP . . . . . 0.534 ' HB2' ' HZ2' ' A' ' 109' ' ' TRP . 34.2 t70 -58.1 -40.03 80.12 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.922 0.391 . . . . 10.0 111.106 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -64.66 -36.99 86.06 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.829 -0.623 . . . . 10.0 110.513 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.42 -24.85 60.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.942 -0.572 . . . . 10.0 111.599 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 123' ' ' VAL . . . . . 0.529 HG23 ' O ' ' B' ' 119' ' ' ILE . 89.3 t -58.53 -37.63 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 121.04 0.448 . . . . 10.0 110.847 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -100.6 16.42 24.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.309 -0.405 . . . . 10.0 110.809 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 92.4 mttt . . . . . 0 C--N 1.327 -0.407 0 CA-C-N 116.172 -0.467 . . . . 10.0 110.247 179.715 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.624 ' HB3' ' HB ' ' A' ' 73' ' ' VAL . . . . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 109.827 -0.434 . . . . 10.0 109.827 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.549 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 41.7 ttm -112.29 103.04 11.16 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.107 0.479 . . . . 10.0 111.316 -179.03 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.474 ' HB2' ' HB ' ' A' ' 71' ' ' VAL . 88.1 m-85 -89.42 173.95 8.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.903 -0.59 . . . . 10.0 109.577 179.15 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.426 ' HG2' ' H ' ' A' ' 66' ' ' GLY . 39.9 tt0 -127.42 126.55 42.6 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.615 0.245 . . . . 10.0 110.64 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.586 HD11 HG23 ' A' ' 84' ' ' ILE . 10.7 pt -117.39 15.44 7.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.321 -0.4 . . . . 10.0 110.885 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.426 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 154.07 175.75 25.66 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.312 -0.947 . . . . 10.0 112.595 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.606 ' HG2' ' HG2' ' A' ' 68' ' ' MET . 42.0 tttp -60.12 113.48 2.37 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 122.698 0.399 . . . . 10.0 110.91 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.606 ' HG2' ' HG2' ' A' ' 67' ' ' LYS . 66.8 mmm 69.87 17.68 7.51 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 123.784 0.678 . . . . 10.0 111.644 179.006 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.482 ' HB3' HG13 ' A' ' 65' ' ' ILE . 5.9 mpt_? -119.94 107.29 12.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.088 0.471 . . . . 10.0 109.936 178.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.509 ' HB3' ' HG2' ' A' ' 62' ' ' MET . 63.8 m-85 -115.3 152.0 33.55 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.728 -0.669 . . . . 10.0 110.838 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.638 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 23.4 t -102.05 111.59 32.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.421 -0.809 . . . . 10.0 110.203 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.633 ' HB2' ' HB3' ' A' ' 83' ' ' ASP . 0.9 OUTLIER -85.14 87.75 7.41 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.027 0.441 . . . . 10.0 111.43 -179.486 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.684 HG22 HG22 ' A' ' 82' ' ' ILE . 16.5 t -86.98 108.21 17.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.589 -0.893 . . . . 10.0 108.589 178.2 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -153.77 -179.64 8.01 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.306 0.574 . . . . 10.0 111.998 -178.219 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.523 ' HB2' HG22 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -120.53 123.02 41.88 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.814 -1.085 . . . . 10.0 109.075 178.457 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -115.67 86.11 2.41 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.014 0.435 . . . . 10.0 110.929 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt 57.35 41.49 26.38 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.257 -0.883 . . . . 10.0 111.348 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 112.38 -24.5 13.81 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.511 -0.852 . . . . 10.0 112.346 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -84.3 82.72 8.26 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.887 0.375 . . . . 10.0 110.554 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.523 HG22 ' HB2' ' A' ' 75' ' ' ASP . 2.8 t -90.37 103.37 14.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 108.958 -0.756 . . . . 10.0 108.958 178.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.741 ' HB3' ' HA ' ' A' ' 105' ' ' ASN . 0.2 OUTLIER -157.97 174.19 15.63 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.952 0.406 . . . . 10.0 111.369 -178.479 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.684 HG22 HG22 ' A' ' 73' ' ' VAL . 38.7 pt -92.64 172.39 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.993 -0.549 . . . . 10.0 110.194 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.638 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 4.1 t70 -151.01 147.49 27.2 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.617 0.246 . . . . 10.0 111.216 -178.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.586 HG23 HD11 ' A' ' 65' ' ' ILE . 60.7 mt -121.22 106.83 19.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.326 -0.62 . . . . 10.0 109.326 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.446 ' HG2' ' HA3' ' A' ' 101' ' ' GLY . 60.2 mtm180 -129.72 151.89 49.82 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.949 0.404 . . . . 10.0 111.451 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -83.11 97.73 8.95 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.382 -0.97 . . . . 10.0 108.382 178.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 97' ' ' PRO . 18.6 m-85 -81.32 142.68 32.84 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.434 -0.803 . . . . 10.0 112.693 -177.433 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 13.8 m0 -128.6 177.25 7.16 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.489 -0.93 . . . . 10.0 108.489 178.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 1.1 ttt -103.97 127.51 51.51 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 110.059 -0.349 . . . . 10.0 110.059 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.515 ' OD2' ' HB2' ' A' ' 94' ' ' GLU . 4.2 p30 -85.02 167.21 27.43 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.636 -0.256 . . . . 10.0 110.359 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -61.63 -19.25 64.23 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.904 2.403 . . . . 10.0 113.403 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -77.68 -46.79 20.88 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.077 0.465 . . . . 10.0 110.006 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 133.36 15.79 1.25 Allowed Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.982 -0.628 . . . . 10.0 112.5 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.515 ' HB2' ' OD2' ' A' ' 90' ' ' ASP . 23.9 mt-10 -106.94 179.18 4.34 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.858 0.361 . . . . 10.0 110.386 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 85.7 mmm -106.55 109.93 21.99 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.205 -0.452 . . . . 10.0 110.737 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.462 ' HA ' ' HD3' ' A' ' 97' ' ' PRO . 48.5 mmtt -125.37 128.67 24.66 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.828 -0.623 . . . . 10.0 109.577 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 96' ' ' LYS . 4.6 Cg_endo -82.63 177.28 7.07 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.078 2.519 . . . . 10.0 113.129 -179.081 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -100.82 -169.27 28.59 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.794 -0.639 . . . . 10.0 111.884 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -80.09 55.98 2.29 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.839 0.352 . . . . 10.0 111.282 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -160.6 132.98 6.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.261 -0.427 . . . . 10.0 110.231 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.446 ' HA3' ' HG2' ' A' ' 85' ' ' ARG . . . 172.19 -170.95 43.91 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.066 -0.588 . . . . 10.0 111.754 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.471 ' HB ' ' N ' ' B' ' 101' ' ' GLY . 8.9 tt -165.85 127.56 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.945 0.402 . . . . 10.0 110.897 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.583 ' HA ' ' HA ' ' A' ' 83' ' ' ASP . 51.7 m -105.56 145.05 31.47 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.235 -0.654 . . . . 10.0 109.235 178.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.423 HD11 HD11 ' A' ' 82' ' ' ILE . 0.5 OUTLIER -131.59 129.68 41.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.028 0.442 . . . . 10.0 110.351 179.71 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.741 ' HA ' ' HB3' ' A' ' 81' ' ' LEU . 3.5 p30 -75.25 164.0 64.08 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.36 -0.837 . . . . 10.0 111.263 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -48.27 -38.37 33.52 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.619 2.88 . . . . 10.0 114.224 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -65.31 -42.22 93.23 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.042 -0.355 . . . . 10.0 110.042 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -65.48 -45.37 83.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.136 0.493 . . . . 10.0 109.801 178.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 56.2 t-105 -56.79 -42.43 79.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.281 -0.872 . . . . 10.0 110.462 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.4 m -65.49 -46.42 79.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.269 -0.423 . . . . 10.0 110.605 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -61.5 -42.74 99.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.494 . . . . 10.0 110.847 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.438 ' O ' HG13 ' A' ' 116' ' ' ILE . 53.8 tp -57.85 -45.75 85.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.901 -0.591 . . . . 10.0 111.314 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -59.0 -42.47 90.15 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.328 -0.396 . . . . 10.0 111.322 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -74.04 -16.99 61.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.184 -0.462 . . . . 10.0 111.758 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -93.14 -10.6 35.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.745 0.307 . . . . 10.0 110.989 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 112' ' ' LEU . 70.7 mt -56.71 -37.53 53.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.571 -0.286 . . . . 10.0 111.45 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.14 -23.58 64.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.904 0.383 . . . . 10.0 111.397 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -97.73 -44.4 6.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.138 0.494 . . . . 10.0 110.088 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.498 ' O ' HG23 ' A' ' 123' ' ' VAL . 67.1 mt -60.25 -52.43 61.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.876 -0.602 . . . . 10.0 111.2 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -61.51 -33.82 74.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.995 -0.548 . . . . 10.0 110.268 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -66.41 -35.62 80.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.533 -0.758 . . . . 10.0 110.259 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.52 -37.42 63.09 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.932 -0.576 . . . . 10.0 110.767 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 119' ' ' ILE . 99.4 t -61.78 -34.54 62.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 10.0 110.805 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 13.9 mtm105 -78.05 -13.72 59.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.131 -0.486 . . . . 10.0 111.417 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -95.37 -31.48 13.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.862 0.363 . . . . 10.0 111.139 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 75.4 mt . . . . . 0 C--N 1.325 -0.48 0 CA-C-N 116.473 -0.33 . . . . 10.0 110.518 179.709 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.18 0 CA-C-O 121.019 0.438 . . . . 10.0 111.021 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 97.3 mmm -108.12 89.89 3.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.991 -0.55 . . . . 10.0 109.621 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 63' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -98.49 133.03 43.43 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.161 -0.472 . . . . 10.0 110.669 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -92.17 132.37 36.69 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.814 0.34 . . . . 10.0 110.746 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 65' ' ' ILE . . . . . 0.407 HD13 HD13 ' A' ' 112' ' ' LEU . 30.5 pt -125.73 16.86 4.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.188 0.518 . . . . 10.0 110.174 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 167.78 165.28 24.92 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.041 -0.824 . . . . 10.0 111.041 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 67' ' ' LYS . . . . . 0.543 ' O ' ' HD2' ' B' ' 69' ' ' ARG . 15.6 mttp -64.07 116.6 6.07 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.944 0.372 . . . . 10.0 110.126 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 68' ' ' MET . . . . . . . . . . . . . 17.5 mmt 69.64 15.73 8.1 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.868 -0.605 . . . . 10.0 110.824 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 69' ' ' ARG . . . . . 0.543 ' HD2' ' O ' ' B' ' 67' ' ' LYS . 2.0 mpt_? -119.17 109.81 16.31 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.436 -0.579 . . . . 10.0 109.436 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 70' ' ' TYR . . . . . 0.451 ' HB2' ' HE2' ' B' ' 87' ' ' TYR . 88.5 m-85 -122.33 142.36 50.58 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.353 0.597 . . . . 10.0 112.078 -178.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 70.8 t -94.48 93.67 4.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 107.809 -1.182 . . . . 10.0 107.809 177.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 8.5 t -84.15 95.87 8.77 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.889 -0.596 . . . . 10.0 111.551 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 73' ' ' VAL . . . . . 0.495 HG21 HG23 ' A' ' 119' ' ' ILE . 17.4 t -90.07 87.92 2.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.533 -0.914 . . . . 10.0 108.533 178.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 74' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' B' ' 74' ' ' ARG . 10.4 ptt-85 -118.09 172.97 7.05 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.146 -0.479 . . . . 10.0 111.207 -178.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -105.54 128.87 53.83 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.811 -0.631 . . . . 10.0 110.67 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -108.8 78.0 1.11 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.302 -0.408 . . . . 10.0 109.93 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 35.5 mttm 60.56 50.97 5.36 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.713 -0.676 . . . . 10.0 111.768 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.18 4.61 71.29 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.683 -0.77 . . . . 10.0 112.356 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -118.29 99.3 6.76 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.65 0.262 . . . . 10.0 110.373 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 41.7 t -67.46 116.88 7.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.653 -0.499 . . . . 10.0 109.653 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 95.9 mt -123.53 132.03 53.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.232 0.539 . . . . 10.0 111.818 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 82' ' ' ILE . . . . . 0.401 HD13 ' HB2' ' B' ' 109' ' ' TRP . 5.2 mp -92.63 87.72 2.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 107.834 -1.173 . . . . 10.0 107.834 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 83' ' ' ASP . . . . . 0.632 ' HA ' ' HA ' ' B' ' 103' ' ' SER . 34.1 t70 -85.39 94.79 9.06 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.745 -0.662 . . . . 10.0 112.014 -178.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 50.9 mt -87.43 99.62 8.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 107.272 -1.381 . . . . 10.0 107.272 177.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 85' ' ' ARG . . . . . 0.735 ' HG3' ' HA3' ' B' ' 101' ' ' GLY . 12.7 ttm-85 -138.33 154.97 48.98 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.28 0.562 . . . . 10.0 111.819 -177.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 86' ' ' GLU . . . . . 0.516 ' HG3' ' HA3' ' B' ' 98' ' ' GLY . 17.1 pt-20 -82.25 148.82 28.17 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.362 -0.835 . . . . 10.0 109.56 178.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 87' ' ' TYR . . . . . 0.451 ' HE2' ' HB2' ' B' ' 70' ' ' TYR . 62.8 m-85 -132.65 121.63 23.45 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.594 -0.521 . . . . 10.0 109.594 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 88' ' ' TRP . . . . . . . . . . . . . 23.7 m0 -99.19 143.44 29.46 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.225 -0.443 . . . . 10.0 110.469 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 42.6 ttm -84.62 120.18 26.07 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.314 -0.403 . . . . 10.0 110.061 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 90' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.52 163.65 53.29 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.963 -0.562 . . . . 10.0 110.856 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -57.83 -32.34 94.69 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.233 2.622 . . . . 10.0 113.44 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.44 -49.57 66.27 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.888 0.375 . . . . 10.0 110.465 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 136.68 24.73 0.47 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.718 -0.754 . . . . 10.0 112.669 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 94' ' ' GLU . . . . . 0.808 ' HB2' ' HE2' ' B' ' 96' ' ' LYS . 26.9 mt-10 -115.35 161.98 17.76 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.938 0.399 . . . . 10.0 110.606 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 95' ' ' MET . . . . . . . . . . . . . 96.9 mmm -101.55 106.24 17.3 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.871 -0.604 . . . . 10.0 109.387 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 96' ' ' LYS . . . . . 0.808 ' HE2' ' HB2' ' B' ' 94' ' ' GLU . 35.4 mmtt -98.91 136.25 20.67 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 116.127 -0.488 . . . . 10.0 110.233 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -58.21 139.16 89.46 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.756 2.304 . . . . 10.0 112.194 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 98' ' ' GLY . . . . . 0.516 ' HA3' ' HG3' ' B' ' 86' ' ' GLU . . . -82.62 -140.13 3.53 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 121.061 -0.59 . . . . 10.0 112.455 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 60.8 mtp85 -117.32 -27.57 6.38 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.945 0.402 . . . . 10.0 110.645 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 4.3 mtmt -88.57 114.32 25.07 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.945 -0.571 . . . . 10.0 110.134 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 101' ' ' GLY . . . . . 0.735 ' HA3' ' HG3' ' B' ' 85' ' ' ARG . . . 166.01 156.81 9.63 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.522 -0.847 . . . . 10.0 112.727 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 18.8 tt -156.38 140.92 8.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.001 0.429 . . . . 10.0 110.402 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 103' ' ' SER . . . . . 0.632 ' HA ' ' HA ' ' B' ' 83' ' ' ASP . 3.4 m -88.56 108.23 19.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.209 -0.45 . . . . 10.0 110.29 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 68.5 mt -87.12 131.5 34.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.206 -0.452 . . . . 10.0 110.443 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -88.2 166.65 22.71 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 109.295 -0.631 . . . . 10.0 109.295 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -47.13 -32.44 13.65 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.005 2.47 . . . . 10.0 113.251 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -67.45 -56.12 10.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.291 -0.413 . . . . 10.0 110.46 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -63.33 -34.07 76.91 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.044 -0.525 . . . . 10.0 110.285 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 109' ' ' TRP . . . . . 0.401 ' HB2' HD13 ' B' ' 82' ' ' ILE . 52.0 t-105 -61.37 -43.06 99.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.857 -0.61 . . . . 10.0 109.908 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 1.6 t -66.29 -45.46 80.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.807 -0.633 . . . . 10.0 109.494 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -56.52 -47.97 78.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.51 -0.768 . . . . 10.0 111.014 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 56.4 tp -58.62 -43.8 89.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.257 -0.429 . . . . 10.0 110.753 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -63.13 -38.54 91.6 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.953 0.406 . . . . 10.0 111.193 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -80.72 -6.65 58.73 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.203 -0.453 . . . . 10.0 111.503 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 13.6 mm-40 -105.26 -6.01 20.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.664 0.269 . . . . 10.0 111.078 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 116' ' ' ILE . . . . . 0.464 ' O ' ' HB2' ' B' ' 120' ' ' ASP . 85.1 mt -52.49 -47.23 48.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 10.0 111.921 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.57 -40.94 72.63 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.227 0.454 . . . . 10.0 112.227 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -76.04 -47.36 25.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.358 -0.383 . . . . 10.0 111.537 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 119' ' ' ILE . . . . . 0.453 ' O ' HG23 ' B' ' 123' ' ' VAL . 70.5 mt -64.21 -42.35 95.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.729 0.299 . . . . 10.0 110.904 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 120' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' B' ' 116' ' ' ILE . 2.1 t70 -60.68 -37.37 81.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.118 0.485 . . . . 10.0 110.422 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -69.33 -31.44 69.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.695 -0.684 . . . . 10.0 110.55 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.04 -32.44 63.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.259 -0.428 . . . . 10.0 110.212 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 123' ' ' VAL . . . . . 0.453 HG23 ' O ' ' B' ' 119' ' ' ILE . 95.0 t -69.2 -41.79 81.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.987 -0.551 . . . . 10.0 110.769 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 124' ' ' ARG . . . . . 0.709 ' HG3' ' HG3' ' B' ' 125' ' ' LYS . 7.8 ptp180 -75.27 -31.52 60.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.509 -0.314 . . . . 10.0 111.095 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 125' ' ' LYS . . . . . 0.709 ' HG3' ' HG3' ' B' ' 124' ' ' ARG . 86.0 mttt . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 116.426 -0.352 . . . . 10.0 110.805 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 110.412 -0.218 . . . . 10.0 110.412 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 54.0 ttm -107.44 115.46 30.2 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.968 -0.382 . . . . 10.0 109.968 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -98.83 149.75 22.58 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.413 -0.358 . . . . 10.0 110.482 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -102.83 124.35 48.18 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.699 0.285 . . . . 10.0 111.239 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 37.1 pt -116.38 0.31 8.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.368 -0.378 . . . . 10.0 110.859 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.464 ' HA3' ' NE2' ' B' ' 108' ' ' GLN . . . 168.45 -179.02 41.71 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.509 -0.853 . . . . 10.0 112.522 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.591 ' HG2' ' HG2' ' A' ' 68' ' ' MET . 37.3 tttp -64.4 117.52 7.39 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.728 0.299 . . . . 10.0 110.92 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.591 ' HG2' ' HG2' ' A' ' 67' ' ' LYS . 39.9 mmm 65.3 7.95 4.58 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.434 -0.803 . . . . 10.0 112.033 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -113.54 112.11 23.01 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.733 -0.469 . . . . 10.0 109.733 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.556 ' HB2' ' CD1' ' A' ' 87' ' ' TYR . 98.1 m-85 -125.55 157.05 38.06 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.08 -0.509 . . . . 10.0 111.342 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 86.3 t -117.78 101.0 11.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.048 -0.978 . . . . 10.0 109.344 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.9 m -89.42 98.72 11.93 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.109 -0.496 . . . . 10.0 110.987 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.1 t -86.64 117.64 31.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.066 -0.516 . . . . 10.0 110.213 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.946 HH12 ' HB2' ' A' ' 83' ' ' ASP . 27.1 ptt-85 -136.62 173.2 11.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.234 -0.439 . . . . 10.0 110.141 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -113.33 153.08 29.07 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.755 0.312 . . . . 10.0 110.351 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.563 ' HD1' ' HG3' ' A' ' 77' ' ' LYS . 1.5 t80 -161.16 119.34 2.41 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.085 -0.507 . . . . 10.0 109.842 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.563 ' HG3' ' HD1' ' A' ' 76' ' ' PHE . 30.4 mtmt 66.34 25.21 10.45 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.504 0.502 . . . . 10.0 110.264 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.41 1.89 90.52 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.706 -0.759 . . . . 10.0 111.399 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -102.12 -175.86 2.96 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.988 -0.375 . . . . 10.0 109.988 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.628 HG21 HG13 ' B' ' 123' ' ' VAL . 42.5 t -119.61 137.0 54.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.039 0.447 . . . . 10.0 111.267 -178.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 73.6 mt -121.27 100.83 7.26 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.482 -0.781 . . . . 10.0 110.301 178.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.45 ' HB ' ' HB2' ' A' ' 104' ' ' LEU . 44.8 mt -89.17 95.49 5.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.303 -0.629 . . . . 10.0 109.303 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.946 ' HB2' HH12 ' A' ' 74' ' ' ARG . 0.8 OUTLIER -79.34 109.97 14.18 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.464 0.542 . . . . 10.0 112.464 -177.748 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 35.3 mt -109.27 90.88 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.395 -0.965 . . . . 10.0 108.395 177.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 1.004 ' HG3' ' HA3' ' A' ' 101' ' ' GLY . 1.4 ttm-85 -137.35 168.07 20.36 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.969 -0.56 . . . . 10.0 111.678 -177.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -91.64 129.77 37.56 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.413 -0.958 . . . . 10.0 108.413 178.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.586 ' HB3' ' HB3' ' A' ' 95' ' ' MET . 95.8 m-85 -114.02 118.6 34.55 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.9 0.381 . . . . 10.0 110.068 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 81.6 m95 -102.43 146.23 28.39 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.896 -0.593 . . . . 10.0 110.726 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 34.2 ttm -68.35 128.63 37.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.144 -0.48 . . . . 10.0 111.474 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.407 ' HB2' ' CD ' ' A' ' 91' ' ' PRO . 34.5 p30 -97.46 171.79 5.61 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 115.61 -0.723 . . . . 10.0 110.845 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.407 ' CD ' ' HB2' ' A' ' 90' ' ' ASP . 3.2 Cg_exo -78.39 32.0 0.45 Allowed 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.927 2.418 . . . . 10.0 111.711 178.35 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -123.0 -44.4 2.18 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.976 -0.749 . . . . 10.0 108.976 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 126.93 18.49 2.12 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 114.871 -1.059 . . . . 10.0 110.973 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.524 ' HG2' ' H ' ' A' ' 95' ' ' MET . 16.7 tt0 -121.24 -177.68 3.58 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.806 -0.442 . . . . 10.0 109.806 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.586 ' HB3' ' HB3' ' A' ' 87' ' ' TYR . 61.0 mmm -117.57 115.16 24.56 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.791 -0.448 . . . . 10.0 109.791 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.439 ' HA ' ' HD3' ' A' ' 97' ' ' PRO . 9.3 mmpt? -95.36 139.58 22.05 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.138 -0.483 . . . . 10.0 110.572 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 96' ' ' LYS . 11.7 Cg_exo -69.36 118.8 5.9 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.941 2.427 . . . . 10.0 112.622 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -70.14 168.87 47.22 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 121.173 -0.537 . . . . 10.0 111.827 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.481 ' HD3' ' HA ' ' A' ' 99' ' ' ARG . 9.4 mmt180 -81.24 56.53 2.89 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.873 0.368 . . . . 10.0 111.8 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 13.2 ttmt -167.29 108.38 0.62 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.779 -0.646 . . . . 10.0 109.901 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 1.004 ' HA3' ' HG3' ' A' ' 85' ' ' ARG . . . 170.44 175.98 39.58 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.017 -1.087 . . . . 10.0 112.929 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.421 HG22 HG22 ' B' ' 102' ' ' ILE . 13.9 tt -155.21 157.65 4.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.313 -0.625 . . . . 10.0 109.313 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.1 p -112.24 173.92 6.13 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 121.069 -0.252 . . . . 10.0 110.861 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.45 ' HB2' ' HB ' ' A' ' 82' ' ' ILE . 37.7 mt -136.7 149.95 48.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.412 -0.358 . . . . 10.0 110.301 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 11.9 p-10 -117.95 167.37 11.4 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 109.538 -0.541 . . . . 10.0 109.538 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.417 ' HD3' ' HB ' ' A' ' 80' ' ' VAL . 80.1 Cg_exo -47.27 -45.59 21.76 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.944 2.429 . . . . 10.0 113.389 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -56.48 -50.54 71.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.089 -0.505 . . . . 10.0 111.514 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.42 ' OE1' ' HD3' ' B' ' 69' ' ' ARG . 44.5 mt-30 -71.97 -36.75 69.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.432 -0.349 . . . . 10.0 110.701 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 69.0 t-105 -56.45 -45.21 80.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.916 -0.584 . . . . 10.0 111.029 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.0 t -61.6 -51.38 68.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.334 -0.393 . . . . 10.0 110.182 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -61.55 -37.23 83.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.082 -0.508 . . . . 10.0 111.508 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 66.5 tp -61.47 -45.11 95.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.921 0.391 . . . . 10.0 110.2 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -65.08 -36.26 83.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.267 0.556 . . . . 10.0 110.172 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -74.42 -9.21 58.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.476 -0.783 . . . . 10.0 111.48 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -112.01 1.71 16.52 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.706 -0.225 . . . . 10.0 111.53 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.5 mt -55.28 -53.29 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.659 -0.246 . . . . 10.0 111.344 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.85 -39.1 80.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 10.0 111.446 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.539 ' HB3' ' CE1' ' B' ' 63' ' ' PHE . 2.0 m-20 -67.19 -51.39 54.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.131 -0.486 . . . . 10.0 111.566 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.456 HG12 ' CD2' ' B' ' 63' ' ' PHE . 62.6 mt -65.33 -45.05 94.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.351 -0.386 . . . . 10.0 111.182 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -60.32 -42.09 94.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.103 -0.499 . . . . 10.0 111.612 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -66.33 -36.87 84.02 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 120.836 0.35 . . . . 10.0 110.195 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.13 -41.95 97.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.936 -0.575 . . . . 10.0 109.974 178.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 119' ' ' ILE . 97.3 t -65.52 -41.98 92.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.784 -0.644 . . . . 10.0 109.856 178.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 27.3 mtm105 -67.12 -22.62 65.79 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.746 -0.661 . . . . 10.0 111.144 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 35.6 mttp -78.63 -30.39 46.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 10.0 110.283 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 70.8 mt . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 115.993 -0.549 . . . . 10.0 110.679 179.993 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.162 0 CA-C-O 120.91 0.385 . . . . 10.0 110.756 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 86.5 mmm -95.09 84.64 4.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.058 0.456 . . . . 10.0 110.274 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 63' ' ' PHE . . . . . 0.539 ' CE1' ' HB3' ' A' ' 118' ' ' ASP . 97.9 m-85 -82.22 159.46 23.23 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.757 -0.656 . . . . 10.0 110.091 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -133.6 119.01 18.89 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.942 0.401 . . . . 10.0 110.972 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 65' ' ' ILE . . . . . 0.416 HD11 HG21 ' B' ' 84' ' ' ILE . 3.0 pt -97.02 95.05 4.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.137 -0.69 . . . . 10.0 109.137 178.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.82 -93.06 1.78 Allowed Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 110.74 -0.944 . . . . 10.0 110.74 -178.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 67' ' ' LYS . . . . . 0.499 ' O ' ' HD2' ' B' ' 69' ' ' ARG . 1.3 ttpm? -165.37 151.92 10.11 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.652 -0.499 . . . . 10.0 109.652 178.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 68' ' ' MET . . . . . 0.479 ' HB2' ' O ' ' B' ' 67' ' ' LYS . 1.2 mpt? 74.93 -50.76 0.67 Allowed 'General case' 0 N--CA 1.473 0.69 0 O-C-N 123.856 0.722 . . . . 10.0 111.67 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 69' ' ' ARG . . . . . 0.624 ' HD2' ' H ' ' B' ' 69' ' ' ARG . 1.6 mpt_? -75.7 110.51 10.17 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.752 0.311 . . . . 10.0 110.365 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -110.26 131.16 55.3 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.184 -0.462 . . . . 10.0 111.086 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 22.3 t -78.65 83.54 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.698 -0.853 . . . . 10.0 108.698 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 26.1 t -87.22 92.59 9.11 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.576 -0.738 . . . . 10.0 111.731 -178.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 73' ' ' VAL . . . . . 0.725 HG13 HG12 ' B' ' 82' ' ' ILE . 3.8 t -86.0 73.69 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.657 -0.868 . . . . 10.0 108.657 177.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 74' ' ' ARG . . . . . 0.43 ' NH1' ' HB3' ' B' ' 83' ' ' ASP . 35.0 ptt-85 -102.29 144.05 31.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.484 0.659 . . . . 10.0 112.093 -177.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -82.71 126.22 32.12 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.974 -1.012 . . . . 10.0 108.939 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -118.27 100.97 7.84 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.644 0.259 . . . . 10.0 110.674 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 63.7 mttm 58.78 35.46 24.33 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.8 -0.636 . . . . 10.0 111.872 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.19 8.27 61.59 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.613 -0.803 . . . . 10.0 112.265 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 79' ' ' LYS . . . . . 0.403 ' HA ' ' HD3' ' B' ' 79' ' ' LYS . 42.0 mmtt -117.43 107.45 14.35 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-O 120.78 0.324 . . . . 10.0 110.681 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 21.9 t -74.42 105.26 3.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.529 -0.545 . . . . 10.0 109.529 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 98.5 mt -118.07 125.05 49.55 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.197 0.523 . . . . 10.0 111.364 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 82' ' ' ILE . . . . . 0.725 HG12 HG13 ' B' ' 73' ' ' VAL . 32.7 mt -85.87 82.84 2.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.16 -1.052 . . . . 10.0 108.16 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 83' ' ' ASP . . . . . 0.509 ' HA ' ' HA ' ' B' ' 103' ' ' SER . 35.1 t70 -93.65 100.71 12.9 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.395 -0.82 . . . . 10.0 111.086 -178.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 84' ' ' ILE . . . . . 0.416 HG21 HD11 ' B' ' 65' ' ' ILE . 36.0 mt -84.24 94.93 3.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 108.353 -0.98 . . . . 10.0 108.353 178.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 85' ' ' ARG . . . . . 0.402 ' HD3' ' O ' ' B' ' 98' ' ' GLY . 5.6 ttm-85 -106.0 151.0 25.18 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.831 -0.622 . . . . 10.0 111.686 -177.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 86' ' ' GLU . . . . . 0.533 ' HG2' ' HG3' ' B' ' 69' ' ' ARG . 55.9 mt-10 -83.56 116.07 22.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.716 -0.674 . . . . 10.0 110.24 178.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 87' ' ' TYR . . . . . 0.84 ' HB3' ' HB3' ' B' ' 95' ' ' MET . 48.7 m-85 -96.03 106.74 18.95 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.942 -0.572 . . . . 10.0 109.855 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 88' ' ' TRP . . . . . . . . . . . . . 76.8 m95 -104.52 139.42 39.44 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.898 -0.592 . . . . 10.0 110.335 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 89' ' ' MET . . . . . 0.487 ' HA ' ' O ' ' B' ' 94' ' ' GLU . 39.3 ttm -69.05 130.44 42.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.953 -0.567 . . . . 10.0 111.665 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 90' ' ' ASP . . . . . 0.455 ' HB2' ' HD2' ' B' ' 91' ' ' PRO . 49.0 p30 -90.35 173.88 5.23 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.477 -0.783 . . . . 10.0 109.724 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 91' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' B' ' 90' ' ' ASP . 37.7 Cg_exo -61.55 -20.32 68.21 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.228 1.952 . . . . 10.0 112.56 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -74.66 -44.0 52.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.281 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 124.48 20.86 2.32 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.925 -0.655 . . . . 10.0 112.165 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 94' ' ' GLU . . . . . 0.601 ' HB3' ' HE2' ' B' ' 96' ' ' LYS . 4.5 tt0 -114.77 161.9 17.57 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.182 -0.303 . . . . 10.0 110.182 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 95' ' ' MET . . . . . 0.84 ' HB3' ' HB3' ' B' ' 87' ' ' TYR . 8.2 mmt -93.31 113.96 26.28 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.824 -0.435 . . . . 10.0 109.824 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 96' ' ' LYS . . . . . 0.601 ' HE2' ' HB3' ' B' ' 94' ' ' GLU . 48.1 mmtt -105.97 126.05 31.62 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.042 -0.526 . . . . 10.0 111.119 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.98 118.36 5.53 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.591 2.194 . . . . 10.0 111.819 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 98' ' ' GLY . . . . . 0.402 ' O ' ' HD3' ' B' ' 85' ' ' ARG . . . -83.46 -157.84 25.16 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.767 -0.73 . . . . 10.0 112.712 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 99' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' B' ' 99' ' ' ARG . 52.6 mtt180 -86.17 -20.74 28.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.868 0.366 . . . . 10.0 110.448 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 100' ' ' LYS . . . . . 0.426 ' HD3' ' OE1' ' B' ' 86' ' ' GLU . 6.8 mtpm? -69.39 106.36 2.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.905 -0.588 . . . . 10.0 109.694 178.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . 161.83 157.11 8.7 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.727 -0.669 . . . . 10.0 111.464 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 102' ' ' ILE . . . . . 0.421 HG22 HG22 ' A' ' 102' ' ' ILE . 6.5 tp -133.63 134.99 56.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.946 0.403 . . . . 10.0 110.731 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 103' ' ' SER . . . . . 0.509 ' HA ' ' HA ' ' B' ' 83' ' ' ASP . 0.8 OUTLIER -97.21 108.49 21.23 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.826 -0.625 . . . . 10.0 110.481 179.817 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 80.4 mt -111.4 137.74 48.79 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.979 0.419 . . . . 10.0 110.835 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 105' ' ' ASN . . . . . 0.557 ' ND2' ' HB3' ' B' ' 107' ' ' GLU . 36.5 p-10 -85.95 168.25 20.33 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.325 -0.398 . . . . 10.0 109.932 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 106' ' ' PRO . . . . . 0.406 ' HD2' ' HB2' ' B' ' 105' ' ' ASN . 76.3 Cg_exo -52.63 -27.33 32.77 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.775 2.317 . . . . 10.0 112.526 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 107' ' ' GLU . . . . . 0.557 ' HB3' ' ND2' ' B' ' 105' ' ' ASN . 7.5 tt0 -66.38 -51.38 57.7 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.936 -0.574 . . . . 10.0 109.942 178.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 108' ' ' GLN . . . . . 0.464 ' NE2' ' HA3' ' A' ' 66' ' ' GLY . 0.2 OUTLIER -65.63 -33.21 75.37 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.979 -0.555 . . . . 10.0 110.355 179.53 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 109' ' ' TRP . . . . . . . . . . . . . 45.9 t-105 -57.8 -41.91 83.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.126 -0.488 . . . . 10.0 110.699 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 13.6 t -68.04 -53.31 26.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.315 -0.402 . . . . 10.0 110.736 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -59.33 -36.59 75.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.481 . . . . 10.0 111.303 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 112' ' ' LEU . . . . . 0.459 ' O ' HG13 ' B' ' 116' ' ' ILE . 64.2 tp -60.12 -48.0 83.55 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.162 -0.31 . . . . 10.0 110.162 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 113' ' ' LYS . . . . . 0.412 ' HB2' ' HE3' ' B' ' 113' ' ' LYS . 42.6 mtmt -62.9 -39.11 93.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.142 -0.481 . . . . 10.0 110.881 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -68.29 -30.66 69.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.938 -0.574 . . . . 10.0 111.429 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -85.39 -8.3 58.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.676 -0.238 . . . . 10.0 111.265 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 116' ' ' ILE . . . . . 0.459 HG13 ' O ' ' B' ' 112' ' ' LEU . 27.3 mt -57.22 -37.4 56.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.676 -0.238 . . . . 10.0 111.513 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.12 -29.42 67.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.945 0.402 . . . . 10.0 111.282 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -91.2 -42.81 10.22 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.168 -0.469 . . . . 10.0 110.68 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 119' ' ' ILE . . . . . 0.513 ' O ' HG23 ' B' ' 123' ' ' VAL . 82.8 mt -64.05 -47.14 91.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.893 -0.594 . . . . 10.0 111.206 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 120' ' ' ASP . . . . . 0.411 ' O ' ' HG2' ' B' ' 124' ' ' ARG . 23.9 t70 -60.01 -38.96 84.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.565 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -63.85 -42.66 97.53 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.641 -0.709 . . . . 10.0 110.249 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.63 -33.96 77.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.971 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 123' ' ' VAL . . . . . 0.628 HG13 HG21 ' A' ' 80' ' ' VAL . 71.3 t -60.4 -35.22 61.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-O 121.362 0.601 . . . . 10.0 110.708 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 124' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' B' ' 120' ' ' ASP . 7.3 ptt85 -102.99 21.22 16.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.803 -0.635 . . . . 10.0 110.613 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 17.4 ttmt . . . . . 0 C--N 1.325 -0.498 0 CA-C-O 121.412 0.625 . . . . 10.0 109.821 179.941 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 109.933 -0.395 . . . . 10.0 109.933 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 49.1 ttm -126.55 105.54 8.81 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.917 0.389 . . . . 10.0 110.618 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -96.37 126.47 41.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.004 -0.544 . . . . 10.0 110.407 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.443 ' HG2' ' H ' ' A' ' 66' ' ' GLY . 23.4 tt0 -85.74 131.48 34.32 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.009 -0.367 . . . . 10.0 110.009 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 26.9 pt -119.62 11.68 6.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.147 0.498 . . . . 10.0 110.807 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.783 ' HA3' ' HG2' ' B' ' 108' ' ' GLN . . . 161.39 174.71 31.6 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.401 -0.68 . . . . 10.0 111.401 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.56 ' HG2' ' HG2' ' A' ' 68' ' ' MET . 52.4 tttp -61.85 120.32 10.51 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.058 0.456 . . . . 10.0 110.873 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.56 ' HG2' ' HG2' ' A' ' 67' ' ' LYS . 36.1 mmm 66.19 12.7 8.72 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.079 -0.964 . . . . 10.0 111.964 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.787 ' HE ' ' HB3' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -114.81 113.0 23.66 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.718 -0.475 . . . . 10.0 109.718 179.128 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -126.73 134.27 50.69 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.116 0.484 . . . . 10.0 111.71 -177.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 38.7 t -93.82 105.16 16.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 108.912 -0.773 . . . . 10.0 108.912 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.404 ' HB2' ' HB3' ' A' ' 83' ' ' ASP . 1.2 m -80.8 82.99 6.65 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.502 -0.772 . . . . 10.0 111.3 -178.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.472 HG22 HG23 ' A' ' 82' ' ' ILE . 10.8 t -83.41 93.55 3.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.912 -0.773 . . . . 10.0 108.912 178.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -133.92 -175.37 3.82 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.816 -0.629 . . . . 10.0 111.029 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.429 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 7.3 t0 -117.07 142.45 46.96 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.873 -0.603 . . . . 10.0 110.033 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.457 ' HD1' ' HA ' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -145.38 96.53 2.85 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.018 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.8 mttp 68.48 29.15 5.77 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.016 -0.538 . . . . 10.0 111.057 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 84.37 54.15 3.06 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.545 -0.836 . . . . 10.0 111.834 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 18.8 mttp -146.41 130.52 17.39 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.783 -0.209 . . . . 10.0 110.472 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.3 t -80.2 84.69 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.54 -0.911 . . . . 10.0 108.54 178.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 30.5 mt -83.7 104.84 14.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.892 -0.595 . . . . 10.0 112.126 -178.07 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.472 HG23 HG22 ' A' ' 73' ' ' VAL . 16.6 mt -97.25 64.07 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 106.704 -1.591 . . . . 10.0 106.704 176.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.886 ' HA ' ' HA ' ' A' ' 103' ' ' SER . 19.9 t70 -68.41 101.68 1.28 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.735 -1.12 . . . . 10.0 113.375 -176.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 63.0 mt -84.21 108.0 16.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 107.383 -1.34 . . . . 10.0 107.383 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.818 ' HD2' ' HB2' ' A' ' 97' ' ' PRO . 12.3 ttm180 -143.69 170.47 15.8 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.599 0.714 . . . . 10.0 112.335 -177.04 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.787 ' HB3' ' HE ' ' A' ' 69' ' ' ARG . 6.9 pt-20 -99.95 140.77 33.7 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.282 -0.872 . . . . 10.0 108.911 177.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -122.23 121.76 37.58 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.912 0.387 . . . . 10.0 110.462 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -114.49 153.57 29.76 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.763 -0.653 . . . . 10.0 109.943 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 2.3 ttm -83.02 122.14 27.93 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.836 -0.431 . . . . 10.0 109.836 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.47 170.76 13.66 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.824 -0.626 . . . . 10.0 110.726 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -54.19 -29.78 58.17 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 123.053 2.502 . . . . 10.0 113.458 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -73.75 -45.2 53.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.965 0.412 . . . . 10.0 110.608 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 124.51 30.18 1.01 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.63 -0.795 . . . . 10.0 112.0 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -116.33 167.76 10.74 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.78 0.324 . . . . 10.0 110.32 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 92.3 mmm -89.42 98.25 11.66 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.251 -0.648 . . . . 10.0 109.251 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -98.23 124.54 46.77 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.447 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.818 ' HB2' ' HD2' ' A' ' 85' ' ' ARG . 80.1 Cg_endo -78.02 146.86 23.34 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.727 2.284 . . . . 10.0 112.891 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.54 ' O ' ' HD3' ' A' ' 85' ' ' ARG . . . -85.08 -174.1 50.13 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.725 -0.75 . . . . 10.0 112.332 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -76.06 -26.92 56.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.98 0.419 . . . . 10.0 110.758 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -76.38 81.38 3.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.863 -0.608 . . . . 10.0 110.609 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.438 ' HA3' ' NE ' ' A' ' 85' ' ' ARG . . . -146.62 129.48 3.33 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.959 -0.564 . . . . 10.0 111.766 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 8.5 tt -127.29 113.86 33.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.201 0.524 . . . . 10.0 110.702 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.886 ' HA ' ' HA ' ' A' ' 83' ' ' ASP . 2.3 m -79.27 99.9 7.28 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.089 -0.505 . . . . 10.0 110.679 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.47 ' HB2' ' HB ' ' A' ' 82' ' ' ILE . 34.7 mt -76.53 171.66 14.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.153 0.501 . . . . 10.0 110.442 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -133.03 158.32 76.13 Favored Pre-proline 0 C--N 1.316 -0.87 0 N-CA-C 108.835 -0.802 . . . . 10.0 108.835 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -41.39 -45.3 5.91 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.825 3.017 . . . . 10.0 113.891 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -64.38 -49.69 70.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.709 0.29 . . . . 10.0 110.833 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.571 ' NE2' ' HD3' ' B' ' 69' ' ' ARG . 72.3 mt-30 -63.56 -40.74 97.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.266 -0.424 . . . . 10.0 110.586 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -59.47 -44.79 92.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.924 -0.58 . . . . 10.0 110.294 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.482 ' HA ' ' CE ' ' A' ' 113' ' ' LYS . 56.8 m -64.4 -41.02 96.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.226 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.47 ' O ' ' HG2' ' A' ' 115' ' ' GLN . 46.5 mt-30 -63.98 -42.02 97.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.254 -0.43 . . . . 10.0 110.395 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 22.9 tp -59.36 -40.99 88.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.992 -0.549 . . . . 10.0 110.543 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.482 ' CE ' ' HA ' ' A' ' 110' ' ' SER . 53.3 mtmt -63.95 -33.49 75.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.856 -0.611 . . . . 10.0 111.121 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -76.82 -15.4 59.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.324 -0.398 . . . . 10.0 111.115 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.47 ' HG2' ' O ' ' A' ' 111' ' ' GLN . 14.2 mm-40 -99.55 -5.18 29.61 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.547 -0.297 . . . . 10.0 110.879 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.467 HG12 ' HH2' ' B' ' 109' ' ' TRP . 56.7 mt -56.56 -39.73 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.396 -0.365 . . . . 10.0 111.489 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.14 -30.21 69.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.109 -0.496 . . . . 10.0 111.099 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.425 ' HB3' ' CE1' ' B' ' 63' ' ' PHE . 2.6 m-20 -90.04 -39.93 12.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.756 -0.656 . . . . 10.0 110.571 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.48 ' O ' HG23 ' A' ' 123' ' ' VAL . 92.8 mt -62.21 -51.22 75.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.323 -0.399 . . . . 10.0 110.628 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -62.05 -28.7 69.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.243 0.544 . . . . 10.0 110.329 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -63.64 -49.78 71.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.422 -0.808 . . . . 10.0 110.064 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.47 -34.18 77.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.778 -0.647 . . . . 10.0 110.969 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.66 ' HA ' HG11 ' B' ' 80' ' ' VAL . 72.5 t -61.44 -42.65 94.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.964 0.412 . . . . 10.0 110.678 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 24.1 mtm180 -75.03 -24.25 58.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.018 -0.537 . . . . 10.0 111.143 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -74.78 -46.34 37.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.021 0.439 . . . . 10.0 110.81 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 17.6 mt . . . . . 0 C--N 1.326 -0.452 0 CA-C-N 116.008 -0.542 . . . . 10.0 111.14 -179.724 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.163 0 CA-C-O 121.171 0.51 . . . . 10.0 110.471 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 86.5 mmm -109.14 111.01 22.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.7 -0.682 . . . . 10.0 109.914 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 63' ' ' PHE . . . . . 0.425 ' CE1' ' HB3' ' A' ' 118' ' ' ASP . 15.6 m-85 -107.87 157.65 17.99 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.268 -0.424 . . . . 10.0 110.462 -179.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -117.38 135.07 54.13 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.486 -0.325 . . . . 10.0 110.284 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 21.2 pt -126.84 29.13 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.176 -0.465 . . . . 10.0 111.113 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 149.97 -172.1 29.89 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.929 -0.653 . . . . 10.0 111.616 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 67' ' ' LYS . . . . . 0.479 ' O ' ' HB2' ' B' ' 68' ' ' MET . 43.3 mtmt -69.24 105.87 2.67 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.555 0.178 . . . . 10.0 110.735 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 68' ' ' MET . . . . . 0.479 ' HB2' ' O ' ' B' ' 67' ' ' LYS . 0.3 OUTLIER 76.01 -12.8 0.96 Allowed 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.71 0.633 . . . . 10.0 112.71 178.705 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 69' ' ' ARG . . . . . 0.571 ' HD3' ' NE2' ' A' ' 108' ' ' GLN . 0.7 OUTLIER -79.75 113.87 18.24 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.861 -0.422 . . . . 10.0 109.861 179.276 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -119.88 161.79 20.24 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.439 0.638 . . . . 10.0 112.15 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 95.2 t -119.84 114.5 44.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.0 -1.0 . . . . 10.0 108.361 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 4.9 t -104.04 106.59 17.15 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.0 0.428 . . . . 10.0 111.571 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 73' ' ' VAL . . . . . 0.445 HG22 HG23 ' B' ' 82' ' ' ILE . 31.2 t -104.9 110.01 29.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.972 -0.751 . . . . 10.0 108.972 178.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 7.0 ptt-85 -151.73 163.02 40.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.941 0.4 . . . . 10.0 111.686 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -82.64 113.38 20.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.823 -0.626 . . . . 10.0 109.984 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -105.24 84.25 2.08 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.364 -0.38 . . . . 10.0 110.787 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 59.0 mttm 62.41 43.6 7.91 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.69 -0.686 . . . . 10.0 111.477 178.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 86.87 35.52 9.93 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.528 -0.844 . . . . 10.0 112.429 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 19.1 mmtm -150.84 115.71 5.26 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 122.196 0.198 . . . . 10.0 110.557 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 80' ' ' VAL . . . . . 0.66 HG11 ' HA ' ' A' ' 123' ' ' VAL . 28.4 t -75.82 90.21 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.692 -0.855 . . . . 10.0 108.692 178.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 45.6 mt -95.21 130.99 41.74 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.358 0.599 . . . . 10.0 111.98 -178.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 82' ' ' ILE . . . . . 0.445 HG23 HG22 ' B' ' 73' ' ' VAL . 3.1 mp -103.13 91.06 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 107.799 -1.185 . . . . 10.0 107.799 178.071 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 83' ' ' ASP . . . . . 0.532 ' HA ' ' HA ' ' B' ' 103' ' ' SER . 34.1 t70 -89.85 104.46 17.02 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.588 -0.733 . . . . 10.0 111.69 -178.132 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 54.3 mt -87.28 97.56 6.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 107.501 -1.296 . . . . 10.0 107.501 177.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 85' ' ' ARG . . . . . 0.556 ' HD3' ' O ' ' B' ' 98' ' ' GLY . 12.6 ttm180 -132.0 150.28 52.2 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.886 -0.597 . . . . 10.0 112.127 -176.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -83.55 128.49 34.56 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.85 -0.796 . . . . 10.0 108.85 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 87' ' ' TYR . . . . . 0.565 ' HB3' ' HB3' ' B' ' 95' ' ' MET . 4.8 m-85 -103.01 122.14 44.01 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.971 0.415 . . . . 10.0 110.546 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 88' ' ' TRP . . . . . . . . . . . . . 22.4 m0 -99.92 136.88 39.16 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.859 -0.609 . . . . 10.0 109.851 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 44.2 ttm -73.33 141.02 47.11 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.109 0.481 . . . . 10.0 110.864 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 90' ' ' ASP . . . . . 0.421 ' OD2' ' HB2' ' B' ' 92' ' ' GLU . 0.0 OUTLIER -103.37 165.45 13.53 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 115.605 -0.725 . . . . 10.0 110.238 179.776 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -55.09 -29.71 66.89 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.113 2.542 . . . . 10.0 113.815 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 92' ' ' GLU . . . . . 0.421 ' HB2' ' OD2' ' B' ' 90' ' ' ASP . 0.5 OUTLIER -70.75 -35.24 72.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.966 0.412 . . . . 10.0 110.384 179.585 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 119.52 20.26 3.95 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.639 -0.791 . . . . 10.0 112.966 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 94' ' ' GLU . . . . . 0.764 ' HB2' ' HE2' ' B' ' 96' ' ' LYS . 3.3 mt-10 -111.56 160.68 16.96 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.88 0.34 . . . . 10.0 110.366 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 95' ' ' MET . . . . . 0.565 ' HB3' ' HB3' ' B' ' 87' ' ' TYR . 84.6 mmm -98.11 111.2 23.6 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.73 -0.47 . . . . 10.0 109.73 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 96' ' ' LYS . . . . . 0.764 ' HE2' ' HB2' ' B' ' 94' ' ' GLU . 49.8 mmtt -100.66 135.98 19.99 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.231 -0.44 . . . . 10.0 111.01 -178.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -63.0 118.88 5.77 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.394 2.063 . . . . 10.0 111.845 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 98' ' ' GLY . . . . . 0.556 ' O ' ' HD3' ' B' ' 85' ' ' ARG . . . -68.57 167.95 43.67 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.741 -0.743 . . . . 10.0 112.039 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 5.4 mtm180 -82.26 47.97 1.21 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.192 0.52 . . . . 10.0 110.98 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -161.78 104.87 1.21 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.689 -0.687 . . . . 10.0 110.418 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -173.93 161.13 31.37 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 110.805 -0.918 . . . . 10.0 110.805 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 7.5 tp -119.8 122.46 68.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.298 0.57 . . . . 10.0 111.244 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 103' ' ' SER . . . . . 0.532 ' HA ' ' HA ' ' B' ' 83' ' ' ASP . 0.8 OUTLIER -94.37 104.84 16.81 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.825 -0.625 . . . . 10.0 110.254 179.854 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 83.9 mt -98.27 163.62 12.64 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.231 -0.441 . . . . 10.0 110.628 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 105' ' ' ASN . . . . . 0.447 ' HB2' ' HD2' ' B' ' 106' ' ' PRO . 45.4 p30 -115.83 169.95 6.32 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 108.652 -0.87 . . . . 10.0 108.652 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 106' ' ' PRO . . . . . 0.53 ' HD3' ' O ' ' B' ' 80' ' ' VAL . 53.1 Cg_exo -53.61 -30.38 54.94 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.283 1.988 . . . . 10.0 112.445 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -65.02 -56.53 12.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.601 -0.727 . . . . 10.0 110.799 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 108' ' ' GLN . . . . . 0.783 ' HG2' ' HA3' ' A' ' 66' ' ' GLY . 19.9 mt-30 -72.49 -27.52 62.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.258 -0.428 . . . . 10.0 110.409 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 109' ' ' TRP . . . . . 0.467 ' HH2' HG12 ' A' ' 116' ' ' ILE . 34.9 t-105 -65.92 -36.78 84.33 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.962 -0.755 . . . . 10.0 108.962 177.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 110' ' ' SER . . . . . 0.497 ' O ' ' HG3' ' B' ' 114' ' ' GLU . 29.2 t -64.35 -51.16 64.75 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.322 -0.854 . . . . 10.0 109.437 178.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -62.22 -36.1 80.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.757 -0.656 . . . . 10.0 111.076 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 112' ' ' LEU . . . . . 0.471 ' O ' HG13 ' B' ' 116' ' ' ILE . 52.7 tp -59.25 -44.24 92.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.92 0.39 . . . . 10.0 110.069 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -66.38 -30.54 70.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.926 -0.579 . . . . 10.0 110.751 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 114' ' ' GLU . . . . . 0.497 ' HG3' ' O ' ' B' ' 110' ' ' SER . 43.3 mt-10 -79.75 -25.8 40.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.19 -0.459 . . . . 10.0 111.01 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -84.03 -10.44 57.87 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.337 -0.392 . . . . 10.0 111.217 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 116' ' ' ILE . . . . . 0.499 ' O ' ' HB2' ' B' ' 120' ' ' ASP . 73.0 mt -56.53 -43.29 77.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.375 -0.375 . . . . 10.0 111.787 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.23 -28.75 68.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.871 0.367 . . . . 10.0 111.695 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.79 -43.09 12.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.304 -0.407 . . . . 10.0 110.99 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 78.5 mt -67.26 -46.1 84.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.14 -0.482 . . . . 10.0 110.773 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 120' ' ' ASP . . . . . 0.499 ' HB2' ' O ' ' B' ' 116' ' ' ILE . 0.3 OUTLIER -55.88 -43.84 77.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.019 -0.537 . . . . 10.0 110.828 -179.916 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 121' ' ' ASP . . . . . 0.446 ' HA ' ' NE ' ' B' ' 124' ' ' ARG . 29.2 t70 -61.32 -37.52 83.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.525 -0.761 . . . . 10.0 111.242 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.49 -41.64 54.87 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.354 -0.385 . . . . 10.0 111.15 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 77.1 t -62.9 -42.5 96.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.197 -0.456 . . . . 10.0 111.441 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 124' ' ' ARG . . . . . 0.446 ' NE ' ' HA ' ' B' ' 121' ' ' ASP . 20.1 ptt180 -73.41 -6.77 48.37 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.801 0.297 . . . . 10.0 111.801 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 63.7 mttt . . . . . 0 C--N 1.327 -0.371 0 CA-C-O 121.025 0.441 . . . . 10.0 110.734 179.493 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 110.282 -0.266 . . . . 10.0 110.282 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.657 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -111.88 122.73 48.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.805 0.336 . . . . 10.0 111.162 -179.53 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -117.95 144.13 45.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.106 -0.497 . . . . 10.0 110.122 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -84.2 125.25 32.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.928 0.394 . . . . 10.0 110.76 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.3 pt -115.88 16.36 7.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.198 -0.456 . . . . 10.0 110.478 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 154.75 176.24 26.77 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.594 -0.602 . . . . 10.0 111.594 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.829 ' HG2' ' HG2' ' A' ' 68' ' ' MET . 51.8 tttp -65.61 120.17 12.45 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.688 0.28 . . . . 10.0 110.731 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.829 ' HG2' ' HG2' ' A' ' 67' ' ' LYS . 59.7 mmm 66.18 24.67 10.77 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.54 -0.755 . . . . 10.0 112.05 178.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -132.18 119.81 21.39 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.201 -0.296 . . . . 10.0 110.201 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.414 ' HB2' ' CD1' ' A' ' 87' ' ' TYR . 26.9 m-85 -128.3 135.23 49.33 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.054 0.454 . . . . 10.0 111.751 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.657 ' O ' ' HA ' ' A' ' 62' ' ' MET . 41.4 t -90.05 107.33 18.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 108.696 -0.853 . . . . 10.0 108.696 178.264 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.566 ' HB2' ' HB3' ' A' ' 83' ' ' ASP . 3.8 m -94.9 90.35 5.97 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.943 0.401 . . . . 10.0 111.799 -178.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 45.5 t -78.11 111.08 14.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.886 -0.783 . . . . 10.0 108.886 178.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.1 ptt180 -138.08 -167.01 2.08 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.106 -0.497 . . . . 10.0 110.596 -178.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -126.76 139.62 52.99 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.257 -0.428 . . . . 10.0 110.127 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.465 ' HD2' ' HE3' ' A' ' 77' ' ' LYS . 2.3 t80 -148.03 112.85 5.42 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.226 -0.443 . . . . 10.0 110.125 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.465 ' HE3' ' HD2' ' A' ' 76' ' ' PHE . 6.8 mtmp? 68.42 15.11 9.22 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.755 -0.657 . . . . 10.0 111.234 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 100.21 0.39 55.9 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.278 -0.963 . . . . 10.0 112.485 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.3 mtpt -109.38 132.51 54.06 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.214 -0.291 . . . . 10.0 110.214 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.498 ' O ' ' HD3' ' A' ' 106' ' ' PRO . 43.8 t -70.74 107.32 2.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.204 -0.665 . . . . 10.0 109.204 178.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.454 ' HA ' HD23 ' A' ' 81' ' ' LEU . 6.7 mt -97.21 113.54 25.15 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.235 0.54 . . . . 10.0 112.376 -178.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.41 HD11 HG21 ' B' ' 123' ' ' VAL . 70.4 mt -89.1 89.38 3.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 107.322 -1.362 . . . . 10.0 107.322 177.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.566 ' HB3' ' HB2' ' A' ' 72' ' ' SER . 3.5 t70 -79.2 101.9 8.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.499 -0.773 . . . . 10.0 112.655 -177.25 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.5 mt -94.34 81.25 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.537 -0.912 . . . . 10.0 108.537 178.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.761 ' HG3' ' HA3' ' A' ' 101' ' ' GLY . 4.9 ttm180 -117.07 155.19 29.68 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.675 -0.693 . . . . 10.0 110.961 -178.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.464 ' O ' ' HA ' ' A' ' 97' ' ' PRO . 61.5 mt-10 -72.0 139.22 48.49 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.518 -0.549 . . . . 10.0 109.518 178.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.696 ' HD2' ' HB3' ' A' ' 95' ' ' MET . 5.4 m-85 -118.29 111.58 18.95 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.956 0.408 . . . . 10.0 110.229 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -103.02 145.65 29.56 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.761 -0.654 . . . . 10.0 109.897 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 40.8 ttm -87.62 137.74 32.08 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.112 -0.329 . . . . 10.0 110.112 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.493 ' HB2' ' CD ' ' A' ' 91' ' ' PRO . 53.0 p-10 -99.35 177.57 1.53 Allowed Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.071 -0.513 . . . . 10.0 110.275 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.493 ' CD ' ' HB2' ' A' ' 90' ' ' ASP . 28.0 Cg_exo -63.95 -12.46 32.15 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.513 2.142 . . . . 10.0 113.018 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -88.16 -16.76 32.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.291 0.567 . . . . 10.0 110.073 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.11 14.75 55.65 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.637 -0.71 . . . . 10.0 111.745 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.437 ' HB2' ' HD3' ' A' ' 96' ' ' LYS . 6.0 mm-40 -94.51 157.73 15.86 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.052 0.453 . . . . 10.0 110.751 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.696 ' HB3' ' HD2' ' A' ' 87' ' ' TYR . 87.1 mmm -92.64 108.71 20.19 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.181 -0.674 . . . . 10.0 109.181 178.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.437 ' HD3' ' HB2' ' A' ' 94' ' ' GLU . 2.2 mmmm -108.62 128.91 24.68 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 116.154 -0.475 . . . . 10.0 111.099 -178.355 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 58.2 Cg_endo -72.06 139.14 32.21 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.348 2.032 . . . . 10.0 112.283 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -84.16 -169.36 45.31 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.433 -0.667 . . . . 10.0 111.433 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.479 ' HA ' ' HD2' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -91.03 -7.72 51.09 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 117.3 0.55 . . . . 10.0 110.969 -179.856 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 21.2 ttmt -100.25 113.9 26.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.173 -0.467 . . . . 10.0 110.108 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.761 ' HA3' ' HG3' ' A' ' 85' ' ' ARG . . . -175.7 168.66 41.11 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.85 -0.691 . . . . 10.0 111.8 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.695 ' HB ' ' HA2' ' B' ' 101' ' ' GLY . 17.2 tt -139.58 121.53 16.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.332 0.587 . . . . 10.0 111.006 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 83' ' ' ASP . 0.9 OUTLIER -97.77 113.0 24.68 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.952 -0.567 . . . . 10.0 109.704 179.519 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.51 ' HB3' ' HB2' ' A' ' 108' ' ' GLN . 25.2 mt -111.68 133.64 53.79 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.011 -0.54 . . . . 10.0 110.379 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.73 ' HB2' ' HD2' ' A' ' 106' ' ' PRO . 14.5 p30 -91.55 172.82 6.03 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 109.32 -0.622 . . . . 10.0 109.32 178.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.73 ' HD2' ' HB2' ' A' ' 105' ' ' ASN . 70.6 Cg_exo -42.77 -37.91 6.22 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 123.505 2.803 . . . . 10.0 114.282 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.418 ' HB3' ' NE2' ' A' ' 108' ' ' GLN . 19.0 tt0 -57.03 -49.56 75.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.645 0.26 . . . . 10.0 111.02 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.51 ' HB2' ' HB3' ' A' ' 104' ' ' LEU . 1.0 OUTLIER -74.4 -33.54 63.04 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 110.032 -0.358 . . . . 10.0 110.032 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.497 ' CH2' HG12 ' B' ' 116' ' ' ILE . 69.1 t-105 -57.91 -53.66 55.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.878 -0.601 . . . . 10.0 110.911 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.7 m -61.95 -42.52 99.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.296 -0.411 . . . . 10.0 110.748 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -64.35 -41.47 96.73 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.306 -0.406 . . . . 10.0 110.731 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.565 ' O ' HG13 ' A' ' 116' ' ' ILE . 61.2 tp -61.91 -43.89 97.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 10.0 110.615 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.58 ' HA ' HD12 ' A' ' 116' ' ' ILE . 43.5 mtmt -61.71 -27.83 68.98 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.925 0.393 . . . . 10.0 110.735 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -77.15 -38.19 52.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.096 0.475 . . . . 10.0 110.312 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.444 ' O ' HG13 ' A' ' 119' ' ' ILE . 20.5 mm-40 -76.42 -18.88 58.6 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.74 -0.664 . . . . 10.0 111.541 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.58 HD12 ' HA ' ' A' ' 113' ' ' LYS . 44.4 mt -51.62 -39.61 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 112.072 0.397 . . . . 10.0 112.072 -179.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 18.1 m -65.31 -17.52 64.58 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.968 0.359 . . . . 10.0 111.968 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.08 -34.29 8.47 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.745 -0.465 . . . . 10.0 109.745 178.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.573 HG23 HG21 ' B' ' 73' ' ' VAL . 83.0 mt -64.68 -48.72 83.53 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-N 115.827 -0.624 . . . . 10.0 109.966 178.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.42 ' O ' ' HG3' ' A' ' 124' ' ' ARG . 16.6 t70 -58.31 -38.47 77.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.448 -0.796 . . . . 10.0 110.326 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -65.87 -41.58 91.44 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.217 -0.902 . . . . 10.0 110.561 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.23 -37.95 89.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.87 -0.605 . . . . 10.0 110.874 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 119' ' ' ILE . 95.6 t -62.41 -40.66 88.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 10.0 110.35 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 120' ' ' ASP . 12.1 mtt85 -68.92 -30.43 68.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.831 -0.622 . . . . 10.0 110.872 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 16.9 mttp -71.21 -25.52 62.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.089 0.471 . . . . 10.0 110.762 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 62.3 mt . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 116.064 -0.516 . . . . 10.0 110.522 179.783 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.264 0 CA-C-O 121.143 0.497 . . . . 10.0 110.566 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 88.0 mmm -119.12 99.29 6.63 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.562 -0.745 . . . . 10.0 110.088 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 63' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -101.54 139.22 37.49 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.922 -0.581 . . . . 10.0 110.33 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -93.52 139.62 30.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.049 0.452 . . . . 10.0 111.708 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 65' ' ' ILE . . . . . 0.435 ' O ' ' HB3' ' B' ' 69' ' ' ARG . 5.8 pt -138.0 94.33 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.507 -0.769 . . . . 10.0 109.529 178.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.64 -135.98 12.45 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.669 -0.777 . . . . 10.0 111.387 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -117.63 120.96 39.63 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.369 -0.234 . . . . 10.0 110.369 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 68' ' ' MET . . . . . . . . . . . . . 96.4 mmm 65.26 2.11 1.8 Allowed 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.817 0.673 . . . . 10.0 112.817 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 69' ' ' ARG . . . . . 0.453 ' HD2' HD11 ' A' ' 102' ' ' ILE . 2.3 tpp180 -98.95 126.36 44.62 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.819 -0.438 . . . . 10.0 109.819 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -130.66 142.67 50.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.514 0.673 . . . . 10.0 112.3 -178.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.418 HG13 HG12 ' B' ' 84' ' ' ILE . 62.1 t -93.41 110.44 23.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.586 -0.894 . . . . 10.0 108.586 178.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 13.3 t -100.4 103.29 14.66 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.14 0.495 . . . . 10.0 111.919 -178.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 73' ' ' VAL . . . . . 0.573 HG21 HG23 ' A' ' 119' ' ' ILE . 19.3 t -96.2 98.33 7.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 108.943 -0.762 . . . . 10.0 108.943 178.26 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 74' ' ' ARG . . . . . 0.458 ' NH1' ' HB3' ' B' ' 83' ' ' ASP . 19.6 ptt-85 -131.51 155.07 48.06 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.221 0.534 . . . . 10.0 111.966 -178.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -95.79 113.43 25.07 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.288 -0.869 . . . . 10.0 109.871 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -92.77 78.6 4.78 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.379 -0.373 . . . . 10.0 110.526 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 90.1 mttt 56.53 57.53 4.79 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.743 -0.662 . . . . 10.0 111.092 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.27 29.56 33.21 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.636 -0.792 . . . . 10.0 112.02 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -142.21 88.97 2.13 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.744 0.307 . . . . 10.0 110.252 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 12.0 t -70.01 102.31 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.408 -0.589 . . . . 10.0 109.408 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 37.0 mt -117.98 132.34 56.4 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.014 0.435 . . . . 10.0 111.366 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 82' ' ' ILE . . . . . 0.525 HD13 ' HB2' ' B' ' 109' ' ' TRP . 4.1 mp -91.65 86.9 2.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 108.138 -1.06 . . . . 10.0 108.138 178.265 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 83' ' ' ASP . . . . . 0.596 ' HA ' ' HA ' ' B' ' 103' ' ' SER . 37.4 t70 -89.78 95.89 10.44 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.315 -0.857 . . . . 10.0 110.937 -178.284 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 84' ' ' ILE . . . . . 0.418 HG12 HG13 ' B' ' 71' ' ' VAL . 21.7 mt -78.67 116.41 22.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 108.217 -1.031 . . . . 10.0 108.217 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 20.3 ttm-85 -142.38 151.42 41.85 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.296 0.57 . . . . 10.0 112.163 -177.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 86' ' ' GLU . . . . . 0.49 ' HG3' ' HA3' ' B' ' 98' ' ' GLY . 5.0 pt-20 -89.8 162.88 15.29 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.669 -0.696 . . . . 10.0 109.373 178.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 87' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -111.79 129.81 56.01 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.056 0.455 . . . . 10.0 111.251 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 88' ' ' TRP . . . . . . . . . . . . . 24.3 m95 -117.03 145.89 43.41 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.394 -0.965 . . . . 10.0 108.394 178.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 30.1 ttm -108.65 137.71 46.15 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.549 -0.461 . . . . 10.0 110.469 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 90' ' ' ASP . . . . . 0.438 ' HB2' ' CD ' ' B' ' 91' ' ' PRO . 55.1 p30 -93.83 171.78 6.62 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.165 -0.471 . . . . 10.0 110.644 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 91' ' ' PRO . . . . . 0.438 ' CD ' ' HB2' ' B' ' 90' ' ' ASP . 24.7 Cg_exo -64.65 -13.3 38.21 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.619 2.213 . . . . 10.0 113.098 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -82.71 -41.64 19.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.893 0.378 . . . . 10.0 110.048 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 119.87 27.84 2.01 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 121.085 -0.579 . . . . 10.0 111.886 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 94' ' ' GLU . . . . . 0.712 ' HB3' ' HE2' ' B' ' 96' ' ' LYS . 0.0 OUTLIER -110.24 151.39 27.4 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.965 0.412 . . . . 10.0 110.341 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 95' ' ' MET . . . . . . . . . . . . . 82.4 mmm -90.01 112.05 23.34 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.854 -0.612 . . . . 10.0 109.99 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 96' ' ' LYS . . . . . 0.712 ' HE2' ' HB3' ' B' ' 94' ' ' GLU . 61.2 mmtt -111.17 140.5 22.92 Favored Pre-proline 0 C--N 1.318 -0.786 0 CA-C-N 116.444 -0.344 . . . . 10.0 110.522 -179.414 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -63.22 131.38 32.05 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 122.607 2.205 . . . . 10.0 111.843 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 98' ' ' GLY . . . . . 0.49 ' HA3' ' HG3' ' B' ' 86' ' ' GLU . . . -68.69 160.88 51.63 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 121.151 -0.547 . . . . 10.0 112.835 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -71.83 -23.5 61.55 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.878 0.371 . . . . 10.0 110.877 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -88.45 142.84 27.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.195 -0.457 . . . . 10.0 110.378 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 101' ' ' GLY . . . . . 0.695 ' HA2' ' HB ' ' A' ' 102' ' ' ILE . . . 138.98 163.47 9.52 Favored Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 111.503 -0.639 . . . . 10.0 111.503 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 20.0 tt -145.39 142.99 22.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.888 0.375 . . . . 10.0 110.97 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 103' ' ' SER . . . . . 0.596 ' HA ' ' HA ' ' B' ' 83' ' ' ASP . 0.8 OUTLIER -97.11 110.87 23.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.911 -0.586 . . . . 10.0 110.194 179.509 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 104' ' ' LEU . . . . . 0.414 HD22 ' HB3' ' B' ' 108' ' ' GLN . 94.8 mt -95.49 133.98 38.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.779 0.323 . . . . 10.0 110.914 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -88.54 168.85 14.91 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.471 -0.566 . . . . 10.0 109.471 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -45.69 -37.78 16.27 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.995 2.463 . . . . 10.0 113.836 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -68.14 -52.98 28.52 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.972 0.415 . . . . 10.0 110.314 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 108' ' ' GLN . . . . . 0.414 ' HB3' HD22 ' B' ' 104' ' ' LEU . 11.4 mt-30 -62.58 -34.69 77.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.738 -0.664 . . . . 10.0 110.854 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 109' ' ' TRP . . . . . 0.525 ' HB2' HD13 ' B' ' 82' ' ' ILE . 34.7 t-105 -59.4 -43.74 92.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.114 -0.493 . . . . 10.0 110.143 178.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 110' ' ' SER . . . . . 0.447 ' HA ' ' HE3' ' B' ' 113' ' ' LYS . 19.3 t -67.97 -46.93 69.98 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.974 -0.557 . . . . 10.0 110.012 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 111' ' ' GLN . . . . . 0.536 ' O ' ' HG2' ' B' ' 115' ' ' GLN . 21.7 mm-40 -58.22 -41.71 84.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.949 -0.569 . . . . 10.0 110.841 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 112' ' ' LEU . . . . . 0.504 ' O ' HG13 ' B' ' 116' ' ' ILE . 43.2 tp -57.79 -46.93 83.92 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.926 0.393 . . . . 10.0 110.09 178.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 113' ' ' LYS . . . . . 0.447 ' HE3' ' HA ' ' B' ' 110' ' ' SER . 48.6 mtmt -65.13 -33.91 77.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.902 -0.59 . . . . 10.0 110.882 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -74.4 -38.43 63.1 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.859 -0.61 . . . . 10.0 112.026 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 115' ' ' GLN . . . . . 0.536 ' HG2' ' O ' ' B' ' 111' ' ' GLN . 10.5 mm-40 -79.06 -5.37 53.84 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.8 0.296 . . . . 10.0 111.8 -179.016 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 116' ' ' ILE . . . . . 0.504 HG13 ' O ' ' B' ' 112' ' ' LEU . 25.7 mt -53.32 -41.26 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.784 -0.189 . . . . 10.0 111.396 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 117' ' ' SER . . . . . 0.431 ' O ' ' HB2' ' B' ' 121' ' ' ASP . 0.2 OUTLIER -57.26 -37.42 72.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.289 -0.414 . . . . 10.0 111.889 -179.372 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.09 -45.29 16.7 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.864 0.364 . . . . 10.0 110.918 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 119' ' ' ILE . . . . . 0.475 ' O ' HG23 ' B' ' 123' ' ' VAL . 71.1 mt -59.82 -52.48 60.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.839 -0.619 . . . . 10.0 110.988 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -61.08 -39.06 88.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.925 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 121' ' ' ASP . . . . . 0.431 ' HB2' ' O ' ' B' ' 117' ' ' SER . 10.6 t70 -58.54 -38.84 78.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.958 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -78.47 -38.55 40.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.268 -0.423 . . . . 10.0 111.054 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 123' ' ' VAL . . . . . 0.475 HG23 ' O ' ' B' ' 119' ' ' ILE . 89.1 t -66.93 -35.45 74.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.34 -0.391 . . . . 10.0 111.466 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 124' ' ' ARG . . . . . 0.462 ' HG3' ' HG3' ' B' ' 125' ' ' LYS . 15.5 ptp180 -81.7 -6.33 58.94 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 111.875 0.324 . . . . 10.0 111.875 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 125' ' ' LYS . . . . . 0.462 ' HG3' ' HG3' ' B' ' 124' ' ' ARG . 91.4 mttt . . . . . 0 C--N 1.326 -0.439 0 CA-C-O 121.103 0.478 . . . . 10.0 111.131 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 110.364 -0.235 . . . . 10.0 110.364 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 41.2 ttm -135.83 110.09 8.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.032 0.444 . . . . 10.0 110.643 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -100.37 169.49 9.07 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.426 -0.583 . . . . 10.0 109.426 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -132.35 132.55 43.02 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.899 -0.321 . . . . 10.0 110.92 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 22.7 pt -117.79 -2.09 9.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.977 0.418 . . . . 10.0 110.999 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 176.99 173.91 42.96 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.838 -0.696 . . . . 10.0 111.724 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.512 ' HG2' ' HG2' ' A' ' 68' ' ' MET . 64.4 tttp -63.91 126.99 29.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.837 0.319 . . . . 10.0 110.225 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.512 ' HG2' ' HG2' ' A' ' 67' ' ' LYS . 87.1 mmm 64.16 17.65 10.8 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.794 -0.639 . . . . 10.0 111.326 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.409 ' HD2' ' O ' ' A' ' 67' ' ' LYS . 0.4 OUTLIER -128.93 109.17 11.01 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 109.948 -0.39 . . . . 10.0 109.948 179.493 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.549 ' HD1' ' HB2' ' A' ' 87' ' ' TYR . 41.4 m-85 -121.76 160.23 25.01 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.789 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 40.9 t -111.69 114.64 47.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.968 -0.56 . . . . 10.0 110.126 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.94 119.4 27.11 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.765 -0.652 . . . . 10.0 110.523 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 81' ' ' LEU . 74.7 t -132.6 106.77 11.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.682 -0.488 . . . . 10.0 109.682 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.3 ptt180 -155.53 169.83 23.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.661 0.267 . . . . 10.0 111.014 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.72 132.46 45.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.045 -0.525 . . . . 10.0 109.94 178.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -145.17 117.41 8.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.632 -0.258 . . . . 10.0 110.731 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.466 ' HE3' ' HB2' ' C' ' 476' ' ' GLU . 74.7 mttt 61.8 -86.75 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.804 -0.635 . . . . 10.0 111.176 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -148.39 31.03 1.28 Allowed Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 111.439 -0.664 . . . . 10.0 111.439 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.425 ' HB2' ' HE3' ' A' ' 79' ' ' LYS . 20.9 ttmt -158.17 169.48 24.43 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.563 -0.532 . . . . 10.0 109.563 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 58.8 t -86.36 119.42 34.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.014 0.435 . . . . 10.0 110.034 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.503 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 1.1 tp -84.06 101.82 12.06 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.836 -0.62 . . . . 10.0 110.675 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.499 HG23 HG22 ' A' ' 73' ' ' VAL . 15.1 mt -108.46 98.23 6.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.586 -0.894 . . . . 10.0 108.586 178.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.475 ' HA ' ' HA ' ' A' ' 103' ' ' SER . 16.0 t70 -118.9 121.83 40.88 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.552 0.575 . . . . 10.0 112.552 -177.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 56.7 mt -100.71 103.58 15.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.115 -1.068 . . . . 10.0 108.115 177.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.679 ' HD2' ' HB2' ' A' ' 97' ' ' PRO . 8.8 ttm-85 -145.98 160.46 41.82 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.931 0.396 . . . . 10.0 111.318 -177.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.714 ' O ' ' HA ' ' A' ' 97' ' ' PRO . 13.2 pt-20 -63.75 141.44 58.77 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.648 -0.871 . . . . 10.0 108.648 177.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.549 ' HB2' ' HD1' ' A' ' 70' ' ' TYR . 1.7 m-85 -113.6 120.54 41.28 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.105 0.479 . . . . 10.0 111.757 -178.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -102.51 155.17 18.45 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.296 -0.865 . . . . 10.0 108.899 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 25.2 ttt -82.42 139.16 34.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.385 0.612 . . . . 10.0 111.733 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -83.33 144.61 46.87 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 114.922 -1.036 . . . . 10.0 109.154 178.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -47.57 -33.47 18.08 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.862 2.375 . . . . 10.0 112.91 178.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.429 ' HG2' ' HD2' ' C' ' 465' ' ' TYR . 1.8 mp0 -75.76 -59.38 2.78 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.338 -0.392 . . . . 10.0 110.72 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 169.44 -11.51 0.05 OUTLIER Glycine 0 CA--C 1.521 0.462 0 C-N-CA 120.107 -1.044 . . . . 10.0 114.029 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -79.33 -175.08 4.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 117.22 0.51 . . . . 10.0 111.31 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 57.2 mmm -134.62 141.92 46.75 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.277 -0.638 . . . . 10.0 109.277 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.87 ' HD2' ' HD2' ' A' ' 97' ' ' PRO . 10.2 mmtp -146.79 156.29 48.1 Favored Pre-proline 0 N--CA 1.464 0.238 0 CA-C-O 120.639 0.256 . . . . 10.0 111.281 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.87 ' HD2' ' HD2' ' A' ' 96' ' ' LYS . 34.0 Cg_endo -63.4 153.7 72.91 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.289 2.659 . . . . 10.0 114.258 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -102.4 -110.41 3.4 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.057 -0.974 . . . . 10.0 112.28 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.412 ' HD3' ' HA ' ' A' ' 99' ' ' ARG . 18.8 mmt180 -122.59 -46.49 2.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.015 0.408 . . . . 10.0 111.874 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 16.1 mttp -71.15 104.79 3.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.702 0.287 . . . . 10.0 110.517 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.6 ' HA3' ' HG3' ' A' ' 85' ' ' ARG . . . 174.42 165.91 31.63 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.862 -0.685 . . . . 10.0 112.378 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.606 ' HA ' ' HE2' ' C' ' 478' ' ' MET . 20.2 tt -146.63 142.03 20.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.99 0.424 . . . . 10.0 110.551 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 83' ' ' ASP . 1.3 m -85.83 136.62 33.24 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.021 -0.536 . . . . 10.0 110.201 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 71.4 mt -93.12 105.23 17.35 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.272 -0.422 . . . . 10.0 110.886 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -62.38 141.43 96.41 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.363 -0.606 . . . . 10.0 109.363 178.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -47.12 -38.08 24.25 Favored 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 122.617 2.211 . . . . 10.0 112.474 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.587 ' HB2' ' HB3' ' C' ' 486' ' ' ASP . 11.0 mm-40 -77.61 -37.28 50.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.125 -0.488 . . . . 10.0 110.295 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -68.05 -31.43 71.08 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.711 -0.677 . . . . 10.0 110.612 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 54.2 t-105 -55.36 -45.63 76.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.88 -0.6 . . . . 10.0 110.797 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.8 t -69.12 -51.81 34.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.383 -0.372 . . . . 10.0 110.395 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -55.51 -42.87 75.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.004 -0.544 . . . . 10.0 111.534 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.506 ' O ' HG13 ' A' ' 116' ' ' ILE . 62.6 tp -61.35 -47.85 84.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.644 0.259 . . . . 10.0 110.816 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.404 ' HA ' HD12 ' A' ' 116' ' ' ILE . 48.0 mtmt -60.54 -37.72 82.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.005 0.431 . . . . 10.0 111.338 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -73.83 -31.62 63.3 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.061 -0.518 . . . . 10.0 111.39 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -81.07 -15.33 56.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.487 -0.324 . . . . 10.0 111.15 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 112' ' ' LEU . 21.4 mt -49.77 -43.5 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 112.215 0.45 . . . . 10.0 112.215 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.4 m -56.97 -37.43 71.58 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.763 0.316 . . . . 10.0 111.643 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -83.6 -39.77 19.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.012 0.434 . . . . 10.0 110.616 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.475 ' O ' HG23 ' A' ' 123' ' ' VAL . 92.2 mt -60.19 -50.44 80.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.777 -0.647 . . . . 10.0 110.242 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -59.59 -37.14 77.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.392 -0.822 . . . . 10.0 110.559 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.416 ' HA ' ' CZ ' ' A' ' 124' ' ' ARG . 7.2 t70 -66.21 -35.72 81.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.312 -0.858 . . . . 10.0 110.814 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -70.83 -33.5 70.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.885 -0.598 . . . . 10.0 110.559 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 119' ' ' ILE . 60.5 t -62.24 -40.55 88.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.347 0.594 . . . . 10.0 110.118 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.416 ' CZ ' ' HA ' ' A' ' 121' ' ' ASP . 12.8 mtm105 -74.35 -13.16 60.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.529 -0.759 . . . . 10.0 111.275 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 38.7 mttp -90.46 -2.62 57.94 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.911 0.386 . . . . 10.0 110.827 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 84.0 mt . . . . . 0 C--N 1.325 -0.458 0 CA-C-N 116.249 -0.432 . . . . 10.0 110.861 -179.948 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 121.067 0.46 . . . . 10.0 110.35 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 88.0 mmm -99.7 102.8 14.38 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.565 -0.743 . . . . 10.0 109.779 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 63' ' ' PHE . . . . . 0.413 ' CD2' HG12 ' A' ' 119' ' ' ILE . 48.4 m-85 -108.03 115.68 30.56 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.387 -0.369 . . . . 10.0 111.223 -179.075 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 64' ' ' GLN . . . . . 0.46 ' HA ' ' HD1' ' B' ' 70' ' ' TYR . 55.1 tt0 -71.34 125.0 25.82 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.171 -0.468 . . . . 10.0 110.378 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 19.1 pt -116.6 2.85 7.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.005 -0.543 . . . . 10.0 110.286 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 170.66 -162.45 35.49 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.993 -0.622 . . . . 10.0 111.969 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 67' ' ' LYS . . . . . 0.776 ' HD2' ' HA ' ' C' ' 486' ' ' ASP . 0.1 OUTLIER -86.33 117.83 25.38 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 110.199 -0.297 . . . . 10.0 110.199 179.692 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 68' ' ' MET . . . . . . . . . . . . . 19.9 mmt 68.33 8.91 6.92 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.545 -0.752 . . . . 10.0 111.566 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 69' ' ' ARG . . . . . 0.571 HH11 HG21 ' C' ' 485' ' ' ILE . 0.7 OUTLIER -120.8 119.26 32.21 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.499 -0.556 . . . . 10.0 109.499 179.199 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 70' ' ' TYR . . . . . 0.46 ' HD1' ' HA ' ' B' ' 64' ' ' GLN . 38.8 m-85 -135.18 138.32 43.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.884 0.373 . . . . 10.0 111.2 -178.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.572 HG22 HG12 ' B' ' 84' ' ' ILE . 75.5 t -89.94 117.78 33.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 108.631 -0.877 . . . . 10.0 108.631 178.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 72' ' ' SER . . . . . 0.51 ' HB3' ' NH1' ' B' ' 74' ' ' ARG . 24.5 t -111.48 109.87 20.03 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.036 0.446 . . . . 10.0 111.289 -178.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.431 ' CG2' HG23 ' A' ' 119' ' ' ILE . 20.4 t -92.73 94.86 4.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.193 -0.669 . . . . 10.0 109.193 178.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 74' ' ' ARG . . . . . 0.51 ' NH1' ' HB3' ' B' ' 72' ' ' SER . 26.5 ptt-85 -122.05 149.18 43.9 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.118 0.485 . . . . 10.0 111.546 -178.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -87.54 115.99 25.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.51 -0.768 . . . . 10.0 109.262 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -110.14 105.81 15.04 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.445 -0.343 . . . . 10.0 111.222 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 33.2 mttm 57.61 30.78 19.34 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.703 -0.68 . . . . 10.0 112.785 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 92.67 30.84 9.24 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.509 -0.853 . . . . 10.0 112.23 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 79' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' B' ' 79' ' ' LYS . 18.4 mmtm -144.22 108.13 4.71 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 122.367 0.267 . . . . 10.0 110.45 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 16.1 t -69.49 106.18 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.387 -0.597 . . . . 10.0 109.387 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 94.5 mt -111.02 128.88 56.0 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.027 0.441 . . . . 10.0 111.665 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 82' ' ' ILE . . . . . . . . . . . . . 5.2 mp -90.75 86.45 2.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 107.499 -1.297 . . . . 10.0 107.499 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 83' ' ' ASP . . . . . 0.501 ' HA ' ' HA ' ' B' ' 103' ' ' SER . 34.8 t70 -85.78 107.61 17.71 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.744 -0.662 . . . . 10.0 112.02 -177.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 84' ' ' ILE . . . . . 0.572 HG12 HG22 ' B' ' 71' ' ' VAL . 63.4 mt -92.63 95.84 5.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 107.5 -1.296 . . . . 10.0 107.5 177.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 85' ' ' ARG . . . . . 0.454 ' HG3' ' HA3' ' B' ' 101' ' ' GLY . 19.7 ttm-85 -132.84 168.84 17.66 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.504 0.669 . . . . 10.0 111.973 -177.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 86' ' ' GLU . . . . . 0.544 ' HB3' ' HE ' ' B' ' 69' ' ' ARG . 11.7 pt-20 -89.25 154.95 19.71 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.214 -0.903 . . . . 10.0 109.348 178.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 87' ' ' TYR . . . . . 0.624 ' HB3' ' HB3' ' B' ' 95' ' ' MET . 38.0 m-85 -131.47 118.8 20.69 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.909 -0.404 . . . . 10.0 109.909 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 88' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -108.28 136.61 47.64 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.976 -0.556 . . . . 10.0 109.798 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 52.4 ttm -75.55 130.99 39.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.072 0.463 . . . . 10.0 111.41 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 90' ' ' ASP . . . . . 0.491 ' OD2' ' HE2' ' B' ' 96' ' ' LYS . 35.0 p30 -84.79 172.23 9.37 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.579 -0.737 . . . . 10.0 109.774 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 91' ' ' PRO . . . . . 0.447 ' HD2' ' HB2' ' B' ' 90' ' ' ASP . 32.0 Cg_exo -61.89 -13.08 28.83 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.695 2.263 . . . . 10.0 112.863 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -84.72 -43.81 13.95 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.968 0.413 . . . . 10.0 110.254 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 129.57 16.26 1.88 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.945 -0.645 . . . . 10.0 112.317 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -109.74 147.02 33.94 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.725 0.298 . . . . 10.0 110.279 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 95' ' ' MET . . . . . 0.624 ' HB3' ' HB3' ' B' ' 87' ' ' TYR . 84.3 mmm -88.7 115.84 26.52 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 110.047 -0.353 . . . . 10.0 110.047 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 96' ' ' LYS . . . . . 0.491 ' HE2' ' OD2' ' B' ' 90' ' ' ASP . 72.0 mmtt -104.12 140.78 21.4 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 116.347 -0.388 . . . . 10.0 110.053 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.13 129.04 20.78 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.438 2.092 . . . . 10.0 112.159 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 98' ' ' GLY . . . . . 0.405 ' O ' ' HD3' ' B' ' 85' ' ' ARG . . . -76.17 -173.63 36.17 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.107 -0.568 . . . . 10.0 112.199 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -88.3 -23.28 23.5 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.894 0.378 . . . . 10.0 111.202 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 100' ' ' LYS . . . . . 0.484 ' HZ2' ' CD ' ' B' ' 86' ' ' GLU . 7.0 mtmp? -88.08 113.81 24.09 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.282 0.563 . . . . 10.0 110.851 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 101' ' ' GLY . . . . . 0.517 ' HA2' ' HB ' ' A' ' 102' ' ' ILE . . . 169.13 175.67 38.6 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 110.894 -0.882 . . . . 10.0 110.894 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 102' ' ' ILE . . . . . 0.592 ' HB ' ' HA2' ' A' ' 101' ' ' GLY . 21.1 tt -143.56 138.44 25.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 117.299 0.549 . . . . 10.0 111.425 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 103' ' ' SER . . . . . 0.501 ' HA ' ' HA ' ' B' ' 83' ' ' ASP . 1.5 m -98.33 107.71 20.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.781 -0.645 . . . . 10.0 109.986 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 46.3 mt -99.39 135.56 40.62 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.466 -0.334 . . . . 10.0 110.741 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 105' ' ' ASN . . . . . 0.542 ' HB2' ' HD2' ' B' ' 106' ' ' PRO . 8.7 p-10 -88.18 164.23 34.01 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 108.836 -0.802 . . . . 10.0 108.836 178.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 106' ' ' PRO . . . . . 0.542 ' HD2' ' HB2' ' B' ' 105' ' ' ASN . 7.6 Cg_endo -49.43 -32.26 26.04 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.179 2.586 . . . . 10.0 113.305 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -64.22 -57.95 8.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.266 -0.424 . . . . 10.0 110.69 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -66.88 -30.85 71.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.094 0.473 . . . . 10.0 109.949 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 109' ' ' TRP . . . . . 0.502 ' CH2' HG12 ' A' ' 116' ' ' ILE . 48.7 t-105 -59.54 -42.33 92.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.543 -0.753 . . . . 10.0 110.04 179.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 110' ' ' SER . . . . . 0.429 ' O ' ' HG3' ' B' ' 114' ' ' GLU . 29.9 t -63.9 -47.61 79.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 10.0 109.784 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -61.05 -38.95 87.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.816 -0.629 . . . . 10.0 111.073 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 112' ' ' LEU . . . . . 0.408 ' O ' HG13 ' B' ' 116' ' ' ILE . 49.6 tp -58.6 -45.93 88.09 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.801 0.334 . . . . 10.0 110.373 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 113' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' B' ' 109' ' ' TRP . 45.4 mtmt -66.25 -36.06 82.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.172 0.51 . . . . 10.0 110.984 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 114' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' B' ' 110' ' ' SER . 47.7 mt-10 -74.06 -32.54 63.33 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.104 -0.498 . . . . 10.0 111.274 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -75.76 -11.86 60.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.194 -0.457 . . . . 10.0 111.213 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 116' ' ' ILE . . . . . 0.408 HG13 ' O ' ' B' ' 112' ' ' LEU . 58.0 mt -55.18 -39.65 52.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.501 -0.318 . . . . 10.0 111.26 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 4.9 m -59.36 -24.08 63.09 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.876 0.369 . . . . 10.0 111.523 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.02 -44.38 7.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.915 0.388 . . . . 10.0 110.752 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 119' ' ' ILE . . . . . 0.504 ' O ' HG23 ' B' ' 123' ' ' VAL . 61.5 mt -63.78 -46.82 93.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.997 -0.547 . . . . 10.0 111.397 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -57.63 -33.08 67.89 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.36 -0.382 . . . . 10.0 111.14 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 121' ' ' ASP . . . . . 0.545 ' HA ' ' NE ' ' B' ' 124' ' ' ARG . 26.8 t70 -63.27 -42.55 99.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.291 -0.413 . . . . 10.0 110.912 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.2 -30.73 66.74 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.839 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 123' ' ' VAL . . . . . 0.504 HG23 ' O ' ' B' ' 119' ' ' ILE . 45.1 t -75.81 -38.09 36.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 10.0 110.968 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 124' ' ' ARG . . . . . 0.545 ' NE ' ' HA ' ' B' ' 121' ' ' ASP . 31.0 ptt180 -78.72 -6.29 55.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 10.0 111.235 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 65.7 mttt -104.76 86.02 2.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.971 0.415 . . . . 10.0 110.273 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 66.4 mt . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.45 -0.786 . . . . 10.0 110.229 -179.956 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 465' ' ' TYR . . . . . 0.69 ' HA ' ' HB3' ' C' ' 468' ' ' LEU . 82.2 m-85 . . . . . 0 N--CA 1.477 0.922 0 N-CA-C 110.437 -0.209 . . . . 10.0 110.437 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 466' ' ' GLY . . . . . . . . . . . . . . . -57.01 -44.98 92.8 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.251 -0.5 . . . . 10.0 112.685 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 467' ' ' ALA . . . . . . . . . . . . . . . -97.72 -26.14 14.84 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.644 -0.502 . . . . 10.0 109.644 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 468' ' ' LEU . . . . . 0.69 ' HB3' ' HA ' ' C' ' 465' ' ' TYR . 11.2 tp -57.22 -51.9 67.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.347 -0.842 . . . . 10.0 111.158 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 469' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -73.21 -34.87 66.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.123 0.487 . . . . 10.0 110.674 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 470' ' ' MET . . . . . . . . . . . . . 22.5 ttt -61.26 -50.68 72.07 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.628 -0.714 . . . . 10.0 110.464 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 471' ' ' ALA . . . . . 0.529 ' HB3' ' HB3' ' A' ' 96' ' ' LYS . . . -85.38 40.5 0.84 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.279 0.561 . . . . 10.0 110.605 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 472' ' ' ASP . . . . . 0.557 ' O ' ' HB2' ' C' ' 475' ' ' PHE . 0.9 OUTLIER -133.28 -41.72 0.88 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.925 -0.769 . . . . 10.0 108.925 179.048 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 473' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -64.67 -30.71 71.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.378 -0.828 . . . . 10.0 110.017 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 474' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -84.45 0.5 49.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.781 -0.645 . . . . 10.0 111.701 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 475' ' ' PHE . . . . . 0.557 ' HB2' ' O ' ' C' ' 472' ' ' ASP . 0.1 OUTLIER -68.2 -36.8 80.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.916 0.388 . . . . 10.0 110.849 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 476' ' ' GLU . . . . . 0.726 ' HA ' ' HB3' ' C' ' 479' ' ' PHE . 0.2 OUTLIER -72.39 -16.08 61.85 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.295 -0.412 . . . . 10.0 110.856 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 477' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -64.42 -39.05 93.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.89 -0.595 . . . . 10.0 110.012 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 478' ' ' MET . . . . . 0.606 ' HE2' ' HA ' ' A' ' 102' ' ' ILE . 1.5 ttt -98.46 -16.06 19.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.084 0.468 . . . . 10.0 109.938 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 479' ' ' PHE . . . . . 0.726 ' HB3' ' HA ' ' C' ' 476' ' ' GLU . 75.7 t80 -67.71 -42.17 82.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.18 0.514 . . . . 10.0 109.741 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 480' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.16 19.5 5.78 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.895 -0.593 . . . . 10.0 110.539 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 481' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -129.64 -58.11 1.11 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.953 -0.567 . . . . 10.0 111.09 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 482' ' ' ALA . . . . . . . . . . . . . . . -93.35 -41.04 10.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.964 0.412 . . . . 10.0 110.763 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 483' ' ' LEU . . . . . 0.515 ' HB2' ' HA ' ' C' ' 479' ' ' PHE . 14.2 mt -82.99 9.38 10.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.99 -0.55 . . . . 10.0 110.921 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 484' ' ' GLY . . . . . . . . . . . . . . . -153.07 86.71 0.14 Allowed Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 110.941 -0.864 . . . . 10.0 110.941 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 485' ' ' ILE . . . . . 0.571 HG21 HH11 ' B' ' 69' ' ' ARG . 15.7 tt -174.9 -26.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.965 0.412 . . . . 10.0 111.138 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 486' ' ' ASP . . . . . 0.776 ' HA ' ' HD2' ' B' ' 67' ' ' LYS . 0.1 OUTLIER -81.22 -24.79 37.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.81 0.338 . . . . 10.0 111.102 -179.088 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 487' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.76 -0.33 53.36 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.641 -0.709 . . . . 10.0 109.894 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 488' ' ' TYR . . . . . 0.451 ' HB3' ' O ' ' C' ' 485' ' ' ILE . 16.8 t80 -73.52 -27.06 61.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.437 -0.801 . . . . 10.0 110.45 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 489' ' ' GLY . . . . . . . . . . . . . . . -179.98 128.28 1.2 Allowed Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 111.084 -0.807 . . . . 10.0 111.084 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.789 0 CA-C-O 118.321 -1.266 . . . . 10.0 111.377 -179.833 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.846 0 CA-C-O 120.899 0.38 . . . . 10.0 110.78 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 62.1 mtt -112.11 97.53 6.72 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.708 -0.478 . . . . 10.0 109.708 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.512 ' CD2' HG12 ' B' ' 119' ' ' ILE . 40.4 m-85 -91.02 135.71 33.57 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.36 -0.382 . . . . 10.0 110.599 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.458 ' HG2' ' H ' ' A' ' 66' ' ' GLY . 22.3 tt0 -89.14 128.67 35.79 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.761 0.315 . . . . 10.0 110.41 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.9 pt -117.1 9.02 7.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.175 0.512 . . . . 10.0 110.497 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.458 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 159.88 173.27 28.16 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.719 -0.753 . . . . 10.0 111.945 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.596 ' HG2' ' HG2' ' A' ' 68' ' ' MET . 61.9 tttp -61.92 117.59 6.12 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.648 0.261 . . . . 10.0 110.71 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.596 ' HG2' ' HG2' ' A' ' 67' ' ' LYS . 67.2 mmm 70.41 15.55 7.28 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.389 -0.823 . . . . 10.0 111.557 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.479 ' HE ' ' HG2' ' A' ' 86' ' ' GLU . 5.0 mpt_? -121.72 120.87 35.93 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 122.242 -0.286 . . . . 10.0 110.269 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -132.95 143.84 49.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.398 0.618 . . . . 10.0 111.916 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.469 HG22 HG23 ' A' ' 84' ' ' ILE . 18.2 t -108.83 111.14 34.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 108.312 -0.995 . . . . 10.0 108.312 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.46 ' HB2' ' HE2' ' C' ' 479' ' ' PHE . 2.9 m -101.92 116.39 32.6 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.249 0.547 . . . . 10.0 112.151 -178.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.797 HG22 HG23 ' A' ' 82' ' ' ILE . 21.9 t -103.94 110.73 31.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.409 -0.814 . . . . 10.0 109.581 179.05 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -157.8 179.71 8.95 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.101 0.477 . . . . 10.0 111.134 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.661 ' HB2' HG22 ' A' ' 80' ' ' VAL . 1.6 t70 -112.21 133.21 54.47 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.297 -0.865 . . . . 10.0 109.613 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.45 ' CE2' ' HB3' ' C' ' 476' ' ' GLU . 3.1 t80 -136.49 118.33 15.16 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.567 -0.288 . . . . 10.0 110.269 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 97.4 mttt 57.67 43.92 21.46 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 123.499 0.5 . . . . 10.0 111.596 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.25 40.99 94.97 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.707 -0.759 . . . . 10.0 111.51 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.406 ' HE3' ' HA ' ' C' ' 488' ' ' TYR . 2.9 tmtt? -151.08 102.55 2.96 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.913 0.387 . . . . 10.0 110.121 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.661 HG22 ' HB2' ' A' ' 75' ' ' ASP . 60.5 t -77.93 121.85 31.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.403 -0.591 . . . . 10.0 109.403 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.764 ' HB3' ' HB3' ' A' ' 103' ' ' SER . 24.1 mt -139.12 144.75 38.81 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.621 0.724 . . . . 10.0 112.176 -178.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.797 HG23 HG22 ' A' ' 73' ' ' VAL . 53.0 mt -104.12 98.98 7.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 114.591 -1.186 . . . . 10.0 108.004 178.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.603 ' HA ' ' HA ' ' A' ' 103' ' ' SER . 17.3 t70 -94.19 121.35 35.6 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.554 0.576 . . . . 10.0 112.554 -177.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.469 HG23 HG22 ' A' ' 71' ' ' VAL . 22.8 mt -98.74 108.19 21.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 107.181 -1.415 . . . . 10.0 107.181 177.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.515 ' HB2' ' OD2' ' A' ' 83' ' ' ASP . 11.2 ttm180 -144.63 163.23 34.55 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.573 0.701 . . . . 10.0 112.864 -176.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.479 ' HG2' ' HE ' ' A' ' 69' ' ' ARG . 16.3 mt-10 -89.9 142.09 28.03 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.864 -1.062 . . . . 10.0 109.124 177.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -114.43 135.92 53.57 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.528 -0.306 . . . . 10.0 110.341 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 45.7 t90 -108.67 134.77 50.95 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.72 -0.474 . . . . 10.0 109.72 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 25.2 ttt -84.4 117.67 23.77 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.87 -0.419 . . . . 10.0 109.87 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.24 164.21 55.19 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.932 -0.576 . . . . 10.0 110.868 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -53.39 -33.13 65.23 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.088 2.525 . . . . 10.0 113.318 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -69.74 -57.38 5.19 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.009 -0.367 . . . . 10.0 110.009 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 146.12 21.1 0.12 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.461 -0.876 . . . . 10.0 112.775 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.547 ' HB2' ' HE2' ' A' ' 96' ' ' LYS . 29.8 mt-10 -106.95 149.15 27.8 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.803 0.335 . . . . 10.0 110.306 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 98.4 mmm -88.77 117.67 27.91 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.293 -0.412 . . . . 10.0 110.013 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.547 ' HE2' ' HB2' ' A' ' 94' ' ' GLU . 69.4 mmtt -108.34 133.86 20.42 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.211 -0.449 . . . . 10.0 110.672 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.67 136.31 30.29 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.493 2.129 . . . . 10.0 112.157 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.485 ' O ' ' HD3' ' A' ' 85' ' ' ARG . . . -85.15 -158.43 29.61 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.595 -0.812 . . . . 10.0 112.799 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 99' ' ' ARG . 16.0 mtm180 -103.46 -22.38 13.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.869 0.366 . . . . 10.0 110.973 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 19.6 ttmt -82.65 82.96 7.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.239 -0.437 . . . . 10.0 110.478 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -152.9 165.77 31.22 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.604 -0.599 . . . . 10.0 111.604 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.559 ' HB ' ' HA2' ' B' ' 101' ' ' GLY . 12.0 tt -147.73 124.28 2.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.111 0.481 . . . . 10.0 111.226 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.764 ' HB3' ' HB3' ' A' ' 81' ' ' LEU . 5.3 m -94.62 125.69 39.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.801 -0.636 . . . . 10.0 110.387 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.478 ' HB3' ' HB2' ' A' ' 108' ' ' GLN . 76.6 mt -121.54 135.3 55.02 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.945 -0.391 . . . . 10.0 109.945 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.404 ' HB3' ' OE1' ' C' ' 487' ' ' GLU . 1.6 p30 -81.98 163.22 54.31 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 109.818 -0.438 . . . . 10.0 109.818 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -42.06 -38.98 5.49 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.614 2.876 . . . . 10.0 114.286 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.425 ' HG2' ' NE2' ' A' ' 111' ' ' GLN . 0.2 OUTLIER -61.84 -49.25 77.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.533 -0.303 . . . . 10.0 110.865 179.762 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.5 HE22 ' HD3' ' B' ' 69' ' ' ARG . 6.2 mt-30 -67.96 -37.84 82.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.317 0.579 . . . . 10.0 109.687 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.583 ' HZ2' ' HB2' ' B' ' 120' ' ' ASP . 23.5 t-105 -58.08 -43.29 86.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.272 -0.876 . . . . 10.0 110.709 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.7 t -65.32 -43.98 89.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.045 -0.525 . . . . 10.0 110.617 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.425 ' NE2' ' HG2' ' A' ' 107' ' ' GLU . 40.2 mt-30 -65.32 -36.12 83.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.431 -0.349 . . . . 10.0 110.841 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.427 HD13 HD13 ' B' ' 65' ' ' ILE . 48.6 tp -59.63 -41.14 89.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.429 . . . . 10.0 110.405 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -65.42 -31.08 71.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.997 -0.547 . . . . 10.0 111.394 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -77.43 -28.57 52.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.0 0.429 . . . . 10.0 111.367 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -85.06 -8.47 58.67 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.246 -0.434 . . . . 10.0 111.582 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 112' ' ' LEU . 61.7 mt -53.99 -43.21 57.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 112.016 0.376 . . . . 10.0 112.016 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.14 -30.03 64.08 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.2 0.444 . . . . 10.0 112.2 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -89.79 -41.75 11.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.783 0.325 . . . . 10.0 110.539 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.478 ' O ' HG23 ' A' ' 123' ' ' VAL . 72.1 mt -62.93 -48.4 88.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.938 -0.574 . . . . 10.0 111.054 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -63.59 -34.04 76.93 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.008 -0.542 . . . . 10.0 110.563 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -69.17 -41.09 77.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.637 -0.71 . . . . 10.0 109.855 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.65 -37.94 83.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.727 -0.67 . . . . 10.0 110.224 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 119' ' ' ILE . 92.6 t -60.33 -42.01 89.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 121.228 0.537 . . . . 10.0 109.96 179.031 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.8 mtm105 -71.44 -37.12 71.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.606 -0.725 . . . . 10.0 110.786 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 30.3 mttp -65.67 -42.77 90.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.422 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 72.5 mt . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.041 -0.527 . . . . 10.0 110.74 179.488 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.191 0 CA-C-O 121.27 0.557 . . . . 10.0 110.599 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 82.6 mmm -92.49 96.55 10.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.83 -0.623 . . . . 10.0 109.759 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 63' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -79.62 113.59 17.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.207 -0.451 . . . . 10.0 110.805 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -98.22 128.11 44.51 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.851 -0.426 . . . . 10.0 109.851 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 65' ' ' ILE . . . . . 0.427 HD13 HD13 ' A' ' 112' ' ' LEU . 20.5 pt -116.8 16.0 7.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.671 0.272 . . . . 10.0 111.706 -178.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 158.11 -161.54 31.64 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.155 -1.021 . . . . 10.0 112.726 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 67' ' ' LYS . . . . . 0.563 ' HD2' ' HA2' ' C' ' 490' ' ' GLY . 5.2 mtmp? -67.56 103.86 1.45 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.448 -0.376 . . . . 10.0 111.841 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 68' ' ' MET . . . . . . . . . . . . . 67.4 mmm 64.86 6.47 3.37 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.246 0.832 . . . . 10.0 113.246 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 69' ' ' ARG . . . . . 0.5 ' HD3' HE22 ' A' ' 108' ' ' GLN . 3.0 mpt_? -100.39 121.49 41.6 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 121.783 -0.573 . . . . 10.0 110.696 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 70' ' ' TYR . . . . . 0.452 ' HB2' ' CD1' ' B' ' 87' ' ' TYR . 79.9 m-85 -122.67 149.25 44.29 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.706 -0.679 . . . . 10.0 110.45 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 96.0 t -98.61 103.08 14.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.257 -0.645 . . . . 10.0 109.257 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 10.2 t -88.39 88.11 7.51 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.819 -0.628 . . . . 10.0 111.18 -178.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 3.2 t -84.66 92.35 3.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.694 -0.854 . . . . 10.0 108.694 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 23.4 ptt-85 -126.28 147.93 49.61 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.272 0.558 . . . . 10.0 111.474 -178.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' B' ' 80' ' ' VAL . 12.8 t70 -79.89 115.62 19.58 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.286 -0.87 . . . . 10.0 110.436 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -86.72 61.68 6.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.176 -0.466 . . . . 10.0 110.889 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 30.0 mttm 62.53 58.6 1.64 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.85 -0.614 . . . . 10.0 111.051 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.56 21.29 37.79 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.839 -0.696 . . . . 10.0 111.682 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 62.2 mmtt -145.04 89.49 1.96 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.569 0.223 . . . . 10.0 110.531 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 80' ' ' VAL . . . . . 0.431 HG11 ' HA ' ' A' ' 123' ' ' VAL . 20.2 t -66.44 105.67 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.636 -0.505 . . . . 10.0 109.636 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 79.7 mt -115.42 142.04 47.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.344 0.592 . . . . 10.0 111.456 -178.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 82' ' ' ILE . . . . . 0.488 HD13 ' HB2' ' B' ' 109' ' ' TRP . 5.3 mp -92.07 88.87 2.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.516 -0.92 . . . . 10.0 108.516 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 83' ' ' ASP . . . . . 0.519 ' HA ' ' HA ' ' B' ' 103' ' ' SER . 34.9 t70 -87.97 94.64 9.85 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.876 -0.602 . . . . 10.0 110.833 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 26.8 mt -81.65 95.25 2.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.255 -1.016 . . . . 10.0 108.255 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 85' ' ' ARG . . . . . 0.411 ' HD3' ' O ' ' B' ' 98' ' ' GLY . 17.4 ttm-85 -123.6 145.71 48.71 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.862 -0.608 . . . . 10.0 111.724 -177.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 86' ' ' GLU . . . . . 0.485 ' H ' ' HG2' ' B' ' 86' ' ' GLU . 5.0 pt-20 -76.06 128.39 34.9 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.531 -0.759 . . . . 10.0 109.109 178.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 87' ' ' TYR . . . . . 0.452 ' CD1' ' HB2' ' B' ' 70' ' ' TYR . 23.0 m-85 -98.96 101.38 12.75 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.072 0.463 . . . . 10.0 110.464 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 88' ' ' TRP . . . . . 0.417 ' O ' ' HA ' ' B' ' 95' ' ' MET . 86.1 m95 -84.75 -176.55 6.27 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.561 -0.745 . . . . 10.0 109.789 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 41.6 ttm -133.43 135.11 44.39 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 110.014 -0.365 . . . . 10.0 110.014 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 90' ' ' ASP . . . . . 0.446 ' HB2' ' HD2' ' B' ' 91' ' ' PRO . 29.0 p30 -92.19 171.77 7.24 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 109.899 -0.408 . . . . 10.0 109.899 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 91' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' B' ' 90' ' ' ASP . 35.9 Cg_exo -61.9 -18.9 63.66 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.448 2.098 . . . . 10.0 112.704 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -77.03 -40.6 45.85 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.225 0.535 . . . . 10.0 110.275 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 120.67 21.04 3.36 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.95 -0.643 . . . . 10.0 112.245 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -100.88 147.32 26.25 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.774 0.321 . . . . 10.0 110.7 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 95' ' ' MET . . . . . 0.417 ' HA ' ' O ' ' B' ' 88' ' ' TRP . 82.9 mmm -88.54 96.18 10.52 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.321 -0.622 . . . . 10.0 109.321 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -94.52 128.87 38.42 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.887 -0.597 . . . . 10.0 111.631 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -66.16 128.33 19.33 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.578 2.185 . . . . 10.0 111.339 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 98' ' ' GLY . . . . . 0.411 ' O ' ' HD3' ' B' ' 85' ' ' ARG . . . -74.11 -176.32 34.51 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 121.046 -0.597 . . . . 10.0 113.294 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 14.5 mmt180 -87.89 -32.88 18.74 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.959 0.409 . . . . 10.0 110.201 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 100' ' ' LYS . . . . . 1.047 ' HD2' ' HG ' ' C' ' 483' ' ' LEU . 4.3 mtmp? -77.87 99.1 5.84 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.458 -0.792 . . . . 10.0 110.551 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 101' ' ' GLY . . . . . 0.559 ' HA2' ' HB ' ' A' ' 102' ' ' ILE . . . -178.44 159.79 25.35 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 110.667 -0.973 . . . . 10.0 110.667 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 18.4 tt -131.12 142.41 43.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 117.196 0.498 . . . . 10.0 111.579 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 103' ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' B' ' 83' ' ' ASP . 0.7 OUTLIER -102.5 105.3 15.82 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.831 -0.622 . . . . 10.0 109.776 179.272 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 96.1 mt -93.33 142.27 27.51 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.792 0.329 . . . . 10.0 111.376 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 105' ' ' ASN . . . . . 0.403 ' ND2' ' HB3' ' B' ' 107' ' ' GLU . 41.4 p-10 -93.01 164.71 20.61 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 108.633 -0.877 . . . . 10.0 108.633 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.93 -30.73 31.52 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.489 2.126 . . . . 10.0 112.669 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 107' ' ' GLU . . . . . 0.403 ' HB3' ' ND2' ' B' ' 105' ' ' ASN . 9.2 tt0 -66.71 -59.27 3.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.921 -0.581 . . . . 10.0 110.861 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -67.08 -29.83 69.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.488 -0.324 . . . . 10.0 110.639 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 109' ' ' TRP . . . . . 0.488 ' HB2' HD13 ' B' ' 82' ' ' ILE . 31.0 t-105 -60.56 -42.25 96.21 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.63 -0.507 . . . . 10.0 109.63 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 9.7 t -67.81 -45.4 74.83 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.505 -0.554 . . . . 10.0 109.505 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -57.97 -40.65 81.14 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.015 -0.539 . . . . 10.0 110.54 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 112' ' ' LEU . . . . . 0.442 ' O ' HG13 ' B' ' 116' ' ' ILE . 33.1 tp -59.64 -47.19 86.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.92 -0.582 . . . . 10.0 110.665 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -62.95 -34.63 77.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.101 0.477 . . . . 10.0 110.666 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -74.17 -30.17 62.12 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.801 -0.636 . . . . 10.0 110.787 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 115' ' ' GLN . . . . . 0.401 ' O ' HG13 ' B' ' 119' ' ' ILE . 14.6 mm-40 -82.51 -10.49 58.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.435 . . . . 10.0 111.71 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 116' ' ' ILE . . . . . 0.442 HG13 ' O ' ' B' ' 112' ' ' LEU . 55.8 mt -55.2 -34.82 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 120.708 0.29 . . . . 10.0 111.15 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 1.5 m -60.66 -21.4 62.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.265 -0.425 . . . . 10.0 111.601 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -106.17 -42.42 5.08 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.616 0.246 . . . . 10.0 110.663 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 119' ' ' ILE . . . . . 0.512 HG12 ' CD2' ' A' ' 63' ' ' PHE . 60.6 mt -61.64 -52.03 65.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.885 0.374 . . . . 10.0 110.924 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 120' ' ' ASP . . . . . 0.583 ' HB2' ' HZ2' ' A' ' 109' ' ' TRP . 27.6 t70 -62.35 -38.12 88.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.873 -0.603 . . . . 10.0 111.083 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -62.03 -37.67 85.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.705 -0.679 . . . . 10.0 111.23 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.32 -20.4 57.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.266 -0.425 . . . . 10.0 111.864 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 123' ' ' VAL . . . . . 0.459 HG23 ' O ' ' B' ' 119' ' ' ILE . 78.1 t -58.21 -36.39 57.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.891 0.377 . . . . 10.0 111.416 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 6.6 ptp85 -102.68 14.4 32.04 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.359 -0.382 . . . . 10.0 111.141 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -127.42 56.73 1.53 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.017 0.437 . . . . 10.0 110.206 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 66.9 mt . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.698 -0.668 . . . . 10.0 110.459 -179.76 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 465' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.481 1.103 0 CA-C-O 120.666 0.27 . . . . 10.0 111.207 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 466' ' ' GLY . . . . . . . . . . . . . . . -67.38 -41.15 91.41 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.2 -0.524 . . . . 10.0 112.181 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 467' ' ' ALA . . . . . . . . . . . . . . . -108.59 -51.01 2.94 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.547 -0.538 . . . . 10.0 109.547 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 468' ' ' LEU . . . . . . . . . . . . . 86.8 mt -98.89 105.99 18.2 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.841 -0.618 . . . . 10.0 110.343 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 469' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -147.21 -55.94 0.24 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.03 -0.532 . . . . 10.0 110.283 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 470' ' ' MET . . . . . . . . . . . . . 45.9 ttm -74.0 -49.15 25.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 10.0 110.746 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 471' ' ' ALA . . . . . . . . . . . . . . . -67.57 -12.46 60.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.233 -0.439 . . . . 10.0 111.148 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 472' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.34 -23.09 66.3 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.907 -0.588 . . . . 10.0 110.948 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 473' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -68.49 -21.51 64.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.081 -0.509 . . . . 10.0 110.866 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 474' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -73.99 -23.27 59.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.989 0.424 . . . . 10.0 110.699 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 475' ' ' PHE . . . . . 0.462 ' O ' ' HB2' ' C' ' 479' ' ' PHE . 24.6 m-85 -62.35 -27.95 69.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.703 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 476' ' ' GLU . . . . . 0.45 ' HB3' ' CE2' ' A' ' 76' ' ' PHE . 5.4 mm-40 -70.0 -41.03 74.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.116 -0.493 . . . . 10.0 110.509 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 477' ' ' GLN . . . . . 0.676 ' HA ' ' HB3' ' C' ' 481' ' ' ASP . 2.4 mp0 -70.05 -36.93 75.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.338 0.589 . . . . 10.0 110.038 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 478' ' ' MET . . . . . . . . . . . . . 45.5 ttp -76.54 -12.22 59.99 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.013 -0.54 . . . . 10.0 110.458 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 479' ' ' PHE . . . . . 0.465 ' HB3' ' H ' ' C' ' 480' ' ' THR . 12.7 t80 -91.76 -98.82 0.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 10.0 111.934 -178.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 480' ' ' THR . . . . . 0.465 ' H ' ' HB3' ' C' ' 479' ' ' PHE . 2.8 m -73.59 -32.5 64.15 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.118 0.784 . . . . 10.0 113.118 -177.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 481' ' ' ASP . . . . . 0.676 ' HB3' ' HA ' ' C' ' 477' ' ' GLN . 14.8 t70 -63.45 -47.23 82.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.777 0.322 . . . . 10.0 111.687 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 482' ' ' ALA . . . . . . . . . . . . . . . -60.75 -27.08 67.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.093 -0.503 . . . . 10.0 112.285 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 483' ' ' LEU . . . . . 1.047 ' HG ' ' HD2' ' B' ' 100' ' ' LYS . 0.3 OUTLIER -108.64 11.44 26.57 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.635 -0.257 . . . . 10.0 111.229 -179.775 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 484' ' ' GLY . . . . . 0.474 ' HA2' HD11 ' A' ' 81' ' ' LEU . . . -110.19 -26.58 4.85 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.661 -0.781 . . . . 10.0 111.732 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 485' ' ' ILE . . . . . . . . . . . . . 19.1 tt -66.44 -31.76 55.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.773 0.321 . . . . 10.0 111.347 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 486' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -98.32 -36.69 9.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.641 -0.254 . . . . 10.0 110.716 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 487' ' ' GLU . . . . . 0.564 ' HB2' ' O ' ' C' ' 483' ' ' LEU . 4.1 tm-20 -61.17 -25.44 67.02 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.003 0.43 . . . . 10.0 110.267 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 488' ' ' TYR . . . . . 0.406 ' HA ' ' HE3' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -53.89 -38.02 64.35 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 115.829 -0.623 . . . . 10.0 110.694 179.272 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 489' ' ' GLY . . . . . . . . . . . . . . . -108.23 -49.93 0.79 Allowed Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.641 -0.79 . . . . 10.0 112.388 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 490' ' ' GLY . . . . . 0.563 ' HA2' ' HD2' ' B' ' 67' ' ' LYS . . . . . . . . 0 C--O 1.246 0.868 0 CA-C-O 118.469 -1.184 . . . . 10.0 111.62 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 120.943 0.401 . . . . 10.0 110.224 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.448 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 50.8 ttm -144.81 118.22 9.06 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.283 -0.417 . . . . 10.0 110.646 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.439 ' HB2' ' HB ' ' A' ' 71' ' ' VAL . 67.5 m-85 -95.37 171.15 8.88 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.21 -0.45 . . . . 10.0 110.162 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.55 ' HG2' ' H ' ' A' ' 66' ' ' GLY . 6.8 tt0 -131.99 134.39 45.53 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.199 -0.297 . . . . 10.0 110.199 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.524 HG13 ' HB3' ' A' ' 69' ' ' ARG . 11.6 pt -122.08 12.19 5.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.106 0.479 . . . . 10.0 110.569 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.55 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 156.0 174.54 25.93 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.814 -0.708 . . . . 10.0 111.945 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -57.24 116.62 3.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.622 0.249 . . . . 10.0 111.376 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 2.5 mmt 69.46 11.7 8.09 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.356 -0.838 . . . . 10.0 112.45 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.524 ' HB3' HG13 ' A' ' 65' ' ' ILE . 4.4 mpt_? -111.71 104.13 12.46 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.415 -0.587 . . . . 10.0 109.415 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.489 ' HD2' ' HB2' ' A' ' 87' ' ' TYR . 96.3 m-85 -120.43 145.72 46.93 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.355 0.597 . . . . 10.0 112.406 -178.015 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.534 HG13 HG12 ' A' ' 84' ' ' ILE . 36.6 t -99.16 105.99 18.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.001 -1.0 . . . . 10.0 108.92 178.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.42 ' HB2' ' HZ ' ' C' ' 475' ' ' PHE . 7.6 m -88.39 113.4 23.96 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.885 0.374 . . . . 10.0 111.099 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 38.2 t -106.18 92.89 2.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.066 -0.515 . . . . 10.0 109.846 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.911 ' HG3' ' HB3' ' A' ' 81' ' ' LEU . 7.5 ptm180 -123.63 -171.15 2.26 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.086 -0.506 . . . . 10.0 109.985 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -102.51 160.17 14.79 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.626 0.251 . . . . 10.0 110.343 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.596 ' HZ ' HG23 ' C' ' 480' ' ' THR . 10.1 t80 -119.07 45.63 2.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.049 0.452 . . . . 10.0 110.522 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.425 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 11.2 mptt 55.65 41.5 30.45 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.274 0.559 . . . . 10.0 110.673 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 136.15 -42.41 1.33 Allowed Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 111.057 -0.817 . . . . 10.0 111.057 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.478 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 64.7 mttm -100.83 -167.36 1.42 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.703 -0.48 . . . . 10.0 109.703 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.0 m -105.72 142.53 18.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.738 0.304 . . . . 10.0 110.663 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.911 ' HB3' ' HG3' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -118.53 78.94 1.31 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.105 -0.498 . . . . 10.0 109.894 -179.716 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 27.6 mt -101.46 88.27 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.062 -0.718 . . . . 10.0 109.062 178.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.47 ' OD1' ' HB2' ' A' ' 85' ' ' ARG . 16.5 t70 -113.28 135.9 53.34 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.347 0.594 . . . . 10.0 111.458 -178.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.534 HG12 HG13 ' A' ' 71' ' ' VAL . 45.7 mt -108.19 96.07 4.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 108.407 -0.96 . . . . 10.0 108.407 178.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.602 ' HG3' ' HA3' ' A' ' 101' ' ' GLY . 6.7 ttm180 -118.47 154.82 31.86 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.951 -0.568 . . . . 10.0 111.433 -178.051 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -73.98 124.37 26.09 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.728 -0.842 . . . . 10.0 108.728 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.489 ' HB2' ' HD2' ' A' ' 70' ' ' TYR . 19.1 m-85 -103.99 121.54 43.37 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.931 0.396 . . . . 10.0 110.759 -179.075 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -108.25 137.5 46.12 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.912 -0.585 . . . . 10.0 109.926 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.429 ' HA ' ' O ' ' A' ' 94' ' ' GLU . 6.5 ttt -74.94 126.92 32.02 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.301 -0.409 . . . . 10.0 110.202 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.439 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 44.8 p30 -87.83 171.56 9.38 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 116.154 -0.476 . . . . 10.0 110.605 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.439 ' HD2' ' HB2' ' A' ' 90' ' ' ASP . 48.5 Cg_exo -57.78 -24.95 66.38 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.855 2.37 . . . . 10.0 113.393 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -76.24 -30.87 58.07 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.961 0.41 . . . . 10.0 110.54 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 112.37 22.04 5.97 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.83 -0.7 . . . . 10.0 112.151 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' A' ' 89' ' ' MET . 31.0 mt-10 -110.22 164.4 12.69 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.95 0.405 . . . . 10.0 110.369 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 94.2 mmm -96.9 114.23 25.84 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.062 -0.517 . . . . 10.0 109.809 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 13.7 mmtp -113.81 131.69 22.97 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.226 -0.443 . . . . 10.0 110.493 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.06 133.84 34.73 Favored 'Trans proline' 0 C--O 1.233 0.264 0 C-N-CA 122.554 2.169 . . . . 10.0 112.408 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -81.81 -128.38 1.03 Allowed Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.984 -0.627 . . . . 10.0 113.202 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -110.07 -34.28 6.44 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.648 0.261 . . . . 10.0 111.556 -178.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.1 mtmt -86.87 117.07 25.36 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.188 0.518 . . . . 10.0 111.741 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.602 ' HA3' ' HG3' ' A' ' 85' ' ' ARG . . . -166.8 155.17 26.15 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.716 -0.953 . . . . 10.0 110.716 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.501 HG12 HG22 ' B' ' 84' ' ' ILE . 7.9 tp -134.82 130.6 52.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 117.494 0.647 . . . . 10.0 111.9 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.608 ' HB3' ' CE2' ' C' ' 479' ' ' PHE . 5.8 m -92.26 116.01 28.59 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.146 -0.934 . . . . 10.0 109.661 178.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 82.3 mt -109.56 113.05 25.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.032 0.444 . . . . 10.0 110.958 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.745 ' HB2' HD13 ' C' ' 483' ' ' LEU . 19.8 p30 -81.99 169.3 19.04 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.989 -0.55 . . . . 10.0 110.091 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.603 ' HD2' ' HB2' ' A' ' 105' ' ' ASN . 92.2 Cg_exo -44.41 -47.88 10.54 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 123.064 2.509 . . . . 10.0 113.855 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.0 tp10 -67.35 -50.94 57.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.488 0.185 . . . . 10.0 110.767 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.464 HE22 ' HD3' ' B' ' 69' ' ' ARG . 63.5 mt-30 -55.53 -46.65 77.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.316 -0.402 . . . . 10.0 111.193 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 56.0 t-105 -62.25 -42.87 99.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.908 0.385 . . . . 10.0 110.586 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.474 ' HA ' ' HE2' ' A' ' 113' ' ' LYS . 50.0 m -64.3 -46.71 82.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 10.0 110.757 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -65.6 -37.74 87.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.478 -0.328 . . . . 10.0 110.557 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.518 ' O ' HG13 ' A' ' 116' ' ' ILE . 59.6 tp -57.72 -43.42 85.27 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.279 -0.418 . . . . 10.0 110.81 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.474 ' HE2' ' HA ' ' A' ' 110' ' ' SER . 52.0 mtmt -62.23 -36.98 83.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.293 -0.412 . . . . 10.0 110.89 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -81.77 -17.07 48.97 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.106 0.479 . . . . 10.0 111.044 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -85.53 -18.67 32.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.197 -0.456 . . . . 10.0 110.283 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.518 HG13 ' O ' ' A' ' 112' ' ' LEU . 86.0 mt -54.12 -40.39 46.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.133 -0.485 . . . . 10.0 111.311 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.28 -25.04 61.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 10.0 111.758 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.42 -35.52 9.54 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.872 0.368 . . . . 10.0 110.763 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 83.9 mt -64.75 -47.59 88.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.922 -0.581 . . . . 10.0 110.86 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.14 -32.33 73.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 10.0 110.813 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -64.48 -41.4 96.49 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.815 -0.629 . . . . 10.0 110.124 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.96 -35.66 80.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.997 -0.547 . . . . 10.0 110.32 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 88.4 t -62.91 -37.85 80.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.943 -0.571 . . . . 10.0 110.215 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 16.5 mtm105 -75.2 -25.28 58.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.977 -0.556 . . . . 10.0 111.012 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -78.53 -20.14 51.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.331 -0.395 . . . . 10.0 111.352 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 12.6 mt . . . . . 0 C--N 1.321 -0.659 0 CA-C-N 116.586 -0.279 . . . . 10.0 110.437 179.971 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.094 0 CA-C-O 121.181 0.515 . . . . 10.0 110.683 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 62' ' ' MET . . . . . 0.408 ' HG2' ' HA ' ' B' ' 72' ' ' SER . 59.1 mtm -103.3 128.3 50.39 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.903 -0.589 . . . . 10.0 109.874 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 63' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -114.21 128.12 56.21 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.156 -0.474 . . . . 10.0 110.161 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -79.68 134.09 36.4 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.093 0.473 . . . . 10.0 111.316 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 65' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 108' ' ' GLN . 6.4 pt -112.42 -26.08 3.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.707 -0.679 . . . . 10.0 110.398 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -167.84 -174.53 36.86 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.771 -0.932 . . . . 10.0 110.771 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 67' ' ' LYS . . . . . 0.593 ' HD2' ' HA ' ' C' ' 486' ' ' ASP . 14.8 mttp -70.8 127.64 33.33 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.069 0.462 . . . . 10.0 111.057 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 68' ' ' MET . . . . . 0.513 ' HE3' ' HA ' ' B' ' 88' ' ' TRP . 39.2 mmm 64.26 25.88 13.63 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.057 -0.974 . . . . 10.0 111.703 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 69' ' ' ARG . . . . . 0.484 ' HE ' ' HG2' ' B' ' 86' ' ' GLU . 0.4 OUTLIER -140.11 115.25 9.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.484 -0.325 . . . . 10.0 110.233 179.116 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -126.61 133.15 51.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.045 -0.525 . . . . 10.0 110.758 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.466 HG22 HG23 ' B' ' 84' ' ' ILE . 86.6 t -88.75 115.21 28.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.048 -0.523 . . . . 10.0 109.611 179.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 72' ' ' SER . . . . . 0.408 ' HA ' ' HG2' ' B' ' 62' ' ' MET . 8.1 m -90.68 101.25 14.0 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.946 0.403 . . . . 10.0 111.076 -179.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 8.9 t -97.58 99.34 8.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.168 -0.469 . . . . 10.0 110.003 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -160.03 166.43 29.97 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.258 -0.428 . . . . 10.0 110.211 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.699 ' HA ' ' HA ' ' B' ' 80' ' ' VAL . 0.0 OUTLIER -86.87 145.32 26.62 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.203 0.525 . . . . 10.0 110.333 179.789 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -126.98 100.71 6.25 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 109.132 -0.692 . . . . 10.0 109.132 178.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 66.6 mttm 67.33 33.78 5.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.402 -0.817 . . . . 10.0 111.009 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 96.39 -9.94 67.13 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.734 -0.745 . . . . 10.0 112.971 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 79' ' ' LYS . . . . . 0.418 ' HD3' ' HA ' ' B' ' 79' ' ' LYS . 32.2 mmtt -109.25 113.71 26.78 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.66 0.23 . . . . 10.0 110.919 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 80' ' ' VAL . . . . . 0.699 ' HA ' ' HA ' ' B' ' 75' ' ' ASP . 14.3 t -64.33 117.76 5.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.612 -0.514 . . . . 10.0 109.612 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 97.8 mt -125.73 129.3 49.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.174 0.511 . . . . 10.0 111.699 -178.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 82' ' ' ILE . . . . . . . . . . . . . 5.2 mp -93.25 95.82 5.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 108.08 -1.081 . . . . 10.0 108.08 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 83' ' ' ASP . . . . . 0.4 ' HA ' ' HA ' ' B' ' 103' ' ' SER . 2.2 t70 -85.73 107.31 17.54 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.939 -0.573 . . . . 10.0 111.991 -177.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 84' ' ' ILE . . . . . 0.501 HG22 HG12 ' A' ' 102' ' ' ILE . 12.0 mt -99.23 83.91 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.071 -1.085 . . . . 10.0 108.071 178.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 85' ' ' ARG . . . . . 0.948 ' HG3' ' HA3' ' B' ' 101' ' ' GLY . 6.1 ttm180 -123.89 162.75 22.67 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.711 -0.677 . . . . 10.0 111.089 -177.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 86' ' ' GLU . . . . . 0.732 ' HB2' ' HA3' ' B' ' 98' ' ' GLY . 35.8 mt-10 -70.19 153.06 43.56 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.48 -0.933 . . . . 10.0 108.48 177.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 87' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -140.46 111.16 6.85 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.184 0.516 . . . . 10.0 110.783 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 88' ' ' TRP . . . . . 0.513 ' HA ' ' HE3' ' B' ' 68' ' ' MET . 20.6 m0 -108.64 -170.81 1.73 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.513 -0.767 . . . . 10.0 109.356 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 33.3 ttm -127.82 142.66 51.23 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 110.146 -0.316 . . . . 10.0 110.146 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 90' ' ' ASP . . . . . 0.446 ' HB2' ' HD2' ' B' ' 91' ' ' PRO . 36.9 p30 -99.83 169.94 7.4 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 116.17 -0.468 . . . . 10.0 110.522 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 91' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' B' ' 90' ' ' ASP . 34.8 Cg_exo -59.93 -20.58 60.68 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.713 2.276 . . . . 10.0 112.362 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -73.76 -43.34 59.28 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.994 0.426 . . . . 10.0 110.007 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 118.79 26.54 2.53 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.955 -0.64 . . . . 10.0 112.244 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -113.33 152.22 30.2 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.841 0.353 . . . . 10.0 110.625 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 95' ' ' MET . . . . . . . . . . . . . 95.6 mmm -82.78 105.15 13.56 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.073 -0.714 . . . . 10.0 109.073 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -103.37 145.93 31.51 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.765 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.02 146.94 94.82 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.576 2.184 . . . . 10.0 111.849 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 98' ' ' GLY . . . . . 0.732 ' HA3' ' HB2' ' B' ' 86' ' ' GLU . . . -73.89 -140.72 0.56 Allowed Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.728 -0.669 . . . . 10.0 112.617 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 99' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' B' ' 99' ' ' ARG . 2.4 mtp-105 -102.64 -32.76 9.73 Favored 'General case' 0 C--N 1.32 -0.714 0 O-C-N 122.382 -0.481 . . . . 10.0 111.109 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 100' ' ' LYS . . . . . 0.505 ' HE2' ' SD ' ' C' ' 478' ' ' MET . 2.3 mppt? -127.7 157.1 41.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.243 0.545 . . . . 10.0 111.396 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 101' ' ' GLY . . . . . 0.948 ' HA3' ' HG3' ' B' ' 85' ' ' ARG . . . 171.15 160.86 20.71 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 110.507 -1.037 . . . . 10.0 110.507 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 20.5 tt -133.1 140.8 46.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 117.95 0.875 . . . . 10.0 111.544 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 103' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' B' ' 83' ' ' ASP . 0.9 OUTLIER -101.62 112.19 24.68 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.054 -0.521 . . . . 10.0 110.013 179.549 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 52.1 mt -97.72 134.86 40.32 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.822 0.344 . . . . 10.0 110.615 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -88.97 168.98 14.13 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 108.915 -0.772 . . . . 10.0 108.915 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 106' ' ' PRO . . . . . 0.521 ' HD3' ' O ' ' B' ' 80' ' ' VAL . 86.4 Cg_exo -48.8 -38.73 38.28 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.608 2.205 . . . . 10.0 113.414 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -67.01 -54.7 19.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.63 -0.259 . . . . 10.0 111.172 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -61.74 -35.69 78.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.442 -0.345 . . . . 10.0 110.509 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 109' ' ' TRP . . . . . 0.404 ' CZ2' HG12 ' A' ' 116' ' ' ILE . 65.7 t-105 -61.87 -41.23 97.6 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.106 -0.497 . . . . 10.0 109.699 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 110' ' ' SER . . . . . 0.411 ' O ' ' HG3' ' B' ' 114' ' ' GLU . 25.3 t -63.62 -46.61 84.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.489 . . . . 10.0 109.719 178.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -58.37 -40.17 81.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.881 -0.6 . . . . 10.0 110.815 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 53.5 tp -60.94 -41.4 96.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 10.0 110.461 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 113' ' ' LYS . . . . . 0.43 ' HG2' HD13 ' A' ' 116' ' ' ILE . 55.9 mtmt -68.85 -36.09 77.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.15 0.5 . . . . 10.0 110.737 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 114' ' ' GLU . . . . . 0.411 ' HG3' ' O ' ' B' ' 110' ' ' SER . 45.3 mt-10 -73.79 -25.15 59.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.828 -0.624 . . . . 10.0 111.332 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -86.78 -4.89 59.23 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.302 -0.408 . . . . 10.0 111.397 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 61.7 mt -57.27 -41.38 78.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 120.778 0.323 . . . . 10.0 110.881 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 5.7 m -64.83 -11.95 42.85 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.146 -0.479 . . . . 10.0 112.21 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.25 -47.21 3.57 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.83 0.348 . . . . 10.0 110.447 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 119' ' ' ILE . . . . . 0.473 ' O ' HG23 ' B' ' 123' ' ' VAL . 61.9 mt -66.35 -45.95 88.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.102 -0.499 . . . . 10.0 111.817 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -62.13 -36.23 81.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.728 0.299 . . . . 10.0 111.236 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 121' ' ' ASP . . . . . 0.466 ' O ' ' HG2' ' B' ' 124' ' ' ARG . 36.7 t70 -67.87 -34.89 77.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.983 0.421 . . . . 10.0 110.26 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 122' ' ' ALA . . . . . 0.493 ' O ' ' HG ' ' B' ' 126' ' ' LEU . . . -68.48 -37.53 80.22 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.718 -0.475 . . . . 10.0 109.718 178.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 123' ' ' VAL . . . . . 0.473 HG23 ' O ' ' B' ' 119' ' ' ILE . 83.9 t -64.81 -42.36 94.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.896 -0.593 . . . . 10.0 110.58 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 124' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' B' ' 121' ' ' ASP . 7.1 ptp180 -75.65 -5.9 47.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.795 0.331 . . . . 10.0 110.91 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 43.2 mttp -104.65 1.43 29.52 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.377 -0.374 . . . . 10.0 110.572 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' B' ' 122' ' ' ALA . 82.5 mt . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.73 -0.653 . . . . 10.0 109.813 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 465' ' ' TYR . . . . . . . . . . . . . 58.1 t80 . . . . . 0 N--CA 1.48 1.046 0 CA-C-O 120.282 0.087 . . . . 10.0 111.165 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 466' ' ' GLY . . . . . . . . . . . . . . . -54.5 -40.17 68.65 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 121.566 -0.349 . . . . 10.0 113.522 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 467' ' ' ALA . . . . . . . . . . . . . . . -60.05 -38.17 82.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.984 0.421 . . . . 10.0 110.956 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 468' ' ' LEU . . . . . . . . . . . . . 33.3 tp -80.43 -34.33 36.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.099 0.476 . . . . 10.0 110.461 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 469' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -62.23 -44.66 96.06 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.746 -0.661 . . . . 10.0 110.476 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 470' ' ' MET . . . . . . . . . . . . . 99.0 mmm -80.99 -14.16 58.21 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.814 -0.63 . . . . 10.0 110.988 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 471' ' ' ALA . . . . . . . . . . . . . . . -65.26 -44.39 88.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.871 0.367 . . . . 10.0 110.048 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 472' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -68.03 -33.08 73.91 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.369 -0.604 . . . . 10.0 109.369 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 473' ' ' PHE . . . . . 0.412 ' O ' ' HB3' ' C' ' 477' ' ' GLN . 2.6 m-85 -64.36 -44.08 92.55 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 115.408 -0.814 . . . . 10.0 110.558 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 474' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.1 -19.63 64.86 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.918 0.389 . . . . 10.0 110.831 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 475' ' ' PHE . . . . . 0.578 ' HA ' ' NH1' ' A' ' 85' ' ' ARG . 79.1 t80 -83.27 -51.4 7.49 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.032 -0.531 . . . . 10.0 109.848 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 476' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -69.39 -38.83 78.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.516 -0.765 . . . . 10.0 111.276 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 477' ' ' GLN . . . . . 0.412 ' HB3' ' O ' ' C' ' 473' ' ' PHE . 3.9 tm0? -70.84 91.79 0.86 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.729 0.776 . . . . 10.0 109.939 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 478' ' ' MET . . . . . 0.55 ' HE2' ' H ' ' A' ' 103' ' ' SER . 20.2 ttt -176.8 -44.86 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.488 -1.233 . . . . 10.0 108.413 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 479' ' ' PHE . . . . . 0.608 ' CE2' ' HB3' ' A' ' 103' ' ' SER . 0.8 OUTLIER -67.82 -16.95 64.35 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.523 -0.762 . . . . 10.0 110.818 179.289 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 480' ' ' THR . . . . . 0.596 HG23 ' HZ ' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -60.84 -26.8 67.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.388 0.613 . . . . 10.0 110.172 178.917 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 481' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -111.35 -40.01 4.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.149 -0.932 . . . . 10.0 109.629 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 482' ' ' ALA . . . . . . . . . . . . . . . -79.55 28.72 0.25 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.822 -0.627 . . . . 10.0 112.55 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 483' ' ' LEU . . . . . 0.745 HD13 ' HB2' ' A' ' 105' ' ' ASN . 33.5 tp -171.76 -50.83 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 122.477 0.311 . . . . 10.0 110.199 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 484' ' ' GLY . . . . . . . . . . . . . . . -46.6 -42.9 14.79 Favored Glycine 0 C--N 1.335 0.478 0 O-C-N 123.899 0.749 . . . . 10.0 113.4 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 485' ' ' ILE . . . . . . . . . . . . . 23.2 pt -109.47 -4.59 10.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.715 0.293 . . . . 10.0 111.017 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 486' ' ' ASP . . . . . 0.593 ' HA ' ' HD2' ' B' ' 67' ' ' LYS . 21.3 t0 -87.74 -29.49 21.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.522 -0.308 . . . . 10.0 111.35 -178.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 487' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -74.31 -13.43 60.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.095 0.474 . . . . 10.0 110.411 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 488' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -101.52 93.49 5.4 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.898 -0.592 . . . . 10.0 109.879 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 489' ' ' GLY . . . . . . . . . . . . . . . 99.58 177.26 31.19 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 121.056 -0.593 . . . . 10.0 111.996 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.091 0 CA-C-O 118.798 -1.001 . . . . 10.0 111.722 -179.901 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 120.563 0.22 . . . . 10.0 110.516 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.459 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 29.6 mtm -142.97 130.45 21.17 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.965 -0.383 . . . . 10.0 109.965 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.4 ' CE1' ' HB3' ' B' ' 118' ' ' ASP . 57.5 m-85 -122.15 147.33 46.29 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.13 -0.486 . . . . 10.0 109.97 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -98.07 116.76 30.95 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.408 -0.36 . . . . 10.0 110.43 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.538 HG22 ' HG3' ' B' ' 115' ' ' GLN . 24.6 pt -105.06 10.28 9.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.12 0.486 . . . . 10.0 110.776 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 164.29 173.59 33.12 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.78 -0.724 . . . . 10.0 111.645 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 44.8 tttp -62.28 120.69 11.47 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.47 0.176 . . . . 10.0 110.765 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.418 ' HB3' ' O ' ' A' ' 87' ' ' TYR . 24.8 mmt 64.07 28.26 14.22 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 123.732 0.645 . . . . 10.0 111.888 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -131.08 112.26 12.73 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.967 -0.382 . . . . 10.0 109.967 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.425 ' HB2' ' CE1' ' A' ' 87' ' ' TYR . 50.8 m-85 -120.0 140.98 50.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.095 0.474 . . . . 10.0 111.444 -179.008 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 62' ' ' MET . 21.2 t -94.58 110.55 23.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.779 -0.646 . . . . 10.0 109.448 178.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.795 ' HB3' ' HB3' ' A' ' 83' ' ' ASP . 0.7 OUTLIER -80.39 83.38 6.23 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.992 -0.549 . . . . 10.0 110.697 -179.209 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.0 t -89.7 86.15 2.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.914 -0.773 . . . . 10.0 108.914 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -151.35 172.21 16.27 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.701 -0.681 . . . . 10.0 110.597 -178.873 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.885 ' HB2' HG22 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -106.01 138.0 42.95 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.808 -0.633 . . . . 10.0 109.814 179.352 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.642 ' HE2' ' HG2' ' C' ' 477' ' ' GLN . 1.0 OUTLIER -126.4 95.48 4.38 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.396 -0.365 . . . . 10.0 110.318 179.303 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.3 36.86 25.91 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.667 -0.697 . . . . 10.0 111.892 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 103.05 -17.64 51.67 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.516 -0.85 . . . . 10.0 112.18 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.499 ' HA ' ' HE2' ' C' ' 488' ' ' TYR . 48.7 mtmt -89.18 94.93 10.1 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.994 0.426 . . . . 10.0 110.293 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.885 HG22 ' HB2' ' A' ' 75' ' ' ASP . 2.1 t -100.71 93.63 3.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.878 -0.601 . . . . 10.0 109.684 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.488 HD11 ' HB3' ' A' ' 79' ' ' LYS . 0.9 OUTLIER -128.94 157.12 42.51 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.096 -0.502 . . . . 10.0 110.949 -179.075 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.549 HD13 ' HB2' ' A' ' 109' ' ' TRP . 5.3 mp -81.42 90.32 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.573 -0.899 . . . . 10.0 108.573 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.795 ' HB3' ' HB3' ' A' ' 72' ' ' SER . 20.5 t70 -82.17 102.41 11.08 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.831 -0.622 . . . . 10.0 111.955 -177.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.3 mt -84.51 109.41 17.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 107.727 -1.212 . . . . 10.0 107.727 178.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.467 ' HD3' ' O ' ' A' ' 98' ' ' GLY . 10.9 ttm-85 -128.98 149.15 50.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.446 0.641 . . . . 10.0 112.544 -177.191 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -91.62 149.92 21.42 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.504 -0.924 . . . . 10.0 108.504 178.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.425 ' CE1' ' HB2' ' A' ' 70' ' ' TYR . 8.0 m-85 -120.26 152.37 37.86 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.051 0.453 . . . . 10.0 111.539 -178.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 12.6 t90 -145.03 154.33 42.41 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.926 -0.768 . . . . 10.0 108.926 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.4 ttm -88.03 134.74 33.67 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.909 0.385 . . . . 10.0 110.76 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.877 ' HB3' ' HG3' ' A' ' 96' ' ' LYS . 51.2 p-10 -85.68 175.52 4.44 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.787 -0.642 . . . . 10.0 110.534 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.481 ' HD2' ' HB2' ' A' ' 90' ' ' ASP . 39.3 Cg_exo -61.72 -17.81 56.89 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.568 2.178 . . . . 10.0 112.911 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.79 -41.71 20.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.826 0.346 . . . . 10.0 110.773 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 122.52 18.48 3.32 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.834 -0.698 . . . . 10.0 111.994 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -104.14 163.49 12.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.927 0.394 . . . . 10.0 110.882 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 78.5 mmm -88.06 111.33 21.43 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.916 -0.583 . . . . 10.0 109.479 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.877 ' HG3' ' HB3' ' A' ' 90' ' ' ASP . 18.7 mmmt -109.03 129.97 23.28 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.804 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.43 133.63 19.4 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.234 1.956 . . . . 10.0 111.513 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.467 ' O ' ' HD3' ' A' ' 85' ' ' ARG . . . -63.7 160.15 37.78 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.916 -0.659 . . . . 10.0 112.12 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.429 ' HA ' ' HD3' ' A' ' 99' ' ' ARG . 25.1 mmt180 -77.87 -7.91 57.35 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.161 0.505 . . . . 10.0 110.397 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -104.19 127.49 51.8 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.647 -0.706 . . . . 10.0 109.828 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -166.5 -173.53 34.96 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 111.206 -0.757 . . . . 10.0 111.206 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.9 tp -152.51 113.23 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.208 0.528 . . . . 10.0 110.582 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.772 ' HA ' ' HA ' ' A' ' 83' ' ' ASP . 0.8 OUTLIER -92.5 90.61 7.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.165 -0.47 . . . . 10.0 111.36 -179.478 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.449 ' HG ' ' HB3' ' A' ' 108' ' ' GLN . 2.8 mp -65.97 131.25 45.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.559 -0.291 . . . . 10.0 111.011 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.493 ' HB2' ' HD2' ' A' ' 106' ' ' PRO . 20.2 p-10 -78.98 166.47 41.97 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 110.396 -0.224 . . . . 10.0 110.396 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.493 ' HD2' ' HB2' ' A' ' 105' ' ' ASN . 79.6 Cg_exo -47.45 -41.15 29.4 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.222 2.615 . . . . 10.0 114.004 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -69.51 -45.14 69.58 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.828 -0.349 . . . . 10.0 110.838 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.466 ' HG2' ' HA3' ' B' ' 66' ' ' GLY . 23.6 mt-30 -57.97 -39.83 79.12 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.964 0.411 . . . . 10.0 110.17 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.549 ' HB2' HD13 ' A' ' 82' ' ' ILE . 66.2 t-105 -59.09 -44.4 91.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.782 -0.644 . . . . 10.0 110.564 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.8 t -67.36 -48.28 67.92 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.025 -0.534 . . . . 10.0 110.486 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -60.06 -38.8 83.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.94 -0.573 . . . . 10.0 111.08 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.479 ' O ' HG13 ' A' ' 116' ' ' ILE . 27.9 tp -60.98 -49.53 77.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.465 -0.334 . . . . 10.0 110.594 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.46 ' HA ' HD12 ' A' ' 116' ' ' ILE . 48.6 mtmt -60.54 -38.49 84.64 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.301 -0.409 . . . . 10.0 111.192 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -71.99 -26.5 62.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.962 -0.563 . . . . 10.0 111.831 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -93.42 -9.45 38.56 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.671 0.249 . . . . 10.0 111.671 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 112' ' ' LEU . 16.4 mt -51.55 -44.05 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 112.224 0.453 . . . . 10.0 112.224 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.3 m -60.46 -34.55 74.16 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.871 0.367 . . . . 10.0 111.773 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.08 -41.04 21.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.953 0.406 . . . . 10.0 110.325 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.544 HG23 HG21 ' B' ' 73' ' ' VAL . 82.3 mt -65.38 -48.62 82.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.805 -0.634 . . . . 10.0 111.224 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -59.42 -37.69 78.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.098 -0.501 . . . . 10.0 110.774 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.66 -39.3 94.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.019 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.412 ' HA ' ' HD2' ' A' ' 125' ' ' LYS . . . -64.89 -33.78 76.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.927 -0.579 . . . . 10.0 110.613 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 119' ' ' ILE . 63.1 t -64.36 -37.52 80.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.235 0.54 . . . . 10.0 109.855 179.092 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 19.9 mtm105 -78.84 -27.18 44.16 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.565 -0.743 . . . . 10.0 110.509 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.412 ' HD2' ' HA ' ' A' ' 122' ' ' ALA . 13.7 mttt -69.6 -36.07 75.86 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.99 -0.55 . . . . 10.0 110.566 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 47.2 mt . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 115.855 -0.612 . . . . 10.0 111.322 -179.49 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.219 0 CA-C-O 121.082 0.468 . . . . 10.0 110.665 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 5.6 mmm -97.99 95.92 7.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.773 -0.649 . . . . 10.0 109.708 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 63' ' ' PHE . . . . . 0.477 ' CD2' HG12 ' A' ' 119' ' ' ILE . 38.8 m-85 -90.83 126.28 35.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.067 -0.515 . . . . 10.0 111.166 -179.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -87.73 103.74 15.9 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.199 -0.455 . . . . 10.0 109.823 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 65' ' ' ILE . . . . . 0.503 HG12 HG23 ' B' ' 71' ' ' VAL . 5.6 pt -100.39 5.2 10.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.304 0.573 . . . . 10.0 110.351 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 66' ' ' GLY . . . . . 0.466 ' HA3' ' HG2' ' A' ' 108' ' ' GLN . . . 179.43 158.88 22.49 Favored Glycine 0 N--CA 1.438 -1.179 0 N-CA-C 110.988 -0.845 . . . . 10.0 110.988 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 67' ' ' LYS . . . . . 0.484 ' O ' ' HB2' ' B' ' 68' ' ' MET . 29.9 mttp -64.26 114.95 4.58 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.761 -0.459 . . . . 10.0 109.761 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 68' ' ' MET . . . . . 0.484 ' HB2' ' O ' ' B' ' 67' ' ' LYS . 70.3 mmm 78.91 3.97 2.42 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.313 -0.858 . . . . 10.0 111.128 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 69' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -115.57 124.59 51.4 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.722 -0.473 . . . . 10.0 109.722 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 70' ' ' TYR . . . . . 0.575 ' HB2' ' CD2' ' B' ' 87' ' ' TYR . 95.7 m-85 -131.12 145.32 51.94 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.228 0.537 . . . . 10.0 111.558 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.503 HG23 HG12 ' B' ' 65' ' ' ILE . 65.6 t -103.99 96.03 4.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 108.399 -0.963 . . . . 10.0 108.399 177.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 72' ' ' SER . . . . . 0.458 ' O ' ' HD3' ' B' ' 74' ' ' ARG . 0.5 OUTLIER -87.71 96.65 10.51 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.028 -0.533 . . . . 10.0 110.8 -179.364 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.544 HG21 HG23 ' A' ' 119' ' ' ILE . 28.4 t -84.66 115.01 25.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.369 -0.604 . . . . 10.0 109.369 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 74' ' ' ARG . . . . . 0.458 ' HD3' ' O ' ' B' ' 72' ' ' SER . 0.0 OUTLIER -150.64 161.45 42.58 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.983 0.42 . . . . 10.0 111.02 -179.528 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -85.55 118.63 25.18 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.467 -0.788 . . . . 10.0 110.097 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -109.05 89.15 2.91 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.496 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 61.4 mttm 60.8 44.86 10.51 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.525 -0.762 . . . . 10.0 112.185 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.42 38.24 12.94 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.601 -0.809 . . . . 10.0 111.527 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -151.53 106.44 3.27 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 122.733 0.413 . . . . 10.0 110.138 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 80' ' ' VAL . . . . . 0.492 ' O ' ' HD3' ' B' ' 106' ' ' PRO . 24.4 t -73.2 99.06 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 108.563 -0.903 . . . . 10.0 108.563 178.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 96.2 mt -105.82 132.08 52.37 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.511 0.672 . . . . 10.0 112.599 -177.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 82' ' ' ILE . . . . . . . . . . . . . 4.8 mp -93.35 94.09 4.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 107.322 -1.362 . . . . 10.0 107.322 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -89.0 106.06 18.19 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.962 -0.563 . . . . 10.0 112.223 -177.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 84' ' ' ILE . . . . . 0.421 ' O ' ' HA2' ' B' ' 101' ' ' GLY . 37.7 mt -93.39 99.29 9.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 107.84 -1.17 . . . . 10.0 107.84 177.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 85' ' ' ARG . . . . . 0.805 ' HG3' ' HA3' ' B' ' 101' ' ' GLY . 20.2 ttm-85 -140.97 165.63 27.01 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.223 0.535 . . . . 10.0 112.112 -177.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.11 144.13 25.76 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.51 -0.922 . . . . 10.0 108.51 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 87' ' ' TYR . . . . . 0.575 ' CD2' ' HB2' ' B' ' 70' ' ' TYR . 50.6 m-85 -125.92 125.93 43.57 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.289 0.566 . . . . 10.0 111.047 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 88' ' ' TRP . . . . . . . . . . . . . 66.2 t90 -104.85 136.25 44.7 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.404 -0.817 . . . . 10.0 110.105 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 50.3 ttm -78.97 115.95 18.97 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.034 0.445 . . . . 10.0 110.745 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 90' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.69 161.97 59.53 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.659 -0.7 . . . . 10.0 110.356 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -53.23 -27.03 36.26 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.191 2.594 . . . . 10.0 113.993 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.7 -17.26 59.21 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 122.235 -0.29 . . . . 10.0 110.776 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 103.65 11.6 32.56 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.936 -0.65 . . . . 10.0 113.712 178.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 94' ' ' GLU . . . . . 0.429 ' HB3' ' HE2' ' B' ' 96' ' ' LYS . 11.4 tt0 -103.38 156.76 17.5 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 117.062 0.431 . . . . 10.0 110.696 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 95' ' ' MET . . . . . 0.529 ' HB3' ' HB3' ' B' ' 87' ' ' TYR . 87.7 mmm -94.25 103.0 15.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.252 -0.431 . . . . 10.0 110.024 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 96' ' ' LYS . . . . . 0.429 ' HE2' ' HB3' ' B' ' 94' ' ' GLU . 67.0 mmtt -93.28 147.29 33.47 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.082 -0.508 . . . . 10.0 110.47 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.13 145.57 98.17 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 122.29 1.994 . . . . 10.0 111.789 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . -75.94 -112.78 0.12 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.871 -0.68 . . . . 10.0 112.849 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 71.7 mtp85 -138.51 -22.06 1.01 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.968 0.413 . . . . 10.0 110.934 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 100' ' ' LYS . . . . . 0.407 ' HD3' HD13 ' C' ' 483' ' ' LEU . 39.2 mttt -100.4 -146.22 0.34 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.993 -0.548 . . . . 10.0 109.915 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 101' ' ' GLY . . . . . 0.805 ' HA3' ' HG3' ' B' ' 85' ' ' ARG . . . 94.72 153.95 30.6 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.612 -0.804 . . . . 10.0 112.751 179.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 15.4 tt -145.99 134.31 16.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.951 0.405 . . . . 10.0 110.545 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 4.0 m -92.25 116.14 28.7 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.062 -0.517 . . . . 10.0 109.701 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 96.0 mt -111.67 138.24 48.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.208 -0.451 . . . . 10.0 110.411 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 105' ' ' ASN . . . . . 0.545 ' HB2' ' HD2' ' B' ' 106' ' ' PRO . 33.3 p30 -88.93 170.43 11.03 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.39 -0.596 . . . . 10.0 109.39 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 106' ' ' PRO . . . . . 0.545 ' HD2' ' HB2' ' B' ' 105' ' ' ASN . 75.0 Cg_exo -51.47 -35.06 53.96 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.527 2.151 . . . . 10.0 113.121 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -62.89 -53.85 47.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.305 -0.407 . . . . 10.0 110.342 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -67.41 -34.9 78.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.058 -0.519 . . . . 10.0 110.206 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 109' ' ' TRP . . . . . . . . . . . . . 35.1 t-105 -61.12 -45.52 94.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.898 -0.592 . . . . 10.0 109.955 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 110' ' ' SER . . . . . 0.529 ' HA ' ' HE2' ' B' ' 113' ' ' LYS . 13.3 t -64.03 -43.87 94.27 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.697 -0.482 . . . . 10.0 109.697 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -61.16 -39.57 90.59 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 116.061 -0.518 . . . . 10.0 110.744 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 34.5 tp -60.2 -43.3 96.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.876 0.369 . . . . 10.0 110.204 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 113' ' ' LYS . . . . . 0.529 ' HE2' ' HA ' ' B' ' 110' ' ' SER . 41.5 mtmt -66.49 -39.85 88.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.035 -0.53 . . . . 10.0 110.567 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -74.42 -16.25 60.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.822 -0.626 . . . . 10.0 111.372 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 115' ' ' GLN . . . . . 0.538 ' HG3' HG22 ' A' ' 65' ' ' ILE . 14.7 mm-40 -90.12 -4.63 57.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.52 -0.309 . . . . 10.0 111.193 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 75.3 mt -58.78 -35.42 55.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.69 0.281 . . . . 10.0 110.722 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.25 -12.25 39.33 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.27 -0.423 . . . . 10.0 111.725 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 118' ' ' ASP . . . . . 0.4 ' HB3' ' CE1' ' A' ' 63' ' ' PHE . 1.4 m-20 -111.9 -49.65 2.97 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.884 0.373 . . . . 10.0 110.606 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 43.4 mt -65.42 -53.44 39.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 10.0 111.568 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 120' ' ' ASP . . . . . 0.401 ' HB2' ' HZ2' ' A' ' 109' ' ' TRP . 33.7 t70 -62.54 -31.28 72.04 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.799 0.333 . . . . 10.0 110.627 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -62.03 -47.4 84.89 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.927 -0.579 . . . . 10.0 110.19 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.81 -39.16 80.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.026 -0.534 . . . . 10.0 110.529 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 53.3 t -64.47 -37.23 79.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.818 -0.628 . . . . 10.0 111.207 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 124' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' B' ' 124' ' ' ARG . 8.7 ptp85 -81.77 -6.57 59.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.851 0.358 . . . . 10.0 110.999 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -96.5 5.95 49.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.049 0.452 . . . . 10.0 110.435 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 42.7 mt . . . . . 0 C--O 1.247 0.938 0 CA-C-O 118.3 -0.857 . . . . 10.0 109.995 179.455 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 465' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 . . . . . 0 N--CA 1.482 1.133 0 CA-C-O 120.41 0.148 . . . . 10.0 110.796 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 466' ' ' GLY . . . . . . . . . . . . . . . -55.33 -32.74 57.72 Favored Glycine 0 CA--C 1.52 0.344 0 CA-C-N 116.084 -0.507 . . . . 10.0 113.992 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 467' ' ' ALA . . . . . . . . . . . . . . . -67.49 -56.16 10.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.012 0.435 . . . . 10.0 110.805 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 468' ' ' LEU . . . . . . . . . . . . . 11.2 tp -65.77 -31.27 72.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.988 -0.551 . . . . 10.0 110.872 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 469' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -62.6 -21.03 65.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.615 -0.721 . . . . 10.0 111.884 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 470' ' ' MET . . . . . . . . . . . . . 92.7 mmm -111.13 -48.46 3.11 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.774 0.321 . . . . 10.0 111.834 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 471' ' ' ALA . . . . . . . . . . . . . . . -64.71 -59.52 4.15 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.679 0.622 . . . . 10.0 112.679 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 472' ' ' ASP . . . . . 0.443 ' HA ' ' HD2' ' C' ' 475' ' ' PHE . 36.5 t70 -67.59 -28.55 67.85 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.868 0.321 . . . . 10.0 111.868 -178.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 473' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -57.65 -40.41 79.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.44 -0.346 . . . . 10.0 110.575 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 474' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -62.81 -44.82 95.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.146 -0.479 . . . . 10.0 109.882 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 475' ' ' PHE . . . . . 0.443 ' HD2' ' HA ' ' C' ' 472' ' ' ASP . 55.9 m-85 -62.36 -43.47 98.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.331 -0.395 . . . . 10.0 110.533 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 476' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.5 -39.91 77.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.925 -0.579 . . . . 10.0 110.57 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 477' ' ' GLN . . . . . 0.642 ' HG2' ' HE2' ' A' ' 76' ' ' PHE . 0.8 OUTLIER -79.34 -53.92 6.45 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.797 -0.638 . . . . 10.0 111.421 -179.489 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 478' ' ' MET . . . . . . . . . . . . . 53.8 ttp -57.76 -44.24 86.01 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.861 0.689 . . . . 10.0 112.861 -177.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 479' ' ' PHE . . . . . 0.519 ' O ' ' HB2' ' C' ' 483' ' ' LEU . 15.7 m-85 -68.01 -17.47 64.43 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 121.09 -0.244 . . . . 10.0 111.593 -178.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 480' ' ' THR . . . . . . . . . . . . . 1.7 m -108.56 12.28 26.13 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.698 0.761 . . . . 10.0 109.403 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 481' ' ' ASP . . . . . 0.436 ' HB2' ' CD2' ' A' ' 76' ' ' PHE . 23.8 t70 -119.81 -54.86 2.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.331 -0.85 . . . . 10.0 110.555 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 482' ' ' ALA . . . . . . . . . . . . . . . -78.28 -12.86 60.03 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.748 -0.66 . . . . 10.0 111.33 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 483' ' ' LEU . . . . . 0.519 ' HB2' ' O ' ' C' ' 479' ' ' PHE . 0.3 OUTLIER -56.93 -41.3 77.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.255 -0.43 . . . . 10.0 111.05 -179.664 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 484' ' ' GLY . . . . . . . . . . . . . . . -103.18 31.11 9.1 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.537 -0.839 . . . . 10.0 113.026 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 485' ' ' ILE . . . . . . . . . . . . . 15.6 tt -72.75 -35.68 50.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 117.21 0.505 . . . . 10.0 110.759 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 486' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -109.84 -0.45 18.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.969 0.414 . . . . 10.0 110.226 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 487' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -74.99 -21.06 59.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.765 -0.652 . . . . 10.0 110.096 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 488' ' ' TYR . . . . . 0.499 ' HE2' ' HA ' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -64.2 -15.64 60.34 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.423 -0.808 . . . . 10.0 111.217 -179.49 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 489' ' ' GLY . . . . . . . . . . . . . . . -90.0 -4.73 71.65 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.737 -0.744 . . . . 10.0 112.353 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.172 0 CA-C-O 118.931 -0.927 . . . . 10.0 112.383 -179.592 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.861 0 CA-C-O 120.854 0.359 . . . . 10.0 110.123 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.431 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 54.2 ttm -115.73 117.65 30.84 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.16 -0.473 . . . . 10.0 110.584 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -107.47 179.28 4.29 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.911 -0.586 . . . . 10.0 109.51 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -135.32 138.29 43.27 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 121.006 -0.278 . . . . 10.0 110.923 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.6 pt -117.56 -9.77 11.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.16 -0.473 . . . . 10.0 111.23 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 176.11 -178.92 47.46 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.482 -0.866 . . . . 10.0 112.336 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.486 ' O ' ' HD2' ' A' ' 69' ' ' ARG . 43.3 tttp -58.03 118.15 5.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.688 0.28 . . . . 10.0 111.043 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 66.8 mmm 67.28 8.03 5.93 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.442 -0.799 . . . . 10.0 112.165 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.486 ' HD2' ' O ' ' A' ' 67' ' ' LYS . 2.4 mpt_? -113.35 113.02 24.66 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 120.917 0.389 . . . . 10.0 110.078 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.522 ' HB2' ' CD2' ' A' ' 87' ' ' TYR . 94.8 m-85 -121.17 163.85 17.81 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.894 -0.593 . . . . 10.0 110.879 -178.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 62' ' ' MET . 60.3 t -121.28 102.45 12.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.369 -0.832 . . . . 10.0 108.999 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.42 ' HB2' ' HB3' ' A' ' 83' ' ' ASP . 7.1 m -97.65 98.92 10.29 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.094 0.405 . . . . 10.0 112.094 -178.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.54 HG13 HG12 ' A' ' 82' ' ' ILE . 19.5 t -81.54 82.38 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 108.209 -1.034 . . . . 10.0 108.209 177.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -115.97 167.5 10.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.876 -0.602 . . . . 10.0 111.496 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.45 ' HA ' ' HA ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -112.93 141.2 47.03 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.734 -0.666 . . . . 10.0 110.17 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.556 ' HB3' ' OD1' ' C' ' 481' ' ' ASP . 17.5 m-85 -126.4 101.84 6.88 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.03 -0.532 . . . . 10.0 111.171 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 78.0 mttt 61.32 34.07 18.67 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.004 -0.543 . . . . 10.0 112.018 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.94 18.54 43.27 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.554 -0.831 . . . . 10.0 111.762 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.534 ' HE3' HG13 ' C' ' 485' ' ' ILE . 8.0 mtpt -127.75 99.25 5.47 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.327 -0.249 . . . . 10.0 110.327 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.457 HG11 HD13 ' B' ' 126' ' ' LEU . 96.7 t -69.62 111.88 3.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.844 -0.428 . . . . 10.0 109.844 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 79.3 mt -122.97 119.17 29.61 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.22 -0.445 . . . . 10.0 110.663 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.54 HG12 HG13 ' A' ' 73' ' ' VAL . 75.6 mt -75.79 101.48 2.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 108.955 -0.757 . . . . 10.0 108.955 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.42 ' HB3' ' HB2' ' A' ' 72' ' ' SER . 4.4 t70 -72.9 100.68 2.98 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.722 -0.672 . . . . 10.0 112.258 -178.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 34.8 mt -100.44 91.81 2.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 107.874 -1.158 . . . . 10.0 107.874 177.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.691 ' HG2' ' N ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -160.25 160.52 32.74 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.046 -0.525 . . . . 10.0 111.278 -177.252 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.691 ' N ' ' HG2' ' A' ' 85' ' ' ARG . 7.7 pt-20 -78.39 147.81 33.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.252 0.548 . . . . 10.0 110.788 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.673 ' HB3' ' HG2' ' A' ' 95' ' ' MET . 96.9 m-85 -126.34 125.31 42.05 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.62 -0.718 . . . . 10.0 109.685 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -105.66 167.76 9.55 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.333 -0.394 . . . . 10.0 110.108 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 27.8 ttt -106.01 131.11 53.7 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.691 0.281 . . . . 10.0 110.339 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.428 ' HB2' ' CD ' ' A' ' 91' ' ' PRO . 2.1 p30 -87.11 171.16 10.43 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 116.013 -0.539 . . . . 10.0 110.314 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.428 ' CD ' ' HB2' ' A' ' 90' ' ' ASP . 17.0 Cg_exo -68.64 -10.29 28.64 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.829 2.353 . . . . 10.0 113.257 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.495 ' HB2' ' HD2' ' C' ' 465' ' ' TYR . 7.4 tp10 -85.08 -43.06 14.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.167 0.508 . . . . 10.0 109.801 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 126.98 19.18 2.01 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.614 -0.721 . . . . 10.0 112.223 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -105.94 178.41 4.57 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.985 0.421 . . . . 10.0 110.981 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.673 ' HG2' ' HB3' ' A' ' 87' ' ' TYR . 18.7 ttm -105.43 112.43 25.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.757 -0.656 . . . . 10.0 110.005 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.3 mmpp? -102.02 123.11 44.73 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.187 -0.46 . . . . 10.0 111.62 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.48 ' HB3' ' CE1' ' A' ' 87' ' ' TYR . 73.4 Cg_endo -80.42 128.19 6.93 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.614 2.209 . . . . 10.0 111.824 178.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.403 ' O ' ' HD3' ' A' ' 85' ' ' ARG . . . -68.17 156.58 52.89 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.68 -0.772 . . . . 10.0 111.636 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.686 HH21 ' HB2' ' C' ' 476' ' ' GLU . 0.0 OUTLIER -60.15 -38.43 83.13 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.03 0.443 . . . . 10.0 110.415 -179.555 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.52 ' H ' ' HG3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -76.0 96.67 3.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.608 -0.723 . . . . 10.0 110.385 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.411 ' CA ' ' HB2' ' A' ' 85' ' ' ARG . . . -164.97 136.19 4.08 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.772 -0.728 . . . . 10.0 111.922 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.61 ' HA ' HD21 ' C' ' 483' ' ' LEU . 19.0 tt -116.69 124.18 72.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.533 0.682 . . . . 10.0 110.707 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.635 ' H ' HD23 ' C' ' 483' ' ' LEU . 1.3 m -102.35 110.95 23.04 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.618 -0.719 . . . . 10.0 109.818 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 79.4 mt -97.39 131.61 43.89 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.903 -0.589 . . . . 10.0 111.244 -178.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -84.06 167.14 29.52 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.828 -0.624 . . . . 10.0 109.601 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -43.14 -41.67 9.6 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.317 2.678 . . . . 10.0 113.71 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.36 -46.53 89.63 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.879 0.371 . . . . 10.0 110.781 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -69.91 -39.45 76.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.018 -0.537 . . . . 10.0 109.734 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 68.3 t-105 -56.99 -43.63 81.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.408 -0.815 . . . . 10.0 110.652 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.2 t -61.68 -52.41 64.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.306 -0.406 . . . . 10.0 109.925 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.45 ' O ' ' HG2' ' A' ' 115' ' ' GLN . 36.0 mt-30 -58.5 -41.71 85.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.911 -0.586 . . . . 10.0 110.709 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.614 ' O ' HG13 ' A' ' 116' ' ' ILE . 21.5 tp -55.47 -51.42 67.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.031 -0.531 . . . . 10.0 110.967 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.596 ' HA ' HD12 ' A' ' 116' ' ' ILE . 44.2 mtmt -63.35 -38.34 90.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.311 -0.404 . . . . 10.0 111.441 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -67.49 -36.22 80.68 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.019 -0.537 . . . . 10.0 111.553 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' A' ' 111' ' ' GLN . 14.1 mm-40 -82.18 -17.56 45.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.647 -0.251 . . . . 10.0 111.33 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.614 HG13 ' O ' ' A' ' 112' ' ' LEU . 18.7 mt -49.94 -37.05 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 111.991 0.367 . . . . 10.0 111.991 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.33 -35.68 72.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.42 -0.354 . . . . 10.0 111.414 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.3 -33.48 15.31 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.94 0.4 . . . . 10.0 110.501 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 91.8 mt -60.93 -47.61 92.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.002 -0.545 . . . . 10.0 110.462 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -62.9 -33.59 75.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.812 -0.631 . . . . 10.0 110.569 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -65.83 -33.18 75.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.806 -0.633 . . . . 10.0 110.026 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -70.54 -31.34 68.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.995 -0.548 . . . . 10.0 110.306 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 51.5 t -63.57 -39.02 83.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.999 -0.546 . . . . 10.0 109.789 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 124' ' ' ARG . 5.6 ttm105 -70.42 -23.6 62.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.813 -0.63 . . . . 10.0 110.458 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 16.9 mttp -79.26 -23.53 43.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.823 -0.626 . . . . 10.0 110.557 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 C--N 1.323 -0.544 0 CA-C-N 116.208 -0.451 . . . . 10.0 111.422 -179.989 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.176 0 CA-C-O 121.047 0.451 . . . . 10.0 110.84 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 98.1 mmm -93.82 90.08 6.39 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.436 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 63' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -67.8 126.06 28.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.878 -0.601 . . . . 10.0 110.345 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -96.29 130.47 43.38 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.806 0.336 . . . . 10.0 110.768 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 21.8 pt -121.38 8.17 6.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.894 -0.593 . . . . 10.0 110.438 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 171.1 178.03 41.34 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.043 -0.823 . . . . 10.0 111.043 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 67' ' ' LYS . . . . . 0.507 ' O ' ' HB2' ' B' ' 68' ' ' MET . 28.2 mtmm -67.74 106.13 2.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 117.04 0.42 . . . . 10.0 109.987 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 68' ' ' MET . . . . . 0.507 ' HB2' ' O ' ' B' ' 67' ' ' LYS . 45.6 mtm 78.08 -0.59 2.63 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 124.093 0.87 . . . . 10.0 111.482 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 69' ' ' ARG . . . . . 0.472 ' HG3' ' HB3' ' B' ' 86' ' ' GLU . 6.3 mpt_? -99.12 122.17 41.97 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.771 -0.455 . . . . 10.0 109.771 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -128.84 168.32 16.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.342 0.592 . . . . 10.0 111.806 -178.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 58.4 t -107.27 102.67 14.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 108.103 -1.073 . . . . 10.0 108.103 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 72' ' ' SER . . . . . 0.545 ' HB3' ' HB3' ' B' ' 83' ' ' ASP . 1.4 t -84.94 88.05 7.4 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.493 0.553 . . . . 10.0 112.493 -177.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 44.6 t -89.03 100.14 10.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 107.851 -1.166 . . . . 10.0 107.851 177.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 74' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' B' ' 74' ' ' ARG . 15.1 ptt-85 -131.91 162.7 30.02 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.195 0.522 . . . . 10.0 111.827 -177.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -95.51 108.49 20.73 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.514 -0.766 . . . . 10.0 109.135 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -93.13 84.63 4.87 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.459 -0.337 . . . . 10.0 110.56 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 72.6 mttt 59.51 45.42 13.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.613 -0.722 . . . . 10.0 111.759 179.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.0 5.37 70.82 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.804 -0.713 . . . . 10.0 112.377 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -118.47 101.88 8.49 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.135 -0.32 . . . . 10.0 110.135 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 80' ' ' VAL . . . . . 0.516 ' O ' ' HD3' ' B' ' 106' ' ' PRO . 12.9 t -65.31 115.29 3.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.654 -0.499 . . . . 10.0 109.654 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 78.9 mt -124.48 132.36 53.49 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.114 0.483 . . . . 10.0 111.602 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 82' ' ' ILE . . . . . . . . . . . . . 5.1 mp -94.88 91.14 2.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 107.647 -1.242 . . . . 10.0 107.647 177.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 83' ' ' ASP . . . . . 0.587 ' HA ' ' HA ' ' B' ' 103' ' ' SER . 38.7 t70 -89.3 103.19 15.84 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.388 -0.824 . . . . 10.0 111.74 -177.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 60.2 mt -80.49 107.75 13.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 107.585 -1.265 . . . . 10.0 107.585 177.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 85' ' ' ARG . . . . . 0.621 ' HD3' ' O ' ' B' ' 98' ' ' GLY . 27.0 ttm-85 -152.85 154.07 34.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.02 0.438 . . . . 10.0 111.744 -176.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 86' ' ' GLU . . . . . 0.472 ' HB3' ' HG3' ' B' ' 69' ' ' ARG . 4.1 pt-20 -93.74 150.06 20.71 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.047 -0.524 . . . . 10.0 109.781 178.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 87' ' ' TYR . . . . . 0.803 ' HB3' ' HB3' ' B' ' 95' ' ' MET . 15.7 m-85 -119.54 127.54 53.11 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.195 -0.457 . . . . 10.0 110.43 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 88' ' ' TRP . . . . . . . . . . . . . 2.2 m0 -108.83 136.34 48.55 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.578 -0.527 . . . . 10.0 109.578 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 42.8 ttm -74.66 126.37 30.7 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.976 0.417 . . . . 10.0 110.341 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 90' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.0 171.62 6.38 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.804 -0.634 . . . . 10.0 110.976 -179.042 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -52.71 -32.1 53.67 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 123.163 2.575 . . . . 10.0 113.392 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.05 -28.95 65.86 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.944 0.402 . . . . 10.0 110.269 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 106.84 16.06 14.94 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.826 -0.702 . . . . 10.0 112.214 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 94' ' ' GLU . . . . . 0.535 ' HB2' ' HE2' ' B' ' 96' ' ' LYS . 48.3 mt-10 -106.8 147.74 29.33 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.921 -0.4 . . . . 10.0 109.921 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 95' ' ' MET . . . . . 0.803 ' HB3' ' HB3' ' B' ' 87' ' ' TYR . 89.7 mmm -82.69 105.89 14.09 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.427 -0.583 . . . . 10.0 109.427 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 96' ' ' LYS . . . . . 0.535 ' HE2' ' HB2' ' B' ' 94' ' ' GLU . 73.5 mmtt -88.06 126.69 60.14 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.964 -0.562 . . . . 10.0 111.164 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -65.4 123.97 12.23 Favored 'Trans proline' 0 C--O 1.237 0.452 0 C-N-CA 122.584 2.189 . . . . 10.0 111.459 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 98' ' ' GLY . . . . . 0.621 ' O ' ' HD3' ' B' ' 85' ' ' ARG . . . -60.45 164.45 15.48 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.818 -0.628 . . . . 10.0 113.537 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 52.4 mtm180 -77.11 -4.03 42.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.985 0.422 . . . . 10.0 111.005 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 100' ' ' LYS . . . . . 0.523 ' HD3' HD22 ' C' ' 483' ' ' LEU . 38.1 mttm -114.64 115.07 26.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.171 -0.468 . . . . 10.0 110.722 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -175.93 174.41 46.89 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.681 -0.968 . . . . 10.0 110.681 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 16.3 tt -141.84 122.16 11.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.229 0.537 . . . . 10.0 111.354 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 103' ' ' SER . . . . . 0.587 ' HA ' ' HA ' ' B' ' 83' ' ' ASP . 1.2 m -93.07 102.67 15.0 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.879 -0.6 . . . . 10.0 110.173 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 95.2 mt -96.12 132.35 41.61 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.137 -0.483 . . . . 10.0 111.272 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 105' ' ' ASN . . . . . 0.628 ' ND2' ' HB3' ' B' ' 107' ' ' GLU . 23.7 p-10 -84.08 163.61 47.47 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 108.586 -0.894 . . . . 10.0 108.586 178.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 106' ' ' PRO . . . . . 0.516 ' HD3' ' O ' ' B' ' 80' ' ' VAL . 72.4 Cg_exo -49.38 -32.83 27.39 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.734 2.289 . . . . 10.0 112.542 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 107' ' ' GLU . . . . . 0.628 ' HB3' ' ND2' ' B' ' 105' ' ' ASN . 13.4 tt0 -61.75 -57.94 9.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.762 -0.654 . . . . 10.0 111.059 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -74.05 -28.47 61.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.807 0.337 . . . . 10.0 110.619 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 109' ' ' TRP . . . . . 0.45 ' HH2' HG12 ' A' ' 116' ' ' ILE . 28.8 t-105 -60.26 -43.16 96.39 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.506 -0.553 . . . . 10.0 109.506 178.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 110' ' ' SER . . . . . 0.467 ' O ' ' HG3' ' B' ' 114' ' ' GLU . 37.3 t -63.51 -44.96 92.77 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.505 -0.554 . . . . 10.0 109.505 178.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -58.36 -40.04 81.18 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.68 -0.691 . . . . 10.0 110.613 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 112' ' ' LEU . . . . . 0.555 ' O ' HG13 ' B' ' 116' ' ' ILE . 20.8 tp -59.93 -45.31 93.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 10.0 110.191 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -63.86 -33.6 76.06 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.853 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 114' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' B' ' 110' ' ' SER . 35.9 mt-10 -74.36 -45.61 45.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.998 -0.546 . . . . 10.0 110.648 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -62.93 -18.25 62.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.589 -0.732 . . . . 10.0 112.181 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 116' ' ' ILE . . . . . 0.555 HG13 ' O ' ' B' ' 112' ' ' LEU . 67.8 mt -53.38 -38.25 31.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.778 0.323 . . . . 10.0 110.605 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.19 -28.86 67.03 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.815 -0.63 . . . . 10.0 111.826 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -98.96 -40.13 8.22 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.715 0.293 . . . . 10.0 111.412 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 119' ' ' ILE . . . . . 0.418 ' O ' HG23 ' B' ' 123' ' ' VAL . 83.0 mt -62.79 -48.2 89.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 10.0 110.69 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -63.01 -31.46 72.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.225 0.536 . . . . 10.0 110.377 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -63.96 -36.59 84.47 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.436 -0.802 . . . . 10.0 110.048 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -77.52 -40.53 42.38 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.853 -0.612 . . . . 10.0 110.821 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 123' ' ' VAL . . . . . 0.418 HG23 ' O ' ' B' ' 119' ' ' ILE . 94.1 t -61.48 -43.14 96.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.069 -0.514 . . . . 10.0 111.52 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -70.55 -10.77 60.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.684 0.278 . . . . 10.0 111.602 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -104.12 2.57 32.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.751 0.31 . . . . 10.0 110.933 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.457 HD13 HG11 ' A' ' 80' ' ' VAL . 72.5 mt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.324 -0.846 . . . . 10.0 110.238 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 465' ' ' TYR . . . . . 0.495 ' HD2' ' HB2' ' A' ' 92' ' ' GLU . 31.3 t80 . . . . . 0 N--CA 1.48 1.059 0 CA-C-O 120.684 0.278 . . . . 10.0 110.939 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 466' ' ' GLY . . . . . . . . . . . . . . . -54.38 -31.78 51.35 Favored Glycine 0 C--N 1.334 0.437 0 CA-C-N 116.306 -0.406 . . . . 10.0 113.955 -179.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 467' ' ' ALA . . . . . . . . . . . . . . . -58.09 -40.12 80.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 117.024 0.412 . . . . 10.0 111.596 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 468' ' ' LEU . . . . . . . . . . . . . 40.4 tp -91.51 -33.75 15.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.996 0.427 . . . . 10.0 110.523 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 469' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -62.77 -46.88 85.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.697 -0.683 . . . . 10.0 111.476 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 470' ' ' MET . . . . . . . . . . . . . 49.8 ttm -60.14 -32.63 71.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.132 -0.485 . . . . 10.0 111.227 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 471' ' ' ALA . . . . . . . . . . . . . . . -62.29 -39.69 93.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.967 0.413 . . . . 10.0 110.859 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 472' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -80.14 -44.03 20.61 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.192 -0.458 . . . . 10.0 110.345 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 473' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -59.4 -42.04 90.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.77 -0.65 . . . . 10.0 111.054 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 474' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.49 -42.32 95.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.293 -0.412 . . . . 10.0 110.124 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 475' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -62.96 -47.79 81.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.974 -0.557 . . . . 10.0 110.287 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 476' ' ' GLU . . . . . 0.686 ' HB2' HH21 ' A' ' 99' ' ' ARG . 9.6 tp10 -62.04 -41.62 98.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.959 -0.564 . . . . 10.0 110.858 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 477' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -59.13 -44.92 92.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.377 -0.374 . . . . 10.0 110.462 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 478' ' ' MET . . . . . . . . . . . . . 13.8 tpp -70.04 -38.87 75.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 10.0 110.47 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 479' ' ' PHE . . . . . 0.401 ' HD1' ' HA ' ' C' ' 479' ' ' PHE . 0.1 OUTLIER -63.26 -29.06 70.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.389 0.614 . . . . 10.0 109.991 179.242 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 480' ' ' THR . . . . . 0.453 HG23 ' OG ' ' A' ' 103' ' ' SER . 88.2 m -82.4 -43.21 17.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.333 -0.849 . . . . 10.0 110.121 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 481' ' ' ASP . . . . . 0.556 ' OD1' ' HB3' ' A' ' 76' ' ' PHE . 3.9 t70 -59.59 -37.31 78.21 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.32 -0.855 . . . . 10.0 111.14 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 482' ' ' ALA . . . . . . . . . . . . . . . -98.01 17.18 18.93 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.125 -0.489 . . . . 10.0 111.76 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 483' ' ' LEU . . . . . 0.635 HD23 ' H ' ' A' ' 103' ' ' SER . 29.9 tp -81.38 -78.08 0.2 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.79 0.328 . . . . 10.0 110.547 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 484' ' ' GLY . . . . . . . . . . . . . . . -88.57 33.87 4.02 Favored Glycine 0 C--O 1.229 -0.168 0 C-N-CA 120.796 -0.716 . . . . 10.0 112.067 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 485' ' ' ILE . . . . . 0.534 HG13 ' HE3' ' A' ' 79' ' ' LYS . 12.9 tt -72.79 -31.11 35.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.797 0.332 . . . . 10.0 111.298 -178.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 486' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -81.61 -20.5 39.63 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.477 -0.329 . . . . 10.0 111.412 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 487' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -92.97 -7.89 44.63 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.48 -0.327 . . . . 10.0 111.599 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 488' ' ' TYR . . . . . 0.509 ' CZ ' ' HA ' ' A' ' 79' ' ' LYS . 7.0 t80 -63.57 104.02 0.6 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.921 0.391 . . . . 10.0 110.499 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 489' ' ' GLY . . . . . . . . . . . . . . . 90.18 8.88 66.07 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.783 -0.722 . . . . 10.0 112.104 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.929 0 CA-C-O 118.715 -1.047 . . . . 10.0 111.972 179.757 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.499 ' O ' ' HA ' ' A' ' 72' ' ' SER . . . . . . . . 0 N--CA 1.477 0.889 0 CA-C-O 120.681 0.276 . . . . 10.0 110.506 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 24.0 mmt -123.23 92.78 3.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.239 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.558 ' HB2' ' HB ' ' A' ' 71' ' ' VAL . 91.8 m-85 -96.34 121.09 37.75 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.734 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -87.13 120.11 28.06 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.796 0.332 . . . . 10.0 110.174 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.3 pt -110.23 0.13 9.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.064 0.459 . . . . 10.0 111.063 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.697 ' HA3' ' HG2' ' B' ' 108' ' ' GLN . . . 170.19 -178.64 42.86 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.583 -0.818 . . . . 10.0 111.964 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.449 ' HG2' ' HG2' ' A' ' 68' ' ' MET . 57.0 tttp -65.9 114.25 4.98 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.457 0.17 . . . . 10.0 110.92 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.449 ' HG2' ' HG2' ' A' ' 67' ' ' LYS . 71.5 mmm 69.15 18.78 8.15 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 123.917 0.761 . . . . 10.0 111.663 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -121.83 112.6 18.55 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.934 -0.395 . . . . 10.0 109.934 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -124.91 144.08 50.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.392 0.615 . . . . 10.0 111.671 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.558 ' HB ' ' HB2' ' A' ' 63' ' ' PHE . 48.0 t -104.0 107.22 21.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.177 -0.92 . . . . 10.0 109.037 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 61' ' ' ALA . 1.5 p -102.5 92.48 4.68 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.168 0.508 . . . . 10.0 112.059 -178.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.439 HG22 HG23 ' A' ' 82' ' ' ILE . 16.9 t -83.47 100.54 7.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.085 -0.507 . . . . 10.0 110.003 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.65 156.72 38.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.393 -0.367 . . . . 10.0 110.363 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.51 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 1.1 t70 -83.49 136.07 34.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.145 -0.479 . . . . 10.0 110.86 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.808 ' HE1' ' HG2' ' C' ' 477' ' ' GLN . 1.1 m-85 -135.24 98.73 4.05 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.075 -0.511 . . . . 10.0 110.672 179.054 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.546 ' HE3' ' HB3' ' C' ' 477' ' ' GLN . 84.3 mttt 59.91 42.3 16.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.632 -0.713 . . . . 10.0 111.004 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.32 51.82 3.99 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.634 -0.793 . . . . 10.0 111.556 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.525 ' HG3' ' HE2' ' C' ' 488' ' ' TYR . 0.0 OUTLIER -138.02 89.81 2.43 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.058 -0.349 . . . . 10.0 110.058 -179.626 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.3 t -95.49 91.55 2.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.641 -0.503 . . . . 10.0 109.641 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.734 HD13 ' HB3' ' A' ' 103' ' ' SER . 0.5 OUTLIER -157.14 174.06 16.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.9 -0.591 . . . . 10.0 111.181 -179.08 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.439 HG23 HG22 ' A' ' 73' ' ' VAL . 69.7 mt -88.65 88.87 3.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.267 -0.642 . . . . 10.0 109.267 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.488 ' HA ' ' HA ' ' A' ' 103' ' ' SER . 32.1 t70 -84.39 117.59 23.72 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.86 -0.609 . . . . 10.0 111.806 -178.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.422 HG12 HG13 ' A' ' 71' ' ' VAL . 58.4 mt -103.93 137.54 32.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.97 -0.559 . . . . 10.0 109.642 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.453 ' HD3' ' HD2' ' C' ' 479' ' ' PHE . 10.4 ttm180 -144.92 146.41 31.98 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.711 -0.477 . . . . 10.0 109.711 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -78.59 93.74 4.89 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.402 -0.592 . . . . 10.0 109.402 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 97' ' ' PRO . 16.4 m-85 -78.08 115.95 18.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.702 -0.681 . . . . 10.0 111.717 -178.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.417 ' CH2' ' HA3' ' A' ' 98' ' ' GLY . 35.1 m0 -99.19 -157.39 0.6 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.175 -0.676 . . . . 10.0 109.175 178.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 20.6 ttt -130.58 132.4 45.51 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.042 -0.355 . . . . 10.0 110.042 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.467 ' OD2' ' HB3' ' A' ' 94' ' ' GLU . 2.8 p30 -94.73 167.85 12.38 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 116.273 -0.421 . . . . 10.0 110.565 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -62.48 -14.92 42.28 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.124 2.549 . . . . 10.0 113.452 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.438 ' HA ' ' OE1' ' A' ' 92' ' ' GLU . 2.9 tp10 -83.7 -39.88 19.6 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.12 0.486 . . . . 10.0 110.044 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 123.75 19.19 2.81 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.787 -0.72 . . . . 10.0 112.518 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.467 ' HB3' ' OD2' ' A' ' 90' ' ' ASP . 21.5 tt0 -106.59 166.27 10.68 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.684 -0.487 . . . . 10.0 109.684 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 94.4 mmm -87.33 84.37 7.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.877 0.37 . . . . 10.0 110.484 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.657 ' HE2' ' HA ' ' A' ' 96' ' ' LYS . 0.3 OUTLIER -90.07 108.16 24.24 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.153 -0.476 . . . . 10.0 110.05 179.164 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.625 ' HD2' ' HE2' ' A' ' 96' ' ' LYS . 58.6 Cg_endo -73.95 152.72 46.73 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.251 1.967 . . . . 10.0 112.821 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.417 ' HA3' ' CH2' ' A' ' 88' ' ' TRP . . . -94.24 178.93 37.5 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 111.038 -0.825 . . . . 10.0 111.038 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -78.53 71.59 5.0 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.243 0.544 . . . . 10.0 110.345 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 24.7 ttmt -161.97 133.88 5.55 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.242 -0.89 . . . . 10.0 109.672 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 154.37 -169.47 32.74 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.958 -0.639 . . . . 10.0 111.652 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 20.4 tt -168.91 139.63 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.745 0.307 . . . . 10.0 110.42 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.734 ' HB3' HD13 ' A' ' 81' ' ' LEU . 0.7 OUTLIER -96.01 145.01 25.8 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.506 -0.315 . . . . 10.0 110.268 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 45.6 mt -121.93 117.56 26.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.461 -0.336 . . . . 10.0 110.176 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.673 ' HB3' ' HG3' ' C' ' 487' ' ' GLU . 2.7 p30 -78.61 164.24 56.84 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 109.969 -0.382 . . . . 10.0 109.969 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.545 ' HD2' ' HB2' ' A' ' 105' ' ' ASN . 1.7 Cg_endo -43.22 -45.68 9.66 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.732 2.954 . . . . 10.0 113.866 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -64.01 -42.56 97.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.493 0.187 . . . . 10.0 111.135 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -63.84 -43.6 95.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.991 0.424 . . . . 10.0 110.011 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.534 ' HZ2' ' HB2' ' B' ' 120' ' ' ASP . 62.6 t-105 -59.27 -41.83 89.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.651 -0.704 . . . . 10.0 110.867 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.5 m -66.81 -43.9 82.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.851 -0.613 . . . . 10.0 111.115 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -68.35 -38.95 81.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.36 -0.382 . . . . 10.0 111.038 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.2 tp -59.08 -44.31 91.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.316 -0.402 . . . . 10.0 110.958 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -64.65 -32.54 74.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.272 -0.422 . . . . 10.0 111.1 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -75.45 -33.32 60.87 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.034 0.445 . . . . 10.0 110.888 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -77.81 -8.47 58.06 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.411 0.522 . . . . 10.0 112.411 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 74.7 mt -54.68 -44.46 70.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.674 0.273 . . . . 10.0 111.291 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.31 -19.78 62.17 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.147 -0.479 . . . . 10.0 111.911 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.407 ' HB3' ' CE1' ' B' ' 63' ' ' PHE . 0.6 OUTLIER -101.26 -48.4 4.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.755 0.312 . . . . 10.0 110.718 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.653 HG23 HG21 ' B' ' 73' ' ' VAL . 87.6 mt -58.02 -51.43 70.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.893 -0.594 . . . . 10.0 110.931 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -60.04 -35.66 75.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.73 -0.668 . . . . 10.0 111.38 -178.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.461 ' HA ' ' CZ ' ' A' ' 124' ' ' ARG . 6.9 t70 -66.12 -38.24 87.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.879 0.371 . . . . 10.0 110.259 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.54 -38.29 83.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.128 -0.487 . . . . 10.0 110.1 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 119' ' ' ILE . 59.7 t -63.15 -39.56 85.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.879 -0.6 . . . . 10.0 110.1 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.461 ' CZ ' ' HA ' ' A' ' 121' ' ' ASP . 25.2 mtm105 -72.92 -30.36 63.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.95 -0.568 . . . . 10.0 110.873 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 35.2 mttp -70.98 -35.06 71.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.262 -0.427 . . . . 10.0 110.905 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 26.6 mt . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 116.325 -0.398 . . . . 10.0 110.795 179.88 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.17 0 CA-C-O 121.183 0.516 . . . . 10.0 110.735 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 20.4 mmm -103.45 102.22 12.13 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.079 -0.712 . . . . 10.0 109.079 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 63' ' ' PHE . . . . . 0.419 ' CE2' ' HA ' ' A' ' 119' ' ' ILE . 34.8 m-85 -94.6 114.93 26.97 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.882 -0.599 . . . . 10.0 111.443 -178.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -75.56 121.57 22.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.813 -0.631 . . . . 10.0 110.522 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 12.6 pt -116.05 13.23 7.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.248 -0.433 . . . . 10.0 110.856 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 167.7 -179.31 41.16 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.778 -0.646 . . . . 10.0 111.874 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 67' ' ' LYS . . . . . 0.507 ' O ' ' HD2' ' B' ' 69' ' ' ARG . 0.3 OUTLIER -69.55 111.22 5.23 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.895 0.378 . . . . 10.0 110.06 -179.758 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 68' ' ' MET . . . . . 0.459 ' HB2' ' O ' ' B' ' 67' ' ' LYS . 49.2 mtp 73.17 8.75 5.31 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.2 -0.909 . . . . 10.0 111.175 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 69' ' ' ARG . . . . . 0.507 ' HD2' ' O ' ' B' ' 67' ' ' LYS . 1.5 mpt_? -105.1 118.95 37.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.496 -0.32 . . . . 10.0 110.213 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -132.74 124.09 27.47 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.881 0.372 . . . . 10.0 111.725 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.457 HG12 HG23 ' B' ' 73' ' ' VAL . 46.7 t -76.4 105.32 5.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.716 -0.846 . . . . 10.0 108.716 178.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 5.2 m -84.21 87.77 7.19 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.949 -0.569 . . . . 10.0 111.665 -178.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.653 HG21 HG23 ' A' ' 119' ' ' ILE . 67.5 t -93.87 120.14 42.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.31 -0.626 . . . . 10.0 109.31 178.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 74' ' ' ARG . . . . . 0.647 HH12 ' HB2' ' B' ' 83' ' ' ASP . 0.1 OUTLIER -164.43 172.9 12.77 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.217 -0.447 . . . . 10.0 110.45 -179.375 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -94.11 118.29 31.32 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.047 -0.524 . . . . 10.0 109.91 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -108.36 92.69 4.16 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.307 -0.406 . . . . 10.0 110.306 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 93.5 mttt 60.72 33.44 20.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.357 -0.838 . . . . 10.0 111.824 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 102.78 -1.97 48.68 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.619 -0.801 . . . . 10.0 113.146 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -119.37 115.99 25.26 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 122.596 -0.355 . . . . 10.0 111.216 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 80' ' ' VAL . . . . . 0.486 ' O ' ' HD3' ' B' ' 106' ' ' PRO . 28.5 t -75.64 106.6 5.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.172 -0.677 . . . . 10.0 109.172 178.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 80.6 mt -107.68 127.85 54.03 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.188 0.518 . . . . 10.0 112.163 -178.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 82' ' ' ILE . . . . . . . . . . . . . 5.0 mp -92.47 95.62 5.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 107.503 -1.295 . . . . 10.0 107.503 177.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 83' ' ' ASP . . . . . 0.647 ' HB2' HH12 ' B' ' 74' ' ' ARG . 3.4 t70 -91.07 117.42 29.58 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 112.677 0.621 . . . . 10.0 112.677 -177.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 77.9 mt -100.16 98.9 7.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 107.953 -1.129 . . . . 10.0 107.953 177.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 85' ' ' ARG . . . . . 0.54 ' HG3' ' HA3' ' B' ' 101' ' ' GLY . 8.9 ttm-85 -147.64 166.35 27.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.227 -0.442 . . . . 10.0 111.238 -177.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.87 157.07 17.46 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.917 -0.771 . . . . 10.0 108.917 178.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 87' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -121.03 120.73 36.22 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.961 0.41 . . . . 10.0 110.513 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 88' ' ' TRP . . . . . . . . . . . . . 36.2 m95 -103.52 138.32 40.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.764 -0.653 . . . . 10.0 110.173 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 89' ' ' MET . . . . . 0.503 ' HA ' ' O ' ' B' ' 94' ' ' GLU . 58.1 ttm -91.21 132.28 36.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.756 0.312 . . . . 10.0 110.668 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 90' ' ' ASP . . . . . 0.514 ' HB2' ' HD2' ' B' ' 91' ' ' PRO . 8.7 p30 -91.97 173.14 5.52 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 116.298 -0.41 . . . . 10.0 110.144 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 91' ' ' PRO . . . . . 0.514 ' HD2' ' HB2' ' B' ' 90' ' ' ASP . 39.5 Cg_exo -59.45 -26.28 81.43 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.482 2.121 . . . . 10.0 112.489 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -71.36 -26.43 62.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.004 0.431 . . . . 10.0 110.147 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 104.85 16.71 16.29 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.986 -0.626 . . . . 10.0 112.643 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 94' ' ' GLU . . . . . 0.503 ' O ' ' HA ' ' B' ' 89' ' ' MET . 16.3 mt-10 -98.22 155.23 17.28 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.893 0.378 . . . . 10.0 110.749 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 95' ' ' MET . . . . . . . . . . . . . 98.8 mmm -101.62 100.46 10.86 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.66 -0.496 . . . . 10.0 109.66 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 96' ' ' LYS . . . . . 0.414 ' HA ' ' HD3' ' B' ' 97' ' ' PRO . 71.8 mmtt -97.75 140.14 21.77 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 116.164 -0.471 . . . . 10.0 110.895 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 97' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' B' ' 96' ' ' LYS . 38.2 Cg_exo -60.31 143.16 99.49 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 122.569 2.179 . . . . 10.0 111.337 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.47 168.62 21.24 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 116.1 -0.5 . . . . 10.0 112.923 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 99' ' ' ARG . . . . . 0.441 HH11 ' HD2' ' B' ' 99' ' ' ARG . 8.1 mmt180 -79.85 -3.76 49.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.076 0.465 . . . . 10.0 111.136 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 100' ' ' LYS . . . . . 0.403 ' HB2' ' H ' ' B' ' 101' ' ' GLY . 3.9 pttp -117.79 -160.35 0.78 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.984 -0.746 . . . . 10.0 108.984 178.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 101' ' ' GLY . . . . . 0.54 ' HA3' ' HG3' ' B' ' 85' ' ' ARG . . . 108.53 168.24 21.05 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.655 -0.783 . . . . 10.0 112.386 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 20.9 tt -144.82 139.99 23.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.942 0.401 . . . . 10.0 110.869 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 3.8 m -102.69 110.3 22.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.006 -0.543 . . . . 10.0 110.003 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 92.9 mt -104.06 135.18 46.05 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.053 0.454 . . . . 10.0 111.24 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 105' ' ' ASN . . . . . 0.554 ' ND2' ' HB3' ' B' ' 107' ' ' GLU . 34.1 p-10 -93.1 165.77 17.78 Favored Pre-proline 0 C--N 1.317 -0.83 0 N-CA-C 108.698 -0.853 . . . . 10.0 108.698 178.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 106' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' B' ' 80' ' ' VAL . 73.7 Cg_exo -50.39 -32.43 33.83 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.505 2.137 . . . . 10.0 112.51 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 107' ' ' GLU . . . . . 0.554 ' HB3' ' ND2' ' B' ' 105' ' ' ASN . 6.4 tt0 -63.29 -53.51 51.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.607 -0.724 . . . . 10.0 110.948 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 108' ' ' GLN . . . . . 0.697 ' HG2' ' HA3' ' A' ' 66' ' ' GLY . 76.3 mt-30 -75.01 -30.49 61.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.925 0.393 . . . . 10.0 110.307 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 109' ' ' TRP . . . . . . . . . . . . . 46.7 t-105 -59.55 -41.26 89.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.771 -0.649 . . . . 10.0 109.777 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 110' ' ' SER . . . . . 0.627 ' HA ' ' HE3' ' B' ' 113' ' ' LYS . 22.9 t -63.32 -49.32 74.44 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.609 -0.515 . . . . 10.0 109.609 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -58.6 -40.6 83.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.683 -0.689 . . . . 10.0 110.96 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 112' ' ' LEU . . . . . 0.545 ' O ' HG13 ' B' ' 116' ' ' ILE . 63.5 tp -58.28 -44.68 88.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.557 -0.292 . . . . 10.0 110.214 178.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 113' ' ' LYS . . . . . 0.627 ' HE3' ' HA ' ' B' ' 110' ' ' SER . 51.2 mtmt -62.98 -41.64 99.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.109 -0.496 . . . . 10.0 110.529 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -68.81 -35.52 77.09 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.72 -0.673 . . . . 10.0 111.41 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 115' ' ' GLN . . . . . 0.426 ' HA ' ' OE1' ' B' ' 115' ' ' GLN . 13.6 mm-40 -75.27 -14.75 60.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.254 -0.43 . . . . 10.0 111.398 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 116' ' ' ILE . . . . . 0.545 HG13 ' O ' ' B' ' 112' ' ' LEU . 56.3 mt -57.99 -37.76 63.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 120.705 0.288 . . . . 10.0 110.6 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 1.1 m -65.0 -7.26 10.96 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.066 -0.516 . . . . 10.0 111.706 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -116.7 -47.11 2.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.056 0.455 . . . . 10.0 110.424 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 119' ' ' ILE . . . . . 0.529 ' O ' HG23 ' B' ' 123' ' ' VAL . 65.9 mt -64.66 -49.33 80.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.809 -0.632 . . . . 10.0 111.821 -179.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 120' ' ' ASP . . . . . 0.534 ' HB2' ' HZ2' ' A' ' 109' ' ' TRP . 34.2 t70 -58.1 -40.03 80.12 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.922 0.391 . . . . 10.0 111.106 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -64.66 -36.99 86.06 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.829 -0.623 . . . . 10.0 110.513 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.42 -24.85 60.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.942 -0.572 . . . . 10.0 111.599 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 123' ' ' VAL . . . . . 0.529 HG23 ' O ' ' B' ' 119' ' ' ILE . 89.3 t -58.53 -37.63 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 121.04 0.448 . . . . 10.0 110.847 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -100.6 16.42 24.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.309 -0.405 . . . . 10.0 110.809 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -132.83 31.35 3.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.172 -0.467 . . . . 10.0 110.247 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 82.3 mt . . . . . 0 C--O 1.247 0.944 0 CA-C-O 118.607 -0.711 . . . . 10.0 110.32 179.826 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 465' ' ' TYR . . . . . . . . . . . . . 4.2 t80 . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 120.75 0.309 . . . . 10.0 110.811 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 466' ' ' GLY . . . . . . . . . . . . . . . -80.34 33.42 2.26 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 121.087 -0.577 . . . . 10.0 114.109 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 467' ' ' ALA . . . . . . . . . . . . . . . -85.03 -27.43 26.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.355 0.598 . . . . 10.0 110.136 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 468' ' ' LEU . . . . . . . . . . . . . 13.8 tp -85.88 72.67 10.47 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.599 -0.728 . . . . 10.0 110.054 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 469' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -139.59 -114.97 0.14 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.016 -0.538 . . . . 10.0 110.672 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 470' ' ' MET . . . . . . . . . . . . . 57.3 mmm -59.18 -31.09 68.68 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 111.825 0.305 . . . . 10.0 111.825 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 471' ' ' ALA . . . . . 0.431 ' O ' ' HB2' ' C' ' 475' ' ' PHE . . . -60.04 -48.3 82.28 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.266 -0.424 . . . . 10.0 110.804 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 472' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -78.96 -30.62 44.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 10.0 110.386 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 473' ' ' PHE . . . . . 0.457 ' O ' ' HG3' ' C' ' 477' ' ' GLN . 44.9 t80 -50.95 -59.85 3.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.233 -0.894 . . . . 10.0 111.199 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 474' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -74.71 -26.44 59.81 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.492 -0.322 . . . . 10.0 110.817 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 475' ' ' PHE . . . . . 0.431 ' HB2' ' O ' ' C' ' 471' ' ' ALA . 9.9 t80 -57.73 -47.35 82.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.887 0.375 . . . . 10.0 111.243 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 476' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -78.61 -33.54 47.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.371 -0.377 . . . . 10.0 111.062 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 477' ' ' GLN . . . . . 0.808 ' HG2' ' HE1' ' A' ' 76' ' ' PHE . 26.3 mt-30 -64.75 -56.27 14.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.436 -0.347 . . . . 10.0 110.829 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 478' ' ' MET . . . . . 0.526 ' HA ' ' OD2' ' C' ' 481' ' ' ASP . 21.2 ttt -59.27 -31.85 69.48 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.521 -0.763 . . . . 10.0 111.826 -178.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 479' ' ' PHE . . . . . 0.453 ' HD2' ' HD3' ' A' ' 85' ' ' ARG . 9.8 t80 -62.72 -37.3 85.98 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.517 -0.473 . . . . 10.0 110.525 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 480' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.81 -31.14 70.79 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.296 0.57 . . . . 10.0 109.841 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 481' ' ' ASP . . . . . 0.692 ' O ' ' HB ' ' C' ' 485' ' ' ILE . 61.5 m-20 -66.69 -31.99 73.01 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-N 115.397 -0.819 . . . . 10.0 109.594 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 482' ' ' ALA . . . . . . . . . . . . . . . -85.57 -36.68 20.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.795 -0.639 . . . . 10.0 111.174 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 483' ' ' LEU . . . . . . . . . . . . . 11.9 mt -65.68 -47.36 75.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.342 -0.39 . . . . 10.0 110.778 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 484' ' ' GLY . . . . . 0.451 ' HA2' ' HB2' ' C' ' 487' ' ' GLU . . . -110.19 37.83 3.58 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.423 -0.894 . . . . 10.0 113.203 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 485' ' ' ILE . . . . . 0.692 ' HB ' ' O ' ' C' ' 481' ' ' ASP . 6.9 tt -76.73 -39.22 31.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.185 0.517 . . . . 10.0 110.647 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 486' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -104.16 4.92 34.59 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.024 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 487' ' ' GLU . . . . . 0.673 ' HG3' ' HB3' ' A' ' 105' ' ' ASN . 14.6 tp10 -71.64 -22.74 61.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.676 -0.693 . . . . 10.0 110.751 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 488' ' ' TYR . . . . . 0.525 ' HE2' ' HG3' ' A' ' 79' ' ' LYS . 6.2 m-85 -78.8 58.6 2.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.754 0.787 . . . . 10.0 109.681 178.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 489' ' ' GLY . . . . . . . . . . . . . . . 149.39 35.55 0.04 OUTLIER Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 114.748 -1.114 . . . . 10.0 110.611 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.647 0 CA-C-O 118.82 -0.989 . . . . 10.0 111.31 -179.81 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.624 ' HB3' ' HB ' ' A' ' 73' ' ' VAL . . . . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 109.827 -0.434 . . . . 10.0 109.827 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.549 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 41.7 ttm -112.29 103.04 11.16 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.107 0.479 . . . . 10.0 111.316 -179.03 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.474 ' HB2' ' HB ' ' A' ' 71' ' ' VAL . 88.1 m-85 -89.42 173.95 8.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.903 -0.59 . . . . 10.0 109.577 179.15 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.426 ' HG2' ' H ' ' A' ' 66' ' ' GLY . 39.9 tt0 -127.42 126.55 42.6 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.615 0.245 . . . . 10.0 110.64 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.586 HD11 HG23 ' A' ' 84' ' ' ILE . 10.7 pt -117.39 15.44 7.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.321 -0.4 . . . . 10.0 110.885 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.426 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 154.07 175.75 25.66 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.312 -0.947 . . . . 10.0 112.595 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.606 ' HG2' ' HG2' ' A' ' 68' ' ' MET . 42.0 tttp -60.12 113.48 2.37 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 122.698 0.399 . . . . 10.0 110.91 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.606 ' HG2' ' HG2' ' A' ' 67' ' ' LYS . 66.8 mmm 69.87 17.68 7.51 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 123.784 0.678 . . . . 10.0 111.644 179.006 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.482 ' HB3' HG13 ' A' ' 65' ' ' ILE . 5.9 mpt_? -119.94 107.29 12.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.088 0.471 . . . . 10.0 109.936 178.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.509 ' HB3' ' HG2' ' A' ' 62' ' ' MET . 63.8 m-85 -115.3 152.0 33.55 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.728 -0.669 . . . . 10.0 110.838 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.638 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 23.4 t -102.05 111.59 32.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.421 -0.809 . . . . 10.0 110.203 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.633 ' HB2' ' HB3' ' A' ' 83' ' ' ASP . 0.9 OUTLIER -85.14 87.75 7.41 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.027 0.441 . . . . 10.0 111.43 -179.486 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.684 HG22 HG22 ' A' ' 82' ' ' ILE . 16.5 t -86.98 108.21 17.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.589 -0.893 . . . . 10.0 108.589 178.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -153.77 -179.64 8.01 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.306 0.574 . . . . 10.0 111.998 -178.219 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.523 ' HB2' HG22 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -120.53 123.02 41.88 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.814 -1.085 . . . . 10.0 109.075 178.457 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.558 ' CE2' ' HB ' ' C' ' 480' ' ' THR . 0.5 OUTLIER -115.67 86.11 2.41 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.014 0.435 . . . . 10.0 110.929 179.296 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt 57.35 41.49 26.38 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.257 -0.883 . . . . 10.0 111.348 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 112.38 -24.5 13.81 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.511 -0.852 . . . . 10.0 112.346 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.893 ' HE3' ' HA ' ' C' ' 485' ' ' ILE . 1.7 mppt? -84.3 82.72 8.26 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.887 0.375 . . . . 10.0 110.554 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.523 HG22 ' HB2' ' A' ' 75' ' ' ASP . 2.8 t -90.37 103.37 14.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 108.958 -0.756 . . . . 10.0 108.958 178.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.741 ' HB3' ' HA ' ' A' ' 105' ' ' ASN . 0.2 OUTLIER -157.97 174.19 15.63 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.952 0.406 . . . . 10.0 111.369 -178.479 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.684 HG22 HG22 ' A' ' 73' ' ' VAL . 38.7 pt -92.64 172.39 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.993 -0.549 . . . . 10.0 110.194 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.638 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 4.1 t70 -151.01 147.49 27.2 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.617 0.246 . . . . 10.0 111.216 -178.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.586 HG23 HD11 ' A' ' 65' ' ' ILE . 60.7 mt -121.22 106.83 19.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.326 -0.62 . . . . 10.0 109.326 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.489 ' HD3' HD11 ' C' ' 483' ' ' LEU . 60.2 mtm180 -129.72 151.89 49.82 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.949 0.404 . . . . 10.0 111.451 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -83.11 97.73 8.95 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.382 -0.97 . . . . 10.0 108.382 178.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 97' ' ' PRO . 18.6 m-85 -81.32 142.68 32.84 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.434 -0.803 . . . . 10.0 112.693 -177.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 13.8 m0 -128.6 177.25 7.16 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.489 -0.93 . . . . 10.0 108.489 178.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 1.1 ttt -103.97 127.51 51.51 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 110.059 -0.349 . . . . 10.0 110.059 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.515 ' OD2' ' HB2' ' A' ' 94' ' ' GLU . 4.2 p30 -85.02 167.21 27.43 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.636 -0.256 . . . . 10.0 110.359 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -61.63 -19.25 64.23 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.904 2.403 . . . . 10.0 113.403 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -77.68 -46.79 20.88 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.077 0.465 . . . . 10.0 110.006 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 133.36 15.79 1.25 Allowed Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.982 -0.628 . . . . 10.0 112.5 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.515 ' HB2' ' OD2' ' A' ' 90' ' ' ASP . 23.9 mt-10 -106.94 179.18 4.34 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.858 0.361 . . . . 10.0 110.386 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 85.7 mmm -106.55 109.93 21.99 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.205 -0.452 . . . . 10.0 110.737 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.462 ' HA ' ' HD3' ' A' ' 97' ' ' PRO . 48.5 mmtt -125.37 128.67 24.66 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.828 -0.623 . . . . 10.0 109.577 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.485 ' HD2' ' CE2' ' C' ' 475' ' ' PHE . 4.6 Cg_endo -82.63 177.28 7.07 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.078 2.519 . . . . 10.0 113.129 -179.081 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -100.82 -169.27 28.59 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.794 -0.639 . . . . 10.0 111.884 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -80.09 55.98 2.29 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.839 0.352 . . . . 10.0 111.282 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -160.6 132.98 6.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.261 -0.427 . . . . 10.0 110.231 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.446 ' HA3' ' HG2' ' A' ' 85' ' ' ARG . . . 172.19 -170.95 43.91 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.066 -0.588 . . . . 10.0 111.754 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.471 ' HB ' ' N ' ' B' ' 101' ' ' GLY . 8.9 tt -165.85 127.56 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.945 0.402 . . . . 10.0 110.897 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.583 ' HA ' ' HA ' ' A' ' 83' ' ' ASP . 51.7 m -105.56 145.05 31.47 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.235 -0.654 . . . . 10.0 109.235 178.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.423 HD11 HD11 ' A' ' 82' ' ' ILE . 0.5 OUTLIER -131.59 129.68 41.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.028 0.442 . . . . 10.0 110.351 179.71 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.741 ' HA ' ' HB3' ' A' ' 81' ' ' LEU . 3.5 p30 -75.25 164.0 64.08 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.36 -0.837 . . . . 10.0 111.263 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -48.27 -38.37 33.52 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.619 2.88 . . . . 10.0 114.224 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -65.31 -42.22 93.23 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.042 -0.355 . . . . 10.0 110.042 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -65.48 -45.37 83.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.136 0.493 . . . . 10.0 109.801 178.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 56.2 t-105 -56.79 -42.43 79.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.281 -0.872 . . . . 10.0 110.462 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.4 m -65.49 -46.42 79.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.269 -0.423 . . . . 10.0 110.605 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -61.5 -42.74 99.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.494 . . . . 10.0 110.847 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.438 ' O ' HG13 ' A' ' 116' ' ' ILE . 53.8 tp -57.85 -45.75 85.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.901 -0.591 . . . . 10.0 111.314 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -59.0 -42.47 90.15 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.328 -0.396 . . . . 10.0 111.322 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -74.04 -16.99 61.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.184 -0.462 . . . . 10.0 111.758 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -93.14 -10.6 35.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.745 0.307 . . . . 10.0 110.989 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 112' ' ' LEU . 70.7 mt -56.71 -37.53 53.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.571 -0.286 . . . . 10.0 111.45 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.14 -23.58 64.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.904 0.383 . . . . 10.0 111.397 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -97.73 -44.4 6.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.138 0.494 . . . . 10.0 110.088 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.498 ' O ' HG23 ' A' ' 123' ' ' VAL . 67.1 mt -60.25 -52.43 61.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.876 -0.602 . . . . 10.0 111.2 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -61.51 -33.82 74.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.995 -0.548 . . . . 10.0 110.268 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -66.41 -35.62 80.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.533 -0.758 . . . . 10.0 110.259 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.52 -37.42 63.09 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.932 -0.576 . . . . 10.0 110.767 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 119' ' ' ILE . 99.4 t -61.78 -34.54 62.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 10.0 110.805 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 13.9 mtm105 -78.05 -13.72 59.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.131 -0.486 . . . . 10.0 111.417 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -95.37 -31.48 13.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.862 0.363 . . . . 10.0 111.139 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 75.4 mt . . . . . 0 C--N 1.325 -0.48 0 CA-C-N 116.473 -0.33 . . . . 10.0 110.518 179.709 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.18 0 CA-C-O 121.019 0.438 . . . . 10.0 111.021 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 97.3 mmm -108.12 89.89 3.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.991 -0.55 . . . . 10.0 109.621 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 63' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -98.49 133.03 43.43 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.161 -0.472 . . . . 10.0 110.669 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -92.17 132.37 36.69 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.814 0.34 . . . . 10.0 110.746 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 65' ' ' ILE . . . . . 0.407 HD13 HD13 ' A' ' 112' ' ' LEU . 30.5 pt -125.73 16.86 4.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.188 0.518 . . . . 10.0 110.174 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 167.78 165.28 24.92 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.041 -0.824 . . . . 10.0 111.041 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 67' ' ' LYS . . . . . 0.543 ' O ' ' HD2' ' B' ' 69' ' ' ARG . 15.6 mttp -64.07 116.6 6.07 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.944 0.372 . . . . 10.0 110.126 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 68' ' ' MET . . . . . . . . . . . . . 17.5 mmt 69.64 15.73 8.1 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.868 -0.605 . . . . 10.0 110.824 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 69' ' ' ARG . . . . . 0.543 ' HD2' ' O ' ' B' ' 67' ' ' LYS . 2.0 mpt_? -119.17 109.81 16.31 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.436 -0.579 . . . . 10.0 109.436 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 70' ' ' TYR . . . . . 0.451 ' HB2' ' HE2' ' B' ' 87' ' ' TYR . 88.5 m-85 -122.33 142.36 50.58 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.353 0.597 . . . . 10.0 112.078 -178.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 70.8 t -94.48 93.67 4.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 107.809 -1.182 . . . . 10.0 107.809 177.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 8.5 t -84.15 95.87 8.77 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.889 -0.596 . . . . 10.0 111.551 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.495 HG21 HG23 ' A' ' 119' ' ' ILE . 17.4 t -90.07 87.92 2.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.533 -0.914 . . . . 10.0 108.533 178.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 74' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' B' ' 74' ' ' ARG . 10.4 ptt-85 -118.09 172.97 7.05 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.146 -0.479 . . . . 10.0 111.207 -178.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -105.54 128.87 53.83 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.811 -0.631 . . . . 10.0 110.67 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -108.8 78.0 1.11 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.302 -0.408 . . . . 10.0 109.93 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 35.5 mttm 60.56 50.97 5.36 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.713 -0.676 . . . . 10.0 111.768 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.18 4.61 71.29 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.683 -0.77 . . . . 10.0 112.356 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -118.29 99.3 6.76 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.65 0.262 . . . . 10.0 110.373 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 41.7 t -67.46 116.88 7.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.653 -0.499 . . . . 10.0 109.653 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 95.9 mt -123.53 132.03 53.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.232 0.539 . . . . 10.0 111.818 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 82' ' ' ILE . . . . . 0.401 HD13 ' HB2' ' B' ' 109' ' ' TRP . 5.2 mp -92.63 87.72 2.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 107.834 -1.173 . . . . 10.0 107.834 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 83' ' ' ASP . . . . . 0.632 ' HA ' ' HA ' ' B' ' 103' ' ' SER . 34.1 t70 -85.39 94.79 9.06 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.745 -0.662 . . . . 10.0 112.014 -178.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 50.9 mt -87.43 99.62 8.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 107.272 -1.381 . . . . 10.0 107.272 177.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 85' ' ' ARG . . . . . 0.735 ' HG3' ' HA3' ' B' ' 101' ' ' GLY . 12.7 ttm-85 -138.33 154.97 48.98 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.28 0.562 . . . . 10.0 111.819 -177.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 86' ' ' GLU . . . . . 0.516 ' HG3' ' HA3' ' B' ' 98' ' ' GLY . 17.1 pt-20 -82.25 148.82 28.17 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.362 -0.835 . . . . 10.0 109.56 178.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 87' ' ' TYR . . . . . 0.451 ' HE2' ' HB2' ' B' ' 70' ' ' TYR . 62.8 m-85 -132.65 121.63 23.45 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.594 -0.521 . . . . 10.0 109.594 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 88' ' ' TRP . . . . . . . . . . . . . 23.7 m0 -99.19 143.44 29.46 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.225 -0.443 . . . . 10.0 110.469 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 42.6 ttm -84.62 120.18 26.07 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.314 -0.403 . . . . 10.0 110.061 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 90' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.52 163.65 53.29 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.963 -0.562 . . . . 10.0 110.856 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -57.83 -32.34 94.69 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.233 2.622 . . . . 10.0 113.44 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.44 -49.57 66.27 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.888 0.375 . . . . 10.0 110.465 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 136.68 24.73 0.47 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.718 -0.754 . . . . 10.0 112.669 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 94' ' ' GLU . . . . . 0.808 ' HB2' ' HE2' ' B' ' 96' ' ' LYS . 26.9 mt-10 -115.35 161.98 17.76 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.938 0.399 . . . . 10.0 110.606 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 95' ' ' MET . . . . . . . . . . . . . 96.9 mmm -101.55 106.24 17.3 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.871 -0.604 . . . . 10.0 109.387 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 96' ' ' LYS . . . . . 0.808 ' HE2' ' HB2' ' B' ' 94' ' ' GLU . 35.4 mmtt -98.91 136.25 20.67 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 116.127 -0.488 . . . . 10.0 110.233 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -58.21 139.16 89.46 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.756 2.304 . . . . 10.0 112.194 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 98' ' ' GLY . . . . . 0.516 ' HA3' ' HG3' ' B' ' 86' ' ' GLU . . . -82.62 -140.13 3.53 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 121.061 -0.59 . . . . 10.0 112.455 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 60.8 mtp85 -117.32 -27.57 6.38 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.945 0.402 . . . . 10.0 110.645 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 100' ' ' LYS . . . . . 0.441 ' HG2' HD23 ' C' ' 483' ' ' LEU . 4.3 mtmt -88.57 114.32 25.07 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.945 -0.571 . . . . 10.0 110.134 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 101' ' ' GLY . . . . . 0.735 ' HA3' ' HG3' ' B' ' 85' ' ' ARG . . . 166.01 156.81 9.63 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.522 -0.847 . . . . 10.0 112.727 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 18.8 tt -156.38 140.92 8.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.001 0.429 . . . . 10.0 110.402 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 103' ' ' SER . . . . . 0.632 ' HA ' ' HA ' ' B' ' 83' ' ' ASP . 3.4 m -88.56 108.23 19.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.209 -0.45 . . . . 10.0 110.29 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 68.5 mt -87.12 131.5 34.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.206 -0.452 . . . . 10.0 110.443 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -88.2 166.65 22.71 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 109.295 -0.631 . . . . 10.0 109.295 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -47.13 -32.44 13.65 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.005 2.47 . . . . 10.0 113.251 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -67.45 -56.12 10.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.291 -0.413 . . . . 10.0 110.46 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -63.33 -34.07 76.91 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.044 -0.525 . . . . 10.0 110.285 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 109' ' ' TRP . . . . . 0.401 ' HB2' HD13 ' B' ' 82' ' ' ILE . 52.0 t-105 -61.37 -43.06 99.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.857 -0.61 . . . . 10.0 109.908 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 1.6 t -66.29 -45.46 80.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.807 -0.633 . . . . 10.0 109.494 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -56.52 -47.97 78.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.51 -0.768 . . . . 10.0 111.014 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 56.4 tp -58.62 -43.8 89.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.257 -0.429 . . . . 10.0 110.753 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -63.13 -38.54 91.6 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.953 0.406 . . . . 10.0 111.193 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -80.72 -6.65 58.73 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.203 -0.453 . . . . 10.0 111.503 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 13.6 mm-40 -105.26 -6.01 20.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.664 0.269 . . . . 10.0 111.078 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 116' ' ' ILE . . . . . 0.464 ' O ' ' HB2' ' B' ' 120' ' ' ASP . 85.1 mt -52.49 -47.23 48.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 10.0 111.921 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.57 -40.94 72.63 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.227 0.454 . . . . 10.0 112.227 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -76.04 -47.36 25.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.358 -0.383 . . . . 10.0 111.537 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 119' ' ' ILE . . . . . 0.453 ' O ' HG23 ' B' ' 123' ' ' VAL . 70.5 mt -64.21 -42.35 95.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.729 0.299 . . . . 10.0 110.904 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 120' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' B' ' 116' ' ' ILE . 2.1 t70 -60.68 -37.37 81.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.118 0.485 . . . . 10.0 110.422 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -69.33 -31.44 69.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.695 -0.684 . . . . 10.0 110.55 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.04 -32.44 63.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.259 -0.428 . . . . 10.0 110.212 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 123' ' ' VAL . . . . . 0.453 HG23 ' O ' ' B' ' 119' ' ' ILE . 95.0 t -69.2 -41.79 81.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.987 -0.551 . . . . 10.0 110.769 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 124' ' ' ARG . . . . . 0.709 ' HG3' ' HG3' ' B' ' 125' ' ' LYS . 7.8 ptp180 -75.27 -31.52 60.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.509 -0.314 . . . . 10.0 111.095 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 125' ' ' LYS . . . . . 0.709 ' HG3' ' HG3' ' B' ' 124' ' ' ARG . 86.0 mttt -107.79 78.09 1.17 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.426 -0.352 . . . . 10.0 110.805 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 94.6 mt . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.911 -0.566 . . . . 10.0 110.006 179.622 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 465' ' ' TYR . . . . . . . . . . . . . 28.5 t80 . . . . . 0 N--CA 1.48 1.048 0 CA-C-O 120.653 0.263 . . . . 10.0 110.488 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 466' ' ' GLY . . . . . . . . . . . . . . . -54.52 -42.07 74.9 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 121.297 -0.477 . . . . 10.0 112.513 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 467' ' ' ALA . . . . . . . . . . . . . . . -63.38 -38.15 90.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.047 0.451 . . . . 10.0 110.947 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 468' ' ' LEU . . . . . . . . . . . . . 65.2 tp -68.99 -40.92 78.49 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.996 -0.547 . . . . 10.0 110.539 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 469' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -65.91 -36.3 83.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.041 0.448 . . . . 10.0 110.723 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 470' ' ' MET . . . . . 0.529 ' HA ' ' HD2' ' C' ' 473' ' ' PHE . 90.1 mmm -71.49 -21.93 61.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.167 -0.47 . . . . 10.0 110.625 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 471' ' ' ALA . . . . . . . . . . . . . . . -69.38 -26.01 64.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.337 -0.392 . . . . 10.0 110.982 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 472' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -68.72 -24.94 64.53 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.024 0.44 . . . . 10.0 110.077 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 473' ' ' PHE . . . . . 0.529 ' HD2' ' HA ' ' C' ' 470' ' ' MET . 63.4 m-85 -74.35 -3.95 33.42 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.899 -0.591 . . . . 10.0 110.392 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 474' ' ' GLU . . . . . 0.403 ' O ' ' HB3' ' C' ' 478' ' ' MET . 1.5 tm-20 -101.33 -51.34 3.52 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.949 -0.76 . . . . 10.0 108.949 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 475' ' ' PHE . . . . . 0.485 ' CE2' ' HD2' ' A' ' 97' ' ' PRO . 50.7 t80 -68.53 -63.74 1.0 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.67 -0.695 . . . . 10.0 111.158 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 476' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -81.62 49.86 1.4 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.104 0.478 . . . . 10.0 111.531 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 477' ' ' GLN . . . . . 0.468 HE21 ' HB3' ' C' ' 477' ' ' GLN . 0.6 OUTLIER -165.05 -46.78 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.94 -0.573 . . . . 10.0 110.204 179.602 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 478' ' ' MET . . . . . 0.403 ' HB3' ' O ' ' C' ' 474' ' ' GLU . 27.8 ttp -95.19 -50.86 4.87 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.185 -0.462 . . . . 10.0 110.454 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 479' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -63.14 -51.74 65.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 10.0 111.159 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 480' ' ' THR . . . . . 0.558 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 0.2 OUTLIER -65.38 -17.12 64.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.283 -0.417 . . . . 10.0 112.017 -179.719 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 481' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -86.15 -47.5 9.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.003 0.43 . . . . 10.0 109.864 179.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 482' ' ' ALA . . . . . . . . . . . . . . . -63.67 -22.85 67.12 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.505 -0.771 . . . . 10.0 111.257 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 483' ' ' LEU . . . . . 0.506 HD12 ' HA ' ' C' ' 480' ' ' THR . 29.6 mt -64.39 -23.98 67.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.318 -0.401 . . . . 10.0 111.291 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 484' ' ' GLY . . . . . 0.431 ' HA2' ' HG2' ' C' ' 487' ' ' GLU . . . -141.17 28.55 2.35 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.47 -0.871 . . . . 10.0 112.229 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 485' ' ' ILE . . . . . 0.893 ' HA ' ' HE3' ' A' ' 79' ' ' LYS . 12.9 tt -71.85 -39.96 68.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.835 0.35 . . . . 10.0 111.061 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 486' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -99.14 10.68 40.97 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.857 0.361 . . . . 10.0 110.752 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 487' ' ' GLU . . . . . 0.596 ' HB3' ' HB3' ' A' ' 105' ' ' ASN . 5.2 mm-40 -63.79 -30.0 71.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.075 -0.512 . . . . 10.0 111.689 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 488' ' ' TYR . . . . . 0.838 ' HE2' ' HA ' ' A' ' 79' ' ' LYS . 5.8 m-85 -73.36 -3.03 24.68 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.952 0.406 . . . . 10.0 111.001 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 489' ' ' GLY . . . . . . . . . . . . . . . -117.48 13.63 13.47 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 121.07 -0.586 . . . . 10.0 111.787 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.785 0 CA-C-O 118.702 -1.054 . . . . 10.0 112.177 -179.898 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 110.412 -0.218 . . . . 10.0 110.412 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 54.0 ttm -107.44 115.46 30.2 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.968 -0.382 . . . . 10.0 109.968 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -98.83 149.75 22.58 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.413 -0.358 . . . . 10.0 110.482 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -102.83 124.35 48.18 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.699 0.285 . . . . 10.0 111.239 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 37.1 pt -116.38 0.31 8.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.368 -0.378 . . . . 10.0 110.859 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.464 ' HA3' ' NE2' ' B' ' 108' ' ' GLN . . . 168.45 -179.02 41.71 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.509 -0.853 . . . . 10.0 112.522 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.591 ' HG2' ' HG2' ' A' ' 68' ' ' MET . 37.3 tttp -64.4 117.52 7.39 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.728 0.299 . . . . 10.0 110.92 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.591 ' HG2' ' HG2' ' A' ' 67' ' ' LYS . 39.9 mmm 65.3 7.95 4.58 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.434 -0.803 . . . . 10.0 112.033 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -113.54 112.11 23.01 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.733 -0.469 . . . . 10.0 109.733 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.556 ' HB2' ' CD1' ' A' ' 87' ' ' TYR . 98.1 m-85 -125.55 157.05 38.06 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.08 -0.509 . . . . 10.0 111.342 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 86.3 t -117.78 101.0 11.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.048 -0.978 . . . . 10.0 109.344 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.9 m -89.42 98.72 11.93 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.109 -0.496 . . . . 10.0 110.987 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.1 t -86.64 117.64 31.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.066 -0.516 . . . . 10.0 110.213 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.946 HH12 ' HB2' ' A' ' 83' ' ' ASP . 27.1 ptt-85 -136.62 173.2 11.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.234 -0.439 . . . . 10.0 110.141 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -113.33 153.08 29.07 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.755 0.312 . . . . 10.0 110.351 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.563 ' HD1' ' HG3' ' A' ' 77' ' ' LYS . 1.5 t80 -161.16 119.34 2.41 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.085 -0.507 . . . . 10.0 109.842 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.563 ' HG3' ' HD1' ' A' ' 76' ' ' PHE . 30.4 mtmt 66.34 25.21 10.45 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.504 0.502 . . . . 10.0 110.264 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.41 1.89 90.52 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.706 -0.759 . . . . 10.0 111.399 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -102.12 -175.86 2.96 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.988 -0.375 . . . . 10.0 109.988 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.628 HG21 HG13 ' B' ' 123' ' ' VAL . 42.5 t -119.61 137.0 54.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.039 0.447 . . . . 10.0 111.267 -178.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.481 HD22 ' HB1' ' C' ' 482' ' ' ALA . 73.6 mt -121.27 100.83 7.26 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.482 -0.781 . . . . 10.0 110.301 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.45 ' HB ' ' HB2' ' A' ' 104' ' ' LEU . 44.8 mt -89.17 95.49 5.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.303 -0.629 . . . . 10.0 109.303 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.946 ' HB2' HH12 ' A' ' 74' ' ' ARG . 0.8 OUTLIER -79.34 109.97 14.18 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.464 0.542 . . . . 10.0 112.464 -177.748 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 35.3 mt -109.27 90.88 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.395 -0.965 . . . . 10.0 108.395 177.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 1.004 ' HG3' ' HA3' ' A' ' 101' ' ' GLY . 1.4 ttm-85 -137.35 168.07 20.36 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.969 -0.56 . . . . 10.0 111.678 -177.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -91.64 129.77 37.56 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.413 -0.958 . . . . 10.0 108.413 178.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.586 ' HB3' ' HB3' ' A' ' 95' ' ' MET . 95.8 m-85 -114.02 118.6 34.55 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.9 0.381 . . . . 10.0 110.068 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 81.6 m95 -102.43 146.23 28.39 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.896 -0.593 . . . . 10.0 110.726 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 34.2 ttm -68.35 128.63 37.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.144 -0.48 . . . . 10.0 111.474 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.407 ' HB2' ' CD ' ' A' ' 91' ' ' PRO . 34.5 p30 -97.46 171.79 5.61 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 115.61 -0.723 . . . . 10.0 110.845 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.407 ' CD ' ' HB2' ' A' ' 90' ' ' ASP . 3.2 Cg_exo -78.39 32.0 0.45 Allowed 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.927 2.418 . . . . 10.0 111.711 178.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.479 ' HB2' ' HB2' ' C' ' 467' ' ' ALA . 19.3 tp10 -123.0 -44.4 2.18 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.976 -0.749 . . . . 10.0 108.976 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 126.93 18.49 2.12 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 114.871 -1.059 . . . . 10.0 110.973 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.524 ' HG2' ' H ' ' A' ' 95' ' ' MET . 16.7 tt0 -121.24 -177.68 3.58 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.806 -0.442 . . . . 10.0 109.806 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.586 ' HB3' ' HB3' ' A' ' 87' ' ' TYR . 61.0 mmm -117.57 115.16 24.56 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.791 -0.448 . . . . 10.0 109.791 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.439 ' HA ' ' HD3' ' A' ' 97' ' ' PRO . 9.3 mmpt? -95.36 139.58 22.05 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.138 -0.483 . . . . 10.0 110.572 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.664 ' HD2' ' HB2' ' C' ' 474' ' ' GLU . 11.7 Cg_exo -69.36 118.8 5.9 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.941 2.427 . . . . 10.0 112.622 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -70.14 168.87 47.22 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 121.173 -0.537 . . . . 10.0 111.827 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.481 ' HD3' ' HA ' ' A' ' 99' ' ' ARG . 9.4 mmt180 -81.24 56.53 2.89 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.873 0.368 . . . . 10.0 111.8 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 13.2 ttmt -167.29 108.38 0.62 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.779 -0.646 . . . . 10.0 109.901 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 1.004 ' HA3' ' HG3' ' A' ' 85' ' ' ARG . . . 170.44 175.98 39.58 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.017 -1.087 . . . . 10.0 112.929 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.421 HG22 HG22 ' B' ' 102' ' ' ILE . 13.9 tt -155.21 157.65 4.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.313 -0.625 . . . . 10.0 109.313 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.533 ' OG ' ' HA ' ' C' ' 482' ' ' ALA . 2.1 p -112.24 173.92 6.13 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 121.069 -0.252 . . . . 10.0 110.861 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.45 ' HB2' ' HB ' ' A' ' 82' ' ' ILE . 37.7 mt -136.7 149.95 48.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.412 -0.358 . . . . 10.0 110.301 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.514 ' HB3' ' HA ' ' C' ' 486' ' ' ASP . 11.9 p-10 -117.95 167.37 11.4 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 109.538 -0.541 . . . . 10.0 109.538 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.417 ' HD3' ' HB ' ' A' ' 80' ' ' VAL . 80.1 Cg_exo -47.27 -45.59 21.76 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.944 2.429 . . . . 10.0 113.389 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -56.48 -50.54 71.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.089 -0.505 . . . . 10.0 111.514 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.42 ' OE1' ' HD3' ' B' ' 69' ' ' ARG . 44.5 mt-30 -71.97 -36.75 69.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.432 -0.349 . . . . 10.0 110.701 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 69.0 t-105 -56.45 -45.21 80.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.916 -0.584 . . . . 10.0 111.029 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.0 t -61.6 -51.38 68.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.334 -0.393 . . . . 10.0 110.182 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -61.55 -37.23 83.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.082 -0.508 . . . . 10.0 111.508 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 66.5 tp -61.47 -45.11 95.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.921 0.391 . . . . 10.0 110.2 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -65.08 -36.26 83.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.267 0.556 . . . . 10.0 110.172 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -74.42 -9.21 58.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.476 -0.783 . . . . 10.0 111.48 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -112.01 1.71 16.52 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.706 -0.225 . . . . 10.0 111.53 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.5 mt -55.28 -53.29 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.659 -0.246 . . . . 10.0 111.344 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.85 -39.1 80.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 10.0 111.446 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.539 ' HB3' ' CE1' ' B' ' 63' ' ' PHE . 2.0 m-20 -67.19 -51.39 54.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.131 -0.486 . . . . 10.0 111.566 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.456 HG12 ' CD2' ' B' ' 63' ' ' PHE . 62.6 mt -65.33 -45.05 94.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.351 -0.386 . . . . 10.0 111.182 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -60.32 -42.09 94.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.103 -0.499 . . . . 10.0 111.612 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -66.33 -36.87 84.02 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 120.836 0.35 . . . . 10.0 110.195 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.13 -41.95 97.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.936 -0.575 . . . . 10.0 109.974 178.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 119' ' ' ILE . 97.3 t -65.52 -41.98 92.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.784 -0.644 . . . . 10.0 109.856 178.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 27.3 mtm105 -67.12 -22.62 65.79 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.746 -0.661 . . . . 10.0 111.144 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 35.6 mttp -78.63 -30.39 46.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 10.0 110.283 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 70.8 mt . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 115.993 -0.549 . . . . 10.0 110.679 179.993 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.162 0 CA-C-O 120.91 0.385 . . . . 10.0 110.756 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 86.5 mmm -95.09 84.64 4.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.058 0.456 . . . . 10.0 110.274 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 63' ' ' PHE . . . . . 0.539 ' CE1' ' HB3' ' A' ' 118' ' ' ASP . 97.9 m-85 -82.22 159.46 23.23 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.757 -0.656 . . . . 10.0 110.091 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -133.6 119.01 18.89 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.942 0.401 . . . . 10.0 110.972 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 65' ' ' ILE . . . . . 0.416 HD11 HG21 ' B' ' 84' ' ' ILE . 3.0 pt -97.02 95.05 4.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.137 -0.69 . . . . 10.0 109.137 178.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.82 -93.06 1.78 Allowed Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 110.74 -0.944 . . . . 10.0 110.74 -178.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 67' ' ' LYS . . . . . 0.499 ' O ' ' HD2' ' B' ' 69' ' ' ARG . 1.3 ttpm? -165.37 151.92 10.11 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.652 -0.499 . . . . 10.0 109.652 178.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 68' ' ' MET . . . . . 0.479 ' HB2' ' O ' ' B' ' 67' ' ' LYS . 1.2 mpt? 74.93 -50.76 0.67 Allowed 'General case' 0 N--CA 1.473 0.69 0 O-C-N 123.856 0.722 . . . . 10.0 111.67 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 69' ' ' ARG . . . . . 0.624 ' HD2' ' H ' ' B' ' 69' ' ' ARG . 1.6 mpt_? -75.7 110.51 10.17 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.752 0.311 . . . . 10.0 110.365 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -110.26 131.16 55.3 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.184 -0.462 . . . . 10.0 111.086 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 22.3 t -78.65 83.54 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.698 -0.853 . . . . 10.0 108.698 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 26.1 t -87.22 92.59 9.11 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.576 -0.738 . . . . 10.0 111.731 -178.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.725 HG13 HG12 ' B' ' 82' ' ' ILE . 3.8 t -86.0 73.69 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.657 -0.868 . . . . 10.0 108.657 177.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 74' ' ' ARG . . . . . 0.43 ' NH1' ' HB3' ' B' ' 83' ' ' ASP . 35.0 ptt-85 -102.29 144.05 31.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.484 0.659 . . . . 10.0 112.093 -177.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -82.71 126.22 32.12 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.974 -1.012 . . . . 10.0 108.939 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -118.27 100.97 7.84 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.644 0.259 . . . . 10.0 110.674 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 63.7 mttm 58.78 35.46 24.33 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.8 -0.636 . . . . 10.0 111.872 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.19 8.27 61.59 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.613 -0.803 . . . . 10.0 112.265 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 79' ' ' LYS . . . . . 0.403 ' HA ' ' HD3' ' B' ' 79' ' ' LYS . 42.0 mmtt -117.43 107.45 14.35 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-O 120.78 0.324 . . . . 10.0 110.681 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 21.9 t -74.42 105.26 3.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.529 -0.545 . . . . 10.0 109.529 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 98.5 mt -118.07 125.05 49.55 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.197 0.523 . . . . 10.0 111.364 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 82' ' ' ILE . . . . . 0.725 HG12 HG13 ' B' ' 73' ' ' VAL . 32.7 mt -85.87 82.84 2.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.16 -1.052 . . . . 10.0 108.16 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 83' ' ' ASP . . . . . 0.509 ' HA ' ' HA ' ' B' ' 103' ' ' SER . 35.1 t70 -93.65 100.71 12.9 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.395 -0.82 . . . . 10.0 111.086 -178.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 84' ' ' ILE . . . . . 0.416 HG21 HD11 ' B' ' 65' ' ' ILE . 36.0 mt -84.24 94.93 3.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 108.353 -0.98 . . . . 10.0 108.353 178.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 85' ' ' ARG . . . . . 0.402 ' HD3' ' O ' ' B' ' 98' ' ' GLY . 5.6 ttm-85 -106.0 151.0 25.18 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.831 -0.622 . . . . 10.0 111.686 -177.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 86' ' ' GLU . . . . . 0.533 ' HG2' ' HG3' ' B' ' 69' ' ' ARG . 55.9 mt-10 -83.56 116.07 22.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.716 -0.674 . . . . 10.0 110.24 178.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 87' ' ' TYR . . . . . 0.84 ' HB3' ' HB3' ' B' ' 95' ' ' MET . 48.7 m-85 -96.03 106.74 18.95 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.942 -0.572 . . . . 10.0 109.855 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 88' ' ' TRP . . . . . . . . . . . . . 76.8 m95 -104.52 139.42 39.44 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.898 -0.592 . . . . 10.0 110.335 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 89' ' ' MET . . . . . 0.487 ' HA ' ' O ' ' B' ' 94' ' ' GLU . 39.3 ttm -69.05 130.44 42.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.953 -0.567 . . . . 10.0 111.665 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 90' ' ' ASP . . . . . 0.455 ' HB2' ' HD2' ' B' ' 91' ' ' PRO . 49.0 p30 -90.35 173.88 5.23 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.477 -0.783 . . . . 10.0 109.724 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 91' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' B' ' 90' ' ' ASP . 37.7 Cg_exo -61.55 -20.32 68.21 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.228 1.952 . . . . 10.0 112.56 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -74.66 -44.0 52.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.281 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 124.48 20.86 2.32 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.925 -0.655 . . . . 10.0 112.165 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 94' ' ' GLU . . . . . 0.601 ' HB3' ' HE2' ' B' ' 96' ' ' LYS . 4.5 tt0 -114.77 161.9 17.57 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.182 -0.303 . . . . 10.0 110.182 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 95' ' ' MET . . . . . 0.84 ' HB3' ' HB3' ' B' ' 87' ' ' TYR . 8.2 mmt -93.31 113.96 26.28 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.824 -0.435 . . . . 10.0 109.824 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 96' ' ' LYS . . . . . 0.601 ' HE2' ' HB3' ' B' ' 94' ' ' GLU . 48.1 mmtt -105.97 126.05 31.62 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.042 -0.526 . . . . 10.0 111.119 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.98 118.36 5.53 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.591 2.194 . . . . 10.0 111.819 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 98' ' ' GLY . . . . . 0.402 ' O ' ' HD3' ' B' ' 85' ' ' ARG . . . -83.46 -157.84 25.16 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.767 -0.73 . . . . 10.0 112.712 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 99' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' B' ' 99' ' ' ARG . 52.6 mtt180 -86.17 -20.74 28.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.868 0.366 . . . . 10.0 110.448 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 100' ' ' LYS . . . . . 0.889 ' HE2' ' HA ' ' C' ' 481' ' ' ASP . 6.8 mtpm? -69.39 106.36 2.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.905 -0.588 . . . . 10.0 109.694 178.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . 161.83 157.11 8.7 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.727 -0.669 . . . . 10.0 111.464 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 102' ' ' ILE . . . . . 0.421 HG22 HG22 ' A' ' 102' ' ' ILE . 6.5 tp -133.63 134.99 56.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.946 0.403 . . . . 10.0 110.731 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 103' ' ' SER . . . . . 0.509 ' HA ' ' HA ' ' B' ' 83' ' ' ASP . 0.8 OUTLIER -97.21 108.49 21.23 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.826 -0.625 . . . . 10.0 110.481 179.817 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 80.4 mt -111.4 137.74 48.79 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.979 0.419 . . . . 10.0 110.835 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 105' ' ' ASN . . . . . 0.557 ' ND2' ' HB3' ' B' ' 107' ' ' GLU . 36.5 p-10 -85.95 168.25 20.33 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.325 -0.398 . . . . 10.0 109.932 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 106' ' ' PRO . . . . . 0.406 ' HD2' ' HB2' ' B' ' 105' ' ' ASN . 76.3 Cg_exo -52.63 -27.33 32.77 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.775 2.317 . . . . 10.0 112.526 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 107' ' ' GLU . . . . . 0.557 ' HB3' ' ND2' ' B' ' 105' ' ' ASN . 7.5 tt0 -66.38 -51.38 57.7 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.936 -0.574 . . . . 10.0 109.942 178.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 108' ' ' GLN . . . . . 0.464 ' NE2' ' HA3' ' A' ' 66' ' ' GLY . 0.2 OUTLIER -65.63 -33.21 75.37 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.979 -0.555 . . . . 10.0 110.355 179.53 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 109' ' ' TRP . . . . . . . . . . . . . 45.9 t-105 -57.8 -41.91 83.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.126 -0.488 . . . . 10.0 110.699 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 13.6 t -68.04 -53.31 26.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.315 -0.402 . . . . 10.0 110.736 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -59.33 -36.59 75.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.481 . . . . 10.0 111.303 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 112' ' ' LEU . . . . . 0.459 ' O ' HG13 ' B' ' 116' ' ' ILE . 64.2 tp -60.12 -48.0 83.55 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.162 -0.31 . . . . 10.0 110.162 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 113' ' ' LYS . . . . . 0.412 ' HB2' ' HE3' ' B' ' 113' ' ' LYS . 42.6 mtmt -62.9 -39.11 93.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.142 -0.481 . . . . 10.0 110.881 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -68.29 -30.66 69.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.938 -0.574 . . . . 10.0 111.429 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -85.39 -8.3 58.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.676 -0.238 . . . . 10.0 111.265 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 116' ' ' ILE . . . . . 0.459 HG13 ' O ' ' B' ' 112' ' ' LEU . 27.3 mt -57.22 -37.4 56.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.676 -0.238 . . . . 10.0 111.513 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.12 -29.42 67.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.945 0.402 . . . . 10.0 111.282 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -91.2 -42.81 10.22 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.168 -0.469 . . . . 10.0 110.68 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 119' ' ' ILE . . . . . 0.513 ' O ' HG23 ' B' ' 123' ' ' VAL . 82.8 mt -64.05 -47.14 91.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.893 -0.594 . . . . 10.0 111.206 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 120' ' ' ASP . . . . . 0.411 ' O ' ' HG2' ' B' ' 124' ' ' ARG . 23.9 t70 -60.01 -38.96 84.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.565 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -63.85 -42.66 97.53 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.641 -0.709 . . . . 10.0 110.249 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.63 -33.96 77.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.971 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 123' ' ' VAL . . . . . 0.628 HG13 HG21 ' A' ' 80' ' ' VAL . 71.3 t -60.4 -35.22 61.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-O 121.362 0.601 . . . . 10.0 110.708 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 124' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' B' ' 120' ' ' ASP . 7.3 ptt85 -102.99 21.22 16.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.803 -0.635 . . . . 10.0 110.613 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 17.4 ttmt -136.81 47.27 2.16 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.412 0.625 . . . . 10.0 109.821 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 58.5 mt . . . . . 0 C--O 1.245 0.856 0 CA-C-O 118.517 -0.754 . . . . 10.0 109.922 179.722 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 465' ' ' TYR . . . . . . . . . . . . . 11.1 p90 . . . . . 0 N--CA 1.476 0.869 0 CA-C-O 120.768 0.318 . . . . 10.0 110.896 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 466' ' ' GLY . . . . . . . . . . . . . . . 84.09 -2.9 87.14 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 121.068 -0.587 . . . . 10.0 114.062 178.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 467' ' ' ALA . . . . . 0.479 ' HB2' ' HB2' ' A' ' 92' ' ' GLU . . . -74.8 -32.76 62.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 117.401 0.601 . . . . 10.0 110.754 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 468' ' ' LEU . . . . . . . . . . . . . 69.9 tp -56.8 -35.84 69.2 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.596 -0.729 . . . . 10.0 111.785 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 469' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -64.65 -38.55 91.39 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.688 0.28 . . . . 10.0 111.281 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 470' ' ' MET . . . . . . . . . . . . . 1.2 tmm? -80.07 -25.8 39.92 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.941 0.4 . . . . 10.0 110.117 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 471' ' ' ALA . . . . . 0.476 ' HA ' ' HB3' ' C' ' 474' ' ' GLU . . . -59.36 -30.88 68.71 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.955 -0.566 . . . . 10.0 111.051 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 472' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -59.4 -34.97 73.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.745 -0.661 . . . . 10.0 110.978 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 473' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -96.44 -13.88 22.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.161 -0.472 . . . . 10.0 111.175 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 474' ' ' GLU . . . . . 0.664 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 0.0 OUTLIER -69.36 -39.27 78.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.932 0.396 . . . . 10.0 110.005 179.645 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 475' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -74.85 -21.62 59.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.896 -0.593 . . . . 10.0 111.214 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 476' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -63.51 -61.82 2.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.389 -0.369 . . . . 10.0 110.702 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 477' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -63.55 -27.93 69.59 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.991 0.424 . . . . 10.0 111.113 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 478' ' ' MET . . . . . 0.499 ' HG2' ' NH2' ' A' ' 74' ' ' ARG . 0.4 OUTLIER -77.81 -5.6 51.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.156 -0.475 . . . . 10.0 111.057 -179.788 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 479' ' ' PHE . . . . . 0.42 ' O ' ' HB2' ' C' ' 483' ' ' LEU . 86.1 t80 -113.44 -55.12 2.55 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.509 -0.314 . . . . 10.0 111.705 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 480' ' ' THR . . . . . . . . . . . . . 1.7 p -59.45 -51.99 67.54 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 112.287 0.477 . . . . 10.0 112.287 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 481' ' ' ASP . . . . . 0.889 ' HA ' ' HE2' ' B' ' 100' ' ' LYS . 5.3 t70 -61.96 -45.42 93.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.055 -0.521 . . . . 10.0 110.87 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 482' ' ' ALA . . . . . 0.533 ' HA ' ' OG ' ' A' ' 103' ' ' SER . . . -64.27 -47.28 80.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.889 -0.596 . . . . 10.0 112.263 -178.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 483' ' ' LEU . . . . . 0.42 ' HB2' ' O ' ' C' ' 479' ' ' PHE . 0.2 OUTLIER -57.78 -46.74 84.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.45 -0.341 . . . . 10.0 111.135 -179.152 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 484' ' ' GLY . . . . . . . . . . . . . . . -70.32 -22.61 77.61 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.769 -0.729 . . . . 10.0 112.612 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 485' ' ' ILE . . . . . . . . . . . . . 1.3 mm -76.6 -44.63 34.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.821 0.344 . . . . 10.0 111.401 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 486' ' ' ASP . . . . . 0.514 ' HA ' ' HB3' ' A' ' 105' ' ' ASN . 0.1 OUTLIER -78.76 -45.59 20.73 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.345 -0.388 . . . . 10.0 111.996 -178.771 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 487' ' ' GLU . . . . . 0.543 ' HA ' ' OE1' ' C' ' 487' ' ' GLU . 0.7 OUTLIER -64.91 -42.81 94.43 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.51 0.559 . . . . 10.0 112.51 -178.022 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 488' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -135.59 72.4 1.44 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.974 0.416 . . . . 10.0 110.686 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 489' ' ' GLY . . . . . 0.528 ' HA2' ' NH1' ' B' ' 69' ' ' ARG . . . -98.18 -30.35 7.08 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.915 -0.659 . . . . 10.0 112.075 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.773 -1.015 . . . . 10.0 112.1 -179.804 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 109.933 -0.395 . . . . 10.0 109.933 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 49.1 ttm -126.55 105.54 8.81 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.917 0.389 . . . . 10.0 110.618 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -96.37 126.47 41.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.004 -0.544 . . . . 10.0 110.407 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.443 ' HG2' ' H ' ' A' ' 66' ' ' GLY . 23.4 tt0 -85.74 131.48 34.32 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.009 -0.367 . . . . 10.0 110.009 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 26.9 pt -119.62 11.68 6.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.147 0.498 . . . . 10.0 110.807 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.783 ' HA3' ' HG2' ' B' ' 108' ' ' GLN . . . 161.39 174.71 31.6 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.401 -0.68 . . . . 10.0 111.401 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.56 ' HG2' ' HG2' ' A' ' 68' ' ' MET . 52.4 tttp -61.85 120.32 10.51 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.058 0.456 . . . . 10.0 110.873 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.56 ' HG2' ' HG2' ' A' ' 67' ' ' LYS . 36.1 mmm 66.19 12.7 8.72 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.079 -0.964 . . . . 10.0 111.964 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.787 ' HE ' ' HB3' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -114.81 113.0 23.66 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.718 -0.475 . . . . 10.0 109.718 179.128 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -126.73 134.27 50.69 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.116 0.484 . . . . 10.0 111.71 -177.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 38.7 t -93.82 105.16 16.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 108.912 -0.773 . . . . 10.0 108.912 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.404 ' HB2' ' HB3' ' A' ' 83' ' ' ASP . 1.2 m -80.8 82.99 6.65 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.502 -0.772 . . . . 10.0 111.3 -178.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.472 HG22 HG23 ' A' ' 82' ' ' ILE . 10.8 t -83.41 93.55 3.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.912 -0.773 . . . . 10.0 108.912 178.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -133.92 -175.37 3.82 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.816 -0.629 . . . . 10.0 111.029 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.429 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 7.3 t0 -117.07 142.45 46.96 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.873 -0.603 . . . . 10.0 110.033 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.457 ' HD1' ' HA ' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -145.38 96.53 2.85 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.018 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.8 mttp 68.48 29.15 5.77 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.016 -0.538 . . . . 10.0 111.057 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 84.37 54.15 3.06 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.545 -0.836 . . . . 10.0 111.834 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.94 ' HD3' ' HB ' ' C' ' 485' ' ' ILE . 18.8 mttp -146.41 130.52 17.39 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.783 -0.209 . . . . 10.0 110.472 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.3 t -80.2 84.69 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.54 -0.911 . . . . 10.0 108.54 178.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 30.5 mt -83.7 104.84 14.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.892 -0.595 . . . . 10.0 112.126 -178.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.472 HG23 HG22 ' A' ' 73' ' ' VAL . 16.6 mt -97.25 64.07 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 106.704 -1.591 . . . . 10.0 106.704 176.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.886 ' HA ' ' HA ' ' A' ' 103' ' ' SER . 19.9 t70 -68.41 101.68 1.28 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.735 -1.12 . . . . 10.0 113.375 -176.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 63.0 mt -84.21 108.0 16.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 107.383 -1.34 . . . . 10.0 107.383 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.818 ' HD2' ' HB2' ' A' ' 97' ' ' PRO . 12.3 ttm180 -143.69 170.47 15.8 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.599 0.714 . . . . 10.0 112.335 -177.04 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.787 ' HB3' ' HE ' ' A' ' 69' ' ' ARG . 6.9 pt-20 -99.95 140.77 33.7 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.282 -0.872 . . . . 10.0 108.911 177.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -122.23 121.76 37.58 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.912 0.387 . . . . 10.0 110.462 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -114.49 153.57 29.76 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.763 -0.653 . . . . 10.0 109.943 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 2.3 ttm -83.02 122.14 27.93 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.836 -0.431 . . . . 10.0 109.836 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.47 170.76 13.66 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.824 -0.626 . . . . 10.0 110.726 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -54.19 -29.78 58.17 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 123.053 2.502 . . . . 10.0 113.458 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -73.75 -45.2 53.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.965 0.412 . . . . 10.0 110.608 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 124.51 30.18 1.01 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.63 -0.795 . . . . 10.0 112.0 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -116.33 167.76 10.74 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.78 0.324 . . . . 10.0 110.32 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 92.3 mmm -89.42 98.25 11.66 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.251 -0.648 . . . . 10.0 109.251 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -98.23 124.54 46.77 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.447 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.818 ' HB2' ' HD2' ' A' ' 85' ' ' ARG . 80.1 Cg_endo -78.02 146.86 23.34 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.727 2.284 . . . . 10.0 112.891 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.54 ' O ' ' HD3' ' A' ' 85' ' ' ARG . . . -85.08 -174.1 50.13 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.725 -0.75 . . . . 10.0 112.332 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -76.06 -26.92 56.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.98 0.419 . . . . 10.0 110.758 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -76.38 81.38 3.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.863 -0.608 . . . . 10.0 110.609 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.438 ' HA3' ' NE ' ' A' ' 85' ' ' ARG . . . -146.62 129.48 3.33 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.959 -0.564 . . . . 10.0 111.766 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.578 HG13 HD21 ' C' ' 483' ' ' LEU . 8.5 tt -127.29 113.86 33.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.201 0.524 . . . . 10.0 110.702 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.886 ' HA ' ' HA ' ' A' ' 83' ' ' ASP . 2.3 m -79.27 99.9 7.28 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.089 -0.505 . . . . 10.0 110.679 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.47 ' HB2' ' HB ' ' A' ' 82' ' ' ILE . 34.7 mt -76.53 171.66 14.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.153 0.501 . . . . 10.0 110.442 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -133.03 158.32 76.13 Favored Pre-proline 0 C--N 1.316 -0.87 0 N-CA-C 108.835 -0.802 . . . . 10.0 108.835 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -41.39 -45.3 5.91 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.825 3.017 . . . . 10.0 113.891 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -64.38 -49.69 70.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.709 0.29 . . . . 10.0 110.833 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.571 ' NE2' ' HD3' ' B' ' 69' ' ' ARG . 72.3 mt-30 -63.56 -40.74 97.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.266 -0.424 . . . . 10.0 110.586 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -59.47 -44.79 92.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.924 -0.58 . . . . 10.0 110.294 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.482 ' HA ' ' CE ' ' A' ' 113' ' ' LYS . 56.8 m -64.4 -41.02 96.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.226 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.47 ' O ' ' HG2' ' A' ' 115' ' ' GLN . 46.5 mt-30 -63.98 -42.02 97.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.254 -0.43 . . . . 10.0 110.395 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 22.9 tp -59.36 -40.99 88.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.992 -0.549 . . . . 10.0 110.543 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.482 ' CE ' ' HA ' ' A' ' 110' ' ' SER . 53.3 mtmt -63.95 -33.49 75.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.856 -0.611 . . . . 10.0 111.121 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -76.82 -15.4 59.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.324 -0.398 . . . . 10.0 111.115 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.47 ' HG2' ' O ' ' A' ' 111' ' ' GLN . 14.2 mm-40 -99.55 -5.18 29.61 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.547 -0.297 . . . . 10.0 110.879 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.467 HG12 ' HH2' ' B' ' 109' ' ' TRP . 56.7 mt -56.56 -39.73 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.396 -0.365 . . . . 10.0 111.489 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.14 -30.21 69.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.109 -0.496 . . . . 10.0 111.099 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.425 ' HB3' ' CE1' ' B' ' 63' ' ' PHE . 2.6 m-20 -90.04 -39.93 12.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.756 -0.656 . . . . 10.0 110.571 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.48 ' O ' HG23 ' A' ' 123' ' ' VAL . 92.8 mt -62.21 -51.22 75.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.323 -0.399 . . . . 10.0 110.628 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -62.05 -28.7 69.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.243 0.544 . . . . 10.0 110.329 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -63.64 -49.78 71.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.422 -0.808 . . . . 10.0 110.064 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.47 -34.18 77.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.778 -0.647 . . . . 10.0 110.969 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.66 ' HA ' HG11 ' B' ' 80' ' ' VAL . 72.5 t -61.44 -42.65 94.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.964 0.412 . . . . 10.0 110.678 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 24.1 mtm180 -75.03 -24.25 58.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.018 -0.537 . . . . 10.0 111.143 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -74.78 -46.34 37.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.021 0.439 . . . . 10.0 110.81 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 17.6 mt . . . . . 0 C--N 1.326 -0.452 0 CA-C-N 116.008 -0.542 . . . . 10.0 111.14 -179.724 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.163 0 CA-C-O 121.171 0.51 . . . . 10.0 110.471 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 86.5 mmm -109.14 111.01 22.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.7 -0.682 . . . . 10.0 109.914 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 63' ' ' PHE . . . . . 0.425 ' CE1' ' HB3' ' A' ' 118' ' ' ASP . 15.6 m-85 -107.87 157.65 17.99 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.268 -0.424 . . . . 10.0 110.462 -179.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -117.38 135.07 54.13 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.486 -0.325 . . . . 10.0 110.284 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 21.2 pt -126.84 29.13 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.176 -0.465 . . . . 10.0 111.113 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 149.97 -172.1 29.89 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.929 -0.653 . . . . 10.0 111.616 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 67' ' ' LYS . . . . . 0.479 ' O ' ' HB2' ' B' ' 68' ' ' MET . 43.3 mtmt -69.24 105.87 2.67 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.555 0.178 . . . . 10.0 110.735 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 68' ' ' MET . . . . . 0.479 ' HB2' ' O ' ' B' ' 67' ' ' LYS . 0.3 OUTLIER 76.01 -12.8 0.96 Allowed 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.71 0.633 . . . . 10.0 112.71 178.705 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 69' ' ' ARG . . . . . 0.571 ' HD3' ' NE2' ' A' ' 108' ' ' GLN . 0.7 OUTLIER -79.75 113.87 18.24 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.861 -0.422 . . . . 10.0 109.861 179.276 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -119.88 161.79 20.24 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.439 0.638 . . . . 10.0 112.15 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 95.2 t -119.84 114.5 44.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.0 -1.0 . . . . 10.0 108.361 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 4.9 t -104.04 106.59 17.15 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.0 0.428 . . . . 10.0 111.571 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.445 HG22 HG23 ' B' ' 82' ' ' ILE . 31.2 t -104.9 110.01 29.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.972 -0.751 . . . . 10.0 108.972 178.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 7.0 ptt-85 -151.73 163.02 40.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.941 0.4 . . . . 10.0 111.686 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -82.64 113.38 20.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.823 -0.626 . . . . 10.0 109.984 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -105.24 84.25 2.08 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.364 -0.38 . . . . 10.0 110.787 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 59.0 mttm 62.41 43.6 7.91 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.69 -0.686 . . . . 10.0 111.477 178.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 86.87 35.52 9.93 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.528 -0.844 . . . . 10.0 112.429 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 19.1 mmtm -150.84 115.71 5.26 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 122.196 0.198 . . . . 10.0 110.557 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 80' ' ' VAL . . . . . 0.66 HG11 ' HA ' ' A' ' 123' ' ' VAL . 28.4 t -75.82 90.21 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.692 -0.855 . . . . 10.0 108.692 178.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 45.6 mt -95.21 130.99 41.74 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.358 0.599 . . . . 10.0 111.98 -178.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 82' ' ' ILE . . . . . 0.445 HG23 HG22 ' B' ' 73' ' ' VAL . 3.1 mp -103.13 91.06 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 107.799 -1.185 . . . . 10.0 107.799 178.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 83' ' ' ASP . . . . . 0.532 ' HA ' ' HA ' ' B' ' 103' ' ' SER . 34.1 t70 -89.85 104.46 17.02 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.588 -0.733 . . . . 10.0 111.69 -178.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 54.3 mt -87.28 97.56 6.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 107.501 -1.296 . . . . 10.0 107.501 177.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 85' ' ' ARG . . . . . 0.556 ' HD3' ' O ' ' B' ' 98' ' ' GLY . 12.6 ttm180 -132.0 150.28 52.2 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.886 -0.597 . . . . 10.0 112.127 -176.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -83.55 128.49 34.56 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.85 -0.796 . . . . 10.0 108.85 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 87' ' ' TYR . . . . . 0.565 ' HB3' ' HB3' ' B' ' 95' ' ' MET . 4.8 m-85 -103.01 122.14 44.01 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.971 0.415 . . . . 10.0 110.546 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 88' ' ' TRP . . . . . . . . . . . . . 22.4 m0 -99.92 136.88 39.16 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.859 -0.609 . . . . 10.0 109.851 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 44.2 ttm -73.33 141.02 47.11 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.109 0.481 . . . . 10.0 110.864 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 90' ' ' ASP . . . . . 0.421 ' OD2' ' HB2' ' B' ' 92' ' ' GLU . 0.0 OUTLIER -103.37 165.45 13.53 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 115.605 -0.725 . . . . 10.0 110.238 179.776 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -55.09 -29.71 66.89 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.113 2.542 . . . . 10.0 113.815 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 92' ' ' GLU . . . . . 0.421 ' HB2' ' OD2' ' B' ' 90' ' ' ASP . 0.5 OUTLIER -70.75 -35.24 72.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.966 0.412 . . . . 10.0 110.384 179.585 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 119.52 20.26 3.95 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.639 -0.791 . . . . 10.0 112.966 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 94' ' ' GLU . . . . . 0.764 ' HB2' ' HE2' ' B' ' 96' ' ' LYS . 3.3 mt-10 -111.56 160.68 16.96 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.88 0.34 . . . . 10.0 110.366 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 95' ' ' MET . . . . . 0.565 ' HB3' ' HB3' ' B' ' 87' ' ' TYR . 84.6 mmm -98.11 111.2 23.6 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.73 -0.47 . . . . 10.0 109.73 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 96' ' ' LYS . . . . . 0.764 ' HE2' ' HB2' ' B' ' 94' ' ' GLU . 49.8 mmtt -100.66 135.98 19.99 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.231 -0.44 . . . . 10.0 111.01 -178.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -63.0 118.88 5.77 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.394 2.063 . . . . 10.0 111.845 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 98' ' ' GLY . . . . . 0.556 ' O ' ' HD3' ' B' ' 85' ' ' ARG . . . -68.57 167.95 43.67 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.741 -0.743 . . . . 10.0 112.039 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 5.4 mtm180 -82.26 47.97 1.21 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.192 0.52 . . . . 10.0 110.98 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -161.78 104.87 1.21 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.689 -0.687 . . . . 10.0 110.418 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -173.93 161.13 31.37 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 110.805 -0.918 . . . . 10.0 110.805 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 7.5 tp -119.8 122.46 68.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.298 0.57 . . . . 10.0 111.244 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 103' ' ' SER . . . . . 0.532 ' HA ' ' HA ' ' B' ' 83' ' ' ASP . 0.8 OUTLIER -94.37 104.84 16.81 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.825 -0.625 . . . . 10.0 110.254 179.854 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 83.9 mt -98.27 163.62 12.64 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.231 -0.441 . . . . 10.0 110.628 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 105' ' ' ASN . . . . . 0.447 ' HB2' ' HD2' ' B' ' 106' ' ' PRO . 45.4 p30 -115.83 169.95 6.32 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 108.652 -0.87 . . . . 10.0 108.652 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 106' ' ' PRO . . . . . 0.53 ' HD3' ' O ' ' B' ' 80' ' ' VAL . 53.1 Cg_exo -53.61 -30.38 54.94 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.283 1.988 . . . . 10.0 112.445 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -65.02 -56.53 12.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.601 -0.727 . . . . 10.0 110.799 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 108' ' ' GLN . . . . . 0.783 ' HG2' ' HA3' ' A' ' 66' ' ' GLY . 19.9 mt-30 -72.49 -27.52 62.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.258 -0.428 . . . . 10.0 110.409 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 109' ' ' TRP . . . . . 0.467 ' HH2' HG12 ' A' ' 116' ' ' ILE . 34.9 t-105 -65.92 -36.78 84.33 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.962 -0.755 . . . . 10.0 108.962 177.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 110' ' ' SER . . . . . 0.497 ' O ' ' HG3' ' B' ' 114' ' ' GLU . 29.2 t -64.35 -51.16 64.75 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.322 -0.854 . . . . 10.0 109.437 178.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -62.22 -36.1 80.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.757 -0.656 . . . . 10.0 111.076 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 112' ' ' LEU . . . . . 0.471 ' O ' HG13 ' B' ' 116' ' ' ILE . 52.7 tp -59.25 -44.24 92.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.92 0.39 . . . . 10.0 110.069 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -66.38 -30.54 70.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.926 -0.579 . . . . 10.0 110.751 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 114' ' ' GLU . . . . . 0.497 ' HG3' ' O ' ' B' ' 110' ' ' SER . 43.3 mt-10 -79.75 -25.8 40.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.19 -0.459 . . . . 10.0 111.01 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -84.03 -10.44 57.87 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.337 -0.392 . . . . 10.0 111.217 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 116' ' ' ILE . . . . . 0.499 ' O ' ' HB2' ' B' ' 120' ' ' ASP . 73.0 mt -56.53 -43.29 77.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.375 -0.375 . . . . 10.0 111.787 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.23 -28.75 68.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.871 0.367 . . . . 10.0 111.695 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.79 -43.09 12.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.304 -0.407 . . . . 10.0 110.99 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 78.5 mt -67.26 -46.1 84.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.14 -0.482 . . . . 10.0 110.773 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 120' ' ' ASP . . . . . 0.499 ' HB2' ' O ' ' B' ' 116' ' ' ILE . 0.3 OUTLIER -55.88 -43.84 77.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.019 -0.537 . . . . 10.0 110.828 -179.916 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 121' ' ' ASP . . . . . 0.446 ' HA ' ' NE ' ' B' ' 124' ' ' ARG . 29.2 t70 -61.32 -37.52 83.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.525 -0.761 . . . . 10.0 111.242 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.49 -41.64 54.87 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.354 -0.385 . . . . 10.0 111.15 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 77.1 t -62.9 -42.5 96.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.197 -0.456 . . . . 10.0 111.441 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 124' ' ' ARG . . . . . 0.446 ' NE ' ' HA ' ' B' ' 121' ' ' ASP . 20.1 ptt180 -73.41 -6.77 48.37 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.801 0.297 . . . . 10.0 111.801 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 63.7 mttt -90.51 -4.8 56.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.025 0.441 . . . . 10.0 110.734 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 49.8 tp . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.561 -0.733 . . . . 10.0 109.972 179.578 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 465' ' ' TYR . . . . . . . . . . . . . 25.5 t80 . . . . . 0 N--CA 1.478 0.925 0 CA-C-O 120.389 0.138 . . . . 10.0 110.965 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 466' ' ' GLY . . . . . 0.604 ' HA2' ' HB3' ' C' ' 469' ' ' ASP . . . -54.12 -30.21 46.35 Favored Glycine 0 CA--C 1.519 0.343 0 N-CA-C 114.245 0.458 . . . . 10.0 114.245 -178.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 467' ' ' ALA . . . . . . . . . . . . . . . -56.57 -47.59 79.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 117.209 0.505 . . . . 10.0 111.472 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 468' ' ' LEU . . . . . . . . . . . . . 28.9 tp -88.44 -31.93 18.55 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.005 0.431 . . . . 10.0 110.317 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 469' ' ' ASP . . . . . 0.604 ' HB3' ' HA2' ' C' ' 466' ' ' GLY . 1.6 t70 -56.48 -48.61 76.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.487 -0.779 . . . . 10.0 111.653 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 470' ' ' MET . . . . . . . . . . . . . 1.8 mmm -63.03 -35.69 81.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.338 -0.392 . . . . 10.0 110.625 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 471' ' ' ALA . . . . . . . . . . . . . . . -68.95 -38.65 79.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.101 0.477 . . . . 10.0 110.148 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 472' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -67.81 -45.0 75.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.843 -0.617 . . . . 10.0 110.039 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 473' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -60.39 -42.94 96.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.686 -0.688 . . . . 10.0 109.778 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 474' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -65.64 -33.72 76.55 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.831 -0.622 . . . . 10.0 110.448 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 475' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -63.07 -47.37 83.21 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.811 -0.44 . . . . 10.0 109.811 178.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 476' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -65.98 -43.23 88.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.898 -0.592 . . . . 10.0 110.277 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 477' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -61.32 -38.49 87.06 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.558 -0.747 . . . . 10.0 110.948 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 478' ' ' MET . . . . . . . . . . . . . 31.3 tpp -74.46 -19.69 60.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.006 0.432 . . . . 10.0 111.2 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 479' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -70.59 -47.71 58.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.198 -0.456 . . . . 10.0 109.814 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 480' ' ' THR . . . . . 0.679 ' HB ' ' OG ' ' A' ' 103' ' ' SER . 0.1 OUTLIER -87.78 -4.73 58.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.844 -0.616 . . . . 10.0 111.152 179.798 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 481' ' ' ASP . . . . . 0.459 ' O ' ' HD2' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -55.39 -37.53 67.71 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.872 -0.603 . . . . 10.0 112.022 -179.825 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 482' ' ' ALA . . . . . . . . . . . . . . . -99.02 16.91 21.08 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.111 0.412 . . . . 10.0 112.111 -178.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 483' ' ' LEU . . . . . 0.578 HD21 HG13 ' A' ' 102' ' ' ILE . 33.0 tp -87.15 -51.28 6.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.711 0.291 . . . . 10.0 111.518 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 484' ' ' GLY . . . . . . . . . . . . . . . -75.12 41.99 1.34 Allowed Glycine 0 CA--C 1.521 0.461 0 C-N-CA 121.391 -0.433 . . . . 10.0 113.858 -178.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 485' ' ' ILE . . . . . 0.94 ' HB ' ' HD3' ' A' ' 79' ' ' LYS . 6.3 tp -151.13 -16.05 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.784 0.326 . . . . 10.0 110.507 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 486' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -68.34 -35.38 77.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.949 0.404 . . . . 10.0 110.611 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 487' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -77.17 -2.87 36.64 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.355 -0.384 . . . . 10.0 110.964 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 488' ' ' TYR . . . . . 0.45 ' HB2' ' O ' ' C' ' 485' ' ' ILE . 0.3 OUTLIER -79.7 -21.63 44.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.387 -0.37 . . . . 10.0 111.12 -179.825 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 489' ' ' GLY . . . . . . . . . . . . . . . -171.98 170.8 43.74 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.717 -0.754 . . . . 10.0 112.271 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.873 0 CA-C-O 118.679 -1.067 . . . . 10.0 111.801 -179.756 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 110.282 -0.266 . . . . 10.0 110.282 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.657 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -111.88 122.73 48.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.805 0.336 . . . . 10.0 111.162 -179.53 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -117.95 144.13 45.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.106 -0.497 . . . . 10.0 110.122 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -84.2 125.25 32.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.928 0.394 . . . . 10.0 110.76 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.3 pt -115.88 16.36 7.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.198 -0.456 . . . . 10.0 110.478 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 154.75 176.24 26.77 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.594 -0.602 . . . . 10.0 111.594 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.829 ' HG2' ' HG2' ' A' ' 68' ' ' MET . 51.8 tttp -65.61 120.17 12.45 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.688 0.28 . . . . 10.0 110.731 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.829 ' HG2' ' HG2' ' A' ' 67' ' ' LYS . 59.7 mmm 66.18 24.67 10.77 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.54 -0.755 . . . . 10.0 112.05 178.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -132.18 119.81 21.39 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.201 -0.296 . . . . 10.0 110.201 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.414 ' HB2' ' CD1' ' A' ' 87' ' ' TYR . 26.9 m-85 -128.3 135.23 49.33 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.054 0.454 . . . . 10.0 111.751 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.657 ' O ' ' HA ' ' A' ' 62' ' ' MET . 41.4 t -90.05 107.33 18.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 108.696 -0.853 . . . . 10.0 108.696 178.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.566 ' HB2' ' HB3' ' A' ' 83' ' ' ASP . 3.8 m -94.9 90.35 5.97 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.943 0.401 . . . . 10.0 111.799 -178.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 45.5 t -78.11 111.08 14.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.886 -0.783 . . . . 10.0 108.886 178.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.1 ptt180 -138.08 -167.01 2.08 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.106 -0.497 . . . . 10.0 110.596 -178.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -126.76 139.62 52.99 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.257 -0.428 . . . . 10.0 110.127 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.465 ' HD2' ' HE3' ' A' ' 77' ' ' LYS . 2.3 t80 -148.03 112.85 5.42 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.226 -0.443 . . . . 10.0 110.125 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.575 ' HZ2' ' HB2' ' A' ' 77' ' ' LYS . 6.8 mtmp? 68.42 15.11 9.22 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.755 -0.657 . . . . 10.0 111.234 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 100.21 0.39 55.9 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.278 -0.963 . . . . 10.0 112.485 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.3 mtpt -109.38 132.51 54.06 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.214 -0.291 . . . . 10.0 110.214 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.498 ' O ' ' HD3' ' A' ' 106' ' ' PRO . 43.8 t -70.74 107.32 2.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.204 -0.665 . . . . 10.0 109.204 178.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.597 HD11 ' HB2' ' C' ' 486' ' ' ASP . 6.7 mt -97.21 113.54 25.15 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.235 0.54 . . . . 10.0 112.376 -178.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.41 HD11 HG21 ' B' ' 123' ' ' VAL . 70.4 mt -89.1 89.38 3.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 107.322 -1.362 . . . . 10.0 107.322 177.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.566 ' HB3' ' HB2' ' A' ' 72' ' ' SER . 3.5 t70 -79.2 101.9 8.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.499 -0.773 . . . . 10.0 112.655 -177.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.5 mt -94.34 81.25 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.537 -0.912 . . . . 10.0 108.537 178.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.761 ' HG3' ' HA3' ' A' ' 101' ' ' GLY . 4.9 ttm180 -117.07 155.19 29.68 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.675 -0.693 . . . . 10.0 110.961 -178.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.464 ' O ' ' HA ' ' A' ' 97' ' ' PRO . 61.5 mt-10 -72.0 139.22 48.49 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.518 -0.549 . . . . 10.0 109.518 178.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.696 ' HD2' ' HB3' ' A' ' 95' ' ' MET . 5.4 m-85 -118.29 111.58 18.95 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.956 0.408 . . . . 10.0 110.229 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -103.02 145.65 29.56 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.761 -0.654 . . . . 10.0 109.897 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 40.8 ttm -87.62 137.74 32.08 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.112 -0.329 . . . . 10.0 110.112 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.493 ' HB2' ' CD ' ' A' ' 91' ' ' PRO . 53.0 p-10 -99.35 177.57 1.53 Allowed Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.071 -0.513 . . . . 10.0 110.275 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.493 ' CD ' ' HB2' ' A' ' 90' ' ' ASP . 28.0 Cg_exo -63.95 -12.46 32.15 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.513 2.142 . . . . 10.0 113.018 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -88.16 -16.76 32.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.291 0.567 . . . . 10.0 110.073 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.11 14.75 55.65 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.637 -0.71 . . . . 10.0 111.745 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.437 ' HB2' ' HD3' ' A' ' 96' ' ' LYS . 6.0 mm-40 -94.51 157.73 15.86 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.052 0.453 . . . . 10.0 110.751 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.696 ' HB3' ' HD2' ' A' ' 87' ' ' TYR . 87.1 mmm -92.64 108.71 20.19 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.181 -0.674 . . . . 10.0 109.181 178.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.73 ' HE2' ' HG2' ' C' ' 474' ' ' GLU . 2.2 mmmm -108.62 128.91 24.68 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 116.154 -0.475 . . . . 10.0 111.099 -178.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 58.2 Cg_endo -72.06 139.14 32.21 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.348 2.032 . . . . 10.0 112.283 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -84.16 -169.36 45.31 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.433 -0.667 . . . . 10.0 111.433 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.58 ' HD3' ' HG3' ' C' ' 477' ' ' GLN . 0.0 OUTLIER -91.03 -7.72 51.09 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 117.3 0.55 . . . . 10.0 110.969 -179.856 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 21.2 ttmt -100.25 113.9 26.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.173 -0.467 . . . . 10.0 110.108 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.761 ' HA3' ' HG3' ' A' ' 85' ' ' ARG . . . -175.7 168.66 41.11 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.85 -0.691 . . . . 10.0 111.8 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.816 ' HA ' HD11 ' C' ' 485' ' ' ILE . 17.2 tt -139.58 121.53 16.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.332 0.587 . . . . 10.0 111.006 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 83' ' ' ASP . 0.9 OUTLIER -97.77 113.0 24.68 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.952 -0.567 . . . . 10.0 109.704 179.519 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.51 ' HB3' ' HB2' ' A' ' 108' ' ' GLN . 25.2 mt -111.68 133.64 53.79 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.011 -0.54 . . . . 10.0 110.379 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.73 ' HB2' ' HD2' ' A' ' 106' ' ' PRO . 14.5 p30 -91.55 172.82 6.03 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 109.32 -0.622 . . . . 10.0 109.32 178.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.73 ' HD2' ' HB2' ' A' ' 105' ' ' ASN . 70.6 Cg_exo -42.77 -37.91 6.22 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 123.505 2.803 . . . . 10.0 114.282 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.418 ' HB3' ' NE2' ' A' ' 108' ' ' GLN . 19.0 tt0 -57.03 -49.56 75.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.645 0.26 . . . . 10.0 111.02 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.695 ' NE2' ' HA3' ' C' ' 490' ' ' GLY . 1.0 OUTLIER -74.4 -33.54 63.04 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 110.032 -0.358 . . . . 10.0 110.032 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.497 ' CH2' HG12 ' B' ' 116' ' ' ILE . 69.1 t-105 -57.91 -53.66 55.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.878 -0.601 . . . . 10.0 110.911 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.7 m -61.95 -42.52 99.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.296 -0.411 . . . . 10.0 110.748 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -64.35 -41.47 96.73 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.306 -0.406 . . . . 10.0 110.731 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.565 ' O ' HG13 ' A' ' 116' ' ' ILE . 61.2 tp -61.91 -43.89 97.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 10.0 110.615 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.58 ' HA ' HD12 ' A' ' 116' ' ' ILE . 43.5 mtmt -61.71 -27.83 68.98 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.925 0.393 . . . . 10.0 110.735 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -77.15 -38.19 52.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.096 0.475 . . . . 10.0 110.312 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.444 ' O ' HG13 ' A' ' 119' ' ' ILE . 20.5 mm-40 -76.42 -18.88 58.6 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.74 -0.664 . . . . 10.0 111.541 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.58 HD12 ' HA ' ' A' ' 113' ' ' LYS . 44.4 mt -51.62 -39.61 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 112.072 0.397 . . . . 10.0 112.072 -179.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 18.1 m -65.31 -17.52 64.58 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.968 0.359 . . . . 10.0 111.968 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.08 -34.29 8.47 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.745 -0.465 . . . . 10.0 109.745 178.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.573 HG23 HG21 ' B' ' 73' ' ' VAL . 83.0 mt -64.68 -48.72 83.53 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-N 115.827 -0.624 . . . . 10.0 109.966 178.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.42 ' O ' ' HG3' ' A' ' 124' ' ' ARG . 16.6 t70 -58.31 -38.47 77.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.448 -0.796 . . . . 10.0 110.326 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -65.87 -41.58 91.44 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.217 -0.902 . . . . 10.0 110.561 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.23 -37.95 89.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.87 -0.605 . . . . 10.0 110.874 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 119' ' ' ILE . 95.6 t -62.41 -40.66 88.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 10.0 110.35 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 120' ' ' ASP . 12.1 mtt85 -68.92 -30.43 68.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.831 -0.622 . . . . 10.0 110.872 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 16.9 mttp -71.21 -25.52 62.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.089 0.471 . . . . 10.0 110.762 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 62.3 mt . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 116.064 -0.516 . . . . 10.0 110.522 179.783 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.264 0 CA-C-O 121.143 0.497 . . . . 10.0 110.566 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 88.0 mmm -119.12 99.29 6.63 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.562 -0.745 . . . . 10.0 110.088 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 63' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -101.54 139.22 37.49 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.922 -0.581 . . . . 10.0 110.33 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -93.52 139.62 30.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.049 0.452 . . . . 10.0 111.708 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 65' ' ' ILE . . . . . 0.435 ' O ' ' HB3' ' B' ' 69' ' ' ARG . 5.8 pt -138.0 94.33 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.507 -0.769 . . . . 10.0 109.529 178.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.64 -135.98 12.45 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.669 -0.777 . . . . 10.0 111.387 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 67' ' ' LYS . . . . . 0.603 ' O ' ' HA2' ' C' ' 489' ' ' GLY . 5.6 mptt -117.63 120.96 39.63 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.369 -0.234 . . . . 10.0 110.369 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 68' ' ' MET . . . . . . . . . . . . . 96.4 mmm 65.26 2.11 1.8 Allowed 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.817 0.673 . . . . 10.0 112.817 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 69' ' ' ARG . . . . . 0.548 ' CZ ' ' HA3' ' C' ' 489' ' ' GLY . 2.3 tpp180 -98.95 126.36 44.62 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.819 -0.438 . . . . 10.0 109.819 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -130.66 142.67 50.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.514 0.673 . . . . 10.0 112.3 -178.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.418 HG13 HG12 ' B' ' 84' ' ' ILE . 62.1 t -93.41 110.44 23.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.586 -0.894 . . . . 10.0 108.586 178.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 13.3 t -100.4 103.29 14.66 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.14 0.495 . . . . 10.0 111.919 -178.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.573 HG21 HG23 ' A' ' 119' ' ' ILE . 19.3 t -96.2 98.33 7.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 108.943 -0.762 . . . . 10.0 108.943 178.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 74' ' ' ARG . . . . . 0.458 ' NH1' ' HB3' ' B' ' 83' ' ' ASP . 19.6 ptt-85 -131.51 155.07 48.06 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.221 0.534 . . . . 10.0 111.966 -178.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -95.79 113.43 25.07 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.288 -0.869 . . . . 10.0 109.871 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -92.77 78.6 4.78 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.379 -0.373 . . . . 10.0 110.526 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 90.1 mttt 56.53 57.53 4.79 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.743 -0.662 . . . . 10.0 111.092 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.27 29.56 33.21 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.636 -0.792 . . . . 10.0 112.02 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -142.21 88.97 2.13 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.744 0.307 . . . . 10.0 110.252 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 12.0 t -70.01 102.31 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.408 -0.589 . . . . 10.0 109.408 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 37.0 mt -117.98 132.34 56.4 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.014 0.435 . . . . 10.0 111.366 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 82' ' ' ILE . . . . . 0.525 HD13 ' HB2' ' B' ' 109' ' ' TRP . 4.1 mp -91.65 86.9 2.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 108.138 -1.06 . . . . 10.0 108.138 178.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 83' ' ' ASP . . . . . 0.596 ' HA ' ' HA ' ' B' ' 103' ' ' SER . 37.4 t70 -89.78 95.89 10.44 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.315 -0.857 . . . . 10.0 110.937 -178.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 84' ' ' ILE . . . . . 0.418 HG12 HG13 ' B' ' 71' ' ' VAL . 21.7 mt -78.67 116.41 22.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 108.217 -1.031 . . . . 10.0 108.217 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 20.3 ttm-85 -142.38 151.42 41.85 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.296 0.57 . . . . 10.0 112.163 -177.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 86' ' ' GLU . . . . . 0.49 ' HG3' ' HA3' ' B' ' 98' ' ' GLY . 5.0 pt-20 -89.8 162.88 15.29 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.669 -0.696 . . . . 10.0 109.373 178.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 87' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -111.79 129.81 56.01 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.056 0.455 . . . . 10.0 111.251 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 88' ' ' TRP . . . . . . . . . . . . . 24.3 m95 -117.03 145.89 43.41 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.394 -0.965 . . . . 10.0 108.394 178.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 30.1 ttm -108.65 137.71 46.15 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.549 -0.461 . . . . 10.0 110.469 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 90' ' ' ASP . . . . . 0.438 ' HB2' ' CD ' ' B' ' 91' ' ' PRO . 55.1 p30 -93.83 171.78 6.62 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.165 -0.471 . . . . 10.0 110.644 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 91' ' ' PRO . . . . . 0.438 ' CD ' ' HB2' ' B' ' 90' ' ' ASP . 24.7 Cg_exo -64.65 -13.3 38.21 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.619 2.213 . . . . 10.0 113.098 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -82.71 -41.64 19.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.893 0.378 . . . . 10.0 110.048 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 119.87 27.84 2.01 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 121.085 -0.579 . . . . 10.0 111.886 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 94' ' ' GLU . . . . . 0.712 ' HB3' ' HE2' ' B' ' 96' ' ' LYS . 0.0 OUTLIER -110.24 151.39 27.4 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.965 0.412 . . . . 10.0 110.341 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 95' ' ' MET . . . . . . . . . . . . . 82.4 mmm -90.01 112.05 23.34 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.854 -0.612 . . . . 10.0 109.99 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 96' ' ' LYS . . . . . 0.712 ' HE2' ' HB3' ' B' ' 94' ' ' GLU . 61.2 mmtt -111.17 140.5 22.92 Favored Pre-proline 0 C--N 1.318 -0.786 0 CA-C-N 116.444 -0.344 . . . . 10.0 110.522 -179.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -63.22 131.38 32.05 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 122.607 2.205 . . . . 10.0 111.843 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 98' ' ' GLY . . . . . 0.49 ' HA3' ' HG3' ' B' ' 86' ' ' GLU . . . -68.69 160.88 51.63 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 121.151 -0.547 . . . . 10.0 112.835 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -71.83 -23.5 61.55 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.878 0.371 . . . . 10.0 110.877 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 100' ' ' LYS . . . . . 0.735 ' HD2' HD12 ' C' ' 485' ' ' ILE . 29.5 mmtp -88.45 142.84 27.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.195 -0.457 . . . . 10.0 110.378 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 101' ' ' GLY . . . . . 0.695 ' HA2' ' HB ' ' A' ' 102' ' ' ILE . . . 138.98 163.47 9.52 Favored Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 111.503 -0.639 . . . . 10.0 111.503 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 20.0 tt -145.39 142.99 22.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.888 0.375 . . . . 10.0 110.97 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 103' ' ' SER . . . . . 0.596 ' HA ' ' HA ' ' B' ' 83' ' ' ASP . 0.8 OUTLIER -97.11 110.87 23.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.911 -0.586 . . . . 10.0 110.194 179.509 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 104' ' ' LEU . . . . . 0.414 HD22 ' HB3' ' B' ' 108' ' ' GLN . 94.8 mt -95.49 133.98 38.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.779 0.323 . . . . 10.0 110.914 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -88.54 168.85 14.91 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.471 -0.566 . . . . 10.0 109.471 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -45.69 -37.78 16.27 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.995 2.463 . . . . 10.0 113.836 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -68.14 -52.98 28.52 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.972 0.415 . . . . 10.0 110.314 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 108' ' ' GLN . . . . . 0.414 ' HB3' HD22 ' B' ' 104' ' ' LEU . 11.4 mt-30 -62.58 -34.69 77.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.738 -0.664 . . . . 10.0 110.854 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 109' ' ' TRP . . . . . 0.525 ' HB2' HD13 ' B' ' 82' ' ' ILE . 34.7 t-105 -59.4 -43.74 92.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.114 -0.493 . . . . 10.0 110.143 178.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 110' ' ' SER . . . . . 0.447 ' HA ' ' HE3' ' B' ' 113' ' ' LYS . 19.3 t -67.97 -46.93 69.98 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.974 -0.557 . . . . 10.0 110.012 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 111' ' ' GLN . . . . . 0.536 ' O ' ' HG2' ' B' ' 115' ' ' GLN . 21.7 mm-40 -58.22 -41.71 84.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.949 -0.569 . . . . 10.0 110.841 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 112' ' ' LEU . . . . . 0.504 ' O ' HG13 ' B' ' 116' ' ' ILE . 43.2 tp -57.79 -46.93 83.92 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.926 0.393 . . . . 10.0 110.09 178.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 113' ' ' LYS . . . . . 0.447 ' HE3' ' HA ' ' B' ' 110' ' ' SER . 48.6 mtmt -65.13 -33.91 77.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.902 -0.59 . . . . 10.0 110.882 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -74.4 -38.43 63.1 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.859 -0.61 . . . . 10.0 112.026 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 115' ' ' GLN . . . . . 0.536 ' HG2' ' O ' ' B' ' 111' ' ' GLN . 10.5 mm-40 -79.06 -5.37 53.84 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.8 0.296 . . . . 10.0 111.8 -179.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 116' ' ' ILE . . . . . 0.504 HG13 ' O ' ' B' ' 112' ' ' LEU . 25.7 mt -53.32 -41.26 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.784 -0.189 . . . . 10.0 111.396 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 117' ' ' SER . . . . . 0.431 ' O ' ' HB2' ' B' ' 121' ' ' ASP . 0.2 OUTLIER -57.26 -37.42 72.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.289 -0.414 . . . . 10.0 111.889 -179.372 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.09 -45.29 16.7 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.864 0.364 . . . . 10.0 110.918 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 119' ' ' ILE . . . . . 0.475 ' O ' HG23 ' B' ' 123' ' ' VAL . 71.1 mt -59.82 -52.48 60.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.839 -0.619 . . . . 10.0 110.988 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -61.08 -39.06 88.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.925 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 121' ' ' ASP . . . . . 0.431 ' HB2' ' O ' ' B' ' 117' ' ' SER . 10.6 t70 -58.54 -38.84 78.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.958 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -78.47 -38.55 40.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.268 -0.423 . . . . 10.0 111.054 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 123' ' ' VAL . . . . . 0.475 HG23 ' O ' ' B' ' 119' ' ' ILE . 89.1 t -66.93 -35.45 74.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.34 -0.391 . . . . 10.0 111.466 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 124' ' ' ARG . . . . . 0.462 ' HG3' ' HG3' ' B' ' 125' ' ' LYS . 15.5 ptp180 -81.7 -6.33 58.94 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 111.875 0.324 . . . . 10.0 111.875 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 125' ' ' LYS . . . . . 0.462 ' HG3' ' HG3' ' B' ' 124' ' ' ARG . 91.4 mttt -119.95 83.48 2.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.103 0.478 . . . . 10.0 111.131 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 36.7 tp . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.306 -0.854 . . . . 10.0 109.728 179.627 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 465' ' ' TYR . . . . . . . . . . . . . 21.9 t80 . . . . . 0 N--CA 1.48 1.037 0 CA-C-O 120.416 0.151 . . . . 10.0 110.921 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 466' ' ' GLY . . . . . 0.404 ' C ' ' H ' ' C' ' 468' ' ' LEU . . . -58.11 -43.33 95.28 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.937 -0.649 . . . . 10.0 112.391 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 467' ' ' ALA . . . . . . . . . . . . . . . -77.25 23.84 0.19 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.354 0.597 . . . . 10.0 111.719 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 468' ' ' LEU . . . . . 0.404 ' H ' ' C ' ' C' ' 466' ' ' GLY . 69.8 tp -141.39 -53.91 0.46 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.652 -0.704 . . . . 10.0 109.205 179.122 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 469' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -59.22 -41.21 88.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.531 -0.759 . . . . 10.0 110.89 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 470' ' ' MET . . . . . . . . . . . . . 26.8 ttm -103.49 19.08 20.43 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.055 -0.521 . . . . 10.0 110.5 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 471' ' ' ALA . . . . . . . . . . . . . . . -117.34 -54.58 2.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.908 0.385 . . . . 10.0 110.892 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 472' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -59.61 -35.82 75.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.901 -0.59 . . . . 10.0 110.931 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 473' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -95.77 15.11 21.08 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.107 -0.497 . . . . 10.0 110.918 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 474' ' ' GLU . . . . . 0.73 ' HG2' ' HE2' ' A' ' 96' ' ' LYS . 1.5 tp10 -111.75 -30.19 7.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.0 0.428 . . . . 10.0 110.72 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 475' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -58.5 -39.95 81.46 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.973 -0.558 . . . . 10.0 110.955 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 476' ' ' GLU . . . . . 0.51 ' OE1' ' HB3' ' C' ' 479' ' ' PHE . 43.9 mm-40 -78.85 8.9 4.77 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.833 0.679 . . . . 10.0 112.833 -178.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 477' ' ' GLN . . . . . 0.593 ' HB2' ' O ' ' C' ' 474' ' ' GLU . 1.4 mp0 -73.01 -21.51 60.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.096 0.474 . . . . 10.0 109.878 179.038 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 478' ' ' MET . . . . . . . . . . . . . 3.9 ptp -145.01 -4.12 0.74 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.744 -0.662 . . . . 10.0 111.645 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 479' ' ' PHE . . . . . 0.51 ' HB3' ' OE1' ' C' ' 476' ' ' GLU . 2.6 t80 -71.48 -83.27 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.788 -0.365 . . . . 10.0 111.328 -179.03 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 480' ' ' THR . . . . . . . . . . . . . 13.0 p -65.41 -18.9 65.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.22 0.533 . . . . 10.0 110.774 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 481' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -67.31 -20.56 65.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.306 -0.861 . . . . 10.0 110.876 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 482' ' ' ALA . . . . . . . . . . . . . . . -65.56 -19.71 66.03 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.93 -0.577 . . . . 10.0 111.306 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 483' ' ' LEU . . . . . . . . . . . . . 22.4 tp -70.52 -58.61 3.51 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.442 -0.577 . . . . 10.0 109.442 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 484' ' ' GLY . . . . . . . . . . . . . . . -82.53 57.15 5.03 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.864 -0.607 . . . . 10.0 112.457 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 485' ' ' ILE . . . . . 0.816 HD11 ' HA ' ' A' ' 102' ' ' ILE . 17.9 tt -168.47 -31.82 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.394 -0.595 . . . . 10.0 109.394 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 486' ' ' ASP . . . . . 0.597 ' HB2' HD11 ' A' ' 81' ' ' LEU . 8.0 t70 -89.34 -55.69 3.56 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.126 -0.488 . . . . 10.0 110.033 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 487' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -81.07 61.14 4.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.878 -0.601 . . . . 10.0 111.141 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 488' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -161.55 -52.73 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.567 -0.742 . . . . 10.0 109.745 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 489' ' ' GLY . . . . . 0.603 ' HA2' ' O ' ' B' ' 67' ' ' LYS . . . -87.64 -5.61 78.16 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.45 -0.796 . . . . 10.0 112.898 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 490' ' ' GLY . . . . . 0.695 ' HA3' ' NE2' ' A' ' 108' ' ' GLN . . . . . . . . 0 N--CA 1.444 -0.796 0 CA-C-O 118.512 -1.16 . . . . 10.0 112.412 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 110.364 -0.235 . . . . 10.0 110.364 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 41.2 ttm -135.83 110.09 8.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.032 0.444 . . . . 10.0 110.643 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -100.37 169.49 9.07 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.426 -0.583 . . . . 10.0 109.426 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -132.35 132.55 43.02 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.899 -0.321 . . . . 10.0 110.92 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 22.7 pt -117.79 -2.09 9.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.977 0.418 . . . . 10.0 110.999 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 176.99 173.91 42.96 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.838 -0.696 . . . . 10.0 111.724 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.512 ' HG2' ' HG2' ' A' ' 68' ' ' MET . 64.4 tttp -63.91 126.99 29.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.837 0.319 . . . . 10.0 110.225 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.512 ' HG2' ' HG2' ' A' ' 67' ' ' LYS . 87.1 mmm 64.16 17.65 10.8 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.794 -0.639 . . . . 10.0 111.326 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.409 ' HD2' ' O ' ' A' ' 67' ' ' LYS . 0.4 OUTLIER -128.93 109.17 11.01 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 109.948 -0.39 . . . . 10.0 109.948 179.493 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.549 ' HD1' ' HB2' ' A' ' 87' ' ' TYR . 41.4 m-85 -121.76 160.23 25.01 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.789 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 40.9 t -111.69 114.64 47.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.968 -0.56 . . . . 10.0 110.126 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.94 119.4 27.11 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.765 -0.652 . . . . 10.0 110.523 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 81' ' ' LEU . 74.7 t -132.6 106.77 11.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.682 -0.488 . . . . 10.0 109.682 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.3 ptt180 -155.53 169.83 23.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.661 0.267 . . . . 10.0 111.014 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.72 132.46 45.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.045 -0.525 . . . . 10.0 109.94 178.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -145.17 117.41 8.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.632 -0.258 . . . . 10.0 110.731 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 74.7 mttt 61.8 -86.75 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.804 -0.635 . . . . 10.0 111.176 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -148.39 31.03 1.28 Allowed Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 111.439 -0.664 . . . . 10.0 111.439 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.425 ' HB2' ' HE3' ' A' ' 79' ' ' LYS . 20.9 ttmt -158.17 169.48 24.43 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.563 -0.532 . . . . 10.0 109.563 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 58.8 t -86.36 119.42 34.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.014 0.435 . . . . 10.0 110.034 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.503 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 1.1 tp -84.06 101.82 12.06 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.836 -0.62 . . . . 10.0 110.675 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.499 HG23 HG22 ' A' ' 73' ' ' VAL . 15.1 mt -108.46 98.23 6.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.586 -0.894 . . . . 10.0 108.586 178.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.475 ' HA ' ' HA ' ' A' ' 103' ' ' SER . 16.0 t70 -118.9 121.83 40.88 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.552 0.575 . . . . 10.0 112.552 -177.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 56.7 mt -100.71 103.58 15.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.115 -1.068 . . . . 10.0 108.115 177.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.679 ' HD2' ' HB2' ' A' ' 97' ' ' PRO . 8.8 ttm-85 -145.98 160.46 41.82 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.931 0.396 . . . . 10.0 111.318 -177.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.714 ' O ' ' HA ' ' A' ' 97' ' ' PRO . 13.2 pt-20 -63.75 141.44 58.77 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.648 -0.871 . . . . 10.0 108.648 177.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.549 ' HB2' ' HD1' ' A' ' 70' ' ' TYR . 1.7 m-85 -113.6 120.54 41.28 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.105 0.479 . . . . 10.0 111.757 -178.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -102.51 155.17 18.45 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.296 -0.865 . . . . 10.0 108.899 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 25.2 ttt -82.42 139.16 34.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.385 0.612 . . . . 10.0 111.733 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -83.33 144.61 46.87 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 114.922 -1.036 . . . . 10.0 109.154 178.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -47.57 -33.47 18.08 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.862 2.375 . . . . 10.0 112.91 178.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -75.76 -59.38 2.78 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.338 -0.392 . . . . 10.0 110.72 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 169.44 -11.51 0.05 OUTLIER Glycine 0 CA--C 1.521 0.462 0 C-N-CA 120.107 -1.044 . . . . 10.0 114.029 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -79.33 -175.08 4.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 117.22 0.51 . . . . 10.0 111.31 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 57.2 mmm -134.62 141.92 46.75 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.277 -0.638 . . . . 10.0 109.277 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.87 ' HD2' ' HD2' ' A' ' 97' ' ' PRO . 10.2 mmtp -146.79 156.29 48.1 Favored Pre-proline 0 N--CA 1.464 0.238 0 CA-C-O 120.639 0.256 . . . . 10.0 111.281 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.87 ' HD2' ' HD2' ' A' ' 96' ' ' LYS . 34.0 Cg_endo -63.4 153.7 72.91 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.289 2.659 . . . . 10.0 114.258 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -102.4 -110.41 3.4 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.057 -0.974 . . . . 10.0 112.28 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.412 ' HD3' ' HA ' ' A' ' 99' ' ' ARG . 18.8 mmt180 -122.59 -46.49 2.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.015 0.408 . . . . 10.0 111.874 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 16.1 mttp -71.15 104.79 3.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.702 0.287 . . . . 10.0 110.517 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.6 ' HA3' ' HG3' ' A' ' 85' ' ' ARG . . . 174.42 165.91 31.63 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.862 -0.685 . . . . 10.0 112.378 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.517 ' HB ' ' HA2' ' B' ' 101' ' ' GLY . 20.2 tt -146.63 142.03 20.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.99 0.424 . . . . 10.0 110.551 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 83' ' ' ASP . 1.3 m -85.83 136.62 33.24 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.021 -0.536 . . . . 10.0 110.201 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 71.4 mt -93.12 105.23 17.35 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.272 -0.422 . . . . 10.0 110.886 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -62.38 141.43 96.41 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.363 -0.606 . . . . 10.0 109.363 178.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -47.12 -38.08 24.25 Favored 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 122.617 2.211 . . . . 10.0 112.474 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -77.61 -37.28 50.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.125 -0.488 . . . . 10.0 110.295 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -68.05 -31.43 71.08 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.711 -0.677 . . . . 10.0 110.612 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 54.2 t-105 -55.36 -45.63 76.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.88 -0.6 . . . . 10.0 110.797 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.8 t -69.12 -51.81 34.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.383 -0.372 . . . . 10.0 110.395 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -55.51 -42.87 75.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.004 -0.544 . . . . 10.0 111.534 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.506 ' O ' HG13 ' A' ' 116' ' ' ILE . 62.6 tp -61.35 -47.85 84.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.644 0.259 . . . . 10.0 110.816 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.404 ' HA ' HD12 ' A' ' 116' ' ' ILE . 48.0 mtmt -60.54 -37.72 82.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.005 0.431 . . . . 10.0 111.338 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -73.83 -31.62 63.3 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.061 -0.518 . . . . 10.0 111.39 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -81.07 -15.33 56.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.487 -0.324 . . . . 10.0 111.15 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 112' ' ' LEU . 21.4 mt -49.77 -43.5 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 112.215 0.45 . . . . 10.0 112.215 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.4 m -56.97 -37.43 71.58 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.763 0.316 . . . . 10.0 111.643 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -83.6 -39.77 19.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.012 0.434 . . . . 10.0 110.616 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.475 ' O ' HG23 ' A' ' 123' ' ' VAL . 92.2 mt -60.19 -50.44 80.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.777 -0.647 . . . . 10.0 110.242 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -59.59 -37.14 77.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.392 -0.822 . . . . 10.0 110.559 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.416 ' HA ' ' CZ ' ' A' ' 124' ' ' ARG . 7.2 t70 -66.21 -35.72 81.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.312 -0.858 . . . . 10.0 110.814 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -70.83 -33.5 70.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.885 -0.598 . . . . 10.0 110.559 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 119' ' ' ILE . 60.5 t -62.24 -40.55 88.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.347 0.594 . . . . 10.0 110.118 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.416 ' CZ ' ' HA ' ' A' ' 121' ' ' ASP . 12.8 mtm105 -74.35 -13.16 60.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.529 -0.759 . . . . 10.0 111.275 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 38.7 mttp -90.46 -2.62 57.94 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.911 0.386 . . . . 10.0 110.827 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 84.0 mt . . . . . 0 C--N 1.325 -0.458 0 CA-C-N 116.249 -0.432 . . . . 10.0 110.861 -179.948 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 121.067 0.46 . . . . 10.0 110.35 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 88.0 mmm -99.7 102.8 14.38 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.565 -0.743 . . . . 10.0 109.779 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' PHE . . . . . 0.413 ' CD2' HG12 ' A' ' 119' ' ' ILE . 48.4 m-85 -108.03 115.68 30.56 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.387 -0.369 . . . . 10.0 111.223 -179.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' GLN . . . . . 0.46 ' HA ' ' HD1' ' B' ' 70' ' ' TYR . 55.1 tt0 -71.34 125.0 25.82 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.171 -0.468 . . . . 10.0 110.378 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 19.1 pt -116.6 2.85 7.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.005 -0.543 . . . . 10.0 110.286 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 170.66 -162.45 35.49 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.993 -0.622 . . . . 10.0 111.969 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.33 117.83 25.38 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 110.199 -0.297 . . . . 10.0 110.199 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' MET . . . . . . . . . . . . . 19.9 mmt 68.33 8.91 6.92 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.545 -0.752 . . . . 10.0 111.566 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' ARG . . . . . 0.544 ' HE ' ' HB3' ' B' ' 86' ' ' GLU . 0.7 OUTLIER -120.8 119.26 32.21 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.499 -0.556 . . . . 10.0 109.499 179.199 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' TYR . . . . . 0.46 ' HD1' ' HA ' ' B' ' 64' ' ' GLN . 38.8 m-85 -135.18 138.32 43.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.884 0.373 . . . . 10.0 111.2 -178.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.572 HG22 HG12 ' B' ' 84' ' ' ILE . 75.5 t -89.94 117.78 33.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 108.631 -0.877 . . . . 10.0 108.631 178.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 72' ' ' SER . . . . . 0.51 ' HB3' ' NH1' ' B' ' 74' ' ' ARG . 24.5 t -111.48 109.87 20.03 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.036 0.446 . . . . 10.0 111.289 -178.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . 0.431 ' CG2' HG23 ' A' ' 119' ' ' ILE . 20.4 t -92.73 94.86 4.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.193 -0.669 . . . . 10.0 109.193 178.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . 0.51 ' NH1' ' HB3' ' B' ' 72' ' ' SER . 26.5 ptt-85 -122.05 149.18 43.9 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.118 0.485 . . . . 10.0 111.546 -178.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -87.54 115.99 25.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.51 -0.768 . . . . 10.0 109.262 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -110.14 105.81 15.04 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.445 -0.343 . . . . 10.0 111.222 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 33.2 mttm 57.61 30.78 19.34 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.703 -0.68 . . . . 10.0 112.785 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 92.67 30.84 9.24 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.509 -0.853 . . . . 10.0 112.23 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' B' ' 79' ' ' LYS . 18.4 mmtm -144.22 108.13 4.71 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 122.367 0.267 . . . . 10.0 110.45 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 16.1 t -69.49 106.18 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.387 -0.597 . . . . 10.0 109.387 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 94.5 mt -111.02 128.88 56.0 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.027 0.441 . . . . 10.0 111.665 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 82' ' ' ILE . . . . . . . . . . . . . 5.2 mp -90.75 86.45 2.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 107.499 -1.297 . . . . 10.0 107.499 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . 0.501 ' HA ' ' HA ' ' B' ' 103' ' ' SER . 34.8 t70 -85.78 107.61 17.71 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.744 -0.662 . . . . 10.0 112.02 -177.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . 0.572 HG12 HG22 ' B' ' 71' ' ' VAL . 63.4 mt -92.63 95.84 5.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 107.5 -1.296 . . . . 10.0 107.5 177.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 85' ' ' ARG . . . . . 0.454 ' HG3' ' HA3' ' B' ' 101' ' ' GLY . 19.7 ttm-85 -132.84 168.84 17.66 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.504 0.669 . . . . 10.0 111.973 -177.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 86' ' ' GLU . . . . . 0.544 ' HB3' ' HE ' ' B' ' 69' ' ' ARG . 11.7 pt-20 -89.25 154.95 19.71 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.214 -0.903 . . . . 10.0 109.348 178.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 87' ' ' TYR . . . . . 0.624 ' HB3' ' HB3' ' B' ' 95' ' ' MET . 38.0 m-85 -131.47 118.8 20.69 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.909 -0.404 . . . . 10.0 109.909 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 88' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -108.28 136.61 47.64 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.976 -0.556 . . . . 10.0 109.798 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 52.4 ttm -75.55 130.99 39.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.072 0.463 . . . . 10.0 111.41 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 90' ' ' ASP . . . . . 0.491 ' OD2' ' HE2' ' B' ' 96' ' ' LYS . 35.0 p30 -84.79 172.23 9.37 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.579 -0.737 . . . . 10.0 109.774 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 91' ' ' PRO . . . . . 0.447 ' HD2' ' HB2' ' B' ' 90' ' ' ASP . 32.0 Cg_exo -61.89 -13.08 28.83 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.695 2.263 . . . . 10.0 112.863 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -84.72 -43.81 13.95 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.968 0.413 . . . . 10.0 110.254 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 129.57 16.26 1.88 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.945 -0.645 . . . . 10.0 112.317 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -109.74 147.02 33.94 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.725 0.298 . . . . 10.0 110.279 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 95' ' ' MET . . . . . 0.624 ' HB3' ' HB3' ' B' ' 87' ' ' TYR . 84.3 mmm -88.7 115.84 26.52 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 110.047 -0.353 . . . . 10.0 110.047 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . 0.491 ' HE2' ' OD2' ' B' ' 90' ' ' ASP . 72.0 mmtt -104.12 140.78 21.4 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 116.347 -0.388 . . . . 10.0 110.053 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.13 129.04 20.78 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.438 2.092 . . . . 10.0 112.159 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . 0.405 ' O ' ' HD3' ' B' ' 85' ' ' ARG . . . -76.17 -173.63 36.17 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.107 -0.568 . . . . 10.0 112.199 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -88.3 -23.28 23.5 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.894 0.378 . . . . 10.0 111.202 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 7.0 mtmp? -88.08 113.81 24.09 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.282 0.563 . . . . 10.0 110.851 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 101' ' ' GLY . . . . . 0.517 ' HA2' ' HB ' ' A' ' 102' ' ' ILE . . . 169.13 175.67 38.6 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 110.894 -0.882 . . . . 10.0 110.894 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 102' ' ' ILE . . . . . 0.592 ' HB ' ' HA2' ' A' ' 101' ' ' GLY . 21.1 tt -143.56 138.44 25.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 117.299 0.549 . . . . 10.0 111.425 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 103' ' ' SER . . . . . 0.501 ' HA ' ' HA ' ' B' ' 83' ' ' ASP . 1.5 m -98.33 107.71 20.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.781 -0.645 . . . . 10.0 109.986 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 46.3 mt -99.39 135.56 40.62 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.466 -0.334 . . . . 10.0 110.741 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 105' ' ' ASN . . . . . 0.542 ' HB2' ' HD2' ' B' ' 106' ' ' PRO . 8.7 p-10 -88.18 164.23 34.01 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 108.836 -0.802 . . . . 10.0 108.836 178.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . 0.542 ' HD2' ' HB2' ' B' ' 105' ' ' ASN . 7.6 Cg_endo -49.43 -32.26 26.04 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.179 2.586 . . . . 10.0 113.305 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -64.22 -57.95 8.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.266 -0.424 . . . . 10.0 110.69 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -66.88 -30.85 71.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.094 0.473 . . . . 10.0 109.949 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 109' ' ' TRP . . . . . 0.502 ' CH2' HG12 ' A' ' 116' ' ' ILE . 48.7 t-105 -59.54 -42.33 92.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.543 -0.753 . . . . 10.0 110.04 179.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 110' ' ' SER . . . . . 0.429 ' O ' ' HG3' ' B' ' 114' ' ' GLU . 29.9 t -63.9 -47.61 79.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 10.0 109.784 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -61.05 -38.95 87.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.816 -0.629 . . . . 10.0 111.073 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . 0.408 ' O ' HG13 ' B' ' 116' ' ' ILE . 49.6 tp -58.6 -45.93 88.09 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.801 0.334 . . . . 10.0 110.373 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 113' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' B' ' 109' ' ' TRP . 45.4 mtmt -66.25 -36.06 82.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.172 0.51 . . . . 10.0 110.984 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' B' ' 110' ' ' SER . 47.7 mt-10 -74.06 -32.54 63.33 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.104 -0.498 . . . . 10.0 111.274 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -75.76 -11.86 60.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.194 -0.457 . . . . 10.0 111.213 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 116' ' ' ILE . . . . . 0.408 HG13 ' O ' ' B' ' 112' ' ' LEU . 58.0 mt -55.18 -39.65 52.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.501 -0.318 . . . . 10.0 111.26 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 4.9 m -59.36 -24.08 63.09 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.876 0.369 . . . . 10.0 111.523 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.02 -44.38 7.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.915 0.388 . . . . 10.0 110.752 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 119' ' ' ILE . . . . . 0.504 ' O ' HG23 ' B' ' 123' ' ' VAL . 61.5 mt -63.78 -46.82 93.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.997 -0.547 . . . . 10.0 111.397 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -57.63 -33.08 67.89 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.36 -0.382 . . . . 10.0 111.14 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 121' ' ' ASP . . . . . 0.545 ' HA ' ' NE ' ' B' ' 124' ' ' ARG . 26.8 t70 -63.27 -42.55 99.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.291 -0.413 . . . . 10.0 110.912 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.2 -30.73 66.74 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.839 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . 0.504 HG23 ' O ' ' B' ' 119' ' ' ILE . 45.1 t -75.81 -38.09 36.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 10.0 110.968 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 124' ' ' ARG . . . . . 0.545 ' NE ' ' HA ' ' B' ' 121' ' ' ASP . 31.0 ptt180 -78.72 -6.29 55.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 10.0 111.235 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 65.7 mttt . . . . . 0 C--N 1.327 -0.401 0 CA-C-O 120.971 0.415 . . . . 10.0 110.273 179.775 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.846 0 CA-C-O 120.899 0.38 . . . . 10.0 110.78 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 62.1 mtt -112.11 97.53 6.72 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.708 -0.478 . . . . 10.0 109.708 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.512 ' CD2' HG12 ' B' ' 119' ' ' ILE . 40.4 m-85 -91.02 135.71 33.57 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.36 -0.382 . . . . 10.0 110.599 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.458 ' HG2' ' H ' ' A' ' 66' ' ' GLY . 22.3 tt0 -89.14 128.67 35.79 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.761 0.315 . . . . 10.0 110.41 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.9 pt -117.1 9.02 7.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.175 0.512 . . . . 10.0 110.497 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.458 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 159.88 173.27 28.16 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.719 -0.753 . . . . 10.0 111.945 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.596 ' HG2' ' HG2' ' A' ' 68' ' ' MET . 61.9 tttp -61.92 117.59 6.12 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.648 0.261 . . . . 10.0 110.71 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.596 ' HG2' ' HG2' ' A' ' 67' ' ' LYS . 67.2 mmm 70.41 15.55 7.28 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.389 -0.823 . . . . 10.0 111.557 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.479 ' HE ' ' HG2' ' A' ' 86' ' ' GLU . 5.0 mpt_? -121.72 120.87 35.93 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 122.242 -0.286 . . . . 10.0 110.269 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -132.95 143.84 49.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.398 0.618 . . . . 10.0 111.916 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.469 HG22 HG23 ' A' ' 84' ' ' ILE . 18.2 t -108.83 111.14 34.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 108.312 -0.995 . . . . 10.0 108.312 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.9 m -101.92 116.39 32.6 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.249 0.547 . . . . 10.0 112.151 -178.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.797 HG22 HG23 ' A' ' 82' ' ' ILE . 21.9 t -103.94 110.73 31.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.409 -0.814 . . . . 10.0 109.581 179.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -157.8 179.71 8.95 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.101 0.477 . . . . 10.0 111.134 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.661 ' HB2' HG22 ' A' ' 80' ' ' VAL . 1.6 t70 -112.21 133.21 54.47 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.297 -0.865 . . . . 10.0 109.613 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -136.49 118.33 15.16 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.567 -0.288 . . . . 10.0 110.269 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 97.4 mttt 57.67 43.92 21.46 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 123.499 0.5 . . . . 10.0 111.596 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.25 40.99 94.97 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.707 -0.759 . . . . 10.0 111.51 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? -151.08 102.55 2.96 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.913 0.387 . . . . 10.0 110.121 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.661 HG22 ' HB2' ' A' ' 75' ' ' ASP . 60.5 t -77.93 121.85 31.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.403 -0.591 . . . . 10.0 109.403 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.764 ' HB3' ' HB3' ' A' ' 103' ' ' SER . 24.1 mt -139.12 144.75 38.81 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.621 0.724 . . . . 10.0 112.176 -178.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.797 HG23 HG22 ' A' ' 73' ' ' VAL . 53.0 mt -104.12 98.98 7.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 114.591 -1.186 . . . . 10.0 108.004 178.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.603 ' HA ' ' HA ' ' A' ' 103' ' ' SER . 17.3 t70 -94.19 121.35 35.6 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.554 0.576 . . . . 10.0 112.554 -177.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.469 HG23 HG22 ' A' ' 71' ' ' VAL . 22.8 mt -98.74 108.19 21.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 107.181 -1.415 . . . . 10.0 107.181 177.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.515 ' HB2' ' OD2' ' A' ' 83' ' ' ASP . 11.2 ttm180 -144.63 163.23 34.55 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.573 0.701 . . . . 10.0 112.864 -176.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.479 ' HG2' ' HE ' ' A' ' 69' ' ' ARG . 16.3 mt-10 -89.9 142.09 28.03 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.864 -1.062 . . . . 10.0 109.124 177.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -114.43 135.92 53.57 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.528 -0.306 . . . . 10.0 110.341 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 45.7 t90 -108.67 134.77 50.95 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.72 -0.474 . . . . 10.0 109.72 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 25.2 ttt -84.4 117.67 23.77 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.87 -0.419 . . . . 10.0 109.87 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.24 164.21 55.19 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.932 -0.576 . . . . 10.0 110.868 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -53.39 -33.13 65.23 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.088 2.525 . . . . 10.0 113.318 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -69.74 -57.38 5.19 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.009 -0.367 . . . . 10.0 110.009 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 146.12 21.1 0.12 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.461 -0.876 . . . . 10.0 112.775 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.547 ' HB2' ' HE2' ' A' ' 96' ' ' LYS . 29.8 mt-10 -106.95 149.15 27.8 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.803 0.335 . . . . 10.0 110.306 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 98.4 mmm -88.77 117.67 27.91 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.293 -0.412 . . . . 10.0 110.013 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.547 ' HE2' ' HB2' ' A' ' 94' ' ' GLU . 69.4 mmtt -108.34 133.86 20.42 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.211 -0.449 . . . . 10.0 110.672 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.67 136.31 30.29 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.493 2.129 . . . . 10.0 112.157 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.485 ' O ' ' HD3' ' A' ' 85' ' ' ARG . . . -85.15 -158.43 29.61 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.595 -0.812 . . . . 10.0 112.799 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 99' ' ' ARG . 16.0 mtm180 -103.46 -22.38 13.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.869 0.366 . . . . 10.0 110.973 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 19.6 ttmt -82.65 82.96 7.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.239 -0.437 . . . . 10.0 110.478 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -152.9 165.77 31.22 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.604 -0.599 . . . . 10.0 111.604 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.559 ' HB ' ' HA2' ' B' ' 101' ' ' GLY . 12.0 tt -147.73 124.28 2.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.111 0.481 . . . . 10.0 111.226 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.764 ' HB3' ' HB3' ' A' ' 81' ' ' LEU . 5.3 m -94.62 125.69 39.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.801 -0.636 . . . . 10.0 110.387 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.478 ' HB3' ' HB2' ' A' ' 108' ' ' GLN . 76.6 mt -121.54 135.3 55.02 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.945 -0.391 . . . . 10.0 109.945 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -81.98 163.22 54.31 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 109.818 -0.438 . . . . 10.0 109.818 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -42.06 -38.98 5.49 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.614 2.876 . . . . 10.0 114.286 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.425 ' HG2' ' NE2' ' A' ' 111' ' ' GLN . 0.2 OUTLIER -61.84 -49.25 77.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.533 -0.303 . . . . 10.0 110.865 179.762 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.5 HE22 ' HD3' ' B' ' 69' ' ' ARG . 6.2 mt-30 -67.96 -37.84 82.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.317 0.579 . . . . 10.0 109.687 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.583 ' HZ2' ' HB2' ' B' ' 120' ' ' ASP . 23.5 t-105 -58.08 -43.29 86.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.272 -0.876 . . . . 10.0 110.709 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.7 t -65.32 -43.98 89.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.045 -0.525 . . . . 10.0 110.617 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.425 ' NE2' ' HG2' ' A' ' 107' ' ' GLU . 40.2 mt-30 -65.32 -36.12 83.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.431 -0.349 . . . . 10.0 110.841 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.427 HD13 HD13 ' B' ' 65' ' ' ILE . 48.6 tp -59.63 -41.14 89.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.429 . . . . 10.0 110.405 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -65.42 -31.08 71.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.997 -0.547 . . . . 10.0 111.394 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -77.43 -28.57 52.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.0 0.429 . . . . 10.0 111.367 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -85.06 -8.47 58.67 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.246 -0.434 . . . . 10.0 111.582 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 112' ' ' LEU . 61.7 mt -53.99 -43.21 57.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 112.016 0.376 . . . . 10.0 112.016 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.14 -30.03 64.08 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.2 0.444 . . . . 10.0 112.2 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -89.79 -41.75 11.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.783 0.325 . . . . 10.0 110.539 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.478 ' O ' HG23 ' A' ' 123' ' ' VAL . 72.1 mt -62.93 -48.4 88.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.938 -0.574 . . . . 10.0 111.054 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -63.59 -34.04 76.93 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.008 -0.542 . . . . 10.0 110.563 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -69.17 -41.09 77.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.637 -0.71 . . . . 10.0 109.855 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.65 -37.94 83.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.727 -0.67 . . . . 10.0 110.224 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 119' ' ' ILE . 92.6 t -60.33 -42.01 89.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 121.228 0.537 . . . . 10.0 109.96 179.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.8 mtm105 -71.44 -37.12 71.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.606 -0.725 . . . . 10.0 110.786 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 30.3 mttp -65.67 -42.77 90.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.422 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 72.5 mt . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.041 -0.527 . . . . 10.0 110.74 179.488 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.191 0 CA-C-O 121.27 0.557 . . . . 10.0 110.599 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 82.6 mmm -92.49 96.55 10.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.83 -0.623 . . . . 10.0 109.759 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -79.62 113.59 17.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.207 -0.451 . . . . 10.0 110.805 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -98.22 128.11 44.51 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.851 -0.426 . . . . 10.0 109.851 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' ILE . . . . . 0.427 HD13 HD13 ' A' ' 112' ' ' LEU . 20.5 pt -116.8 16.0 7.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.671 0.272 . . . . 10.0 111.706 -178.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 158.11 -161.54 31.64 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.155 -1.021 . . . . 10.0 112.726 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . 0.439 ' O ' ' HD2' ' B' ' 69' ' ' ARG . 5.2 mtmp? -67.56 103.86 1.45 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.448 -0.376 . . . . 10.0 111.841 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' MET . . . . . . . . . . . . . 67.4 mmm 64.86 6.47 3.37 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.246 0.832 . . . . 10.0 113.246 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' ARG . . . . . 0.5 ' HD3' HE22 ' A' ' 108' ' ' GLN . 3.0 mpt_? -100.39 121.49 41.6 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 121.783 -0.573 . . . . 10.0 110.696 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' TYR . . . . . 0.452 ' HB2' ' CD1' ' B' ' 87' ' ' TYR . 79.9 m-85 -122.67 149.25 44.29 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.706 -0.679 . . . . 10.0 110.45 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 96.0 t -98.61 103.08 14.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.257 -0.645 . . . . 10.0 109.257 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 10.2 t -88.39 88.11 7.51 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.819 -0.628 . . . . 10.0 111.18 -178.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 3.2 t -84.66 92.35 3.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.694 -0.854 . . . . 10.0 108.694 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 23.4 ptt-85 -126.28 147.93 49.61 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.272 0.558 . . . . 10.0 111.474 -178.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' B' ' 80' ' ' VAL . 12.8 t70 -79.89 115.62 19.58 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.286 -0.87 . . . . 10.0 110.436 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -86.72 61.68 6.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.176 -0.466 . . . . 10.0 110.889 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 30.0 mttm 62.53 58.6 1.64 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.85 -0.614 . . . . 10.0 111.051 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.56 21.29 37.79 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.839 -0.696 . . . . 10.0 111.682 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 62.2 mmtt -145.04 89.49 1.96 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.569 0.223 . . . . 10.0 110.531 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . 0.431 HG11 ' HA ' ' A' ' 123' ' ' VAL . 20.2 t -66.44 105.67 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.636 -0.505 . . . . 10.0 109.636 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 79.7 mt -115.42 142.04 47.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.344 0.592 . . . . 10.0 111.456 -178.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 82' ' ' ILE . . . . . 0.488 HD13 ' HB2' ' B' ' 109' ' ' TRP . 5.3 mp -92.07 88.87 2.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.516 -0.92 . . . . 10.0 108.516 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . 0.519 ' HA ' ' HA ' ' B' ' 103' ' ' SER . 34.9 t70 -87.97 94.64 9.85 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.876 -0.602 . . . . 10.0 110.833 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 26.8 mt -81.65 95.25 2.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.255 -1.016 . . . . 10.0 108.255 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 85' ' ' ARG . . . . . 0.411 ' HD3' ' O ' ' B' ' 98' ' ' GLY . 17.4 ttm-85 -123.6 145.71 48.71 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.862 -0.608 . . . . 10.0 111.724 -177.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 86' ' ' GLU . . . . . 0.485 ' H ' ' HG2' ' B' ' 86' ' ' GLU . 5.0 pt-20 -76.06 128.39 34.9 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.531 -0.759 . . . . 10.0 109.109 178.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 87' ' ' TYR . . . . . 0.452 ' CD1' ' HB2' ' B' ' 70' ' ' TYR . 23.0 m-85 -98.96 101.38 12.75 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.072 0.463 . . . . 10.0 110.464 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 88' ' ' TRP . . . . . 0.417 ' O ' ' HA ' ' B' ' 95' ' ' MET . 86.1 m95 -84.75 -176.55 6.27 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.561 -0.745 . . . . 10.0 109.789 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 41.6 ttm -133.43 135.11 44.39 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 110.014 -0.365 . . . . 10.0 110.014 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 90' ' ' ASP . . . . . 0.446 ' HB2' ' HD2' ' B' ' 91' ' ' PRO . 29.0 p30 -92.19 171.77 7.24 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 109.899 -0.408 . . . . 10.0 109.899 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 91' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' B' ' 90' ' ' ASP . 35.9 Cg_exo -61.9 -18.9 63.66 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.448 2.098 . . . . 10.0 112.704 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -77.03 -40.6 45.85 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.225 0.535 . . . . 10.0 110.275 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 120.67 21.04 3.36 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.95 -0.643 . . . . 10.0 112.245 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -100.88 147.32 26.25 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.774 0.321 . . . . 10.0 110.7 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 95' ' ' MET . . . . . 0.417 ' HA ' ' O ' ' B' ' 88' ' ' TRP . 82.9 mmm -88.54 96.18 10.52 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.321 -0.622 . . . . 10.0 109.321 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -94.52 128.87 38.42 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.887 -0.597 . . . . 10.0 111.631 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -66.16 128.33 19.33 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.578 2.185 . . . . 10.0 111.339 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . 0.411 ' O ' ' HD3' ' B' ' 85' ' ' ARG . . . -74.11 -176.32 34.51 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 121.046 -0.597 . . . . 10.0 113.294 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 14.5 mmt180 -87.89 -32.88 18.74 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.959 0.409 . . . . 10.0 110.201 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 4.3 mtmp? -77.87 99.1 5.84 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.458 -0.792 . . . . 10.0 110.551 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 101' ' ' GLY . . . . . 0.559 ' HA2' ' HB ' ' A' ' 102' ' ' ILE . . . -178.44 159.79 25.35 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 110.667 -0.973 . . . . 10.0 110.667 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 18.4 tt -131.12 142.41 43.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 117.196 0.498 . . . . 10.0 111.579 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 103' ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' B' ' 83' ' ' ASP . 0.7 OUTLIER -102.5 105.3 15.82 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.831 -0.622 . . . . 10.0 109.776 179.272 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 96.1 mt -93.33 142.27 27.51 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.792 0.329 . . . . 10.0 111.376 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 105' ' ' ASN . . . . . 0.403 ' ND2' ' HB3' ' B' ' 107' ' ' GLU . 41.4 p-10 -93.01 164.71 20.61 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 108.633 -0.877 . . . . 10.0 108.633 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.93 -30.73 31.52 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.489 2.126 . . . . 10.0 112.669 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 107' ' ' GLU . . . . . 0.403 ' HB3' ' ND2' ' B' ' 105' ' ' ASN . 9.2 tt0 -66.71 -59.27 3.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.921 -0.581 . . . . 10.0 110.861 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -67.08 -29.83 69.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.488 -0.324 . . . . 10.0 110.639 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 109' ' ' TRP . . . . . 0.488 ' HB2' HD13 ' B' ' 82' ' ' ILE . 31.0 t-105 -60.56 -42.25 96.21 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.63 -0.507 . . . . 10.0 109.63 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 9.7 t -67.81 -45.4 74.83 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.505 -0.554 . . . . 10.0 109.505 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -57.97 -40.65 81.14 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.015 -0.539 . . . . 10.0 110.54 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . 0.442 ' O ' HG13 ' B' ' 116' ' ' ILE . 33.1 tp -59.64 -47.19 86.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.92 -0.582 . . . . 10.0 110.665 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -62.95 -34.63 77.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.101 0.477 . . . . 10.0 110.666 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -74.17 -30.17 62.12 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.801 -0.636 . . . . 10.0 110.787 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 115' ' ' GLN . . . . . 0.401 ' O ' HG13 ' B' ' 119' ' ' ILE . 14.6 mm-40 -82.51 -10.49 58.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.435 . . . . 10.0 111.71 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 116' ' ' ILE . . . . . 0.442 HG13 ' O ' ' B' ' 112' ' ' LEU . 55.8 mt -55.2 -34.82 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 120.708 0.29 . . . . 10.0 111.15 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 1.5 m -60.66 -21.4 62.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.265 -0.425 . . . . 10.0 111.601 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -106.17 -42.42 5.08 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.616 0.246 . . . . 10.0 110.663 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 119' ' ' ILE . . . . . 0.512 HG12 ' CD2' ' A' ' 63' ' ' PHE . 60.6 mt -61.64 -52.03 65.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.885 0.374 . . . . 10.0 110.924 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . 0.583 ' HB2' ' HZ2' ' A' ' 109' ' ' TRP . 27.6 t70 -62.35 -38.12 88.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.873 -0.603 . . . . 10.0 111.083 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -62.03 -37.67 85.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.705 -0.679 . . . . 10.0 111.23 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.32 -20.4 57.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.266 -0.425 . . . . 10.0 111.864 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . 0.459 HG23 ' O ' ' B' ' 119' ' ' ILE . 78.1 t -58.21 -36.39 57.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.891 0.377 . . . . 10.0 111.416 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 6.6 ptp85 -102.68 14.4 32.04 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.359 -0.382 . . . . 10.0 111.141 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 98.8 mttt . . . . . 0 C--N 1.326 -0.447 0 CA-C-O 121.017 0.437 . . . . 10.0 110.206 179.961 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 120.943 0.401 . . . . 10.0 110.224 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.448 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 50.8 ttm -144.81 118.22 9.06 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.283 -0.417 . . . . 10.0 110.646 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.439 ' HB2' ' HB ' ' A' ' 71' ' ' VAL . 67.5 m-85 -95.37 171.15 8.88 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.21 -0.45 . . . . 10.0 110.162 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.55 ' HG2' ' H ' ' A' ' 66' ' ' GLY . 6.8 tt0 -131.99 134.39 45.53 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.199 -0.297 . . . . 10.0 110.199 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.524 HG13 ' HB3' ' A' ' 69' ' ' ARG . 11.6 pt -122.08 12.19 5.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.106 0.479 . . . . 10.0 110.569 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.55 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 156.0 174.54 25.93 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.814 -0.708 . . . . 10.0 111.945 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -57.24 116.62 3.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.622 0.249 . . . . 10.0 111.376 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 2.5 mmt 69.46 11.7 8.09 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.356 -0.838 . . . . 10.0 112.45 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.524 ' HB3' HG13 ' A' ' 65' ' ' ILE . 4.4 mpt_? -111.71 104.13 12.46 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.415 -0.587 . . . . 10.0 109.415 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.489 ' HD2' ' HB2' ' A' ' 87' ' ' TYR . 96.3 m-85 -120.43 145.72 46.93 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.355 0.597 . . . . 10.0 112.406 -178.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.534 HG13 HG12 ' A' ' 84' ' ' ILE . 36.6 t -99.16 105.99 18.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.001 -1.0 . . . . 10.0 108.92 178.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.6 m -88.39 113.4 23.96 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.885 0.374 . . . . 10.0 111.099 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 38.2 t -106.18 92.89 2.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.066 -0.515 . . . . 10.0 109.846 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.911 ' HG3' ' HB3' ' A' ' 81' ' ' LEU . 7.5 ptm180 -123.63 -171.15 2.26 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.086 -0.506 . . . . 10.0 109.985 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -102.51 160.17 14.79 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.626 0.251 . . . . 10.0 110.343 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.478 ' HB3' ' HB2' ' A' ' 79' ' ' LYS . 10.1 t80 -119.07 45.63 2.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.049 0.452 . . . . 10.0 110.522 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.425 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 11.2 mptt 55.65 41.5 30.45 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.274 0.559 . . . . 10.0 110.673 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 136.15 -42.41 1.33 Allowed Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 111.057 -0.817 . . . . 10.0 111.057 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.478 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 64.7 mttm -100.83 -167.36 1.42 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.703 -0.48 . . . . 10.0 109.703 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.0 m -105.72 142.53 18.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.738 0.304 . . . . 10.0 110.663 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.911 ' HB3' ' HG3' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -118.53 78.94 1.31 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.105 -0.498 . . . . 10.0 109.894 -179.716 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 27.6 mt -101.46 88.27 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.062 -0.718 . . . . 10.0 109.062 178.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.47 ' OD1' ' HB2' ' A' ' 85' ' ' ARG . 16.5 t70 -113.28 135.9 53.34 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.347 0.594 . . . . 10.0 111.458 -178.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.534 HG12 HG13 ' A' ' 71' ' ' VAL . 45.7 mt -108.19 96.07 4.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 108.407 -0.96 . . . . 10.0 108.407 178.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.602 ' HG3' ' HA3' ' A' ' 101' ' ' GLY . 6.7 ttm180 -118.47 154.82 31.86 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.951 -0.568 . . . . 10.0 111.433 -178.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -73.98 124.37 26.09 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.728 -0.842 . . . . 10.0 108.728 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.489 ' HB2' ' HD2' ' A' ' 70' ' ' TYR . 19.1 m-85 -103.99 121.54 43.37 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.931 0.396 . . . . 10.0 110.759 -179.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -108.25 137.5 46.12 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.912 -0.585 . . . . 10.0 109.926 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.429 ' HA ' ' O ' ' A' ' 94' ' ' GLU . 6.5 ttt -74.94 126.92 32.02 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.301 -0.409 . . . . 10.0 110.202 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.439 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 44.8 p30 -87.83 171.56 9.38 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 116.154 -0.476 . . . . 10.0 110.605 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.439 ' HD2' ' HB2' ' A' ' 90' ' ' ASP . 48.5 Cg_exo -57.78 -24.95 66.38 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.855 2.37 . . . . 10.0 113.393 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -76.24 -30.87 58.07 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.961 0.41 . . . . 10.0 110.54 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 112.37 22.04 5.97 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.83 -0.7 . . . . 10.0 112.151 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' A' ' 89' ' ' MET . 31.0 mt-10 -110.22 164.4 12.69 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.95 0.405 . . . . 10.0 110.369 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 94.2 mmm -96.9 114.23 25.84 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.062 -0.517 . . . . 10.0 109.809 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 13.7 mmtp -113.81 131.69 22.97 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.226 -0.443 . . . . 10.0 110.493 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.06 133.84 34.73 Favored 'Trans proline' 0 C--O 1.233 0.264 0 C-N-CA 122.554 2.169 . . . . 10.0 112.408 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -81.81 -128.38 1.03 Allowed Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.984 -0.627 . . . . 10.0 113.202 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -110.07 -34.28 6.44 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.648 0.261 . . . . 10.0 111.556 -178.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.1 mtmt -86.87 117.07 25.36 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.188 0.518 . . . . 10.0 111.741 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.602 ' HA3' ' HG3' ' A' ' 85' ' ' ARG . . . -166.8 155.17 26.15 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.716 -0.953 . . . . 10.0 110.716 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.501 HG12 HG22 ' B' ' 84' ' ' ILE . 7.9 tp -134.82 130.6 52.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 117.494 0.647 . . . . 10.0 111.9 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.8 m -92.26 116.01 28.59 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.146 -0.934 . . . . 10.0 109.661 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 82.3 mt -109.56 113.05 25.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.032 0.444 . . . . 10.0 110.958 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.603 ' HB2' ' HD2' ' A' ' 106' ' ' PRO . 19.8 p30 -81.99 169.3 19.04 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.989 -0.55 . . . . 10.0 110.091 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.603 ' HD2' ' HB2' ' A' ' 105' ' ' ASN . 92.2 Cg_exo -44.41 -47.88 10.54 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 123.064 2.509 . . . . 10.0 113.855 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.0 tp10 -67.35 -50.94 57.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.488 0.185 . . . . 10.0 110.767 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.464 HE22 ' HD3' ' B' ' 69' ' ' ARG . 63.5 mt-30 -55.53 -46.65 77.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.316 -0.402 . . . . 10.0 111.193 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 56.0 t-105 -62.25 -42.87 99.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.908 0.385 . . . . 10.0 110.586 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.474 ' HA ' ' HE2' ' A' ' 113' ' ' LYS . 50.0 m -64.3 -46.71 82.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 10.0 110.757 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -65.6 -37.74 87.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.478 -0.328 . . . . 10.0 110.557 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.518 ' O ' HG13 ' A' ' 116' ' ' ILE . 59.6 tp -57.72 -43.42 85.27 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.279 -0.418 . . . . 10.0 110.81 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.474 ' HE2' ' HA ' ' A' ' 110' ' ' SER . 52.0 mtmt -62.23 -36.98 83.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.293 -0.412 . . . . 10.0 110.89 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -81.77 -17.07 48.97 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.106 0.479 . . . . 10.0 111.044 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -85.53 -18.67 32.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.197 -0.456 . . . . 10.0 110.283 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.518 HG13 ' O ' ' A' ' 112' ' ' LEU . 86.0 mt -54.12 -40.39 46.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.133 -0.485 . . . . 10.0 111.311 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.28 -25.04 61.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 10.0 111.758 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.42 -35.52 9.54 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.872 0.368 . . . . 10.0 110.763 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 83.9 mt -64.75 -47.59 88.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.922 -0.581 . . . . 10.0 110.86 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.14 -32.33 73.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 10.0 110.813 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -64.48 -41.4 96.49 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.815 -0.629 . . . . 10.0 110.124 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.96 -35.66 80.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.997 -0.547 . . . . 10.0 110.32 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 88.4 t -62.91 -37.85 80.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.943 -0.571 . . . . 10.0 110.215 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 16.5 mtm105 -75.2 -25.28 58.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.977 -0.556 . . . . 10.0 111.012 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -78.53 -20.14 51.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.331 -0.395 . . . . 10.0 111.352 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 12.6 mt . . . . . 0 C--N 1.321 -0.659 0 CA-C-N 116.586 -0.279 . . . . 10.0 110.437 179.971 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.094 0 CA-C-O 121.181 0.515 . . . . 10.0 110.683 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' MET . . . . . 0.408 ' HG2' ' HA ' ' B' ' 72' ' ' SER . 59.1 mtm -103.3 128.3 50.39 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.903 -0.589 . . . . 10.0 109.874 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -114.21 128.12 56.21 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.156 -0.474 . . . . 10.0 110.161 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -79.68 134.09 36.4 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.093 0.473 . . . . 10.0 111.316 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 108' ' ' GLN . 6.4 pt -112.42 -26.08 3.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.707 -0.679 . . . . 10.0 110.398 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -167.84 -174.53 36.86 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.771 -0.932 . . . . 10.0 110.771 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 14.8 mttp -70.8 127.64 33.33 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.069 0.462 . . . . 10.0 111.057 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' MET . . . . . 0.513 ' HE3' ' HA ' ' B' ' 88' ' ' TRP . 39.2 mmm 64.26 25.88 13.63 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.057 -0.974 . . . . 10.0 111.703 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' ARG . . . . . 0.484 ' HE ' ' HG2' ' B' ' 86' ' ' GLU . 0.4 OUTLIER -140.11 115.25 9.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.484 -0.325 . . . . 10.0 110.233 179.116 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -126.61 133.15 51.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.045 -0.525 . . . . 10.0 110.758 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.466 HG22 HG23 ' B' ' 84' ' ' ILE . 86.6 t -88.75 115.21 28.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.048 -0.523 . . . . 10.0 109.611 179.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 72' ' ' SER . . . . . 0.408 ' HA ' ' HG2' ' B' ' 62' ' ' MET . 8.1 m -90.68 101.25 14.0 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.946 0.403 . . . . 10.0 111.076 -179.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 8.9 t -97.58 99.34 8.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.168 -0.469 . . . . 10.0 110.003 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -160.03 166.43 29.97 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.258 -0.428 . . . . 10.0 110.211 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.699 ' HA ' ' HA ' ' B' ' 80' ' ' VAL . 0.0 OUTLIER -86.87 145.32 26.62 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.203 0.525 . . . . 10.0 110.333 179.789 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -126.98 100.71 6.25 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 109.132 -0.692 . . . . 10.0 109.132 178.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 66.6 mttm 67.33 33.78 5.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.402 -0.817 . . . . 10.0 111.009 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 96.39 -9.94 67.13 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.734 -0.745 . . . . 10.0 112.971 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . 0.418 ' HD3' ' HA ' ' B' ' 79' ' ' LYS . 32.2 mmtt -109.25 113.71 26.78 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.66 0.23 . . . . 10.0 110.919 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . 0.699 ' HA ' ' HA ' ' B' ' 75' ' ' ASP . 14.3 t -64.33 117.76 5.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.612 -0.514 . . . . 10.0 109.612 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 97.8 mt -125.73 129.3 49.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.174 0.511 . . . . 10.0 111.699 -178.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 82' ' ' ILE . . . . . . . . . . . . . 5.2 mp -93.25 95.82 5.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 108.08 -1.081 . . . . 10.0 108.08 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . 0.4 ' HA ' ' HA ' ' B' ' 103' ' ' SER . 2.2 t70 -85.73 107.31 17.54 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.939 -0.573 . . . . 10.0 111.991 -177.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . 0.501 HG22 HG12 ' A' ' 102' ' ' ILE . 12.0 mt -99.23 83.91 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.071 -1.085 . . . . 10.0 108.071 178.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 85' ' ' ARG . . . . . 0.948 ' HG3' ' HA3' ' B' ' 101' ' ' GLY . 6.1 ttm180 -123.89 162.75 22.67 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.711 -0.677 . . . . 10.0 111.089 -177.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 86' ' ' GLU . . . . . 0.732 ' HB2' ' HA3' ' B' ' 98' ' ' GLY . 35.8 mt-10 -70.19 153.06 43.56 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.48 -0.933 . . . . 10.0 108.48 177.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 87' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -140.46 111.16 6.85 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.184 0.516 . . . . 10.0 110.783 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 88' ' ' TRP . . . . . 0.513 ' HA ' ' HE3' ' B' ' 68' ' ' MET . 20.6 m0 -108.64 -170.81 1.73 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.513 -0.767 . . . . 10.0 109.356 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 33.3 ttm -127.82 142.66 51.23 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 110.146 -0.316 . . . . 10.0 110.146 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 90' ' ' ASP . . . . . 0.446 ' HB2' ' HD2' ' B' ' 91' ' ' PRO . 36.9 p30 -99.83 169.94 7.4 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 116.17 -0.468 . . . . 10.0 110.522 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 91' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' B' ' 90' ' ' ASP . 34.8 Cg_exo -59.93 -20.58 60.68 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.713 2.276 . . . . 10.0 112.362 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -73.76 -43.34 59.28 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.994 0.426 . . . . 10.0 110.007 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 118.79 26.54 2.53 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.955 -0.64 . . . . 10.0 112.244 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -113.33 152.22 30.2 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.841 0.353 . . . . 10.0 110.625 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 95' ' ' MET . . . . . . . . . . . . . 95.6 mmm -82.78 105.15 13.56 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.073 -0.714 . . . . 10.0 109.073 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -103.37 145.93 31.51 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.765 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.02 146.94 94.82 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.576 2.184 . . . . 10.0 111.849 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . 0.732 ' HA3' ' HB2' ' B' ' 86' ' ' GLU . . . -73.89 -140.72 0.56 Allowed Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.728 -0.669 . . . . 10.0 112.617 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 99' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' B' ' 99' ' ' ARG . 2.4 mtp-105 -102.64 -32.76 9.73 Favored 'General case' 0 C--N 1.32 -0.714 0 O-C-N 122.382 -0.481 . . . . 10.0 111.109 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -127.7 157.1 41.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.243 0.545 . . . . 10.0 111.396 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 101' ' ' GLY . . . . . 0.948 ' HA3' ' HG3' ' B' ' 85' ' ' ARG . . . 171.15 160.86 20.71 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 110.507 -1.037 . . . . 10.0 110.507 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 20.5 tt -133.1 140.8 46.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 117.95 0.875 . . . . 10.0 111.544 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 103' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' B' ' 83' ' ' ASP . 0.9 OUTLIER -101.62 112.19 24.68 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.054 -0.521 . . . . 10.0 110.013 179.549 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 52.1 mt -97.72 134.86 40.32 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.822 0.344 . . . . 10.0 110.615 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -88.97 168.98 14.13 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 108.915 -0.772 . . . . 10.0 108.915 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . 0.521 ' HD3' ' O ' ' B' ' 80' ' ' VAL . 86.4 Cg_exo -48.8 -38.73 38.28 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.608 2.205 . . . . 10.0 113.414 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -67.01 -54.7 19.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.63 -0.259 . . . . 10.0 111.172 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -61.74 -35.69 78.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.442 -0.345 . . . . 10.0 110.509 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 109' ' ' TRP . . . . . 0.404 ' CZ2' HG12 ' A' ' 116' ' ' ILE . 65.7 t-105 -61.87 -41.23 97.6 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.106 -0.497 . . . . 10.0 109.699 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 110' ' ' SER . . . . . 0.411 ' O ' ' HG3' ' B' ' 114' ' ' GLU . 25.3 t -63.62 -46.61 84.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.489 . . . . 10.0 109.719 178.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -58.37 -40.17 81.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.881 -0.6 . . . . 10.0 110.815 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 53.5 tp -60.94 -41.4 96.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 10.0 110.461 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 113' ' ' LYS . . . . . 0.43 ' HG2' HD13 ' A' ' 116' ' ' ILE . 55.9 mtmt -68.85 -36.09 77.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.15 0.5 . . . . 10.0 110.737 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . 0.411 ' HG3' ' O ' ' B' ' 110' ' ' SER . 45.3 mt-10 -73.79 -25.15 59.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.828 -0.624 . . . . 10.0 111.332 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -86.78 -4.89 59.23 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.302 -0.408 . . . . 10.0 111.397 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 61.7 mt -57.27 -41.38 78.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 120.778 0.323 . . . . 10.0 110.881 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 5.7 m -64.83 -11.95 42.85 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.146 -0.479 . . . . 10.0 112.21 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.25 -47.21 3.57 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.83 0.348 . . . . 10.0 110.447 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 119' ' ' ILE . . . . . 0.473 ' O ' HG23 ' B' ' 123' ' ' VAL . 61.9 mt -66.35 -45.95 88.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.102 -0.499 . . . . 10.0 111.817 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -62.13 -36.23 81.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.728 0.299 . . . . 10.0 111.236 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 121' ' ' ASP . . . . . 0.466 ' O ' ' HG2' ' B' ' 124' ' ' ARG . 36.7 t70 -67.87 -34.89 77.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.983 0.421 . . . . 10.0 110.26 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.48 -37.53 80.22 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.718 -0.475 . . . . 10.0 109.718 178.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . 0.473 HG23 ' O ' ' B' ' 119' ' ' ILE . 83.9 t -64.81 -42.36 94.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.896 -0.593 . . . . 10.0 110.58 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 124' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' B' ' 121' ' ' ASP . 7.1 ptp180 -75.65 -5.9 47.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.795 0.331 . . . . 10.0 110.91 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 43.2 mttp . . . . . 0 C--N 1.327 -0.389 0 CA-C-N 116.377 -0.374 . . . . 10.0 110.572 179.614 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 120.563 0.22 . . . . 10.0 110.516 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.459 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 29.6 mtm -142.97 130.45 21.17 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.965 -0.383 . . . . 10.0 109.965 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.4 ' CE1' ' HB3' ' B' ' 118' ' ' ASP . 57.5 m-85 -122.15 147.33 46.29 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.13 -0.486 . . . . 10.0 109.97 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -98.07 116.76 30.95 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.408 -0.36 . . . . 10.0 110.43 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.538 HG22 ' HG3' ' B' ' 115' ' ' GLN . 24.6 pt -105.06 10.28 9.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.12 0.486 . . . . 10.0 110.776 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 164.29 173.59 33.12 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.78 -0.724 . . . . 10.0 111.645 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 44.8 tttp -62.28 120.69 11.47 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.47 0.176 . . . . 10.0 110.765 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.418 ' HB3' ' O ' ' A' ' 87' ' ' TYR . 24.8 mmt 64.07 28.26 14.22 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 123.732 0.645 . . . . 10.0 111.888 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -131.08 112.26 12.73 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.967 -0.382 . . . . 10.0 109.967 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.425 ' HB2' ' CE1' ' A' ' 87' ' ' TYR . 50.8 m-85 -120.0 140.98 50.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.095 0.474 . . . . 10.0 111.444 -179.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 62' ' ' MET . 21.2 t -94.58 110.55 23.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.779 -0.646 . . . . 10.0 109.448 178.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.795 ' HB3' ' HB3' ' A' ' 83' ' ' ASP . 0.7 OUTLIER -80.39 83.38 6.23 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.992 -0.549 . . . . 10.0 110.697 -179.209 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.0 t -89.7 86.15 2.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.914 -0.773 . . . . 10.0 108.914 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -151.35 172.21 16.27 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.701 -0.681 . . . . 10.0 110.597 -178.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.885 ' HB2' HG22 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -106.01 138.0 42.95 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.808 -0.633 . . . . 10.0 109.814 179.352 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -126.4 95.48 4.38 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.396 -0.365 . . . . 10.0 110.318 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.3 36.86 25.91 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.667 -0.697 . . . . 10.0 111.892 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 103.05 -17.64 51.67 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.516 -0.85 . . . . 10.0 112.18 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.488 ' HB3' HD11 ' A' ' 81' ' ' LEU . 48.7 mtmt -89.18 94.93 10.1 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.994 0.426 . . . . 10.0 110.293 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.885 HG22 ' HB2' ' A' ' 75' ' ' ASP . 2.1 t -100.71 93.63 3.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.878 -0.601 . . . . 10.0 109.684 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.488 HD11 ' HB3' ' A' ' 79' ' ' LYS . 0.9 OUTLIER -128.94 157.12 42.51 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.096 -0.502 . . . . 10.0 110.949 -179.075 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.549 HD13 ' HB2' ' A' ' 109' ' ' TRP . 5.3 mp -81.42 90.32 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.573 -0.899 . . . . 10.0 108.573 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.795 ' HB3' ' HB3' ' A' ' 72' ' ' SER . 20.5 t70 -82.17 102.41 11.08 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.831 -0.622 . . . . 10.0 111.955 -177.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.3 mt -84.51 109.41 17.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 107.727 -1.212 . . . . 10.0 107.727 178.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.467 ' HD3' ' O ' ' A' ' 98' ' ' GLY . 10.9 ttm-85 -128.98 149.15 50.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.446 0.641 . . . . 10.0 112.544 -177.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -91.62 149.92 21.42 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.504 -0.924 . . . . 10.0 108.504 178.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.425 ' CE1' ' HB2' ' A' ' 70' ' ' TYR . 8.0 m-85 -120.26 152.37 37.86 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.051 0.453 . . . . 10.0 111.539 -178.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 12.6 t90 -145.03 154.33 42.41 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.926 -0.768 . . . . 10.0 108.926 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.4 ttm -88.03 134.74 33.67 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.909 0.385 . . . . 10.0 110.76 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.877 ' HB3' ' HG3' ' A' ' 96' ' ' LYS . 51.2 p-10 -85.68 175.52 4.44 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.787 -0.642 . . . . 10.0 110.534 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.481 ' HD2' ' HB2' ' A' ' 90' ' ' ASP . 39.3 Cg_exo -61.72 -17.81 56.89 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.568 2.178 . . . . 10.0 112.911 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.79 -41.71 20.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.826 0.346 . . . . 10.0 110.773 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 122.52 18.48 3.32 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.834 -0.698 . . . . 10.0 111.994 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -104.14 163.49 12.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.927 0.394 . . . . 10.0 110.882 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 78.5 mmm -88.06 111.33 21.43 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.916 -0.583 . . . . 10.0 109.479 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.877 ' HG3' ' HB3' ' A' ' 90' ' ' ASP . 18.7 mmmt -109.03 129.97 23.28 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.804 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.43 133.63 19.4 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.234 1.956 . . . . 10.0 111.513 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.467 ' O ' ' HD3' ' A' ' 85' ' ' ARG . . . -63.7 160.15 37.78 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.916 -0.659 . . . . 10.0 112.12 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.429 ' HA ' ' HD3' ' A' ' 99' ' ' ARG . 25.1 mmt180 -77.87 -7.91 57.35 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.161 0.505 . . . . 10.0 110.397 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -104.19 127.49 51.8 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.647 -0.706 . . . . 10.0 109.828 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -166.5 -173.53 34.96 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 111.206 -0.757 . . . . 10.0 111.206 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.9 tp -152.51 113.23 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.208 0.528 . . . . 10.0 110.582 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.772 ' HA ' ' HA ' ' A' ' 83' ' ' ASP . 0.8 OUTLIER -92.5 90.61 7.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.165 -0.47 . . . . 10.0 111.36 -179.478 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.449 ' HG ' ' HB3' ' A' ' 108' ' ' GLN . 2.8 mp -65.97 131.25 45.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.559 -0.291 . . . . 10.0 111.011 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.493 ' HB2' ' HD2' ' A' ' 106' ' ' PRO . 20.2 p-10 -78.98 166.47 41.97 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 110.396 -0.224 . . . . 10.0 110.396 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.493 ' HD2' ' HB2' ' A' ' 105' ' ' ASN . 79.6 Cg_exo -47.45 -41.15 29.4 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.222 2.615 . . . . 10.0 114.004 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -69.51 -45.14 69.58 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.828 -0.349 . . . . 10.0 110.838 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.466 ' HG2' ' HA3' ' B' ' 66' ' ' GLY . 23.6 mt-30 -57.97 -39.83 79.12 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.964 0.411 . . . . 10.0 110.17 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.549 ' HB2' HD13 ' A' ' 82' ' ' ILE . 66.2 t-105 -59.09 -44.4 91.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.782 -0.644 . . . . 10.0 110.564 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.8 t -67.36 -48.28 67.92 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.025 -0.534 . . . . 10.0 110.486 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -60.06 -38.8 83.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.94 -0.573 . . . . 10.0 111.08 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.479 ' O ' HG13 ' A' ' 116' ' ' ILE . 27.9 tp -60.98 -49.53 77.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.465 -0.334 . . . . 10.0 110.594 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.46 ' HA ' HD12 ' A' ' 116' ' ' ILE . 48.6 mtmt -60.54 -38.49 84.64 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.301 -0.409 . . . . 10.0 111.192 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -71.99 -26.5 62.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.962 -0.563 . . . . 10.0 111.831 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -93.42 -9.45 38.56 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.671 0.249 . . . . 10.0 111.671 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 112' ' ' LEU . 16.4 mt -51.55 -44.05 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 112.224 0.453 . . . . 10.0 112.224 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.3 m -60.46 -34.55 74.16 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.871 0.367 . . . . 10.0 111.773 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.08 -41.04 21.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.953 0.406 . . . . 10.0 110.325 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.544 HG23 HG21 ' B' ' 73' ' ' VAL . 82.3 mt -65.38 -48.62 82.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.805 -0.634 . . . . 10.0 111.224 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -59.42 -37.69 78.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.098 -0.501 . . . . 10.0 110.774 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.66 -39.3 94.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.019 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.412 ' HA ' ' HD2' ' A' ' 125' ' ' LYS . . . -64.89 -33.78 76.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.927 -0.579 . . . . 10.0 110.613 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 119' ' ' ILE . 63.1 t -64.36 -37.52 80.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.235 0.54 . . . . 10.0 109.855 179.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 19.9 mtm105 -78.84 -27.18 44.16 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.565 -0.743 . . . . 10.0 110.509 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.412 ' HD2' ' HA ' ' A' ' 122' ' ' ALA . 13.7 mttt -69.6 -36.07 75.86 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.99 -0.55 . . . . 10.0 110.566 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 47.2 mt . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 115.855 -0.612 . . . . 10.0 111.322 -179.49 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.219 0 CA-C-O 121.082 0.468 . . . . 10.0 110.665 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 5.6 mmm -97.99 95.92 7.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.773 -0.649 . . . . 10.0 109.708 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' PHE . . . . . 0.477 ' CD2' HG12 ' A' ' 119' ' ' ILE . 38.8 m-85 -90.83 126.28 35.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.067 -0.515 . . . . 10.0 111.166 -179.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -87.73 103.74 15.9 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.199 -0.455 . . . . 10.0 109.823 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' ILE . . . . . 0.503 HG12 HG23 ' B' ' 71' ' ' VAL . 5.6 pt -100.39 5.2 10.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.304 0.573 . . . . 10.0 110.351 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . 0.466 ' HA3' ' HG2' ' A' ' 108' ' ' GLN . . . 179.43 158.88 22.49 Favored Glycine 0 N--CA 1.438 -1.179 0 N-CA-C 110.988 -0.845 . . . . 10.0 110.988 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . 0.484 ' O ' ' HB2' ' B' ' 68' ' ' MET . 29.9 mttp -64.26 114.95 4.58 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.761 -0.459 . . . . 10.0 109.761 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' MET . . . . . 0.484 ' HB2' ' O ' ' B' ' 67' ' ' LYS . 70.3 mmm 78.91 3.97 2.42 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.313 -0.858 . . . . 10.0 111.128 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -115.57 124.59 51.4 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.722 -0.473 . . . . 10.0 109.722 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' TYR . . . . . 0.575 ' HB2' ' CD2' ' B' ' 87' ' ' TYR . 95.7 m-85 -131.12 145.32 51.94 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.228 0.537 . . . . 10.0 111.558 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.503 HG23 HG12 ' B' ' 65' ' ' ILE . 65.6 t -103.99 96.03 4.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 108.399 -0.963 . . . . 10.0 108.399 177.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 72' ' ' SER . . . . . 0.458 ' O ' ' HD3' ' B' ' 74' ' ' ARG . 0.5 OUTLIER -87.71 96.65 10.51 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.028 -0.533 . . . . 10.0 110.8 -179.364 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . 0.544 HG21 HG23 ' A' ' 119' ' ' ILE . 28.4 t -84.66 115.01 25.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.369 -0.604 . . . . 10.0 109.369 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . 0.458 ' HD3' ' O ' ' B' ' 72' ' ' SER . 0.0 OUTLIER -150.64 161.45 42.58 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.983 0.42 . . . . 10.0 111.02 -179.528 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -85.55 118.63 25.18 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.467 -0.788 . . . . 10.0 110.097 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -109.05 89.15 2.91 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.496 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 61.4 mttm 60.8 44.86 10.51 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.525 -0.762 . . . . 10.0 112.185 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.42 38.24 12.94 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.601 -0.809 . . . . 10.0 111.527 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -151.53 106.44 3.27 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 122.733 0.413 . . . . 10.0 110.138 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . 0.492 ' O ' ' HD3' ' B' ' 106' ' ' PRO . 24.4 t -73.2 99.06 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 108.563 -0.903 . . . . 10.0 108.563 178.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 96.2 mt -105.82 132.08 52.37 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.511 0.672 . . . . 10.0 112.599 -177.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 82' ' ' ILE . . . . . . . . . . . . . 4.8 mp -93.35 94.09 4.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 107.322 -1.362 . . . . 10.0 107.322 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -89.0 106.06 18.19 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.962 -0.563 . . . . 10.0 112.223 -177.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . 0.421 ' O ' ' HA2' ' B' ' 101' ' ' GLY . 37.7 mt -93.39 99.29 9.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 107.84 -1.17 . . . . 10.0 107.84 177.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 85' ' ' ARG . . . . . 0.805 ' HG3' ' HA3' ' B' ' 101' ' ' GLY . 20.2 ttm-85 -140.97 165.63 27.01 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.223 0.535 . . . . 10.0 112.112 -177.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.11 144.13 25.76 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.51 -0.922 . . . . 10.0 108.51 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 87' ' ' TYR . . . . . 0.575 ' CD2' ' HB2' ' B' ' 70' ' ' TYR . 50.6 m-85 -125.92 125.93 43.57 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.289 0.566 . . . . 10.0 111.047 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 88' ' ' TRP . . . . . . . . . . . . . 66.2 t90 -104.85 136.25 44.7 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.404 -0.817 . . . . 10.0 110.105 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 50.3 ttm -78.97 115.95 18.97 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.034 0.445 . . . . 10.0 110.745 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 90' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.69 161.97 59.53 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.659 -0.7 . . . . 10.0 110.356 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -53.23 -27.03 36.26 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.191 2.594 . . . . 10.0 113.993 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.7 -17.26 59.21 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 122.235 -0.29 . . . . 10.0 110.776 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 103.65 11.6 32.56 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.936 -0.65 . . . . 10.0 113.712 178.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 94' ' ' GLU . . . . . 0.429 ' HB3' ' HE2' ' B' ' 96' ' ' LYS . 11.4 tt0 -103.38 156.76 17.5 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 117.062 0.431 . . . . 10.0 110.696 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 95' ' ' MET . . . . . 0.529 ' HB3' ' HB3' ' B' ' 87' ' ' TYR . 87.7 mmm -94.25 103.0 15.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.252 -0.431 . . . . 10.0 110.024 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . 0.429 ' HE2' ' HB3' ' B' ' 94' ' ' GLU . 67.0 mmtt -93.28 147.29 33.47 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.082 -0.508 . . . . 10.0 110.47 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.13 145.57 98.17 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 122.29 1.994 . . . . 10.0 111.789 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . -75.94 -112.78 0.12 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.871 -0.68 . . . . 10.0 112.849 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 71.7 mtp85 -138.51 -22.06 1.01 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.968 0.413 . . . . 10.0 110.934 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 39.2 mttt -100.4 -146.22 0.34 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.993 -0.548 . . . . 10.0 109.915 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 101' ' ' GLY . . . . . 0.805 ' HA3' ' HG3' ' B' ' 85' ' ' ARG . . . 94.72 153.95 30.6 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.612 -0.804 . . . . 10.0 112.751 179.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 15.4 tt -145.99 134.31 16.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.951 0.405 . . . . 10.0 110.545 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 4.0 m -92.25 116.14 28.7 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.062 -0.517 . . . . 10.0 109.701 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 96.0 mt -111.67 138.24 48.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.208 -0.451 . . . . 10.0 110.411 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 105' ' ' ASN . . . . . 0.545 ' HB2' ' HD2' ' B' ' 106' ' ' PRO . 33.3 p30 -88.93 170.43 11.03 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.39 -0.596 . . . . 10.0 109.39 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . 0.545 ' HD2' ' HB2' ' B' ' 105' ' ' ASN . 75.0 Cg_exo -51.47 -35.06 53.96 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.527 2.151 . . . . 10.0 113.121 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -62.89 -53.85 47.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.305 -0.407 . . . . 10.0 110.342 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -67.41 -34.9 78.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.058 -0.519 . . . . 10.0 110.206 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 109' ' ' TRP . . . . . . . . . . . . . 35.1 t-105 -61.12 -45.52 94.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.898 -0.592 . . . . 10.0 109.955 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 110' ' ' SER . . . . . 0.529 ' HA ' ' HE2' ' B' ' 113' ' ' LYS . 13.3 t -64.03 -43.87 94.27 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.697 -0.482 . . . . 10.0 109.697 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -61.16 -39.57 90.59 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 116.061 -0.518 . . . . 10.0 110.744 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 34.5 tp -60.2 -43.3 96.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.876 0.369 . . . . 10.0 110.204 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 113' ' ' LYS . . . . . 0.529 ' HE2' ' HA ' ' B' ' 110' ' ' SER . 41.5 mtmt -66.49 -39.85 88.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.035 -0.53 . . . . 10.0 110.567 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -74.42 -16.25 60.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.822 -0.626 . . . . 10.0 111.372 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 115' ' ' GLN . . . . . 0.538 ' HG3' HG22 ' A' ' 65' ' ' ILE . 14.7 mm-40 -90.12 -4.63 57.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.52 -0.309 . . . . 10.0 111.193 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 75.3 mt -58.78 -35.42 55.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.69 0.281 . . . . 10.0 110.722 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.25 -12.25 39.33 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.27 -0.423 . . . . 10.0 111.725 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 118' ' ' ASP . . . . . 0.4 ' HB3' ' CE1' ' A' ' 63' ' ' PHE . 1.4 m-20 -111.9 -49.65 2.97 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.884 0.373 . . . . 10.0 110.606 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 43.4 mt -65.42 -53.44 39.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 10.0 111.568 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . 0.401 ' HB2' ' HZ2' ' A' ' 109' ' ' TRP . 33.7 t70 -62.54 -31.28 72.04 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.799 0.333 . . . . 10.0 110.627 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -62.03 -47.4 84.89 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.927 -0.579 . . . . 10.0 110.19 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.81 -39.16 80.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.026 -0.534 . . . . 10.0 110.529 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 53.3 t -64.47 -37.23 79.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.818 -0.628 . . . . 10.0 111.207 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 124' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' B' ' 124' ' ' ARG . 8.7 ptp85 -81.77 -6.57 59.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.851 0.358 . . . . 10.0 110.999 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 74.5 mttt . . . . . 0 C--N 1.327 -0.405 0 CA-C-O 121.049 0.452 . . . . 10.0 110.435 179.289 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.861 0 CA-C-O 120.854 0.359 . . . . 10.0 110.123 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.431 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 54.2 ttm -115.73 117.65 30.84 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.16 -0.473 . . . . 10.0 110.584 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -107.47 179.28 4.29 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.911 -0.586 . . . . 10.0 109.51 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -135.32 138.29 43.27 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 121.006 -0.278 . . . . 10.0 110.923 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.6 pt -117.56 -9.77 11.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.16 -0.473 . . . . 10.0 111.23 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 176.11 -178.92 47.46 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.482 -0.866 . . . . 10.0 112.336 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.486 ' O ' ' HD2' ' A' ' 69' ' ' ARG . 43.3 tttp -58.03 118.15 5.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.688 0.28 . . . . 10.0 111.043 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 66.8 mmm 67.28 8.03 5.93 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.442 -0.799 . . . . 10.0 112.165 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.486 ' HD2' ' O ' ' A' ' 67' ' ' LYS . 2.4 mpt_? -113.35 113.02 24.66 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 120.917 0.389 . . . . 10.0 110.078 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.522 ' HB2' ' CD2' ' A' ' 87' ' ' TYR . 94.8 m-85 -121.17 163.85 17.81 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.894 -0.593 . . . . 10.0 110.879 -178.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 62' ' ' MET . 60.3 t -121.28 102.45 12.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.369 -0.832 . . . . 10.0 108.999 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.42 ' HB2' ' HB3' ' A' ' 83' ' ' ASP . 7.1 m -97.65 98.92 10.29 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.094 0.405 . . . . 10.0 112.094 -178.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.54 HG13 HG12 ' A' ' 82' ' ' ILE . 19.5 t -81.54 82.38 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 108.209 -1.034 . . . . 10.0 108.209 177.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -115.97 167.5 10.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.876 -0.602 . . . . 10.0 111.496 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.45 ' HA ' ' HA ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -112.93 141.2 47.03 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.734 -0.666 . . . . 10.0 110.17 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -126.4 101.84 6.88 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.03 -0.532 . . . . 10.0 111.171 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 78.0 mttt 61.32 34.07 18.67 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.004 -0.543 . . . . 10.0 112.018 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.94 18.54 43.27 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.554 -0.831 . . . . 10.0 111.762 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.437 ' HE2' ' HB2' ' A' ' 79' ' ' LYS . 8.0 mtpt -127.75 99.25 5.47 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.327 -0.249 . . . . 10.0 110.327 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 75' ' ' ASP . 96.7 t -69.62 111.88 3.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.844 -0.428 . . . . 10.0 109.844 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 79.3 mt -122.97 119.17 29.61 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.22 -0.445 . . . . 10.0 110.663 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.54 HG12 HG13 ' A' ' 73' ' ' VAL . 75.6 mt -75.79 101.48 2.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 108.955 -0.757 . . . . 10.0 108.955 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.42 ' HB3' ' HB2' ' A' ' 72' ' ' SER . 4.4 t70 -72.9 100.68 2.98 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.722 -0.672 . . . . 10.0 112.258 -178.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 34.8 mt -100.44 91.81 2.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 107.874 -1.158 . . . . 10.0 107.874 177.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.691 ' HG2' ' N ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -160.25 160.52 32.74 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.046 -0.525 . . . . 10.0 111.278 -177.252 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.691 ' N ' ' HG2' ' A' ' 85' ' ' ARG . 7.7 pt-20 -78.39 147.81 33.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.252 0.548 . . . . 10.0 110.788 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.673 ' HB3' ' HG2' ' A' ' 95' ' ' MET . 96.9 m-85 -126.34 125.31 42.05 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.62 -0.718 . . . . 10.0 109.685 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -105.66 167.76 9.55 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.333 -0.394 . . . . 10.0 110.108 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 27.8 ttt -106.01 131.11 53.7 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.691 0.281 . . . . 10.0 110.339 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.428 ' HB2' ' CD ' ' A' ' 91' ' ' PRO . 2.1 p30 -87.11 171.16 10.43 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 116.013 -0.539 . . . . 10.0 110.314 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.428 ' CD ' ' HB2' ' A' ' 90' ' ' ASP . 17.0 Cg_exo -68.64 -10.29 28.64 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.829 2.353 . . . . 10.0 113.257 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -85.08 -43.06 14.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.167 0.508 . . . . 10.0 109.801 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 126.98 19.18 2.01 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.614 -0.721 . . . . 10.0 112.223 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -105.94 178.41 4.57 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.985 0.421 . . . . 10.0 110.981 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.673 ' HG2' ' HB3' ' A' ' 87' ' ' TYR . 18.7 ttm -105.43 112.43 25.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.757 -0.656 . . . . 10.0 110.005 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.3 mmpp? -102.02 123.11 44.73 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.187 -0.46 . . . . 10.0 111.62 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.48 ' HB3' ' CE1' ' A' ' 87' ' ' TYR . 73.4 Cg_endo -80.42 128.19 6.93 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.614 2.209 . . . . 10.0 111.824 178.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.403 ' O ' ' HD3' ' A' ' 85' ' ' ARG . . . -68.17 156.58 52.89 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.68 -0.772 . . . . 10.0 111.636 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.15 -38.43 83.13 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.03 0.443 . . . . 10.0 110.415 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.52 ' H ' ' HG3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -76.0 96.67 3.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.608 -0.723 . . . . 10.0 110.385 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.411 ' CA ' ' HB2' ' A' ' 85' ' ' ARG . . . -164.97 136.19 4.08 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.772 -0.728 . . . . 10.0 111.922 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 19.0 tt -116.69 124.18 72.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.533 0.682 . . . . 10.0 110.707 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.3 m -102.35 110.95 23.04 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.618 -0.719 . . . . 10.0 109.818 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 79.4 mt -97.39 131.61 43.89 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.903 -0.589 . . . . 10.0 111.244 -178.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -84.06 167.14 29.52 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.828 -0.624 . . . . 10.0 109.601 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -43.14 -41.67 9.6 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.317 2.678 . . . . 10.0 113.71 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.36 -46.53 89.63 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.879 0.371 . . . . 10.0 110.781 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -69.91 -39.45 76.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.018 -0.537 . . . . 10.0 109.734 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 68.3 t-105 -56.99 -43.63 81.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.408 -0.815 . . . . 10.0 110.652 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.2 t -61.68 -52.41 64.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.306 -0.406 . . . . 10.0 109.925 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.45 ' O ' ' HG2' ' A' ' 115' ' ' GLN . 36.0 mt-30 -58.5 -41.71 85.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.911 -0.586 . . . . 10.0 110.709 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.614 ' O ' HG13 ' A' ' 116' ' ' ILE . 21.5 tp -55.47 -51.42 67.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.031 -0.531 . . . . 10.0 110.967 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.596 ' HA ' HD12 ' A' ' 116' ' ' ILE . 44.2 mtmt -63.35 -38.34 90.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.311 -0.404 . . . . 10.0 111.441 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -67.49 -36.22 80.68 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.019 -0.537 . . . . 10.0 111.553 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' A' ' 111' ' ' GLN . 14.1 mm-40 -82.18 -17.56 45.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.647 -0.251 . . . . 10.0 111.33 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.614 HG13 ' O ' ' A' ' 112' ' ' LEU . 18.7 mt -49.94 -37.05 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 111.991 0.367 . . . . 10.0 111.991 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.33 -35.68 72.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.42 -0.354 . . . . 10.0 111.414 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.3 -33.48 15.31 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.94 0.4 . . . . 10.0 110.501 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 91.8 mt -60.93 -47.61 92.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.002 -0.545 . . . . 10.0 110.462 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -62.9 -33.59 75.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.812 -0.631 . . . . 10.0 110.569 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -65.83 -33.18 75.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.806 -0.633 . . . . 10.0 110.026 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -70.54 -31.34 68.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.995 -0.548 . . . . 10.0 110.306 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 51.5 t -63.57 -39.02 83.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.999 -0.546 . . . . 10.0 109.789 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 124' ' ' ARG . 5.6 ttm105 -70.42 -23.6 62.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.813 -0.63 . . . . 10.0 110.458 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 16.9 mttp -79.26 -23.53 43.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.823 -0.626 . . . . 10.0 110.557 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 C--N 1.323 -0.544 0 CA-C-N 116.208 -0.451 . . . . 10.0 111.422 -179.989 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.176 0 CA-C-O 121.047 0.451 . . . . 10.0 110.84 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 98.1 mmm -93.82 90.08 6.39 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.436 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -67.8 126.06 28.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.878 -0.601 . . . . 10.0 110.345 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -96.29 130.47 43.38 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.806 0.336 . . . . 10.0 110.768 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 21.8 pt -121.38 8.17 6.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.894 -0.593 . . . . 10.0 110.438 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 171.1 178.03 41.34 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.043 -0.823 . . . . 10.0 111.043 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . 0.507 ' O ' ' HB2' ' B' ' 68' ' ' MET . 28.2 mtmm -67.74 106.13 2.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 117.04 0.42 . . . . 10.0 109.987 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' MET . . . . . 0.507 ' HB2' ' O ' ' B' ' 67' ' ' LYS . 45.6 mtm 78.08 -0.59 2.63 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 124.093 0.87 . . . . 10.0 111.482 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' ARG . . . . . 0.472 ' HG3' ' HB3' ' B' ' 86' ' ' GLU . 6.3 mpt_? -99.12 122.17 41.97 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.771 -0.455 . . . . 10.0 109.771 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -128.84 168.32 16.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.342 0.592 . . . . 10.0 111.806 -178.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 58.4 t -107.27 102.67 14.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 108.103 -1.073 . . . . 10.0 108.103 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 72' ' ' SER . . . . . 0.545 ' HB3' ' HB3' ' B' ' 83' ' ' ASP . 1.4 t -84.94 88.05 7.4 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.493 0.553 . . . . 10.0 112.493 -177.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 44.6 t -89.03 100.14 10.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 107.851 -1.166 . . . . 10.0 107.851 177.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' B' ' 74' ' ' ARG . 15.1 ptt-85 -131.91 162.7 30.02 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.195 0.522 . . . . 10.0 111.827 -177.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -95.51 108.49 20.73 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.514 -0.766 . . . . 10.0 109.135 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -93.13 84.63 4.87 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.459 -0.337 . . . . 10.0 110.56 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 72.6 mttt 59.51 45.42 13.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.613 -0.722 . . . . 10.0 111.759 179.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.0 5.37 70.82 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.804 -0.713 . . . . 10.0 112.377 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -118.47 101.88 8.49 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.135 -0.32 . . . . 10.0 110.135 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . 0.516 ' O ' ' HD3' ' B' ' 106' ' ' PRO . 12.9 t -65.31 115.29 3.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.654 -0.499 . . . . 10.0 109.654 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 78.9 mt -124.48 132.36 53.49 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.114 0.483 . . . . 10.0 111.602 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 82' ' ' ILE . . . . . . . . . . . . . 5.1 mp -94.88 91.14 2.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 107.647 -1.242 . . . . 10.0 107.647 177.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . 0.587 ' HA ' ' HA ' ' B' ' 103' ' ' SER . 38.7 t70 -89.3 103.19 15.84 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.388 -0.824 . . . . 10.0 111.74 -177.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 60.2 mt -80.49 107.75 13.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 107.585 -1.265 . . . . 10.0 107.585 177.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 85' ' ' ARG . . . . . 0.621 ' HD3' ' O ' ' B' ' 98' ' ' GLY . 27.0 ttm-85 -152.85 154.07 34.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.02 0.438 . . . . 10.0 111.744 -176.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 86' ' ' GLU . . . . . 0.472 ' HB3' ' HG3' ' B' ' 69' ' ' ARG . 4.1 pt-20 -93.74 150.06 20.71 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.047 -0.524 . . . . 10.0 109.781 178.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 87' ' ' TYR . . . . . 0.803 ' HB3' ' HB3' ' B' ' 95' ' ' MET . 15.7 m-85 -119.54 127.54 53.11 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.195 -0.457 . . . . 10.0 110.43 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 88' ' ' TRP . . . . . . . . . . . . . 2.2 m0 -108.83 136.34 48.55 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.578 -0.527 . . . . 10.0 109.578 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 42.8 ttm -74.66 126.37 30.7 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.976 0.417 . . . . 10.0 110.341 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 90' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.0 171.62 6.38 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.804 -0.634 . . . . 10.0 110.976 -179.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -52.71 -32.1 53.67 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 123.163 2.575 . . . . 10.0 113.392 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.05 -28.95 65.86 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.944 0.402 . . . . 10.0 110.269 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 106.84 16.06 14.94 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.826 -0.702 . . . . 10.0 112.214 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 94' ' ' GLU . . . . . 0.535 ' HB2' ' HE2' ' B' ' 96' ' ' LYS . 48.3 mt-10 -106.8 147.74 29.33 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.921 -0.4 . . . . 10.0 109.921 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 95' ' ' MET . . . . . 0.803 ' HB3' ' HB3' ' B' ' 87' ' ' TYR . 89.7 mmm -82.69 105.89 14.09 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.427 -0.583 . . . . 10.0 109.427 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . 0.535 ' HE2' ' HB2' ' B' ' 94' ' ' GLU . 73.5 mmtt -88.06 126.69 60.14 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.964 -0.562 . . . . 10.0 111.164 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -65.4 123.97 12.23 Favored 'Trans proline' 0 C--O 1.237 0.452 0 C-N-CA 122.584 2.189 . . . . 10.0 111.459 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . 0.621 ' O ' ' HD3' ' B' ' 85' ' ' ARG . . . -60.45 164.45 15.48 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.818 -0.628 . . . . 10.0 113.537 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 52.4 mtm180 -77.11 -4.03 42.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.985 0.422 . . . . 10.0 111.005 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 38.1 mttm -114.64 115.07 26.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.171 -0.468 . . . . 10.0 110.722 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -175.93 174.41 46.89 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.681 -0.968 . . . . 10.0 110.681 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 16.3 tt -141.84 122.16 11.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.229 0.537 . . . . 10.0 111.354 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 103' ' ' SER . . . . . 0.587 ' HA ' ' HA ' ' B' ' 83' ' ' ASP . 1.2 m -93.07 102.67 15.0 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.879 -0.6 . . . . 10.0 110.173 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 95.2 mt -96.12 132.35 41.61 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.137 -0.483 . . . . 10.0 111.272 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 105' ' ' ASN . . . . . 0.628 ' ND2' ' HB3' ' B' ' 107' ' ' GLU . 23.7 p-10 -84.08 163.61 47.47 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 108.586 -0.894 . . . . 10.0 108.586 178.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . 0.516 ' HD3' ' O ' ' B' ' 80' ' ' VAL . 72.4 Cg_exo -49.38 -32.83 27.39 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.734 2.289 . . . . 10.0 112.542 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 107' ' ' GLU . . . . . 0.628 ' HB3' ' ND2' ' B' ' 105' ' ' ASN . 13.4 tt0 -61.75 -57.94 9.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.762 -0.654 . . . . 10.0 111.059 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -74.05 -28.47 61.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.807 0.337 . . . . 10.0 110.619 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 109' ' ' TRP . . . . . 0.45 ' HH2' HG12 ' A' ' 116' ' ' ILE . 28.8 t-105 -60.26 -43.16 96.39 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.506 -0.553 . . . . 10.0 109.506 178.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 110' ' ' SER . . . . . 0.467 ' O ' ' HG3' ' B' ' 114' ' ' GLU . 37.3 t -63.51 -44.96 92.77 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.505 -0.554 . . . . 10.0 109.505 178.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -58.36 -40.04 81.18 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.68 -0.691 . . . . 10.0 110.613 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . 0.555 ' O ' HG13 ' B' ' 116' ' ' ILE . 20.8 tp -59.93 -45.31 93.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 10.0 110.191 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -63.86 -33.6 76.06 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.853 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' B' ' 110' ' ' SER . 35.9 mt-10 -74.36 -45.61 45.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.998 -0.546 . . . . 10.0 110.648 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -62.93 -18.25 62.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.589 -0.732 . . . . 10.0 112.181 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 116' ' ' ILE . . . . . 0.555 HG13 ' O ' ' B' ' 112' ' ' LEU . 67.8 mt -53.38 -38.25 31.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.778 0.323 . . . . 10.0 110.605 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.19 -28.86 67.03 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.815 -0.63 . . . . 10.0 111.826 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -98.96 -40.13 8.22 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.715 0.293 . . . . 10.0 111.412 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 119' ' ' ILE . . . . . 0.418 ' O ' HG23 ' B' ' 123' ' ' VAL . 83.0 mt -62.79 -48.2 89.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 10.0 110.69 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -63.01 -31.46 72.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.225 0.536 . . . . 10.0 110.377 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -63.96 -36.59 84.47 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.436 -0.802 . . . . 10.0 110.048 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -77.52 -40.53 42.38 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.853 -0.612 . . . . 10.0 110.821 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . 0.418 HG23 ' O ' ' B' ' 119' ' ' ILE . 94.1 t -61.48 -43.14 96.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.069 -0.514 . . . . 10.0 111.52 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -70.55 -10.77 60.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.684 0.278 . . . . 10.0 111.602 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 85.1 mttt . . . . . 0 C--N 1.326 -0.414 0 CA-C-O 120.751 0.31 . . . . 10.0 110.933 179.963 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.499 ' O ' ' HA ' ' A' ' 72' ' ' SER . . . . . . . . 0 N--CA 1.477 0.889 0 CA-C-O 120.681 0.276 . . . . 10.0 110.506 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 24.0 mmt -123.23 92.78 3.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.239 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.558 ' HB2' ' HB ' ' A' ' 71' ' ' VAL . 91.8 m-85 -96.34 121.09 37.75 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.734 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -87.13 120.11 28.06 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.796 0.332 . . . . 10.0 110.174 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.3 pt -110.23 0.13 9.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.064 0.459 . . . . 10.0 111.063 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.697 ' HA3' ' HG2' ' B' ' 108' ' ' GLN . . . 170.19 -178.64 42.86 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.583 -0.818 . . . . 10.0 111.964 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.449 ' HG2' ' HG2' ' A' ' 68' ' ' MET . 57.0 tttp -65.9 114.25 4.98 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.457 0.17 . . . . 10.0 110.92 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.449 ' HG2' ' HG2' ' A' ' 67' ' ' LYS . 71.5 mmm 69.15 18.78 8.15 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 123.917 0.761 . . . . 10.0 111.663 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -121.83 112.6 18.55 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.934 -0.395 . . . . 10.0 109.934 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -124.91 144.08 50.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.392 0.615 . . . . 10.0 111.671 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.558 ' HB ' ' HB2' ' A' ' 63' ' ' PHE . 48.0 t -104.0 107.22 21.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.177 -0.92 . . . . 10.0 109.037 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 61' ' ' ALA . 1.5 p -102.5 92.48 4.68 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.168 0.508 . . . . 10.0 112.059 -178.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.439 HG22 HG23 ' A' ' 82' ' ' ILE . 16.9 t -83.47 100.54 7.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.085 -0.507 . . . . 10.0 110.003 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.65 156.72 38.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.393 -0.367 . . . . 10.0 110.363 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.51 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 1.1 t70 -83.49 136.07 34.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.145 -0.479 . . . . 10.0 110.86 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -135.24 98.73 4.05 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.075 -0.511 . . . . 10.0 110.672 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 84.3 mttt 59.91 42.3 16.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.632 -0.713 . . . . 10.0 111.004 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.32 51.82 3.99 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.634 -0.793 . . . . 10.0 111.556 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -138.02 89.81 2.43 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.058 -0.349 . . . . 10.0 110.058 -179.626 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.3 t -95.49 91.55 2.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.641 -0.503 . . . . 10.0 109.641 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.734 HD13 ' HB3' ' A' ' 103' ' ' SER . 0.5 OUTLIER -157.14 174.06 16.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.9 -0.591 . . . . 10.0 111.181 -179.08 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.439 HG23 HG22 ' A' ' 73' ' ' VAL . 69.7 mt -88.65 88.87 3.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.267 -0.642 . . . . 10.0 109.267 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.488 ' HA ' ' HA ' ' A' ' 103' ' ' SER . 32.1 t70 -84.39 117.59 23.72 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.86 -0.609 . . . . 10.0 111.806 -178.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.422 HG12 HG13 ' A' ' 71' ' ' VAL . 58.4 mt -103.93 137.54 32.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.97 -0.559 . . . . 10.0 109.642 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.418 ' HB3' ' CE1' ' A' ' 87' ' ' TYR . 10.4 ttm180 -144.92 146.41 31.98 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.711 -0.477 . . . . 10.0 109.711 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -78.59 93.74 4.89 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.402 -0.592 . . . . 10.0 109.402 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 97' ' ' PRO . 16.4 m-85 -78.08 115.95 18.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.702 -0.681 . . . . 10.0 111.717 -178.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.417 ' CH2' ' HA3' ' A' ' 98' ' ' GLY . 35.1 m0 -99.19 -157.39 0.6 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.175 -0.676 . . . . 10.0 109.175 178.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 20.6 ttt -130.58 132.4 45.51 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.042 -0.355 . . . . 10.0 110.042 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.467 ' OD2' ' HB3' ' A' ' 94' ' ' GLU . 2.8 p30 -94.73 167.85 12.38 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 116.273 -0.421 . . . . 10.0 110.565 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -62.48 -14.92 42.28 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.124 2.549 . . . . 10.0 113.452 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.438 ' HA ' ' OE1' ' A' ' 92' ' ' GLU . 2.9 tp10 -83.7 -39.88 19.6 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.12 0.486 . . . . 10.0 110.044 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 123.75 19.19 2.81 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.787 -0.72 . . . . 10.0 112.518 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.467 ' HB3' ' OD2' ' A' ' 90' ' ' ASP . 21.5 tt0 -106.59 166.27 10.68 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.684 -0.487 . . . . 10.0 109.684 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 94.4 mmm -87.33 84.37 7.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.877 0.37 . . . . 10.0 110.484 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.657 ' HE2' ' HA ' ' A' ' 96' ' ' LYS . 0.3 OUTLIER -90.07 108.16 24.24 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.153 -0.476 . . . . 10.0 110.05 179.164 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.625 ' HD2' ' HE2' ' A' ' 96' ' ' LYS . 58.6 Cg_endo -73.95 152.72 46.73 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.251 1.967 . . . . 10.0 112.821 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.417 ' HA3' ' CH2' ' A' ' 88' ' ' TRP . . . -94.24 178.93 37.5 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 111.038 -0.825 . . . . 10.0 111.038 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -78.53 71.59 5.0 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.243 0.544 . . . . 10.0 110.345 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 24.7 ttmt -161.97 133.88 5.55 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.242 -0.89 . . . . 10.0 109.672 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 154.37 -169.47 32.74 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.958 -0.639 . . . . 10.0 111.652 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 20.4 tt -168.91 139.63 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.745 0.307 . . . . 10.0 110.42 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.734 ' HB3' HD13 ' A' ' 81' ' ' LEU . 0.7 OUTLIER -96.01 145.01 25.8 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.506 -0.315 . . . . 10.0 110.268 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 45.6 mt -121.93 117.56 26.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.461 -0.336 . . . . 10.0 110.176 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.545 ' HB2' ' HD2' ' A' ' 106' ' ' PRO . 2.7 p30 -78.61 164.24 56.84 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 109.969 -0.382 . . . . 10.0 109.969 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.545 ' HD2' ' HB2' ' A' ' 105' ' ' ASN . 1.7 Cg_endo -43.22 -45.68 9.66 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.732 2.954 . . . . 10.0 113.866 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -64.01 -42.56 97.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.493 0.187 . . . . 10.0 111.135 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -63.84 -43.6 95.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.991 0.424 . . . . 10.0 110.011 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.534 ' HZ2' ' HB2' ' B' ' 120' ' ' ASP . 62.6 t-105 -59.27 -41.83 89.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.651 -0.704 . . . . 10.0 110.867 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.5 m -66.81 -43.9 82.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.851 -0.613 . . . . 10.0 111.115 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -68.35 -38.95 81.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.36 -0.382 . . . . 10.0 111.038 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.2 tp -59.08 -44.31 91.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.316 -0.402 . . . . 10.0 110.958 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -64.65 -32.54 74.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.272 -0.422 . . . . 10.0 111.1 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -75.45 -33.32 60.87 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.034 0.445 . . . . 10.0 110.888 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -77.81 -8.47 58.06 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.411 0.522 . . . . 10.0 112.411 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 74.7 mt -54.68 -44.46 70.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.674 0.273 . . . . 10.0 111.291 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.31 -19.78 62.17 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.147 -0.479 . . . . 10.0 111.911 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.407 ' HB3' ' CE1' ' B' ' 63' ' ' PHE . 0.6 OUTLIER -101.26 -48.4 4.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.755 0.312 . . . . 10.0 110.718 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.653 HG23 HG21 ' B' ' 73' ' ' VAL . 87.6 mt -58.02 -51.43 70.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.893 -0.594 . . . . 10.0 110.931 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -60.04 -35.66 75.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.73 -0.668 . . . . 10.0 111.38 -178.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.461 ' HA ' ' CZ ' ' A' ' 124' ' ' ARG . 6.9 t70 -66.12 -38.24 87.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.879 0.371 . . . . 10.0 110.259 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.54 -38.29 83.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.128 -0.487 . . . . 10.0 110.1 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 119' ' ' ILE . 59.7 t -63.15 -39.56 85.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.879 -0.6 . . . . 10.0 110.1 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.461 ' CZ ' ' HA ' ' A' ' 121' ' ' ASP . 25.2 mtm105 -72.92 -30.36 63.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.95 -0.568 . . . . 10.0 110.873 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 35.2 mttp -70.98 -35.06 71.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.262 -0.427 . . . . 10.0 110.905 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 26.6 mt . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 116.325 -0.398 . . . . 10.0 110.795 179.88 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.17 0 CA-C-O 121.183 0.516 . . . . 10.0 110.735 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 20.4 mmm -103.45 102.22 12.13 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.079 -0.712 . . . . 10.0 109.079 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' PHE . . . . . 0.419 ' CE2' ' HA ' ' A' ' 119' ' ' ILE . 34.8 m-85 -94.6 114.93 26.97 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.882 -0.599 . . . . 10.0 111.443 -178.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -75.56 121.57 22.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.813 -0.631 . . . . 10.0 110.522 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 12.6 pt -116.05 13.23 7.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.248 -0.433 . . . . 10.0 110.856 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 167.7 -179.31 41.16 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.778 -0.646 . . . . 10.0 111.874 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . 0.507 ' O ' ' HD2' ' B' ' 69' ' ' ARG . 0.3 OUTLIER -69.55 111.22 5.23 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.895 0.378 . . . . 10.0 110.06 -179.758 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' MET . . . . . 0.459 ' HB2' ' O ' ' B' ' 67' ' ' LYS . 49.2 mtp 73.17 8.75 5.31 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.2 -0.909 . . . . 10.0 111.175 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' ARG . . . . . 0.507 ' HD2' ' O ' ' B' ' 67' ' ' LYS . 1.5 mpt_? -105.1 118.95 37.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.496 -0.32 . . . . 10.0 110.213 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -132.74 124.09 27.47 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.881 0.372 . . . . 10.0 111.725 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.457 HG12 HG23 ' B' ' 73' ' ' VAL . 46.7 t -76.4 105.32 5.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.716 -0.846 . . . . 10.0 108.716 178.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 5.2 m -84.21 87.77 7.19 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.949 -0.569 . . . . 10.0 111.665 -178.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . 0.653 HG21 HG23 ' A' ' 119' ' ' ILE . 67.5 t -93.87 120.14 42.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.31 -0.626 . . . . 10.0 109.31 178.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . 0.647 HH12 ' HB2' ' B' ' 83' ' ' ASP . 0.1 OUTLIER -164.43 172.9 12.77 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.217 -0.447 . . . . 10.0 110.45 -179.375 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -94.11 118.29 31.32 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.047 -0.524 . . . . 10.0 109.91 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -108.36 92.69 4.16 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.307 -0.406 . . . . 10.0 110.306 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 93.5 mttt 60.72 33.44 20.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.357 -0.838 . . . . 10.0 111.824 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 102.78 -1.97 48.68 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.619 -0.801 . . . . 10.0 113.146 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -119.37 115.99 25.26 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 122.596 -0.355 . . . . 10.0 111.216 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . 0.486 ' O ' ' HD3' ' B' ' 106' ' ' PRO . 28.5 t -75.64 106.6 5.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.172 -0.677 . . . . 10.0 109.172 178.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 80.6 mt -107.68 127.85 54.03 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.188 0.518 . . . . 10.0 112.163 -178.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 82' ' ' ILE . . . . . . . . . . . . . 5.0 mp -92.47 95.62 5.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 107.503 -1.295 . . . . 10.0 107.503 177.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . 0.647 ' HB2' HH12 ' B' ' 74' ' ' ARG . 3.4 t70 -91.07 117.42 29.58 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 112.677 0.621 . . . . 10.0 112.677 -177.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 77.9 mt -100.16 98.9 7.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 107.953 -1.129 . . . . 10.0 107.953 177.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 85' ' ' ARG . . . . . 0.54 ' HG3' ' HA3' ' B' ' 101' ' ' GLY . 8.9 ttm-85 -147.64 166.35 27.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.227 -0.442 . . . . 10.0 111.238 -177.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.87 157.07 17.46 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.917 -0.771 . . . . 10.0 108.917 178.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 87' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -121.03 120.73 36.22 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.961 0.41 . . . . 10.0 110.513 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 88' ' ' TRP . . . . . . . . . . . . . 36.2 m95 -103.52 138.32 40.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.764 -0.653 . . . . 10.0 110.173 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 89' ' ' MET . . . . . 0.503 ' HA ' ' O ' ' B' ' 94' ' ' GLU . 58.1 ttm -91.21 132.28 36.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.756 0.312 . . . . 10.0 110.668 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 90' ' ' ASP . . . . . 0.514 ' HB2' ' HD2' ' B' ' 91' ' ' PRO . 8.7 p30 -91.97 173.14 5.52 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 116.298 -0.41 . . . . 10.0 110.144 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 91' ' ' PRO . . . . . 0.514 ' HD2' ' HB2' ' B' ' 90' ' ' ASP . 39.5 Cg_exo -59.45 -26.28 81.43 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.482 2.121 . . . . 10.0 112.489 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -71.36 -26.43 62.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.004 0.431 . . . . 10.0 110.147 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 104.85 16.71 16.29 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.986 -0.626 . . . . 10.0 112.643 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 94' ' ' GLU . . . . . 0.503 ' O ' ' HA ' ' B' ' 89' ' ' MET . 16.3 mt-10 -98.22 155.23 17.28 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.893 0.378 . . . . 10.0 110.749 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 95' ' ' MET . . . . . . . . . . . . . 98.8 mmm -101.62 100.46 10.86 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.66 -0.496 . . . . 10.0 109.66 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . 0.414 ' HA ' ' HD3' ' B' ' 97' ' ' PRO . 71.8 mmtt -97.75 140.14 21.77 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 116.164 -0.471 . . . . 10.0 110.895 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 97' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' B' ' 96' ' ' LYS . 38.2 Cg_exo -60.31 143.16 99.49 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 122.569 2.179 . . . . 10.0 111.337 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.47 168.62 21.24 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 116.1 -0.5 . . . . 10.0 112.923 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 99' ' ' ARG . . . . . 0.441 HH11 ' HD2' ' B' ' 99' ' ' ARG . 8.1 mmt180 -79.85 -3.76 49.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.076 0.465 . . . . 10.0 111.136 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 100' ' ' LYS . . . . . 0.403 ' HB2' ' H ' ' B' ' 101' ' ' GLY . 3.9 pttp -117.79 -160.35 0.78 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.984 -0.746 . . . . 10.0 108.984 178.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 101' ' ' GLY . . . . . 0.54 ' HA3' ' HG3' ' B' ' 85' ' ' ARG . . . 108.53 168.24 21.05 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.655 -0.783 . . . . 10.0 112.386 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 20.9 tt -144.82 139.99 23.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.942 0.401 . . . . 10.0 110.869 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 3.8 m -102.69 110.3 22.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.006 -0.543 . . . . 10.0 110.003 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 92.9 mt -104.06 135.18 46.05 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.053 0.454 . . . . 10.0 111.24 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 105' ' ' ASN . . . . . 0.554 ' ND2' ' HB3' ' B' ' 107' ' ' GLU . 34.1 p-10 -93.1 165.77 17.78 Favored Pre-proline 0 C--N 1.317 -0.83 0 N-CA-C 108.698 -0.853 . . . . 10.0 108.698 178.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' B' ' 80' ' ' VAL . 73.7 Cg_exo -50.39 -32.43 33.83 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.505 2.137 . . . . 10.0 112.51 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 107' ' ' GLU . . . . . 0.554 ' HB3' ' ND2' ' B' ' 105' ' ' ASN . 6.4 tt0 -63.29 -53.51 51.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.607 -0.724 . . . . 10.0 110.948 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 108' ' ' GLN . . . . . 0.697 ' HG2' ' HA3' ' A' ' 66' ' ' GLY . 76.3 mt-30 -75.01 -30.49 61.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.925 0.393 . . . . 10.0 110.307 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 109' ' ' TRP . . . . . . . . . . . . . 46.7 t-105 -59.55 -41.26 89.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.771 -0.649 . . . . 10.0 109.777 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 110' ' ' SER . . . . . 0.627 ' HA ' ' HE3' ' B' ' 113' ' ' LYS . 22.9 t -63.32 -49.32 74.44 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.609 -0.515 . . . . 10.0 109.609 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -58.6 -40.6 83.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.683 -0.689 . . . . 10.0 110.96 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . 0.545 ' O ' HG13 ' B' ' 116' ' ' ILE . 63.5 tp -58.28 -44.68 88.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.557 -0.292 . . . . 10.0 110.214 178.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 113' ' ' LYS . . . . . 0.627 ' HE3' ' HA ' ' B' ' 110' ' ' SER . 51.2 mtmt -62.98 -41.64 99.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.109 -0.496 . . . . 10.0 110.529 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -68.81 -35.52 77.09 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.72 -0.673 . . . . 10.0 111.41 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 115' ' ' GLN . . . . . 0.426 ' HA ' ' OE1' ' B' ' 115' ' ' GLN . 13.6 mm-40 -75.27 -14.75 60.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.254 -0.43 . . . . 10.0 111.398 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 116' ' ' ILE . . . . . 0.545 HG13 ' O ' ' B' ' 112' ' ' LEU . 56.3 mt -57.99 -37.76 63.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 120.705 0.288 . . . . 10.0 110.6 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 1.1 m -65.0 -7.26 10.96 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.066 -0.516 . . . . 10.0 111.706 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -116.7 -47.11 2.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.056 0.455 . . . . 10.0 110.424 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 119' ' ' ILE . . . . . 0.529 ' O ' HG23 ' B' ' 123' ' ' VAL . 65.9 mt -64.66 -49.33 80.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.809 -0.632 . . . . 10.0 111.821 -179.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . 0.534 ' HB2' ' HZ2' ' A' ' 109' ' ' TRP . 34.2 t70 -58.1 -40.03 80.12 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.922 0.391 . . . . 10.0 111.106 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -64.66 -36.99 86.06 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.829 -0.623 . . . . 10.0 110.513 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.42 -24.85 60.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.942 -0.572 . . . . 10.0 111.599 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . 0.529 HG23 ' O ' ' B' ' 119' ' ' ILE . 89.3 t -58.53 -37.63 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 121.04 0.448 . . . . 10.0 110.847 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -100.6 16.42 24.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.309 -0.405 . . . . 10.0 110.809 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 92.4 mttt . . . . . 0 C--N 1.327 -0.407 0 CA-C-N 116.172 -0.467 . . . . 10.0 110.247 179.715 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.624 ' HB3' ' HB ' ' A' ' 73' ' ' VAL . . . . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 109.827 -0.434 . . . . 10.0 109.827 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.549 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 41.7 ttm -112.29 103.04 11.16 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.107 0.479 . . . . 10.0 111.316 -179.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.474 ' HB2' ' HB ' ' A' ' 71' ' ' VAL . 88.1 m-85 -89.42 173.95 8.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.903 -0.59 . . . . 10.0 109.577 179.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.426 ' HG2' ' H ' ' A' ' 66' ' ' GLY . 39.9 tt0 -127.42 126.55 42.6 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.615 0.245 . . . . 10.0 110.64 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.586 HD11 HG23 ' A' ' 84' ' ' ILE . 10.7 pt -117.39 15.44 7.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.321 -0.4 . . . . 10.0 110.885 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.426 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 154.07 175.75 25.66 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.312 -0.947 . . . . 10.0 112.595 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.606 ' HG2' ' HG2' ' A' ' 68' ' ' MET . 42.0 tttp -60.12 113.48 2.37 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 122.698 0.399 . . . . 10.0 110.91 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.606 ' HG2' ' HG2' ' A' ' 67' ' ' LYS . 66.8 mmm 69.87 17.68 7.51 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 123.784 0.678 . . . . 10.0 111.644 179.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.482 ' HB3' HG13 ' A' ' 65' ' ' ILE . 5.9 mpt_? -119.94 107.29 12.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.088 0.471 . . . . 10.0 109.936 178.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.509 ' HB3' ' HG2' ' A' ' 62' ' ' MET . 63.8 m-85 -115.3 152.0 33.55 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.728 -0.669 . . . . 10.0 110.838 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.638 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 23.4 t -102.05 111.59 32.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.421 -0.809 . . . . 10.0 110.203 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.633 ' HB2' ' HB3' ' A' ' 83' ' ' ASP . 0.9 OUTLIER -85.14 87.75 7.41 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.027 0.441 . . . . 10.0 111.43 -179.486 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.684 HG22 HG22 ' A' ' 82' ' ' ILE . 16.5 t -86.98 108.21 17.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.589 -0.893 . . . . 10.0 108.589 178.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -153.77 -179.64 8.01 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.306 0.574 . . . . 10.0 111.998 -178.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.523 ' HB2' HG22 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -120.53 123.02 41.88 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.814 -1.085 . . . . 10.0 109.075 178.457 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -115.67 86.11 2.41 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.014 0.435 . . . . 10.0 110.929 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt 57.35 41.49 26.38 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.257 -0.883 . . . . 10.0 111.348 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 112.38 -24.5 13.81 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.511 -0.852 . . . . 10.0 112.346 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -84.3 82.72 8.26 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.887 0.375 . . . . 10.0 110.554 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.523 HG22 ' HB2' ' A' ' 75' ' ' ASP . 2.8 t -90.37 103.37 14.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 108.958 -0.756 . . . . 10.0 108.958 178.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.741 ' HB3' ' HA ' ' A' ' 105' ' ' ASN . 0.2 OUTLIER -157.97 174.19 15.63 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.952 0.406 . . . . 10.0 111.369 -178.479 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.684 HG22 HG22 ' A' ' 73' ' ' VAL . 38.7 pt -92.64 172.39 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.993 -0.549 . . . . 10.0 110.194 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.638 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 4.1 t70 -151.01 147.49 27.2 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.617 0.246 . . . . 10.0 111.216 -178.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.586 HG23 HD11 ' A' ' 65' ' ' ILE . 60.7 mt -121.22 106.83 19.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.326 -0.62 . . . . 10.0 109.326 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.446 ' HG2' ' HA3' ' A' ' 101' ' ' GLY . 60.2 mtm180 -129.72 151.89 49.82 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.949 0.404 . . . . 10.0 111.451 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -83.11 97.73 8.95 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.382 -0.97 . . . . 10.0 108.382 178.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 97' ' ' PRO . 18.6 m-85 -81.32 142.68 32.84 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.434 -0.803 . . . . 10.0 112.693 -177.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 13.8 m0 -128.6 177.25 7.16 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.489 -0.93 . . . . 10.0 108.489 178.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 1.1 ttt -103.97 127.51 51.51 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 110.059 -0.349 . . . . 10.0 110.059 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.515 ' OD2' ' HB2' ' A' ' 94' ' ' GLU . 4.2 p30 -85.02 167.21 27.43 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.636 -0.256 . . . . 10.0 110.359 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -61.63 -19.25 64.23 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.904 2.403 . . . . 10.0 113.403 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -77.68 -46.79 20.88 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.077 0.465 . . . . 10.0 110.006 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 133.36 15.79 1.25 Allowed Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.982 -0.628 . . . . 10.0 112.5 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.515 ' HB2' ' OD2' ' A' ' 90' ' ' ASP . 23.9 mt-10 -106.94 179.18 4.34 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.858 0.361 . . . . 10.0 110.386 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 85.7 mmm -106.55 109.93 21.99 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.205 -0.452 . . . . 10.0 110.737 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.462 ' HA ' ' HD3' ' A' ' 97' ' ' PRO . 48.5 mmtt -125.37 128.67 24.66 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.828 -0.623 . . . . 10.0 109.577 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 96' ' ' LYS . 4.6 Cg_endo -82.63 177.28 7.07 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.078 2.519 . . . . 10.0 113.129 -179.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -100.82 -169.27 28.59 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.794 -0.639 . . . . 10.0 111.884 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -80.09 55.98 2.29 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.839 0.352 . . . . 10.0 111.282 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -160.6 132.98 6.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.261 -0.427 . . . . 10.0 110.231 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.446 ' HA3' ' HG2' ' A' ' 85' ' ' ARG . . . 172.19 -170.95 43.91 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.066 -0.588 . . . . 10.0 111.754 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.471 ' HB ' ' N ' ' B' ' 101' ' ' GLY . 8.9 tt -165.85 127.56 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.945 0.402 . . . . 10.0 110.897 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.583 ' HA ' ' HA ' ' A' ' 83' ' ' ASP . 51.7 m -105.56 145.05 31.47 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.235 -0.654 . . . . 10.0 109.235 178.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.423 HD11 HD11 ' A' ' 82' ' ' ILE . 0.5 OUTLIER -131.59 129.68 41.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.028 0.442 . . . . 10.0 110.351 179.71 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.741 ' HA ' ' HB3' ' A' ' 81' ' ' LEU . 3.5 p30 -75.25 164.0 64.08 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.36 -0.837 . . . . 10.0 111.263 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -48.27 -38.37 33.52 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.619 2.88 . . . . 10.0 114.224 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -65.31 -42.22 93.23 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.042 -0.355 . . . . 10.0 110.042 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -65.48 -45.37 83.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.136 0.493 . . . . 10.0 109.801 178.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 56.2 t-105 -56.79 -42.43 79.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.281 -0.872 . . . . 10.0 110.462 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.4 m -65.49 -46.42 79.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.269 -0.423 . . . . 10.0 110.605 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -61.5 -42.74 99.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.494 . . . . 10.0 110.847 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.438 ' O ' HG13 ' A' ' 116' ' ' ILE . 53.8 tp -57.85 -45.75 85.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.901 -0.591 . . . . 10.0 111.314 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -59.0 -42.47 90.15 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.328 -0.396 . . . . 10.0 111.322 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -74.04 -16.99 61.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.184 -0.462 . . . . 10.0 111.758 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -93.14 -10.6 35.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.745 0.307 . . . . 10.0 110.989 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 112' ' ' LEU . 70.7 mt -56.71 -37.53 53.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.571 -0.286 . . . . 10.0 111.45 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.14 -23.58 64.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.904 0.383 . . . . 10.0 111.397 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -97.73 -44.4 6.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.138 0.494 . . . . 10.0 110.088 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.498 ' O ' HG23 ' A' ' 123' ' ' VAL . 67.1 mt -60.25 -52.43 61.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.876 -0.602 . . . . 10.0 111.2 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -61.51 -33.82 74.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.995 -0.548 . . . . 10.0 110.268 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -66.41 -35.62 80.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.533 -0.758 . . . . 10.0 110.259 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.52 -37.42 63.09 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.932 -0.576 . . . . 10.0 110.767 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 119' ' ' ILE . 99.4 t -61.78 -34.54 62.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 10.0 110.805 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 13.9 mtm105 -78.05 -13.72 59.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.131 -0.486 . . . . 10.0 111.417 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -95.37 -31.48 13.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.862 0.363 . . . . 10.0 111.139 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 75.4 mt . . . . . 0 C--N 1.325 -0.48 0 CA-C-N 116.473 -0.33 . . . . 10.0 110.518 179.709 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.18 0 CA-C-O 121.019 0.438 . . . . 10.0 111.021 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 97.3 mmm -108.12 89.89 3.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.991 -0.55 . . . . 10.0 109.621 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -98.49 133.03 43.43 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.161 -0.472 . . . . 10.0 110.669 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -92.17 132.37 36.69 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.814 0.34 . . . . 10.0 110.746 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' ILE . . . . . 0.407 HD13 HD13 ' A' ' 112' ' ' LEU . 30.5 pt -125.73 16.86 4.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.188 0.518 . . . . 10.0 110.174 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 167.78 165.28 24.92 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.041 -0.824 . . . . 10.0 111.041 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . 0.543 ' O ' ' HD2' ' B' ' 69' ' ' ARG . 15.6 mttp -64.07 116.6 6.07 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.944 0.372 . . . . 10.0 110.126 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' MET . . . . . . . . . . . . . 17.5 mmt 69.64 15.73 8.1 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.868 -0.605 . . . . 10.0 110.824 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' ARG . . . . . 0.543 ' HD2' ' O ' ' B' ' 67' ' ' LYS . 2.0 mpt_? -119.17 109.81 16.31 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.436 -0.579 . . . . 10.0 109.436 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' TYR . . . . . 0.451 ' HB2' ' HE2' ' B' ' 87' ' ' TYR . 88.5 m-85 -122.33 142.36 50.58 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.353 0.597 . . . . 10.0 112.078 -178.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 70.8 t -94.48 93.67 4.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 107.809 -1.182 . . . . 10.0 107.809 177.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 8.5 t -84.15 95.87 8.77 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.889 -0.596 . . . . 10.0 111.551 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . 0.495 HG21 HG23 ' A' ' 119' ' ' ILE . 17.4 t -90.07 87.92 2.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.533 -0.914 . . . . 10.0 108.533 178.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' B' ' 74' ' ' ARG . 10.4 ptt-85 -118.09 172.97 7.05 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.146 -0.479 . . . . 10.0 111.207 -178.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -105.54 128.87 53.83 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.811 -0.631 . . . . 10.0 110.67 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -108.8 78.0 1.11 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.302 -0.408 . . . . 10.0 109.93 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 35.5 mttm 60.56 50.97 5.36 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.713 -0.676 . . . . 10.0 111.768 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.18 4.61 71.29 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.683 -0.77 . . . . 10.0 112.356 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -118.29 99.3 6.76 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.65 0.262 . . . . 10.0 110.373 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 41.7 t -67.46 116.88 7.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.653 -0.499 . . . . 10.0 109.653 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 95.9 mt -123.53 132.03 53.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.232 0.539 . . . . 10.0 111.818 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 82' ' ' ILE . . . . . 0.401 HD13 ' HB2' ' B' ' 109' ' ' TRP . 5.2 mp -92.63 87.72 2.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 107.834 -1.173 . . . . 10.0 107.834 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . 0.632 ' HA ' ' HA ' ' B' ' 103' ' ' SER . 34.1 t70 -85.39 94.79 9.06 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.745 -0.662 . . . . 10.0 112.014 -178.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 50.9 mt -87.43 99.62 8.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 107.272 -1.381 . . . . 10.0 107.272 177.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 85' ' ' ARG . . . . . 0.735 ' HG3' ' HA3' ' B' ' 101' ' ' GLY . 12.7 ttm-85 -138.33 154.97 48.98 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.28 0.562 . . . . 10.0 111.819 -177.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 86' ' ' GLU . . . . . 0.516 ' HG3' ' HA3' ' B' ' 98' ' ' GLY . 17.1 pt-20 -82.25 148.82 28.17 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.362 -0.835 . . . . 10.0 109.56 178.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 87' ' ' TYR . . . . . 0.451 ' HE2' ' HB2' ' B' ' 70' ' ' TYR . 62.8 m-85 -132.65 121.63 23.45 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.594 -0.521 . . . . 10.0 109.594 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 88' ' ' TRP . . . . . . . . . . . . . 23.7 m0 -99.19 143.44 29.46 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.225 -0.443 . . . . 10.0 110.469 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 42.6 ttm -84.62 120.18 26.07 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.314 -0.403 . . . . 10.0 110.061 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 90' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.52 163.65 53.29 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.963 -0.562 . . . . 10.0 110.856 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -57.83 -32.34 94.69 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.233 2.622 . . . . 10.0 113.44 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.44 -49.57 66.27 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.888 0.375 . . . . 10.0 110.465 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 136.68 24.73 0.47 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.718 -0.754 . . . . 10.0 112.669 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 94' ' ' GLU . . . . . 0.808 ' HB2' ' HE2' ' B' ' 96' ' ' LYS . 26.9 mt-10 -115.35 161.98 17.76 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.938 0.399 . . . . 10.0 110.606 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 95' ' ' MET . . . . . . . . . . . . . 96.9 mmm -101.55 106.24 17.3 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.871 -0.604 . . . . 10.0 109.387 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . 0.808 ' HE2' ' HB2' ' B' ' 94' ' ' GLU . 35.4 mmtt -98.91 136.25 20.67 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 116.127 -0.488 . . . . 10.0 110.233 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -58.21 139.16 89.46 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.756 2.304 . . . . 10.0 112.194 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . 0.516 ' HA3' ' HG3' ' B' ' 86' ' ' GLU . . . -82.62 -140.13 3.53 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 121.061 -0.59 . . . . 10.0 112.455 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 60.8 mtp85 -117.32 -27.57 6.38 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.945 0.402 . . . . 10.0 110.645 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 4.3 mtmt -88.57 114.32 25.07 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.945 -0.571 . . . . 10.0 110.134 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 101' ' ' GLY . . . . . 0.735 ' HA3' ' HG3' ' B' ' 85' ' ' ARG . . . 166.01 156.81 9.63 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.522 -0.847 . . . . 10.0 112.727 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 18.8 tt -156.38 140.92 8.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.001 0.429 . . . . 10.0 110.402 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 103' ' ' SER . . . . . 0.632 ' HA ' ' HA ' ' B' ' 83' ' ' ASP . 3.4 m -88.56 108.23 19.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.209 -0.45 . . . . 10.0 110.29 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 68.5 mt -87.12 131.5 34.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.206 -0.452 . . . . 10.0 110.443 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -88.2 166.65 22.71 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 109.295 -0.631 . . . . 10.0 109.295 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -47.13 -32.44 13.65 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.005 2.47 . . . . 10.0 113.251 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -67.45 -56.12 10.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.291 -0.413 . . . . 10.0 110.46 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -63.33 -34.07 76.91 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.044 -0.525 . . . . 10.0 110.285 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 109' ' ' TRP . . . . . 0.401 ' HB2' HD13 ' B' ' 82' ' ' ILE . 52.0 t-105 -61.37 -43.06 99.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.857 -0.61 . . . . 10.0 109.908 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 1.6 t -66.29 -45.46 80.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.807 -0.633 . . . . 10.0 109.494 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -56.52 -47.97 78.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.51 -0.768 . . . . 10.0 111.014 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 56.4 tp -58.62 -43.8 89.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.257 -0.429 . . . . 10.0 110.753 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -63.13 -38.54 91.6 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.953 0.406 . . . . 10.0 111.193 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -80.72 -6.65 58.73 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.203 -0.453 . . . . 10.0 111.503 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 13.6 mm-40 -105.26 -6.01 20.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.664 0.269 . . . . 10.0 111.078 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 116' ' ' ILE . . . . . 0.464 ' O ' ' HB2' ' B' ' 120' ' ' ASP . 85.1 mt -52.49 -47.23 48.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 10.0 111.921 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.57 -40.94 72.63 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.227 0.454 . . . . 10.0 112.227 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -76.04 -47.36 25.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.358 -0.383 . . . . 10.0 111.537 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 119' ' ' ILE . . . . . 0.453 ' O ' HG23 ' B' ' 123' ' ' VAL . 70.5 mt -64.21 -42.35 95.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.729 0.299 . . . . 10.0 110.904 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' B' ' 116' ' ' ILE . 2.1 t70 -60.68 -37.37 81.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.118 0.485 . . . . 10.0 110.422 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -69.33 -31.44 69.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.695 -0.684 . . . . 10.0 110.55 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.04 -32.44 63.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.259 -0.428 . . . . 10.0 110.212 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . 0.453 HG23 ' O ' ' B' ' 119' ' ' ILE . 95.0 t -69.2 -41.79 81.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.987 -0.551 . . . . 10.0 110.769 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 124' ' ' ARG . . . . . 0.709 ' HG3' ' HG3' ' B' ' 125' ' ' LYS . 7.8 ptp180 -75.27 -31.52 60.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.509 -0.314 . . . . 10.0 111.095 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 125' ' ' LYS . . . . . 0.709 ' HG3' ' HG3' ' B' ' 124' ' ' ARG . 86.0 mttt . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 116.426 -0.352 . . . . 10.0 110.805 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 110.412 -0.218 . . . . 10.0 110.412 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 54.0 ttm -107.44 115.46 30.2 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.968 -0.382 . . . . 10.0 109.968 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -98.83 149.75 22.58 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.413 -0.358 . . . . 10.0 110.482 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -102.83 124.35 48.18 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.699 0.285 . . . . 10.0 111.239 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 37.1 pt -116.38 0.31 8.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.368 -0.378 . . . . 10.0 110.859 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.464 ' HA3' ' NE2' ' B' ' 108' ' ' GLN . . . 168.45 -179.02 41.71 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.509 -0.853 . . . . 10.0 112.522 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.591 ' HG2' ' HG2' ' A' ' 68' ' ' MET . 37.3 tttp -64.4 117.52 7.39 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.728 0.299 . . . . 10.0 110.92 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.591 ' HG2' ' HG2' ' A' ' 67' ' ' LYS . 39.9 mmm 65.3 7.95 4.58 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.434 -0.803 . . . . 10.0 112.033 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -113.54 112.11 23.01 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.733 -0.469 . . . . 10.0 109.733 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.556 ' HB2' ' CD1' ' A' ' 87' ' ' TYR . 98.1 m-85 -125.55 157.05 38.06 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.08 -0.509 . . . . 10.0 111.342 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 86.3 t -117.78 101.0 11.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.048 -0.978 . . . . 10.0 109.344 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.9 m -89.42 98.72 11.93 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.109 -0.496 . . . . 10.0 110.987 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.1 t -86.64 117.64 31.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.066 -0.516 . . . . 10.0 110.213 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.946 HH12 ' HB2' ' A' ' 83' ' ' ASP . 27.1 ptt-85 -136.62 173.2 11.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.234 -0.439 . . . . 10.0 110.141 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -113.33 153.08 29.07 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.755 0.312 . . . . 10.0 110.351 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.563 ' HD1' ' HG3' ' A' ' 77' ' ' LYS . 1.5 t80 -161.16 119.34 2.41 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.085 -0.507 . . . . 10.0 109.842 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.563 ' HG3' ' HD1' ' A' ' 76' ' ' PHE . 30.4 mtmt 66.34 25.21 10.45 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.504 0.502 . . . . 10.0 110.264 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.41 1.89 90.52 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.706 -0.759 . . . . 10.0 111.399 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -102.12 -175.86 2.96 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.988 -0.375 . . . . 10.0 109.988 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.628 HG21 HG13 ' B' ' 123' ' ' VAL . 42.5 t -119.61 137.0 54.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.039 0.447 . . . . 10.0 111.267 -178.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 73.6 mt -121.27 100.83 7.26 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.482 -0.781 . . . . 10.0 110.301 178.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.45 ' HB ' ' HB2' ' A' ' 104' ' ' LEU . 44.8 mt -89.17 95.49 5.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.303 -0.629 . . . . 10.0 109.303 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.946 ' HB2' HH12 ' A' ' 74' ' ' ARG . 0.8 OUTLIER -79.34 109.97 14.18 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.464 0.542 . . . . 10.0 112.464 -177.748 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 35.3 mt -109.27 90.88 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.395 -0.965 . . . . 10.0 108.395 177.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 1.004 ' HG3' ' HA3' ' A' ' 101' ' ' GLY . 1.4 ttm-85 -137.35 168.07 20.36 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.969 -0.56 . . . . 10.0 111.678 -177.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -91.64 129.77 37.56 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.413 -0.958 . . . . 10.0 108.413 178.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.586 ' HB3' ' HB3' ' A' ' 95' ' ' MET . 95.8 m-85 -114.02 118.6 34.55 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.9 0.381 . . . . 10.0 110.068 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 81.6 m95 -102.43 146.23 28.39 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.896 -0.593 . . . . 10.0 110.726 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 34.2 ttm -68.35 128.63 37.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.144 -0.48 . . . . 10.0 111.474 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.407 ' HB2' ' CD ' ' A' ' 91' ' ' PRO . 34.5 p30 -97.46 171.79 5.61 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 115.61 -0.723 . . . . 10.0 110.845 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.407 ' CD ' ' HB2' ' A' ' 90' ' ' ASP . 3.2 Cg_exo -78.39 32.0 0.45 Allowed 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.927 2.418 . . . . 10.0 111.711 178.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -123.0 -44.4 2.18 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.976 -0.749 . . . . 10.0 108.976 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 126.93 18.49 2.12 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 114.871 -1.059 . . . . 10.0 110.973 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.524 ' HG2' ' H ' ' A' ' 95' ' ' MET . 16.7 tt0 -121.24 -177.68 3.58 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.806 -0.442 . . . . 10.0 109.806 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.586 ' HB3' ' HB3' ' A' ' 87' ' ' TYR . 61.0 mmm -117.57 115.16 24.56 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.791 -0.448 . . . . 10.0 109.791 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.439 ' HA ' ' HD3' ' A' ' 97' ' ' PRO . 9.3 mmpt? -95.36 139.58 22.05 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.138 -0.483 . . . . 10.0 110.572 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 96' ' ' LYS . 11.7 Cg_exo -69.36 118.8 5.9 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.941 2.427 . . . . 10.0 112.622 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -70.14 168.87 47.22 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 121.173 -0.537 . . . . 10.0 111.827 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.481 ' HD3' ' HA ' ' A' ' 99' ' ' ARG . 9.4 mmt180 -81.24 56.53 2.89 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.873 0.368 . . . . 10.0 111.8 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 13.2 ttmt -167.29 108.38 0.62 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.779 -0.646 . . . . 10.0 109.901 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 1.004 ' HA3' ' HG3' ' A' ' 85' ' ' ARG . . . 170.44 175.98 39.58 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.017 -1.087 . . . . 10.0 112.929 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.421 HG22 HG22 ' B' ' 102' ' ' ILE . 13.9 tt -155.21 157.65 4.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.313 -0.625 . . . . 10.0 109.313 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.1 p -112.24 173.92 6.13 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 121.069 -0.252 . . . . 10.0 110.861 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.45 ' HB2' ' HB ' ' A' ' 82' ' ' ILE . 37.7 mt -136.7 149.95 48.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.412 -0.358 . . . . 10.0 110.301 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 11.9 p-10 -117.95 167.37 11.4 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 109.538 -0.541 . . . . 10.0 109.538 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.417 ' HD3' ' HB ' ' A' ' 80' ' ' VAL . 80.1 Cg_exo -47.27 -45.59 21.76 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.944 2.429 . . . . 10.0 113.389 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -56.48 -50.54 71.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.089 -0.505 . . . . 10.0 111.514 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.42 ' OE1' ' HD3' ' B' ' 69' ' ' ARG . 44.5 mt-30 -71.97 -36.75 69.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.432 -0.349 . . . . 10.0 110.701 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 69.0 t-105 -56.45 -45.21 80.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.916 -0.584 . . . . 10.0 111.029 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.0 t -61.6 -51.38 68.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.334 -0.393 . . . . 10.0 110.182 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -61.55 -37.23 83.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.082 -0.508 . . . . 10.0 111.508 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 66.5 tp -61.47 -45.11 95.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.921 0.391 . . . . 10.0 110.2 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -65.08 -36.26 83.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.267 0.556 . . . . 10.0 110.172 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -74.42 -9.21 58.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.476 -0.783 . . . . 10.0 111.48 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -112.01 1.71 16.52 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.706 -0.225 . . . . 10.0 111.53 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.5 mt -55.28 -53.29 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.659 -0.246 . . . . 10.0 111.344 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.85 -39.1 80.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 10.0 111.446 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.539 ' HB3' ' CE1' ' B' ' 63' ' ' PHE . 2.0 m-20 -67.19 -51.39 54.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.131 -0.486 . . . . 10.0 111.566 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.456 HG12 ' CD2' ' B' ' 63' ' ' PHE . 62.6 mt -65.33 -45.05 94.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.351 -0.386 . . . . 10.0 111.182 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -60.32 -42.09 94.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.103 -0.499 . . . . 10.0 111.612 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -66.33 -36.87 84.02 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 120.836 0.35 . . . . 10.0 110.195 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.13 -41.95 97.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.936 -0.575 . . . . 10.0 109.974 178.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 119' ' ' ILE . 97.3 t -65.52 -41.98 92.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.784 -0.644 . . . . 10.0 109.856 178.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 27.3 mtm105 -67.12 -22.62 65.79 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.746 -0.661 . . . . 10.0 111.144 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 35.6 mttp -78.63 -30.39 46.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 10.0 110.283 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 70.8 mt . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 115.993 -0.549 . . . . 10.0 110.679 179.993 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.162 0 CA-C-O 120.91 0.385 . . . . 10.0 110.756 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 86.5 mmm -95.09 84.64 4.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.058 0.456 . . . . 10.0 110.274 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' PHE . . . . . 0.539 ' CE1' ' HB3' ' A' ' 118' ' ' ASP . 97.9 m-85 -82.22 159.46 23.23 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.757 -0.656 . . . . 10.0 110.091 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -133.6 119.01 18.89 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.942 0.401 . . . . 10.0 110.972 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' ILE . . . . . 0.416 HD11 HG21 ' B' ' 84' ' ' ILE . 3.0 pt -97.02 95.05 4.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.137 -0.69 . . . . 10.0 109.137 178.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.82 -93.06 1.78 Allowed Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 110.74 -0.944 . . . . 10.0 110.74 -178.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . 0.499 ' O ' ' HD2' ' B' ' 69' ' ' ARG . 1.3 ttpm? -165.37 151.92 10.11 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.652 -0.499 . . . . 10.0 109.652 178.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' MET . . . . . 0.479 ' HB2' ' O ' ' B' ' 67' ' ' LYS . 1.2 mpt? 74.93 -50.76 0.67 Allowed 'General case' 0 N--CA 1.473 0.69 0 O-C-N 123.856 0.722 . . . . 10.0 111.67 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' ARG . . . . . 0.624 ' HD2' ' H ' ' B' ' 69' ' ' ARG . 1.6 mpt_? -75.7 110.51 10.17 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.752 0.311 . . . . 10.0 110.365 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -110.26 131.16 55.3 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.184 -0.462 . . . . 10.0 111.086 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 22.3 t -78.65 83.54 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.698 -0.853 . . . . 10.0 108.698 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 26.1 t -87.22 92.59 9.11 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.576 -0.738 . . . . 10.0 111.731 -178.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . 0.725 HG13 HG12 ' B' ' 82' ' ' ILE . 3.8 t -86.0 73.69 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.657 -0.868 . . . . 10.0 108.657 177.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . 0.43 ' NH1' ' HB3' ' B' ' 83' ' ' ASP . 35.0 ptt-85 -102.29 144.05 31.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.484 0.659 . . . . 10.0 112.093 -177.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -82.71 126.22 32.12 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.974 -1.012 . . . . 10.0 108.939 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -118.27 100.97 7.84 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.644 0.259 . . . . 10.0 110.674 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 63.7 mttm 58.78 35.46 24.33 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.8 -0.636 . . . . 10.0 111.872 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.19 8.27 61.59 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.613 -0.803 . . . . 10.0 112.265 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . 0.403 ' HA ' ' HD3' ' B' ' 79' ' ' LYS . 42.0 mmtt -117.43 107.45 14.35 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-O 120.78 0.324 . . . . 10.0 110.681 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 21.9 t -74.42 105.26 3.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.529 -0.545 . . . . 10.0 109.529 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 98.5 mt -118.07 125.05 49.55 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.197 0.523 . . . . 10.0 111.364 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 82' ' ' ILE . . . . . 0.725 HG12 HG13 ' B' ' 73' ' ' VAL . 32.7 mt -85.87 82.84 2.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.16 -1.052 . . . . 10.0 108.16 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . 0.509 ' HA ' ' HA ' ' B' ' 103' ' ' SER . 35.1 t70 -93.65 100.71 12.9 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.395 -0.82 . . . . 10.0 111.086 -178.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . 0.416 HG21 HD11 ' B' ' 65' ' ' ILE . 36.0 mt -84.24 94.93 3.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 108.353 -0.98 . . . . 10.0 108.353 178.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 85' ' ' ARG . . . . . 0.402 ' HD3' ' O ' ' B' ' 98' ' ' GLY . 5.6 ttm-85 -106.0 151.0 25.18 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.831 -0.622 . . . . 10.0 111.686 -177.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 86' ' ' GLU . . . . . 0.533 ' HG2' ' HG3' ' B' ' 69' ' ' ARG . 55.9 mt-10 -83.56 116.07 22.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.716 -0.674 . . . . 10.0 110.24 178.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 87' ' ' TYR . . . . . 0.84 ' HB3' ' HB3' ' B' ' 95' ' ' MET . 48.7 m-85 -96.03 106.74 18.95 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.942 -0.572 . . . . 10.0 109.855 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 88' ' ' TRP . . . . . . . . . . . . . 76.8 m95 -104.52 139.42 39.44 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.898 -0.592 . . . . 10.0 110.335 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 89' ' ' MET . . . . . 0.487 ' HA ' ' O ' ' B' ' 94' ' ' GLU . 39.3 ttm -69.05 130.44 42.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.953 -0.567 . . . . 10.0 111.665 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 90' ' ' ASP . . . . . 0.455 ' HB2' ' HD2' ' B' ' 91' ' ' PRO . 49.0 p30 -90.35 173.88 5.23 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.477 -0.783 . . . . 10.0 109.724 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 91' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' B' ' 90' ' ' ASP . 37.7 Cg_exo -61.55 -20.32 68.21 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.228 1.952 . . . . 10.0 112.56 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -74.66 -44.0 52.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.281 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 124.48 20.86 2.32 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.925 -0.655 . . . . 10.0 112.165 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 94' ' ' GLU . . . . . 0.601 ' HB3' ' HE2' ' B' ' 96' ' ' LYS . 4.5 tt0 -114.77 161.9 17.57 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.182 -0.303 . . . . 10.0 110.182 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 95' ' ' MET . . . . . 0.84 ' HB3' ' HB3' ' B' ' 87' ' ' TYR . 8.2 mmt -93.31 113.96 26.28 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.824 -0.435 . . . . 10.0 109.824 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . 0.601 ' HE2' ' HB3' ' B' ' 94' ' ' GLU . 48.1 mmtt -105.97 126.05 31.62 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.042 -0.526 . . . . 10.0 111.119 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.98 118.36 5.53 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.591 2.194 . . . . 10.0 111.819 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . 0.402 ' O ' ' HD3' ' B' ' 85' ' ' ARG . . . -83.46 -157.84 25.16 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.767 -0.73 . . . . 10.0 112.712 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 99' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' B' ' 99' ' ' ARG . 52.6 mtt180 -86.17 -20.74 28.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.868 0.366 . . . . 10.0 110.448 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 100' ' ' LYS . . . . . 0.426 ' HD3' ' OE1' ' B' ' 86' ' ' GLU . 6.8 mtpm? -69.39 106.36 2.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.905 -0.588 . . . . 10.0 109.694 178.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . 161.83 157.11 8.7 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.727 -0.669 . . . . 10.0 111.464 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 102' ' ' ILE . . . . . 0.421 HG22 HG22 ' A' ' 102' ' ' ILE . 6.5 tp -133.63 134.99 56.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.946 0.403 . . . . 10.0 110.731 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 103' ' ' SER . . . . . 0.509 ' HA ' ' HA ' ' B' ' 83' ' ' ASP . 0.8 OUTLIER -97.21 108.49 21.23 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.826 -0.625 . . . . 10.0 110.481 179.817 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 80.4 mt -111.4 137.74 48.79 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.979 0.419 . . . . 10.0 110.835 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 105' ' ' ASN . . . . . 0.557 ' ND2' ' HB3' ' B' ' 107' ' ' GLU . 36.5 p-10 -85.95 168.25 20.33 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.325 -0.398 . . . . 10.0 109.932 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . 0.406 ' HD2' ' HB2' ' B' ' 105' ' ' ASN . 76.3 Cg_exo -52.63 -27.33 32.77 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.775 2.317 . . . . 10.0 112.526 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 107' ' ' GLU . . . . . 0.557 ' HB3' ' ND2' ' B' ' 105' ' ' ASN . 7.5 tt0 -66.38 -51.38 57.7 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.936 -0.574 . . . . 10.0 109.942 178.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 108' ' ' GLN . . . . . 0.464 ' NE2' ' HA3' ' A' ' 66' ' ' GLY . 0.2 OUTLIER -65.63 -33.21 75.37 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.979 -0.555 . . . . 10.0 110.355 179.53 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 109' ' ' TRP . . . . . . . . . . . . . 45.9 t-105 -57.8 -41.91 83.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.126 -0.488 . . . . 10.0 110.699 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 13.6 t -68.04 -53.31 26.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.315 -0.402 . . . . 10.0 110.736 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -59.33 -36.59 75.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.481 . . . . 10.0 111.303 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . 0.459 ' O ' HG13 ' B' ' 116' ' ' ILE . 64.2 tp -60.12 -48.0 83.55 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.162 -0.31 . . . . 10.0 110.162 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 113' ' ' LYS . . . . . 0.412 ' HB2' ' HE3' ' B' ' 113' ' ' LYS . 42.6 mtmt -62.9 -39.11 93.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.142 -0.481 . . . . 10.0 110.881 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -68.29 -30.66 69.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.938 -0.574 . . . . 10.0 111.429 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -85.39 -8.3 58.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.676 -0.238 . . . . 10.0 111.265 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 116' ' ' ILE . . . . . 0.459 HG13 ' O ' ' B' ' 112' ' ' LEU . 27.3 mt -57.22 -37.4 56.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.676 -0.238 . . . . 10.0 111.513 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.12 -29.42 67.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.945 0.402 . . . . 10.0 111.282 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -91.2 -42.81 10.22 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.168 -0.469 . . . . 10.0 110.68 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 119' ' ' ILE . . . . . 0.513 ' O ' HG23 ' B' ' 123' ' ' VAL . 82.8 mt -64.05 -47.14 91.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.893 -0.594 . . . . 10.0 111.206 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . 0.411 ' O ' ' HG2' ' B' ' 124' ' ' ARG . 23.9 t70 -60.01 -38.96 84.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.565 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -63.85 -42.66 97.53 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.641 -0.709 . . . . 10.0 110.249 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.63 -33.96 77.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.971 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . 0.628 HG13 HG21 ' A' ' 80' ' ' VAL . 71.3 t -60.4 -35.22 61.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-O 121.362 0.601 . . . . 10.0 110.708 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 124' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' B' ' 120' ' ' ASP . 7.3 ptt85 -102.99 21.22 16.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.803 -0.635 . . . . 10.0 110.613 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 17.4 ttmt . . . . . 0 C--N 1.325 -0.498 0 CA-C-O 121.412 0.625 . . . . 10.0 109.821 179.941 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 109.933 -0.395 . . . . 10.0 109.933 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 49.1 ttm -126.55 105.54 8.81 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.917 0.389 . . . . 10.0 110.618 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -96.37 126.47 41.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.004 -0.544 . . . . 10.0 110.407 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.443 ' HG2' ' H ' ' A' ' 66' ' ' GLY . 23.4 tt0 -85.74 131.48 34.32 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.009 -0.367 . . . . 10.0 110.009 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 26.9 pt -119.62 11.68 6.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.147 0.498 . . . . 10.0 110.807 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.783 ' HA3' ' HG2' ' B' ' 108' ' ' GLN . . . 161.39 174.71 31.6 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.401 -0.68 . . . . 10.0 111.401 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.56 ' HG2' ' HG2' ' A' ' 68' ' ' MET . 52.4 tttp -61.85 120.32 10.51 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.058 0.456 . . . . 10.0 110.873 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.56 ' HG2' ' HG2' ' A' ' 67' ' ' LYS . 36.1 mmm 66.19 12.7 8.72 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.079 -0.964 . . . . 10.0 111.964 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.787 ' HE ' ' HB3' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -114.81 113.0 23.66 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.718 -0.475 . . . . 10.0 109.718 179.128 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -126.73 134.27 50.69 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.116 0.484 . . . . 10.0 111.71 -177.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 38.7 t -93.82 105.16 16.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 108.912 -0.773 . . . . 10.0 108.912 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.404 ' HB2' ' HB3' ' A' ' 83' ' ' ASP . 1.2 m -80.8 82.99 6.65 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.502 -0.772 . . . . 10.0 111.3 -178.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.472 HG22 HG23 ' A' ' 82' ' ' ILE . 10.8 t -83.41 93.55 3.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.912 -0.773 . . . . 10.0 108.912 178.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -133.92 -175.37 3.82 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.816 -0.629 . . . . 10.0 111.029 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.429 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 7.3 t0 -117.07 142.45 46.96 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.873 -0.603 . . . . 10.0 110.033 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.457 ' HD1' ' HA ' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -145.38 96.53 2.85 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.018 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.8 mttp 68.48 29.15 5.77 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.016 -0.538 . . . . 10.0 111.057 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 84.37 54.15 3.06 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.545 -0.836 . . . . 10.0 111.834 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 18.8 mttp -146.41 130.52 17.39 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.783 -0.209 . . . . 10.0 110.472 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.3 t -80.2 84.69 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.54 -0.911 . . . . 10.0 108.54 178.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 30.5 mt -83.7 104.84 14.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.892 -0.595 . . . . 10.0 112.126 -178.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.472 HG23 HG22 ' A' ' 73' ' ' VAL . 16.6 mt -97.25 64.07 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 106.704 -1.591 . . . . 10.0 106.704 176.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.886 ' HA ' ' HA ' ' A' ' 103' ' ' SER . 19.9 t70 -68.41 101.68 1.28 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.735 -1.12 . . . . 10.0 113.375 -176.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 63.0 mt -84.21 108.0 16.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 107.383 -1.34 . . . . 10.0 107.383 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.818 ' HD2' ' HB2' ' A' ' 97' ' ' PRO . 12.3 ttm180 -143.69 170.47 15.8 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.599 0.714 . . . . 10.0 112.335 -177.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.787 ' HB3' ' HE ' ' A' ' 69' ' ' ARG . 6.9 pt-20 -99.95 140.77 33.7 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.282 -0.872 . . . . 10.0 108.911 177.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -122.23 121.76 37.58 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.912 0.387 . . . . 10.0 110.462 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -114.49 153.57 29.76 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.763 -0.653 . . . . 10.0 109.943 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 2.3 ttm -83.02 122.14 27.93 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.836 -0.431 . . . . 10.0 109.836 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.47 170.76 13.66 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.824 -0.626 . . . . 10.0 110.726 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -54.19 -29.78 58.17 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 123.053 2.502 . . . . 10.0 113.458 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -73.75 -45.2 53.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.965 0.412 . . . . 10.0 110.608 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 124.51 30.18 1.01 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.63 -0.795 . . . . 10.0 112.0 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -116.33 167.76 10.74 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.78 0.324 . . . . 10.0 110.32 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 92.3 mmm -89.42 98.25 11.66 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.251 -0.648 . . . . 10.0 109.251 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -98.23 124.54 46.77 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.447 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.818 ' HB2' ' HD2' ' A' ' 85' ' ' ARG . 80.1 Cg_endo -78.02 146.86 23.34 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.727 2.284 . . . . 10.0 112.891 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.54 ' O ' ' HD3' ' A' ' 85' ' ' ARG . . . -85.08 -174.1 50.13 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.725 -0.75 . . . . 10.0 112.332 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -76.06 -26.92 56.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.98 0.419 . . . . 10.0 110.758 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -76.38 81.38 3.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.863 -0.608 . . . . 10.0 110.609 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.438 ' HA3' ' NE ' ' A' ' 85' ' ' ARG . . . -146.62 129.48 3.33 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.959 -0.564 . . . . 10.0 111.766 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 8.5 tt -127.29 113.86 33.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.201 0.524 . . . . 10.0 110.702 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.886 ' HA ' ' HA ' ' A' ' 83' ' ' ASP . 2.3 m -79.27 99.9 7.28 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.089 -0.505 . . . . 10.0 110.679 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.47 ' HB2' ' HB ' ' A' ' 82' ' ' ILE . 34.7 mt -76.53 171.66 14.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.153 0.501 . . . . 10.0 110.442 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -133.03 158.32 76.13 Favored Pre-proline 0 C--N 1.316 -0.87 0 N-CA-C 108.835 -0.802 . . . . 10.0 108.835 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -41.39 -45.3 5.91 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.825 3.017 . . . . 10.0 113.891 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -64.38 -49.69 70.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.709 0.29 . . . . 10.0 110.833 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.571 ' NE2' ' HD3' ' B' ' 69' ' ' ARG . 72.3 mt-30 -63.56 -40.74 97.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.266 -0.424 . . . . 10.0 110.586 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -59.47 -44.79 92.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.924 -0.58 . . . . 10.0 110.294 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.482 ' HA ' ' CE ' ' A' ' 113' ' ' LYS . 56.8 m -64.4 -41.02 96.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.226 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.47 ' O ' ' HG2' ' A' ' 115' ' ' GLN . 46.5 mt-30 -63.98 -42.02 97.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.254 -0.43 . . . . 10.0 110.395 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 22.9 tp -59.36 -40.99 88.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.992 -0.549 . . . . 10.0 110.543 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.482 ' CE ' ' HA ' ' A' ' 110' ' ' SER . 53.3 mtmt -63.95 -33.49 75.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.856 -0.611 . . . . 10.0 111.121 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -76.82 -15.4 59.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.324 -0.398 . . . . 10.0 111.115 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.47 ' HG2' ' O ' ' A' ' 111' ' ' GLN . 14.2 mm-40 -99.55 -5.18 29.61 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.547 -0.297 . . . . 10.0 110.879 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.467 HG12 ' HH2' ' B' ' 109' ' ' TRP . 56.7 mt -56.56 -39.73 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.396 -0.365 . . . . 10.0 111.489 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.14 -30.21 69.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.109 -0.496 . . . . 10.0 111.099 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.425 ' HB3' ' CE1' ' B' ' 63' ' ' PHE . 2.6 m-20 -90.04 -39.93 12.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.756 -0.656 . . . . 10.0 110.571 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.48 ' O ' HG23 ' A' ' 123' ' ' VAL . 92.8 mt -62.21 -51.22 75.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.323 -0.399 . . . . 10.0 110.628 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -62.05 -28.7 69.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.243 0.544 . . . . 10.0 110.329 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -63.64 -49.78 71.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.422 -0.808 . . . . 10.0 110.064 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.47 -34.18 77.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.778 -0.647 . . . . 10.0 110.969 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.66 ' HA ' HG11 ' B' ' 80' ' ' VAL . 72.5 t -61.44 -42.65 94.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.964 0.412 . . . . 10.0 110.678 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 24.1 mtm180 -75.03 -24.25 58.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.018 -0.537 . . . . 10.0 111.143 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -74.78 -46.34 37.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.021 0.439 . . . . 10.0 110.81 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 17.6 mt . . . . . 0 C--N 1.326 -0.452 0 CA-C-N 116.008 -0.542 . . . . 10.0 111.14 -179.724 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.163 0 CA-C-O 121.171 0.51 . . . . 10.0 110.471 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 86.5 mmm -109.14 111.01 22.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.7 -0.682 . . . . 10.0 109.914 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' PHE . . . . . 0.425 ' CE1' ' HB3' ' A' ' 118' ' ' ASP . 15.6 m-85 -107.87 157.65 17.99 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.268 -0.424 . . . . 10.0 110.462 -179.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -117.38 135.07 54.13 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.486 -0.325 . . . . 10.0 110.284 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 21.2 pt -126.84 29.13 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.176 -0.465 . . . . 10.0 111.113 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 149.97 -172.1 29.89 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.929 -0.653 . . . . 10.0 111.616 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . 0.479 ' O ' ' HB2' ' B' ' 68' ' ' MET . 43.3 mtmt -69.24 105.87 2.67 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.555 0.178 . . . . 10.0 110.735 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' MET . . . . . 0.479 ' HB2' ' O ' ' B' ' 67' ' ' LYS . 0.3 OUTLIER 76.01 -12.8 0.96 Allowed 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.71 0.633 . . . . 10.0 112.71 178.705 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' ARG . . . . . 0.571 ' HD3' ' NE2' ' A' ' 108' ' ' GLN . 0.7 OUTLIER -79.75 113.87 18.24 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.861 -0.422 . . . . 10.0 109.861 179.276 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -119.88 161.79 20.24 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.439 0.638 . . . . 10.0 112.15 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 95.2 t -119.84 114.5 44.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.0 -1.0 . . . . 10.0 108.361 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 4.9 t -104.04 106.59 17.15 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.0 0.428 . . . . 10.0 111.571 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . 0.445 HG22 HG23 ' B' ' 82' ' ' ILE . 31.2 t -104.9 110.01 29.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.972 -0.751 . . . . 10.0 108.972 178.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 7.0 ptt-85 -151.73 163.02 40.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.941 0.4 . . . . 10.0 111.686 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -82.64 113.38 20.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.823 -0.626 . . . . 10.0 109.984 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -105.24 84.25 2.08 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.364 -0.38 . . . . 10.0 110.787 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 59.0 mttm 62.41 43.6 7.91 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.69 -0.686 . . . . 10.0 111.477 178.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 86.87 35.52 9.93 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.528 -0.844 . . . . 10.0 112.429 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 19.1 mmtm -150.84 115.71 5.26 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 122.196 0.198 . . . . 10.0 110.557 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . 0.66 HG11 ' HA ' ' A' ' 123' ' ' VAL . 28.4 t -75.82 90.21 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.692 -0.855 . . . . 10.0 108.692 178.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 45.6 mt -95.21 130.99 41.74 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.358 0.599 . . . . 10.0 111.98 -178.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 82' ' ' ILE . . . . . 0.445 HG23 HG22 ' B' ' 73' ' ' VAL . 3.1 mp -103.13 91.06 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 107.799 -1.185 . . . . 10.0 107.799 178.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . 0.532 ' HA ' ' HA ' ' B' ' 103' ' ' SER . 34.1 t70 -89.85 104.46 17.02 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.588 -0.733 . . . . 10.0 111.69 -178.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 54.3 mt -87.28 97.56 6.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 107.501 -1.296 . . . . 10.0 107.501 177.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 85' ' ' ARG . . . . . 0.556 ' HD3' ' O ' ' B' ' 98' ' ' GLY . 12.6 ttm180 -132.0 150.28 52.2 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.886 -0.597 . . . . 10.0 112.127 -176.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -83.55 128.49 34.56 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.85 -0.796 . . . . 10.0 108.85 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 87' ' ' TYR . . . . . 0.565 ' HB3' ' HB3' ' B' ' 95' ' ' MET . 4.8 m-85 -103.01 122.14 44.01 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.971 0.415 . . . . 10.0 110.546 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 88' ' ' TRP . . . . . . . . . . . . . 22.4 m0 -99.92 136.88 39.16 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.859 -0.609 . . . . 10.0 109.851 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 44.2 ttm -73.33 141.02 47.11 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.109 0.481 . . . . 10.0 110.864 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 90' ' ' ASP . . . . . 0.421 ' OD2' ' HB2' ' B' ' 92' ' ' GLU . 0.0 OUTLIER -103.37 165.45 13.53 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 115.605 -0.725 . . . . 10.0 110.238 179.776 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -55.09 -29.71 66.89 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.113 2.542 . . . . 10.0 113.815 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . 0.421 ' HB2' ' OD2' ' B' ' 90' ' ' ASP . 0.5 OUTLIER -70.75 -35.24 72.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.966 0.412 . . . . 10.0 110.384 179.585 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 119.52 20.26 3.95 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.639 -0.791 . . . . 10.0 112.966 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 94' ' ' GLU . . . . . 0.764 ' HB2' ' HE2' ' B' ' 96' ' ' LYS . 3.3 mt-10 -111.56 160.68 16.96 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.88 0.34 . . . . 10.0 110.366 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 95' ' ' MET . . . . . 0.565 ' HB3' ' HB3' ' B' ' 87' ' ' TYR . 84.6 mmm -98.11 111.2 23.6 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.73 -0.47 . . . . 10.0 109.73 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . 0.764 ' HE2' ' HB2' ' B' ' 94' ' ' GLU . 49.8 mmtt -100.66 135.98 19.99 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.231 -0.44 . . . . 10.0 111.01 -178.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -63.0 118.88 5.77 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.394 2.063 . . . . 10.0 111.845 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . 0.556 ' O ' ' HD3' ' B' ' 85' ' ' ARG . . . -68.57 167.95 43.67 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.741 -0.743 . . . . 10.0 112.039 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 5.4 mtm180 -82.26 47.97 1.21 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.192 0.52 . . . . 10.0 110.98 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -161.78 104.87 1.21 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.689 -0.687 . . . . 10.0 110.418 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -173.93 161.13 31.37 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 110.805 -0.918 . . . . 10.0 110.805 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 7.5 tp -119.8 122.46 68.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.298 0.57 . . . . 10.0 111.244 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 103' ' ' SER . . . . . 0.532 ' HA ' ' HA ' ' B' ' 83' ' ' ASP . 0.8 OUTLIER -94.37 104.84 16.81 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.825 -0.625 . . . . 10.0 110.254 179.854 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 83.9 mt -98.27 163.62 12.64 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.231 -0.441 . . . . 10.0 110.628 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 105' ' ' ASN . . . . . 0.447 ' HB2' ' HD2' ' B' ' 106' ' ' PRO . 45.4 p30 -115.83 169.95 6.32 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 108.652 -0.87 . . . . 10.0 108.652 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . 0.53 ' HD3' ' O ' ' B' ' 80' ' ' VAL . 53.1 Cg_exo -53.61 -30.38 54.94 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.283 1.988 . . . . 10.0 112.445 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -65.02 -56.53 12.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.601 -0.727 . . . . 10.0 110.799 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 108' ' ' GLN . . . . . 0.783 ' HG2' ' HA3' ' A' ' 66' ' ' GLY . 19.9 mt-30 -72.49 -27.52 62.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.258 -0.428 . . . . 10.0 110.409 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 109' ' ' TRP . . . . . 0.467 ' HH2' HG12 ' A' ' 116' ' ' ILE . 34.9 t-105 -65.92 -36.78 84.33 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.962 -0.755 . . . . 10.0 108.962 177.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 110' ' ' SER . . . . . 0.497 ' O ' ' HG3' ' B' ' 114' ' ' GLU . 29.2 t -64.35 -51.16 64.75 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.322 -0.854 . . . . 10.0 109.437 178.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -62.22 -36.1 80.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.757 -0.656 . . . . 10.0 111.076 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . 0.471 ' O ' HG13 ' B' ' 116' ' ' ILE . 52.7 tp -59.25 -44.24 92.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.92 0.39 . . . . 10.0 110.069 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -66.38 -30.54 70.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.926 -0.579 . . . . 10.0 110.751 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . 0.497 ' HG3' ' O ' ' B' ' 110' ' ' SER . 43.3 mt-10 -79.75 -25.8 40.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.19 -0.459 . . . . 10.0 111.01 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -84.03 -10.44 57.87 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.337 -0.392 . . . . 10.0 111.217 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 116' ' ' ILE . . . . . 0.499 ' O ' ' HB2' ' B' ' 120' ' ' ASP . 73.0 mt -56.53 -43.29 77.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.375 -0.375 . . . . 10.0 111.787 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.23 -28.75 68.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.871 0.367 . . . . 10.0 111.695 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.79 -43.09 12.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.304 -0.407 . . . . 10.0 110.99 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 78.5 mt -67.26 -46.1 84.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.14 -0.482 . . . . 10.0 110.773 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . 0.499 ' HB2' ' O ' ' B' ' 116' ' ' ILE . 0.3 OUTLIER -55.88 -43.84 77.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.019 -0.537 . . . . 10.0 110.828 -179.916 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 121' ' ' ASP . . . . . 0.446 ' HA ' ' NE ' ' B' ' 124' ' ' ARG . 29.2 t70 -61.32 -37.52 83.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.525 -0.761 . . . . 10.0 111.242 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.49 -41.64 54.87 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.354 -0.385 . . . . 10.0 111.15 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 77.1 t -62.9 -42.5 96.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.197 -0.456 . . . . 10.0 111.441 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 124' ' ' ARG . . . . . 0.446 ' NE ' ' HA ' ' B' ' 121' ' ' ASP . 20.1 ptt180 -73.41 -6.77 48.37 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.801 0.297 . . . . 10.0 111.801 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 63.7 mttt . . . . . 0 C--N 1.327 -0.371 0 CA-C-O 121.025 0.441 . . . . 10.0 110.734 179.493 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 110.282 -0.266 . . . . 10.0 110.282 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.657 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -111.88 122.73 48.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.805 0.336 . . . . 10.0 111.162 -179.53 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -117.95 144.13 45.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.106 -0.497 . . . . 10.0 110.122 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -84.2 125.25 32.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.928 0.394 . . . . 10.0 110.76 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.3 pt -115.88 16.36 7.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.198 -0.456 . . . . 10.0 110.478 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 154.75 176.24 26.77 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.594 -0.602 . . . . 10.0 111.594 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.829 ' HG2' ' HG2' ' A' ' 68' ' ' MET . 51.8 tttp -65.61 120.17 12.45 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.688 0.28 . . . . 10.0 110.731 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.829 ' HG2' ' HG2' ' A' ' 67' ' ' LYS . 59.7 mmm 66.18 24.67 10.77 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.54 -0.755 . . . . 10.0 112.05 178.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -132.18 119.81 21.39 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.201 -0.296 . . . . 10.0 110.201 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.414 ' HB2' ' CD1' ' A' ' 87' ' ' TYR . 26.9 m-85 -128.3 135.23 49.33 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.054 0.454 . . . . 10.0 111.751 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.657 ' O ' ' HA ' ' A' ' 62' ' ' MET . 41.4 t -90.05 107.33 18.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 108.696 -0.853 . . . . 10.0 108.696 178.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.566 ' HB2' ' HB3' ' A' ' 83' ' ' ASP . 3.8 m -94.9 90.35 5.97 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.943 0.401 . . . . 10.0 111.799 -178.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 45.5 t -78.11 111.08 14.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.886 -0.783 . . . . 10.0 108.886 178.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.1 ptt180 -138.08 -167.01 2.08 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.106 -0.497 . . . . 10.0 110.596 -178.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -126.76 139.62 52.99 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.257 -0.428 . . . . 10.0 110.127 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.465 ' HD2' ' HE3' ' A' ' 77' ' ' LYS . 2.3 t80 -148.03 112.85 5.42 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.226 -0.443 . . . . 10.0 110.125 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.465 ' HE3' ' HD2' ' A' ' 76' ' ' PHE . 6.8 mtmp? 68.42 15.11 9.22 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.755 -0.657 . . . . 10.0 111.234 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 100.21 0.39 55.9 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.278 -0.963 . . . . 10.0 112.485 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.3 mtpt -109.38 132.51 54.06 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.214 -0.291 . . . . 10.0 110.214 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.498 ' O ' ' HD3' ' A' ' 106' ' ' PRO . 43.8 t -70.74 107.32 2.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.204 -0.665 . . . . 10.0 109.204 178.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.454 ' HA ' HD23 ' A' ' 81' ' ' LEU . 6.7 mt -97.21 113.54 25.15 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.235 0.54 . . . . 10.0 112.376 -178.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.41 HD11 HG21 ' B' ' 123' ' ' VAL . 70.4 mt -89.1 89.38 3.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 107.322 -1.362 . . . . 10.0 107.322 177.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.566 ' HB3' ' HB2' ' A' ' 72' ' ' SER . 3.5 t70 -79.2 101.9 8.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.499 -0.773 . . . . 10.0 112.655 -177.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.5 mt -94.34 81.25 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.537 -0.912 . . . . 10.0 108.537 178.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.761 ' HG3' ' HA3' ' A' ' 101' ' ' GLY . 4.9 ttm180 -117.07 155.19 29.68 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.675 -0.693 . . . . 10.0 110.961 -178.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.464 ' O ' ' HA ' ' A' ' 97' ' ' PRO . 61.5 mt-10 -72.0 139.22 48.49 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.518 -0.549 . . . . 10.0 109.518 178.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.696 ' HD2' ' HB3' ' A' ' 95' ' ' MET . 5.4 m-85 -118.29 111.58 18.95 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.956 0.408 . . . . 10.0 110.229 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -103.02 145.65 29.56 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.761 -0.654 . . . . 10.0 109.897 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 40.8 ttm -87.62 137.74 32.08 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.112 -0.329 . . . . 10.0 110.112 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.493 ' HB2' ' CD ' ' A' ' 91' ' ' PRO . 53.0 p-10 -99.35 177.57 1.53 Allowed Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.071 -0.513 . . . . 10.0 110.275 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.493 ' CD ' ' HB2' ' A' ' 90' ' ' ASP . 28.0 Cg_exo -63.95 -12.46 32.15 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.513 2.142 . . . . 10.0 113.018 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -88.16 -16.76 32.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.291 0.567 . . . . 10.0 110.073 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.11 14.75 55.65 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.637 -0.71 . . . . 10.0 111.745 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.437 ' HB2' ' HD3' ' A' ' 96' ' ' LYS . 6.0 mm-40 -94.51 157.73 15.86 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.052 0.453 . . . . 10.0 110.751 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.696 ' HB3' ' HD2' ' A' ' 87' ' ' TYR . 87.1 mmm -92.64 108.71 20.19 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.181 -0.674 . . . . 10.0 109.181 178.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.437 ' HD3' ' HB2' ' A' ' 94' ' ' GLU . 2.2 mmmm -108.62 128.91 24.68 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 116.154 -0.475 . . . . 10.0 111.099 -178.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 58.2 Cg_endo -72.06 139.14 32.21 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.348 2.032 . . . . 10.0 112.283 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -84.16 -169.36 45.31 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.433 -0.667 . . . . 10.0 111.433 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.479 ' HA ' ' HD2' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -91.03 -7.72 51.09 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 117.3 0.55 . . . . 10.0 110.969 -179.856 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 21.2 ttmt -100.25 113.9 26.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.173 -0.467 . . . . 10.0 110.108 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.761 ' HA3' ' HG3' ' A' ' 85' ' ' ARG . . . -175.7 168.66 41.11 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.85 -0.691 . . . . 10.0 111.8 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.695 ' HB ' ' HA2' ' B' ' 101' ' ' GLY . 17.2 tt -139.58 121.53 16.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.332 0.587 . . . . 10.0 111.006 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 83' ' ' ASP . 0.9 OUTLIER -97.77 113.0 24.68 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.952 -0.567 . . . . 10.0 109.704 179.519 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.51 ' HB3' ' HB2' ' A' ' 108' ' ' GLN . 25.2 mt -111.68 133.64 53.79 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.011 -0.54 . . . . 10.0 110.379 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.73 ' HB2' ' HD2' ' A' ' 106' ' ' PRO . 14.5 p30 -91.55 172.82 6.03 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 109.32 -0.622 . . . . 10.0 109.32 178.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.73 ' HD2' ' HB2' ' A' ' 105' ' ' ASN . 70.6 Cg_exo -42.77 -37.91 6.22 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 123.505 2.803 . . . . 10.0 114.282 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.418 ' HB3' ' NE2' ' A' ' 108' ' ' GLN . 19.0 tt0 -57.03 -49.56 75.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.645 0.26 . . . . 10.0 111.02 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.51 ' HB2' ' HB3' ' A' ' 104' ' ' LEU . 1.0 OUTLIER -74.4 -33.54 63.04 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 110.032 -0.358 . . . . 10.0 110.032 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.497 ' CH2' HG12 ' B' ' 116' ' ' ILE . 69.1 t-105 -57.91 -53.66 55.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.878 -0.601 . . . . 10.0 110.911 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.7 m -61.95 -42.52 99.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.296 -0.411 . . . . 10.0 110.748 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -64.35 -41.47 96.73 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.306 -0.406 . . . . 10.0 110.731 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.565 ' O ' HG13 ' A' ' 116' ' ' ILE . 61.2 tp -61.91 -43.89 97.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 10.0 110.615 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.58 ' HA ' HD12 ' A' ' 116' ' ' ILE . 43.5 mtmt -61.71 -27.83 68.98 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.925 0.393 . . . . 10.0 110.735 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -77.15 -38.19 52.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.096 0.475 . . . . 10.0 110.312 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.444 ' O ' HG13 ' A' ' 119' ' ' ILE . 20.5 mm-40 -76.42 -18.88 58.6 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.74 -0.664 . . . . 10.0 111.541 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.58 HD12 ' HA ' ' A' ' 113' ' ' LYS . 44.4 mt -51.62 -39.61 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 112.072 0.397 . . . . 10.0 112.072 -179.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 18.1 m -65.31 -17.52 64.58 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.968 0.359 . . . . 10.0 111.968 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.08 -34.29 8.47 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.745 -0.465 . . . . 10.0 109.745 178.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.573 HG23 HG21 ' B' ' 73' ' ' VAL . 83.0 mt -64.68 -48.72 83.53 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-N 115.827 -0.624 . . . . 10.0 109.966 178.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.42 ' O ' ' HG3' ' A' ' 124' ' ' ARG . 16.6 t70 -58.31 -38.47 77.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.448 -0.796 . . . . 10.0 110.326 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -65.87 -41.58 91.44 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.217 -0.902 . . . . 10.0 110.561 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.23 -37.95 89.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.87 -0.605 . . . . 10.0 110.874 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 119' ' ' ILE . 95.6 t -62.41 -40.66 88.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 10.0 110.35 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 120' ' ' ASP . 12.1 mtt85 -68.92 -30.43 68.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.831 -0.622 . . . . 10.0 110.872 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 16.9 mttp -71.21 -25.52 62.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.089 0.471 . . . . 10.0 110.762 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 62.3 mt . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 116.064 -0.516 . . . . 10.0 110.522 179.783 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.264 0 CA-C-O 121.143 0.497 . . . . 10.0 110.566 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 88.0 mmm -119.12 99.29 6.63 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.562 -0.745 . . . . 10.0 110.088 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -101.54 139.22 37.49 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.922 -0.581 . . . . 10.0 110.33 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -93.52 139.62 30.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.049 0.452 . . . . 10.0 111.708 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' ILE . . . . . 0.435 ' O ' ' HB3' ' B' ' 69' ' ' ARG . 5.8 pt -138.0 94.33 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.507 -0.769 . . . . 10.0 109.529 178.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.64 -135.98 12.45 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.669 -0.777 . . . . 10.0 111.387 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -117.63 120.96 39.63 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.369 -0.234 . . . . 10.0 110.369 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' MET . . . . . . . . . . . . . 96.4 mmm 65.26 2.11 1.8 Allowed 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.817 0.673 . . . . 10.0 112.817 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' ARG . . . . . 0.453 ' HD2' HD11 ' A' ' 102' ' ' ILE . 2.3 tpp180 -98.95 126.36 44.62 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.819 -0.438 . . . . 10.0 109.819 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -130.66 142.67 50.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.514 0.673 . . . . 10.0 112.3 -178.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.418 HG13 HG12 ' B' ' 84' ' ' ILE . 62.1 t -93.41 110.44 23.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.586 -0.894 . . . . 10.0 108.586 178.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 13.3 t -100.4 103.29 14.66 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.14 0.495 . . . . 10.0 111.919 -178.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . 0.573 HG21 HG23 ' A' ' 119' ' ' ILE . 19.3 t -96.2 98.33 7.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 108.943 -0.762 . . . . 10.0 108.943 178.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . 0.458 ' NH1' ' HB3' ' B' ' 83' ' ' ASP . 19.6 ptt-85 -131.51 155.07 48.06 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.221 0.534 . . . . 10.0 111.966 -178.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -95.79 113.43 25.07 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.288 -0.869 . . . . 10.0 109.871 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -92.77 78.6 4.78 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.379 -0.373 . . . . 10.0 110.526 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 90.1 mttt 56.53 57.53 4.79 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.743 -0.662 . . . . 10.0 111.092 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.27 29.56 33.21 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.636 -0.792 . . . . 10.0 112.02 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -142.21 88.97 2.13 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.744 0.307 . . . . 10.0 110.252 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 12.0 t -70.01 102.31 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.408 -0.589 . . . . 10.0 109.408 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 37.0 mt -117.98 132.34 56.4 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.014 0.435 . . . . 10.0 111.366 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 82' ' ' ILE . . . . . 0.525 HD13 ' HB2' ' B' ' 109' ' ' TRP . 4.1 mp -91.65 86.9 2.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 108.138 -1.06 . . . . 10.0 108.138 178.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . 0.596 ' HA ' ' HA ' ' B' ' 103' ' ' SER . 37.4 t70 -89.78 95.89 10.44 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.315 -0.857 . . . . 10.0 110.937 -178.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . 0.418 HG12 HG13 ' B' ' 71' ' ' VAL . 21.7 mt -78.67 116.41 22.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 108.217 -1.031 . . . . 10.0 108.217 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 20.3 ttm-85 -142.38 151.42 41.85 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.296 0.57 . . . . 10.0 112.163 -177.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 86' ' ' GLU . . . . . 0.49 ' HG3' ' HA3' ' B' ' 98' ' ' GLY . 5.0 pt-20 -89.8 162.88 15.29 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.669 -0.696 . . . . 10.0 109.373 178.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 87' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -111.79 129.81 56.01 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.056 0.455 . . . . 10.0 111.251 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 88' ' ' TRP . . . . . . . . . . . . . 24.3 m95 -117.03 145.89 43.41 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.394 -0.965 . . . . 10.0 108.394 178.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 30.1 ttm -108.65 137.71 46.15 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.549 -0.461 . . . . 10.0 110.469 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 90' ' ' ASP . . . . . 0.438 ' HB2' ' CD ' ' B' ' 91' ' ' PRO . 55.1 p30 -93.83 171.78 6.62 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.165 -0.471 . . . . 10.0 110.644 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 91' ' ' PRO . . . . . 0.438 ' CD ' ' HB2' ' B' ' 90' ' ' ASP . 24.7 Cg_exo -64.65 -13.3 38.21 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.619 2.213 . . . . 10.0 113.098 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -82.71 -41.64 19.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.893 0.378 . . . . 10.0 110.048 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 119.87 27.84 2.01 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 121.085 -0.579 . . . . 10.0 111.886 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 94' ' ' GLU . . . . . 0.712 ' HB3' ' HE2' ' B' ' 96' ' ' LYS . 0.0 OUTLIER -110.24 151.39 27.4 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.965 0.412 . . . . 10.0 110.341 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 95' ' ' MET . . . . . . . . . . . . . 82.4 mmm -90.01 112.05 23.34 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.854 -0.612 . . . . 10.0 109.99 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . 0.712 ' HE2' ' HB3' ' B' ' 94' ' ' GLU . 61.2 mmtt -111.17 140.5 22.92 Favored Pre-proline 0 C--N 1.318 -0.786 0 CA-C-N 116.444 -0.344 . . . . 10.0 110.522 -179.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -63.22 131.38 32.05 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 122.607 2.205 . . . . 10.0 111.843 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . 0.49 ' HA3' ' HG3' ' B' ' 86' ' ' GLU . . . -68.69 160.88 51.63 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 121.151 -0.547 . . . . 10.0 112.835 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -71.83 -23.5 61.55 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.878 0.371 . . . . 10.0 110.877 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -88.45 142.84 27.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.195 -0.457 . . . . 10.0 110.378 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 101' ' ' GLY . . . . . 0.695 ' HA2' ' HB ' ' A' ' 102' ' ' ILE . . . 138.98 163.47 9.52 Favored Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 111.503 -0.639 . . . . 10.0 111.503 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 20.0 tt -145.39 142.99 22.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.888 0.375 . . . . 10.0 110.97 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 103' ' ' SER . . . . . 0.596 ' HA ' ' HA ' ' B' ' 83' ' ' ASP . 0.8 OUTLIER -97.11 110.87 23.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.911 -0.586 . . . . 10.0 110.194 179.509 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 104' ' ' LEU . . . . . 0.414 HD22 ' HB3' ' B' ' 108' ' ' GLN . 94.8 mt -95.49 133.98 38.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.779 0.323 . . . . 10.0 110.914 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -88.54 168.85 14.91 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.471 -0.566 . . . . 10.0 109.471 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -45.69 -37.78 16.27 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.995 2.463 . . . . 10.0 113.836 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -68.14 -52.98 28.52 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.972 0.415 . . . . 10.0 110.314 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 108' ' ' GLN . . . . . 0.414 ' HB3' HD22 ' B' ' 104' ' ' LEU . 11.4 mt-30 -62.58 -34.69 77.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.738 -0.664 . . . . 10.0 110.854 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 109' ' ' TRP . . . . . 0.525 ' HB2' HD13 ' B' ' 82' ' ' ILE . 34.7 t-105 -59.4 -43.74 92.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.114 -0.493 . . . . 10.0 110.143 178.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 110' ' ' SER . . . . . 0.447 ' HA ' ' HE3' ' B' ' 113' ' ' LYS . 19.3 t -67.97 -46.93 69.98 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.974 -0.557 . . . . 10.0 110.012 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 111' ' ' GLN . . . . . 0.536 ' O ' ' HG2' ' B' ' 115' ' ' GLN . 21.7 mm-40 -58.22 -41.71 84.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.949 -0.569 . . . . 10.0 110.841 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . 0.504 ' O ' HG13 ' B' ' 116' ' ' ILE . 43.2 tp -57.79 -46.93 83.92 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.926 0.393 . . . . 10.0 110.09 178.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 113' ' ' LYS . . . . . 0.447 ' HE3' ' HA ' ' B' ' 110' ' ' SER . 48.6 mtmt -65.13 -33.91 77.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.902 -0.59 . . . . 10.0 110.882 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -74.4 -38.43 63.1 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.859 -0.61 . . . . 10.0 112.026 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 115' ' ' GLN . . . . . 0.536 ' HG2' ' O ' ' B' ' 111' ' ' GLN . 10.5 mm-40 -79.06 -5.37 53.84 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.8 0.296 . . . . 10.0 111.8 -179.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 116' ' ' ILE . . . . . 0.504 HG13 ' O ' ' B' ' 112' ' ' LEU . 25.7 mt -53.32 -41.26 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.784 -0.189 . . . . 10.0 111.396 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 117' ' ' SER . . . . . 0.431 ' O ' ' HB2' ' B' ' 121' ' ' ASP . 0.2 OUTLIER -57.26 -37.42 72.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.289 -0.414 . . . . 10.0 111.889 -179.372 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.09 -45.29 16.7 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.864 0.364 . . . . 10.0 110.918 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 119' ' ' ILE . . . . . 0.475 ' O ' HG23 ' B' ' 123' ' ' VAL . 71.1 mt -59.82 -52.48 60.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.839 -0.619 . . . . 10.0 110.988 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -61.08 -39.06 88.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.925 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 121' ' ' ASP . . . . . 0.431 ' HB2' ' O ' ' B' ' 117' ' ' SER . 10.6 t70 -58.54 -38.84 78.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.958 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -78.47 -38.55 40.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.268 -0.423 . . . . 10.0 111.054 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . 0.475 HG23 ' O ' ' B' ' 119' ' ' ILE . 89.1 t -66.93 -35.45 74.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.34 -0.391 . . . . 10.0 111.466 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 124' ' ' ARG . . . . . 0.462 ' HG3' ' HG3' ' B' ' 125' ' ' LYS . 15.5 ptp180 -81.7 -6.33 58.94 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 111.875 0.324 . . . . 10.0 111.875 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 125' ' ' LYS . . . . . 0.462 ' HG3' ' HG3' ' B' ' 124' ' ' ARG . 91.4 mttt . . . . . 0 C--N 1.326 -0.439 0 CA-C-O 121.103 0.478 . . . . 10.0 111.131 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 110.364 -0.235 . . . . 10.0 110.364 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 41.2 ttm -135.83 110.09 8.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.032 0.444 . . . . 10.0 110.643 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -100.37 169.49 9.07 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.426 -0.583 . . . . 10.0 109.426 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -132.35 132.55 43.02 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.899 -0.321 . . . . 10.0 110.92 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 22.7 pt -117.79 -2.09 9.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.977 0.418 . . . . 10.0 110.999 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 176.99 173.91 42.96 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.838 -0.696 . . . . 10.0 111.724 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.512 ' HG2' ' HG2' ' A' ' 68' ' ' MET . 64.4 tttp -63.91 126.99 29.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.837 0.319 . . . . 10.0 110.225 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.512 ' HG2' ' HG2' ' A' ' 67' ' ' LYS . 87.1 mmm 64.16 17.65 10.8 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.794 -0.639 . . . . 10.0 111.326 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.409 ' HD2' ' O ' ' A' ' 67' ' ' LYS . 0.4 OUTLIER -128.93 109.17 11.01 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 109.948 -0.39 . . . . 10.0 109.948 179.493 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.549 ' HD1' ' HB2' ' A' ' 87' ' ' TYR . 41.4 m-85 -121.76 160.23 25.01 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.789 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 40.9 t -111.69 114.64 47.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.968 -0.56 . . . . 10.0 110.126 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.94 119.4 27.11 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.765 -0.652 . . . . 10.0 110.523 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 81' ' ' LEU . 74.7 t -132.6 106.77 11.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.682 -0.488 . . . . 10.0 109.682 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.3 ptt180 -155.53 169.83 23.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.661 0.267 . . . . 10.0 111.014 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.72 132.46 45.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.045 -0.525 . . . . 10.0 109.94 178.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -145.17 117.41 8.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.632 -0.258 . . . . 10.0 110.731 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.466 ' HE3' ' HB2' ' C' ' 476' ' ' GLU . 74.7 mttt 61.8 -86.75 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.804 -0.635 . . . . 10.0 111.176 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -148.39 31.03 1.28 Allowed Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 111.439 -0.664 . . . . 10.0 111.439 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.425 ' HB2' ' HE3' ' A' ' 79' ' ' LYS . 20.9 ttmt -158.17 169.48 24.43 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.563 -0.532 . . . . 10.0 109.563 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 58.8 t -86.36 119.42 34.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.014 0.435 . . . . 10.0 110.034 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.503 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 1.1 tp -84.06 101.82 12.06 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.836 -0.62 . . . . 10.0 110.675 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.499 HG23 HG22 ' A' ' 73' ' ' VAL . 15.1 mt -108.46 98.23 6.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.586 -0.894 . . . . 10.0 108.586 178.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.475 ' HA ' ' HA ' ' A' ' 103' ' ' SER . 16.0 t70 -118.9 121.83 40.88 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.552 0.575 . . . . 10.0 112.552 -177.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 56.7 mt -100.71 103.58 15.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.115 -1.068 . . . . 10.0 108.115 177.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.679 ' HD2' ' HB2' ' A' ' 97' ' ' PRO . 8.8 ttm-85 -145.98 160.46 41.82 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.931 0.396 . . . . 10.0 111.318 -177.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.714 ' O ' ' HA ' ' A' ' 97' ' ' PRO . 13.2 pt-20 -63.75 141.44 58.77 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.648 -0.871 . . . . 10.0 108.648 177.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.549 ' HB2' ' HD1' ' A' ' 70' ' ' TYR . 1.7 m-85 -113.6 120.54 41.28 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.105 0.479 . . . . 10.0 111.757 -178.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -102.51 155.17 18.45 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.296 -0.865 . . . . 10.0 108.899 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 25.2 ttt -82.42 139.16 34.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.385 0.612 . . . . 10.0 111.733 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -83.33 144.61 46.87 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 114.922 -1.036 . . . . 10.0 109.154 178.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -47.57 -33.47 18.08 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.862 2.375 . . . . 10.0 112.91 178.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.429 ' HG2' ' HD2' ' C' ' 465' ' ' TYR . 1.8 mp0 -75.76 -59.38 2.78 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.338 -0.392 . . . . 10.0 110.72 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 169.44 -11.51 0.05 OUTLIER Glycine 0 CA--C 1.521 0.462 0 C-N-CA 120.107 -1.044 . . . . 10.0 114.029 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -79.33 -175.08 4.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 117.22 0.51 . . . . 10.0 111.31 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 57.2 mmm -134.62 141.92 46.75 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.277 -0.638 . . . . 10.0 109.277 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.87 ' HD2' ' HD2' ' A' ' 97' ' ' PRO . 10.2 mmtp -146.79 156.29 48.1 Favored Pre-proline 0 N--CA 1.464 0.238 0 CA-C-O 120.639 0.256 . . . . 10.0 111.281 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.87 ' HD2' ' HD2' ' A' ' 96' ' ' LYS . 34.0 Cg_endo -63.4 153.7 72.91 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.289 2.659 . . . . 10.0 114.258 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -102.4 -110.41 3.4 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.057 -0.974 . . . . 10.0 112.28 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.412 ' HD3' ' HA ' ' A' ' 99' ' ' ARG . 18.8 mmt180 -122.59 -46.49 2.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.015 0.408 . . . . 10.0 111.874 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 16.1 mttp -71.15 104.79 3.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.702 0.287 . . . . 10.0 110.517 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.6 ' HA3' ' HG3' ' A' ' 85' ' ' ARG . . . 174.42 165.91 31.63 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.862 -0.685 . . . . 10.0 112.378 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.606 ' HA ' ' HE2' ' C' ' 478' ' ' MET . 20.2 tt -146.63 142.03 20.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.99 0.424 . . . . 10.0 110.551 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 83' ' ' ASP . 1.3 m -85.83 136.62 33.24 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.021 -0.536 . . . . 10.0 110.201 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 71.4 mt -93.12 105.23 17.35 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.272 -0.422 . . . . 10.0 110.886 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -62.38 141.43 96.41 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.363 -0.606 . . . . 10.0 109.363 178.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -47.12 -38.08 24.25 Favored 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 122.617 2.211 . . . . 10.0 112.474 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.587 ' HB2' ' HB3' ' C' ' 486' ' ' ASP . 11.0 mm-40 -77.61 -37.28 50.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.125 -0.488 . . . . 10.0 110.295 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -68.05 -31.43 71.08 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.711 -0.677 . . . . 10.0 110.612 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 54.2 t-105 -55.36 -45.63 76.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.88 -0.6 . . . . 10.0 110.797 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.8 t -69.12 -51.81 34.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.383 -0.372 . . . . 10.0 110.395 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -55.51 -42.87 75.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.004 -0.544 . . . . 10.0 111.534 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.506 ' O ' HG13 ' A' ' 116' ' ' ILE . 62.6 tp -61.35 -47.85 84.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.644 0.259 . . . . 10.0 110.816 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.404 ' HA ' HD12 ' A' ' 116' ' ' ILE . 48.0 mtmt -60.54 -37.72 82.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.005 0.431 . . . . 10.0 111.338 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -73.83 -31.62 63.3 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.061 -0.518 . . . . 10.0 111.39 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -81.07 -15.33 56.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.487 -0.324 . . . . 10.0 111.15 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 112' ' ' LEU . 21.4 mt -49.77 -43.5 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 112.215 0.45 . . . . 10.0 112.215 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.4 m -56.97 -37.43 71.58 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.763 0.316 . . . . 10.0 111.643 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -83.6 -39.77 19.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.012 0.434 . . . . 10.0 110.616 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.475 ' O ' HG23 ' A' ' 123' ' ' VAL . 92.2 mt -60.19 -50.44 80.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.777 -0.647 . . . . 10.0 110.242 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -59.59 -37.14 77.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.392 -0.822 . . . . 10.0 110.559 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.416 ' HA ' ' CZ ' ' A' ' 124' ' ' ARG . 7.2 t70 -66.21 -35.72 81.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.312 -0.858 . . . . 10.0 110.814 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -70.83 -33.5 70.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.885 -0.598 . . . . 10.0 110.559 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 119' ' ' ILE . 60.5 t -62.24 -40.55 88.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.347 0.594 . . . . 10.0 110.118 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.416 ' CZ ' ' HA ' ' A' ' 121' ' ' ASP . 12.8 mtm105 -74.35 -13.16 60.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.529 -0.759 . . . . 10.0 111.275 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 38.7 mttp -90.46 -2.62 57.94 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.911 0.386 . . . . 10.0 110.827 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 84.0 mt . . . . . 0 C--N 1.325 -0.458 0 CA-C-N 116.249 -0.432 . . . . 10.0 110.861 -179.948 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 121.067 0.46 . . . . 10.0 110.35 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 88.0 mmm -99.7 102.8 14.38 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.565 -0.743 . . . . 10.0 109.779 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' PHE . . . . . 0.413 ' CD2' HG12 ' A' ' 119' ' ' ILE . 48.4 m-85 -108.03 115.68 30.56 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.387 -0.369 . . . . 10.0 111.223 -179.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . 0.46 ' HA ' ' HD1' ' B' ' 70' ' ' TYR . 55.1 tt0 -71.34 125.0 25.82 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.171 -0.468 . . . . 10.0 110.378 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 19.1 pt -116.6 2.85 7.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.005 -0.543 . . . . 10.0 110.286 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 170.66 -162.45 35.49 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.993 -0.622 . . . . 10.0 111.969 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . 0.776 ' HD2' ' HA ' ' C' ' 486' ' ' ASP . 0.1 OUTLIER -86.33 117.83 25.38 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 110.199 -0.297 . . . . 10.0 110.199 179.692 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' MET . . . . . . . . . . . . . 19.9 mmt 68.33 8.91 6.92 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.545 -0.752 . . . . 10.0 111.566 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' ARG . . . . . 0.571 HH11 HG21 ' C' ' 485' ' ' ILE . 0.7 OUTLIER -120.8 119.26 32.21 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.499 -0.556 . . . . 10.0 109.499 179.199 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' TYR . . . . . 0.46 ' HD1' ' HA ' ' B' ' 64' ' ' GLN . 38.8 m-85 -135.18 138.32 43.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.884 0.373 . . . . 10.0 111.2 -178.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.572 HG22 HG12 ' B' ' 84' ' ' ILE . 75.5 t -89.94 117.78 33.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 108.631 -0.877 . . . . 10.0 108.631 178.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . 0.51 ' HB3' ' NH1' ' B' ' 74' ' ' ARG . 24.5 t -111.48 109.87 20.03 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.036 0.446 . . . . 10.0 111.289 -178.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.431 ' CG2' HG23 ' A' ' 119' ' ' ILE . 20.4 t -92.73 94.86 4.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.193 -0.669 . . . . 10.0 109.193 178.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . 0.51 ' NH1' ' HB3' ' B' ' 72' ' ' SER . 26.5 ptt-85 -122.05 149.18 43.9 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.118 0.485 . . . . 10.0 111.546 -178.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -87.54 115.99 25.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.51 -0.768 . . . . 10.0 109.262 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -110.14 105.81 15.04 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.445 -0.343 . . . . 10.0 111.222 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 33.2 mttm 57.61 30.78 19.34 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.703 -0.68 . . . . 10.0 112.785 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 92.67 30.84 9.24 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.509 -0.853 . . . . 10.0 112.23 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' B' ' 79' ' ' LYS . 18.4 mmtm -144.22 108.13 4.71 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 122.367 0.267 . . . . 10.0 110.45 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 16.1 t -69.49 106.18 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.387 -0.597 . . . . 10.0 109.387 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 94.5 mt -111.02 128.88 56.0 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.027 0.441 . . . . 10.0 111.665 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' ILE . . . . . . . . . . . . . 5.2 mp -90.75 86.45 2.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 107.499 -1.297 . . . . 10.0 107.499 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . 0.501 ' HA ' ' HA ' ' B' ' 103' ' ' SER . 34.8 t70 -85.78 107.61 17.71 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.744 -0.662 . . . . 10.0 112.02 -177.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . 0.572 HG12 HG22 ' B' ' 71' ' ' VAL . 63.4 mt -92.63 95.84 5.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 107.5 -1.296 . . . . 10.0 107.5 177.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' ARG . . . . . 0.454 ' HG3' ' HA3' ' B' ' 101' ' ' GLY . 19.7 ttm-85 -132.84 168.84 17.66 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.504 0.669 . . . . 10.0 111.973 -177.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' GLU . . . . . 0.544 ' HB3' ' HE ' ' B' ' 69' ' ' ARG . 11.7 pt-20 -89.25 154.95 19.71 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.214 -0.903 . . . . 10.0 109.348 178.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' TYR . . . . . 0.624 ' HB3' ' HB3' ' B' ' 95' ' ' MET . 38.0 m-85 -131.47 118.8 20.69 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.909 -0.404 . . . . 10.0 109.909 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -108.28 136.61 47.64 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.976 -0.556 . . . . 10.0 109.798 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 52.4 ttm -75.55 130.99 39.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.072 0.463 . . . . 10.0 111.41 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' ASP . . . . . 0.491 ' OD2' ' HE2' ' B' ' 96' ' ' LYS . 35.0 p30 -84.79 172.23 9.37 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.579 -0.737 . . . . 10.0 109.774 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' PRO . . . . . 0.447 ' HD2' ' HB2' ' B' ' 90' ' ' ASP . 32.0 Cg_exo -61.89 -13.08 28.83 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.695 2.263 . . . . 10.0 112.863 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -84.72 -43.81 13.95 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.968 0.413 . . . . 10.0 110.254 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 129.57 16.26 1.88 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.945 -0.645 . . . . 10.0 112.317 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -109.74 147.02 33.94 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.725 0.298 . . . . 10.0 110.279 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' MET . . . . . 0.624 ' HB3' ' HB3' ' B' ' 87' ' ' TYR . 84.3 mmm -88.7 115.84 26.52 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 110.047 -0.353 . . . . 10.0 110.047 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . 0.491 ' HE2' ' OD2' ' B' ' 90' ' ' ASP . 72.0 mmtt -104.12 140.78 21.4 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 116.347 -0.388 . . . . 10.0 110.053 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.13 129.04 20.78 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.438 2.092 . . . . 10.0 112.159 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . 0.405 ' O ' ' HD3' ' B' ' 85' ' ' ARG . . . -76.17 -173.63 36.17 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.107 -0.568 . . . . 10.0 112.199 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -88.3 -23.28 23.5 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.894 0.378 . . . . 10.0 111.202 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . 0.484 ' HZ2' ' CD ' ' B' ' 86' ' ' GLU . 7.0 mtmp? -88.08 113.81 24.09 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.282 0.563 . . . . 10.0 110.851 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' GLY . . . . . 0.517 ' HA2' ' HB ' ' A' ' 102' ' ' ILE . . . 169.13 175.67 38.6 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 110.894 -0.882 . . . . 10.0 110.894 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' ILE . . . . . 0.592 ' HB ' ' HA2' ' A' ' 101' ' ' GLY . 21.1 tt -143.56 138.44 25.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 117.299 0.549 . . . . 10.0 111.425 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' SER . . . . . 0.501 ' HA ' ' HA ' ' B' ' 83' ' ' ASP . 1.5 m -98.33 107.71 20.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.781 -0.645 . . . . 10.0 109.986 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 46.3 mt -99.39 135.56 40.62 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.466 -0.334 . . . . 10.0 110.741 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' ASN . . . . . 0.542 ' HB2' ' HD2' ' B' ' 106' ' ' PRO . 8.7 p-10 -88.18 164.23 34.01 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 108.836 -0.802 . . . . 10.0 108.836 178.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . 0.542 ' HD2' ' HB2' ' B' ' 105' ' ' ASN . 7.6 Cg_endo -49.43 -32.26 26.04 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.179 2.586 . . . . 10.0 113.305 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -64.22 -57.95 8.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.266 -0.424 . . . . 10.0 110.69 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -66.88 -30.85 71.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.094 0.473 . . . . 10.0 109.949 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' TRP . . . . . 0.502 ' CH2' HG12 ' A' ' 116' ' ' ILE . 48.7 t-105 -59.54 -42.33 92.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.543 -0.753 . . . . 10.0 110.04 179.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' SER . . . . . 0.429 ' O ' ' HG3' ' B' ' 114' ' ' GLU . 29.9 t -63.9 -47.61 79.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 10.0 109.784 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -61.05 -38.95 87.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.816 -0.629 . . . . 10.0 111.073 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . 0.408 ' O ' HG13 ' B' ' 116' ' ' ILE . 49.6 tp -58.6 -45.93 88.09 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.801 0.334 . . . . 10.0 110.373 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' B' ' 109' ' ' TRP . 45.4 mtmt -66.25 -36.06 82.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.172 0.51 . . . . 10.0 110.984 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' B' ' 110' ' ' SER . 47.7 mt-10 -74.06 -32.54 63.33 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.104 -0.498 . . . . 10.0 111.274 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -75.76 -11.86 60.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.194 -0.457 . . . . 10.0 111.213 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' ILE . . . . . 0.408 HG13 ' O ' ' B' ' 112' ' ' LEU . 58.0 mt -55.18 -39.65 52.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.501 -0.318 . . . . 10.0 111.26 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 4.9 m -59.36 -24.08 63.09 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.876 0.369 . . . . 10.0 111.523 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.02 -44.38 7.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.915 0.388 . . . . 10.0 110.752 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . 0.504 ' O ' HG23 ' B' ' 123' ' ' VAL . 61.5 mt -63.78 -46.82 93.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.997 -0.547 . . . . 10.0 111.397 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -57.63 -33.08 67.89 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.36 -0.382 . . . . 10.0 111.14 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 121' ' ' ASP . . . . . 0.545 ' HA ' ' NE ' ' B' ' 124' ' ' ARG . 26.8 t70 -63.27 -42.55 99.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.291 -0.413 . . . . 10.0 110.912 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.2 -30.73 66.74 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.839 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . 0.504 HG23 ' O ' ' B' ' 119' ' ' ILE . 45.1 t -75.81 -38.09 36.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 10.0 110.968 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . 0.545 ' NE ' ' HA ' ' B' ' 121' ' ' ASP . 31.0 ptt180 -78.72 -6.29 55.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 10.0 111.235 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 65.7 mttt -104.76 86.02 2.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.971 0.415 . . . . 10.0 110.273 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 66.4 mt . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.45 -0.786 . . . . 10.0 110.229 -179.956 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 465' ' ' TYR . . . . . 0.69 ' HA ' ' HB3' ' C' ' 468' ' ' LEU . 82.2 m-85 . . . . . 0 N--CA 1.477 0.922 0 N-CA-C 110.437 -0.209 . . . . 10.0 110.437 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 466' ' ' GLY . . . . . . . . . . . . . . . -57.01 -44.98 92.8 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.251 -0.5 . . . . 10.0 112.685 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 467' ' ' ALA . . . . . . . . . . . . . . . -97.72 -26.14 14.84 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.644 -0.502 . . . . 10.0 109.644 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 468' ' ' LEU . . . . . 0.69 ' HB3' ' HA ' ' C' ' 465' ' ' TYR . 11.2 tp -57.22 -51.9 67.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.347 -0.842 . . . . 10.0 111.158 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 469' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -73.21 -34.87 66.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.123 0.487 . . . . 10.0 110.674 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 470' ' ' MET . . . . . . . . . . . . . 22.5 ttt -61.26 -50.68 72.07 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.628 -0.714 . . . . 10.0 110.464 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 471' ' ' ALA . . . . . 0.529 ' HB3' ' HB3' ' A' ' 96' ' ' LYS . . . -85.38 40.5 0.84 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.279 0.561 . . . . 10.0 110.605 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 472' ' ' ASP . . . . . 0.557 ' O ' ' HB2' ' C' ' 475' ' ' PHE . 0.9 OUTLIER -133.28 -41.72 0.88 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.925 -0.769 . . . . 10.0 108.925 179.048 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 473' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -64.67 -30.71 71.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.378 -0.828 . . . . 10.0 110.017 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 474' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -84.45 0.5 49.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.781 -0.645 . . . . 10.0 111.701 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 475' ' ' PHE . . . . . 0.557 ' HB2' ' O ' ' C' ' 472' ' ' ASP . 0.1 OUTLIER -68.2 -36.8 80.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.916 0.388 . . . . 10.0 110.849 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 476' ' ' GLU . . . . . 0.726 ' HA ' ' HB3' ' C' ' 479' ' ' PHE . 0.2 OUTLIER -72.39 -16.08 61.85 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.295 -0.412 . . . . 10.0 110.856 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 477' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -64.42 -39.05 93.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.89 -0.595 . . . . 10.0 110.012 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 478' ' ' MET . . . . . 0.606 ' HE2' ' HA ' ' A' ' 102' ' ' ILE . 1.5 ttt -98.46 -16.06 19.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.084 0.468 . . . . 10.0 109.938 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 479' ' ' PHE . . . . . 0.726 ' HB3' ' HA ' ' C' ' 476' ' ' GLU . 75.7 t80 -67.71 -42.17 82.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.18 0.514 . . . . 10.0 109.741 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 480' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.16 19.5 5.78 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.895 -0.593 . . . . 10.0 110.539 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 481' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -129.64 -58.11 1.11 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.953 -0.567 . . . . 10.0 111.09 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 482' ' ' ALA . . . . . . . . . . . . . . . -93.35 -41.04 10.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.964 0.412 . . . . 10.0 110.763 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 483' ' ' LEU . . . . . 0.515 ' HB2' ' HA ' ' C' ' 479' ' ' PHE . 14.2 mt -82.99 9.38 10.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.99 -0.55 . . . . 10.0 110.921 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 484' ' ' GLY . . . . . . . . . . . . . . . -153.07 86.71 0.14 Allowed Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 110.941 -0.864 . . . . 10.0 110.941 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 485' ' ' ILE . . . . . 0.571 HG21 HH11 ' B' ' 69' ' ' ARG . 15.7 tt -174.9 -26.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.965 0.412 . . . . 10.0 111.138 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 486' ' ' ASP . . . . . 0.776 ' HA ' ' HD2' ' B' ' 67' ' ' LYS . 0.1 OUTLIER -81.22 -24.79 37.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.81 0.338 . . . . 10.0 111.102 -179.088 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 487' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.76 -0.33 53.36 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.641 -0.709 . . . . 10.0 109.894 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 488' ' ' TYR . . . . . 0.451 ' HB3' ' O ' ' C' ' 485' ' ' ILE . 16.8 t80 -73.52 -27.06 61.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.437 -0.801 . . . . 10.0 110.45 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 489' ' ' GLY . . . . . . . . . . . . . . . -179.98 128.28 1.2 Allowed Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 111.084 -0.807 . . . . 10.0 111.084 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.789 0 CA-C-O 118.321 -1.266 . . . . 10.0 111.377 -179.833 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.846 0 CA-C-O 120.899 0.38 . . . . 10.0 110.78 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 62.1 mtt -112.11 97.53 6.72 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.708 -0.478 . . . . 10.0 109.708 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.512 ' CD2' HG12 ' B' ' 119' ' ' ILE . 40.4 m-85 -91.02 135.71 33.57 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.36 -0.382 . . . . 10.0 110.599 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.458 ' HG2' ' H ' ' A' ' 66' ' ' GLY . 22.3 tt0 -89.14 128.67 35.79 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.761 0.315 . . . . 10.0 110.41 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.9 pt -117.1 9.02 7.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.175 0.512 . . . . 10.0 110.497 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.458 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 159.88 173.27 28.16 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.719 -0.753 . . . . 10.0 111.945 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.596 ' HG2' ' HG2' ' A' ' 68' ' ' MET . 61.9 tttp -61.92 117.59 6.12 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.648 0.261 . . . . 10.0 110.71 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.596 ' HG2' ' HG2' ' A' ' 67' ' ' LYS . 67.2 mmm 70.41 15.55 7.28 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.389 -0.823 . . . . 10.0 111.557 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.479 ' HE ' ' HG2' ' A' ' 86' ' ' GLU . 5.0 mpt_? -121.72 120.87 35.93 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 122.242 -0.286 . . . . 10.0 110.269 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -132.95 143.84 49.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.398 0.618 . . . . 10.0 111.916 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.469 HG22 HG23 ' A' ' 84' ' ' ILE . 18.2 t -108.83 111.14 34.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 108.312 -0.995 . . . . 10.0 108.312 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.46 ' HB2' ' HE2' ' C' ' 479' ' ' PHE . 2.9 m -101.92 116.39 32.6 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.249 0.547 . . . . 10.0 112.151 -178.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.797 HG22 HG23 ' A' ' 82' ' ' ILE . 21.9 t -103.94 110.73 31.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.409 -0.814 . . . . 10.0 109.581 179.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -157.8 179.71 8.95 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.101 0.477 . . . . 10.0 111.134 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.661 ' HB2' HG22 ' A' ' 80' ' ' VAL . 1.6 t70 -112.21 133.21 54.47 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.297 -0.865 . . . . 10.0 109.613 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.45 ' CE2' ' HB3' ' C' ' 476' ' ' GLU . 3.1 t80 -136.49 118.33 15.16 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.567 -0.288 . . . . 10.0 110.269 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 97.4 mttt 57.67 43.92 21.46 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 123.499 0.5 . . . . 10.0 111.596 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.25 40.99 94.97 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.707 -0.759 . . . . 10.0 111.51 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.406 ' HE3' ' HA ' ' C' ' 488' ' ' TYR . 2.9 tmtt? -151.08 102.55 2.96 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.913 0.387 . . . . 10.0 110.121 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.661 HG22 ' HB2' ' A' ' 75' ' ' ASP . 60.5 t -77.93 121.85 31.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.403 -0.591 . . . . 10.0 109.403 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.764 ' HB3' ' HB3' ' A' ' 103' ' ' SER . 24.1 mt -139.12 144.75 38.81 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.621 0.724 . . . . 10.0 112.176 -178.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.797 HG23 HG22 ' A' ' 73' ' ' VAL . 53.0 mt -104.12 98.98 7.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 114.591 -1.186 . . . . 10.0 108.004 178.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.603 ' HA ' ' HA ' ' A' ' 103' ' ' SER . 17.3 t70 -94.19 121.35 35.6 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.554 0.576 . . . . 10.0 112.554 -177.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.469 HG23 HG22 ' A' ' 71' ' ' VAL . 22.8 mt -98.74 108.19 21.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 107.181 -1.415 . . . . 10.0 107.181 177.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.515 ' HB2' ' OD2' ' A' ' 83' ' ' ASP . 11.2 ttm180 -144.63 163.23 34.55 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.573 0.701 . . . . 10.0 112.864 -176.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.479 ' HG2' ' HE ' ' A' ' 69' ' ' ARG . 16.3 mt-10 -89.9 142.09 28.03 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.864 -1.062 . . . . 10.0 109.124 177.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -114.43 135.92 53.57 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.528 -0.306 . . . . 10.0 110.341 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 45.7 t90 -108.67 134.77 50.95 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.72 -0.474 . . . . 10.0 109.72 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 25.2 ttt -84.4 117.67 23.77 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.87 -0.419 . . . . 10.0 109.87 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.24 164.21 55.19 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.932 -0.576 . . . . 10.0 110.868 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -53.39 -33.13 65.23 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.088 2.525 . . . . 10.0 113.318 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -69.74 -57.38 5.19 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.009 -0.367 . . . . 10.0 110.009 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 146.12 21.1 0.12 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.461 -0.876 . . . . 10.0 112.775 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.547 ' HB2' ' HE2' ' A' ' 96' ' ' LYS . 29.8 mt-10 -106.95 149.15 27.8 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.803 0.335 . . . . 10.0 110.306 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 98.4 mmm -88.77 117.67 27.91 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.293 -0.412 . . . . 10.0 110.013 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.547 ' HE2' ' HB2' ' A' ' 94' ' ' GLU . 69.4 mmtt -108.34 133.86 20.42 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.211 -0.449 . . . . 10.0 110.672 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.67 136.31 30.29 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.493 2.129 . . . . 10.0 112.157 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.485 ' O ' ' HD3' ' A' ' 85' ' ' ARG . . . -85.15 -158.43 29.61 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.595 -0.812 . . . . 10.0 112.799 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 99' ' ' ARG . 16.0 mtm180 -103.46 -22.38 13.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.869 0.366 . . . . 10.0 110.973 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 19.6 ttmt -82.65 82.96 7.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.239 -0.437 . . . . 10.0 110.478 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -152.9 165.77 31.22 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.604 -0.599 . . . . 10.0 111.604 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.559 ' HB ' ' HA2' ' B' ' 101' ' ' GLY . 12.0 tt -147.73 124.28 2.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.111 0.481 . . . . 10.0 111.226 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.764 ' HB3' ' HB3' ' A' ' 81' ' ' LEU . 5.3 m -94.62 125.69 39.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.801 -0.636 . . . . 10.0 110.387 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.478 ' HB3' ' HB2' ' A' ' 108' ' ' GLN . 76.6 mt -121.54 135.3 55.02 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.945 -0.391 . . . . 10.0 109.945 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.404 ' HB3' ' OE1' ' C' ' 487' ' ' GLU . 1.6 p30 -81.98 163.22 54.31 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 109.818 -0.438 . . . . 10.0 109.818 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -42.06 -38.98 5.49 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.614 2.876 . . . . 10.0 114.286 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.425 ' HG2' ' NE2' ' A' ' 111' ' ' GLN . 0.2 OUTLIER -61.84 -49.25 77.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.533 -0.303 . . . . 10.0 110.865 179.762 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.5 HE22 ' HD3' ' B' ' 69' ' ' ARG . 6.2 mt-30 -67.96 -37.84 82.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.317 0.579 . . . . 10.0 109.687 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.583 ' HZ2' ' HB2' ' B' ' 120' ' ' ASP . 23.5 t-105 -58.08 -43.29 86.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.272 -0.876 . . . . 10.0 110.709 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.7 t -65.32 -43.98 89.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.045 -0.525 . . . . 10.0 110.617 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.425 ' NE2' ' HG2' ' A' ' 107' ' ' GLU . 40.2 mt-30 -65.32 -36.12 83.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.431 -0.349 . . . . 10.0 110.841 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.427 HD13 HD13 ' B' ' 65' ' ' ILE . 48.6 tp -59.63 -41.14 89.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.429 . . . . 10.0 110.405 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -65.42 -31.08 71.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.997 -0.547 . . . . 10.0 111.394 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -77.43 -28.57 52.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.0 0.429 . . . . 10.0 111.367 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -85.06 -8.47 58.67 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.246 -0.434 . . . . 10.0 111.582 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 112' ' ' LEU . 61.7 mt -53.99 -43.21 57.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 112.016 0.376 . . . . 10.0 112.016 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.14 -30.03 64.08 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.2 0.444 . . . . 10.0 112.2 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -89.79 -41.75 11.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.783 0.325 . . . . 10.0 110.539 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.478 ' O ' HG23 ' A' ' 123' ' ' VAL . 72.1 mt -62.93 -48.4 88.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.938 -0.574 . . . . 10.0 111.054 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -63.59 -34.04 76.93 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.008 -0.542 . . . . 10.0 110.563 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -69.17 -41.09 77.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.637 -0.71 . . . . 10.0 109.855 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.65 -37.94 83.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.727 -0.67 . . . . 10.0 110.224 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 119' ' ' ILE . 92.6 t -60.33 -42.01 89.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 121.228 0.537 . . . . 10.0 109.96 179.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.8 mtm105 -71.44 -37.12 71.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.606 -0.725 . . . . 10.0 110.786 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 30.3 mttp -65.67 -42.77 90.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.422 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 72.5 mt . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.041 -0.527 . . . . 10.0 110.74 179.488 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.191 0 CA-C-O 121.27 0.557 . . . . 10.0 110.599 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 82.6 mmm -92.49 96.55 10.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.83 -0.623 . . . . 10.0 109.759 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -79.62 113.59 17.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.207 -0.451 . . . . 10.0 110.805 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -98.22 128.11 44.51 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.851 -0.426 . . . . 10.0 109.851 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' ILE . . . . . 0.427 HD13 HD13 ' A' ' 112' ' ' LEU . 20.5 pt -116.8 16.0 7.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.671 0.272 . . . . 10.0 111.706 -178.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 158.11 -161.54 31.64 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.155 -1.021 . . . . 10.0 112.726 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . 0.563 ' HD2' ' HA2' ' C' ' 490' ' ' GLY . 5.2 mtmp? -67.56 103.86 1.45 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.448 -0.376 . . . . 10.0 111.841 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' MET . . . . . . . . . . . . . 67.4 mmm 64.86 6.47 3.37 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.246 0.832 . . . . 10.0 113.246 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' ARG . . . . . 0.5 ' HD3' HE22 ' A' ' 108' ' ' GLN . 3.0 mpt_? -100.39 121.49 41.6 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 121.783 -0.573 . . . . 10.0 110.696 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' TYR . . . . . 0.452 ' HB2' ' CD1' ' B' ' 87' ' ' TYR . 79.9 m-85 -122.67 149.25 44.29 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.706 -0.679 . . . . 10.0 110.45 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 96.0 t -98.61 103.08 14.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.257 -0.645 . . . . 10.0 109.257 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 10.2 t -88.39 88.11 7.51 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.819 -0.628 . . . . 10.0 111.18 -178.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 3.2 t -84.66 92.35 3.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.694 -0.854 . . . . 10.0 108.694 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 23.4 ptt-85 -126.28 147.93 49.61 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.272 0.558 . . . . 10.0 111.474 -178.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' B' ' 80' ' ' VAL . 12.8 t70 -79.89 115.62 19.58 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.286 -0.87 . . . . 10.0 110.436 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -86.72 61.68 6.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.176 -0.466 . . . . 10.0 110.889 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 30.0 mttm 62.53 58.6 1.64 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.85 -0.614 . . . . 10.0 111.051 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.56 21.29 37.79 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.839 -0.696 . . . . 10.0 111.682 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 62.2 mmtt -145.04 89.49 1.96 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.569 0.223 . . . . 10.0 110.531 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . 0.431 HG11 ' HA ' ' A' ' 123' ' ' VAL . 20.2 t -66.44 105.67 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.636 -0.505 . . . . 10.0 109.636 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 79.7 mt -115.42 142.04 47.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.344 0.592 . . . . 10.0 111.456 -178.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' ILE . . . . . 0.488 HD13 ' HB2' ' B' ' 109' ' ' TRP . 5.3 mp -92.07 88.87 2.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.516 -0.92 . . . . 10.0 108.516 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . 0.519 ' HA ' ' HA ' ' B' ' 103' ' ' SER . 34.9 t70 -87.97 94.64 9.85 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.876 -0.602 . . . . 10.0 110.833 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 26.8 mt -81.65 95.25 2.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.255 -1.016 . . . . 10.0 108.255 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' ARG . . . . . 0.411 ' HD3' ' O ' ' B' ' 98' ' ' GLY . 17.4 ttm-85 -123.6 145.71 48.71 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.862 -0.608 . . . . 10.0 111.724 -177.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' GLU . . . . . 0.485 ' H ' ' HG2' ' B' ' 86' ' ' GLU . 5.0 pt-20 -76.06 128.39 34.9 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.531 -0.759 . . . . 10.0 109.109 178.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' TYR . . . . . 0.452 ' CD1' ' HB2' ' B' ' 70' ' ' TYR . 23.0 m-85 -98.96 101.38 12.75 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.072 0.463 . . . . 10.0 110.464 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' TRP . . . . . 0.417 ' O ' ' HA ' ' B' ' 95' ' ' MET . 86.1 m95 -84.75 -176.55 6.27 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.561 -0.745 . . . . 10.0 109.789 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 41.6 ttm -133.43 135.11 44.39 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 110.014 -0.365 . . . . 10.0 110.014 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' ASP . . . . . 0.446 ' HB2' ' HD2' ' B' ' 91' ' ' PRO . 29.0 p30 -92.19 171.77 7.24 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 109.899 -0.408 . . . . 10.0 109.899 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' B' ' 90' ' ' ASP . 35.9 Cg_exo -61.9 -18.9 63.66 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.448 2.098 . . . . 10.0 112.704 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -77.03 -40.6 45.85 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.225 0.535 . . . . 10.0 110.275 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 120.67 21.04 3.36 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.95 -0.643 . . . . 10.0 112.245 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -100.88 147.32 26.25 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.774 0.321 . . . . 10.0 110.7 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' MET . . . . . 0.417 ' HA ' ' O ' ' B' ' 88' ' ' TRP . 82.9 mmm -88.54 96.18 10.52 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.321 -0.622 . . . . 10.0 109.321 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -94.52 128.87 38.42 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.887 -0.597 . . . . 10.0 111.631 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -66.16 128.33 19.33 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.578 2.185 . . . . 10.0 111.339 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . 0.411 ' O ' ' HD3' ' B' ' 85' ' ' ARG . . . -74.11 -176.32 34.51 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 121.046 -0.597 . . . . 10.0 113.294 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 14.5 mmt180 -87.89 -32.88 18.74 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.959 0.409 . . . . 10.0 110.201 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . 1.047 ' HD2' ' HG ' ' C' ' 483' ' ' LEU . 4.3 mtmp? -77.87 99.1 5.84 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.458 -0.792 . . . . 10.0 110.551 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' GLY . . . . . 0.559 ' HA2' ' HB ' ' A' ' 102' ' ' ILE . . . -178.44 159.79 25.35 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 110.667 -0.973 . . . . 10.0 110.667 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 18.4 tt -131.12 142.41 43.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 117.196 0.498 . . . . 10.0 111.579 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' B' ' 83' ' ' ASP . 0.7 OUTLIER -102.5 105.3 15.82 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.831 -0.622 . . . . 10.0 109.776 179.272 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 96.1 mt -93.33 142.27 27.51 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.792 0.329 . . . . 10.0 111.376 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' ASN . . . . . 0.403 ' ND2' ' HB3' ' B' ' 107' ' ' GLU . 41.4 p-10 -93.01 164.71 20.61 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 108.633 -0.877 . . . . 10.0 108.633 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.93 -30.73 31.52 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.489 2.126 . . . . 10.0 112.669 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' GLU . . . . . 0.403 ' HB3' ' ND2' ' B' ' 105' ' ' ASN . 9.2 tt0 -66.71 -59.27 3.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.921 -0.581 . . . . 10.0 110.861 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -67.08 -29.83 69.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.488 -0.324 . . . . 10.0 110.639 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' TRP . . . . . 0.488 ' HB2' HD13 ' B' ' 82' ' ' ILE . 31.0 t-105 -60.56 -42.25 96.21 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.63 -0.507 . . . . 10.0 109.63 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 9.7 t -67.81 -45.4 74.83 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.505 -0.554 . . . . 10.0 109.505 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -57.97 -40.65 81.14 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.015 -0.539 . . . . 10.0 110.54 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . 0.442 ' O ' HG13 ' B' ' 116' ' ' ILE . 33.1 tp -59.64 -47.19 86.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.92 -0.582 . . . . 10.0 110.665 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -62.95 -34.63 77.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.101 0.477 . . . . 10.0 110.666 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -74.17 -30.17 62.12 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.801 -0.636 . . . . 10.0 110.787 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' GLN . . . . . 0.401 ' O ' HG13 ' B' ' 119' ' ' ILE . 14.6 mm-40 -82.51 -10.49 58.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.435 . . . . 10.0 111.71 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' ILE . . . . . 0.442 HG13 ' O ' ' B' ' 112' ' ' LEU . 55.8 mt -55.2 -34.82 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 120.708 0.29 . . . . 10.0 111.15 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 1.5 m -60.66 -21.4 62.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.265 -0.425 . . . . 10.0 111.601 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -106.17 -42.42 5.08 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.616 0.246 . . . . 10.0 110.663 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . 0.512 HG12 ' CD2' ' A' ' 63' ' ' PHE . 60.6 mt -61.64 -52.03 65.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.885 0.374 . . . . 10.0 110.924 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . 0.583 ' HB2' ' HZ2' ' A' ' 109' ' ' TRP . 27.6 t70 -62.35 -38.12 88.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.873 -0.603 . . . . 10.0 111.083 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -62.03 -37.67 85.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.705 -0.679 . . . . 10.0 111.23 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.32 -20.4 57.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.266 -0.425 . . . . 10.0 111.864 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . 0.459 HG23 ' O ' ' B' ' 119' ' ' ILE . 78.1 t -58.21 -36.39 57.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.891 0.377 . . . . 10.0 111.416 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 6.6 ptp85 -102.68 14.4 32.04 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.359 -0.382 . . . . 10.0 111.141 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -127.42 56.73 1.53 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.017 0.437 . . . . 10.0 110.206 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 66.9 mt . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.698 -0.668 . . . . 10.0 110.459 -179.76 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 465' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.481 1.103 0 CA-C-O 120.666 0.27 . . . . 10.0 111.207 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 466' ' ' GLY . . . . . . . . . . . . . . . -67.38 -41.15 91.41 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.2 -0.524 . . . . 10.0 112.181 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 467' ' ' ALA . . . . . . . . . . . . . . . -108.59 -51.01 2.94 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.547 -0.538 . . . . 10.0 109.547 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 468' ' ' LEU . . . . . . . . . . . . . 86.8 mt -98.89 105.99 18.2 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.841 -0.618 . . . . 10.0 110.343 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 469' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -147.21 -55.94 0.24 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.03 -0.532 . . . . 10.0 110.283 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 470' ' ' MET . . . . . . . . . . . . . 45.9 ttm -74.0 -49.15 25.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 10.0 110.746 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 471' ' ' ALA . . . . . . . . . . . . . . . -67.57 -12.46 60.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.233 -0.439 . . . . 10.0 111.148 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 472' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.34 -23.09 66.3 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.907 -0.588 . . . . 10.0 110.948 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 473' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -68.49 -21.51 64.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.081 -0.509 . . . . 10.0 110.866 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 474' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -73.99 -23.27 59.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.989 0.424 . . . . 10.0 110.699 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 475' ' ' PHE . . . . . 0.462 ' O ' ' HB2' ' C' ' 479' ' ' PHE . 24.6 m-85 -62.35 -27.95 69.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.703 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 476' ' ' GLU . . . . . 0.45 ' HB3' ' CE2' ' A' ' 76' ' ' PHE . 5.4 mm-40 -70.0 -41.03 74.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.116 -0.493 . . . . 10.0 110.509 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 477' ' ' GLN . . . . . 0.676 ' HA ' ' HB3' ' C' ' 481' ' ' ASP . 2.4 mp0 -70.05 -36.93 75.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.338 0.589 . . . . 10.0 110.038 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 478' ' ' MET . . . . . . . . . . . . . 45.5 ttp -76.54 -12.22 59.99 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.013 -0.54 . . . . 10.0 110.458 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 479' ' ' PHE . . . . . 0.465 ' HB3' ' H ' ' C' ' 480' ' ' THR . 12.7 t80 -91.76 -98.82 0.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 10.0 111.934 -178.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 480' ' ' THR . . . . . 0.465 ' H ' ' HB3' ' C' ' 479' ' ' PHE . 2.8 m -73.59 -32.5 64.15 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.118 0.784 . . . . 10.0 113.118 -177.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 481' ' ' ASP . . . . . 0.676 ' HB3' ' HA ' ' C' ' 477' ' ' GLN . 14.8 t70 -63.45 -47.23 82.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.777 0.322 . . . . 10.0 111.687 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 482' ' ' ALA . . . . . . . . . . . . . . . -60.75 -27.08 67.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.093 -0.503 . . . . 10.0 112.285 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 483' ' ' LEU . . . . . 1.047 ' HG ' ' HD2' ' B' ' 100' ' ' LYS . 0.3 OUTLIER -108.64 11.44 26.57 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.635 -0.257 . . . . 10.0 111.229 -179.775 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 484' ' ' GLY . . . . . 0.474 ' HA2' HD11 ' A' ' 81' ' ' LEU . . . -110.19 -26.58 4.85 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.661 -0.781 . . . . 10.0 111.732 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 485' ' ' ILE . . . . . . . . . . . . . 19.1 tt -66.44 -31.76 55.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.773 0.321 . . . . 10.0 111.347 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 486' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -98.32 -36.69 9.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.641 -0.254 . . . . 10.0 110.716 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 487' ' ' GLU . . . . . 0.564 ' HB2' ' O ' ' C' ' 483' ' ' LEU . 4.1 tm-20 -61.17 -25.44 67.02 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.003 0.43 . . . . 10.0 110.267 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 488' ' ' TYR . . . . . 0.406 ' HA ' ' HE3' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -53.89 -38.02 64.35 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 115.829 -0.623 . . . . 10.0 110.694 179.272 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 489' ' ' GLY . . . . . . . . . . . . . . . -108.23 -49.93 0.79 Allowed Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.641 -0.79 . . . . 10.0 112.388 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 490' ' ' GLY . . . . . 0.563 ' HA2' ' HD2' ' B' ' 67' ' ' LYS . . . . . . . . 0 C--O 1.246 0.868 0 CA-C-O 118.469 -1.184 . . . . 10.0 111.62 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 120.943 0.401 . . . . 10.0 110.224 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.448 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 50.8 ttm -144.81 118.22 9.06 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.283 -0.417 . . . . 10.0 110.646 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.439 ' HB2' ' HB ' ' A' ' 71' ' ' VAL . 67.5 m-85 -95.37 171.15 8.88 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.21 -0.45 . . . . 10.0 110.162 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.55 ' HG2' ' H ' ' A' ' 66' ' ' GLY . 6.8 tt0 -131.99 134.39 45.53 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.199 -0.297 . . . . 10.0 110.199 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.524 HG13 ' HB3' ' A' ' 69' ' ' ARG . 11.6 pt -122.08 12.19 5.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.106 0.479 . . . . 10.0 110.569 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.55 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 156.0 174.54 25.93 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.814 -0.708 . . . . 10.0 111.945 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -57.24 116.62 3.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.622 0.249 . . . . 10.0 111.376 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 2.5 mmt 69.46 11.7 8.09 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.356 -0.838 . . . . 10.0 112.45 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.524 ' HB3' HG13 ' A' ' 65' ' ' ILE . 4.4 mpt_? -111.71 104.13 12.46 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.415 -0.587 . . . . 10.0 109.415 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.489 ' HD2' ' HB2' ' A' ' 87' ' ' TYR . 96.3 m-85 -120.43 145.72 46.93 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.355 0.597 . . . . 10.0 112.406 -178.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.534 HG13 HG12 ' A' ' 84' ' ' ILE . 36.6 t -99.16 105.99 18.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.001 -1.0 . . . . 10.0 108.92 178.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.42 ' HB2' ' HZ ' ' C' ' 475' ' ' PHE . 7.6 m -88.39 113.4 23.96 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.885 0.374 . . . . 10.0 111.099 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 38.2 t -106.18 92.89 2.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.066 -0.515 . . . . 10.0 109.846 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.911 ' HG3' ' HB3' ' A' ' 81' ' ' LEU . 7.5 ptm180 -123.63 -171.15 2.26 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.086 -0.506 . . . . 10.0 109.985 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -102.51 160.17 14.79 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.626 0.251 . . . . 10.0 110.343 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.596 ' HZ ' HG23 ' C' ' 480' ' ' THR . 10.1 t80 -119.07 45.63 2.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.049 0.452 . . . . 10.0 110.522 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.425 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 11.2 mptt 55.65 41.5 30.45 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.274 0.559 . . . . 10.0 110.673 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 136.15 -42.41 1.33 Allowed Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 111.057 -0.817 . . . . 10.0 111.057 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.478 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . 64.7 mttm -100.83 -167.36 1.42 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.703 -0.48 . . . . 10.0 109.703 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.0 m -105.72 142.53 18.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.738 0.304 . . . . 10.0 110.663 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.911 ' HB3' ' HG3' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -118.53 78.94 1.31 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.105 -0.498 . . . . 10.0 109.894 -179.716 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 27.6 mt -101.46 88.27 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.062 -0.718 . . . . 10.0 109.062 178.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.47 ' OD1' ' HB2' ' A' ' 85' ' ' ARG . 16.5 t70 -113.28 135.9 53.34 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.347 0.594 . . . . 10.0 111.458 -178.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.534 HG12 HG13 ' A' ' 71' ' ' VAL . 45.7 mt -108.19 96.07 4.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 108.407 -0.96 . . . . 10.0 108.407 178.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.602 ' HG3' ' HA3' ' A' ' 101' ' ' GLY . 6.7 ttm180 -118.47 154.82 31.86 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.951 -0.568 . . . . 10.0 111.433 -178.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -73.98 124.37 26.09 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.728 -0.842 . . . . 10.0 108.728 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.489 ' HB2' ' HD2' ' A' ' 70' ' ' TYR . 19.1 m-85 -103.99 121.54 43.37 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.931 0.396 . . . . 10.0 110.759 -179.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -108.25 137.5 46.12 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.912 -0.585 . . . . 10.0 109.926 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.429 ' HA ' ' O ' ' A' ' 94' ' ' GLU . 6.5 ttt -74.94 126.92 32.02 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.301 -0.409 . . . . 10.0 110.202 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.439 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 44.8 p30 -87.83 171.56 9.38 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 116.154 -0.476 . . . . 10.0 110.605 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.439 ' HD2' ' HB2' ' A' ' 90' ' ' ASP . 48.5 Cg_exo -57.78 -24.95 66.38 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.855 2.37 . . . . 10.0 113.393 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -76.24 -30.87 58.07 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.961 0.41 . . . . 10.0 110.54 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 112.37 22.04 5.97 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.83 -0.7 . . . . 10.0 112.151 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' A' ' 89' ' ' MET . 31.0 mt-10 -110.22 164.4 12.69 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.95 0.405 . . . . 10.0 110.369 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 94.2 mmm -96.9 114.23 25.84 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.062 -0.517 . . . . 10.0 109.809 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 13.7 mmtp -113.81 131.69 22.97 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.226 -0.443 . . . . 10.0 110.493 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.06 133.84 34.73 Favored 'Trans proline' 0 C--O 1.233 0.264 0 C-N-CA 122.554 2.169 . . . . 10.0 112.408 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -81.81 -128.38 1.03 Allowed Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.984 -0.627 . . . . 10.0 113.202 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -110.07 -34.28 6.44 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.648 0.261 . . . . 10.0 111.556 -178.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.1 mtmt -86.87 117.07 25.36 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.188 0.518 . . . . 10.0 111.741 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.602 ' HA3' ' HG3' ' A' ' 85' ' ' ARG . . . -166.8 155.17 26.15 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.716 -0.953 . . . . 10.0 110.716 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.501 HG12 HG22 ' B' ' 84' ' ' ILE . 7.9 tp -134.82 130.6 52.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 117.494 0.647 . . . . 10.0 111.9 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.608 ' HB3' ' CE2' ' C' ' 479' ' ' PHE . 5.8 m -92.26 116.01 28.59 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.146 -0.934 . . . . 10.0 109.661 178.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 82.3 mt -109.56 113.05 25.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.032 0.444 . . . . 10.0 110.958 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.745 ' HB2' HD13 ' C' ' 483' ' ' LEU . 19.8 p30 -81.99 169.3 19.04 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.989 -0.55 . . . . 10.0 110.091 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.603 ' HD2' ' HB2' ' A' ' 105' ' ' ASN . 92.2 Cg_exo -44.41 -47.88 10.54 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 123.064 2.509 . . . . 10.0 113.855 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.0 tp10 -67.35 -50.94 57.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.488 0.185 . . . . 10.0 110.767 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.464 HE22 ' HD3' ' B' ' 69' ' ' ARG . 63.5 mt-30 -55.53 -46.65 77.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.316 -0.402 . . . . 10.0 111.193 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 56.0 t-105 -62.25 -42.87 99.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.908 0.385 . . . . 10.0 110.586 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.474 ' HA ' ' HE2' ' A' ' 113' ' ' LYS . 50.0 m -64.3 -46.71 82.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 10.0 110.757 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -65.6 -37.74 87.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.478 -0.328 . . . . 10.0 110.557 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.518 ' O ' HG13 ' A' ' 116' ' ' ILE . 59.6 tp -57.72 -43.42 85.27 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.279 -0.418 . . . . 10.0 110.81 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.474 ' HE2' ' HA ' ' A' ' 110' ' ' SER . 52.0 mtmt -62.23 -36.98 83.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.293 -0.412 . . . . 10.0 110.89 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -81.77 -17.07 48.97 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.106 0.479 . . . . 10.0 111.044 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -85.53 -18.67 32.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.197 -0.456 . . . . 10.0 110.283 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.518 HG13 ' O ' ' A' ' 112' ' ' LEU . 86.0 mt -54.12 -40.39 46.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.133 -0.485 . . . . 10.0 111.311 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.28 -25.04 61.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 10.0 111.758 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.42 -35.52 9.54 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.872 0.368 . . . . 10.0 110.763 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 83.9 mt -64.75 -47.59 88.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.922 -0.581 . . . . 10.0 110.86 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.14 -32.33 73.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 10.0 110.813 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -64.48 -41.4 96.49 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.815 -0.629 . . . . 10.0 110.124 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.96 -35.66 80.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.997 -0.547 . . . . 10.0 110.32 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 88.4 t -62.91 -37.85 80.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.943 -0.571 . . . . 10.0 110.215 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 16.5 mtm105 -75.2 -25.28 58.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.977 -0.556 . . . . 10.0 111.012 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -78.53 -20.14 51.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.331 -0.395 . . . . 10.0 111.352 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 12.6 mt . . . . . 0 C--N 1.321 -0.659 0 CA-C-N 116.586 -0.279 . . . . 10.0 110.437 179.971 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.094 0 CA-C-O 121.181 0.515 . . . . 10.0 110.683 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' MET . . . . . 0.408 ' HG2' ' HA ' ' B' ' 72' ' ' SER . 59.1 mtm -103.3 128.3 50.39 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.903 -0.589 . . . . 10.0 109.874 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -114.21 128.12 56.21 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.156 -0.474 . . . . 10.0 110.161 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -79.68 134.09 36.4 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.093 0.473 . . . . 10.0 111.316 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 108' ' ' GLN . 6.4 pt -112.42 -26.08 3.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.707 -0.679 . . . . 10.0 110.398 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -167.84 -174.53 36.86 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.771 -0.932 . . . . 10.0 110.771 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . 0.593 ' HD2' ' HA ' ' C' ' 486' ' ' ASP . 14.8 mttp -70.8 127.64 33.33 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.069 0.462 . . . . 10.0 111.057 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' MET . . . . . 0.513 ' HE3' ' HA ' ' B' ' 88' ' ' TRP . 39.2 mmm 64.26 25.88 13.63 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.057 -0.974 . . . . 10.0 111.703 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' ARG . . . . . 0.484 ' HE ' ' HG2' ' B' ' 86' ' ' GLU . 0.4 OUTLIER -140.11 115.25 9.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.484 -0.325 . . . . 10.0 110.233 179.116 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -126.61 133.15 51.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.045 -0.525 . . . . 10.0 110.758 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.466 HG22 HG23 ' B' ' 84' ' ' ILE . 86.6 t -88.75 115.21 28.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.048 -0.523 . . . . 10.0 109.611 179.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . 0.408 ' HA ' ' HG2' ' B' ' 62' ' ' MET . 8.1 m -90.68 101.25 14.0 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.946 0.403 . . . . 10.0 111.076 -179.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 8.9 t -97.58 99.34 8.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.168 -0.469 . . . . 10.0 110.003 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -160.03 166.43 29.97 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.258 -0.428 . . . . 10.0 110.211 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.699 ' HA ' ' HA ' ' B' ' 80' ' ' VAL . 0.0 OUTLIER -86.87 145.32 26.62 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.203 0.525 . . . . 10.0 110.333 179.789 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -126.98 100.71 6.25 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 109.132 -0.692 . . . . 10.0 109.132 178.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 66.6 mttm 67.33 33.78 5.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.402 -0.817 . . . . 10.0 111.009 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 96.39 -9.94 67.13 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.734 -0.745 . . . . 10.0 112.971 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . 0.418 ' HD3' ' HA ' ' B' ' 79' ' ' LYS . 32.2 mmtt -109.25 113.71 26.78 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.66 0.23 . . . . 10.0 110.919 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . 0.699 ' HA ' ' HA ' ' B' ' 75' ' ' ASP . 14.3 t -64.33 117.76 5.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.612 -0.514 . . . . 10.0 109.612 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 97.8 mt -125.73 129.3 49.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.174 0.511 . . . . 10.0 111.699 -178.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' ILE . . . . . . . . . . . . . 5.2 mp -93.25 95.82 5.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 108.08 -1.081 . . . . 10.0 108.08 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . 0.4 ' HA ' ' HA ' ' B' ' 103' ' ' SER . 2.2 t70 -85.73 107.31 17.54 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.939 -0.573 . . . . 10.0 111.991 -177.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . 0.501 HG22 HG12 ' A' ' 102' ' ' ILE . 12.0 mt -99.23 83.91 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.071 -1.085 . . . . 10.0 108.071 178.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' ARG . . . . . 0.948 ' HG3' ' HA3' ' B' ' 101' ' ' GLY . 6.1 ttm180 -123.89 162.75 22.67 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.711 -0.677 . . . . 10.0 111.089 -177.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' GLU . . . . . 0.732 ' HB2' ' HA3' ' B' ' 98' ' ' GLY . 35.8 mt-10 -70.19 153.06 43.56 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.48 -0.933 . . . . 10.0 108.48 177.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -140.46 111.16 6.85 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.184 0.516 . . . . 10.0 110.783 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' TRP . . . . . 0.513 ' HA ' ' HE3' ' B' ' 68' ' ' MET . 20.6 m0 -108.64 -170.81 1.73 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.513 -0.767 . . . . 10.0 109.356 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 33.3 ttm -127.82 142.66 51.23 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 110.146 -0.316 . . . . 10.0 110.146 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' ASP . . . . . 0.446 ' HB2' ' HD2' ' B' ' 91' ' ' PRO . 36.9 p30 -99.83 169.94 7.4 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 116.17 -0.468 . . . . 10.0 110.522 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' B' ' 90' ' ' ASP . 34.8 Cg_exo -59.93 -20.58 60.68 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.713 2.276 . . . . 10.0 112.362 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -73.76 -43.34 59.28 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.994 0.426 . . . . 10.0 110.007 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 118.79 26.54 2.53 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.955 -0.64 . . . . 10.0 112.244 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -113.33 152.22 30.2 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.841 0.353 . . . . 10.0 110.625 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' MET . . . . . . . . . . . . . 95.6 mmm -82.78 105.15 13.56 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.073 -0.714 . . . . 10.0 109.073 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -103.37 145.93 31.51 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.765 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.02 146.94 94.82 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.576 2.184 . . . . 10.0 111.849 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . 0.732 ' HA3' ' HB2' ' B' ' 86' ' ' GLU . . . -73.89 -140.72 0.56 Allowed Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.728 -0.669 . . . . 10.0 112.617 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 99' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' B' ' 99' ' ' ARG . 2.4 mtp-105 -102.64 -32.76 9.73 Favored 'General case' 0 C--N 1.32 -0.714 0 O-C-N 122.382 -0.481 . . . . 10.0 111.109 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . 0.505 ' HE2' ' SD ' ' C' ' 478' ' ' MET . 2.3 mppt? -127.7 157.1 41.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.243 0.545 . . . . 10.0 111.396 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' GLY . . . . . 0.948 ' HA3' ' HG3' ' B' ' 85' ' ' ARG . . . 171.15 160.86 20.71 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 110.507 -1.037 . . . . 10.0 110.507 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 20.5 tt -133.1 140.8 46.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 117.95 0.875 . . . . 10.0 111.544 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' B' ' 83' ' ' ASP . 0.9 OUTLIER -101.62 112.19 24.68 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.054 -0.521 . . . . 10.0 110.013 179.549 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 52.1 mt -97.72 134.86 40.32 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.822 0.344 . . . . 10.0 110.615 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -88.97 168.98 14.13 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 108.915 -0.772 . . . . 10.0 108.915 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . 0.521 ' HD3' ' O ' ' B' ' 80' ' ' VAL . 86.4 Cg_exo -48.8 -38.73 38.28 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.608 2.205 . . . . 10.0 113.414 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -67.01 -54.7 19.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.63 -0.259 . . . . 10.0 111.172 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -61.74 -35.69 78.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.442 -0.345 . . . . 10.0 110.509 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' TRP . . . . . 0.404 ' CZ2' HG12 ' A' ' 116' ' ' ILE . 65.7 t-105 -61.87 -41.23 97.6 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.106 -0.497 . . . . 10.0 109.699 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' SER . . . . . 0.411 ' O ' ' HG3' ' B' ' 114' ' ' GLU . 25.3 t -63.62 -46.61 84.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.489 . . . . 10.0 109.719 178.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -58.37 -40.17 81.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.881 -0.6 . . . . 10.0 110.815 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 53.5 tp -60.94 -41.4 96.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 10.0 110.461 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' LYS . . . . . 0.43 ' HG2' HD13 ' A' ' 116' ' ' ILE . 55.9 mtmt -68.85 -36.09 77.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.15 0.5 . . . . 10.0 110.737 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . 0.411 ' HG3' ' O ' ' B' ' 110' ' ' SER . 45.3 mt-10 -73.79 -25.15 59.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.828 -0.624 . . . . 10.0 111.332 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -86.78 -4.89 59.23 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.302 -0.408 . . . . 10.0 111.397 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 61.7 mt -57.27 -41.38 78.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 120.778 0.323 . . . . 10.0 110.881 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 5.7 m -64.83 -11.95 42.85 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.146 -0.479 . . . . 10.0 112.21 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.25 -47.21 3.57 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.83 0.348 . . . . 10.0 110.447 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . 0.473 ' O ' HG23 ' B' ' 123' ' ' VAL . 61.9 mt -66.35 -45.95 88.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.102 -0.499 . . . . 10.0 111.817 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -62.13 -36.23 81.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.728 0.299 . . . . 10.0 111.236 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 121' ' ' ASP . . . . . 0.466 ' O ' ' HG2' ' B' ' 124' ' ' ARG . 36.7 t70 -67.87 -34.89 77.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.983 0.421 . . . . 10.0 110.26 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 122' ' ' ALA . . . . . 0.493 ' O ' ' HG ' ' B' ' 126' ' ' LEU . . . -68.48 -37.53 80.22 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.718 -0.475 . . . . 10.0 109.718 178.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . 0.473 HG23 ' O ' ' B' ' 119' ' ' ILE . 83.9 t -64.81 -42.36 94.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.896 -0.593 . . . . 10.0 110.58 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' B' ' 121' ' ' ASP . 7.1 ptp180 -75.65 -5.9 47.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.795 0.331 . . . . 10.0 110.91 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 43.2 mttp -104.65 1.43 29.52 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.377 -0.374 . . . . 10.0 110.572 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' B' ' 122' ' ' ALA . 82.5 mt . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.73 -0.653 . . . . 10.0 109.813 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 465' ' ' TYR . . . . . . . . . . . . . 58.1 t80 . . . . . 0 N--CA 1.48 1.046 0 CA-C-O 120.282 0.087 . . . . 10.0 111.165 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 466' ' ' GLY . . . . . . . . . . . . . . . -54.5 -40.17 68.65 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 121.566 -0.349 . . . . 10.0 113.522 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 467' ' ' ALA . . . . . . . . . . . . . . . -60.05 -38.17 82.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.984 0.421 . . . . 10.0 110.956 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 468' ' ' LEU . . . . . . . . . . . . . 33.3 tp -80.43 -34.33 36.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.099 0.476 . . . . 10.0 110.461 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 469' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -62.23 -44.66 96.06 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.746 -0.661 . . . . 10.0 110.476 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 470' ' ' MET . . . . . . . . . . . . . 99.0 mmm -80.99 -14.16 58.21 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.814 -0.63 . . . . 10.0 110.988 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 471' ' ' ALA . . . . . . . . . . . . . . . -65.26 -44.39 88.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.871 0.367 . . . . 10.0 110.048 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 472' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -68.03 -33.08 73.91 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.369 -0.604 . . . . 10.0 109.369 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 473' ' ' PHE . . . . . 0.412 ' O ' ' HB3' ' C' ' 477' ' ' GLN . 2.6 m-85 -64.36 -44.08 92.55 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 115.408 -0.814 . . . . 10.0 110.558 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 474' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.1 -19.63 64.86 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.918 0.389 . . . . 10.0 110.831 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 475' ' ' PHE . . . . . 0.578 ' HA ' ' NH1' ' A' ' 85' ' ' ARG . 79.1 t80 -83.27 -51.4 7.49 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.032 -0.531 . . . . 10.0 109.848 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 476' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -69.39 -38.83 78.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.516 -0.765 . . . . 10.0 111.276 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 477' ' ' GLN . . . . . 0.468 HE21 ' HB3' ' C' ' 477' ' ' GLN . 0.0 OUTLIER -70.84 91.79 0.86 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.729 0.776 . . . . 10.0 109.939 179.896 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 478' ' ' MET . . . . . 0.55 ' HE2' ' H ' ' A' ' 103' ' ' SER . 20.2 ttt -176.8 -44.86 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.488 -1.233 . . . . 10.0 108.413 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 479' ' ' PHE . . . . . 0.608 ' CE2' ' HB3' ' A' ' 103' ' ' SER . 0.8 OUTLIER -67.82 -16.95 64.35 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.523 -0.762 . . . . 10.0 110.818 179.289 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 480' ' ' THR . . . . . 0.596 HG23 ' HZ ' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -60.84 -26.8 67.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.388 0.613 . . . . 10.0 110.172 178.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 481' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -111.35 -40.01 4.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.149 -0.932 . . . . 10.0 109.629 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 482' ' ' ALA . . . . . . . . . . . . . . . -79.55 28.72 0.25 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.822 -0.627 . . . . 10.0 112.55 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 483' ' ' LEU . . . . . 0.745 HD13 ' HB2' ' A' ' 105' ' ' ASN . 33.5 tp -171.76 -50.83 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 122.477 0.311 . . . . 10.0 110.199 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 484' ' ' GLY . . . . . . . . . . . . . . . -46.6 -42.9 14.79 Favored Glycine 0 C--N 1.335 0.478 0 O-C-N 123.899 0.749 . . . . 10.0 113.4 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 485' ' ' ILE . . . . . . . . . . . . . 23.2 pt -109.47 -4.59 10.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.715 0.293 . . . . 10.0 111.017 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 486' ' ' ASP . . . . . 0.593 ' HA ' ' HD2' ' B' ' 67' ' ' LYS . 21.3 t0 -87.74 -29.49 21.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.522 -0.308 . . . . 10.0 111.35 -178.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 487' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -74.31 -13.43 60.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.095 0.474 . . . . 10.0 110.411 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 488' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -101.52 93.49 5.4 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.898 -0.592 . . . . 10.0 109.879 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 489' ' ' GLY . . . . . . . . . . . . . . . 99.58 177.26 31.19 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 121.056 -0.593 . . . . 10.0 111.996 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.091 0 CA-C-O 118.798 -1.001 . . . . 10.0 111.722 -179.901 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 120.563 0.22 . . . . 10.0 110.516 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.459 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 29.6 mtm -142.97 130.45 21.17 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.965 -0.383 . . . . 10.0 109.965 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.4 ' CE1' ' HB3' ' B' ' 118' ' ' ASP . 57.5 m-85 -122.15 147.33 46.29 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.13 -0.486 . . . . 10.0 109.97 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -98.07 116.76 30.95 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.408 -0.36 . . . . 10.0 110.43 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.538 HG22 ' HG3' ' B' ' 115' ' ' GLN . 24.6 pt -105.06 10.28 9.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.12 0.486 . . . . 10.0 110.776 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 164.29 173.59 33.12 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.78 -0.724 . . . . 10.0 111.645 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 44.8 tttp -62.28 120.69 11.47 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.47 0.176 . . . . 10.0 110.765 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.418 ' HB3' ' O ' ' A' ' 87' ' ' TYR . 24.8 mmt 64.07 28.26 14.22 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 123.732 0.645 . . . . 10.0 111.888 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -131.08 112.26 12.73 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.967 -0.382 . . . . 10.0 109.967 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.425 ' HB2' ' CE1' ' A' ' 87' ' ' TYR . 50.8 m-85 -120.0 140.98 50.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.095 0.474 . . . . 10.0 111.444 -179.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 62' ' ' MET . 21.2 t -94.58 110.55 23.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.779 -0.646 . . . . 10.0 109.448 178.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.795 ' HB3' ' HB3' ' A' ' 83' ' ' ASP . 0.7 OUTLIER -80.39 83.38 6.23 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.992 -0.549 . . . . 10.0 110.697 -179.209 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.0 t -89.7 86.15 2.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.914 -0.773 . . . . 10.0 108.914 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -151.35 172.21 16.27 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.701 -0.681 . . . . 10.0 110.597 -178.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.885 ' HB2' HG22 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -106.01 138.0 42.95 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.808 -0.633 . . . . 10.0 109.814 179.352 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.642 ' HE2' ' HG2' ' C' ' 477' ' ' GLN . 1.0 OUTLIER -126.4 95.48 4.38 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.396 -0.365 . . . . 10.0 110.318 179.303 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.3 36.86 25.91 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.667 -0.697 . . . . 10.0 111.892 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 103.05 -17.64 51.67 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.516 -0.85 . . . . 10.0 112.18 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.499 ' HA ' ' HE2' ' C' ' 488' ' ' TYR . 48.7 mtmt -89.18 94.93 10.1 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.994 0.426 . . . . 10.0 110.293 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.885 HG22 ' HB2' ' A' ' 75' ' ' ASP . 2.1 t -100.71 93.63 3.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.878 -0.601 . . . . 10.0 109.684 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.488 HD11 ' HB3' ' A' ' 79' ' ' LYS . 0.9 OUTLIER -128.94 157.12 42.51 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.096 -0.502 . . . . 10.0 110.949 -179.075 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.549 HD13 ' HB2' ' A' ' 109' ' ' TRP . 5.3 mp -81.42 90.32 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.573 -0.899 . . . . 10.0 108.573 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.795 ' HB3' ' HB3' ' A' ' 72' ' ' SER . 20.5 t70 -82.17 102.41 11.08 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.831 -0.622 . . . . 10.0 111.955 -177.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.3 mt -84.51 109.41 17.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 107.727 -1.212 . . . . 10.0 107.727 178.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.467 ' HD3' ' O ' ' A' ' 98' ' ' GLY . 10.9 ttm-85 -128.98 149.15 50.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.446 0.641 . . . . 10.0 112.544 -177.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -91.62 149.92 21.42 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.504 -0.924 . . . . 10.0 108.504 178.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.425 ' CE1' ' HB2' ' A' ' 70' ' ' TYR . 8.0 m-85 -120.26 152.37 37.86 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.051 0.453 . . . . 10.0 111.539 -178.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 12.6 t90 -145.03 154.33 42.41 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.926 -0.768 . . . . 10.0 108.926 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.4 ttm -88.03 134.74 33.67 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.909 0.385 . . . . 10.0 110.76 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.877 ' HB3' ' HG3' ' A' ' 96' ' ' LYS . 51.2 p-10 -85.68 175.52 4.44 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.787 -0.642 . . . . 10.0 110.534 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.481 ' HD2' ' HB2' ' A' ' 90' ' ' ASP . 39.3 Cg_exo -61.72 -17.81 56.89 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.568 2.178 . . . . 10.0 112.911 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.79 -41.71 20.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.826 0.346 . . . . 10.0 110.773 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 122.52 18.48 3.32 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.834 -0.698 . . . . 10.0 111.994 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -104.14 163.49 12.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.927 0.394 . . . . 10.0 110.882 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 78.5 mmm -88.06 111.33 21.43 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.916 -0.583 . . . . 10.0 109.479 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.877 ' HG3' ' HB3' ' A' ' 90' ' ' ASP . 18.7 mmmt -109.03 129.97 23.28 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.804 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.43 133.63 19.4 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.234 1.956 . . . . 10.0 111.513 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.467 ' O ' ' HD3' ' A' ' 85' ' ' ARG . . . -63.7 160.15 37.78 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.916 -0.659 . . . . 10.0 112.12 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.429 ' HA ' ' HD3' ' A' ' 99' ' ' ARG . 25.1 mmt180 -77.87 -7.91 57.35 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.161 0.505 . . . . 10.0 110.397 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -104.19 127.49 51.8 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.647 -0.706 . . . . 10.0 109.828 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -166.5 -173.53 34.96 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 111.206 -0.757 . . . . 10.0 111.206 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.9 tp -152.51 113.23 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.208 0.528 . . . . 10.0 110.582 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.772 ' HA ' ' HA ' ' A' ' 83' ' ' ASP . 0.8 OUTLIER -92.5 90.61 7.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.165 -0.47 . . . . 10.0 111.36 -179.478 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.449 ' HG ' ' HB3' ' A' ' 108' ' ' GLN . 2.8 mp -65.97 131.25 45.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.559 -0.291 . . . . 10.0 111.011 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.493 ' HB2' ' HD2' ' A' ' 106' ' ' PRO . 20.2 p-10 -78.98 166.47 41.97 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 110.396 -0.224 . . . . 10.0 110.396 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.493 ' HD2' ' HB2' ' A' ' 105' ' ' ASN . 79.6 Cg_exo -47.45 -41.15 29.4 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.222 2.615 . . . . 10.0 114.004 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -69.51 -45.14 69.58 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.828 -0.349 . . . . 10.0 110.838 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.466 ' HG2' ' HA3' ' B' ' 66' ' ' GLY . 23.6 mt-30 -57.97 -39.83 79.12 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.964 0.411 . . . . 10.0 110.17 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.549 ' HB2' HD13 ' A' ' 82' ' ' ILE . 66.2 t-105 -59.09 -44.4 91.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.782 -0.644 . . . . 10.0 110.564 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.8 t -67.36 -48.28 67.92 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.025 -0.534 . . . . 10.0 110.486 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -60.06 -38.8 83.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.94 -0.573 . . . . 10.0 111.08 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.479 ' O ' HG13 ' A' ' 116' ' ' ILE . 27.9 tp -60.98 -49.53 77.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.465 -0.334 . . . . 10.0 110.594 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.46 ' HA ' HD12 ' A' ' 116' ' ' ILE . 48.6 mtmt -60.54 -38.49 84.64 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.301 -0.409 . . . . 10.0 111.192 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -71.99 -26.5 62.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.962 -0.563 . . . . 10.0 111.831 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -93.42 -9.45 38.56 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.671 0.249 . . . . 10.0 111.671 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 112' ' ' LEU . 16.4 mt -51.55 -44.05 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 112.224 0.453 . . . . 10.0 112.224 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.3 m -60.46 -34.55 74.16 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.871 0.367 . . . . 10.0 111.773 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.08 -41.04 21.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.953 0.406 . . . . 10.0 110.325 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.544 HG23 HG21 ' B' ' 73' ' ' VAL . 82.3 mt -65.38 -48.62 82.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.805 -0.634 . . . . 10.0 111.224 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -59.42 -37.69 78.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.098 -0.501 . . . . 10.0 110.774 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.66 -39.3 94.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.019 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.412 ' HA ' ' HD2' ' A' ' 125' ' ' LYS . . . -64.89 -33.78 76.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.927 -0.579 . . . . 10.0 110.613 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 119' ' ' ILE . 63.1 t -64.36 -37.52 80.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.235 0.54 . . . . 10.0 109.855 179.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 19.9 mtm105 -78.84 -27.18 44.16 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.565 -0.743 . . . . 10.0 110.509 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.412 ' HD2' ' HA ' ' A' ' 122' ' ' ALA . 13.7 mttt -69.6 -36.07 75.86 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.99 -0.55 . . . . 10.0 110.566 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 47.2 mt . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 115.855 -0.612 . . . . 10.0 111.322 -179.49 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.219 0 CA-C-O 121.082 0.468 . . . . 10.0 110.665 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 5.6 mmm -97.99 95.92 7.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.773 -0.649 . . . . 10.0 109.708 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' PHE . . . . . 0.477 ' CD2' HG12 ' A' ' 119' ' ' ILE . 38.8 m-85 -90.83 126.28 35.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.067 -0.515 . . . . 10.0 111.166 -179.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -87.73 103.74 15.9 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.199 -0.455 . . . . 10.0 109.823 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' ILE . . . . . 0.503 HG12 HG23 ' B' ' 71' ' ' VAL . 5.6 pt -100.39 5.2 10.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.304 0.573 . . . . 10.0 110.351 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . 0.466 ' HA3' ' HG2' ' A' ' 108' ' ' GLN . . . 179.43 158.88 22.49 Favored Glycine 0 N--CA 1.438 -1.179 0 N-CA-C 110.988 -0.845 . . . . 10.0 110.988 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . 0.484 ' O ' ' HB2' ' B' ' 68' ' ' MET . 29.9 mttp -64.26 114.95 4.58 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.761 -0.459 . . . . 10.0 109.761 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' MET . . . . . 0.484 ' HB2' ' O ' ' B' ' 67' ' ' LYS . 70.3 mmm 78.91 3.97 2.42 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.313 -0.858 . . . . 10.0 111.128 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -115.57 124.59 51.4 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.722 -0.473 . . . . 10.0 109.722 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' TYR . . . . . 0.575 ' HB2' ' CD2' ' B' ' 87' ' ' TYR . 95.7 m-85 -131.12 145.32 51.94 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.228 0.537 . . . . 10.0 111.558 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.503 HG23 HG12 ' B' ' 65' ' ' ILE . 65.6 t -103.99 96.03 4.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 108.399 -0.963 . . . . 10.0 108.399 177.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . 0.458 ' O ' ' HD3' ' B' ' 74' ' ' ARG . 0.5 OUTLIER -87.71 96.65 10.51 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.028 -0.533 . . . . 10.0 110.8 -179.364 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.544 HG21 HG23 ' A' ' 119' ' ' ILE . 28.4 t -84.66 115.01 25.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.369 -0.604 . . . . 10.0 109.369 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . 0.458 ' HD3' ' O ' ' B' ' 72' ' ' SER . 0.0 OUTLIER -150.64 161.45 42.58 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.983 0.42 . . . . 10.0 111.02 -179.528 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -85.55 118.63 25.18 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.467 -0.788 . . . . 10.0 110.097 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -109.05 89.15 2.91 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.496 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 61.4 mttm 60.8 44.86 10.51 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.525 -0.762 . . . . 10.0 112.185 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.42 38.24 12.94 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.601 -0.809 . . . . 10.0 111.527 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -151.53 106.44 3.27 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 122.733 0.413 . . . . 10.0 110.138 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . 0.492 ' O ' ' HD3' ' B' ' 106' ' ' PRO . 24.4 t -73.2 99.06 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 108.563 -0.903 . . . . 10.0 108.563 178.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 96.2 mt -105.82 132.08 52.37 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.511 0.672 . . . . 10.0 112.599 -177.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' ILE . . . . . . . . . . . . . 4.8 mp -93.35 94.09 4.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 107.322 -1.362 . . . . 10.0 107.322 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -89.0 106.06 18.19 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.962 -0.563 . . . . 10.0 112.223 -177.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . 0.421 ' O ' ' HA2' ' B' ' 101' ' ' GLY . 37.7 mt -93.39 99.29 9.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 107.84 -1.17 . . . . 10.0 107.84 177.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' ARG . . . . . 0.805 ' HG3' ' HA3' ' B' ' 101' ' ' GLY . 20.2 ttm-85 -140.97 165.63 27.01 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.223 0.535 . . . . 10.0 112.112 -177.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.11 144.13 25.76 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.51 -0.922 . . . . 10.0 108.51 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' TYR . . . . . 0.575 ' CD2' ' HB2' ' B' ' 70' ' ' TYR . 50.6 m-85 -125.92 125.93 43.57 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.289 0.566 . . . . 10.0 111.047 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' TRP . . . . . . . . . . . . . 66.2 t90 -104.85 136.25 44.7 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.404 -0.817 . . . . 10.0 110.105 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 50.3 ttm -78.97 115.95 18.97 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.034 0.445 . . . . 10.0 110.745 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.69 161.97 59.53 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.659 -0.7 . . . . 10.0 110.356 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -53.23 -27.03 36.26 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.191 2.594 . . . . 10.0 113.993 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.7 -17.26 59.21 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 122.235 -0.29 . . . . 10.0 110.776 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 103.65 11.6 32.56 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.936 -0.65 . . . . 10.0 113.712 178.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' GLU . . . . . 0.429 ' HB3' ' HE2' ' B' ' 96' ' ' LYS . 11.4 tt0 -103.38 156.76 17.5 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 117.062 0.431 . . . . 10.0 110.696 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' MET . . . . . 0.529 ' HB3' ' HB3' ' B' ' 87' ' ' TYR . 87.7 mmm -94.25 103.0 15.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.252 -0.431 . . . . 10.0 110.024 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . 0.429 ' HE2' ' HB3' ' B' ' 94' ' ' GLU . 67.0 mmtt -93.28 147.29 33.47 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.082 -0.508 . . . . 10.0 110.47 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.13 145.57 98.17 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 122.29 1.994 . . . . 10.0 111.789 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . -75.94 -112.78 0.12 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.871 -0.68 . . . . 10.0 112.849 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 71.7 mtp85 -138.51 -22.06 1.01 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.968 0.413 . . . . 10.0 110.934 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . 0.407 ' HD3' HD13 ' C' ' 483' ' ' LEU . 39.2 mttt -100.4 -146.22 0.34 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.993 -0.548 . . . . 10.0 109.915 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' GLY . . . . . 0.805 ' HA3' ' HG3' ' B' ' 85' ' ' ARG . . . 94.72 153.95 30.6 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.612 -0.804 . . . . 10.0 112.751 179.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 15.4 tt -145.99 134.31 16.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.951 0.405 . . . . 10.0 110.545 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 4.0 m -92.25 116.14 28.7 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.062 -0.517 . . . . 10.0 109.701 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 96.0 mt -111.67 138.24 48.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.208 -0.451 . . . . 10.0 110.411 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' ASN . . . . . 0.545 ' HB2' ' HD2' ' B' ' 106' ' ' PRO . 33.3 p30 -88.93 170.43 11.03 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.39 -0.596 . . . . 10.0 109.39 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . 0.545 ' HD2' ' HB2' ' B' ' 105' ' ' ASN . 75.0 Cg_exo -51.47 -35.06 53.96 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.527 2.151 . . . . 10.0 113.121 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -62.89 -53.85 47.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.305 -0.407 . . . . 10.0 110.342 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -67.41 -34.9 78.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.058 -0.519 . . . . 10.0 110.206 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' TRP . . . . . . . . . . . . . 35.1 t-105 -61.12 -45.52 94.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.898 -0.592 . . . . 10.0 109.955 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' SER . . . . . 0.529 ' HA ' ' HE2' ' B' ' 113' ' ' LYS . 13.3 t -64.03 -43.87 94.27 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.697 -0.482 . . . . 10.0 109.697 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -61.16 -39.57 90.59 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 116.061 -0.518 . . . . 10.0 110.744 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 34.5 tp -60.2 -43.3 96.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.876 0.369 . . . . 10.0 110.204 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' LYS . . . . . 0.529 ' HE2' ' HA ' ' B' ' 110' ' ' SER . 41.5 mtmt -66.49 -39.85 88.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.035 -0.53 . . . . 10.0 110.567 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -74.42 -16.25 60.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.822 -0.626 . . . . 10.0 111.372 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' GLN . . . . . 0.538 ' HG3' HG22 ' A' ' 65' ' ' ILE . 14.7 mm-40 -90.12 -4.63 57.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.52 -0.309 . . . . 10.0 111.193 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 75.3 mt -58.78 -35.42 55.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.69 0.281 . . . . 10.0 110.722 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.25 -12.25 39.33 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.27 -0.423 . . . . 10.0 111.725 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' ASP . . . . . 0.4 ' HB3' ' CE1' ' A' ' 63' ' ' PHE . 1.4 m-20 -111.9 -49.65 2.97 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.884 0.373 . . . . 10.0 110.606 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 43.4 mt -65.42 -53.44 39.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 10.0 111.568 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . 0.401 ' HB2' ' HZ2' ' A' ' 109' ' ' TRP . 33.7 t70 -62.54 -31.28 72.04 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.799 0.333 . . . . 10.0 110.627 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -62.03 -47.4 84.89 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.927 -0.579 . . . . 10.0 110.19 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.81 -39.16 80.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.026 -0.534 . . . . 10.0 110.529 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 53.3 t -64.47 -37.23 79.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.818 -0.628 . . . . 10.0 111.207 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' B' ' 124' ' ' ARG . 8.7 ptp85 -81.77 -6.57 59.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.851 0.358 . . . . 10.0 110.999 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -96.5 5.95 49.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.049 0.452 . . . . 10.0 110.435 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 42.7 mt . . . . . 0 C--O 1.247 0.938 0 CA-C-O 118.3 -0.857 . . . . 10.0 109.995 179.455 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 465' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 . . . . . 0 N--CA 1.482 1.133 0 CA-C-O 120.41 0.148 . . . . 10.0 110.796 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 466' ' ' GLY . . . . . . . . . . . . . . . -55.33 -32.74 57.72 Favored Glycine 0 CA--C 1.52 0.344 0 CA-C-N 116.084 -0.507 . . . . 10.0 113.992 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 467' ' ' ALA . . . . . . . . . . . . . . . -67.49 -56.16 10.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.012 0.435 . . . . 10.0 110.805 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 468' ' ' LEU . . . . . . . . . . . . . 11.2 tp -65.77 -31.27 72.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.988 -0.551 . . . . 10.0 110.872 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 469' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -62.6 -21.03 65.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.615 -0.721 . . . . 10.0 111.884 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 470' ' ' MET . . . . . . . . . . . . . 92.7 mmm -111.13 -48.46 3.11 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.774 0.321 . . . . 10.0 111.834 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 471' ' ' ALA . . . . . . . . . . . . . . . -64.71 -59.52 4.15 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.679 0.622 . . . . 10.0 112.679 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 472' ' ' ASP . . . . . 0.443 ' HA ' ' HD2' ' C' ' 475' ' ' PHE . 36.5 t70 -67.59 -28.55 67.85 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.868 0.321 . . . . 10.0 111.868 -178.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 473' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -57.65 -40.41 79.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.44 -0.346 . . . . 10.0 110.575 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 474' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -62.81 -44.82 95.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.146 -0.479 . . . . 10.0 109.882 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 475' ' ' PHE . . . . . 0.443 ' HD2' ' HA ' ' C' ' 472' ' ' ASP . 55.9 m-85 -62.36 -43.47 98.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.331 -0.395 . . . . 10.0 110.533 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 476' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.5 -39.91 77.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.925 -0.579 . . . . 10.0 110.57 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 477' ' ' GLN . . . . . 0.642 ' HG2' ' HE2' ' A' ' 76' ' ' PHE . 0.8 OUTLIER -79.34 -53.92 6.45 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.797 -0.638 . . . . 10.0 111.421 -179.489 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 478' ' ' MET . . . . . . . . . . . . . 53.8 ttp -57.76 -44.24 86.01 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.861 0.689 . . . . 10.0 112.861 -177.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 479' ' ' PHE . . . . . 0.519 ' O ' ' HB2' ' C' ' 483' ' ' LEU . 15.7 m-85 -68.01 -17.47 64.43 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 121.09 -0.244 . . . . 10.0 111.593 -178.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 480' ' ' THR . . . . . . . . . . . . . 1.7 m -108.56 12.28 26.13 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.698 0.761 . . . . 10.0 109.403 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 481' ' ' ASP . . . . . 0.436 ' HB2' ' CD2' ' A' ' 76' ' ' PHE . 23.8 t70 -119.81 -54.86 2.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.331 -0.85 . . . . 10.0 110.555 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 482' ' ' ALA . . . . . . . . . . . . . . . -78.28 -12.86 60.03 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.748 -0.66 . . . . 10.0 111.33 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 483' ' ' LEU . . . . . 0.519 ' HB2' ' O ' ' C' ' 479' ' ' PHE . 0.3 OUTLIER -56.93 -41.3 77.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.255 -0.43 . . . . 10.0 111.05 -179.664 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 484' ' ' GLY . . . . . . . . . . . . . . . -103.18 31.11 9.1 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.537 -0.839 . . . . 10.0 113.026 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 485' ' ' ILE . . . . . . . . . . . . . 15.6 tt -72.75 -35.68 50.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 117.21 0.505 . . . . 10.0 110.759 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 486' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -109.84 -0.45 18.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.969 0.414 . . . . 10.0 110.226 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 487' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -74.99 -21.06 59.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.765 -0.652 . . . . 10.0 110.096 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 488' ' ' TYR . . . . . 0.499 ' HE2' ' HA ' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -64.2 -15.64 60.34 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.423 -0.808 . . . . 10.0 111.217 -179.49 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 489' ' ' GLY . . . . . . . . . . . . . . . -90.0 -4.73 71.65 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.737 -0.744 . . . . 10.0 112.353 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.172 0 CA-C-O 118.931 -0.927 . . . . 10.0 112.383 -179.592 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.861 0 CA-C-O 120.854 0.359 . . . . 10.0 110.123 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.431 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 54.2 ttm -115.73 117.65 30.84 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.16 -0.473 . . . . 10.0 110.584 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -107.47 179.28 4.29 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.911 -0.586 . . . . 10.0 109.51 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -135.32 138.29 43.27 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 121.006 -0.278 . . . . 10.0 110.923 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.6 pt -117.56 -9.77 11.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.16 -0.473 . . . . 10.0 111.23 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 176.11 -178.92 47.46 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.482 -0.866 . . . . 10.0 112.336 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.486 ' O ' ' HD2' ' A' ' 69' ' ' ARG . 43.3 tttp -58.03 118.15 5.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.688 0.28 . . . . 10.0 111.043 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 66.8 mmm 67.28 8.03 5.93 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.442 -0.799 . . . . 10.0 112.165 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.486 ' HD2' ' O ' ' A' ' 67' ' ' LYS . 2.4 mpt_? -113.35 113.02 24.66 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 120.917 0.389 . . . . 10.0 110.078 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.522 ' HB2' ' CD2' ' A' ' 87' ' ' TYR . 94.8 m-85 -121.17 163.85 17.81 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.894 -0.593 . . . . 10.0 110.879 -178.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 62' ' ' MET . 60.3 t -121.28 102.45 12.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.369 -0.832 . . . . 10.0 108.999 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.42 ' HB2' ' HB3' ' A' ' 83' ' ' ASP . 7.1 m -97.65 98.92 10.29 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.094 0.405 . . . . 10.0 112.094 -178.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.54 HG13 HG12 ' A' ' 82' ' ' ILE . 19.5 t -81.54 82.38 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 108.209 -1.034 . . . . 10.0 108.209 177.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -115.97 167.5 10.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.876 -0.602 . . . . 10.0 111.496 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.45 ' HA ' ' HA ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -112.93 141.2 47.03 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.734 -0.666 . . . . 10.0 110.17 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.556 ' HB3' ' OD1' ' C' ' 481' ' ' ASP . 17.5 m-85 -126.4 101.84 6.88 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.03 -0.532 . . . . 10.0 111.171 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 78.0 mttt 61.32 34.07 18.67 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.004 -0.543 . . . . 10.0 112.018 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.94 18.54 43.27 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.554 -0.831 . . . . 10.0 111.762 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.534 ' HE3' HG13 ' C' ' 485' ' ' ILE . 8.0 mtpt -127.75 99.25 5.47 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.327 -0.249 . . . . 10.0 110.327 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.457 HG11 HD13 ' B' ' 126' ' ' LEU . 96.7 t -69.62 111.88 3.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.844 -0.428 . . . . 10.0 109.844 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 79.3 mt -122.97 119.17 29.61 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.22 -0.445 . . . . 10.0 110.663 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.54 HG12 HG13 ' A' ' 73' ' ' VAL . 75.6 mt -75.79 101.48 2.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 108.955 -0.757 . . . . 10.0 108.955 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.42 ' HB3' ' HB2' ' A' ' 72' ' ' SER . 4.4 t70 -72.9 100.68 2.98 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.722 -0.672 . . . . 10.0 112.258 -178.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 34.8 mt -100.44 91.81 2.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 107.874 -1.158 . . . . 10.0 107.874 177.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.691 ' HG2' ' N ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -160.25 160.52 32.74 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.046 -0.525 . . . . 10.0 111.278 -177.252 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.691 ' N ' ' HG2' ' A' ' 85' ' ' ARG . 7.7 pt-20 -78.39 147.81 33.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.252 0.548 . . . . 10.0 110.788 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.673 ' HB3' ' HG2' ' A' ' 95' ' ' MET . 96.9 m-85 -126.34 125.31 42.05 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.62 -0.718 . . . . 10.0 109.685 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -105.66 167.76 9.55 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.333 -0.394 . . . . 10.0 110.108 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 27.8 ttt -106.01 131.11 53.7 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.691 0.281 . . . . 10.0 110.339 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.428 ' HB2' ' CD ' ' A' ' 91' ' ' PRO . 2.1 p30 -87.11 171.16 10.43 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 116.013 -0.539 . . . . 10.0 110.314 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.428 ' CD ' ' HB2' ' A' ' 90' ' ' ASP . 17.0 Cg_exo -68.64 -10.29 28.64 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.829 2.353 . . . . 10.0 113.257 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.495 ' HB2' ' HD2' ' C' ' 465' ' ' TYR . 7.4 tp10 -85.08 -43.06 14.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.167 0.508 . . . . 10.0 109.801 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 126.98 19.18 2.01 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.614 -0.721 . . . . 10.0 112.223 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -105.94 178.41 4.57 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.985 0.421 . . . . 10.0 110.981 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.673 ' HG2' ' HB3' ' A' ' 87' ' ' TYR . 18.7 ttm -105.43 112.43 25.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.757 -0.656 . . . . 10.0 110.005 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.3 mmpp? -102.02 123.11 44.73 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.187 -0.46 . . . . 10.0 111.62 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.48 ' HB3' ' CE1' ' A' ' 87' ' ' TYR . 73.4 Cg_endo -80.42 128.19 6.93 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.614 2.209 . . . . 10.0 111.824 178.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.403 ' O ' ' HD3' ' A' ' 85' ' ' ARG . . . -68.17 156.58 52.89 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.68 -0.772 . . . . 10.0 111.636 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.686 HH21 ' HB2' ' C' ' 476' ' ' GLU . 0.0 OUTLIER -60.15 -38.43 83.13 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.03 0.443 . . . . 10.0 110.415 -179.555 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.52 ' H ' ' HG3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -76.0 96.67 3.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.608 -0.723 . . . . 10.0 110.385 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.411 ' CA ' ' HB2' ' A' ' 85' ' ' ARG . . . -164.97 136.19 4.08 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.772 -0.728 . . . . 10.0 111.922 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.61 ' HA ' HD21 ' C' ' 483' ' ' LEU . 19.0 tt -116.69 124.18 72.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.533 0.682 . . . . 10.0 110.707 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.635 ' H ' HD23 ' C' ' 483' ' ' LEU . 1.3 m -102.35 110.95 23.04 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.618 -0.719 . . . . 10.0 109.818 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 79.4 mt -97.39 131.61 43.89 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.903 -0.589 . . . . 10.0 111.244 -178.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -84.06 167.14 29.52 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.828 -0.624 . . . . 10.0 109.601 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -43.14 -41.67 9.6 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.317 2.678 . . . . 10.0 113.71 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.36 -46.53 89.63 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.879 0.371 . . . . 10.0 110.781 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -69.91 -39.45 76.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.018 -0.537 . . . . 10.0 109.734 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 68.3 t-105 -56.99 -43.63 81.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.408 -0.815 . . . . 10.0 110.652 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.2 t -61.68 -52.41 64.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.306 -0.406 . . . . 10.0 109.925 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.45 ' O ' ' HG2' ' A' ' 115' ' ' GLN . 36.0 mt-30 -58.5 -41.71 85.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.911 -0.586 . . . . 10.0 110.709 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.614 ' O ' HG13 ' A' ' 116' ' ' ILE . 21.5 tp -55.47 -51.42 67.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.031 -0.531 . . . . 10.0 110.967 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.596 ' HA ' HD12 ' A' ' 116' ' ' ILE . 44.2 mtmt -63.35 -38.34 90.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.311 -0.404 . . . . 10.0 111.441 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -67.49 -36.22 80.68 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.019 -0.537 . . . . 10.0 111.553 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' A' ' 111' ' ' GLN . 14.1 mm-40 -82.18 -17.56 45.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.647 -0.251 . . . . 10.0 111.33 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.614 HG13 ' O ' ' A' ' 112' ' ' LEU . 18.7 mt -49.94 -37.05 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 111.991 0.367 . . . . 10.0 111.991 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.33 -35.68 72.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.42 -0.354 . . . . 10.0 111.414 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.3 -33.48 15.31 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.94 0.4 . . . . 10.0 110.501 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 91.8 mt -60.93 -47.61 92.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.002 -0.545 . . . . 10.0 110.462 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -62.9 -33.59 75.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.812 -0.631 . . . . 10.0 110.569 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -65.83 -33.18 75.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.806 -0.633 . . . . 10.0 110.026 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -70.54 -31.34 68.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.995 -0.548 . . . . 10.0 110.306 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 51.5 t -63.57 -39.02 83.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.999 -0.546 . . . . 10.0 109.789 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 124' ' ' ARG . 5.6 ttm105 -70.42 -23.6 62.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.813 -0.63 . . . . 10.0 110.458 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 16.9 mttp -79.26 -23.53 43.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.823 -0.626 . . . . 10.0 110.557 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 C--N 1.323 -0.544 0 CA-C-N 116.208 -0.451 . . . . 10.0 111.422 -179.989 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.176 0 CA-C-O 121.047 0.451 . . . . 10.0 110.84 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 98.1 mmm -93.82 90.08 6.39 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.436 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -67.8 126.06 28.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.878 -0.601 . . . . 10.0 110.345 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -96.29 130.47 43.38 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.806 0.336 . . . . 10.0 110.768 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 21.8 pt -121.38 8.17 6.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.894 -0.593 . . . . 10.0 110.438 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 171.1 178.03 41.34 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.043 -0.823 . . . . 10.0 111.043 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . 0.507 ' O ' ' HB2' ' B' ' 68' ' ' MET . 28.2 mtmm -67.74 106.13 2.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 117.04 0.42 . . . . 10.0 109.987 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' MET . . . . . 0.507 ' HB2' ' O ' ' B' ' 67' ' ' LYS . 45.6 mtm 78.08 -0.59 2.63 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 124.093 0.87 . . . . 10.0 111.482 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' ARG . . . . . 0.472 ' HG3' ' HB3' ' B' ' 86' ' ' GLU . 6.3 mpt_? -99.12 122.17 41.97 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.771 -0.455 . . . . 10.0 109.771 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -128.84 168.32 16.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.342 0.592 . . . . 10.0 111.806 -178.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 58.4 t -107.27 102.67 14.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 108.103 -1.073 . . . . 10.0 108.103 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . 0.545 ' HB3' ' HB3' ' B' ' 83' ' ' ASP . 1.4 t -84.94 88.05 7.4 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.493 0.553 . . . . 10.0 112.493 -177.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 44.6 t -89.03 100.14 10.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 107.851 -1.166 . . . . 10.0 107.851 177.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' B' ' 74' ' ' ARG . 15.1 ptt-85 -131.91 162.7 30.02 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.195 0.522 . . . . 10.0 111.827 -177.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -95.51 108.49 20.73 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.514 -0.766 . . . . 10.0 109.135 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -93.13 84.63 4.87 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.459 -0.337 . . . . 10.0 110.56 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 72.6 mttt 59.51 45.42 13.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.613 -0.722 . . . . 10.0 111.759 179.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.0 5.37 70.82 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.804 -0.713 . . . . 10.0 112.377 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -118.47 101.88 8.49 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.135 -0.32 . . . . 10.0 110.135 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . 0.516 ' O ' ' HD3' ' B' ' 106' ' ' PRO . 12.9 t -65.31 115.29 3.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.654 -0.499 . . . . 10.0 109.654 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 78.9 mt -124.48 132.36 53.49 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.114 0.483 . . . . 10.0 111.602 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' ILE . . . . . . . . . . . . . 5.1 mp -94.88 91.14 2.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 107.647 -1.242 . . . . 10.0 107.647 177.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . 0.587 ' HA ' ' HA ' ' B' ' 103' ' ' SER . 38.7 t70 -89.3 103.19 15.84 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.388 -0.824 . . . . 10.0 111.74 -177.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 60.2 mt -80.49 107.75 13.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 107.585 -1.265 . . . . 10.0 107.585 177.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' ARG . . . . . 0.621 ' HD3' ' O ' ' B' ' 98' ' ' GLY . 27.0 ttm-85 -152.85 154.07 34.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.02 0.438 . . . . 10.0 111.744 -176.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' GLU . . . . . 0.472 ' HB3' ' HG3' ' B' ' 69' ' ' ARG . 4.1 pt-20 -93.74 150.06 20.71 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.047 -0.524 . . . . 10.0 109.781 178.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' TYR . . . . . 0.803 ' HB3' ' HB3' ' B' ' 95' ' ' MET . 15.7 m-85 -119.54 127.54 53.11 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.195 -0.457 . . . . 10.0 110.43 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' TRP . . . . . . . . . . . . . 2.2 m0 -108.83 136.34 48.55 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.578 -0.527 . . . . 10.0 109.578 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 42.8 ttm -74.66 126.37 30.7 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.976 0.417 . . . . 10.0 110.341 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.0 171.62 6.38 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.804 -0.634 . . . . 10.0 110.976 -179.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -52.71 -32.1 53.67 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 123.163 2.575 . . . . 10.0 113.392 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.05 -28.95 65.86 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.944 0.402 . . . . 10.0 110.269 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 106.84 16.06 14.94 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.826 -0.702 . . . . 10.0 112.214 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' GLU . . . . . 0.535 ' HB2' ' HE2' ' B' ' 96' ' ' LYS . 48.3 mt-10 -106.8 147.74 29.33 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.921 -0.4 . . . . 10.0 109.921 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' MET . . . . . 0.803 ' HB3' ' HB3' ' B' ' 87' ' ' TYR . 89.7 mmm -82.69 105.89 14.09 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.427 -0.583 . . . . 10.0 109.427 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . 0.535 ' HE2' ' HB2' ' B' ' 94' ' ' GLU . 73.5 mmtt -88.06 126.69 60.14 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.964 -0.562 . . . . 10.0 111.164 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -65.4 123.97 12.23 Favored 'Trans proline' 0 C--O 1.237 0.452 0 C-N-CA 122.584 2.189 . . . . 10.0 111.459 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . 0.621 ' O ' ' HD3' ' B' ' 85' ' ' ARG . . . -60.45 164.45 15.48 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.818 -0.628 . . . . 10.0 113.537 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 52.4 mtm180 -77.11 -4.03 42.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.985 0.422 . . . . 10.0 111.005 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . 0.523 ' HD3' HD22 ' C' ' 483' ' ' LEU . 38.1 mttm -114.64 115.07 26.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.171 -0.468 . . . . 10.0 110.722 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -175.93 174.41 46.89 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.681 -0.968 . . . . 10.0 110.681 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 16.3 tt -141.84 122.16 11.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.229 0.537 . . . . 10.0 111.354 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' SER . . . . . 0.587 ' HA ' ' HA ' ' B' ' 83' ' ' ASP . 1.2 m -93.07 102.67 15.0 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.879 -0.6 . . . . 10.0 110.173 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 95.2 mt -96.12 132.35 41.61 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.137 -0.483 . . . . 10.0 111.272 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' ASN . . . . . 0.628 ' ND2' ' HB3' ' B' ' 107' ' ' GLU . 23.7 p-10 -84.08 163.61 47.47 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 108.586 -0.894 . . . . 10.0 108.586 178.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . 0.516 ' HD3' ' O ' ' B' ' 80' ' ' VAL . 72.4 Cg_exo -49.38 -32.83 27.39 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.734 2.289 . . . . 10.0 112.542 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' GLU . . . . . 0.628 ' HB3' ' ND2' ' B' ' 105' ' ' ASN . 13.4 tt0 -61.75 -57.94 9.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.762 -0.654 . . . . 10.0 111.059 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -74.05 -28.47 61.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.807 0.337 . . . . 10.0 110.619 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' TRP . . . . . 0.45 ' HH2' HG12 ' A' ' 116' ' ' ILE . 28.8 t-105 -60.26 -43.16 96.39 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.506 -0.553 . . . . 10.0 109.506 178.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' SER . . . . . 0.467 ' O ' ' HG3' ' B' ' 114' ' ' GLU . 37.3 t -63.51 -44.96 92.77 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.505 -0.554 . . . . 10.0 109.505 178.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -58.36 -40.04 81.18 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.68 -0.691 . . . . 10.0 110.613 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . 0.555 ' O ' HG13 ' B' ' 116' ' ' ILE . 20.8 tp -59.93 -45.31 93.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 10.0 110.191 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -63.86 -33.6 76.06 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.853 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' B' ' 110' ' ' SER . 35.9 mt-10 -74.36 -45.61 45.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.998 -0.546 . . . . 10.0 110.648 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -62.93 -18.25 62.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.589 -0.732 . . . . 10.0 112.181 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' ILE . . . . . 0.555 HG13 ' O ' ' B' ' 112' ' ' LEU . 67.8 mt -53.38 -38.25 31.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.778 0.323 . . . . 10.0 110.605 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.19 -28.86 67.03 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.815 -0.63 . . . . 10.0 111.826 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -98.96 -40.13 8.22 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.715 0.293 . . . . 10.0 111.412 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . 0.418 ' O ' HG23 ' B' ' 123' ' ' VAL . 83.0 mt -62.79 -48.2 89.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 10.0 110.69 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -63.01 -31.46 72.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.225 0.536 . . . . 10.0 110.377 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -63.96 -36.59 84.47 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.436 -0.802 . . . . 10.0 110.048 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -77.52 -40.53 42.38 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.853 -0.612 . . . . 10.0 110.821 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . 0.418 HG23 ' O ' ' B' ' 119' ' ' ILE . 94.1 t -61.48 -43.14 96.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.069 -0.514 . . . . 10.0 111.52 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -70.55 -10.77 60.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.684 0.278 . . . . 10.0 111.602 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -104.12 2.57 32.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.751 0.31 . . . . 10.0 110.933 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.457 HD13 HG11 ' A' ' 80' ' ' VAL . 72.5 mt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.324 -0.846 . . . . 10.0 110.238 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 465' ' ' TYR . . . . . 0.495 ' HD2' ' HB2' ' A' ' 92' ' ' GLU . 31.3 t80 . . . . . 0 N--CA 1.48 1.059 0 CA-C-O 120.684 0.278 . . . . 10.0 110.939 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 466' ' ' GLY . . . . . . . . . . . . . . . -54.38 -31.78 51.35 Favored Glycine 0 C--N 1.334 0.437 0 CA-C-N 116.306 -0.406 . . . . 10.0 113.955 -179.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 467' ' ' ALA . . . . . . . . . . . . . . . -58.09 -40.12 80.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 117.024 0.412 . . . . 10.0 111.596 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 468' ' ' LEU . . . . . . . . . . . . . 40.4 tp -91.51 -33.75 15.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.996 0.427 . . . . 10.0 110.523 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 469' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -62.77 -46.88 85.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.697 -0.683 . . . . 10.0 111.476 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 470' ' ' MET . . . . . . . . . . . . . 49.8 ttm -60.14 -32.63 71.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.132 -0.485 . . . . 10.0 111.227 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 471' ' ' ALA . . . . . . . . . . . . . . . -62.29 -39.69 93.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.967 0.413 . . . . 10.0 110.859 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 472' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -80.14 -44.03 20.61 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.192 -0.458 . . . . 10.0 110.345 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 473' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -59.4 -42.04 90.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.77 -0.65 . . . . 10.0 111.054 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 474' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.49 -42.32 95.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.293 -0.412 . . . . 10.0 110.124 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 475' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -62.96 -47.79 81.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.974 -0.557 . . . . 10.0 110.287 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 476' ' ' GLU . . . . . 0.686 ' HB2' HH21 ' A' ' 99' ' ' ARG . 9.6 tp10 -62.04 -41.62 98.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.959 -0.564 . . . . 10.0 110.858 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 477' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -59.13 -44.92 92.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.377 -0.374 . . . . 10.0 110.462 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 478' ' ' MET . . . . . . . . . . . . . 13.8 tpp -70.04 -38.87 75.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 10.0 110.47 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 479' ' ' PHE . . . . . 0.401 ' HD1' ' HA ' ' C' ' 479' ' ' PHE . 0.1 OUTLIER -63.26 -29.06 70.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.389 0.614 . . . . 10.0 109.991 179.242 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 480' ' ' THR . . . . . 0.453 HG23 ' OG ' ' A' ' 103' ' ' SER . 88.2 m -82.4 -43.21 17.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.333 -0.849 . . . . 10.0 110.121 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 481' ' ' ASP . . . . . 0.556 ' OD1' ' HB3' ' A' ' 76' ' ' PHE . 3.9 t70 -59.59 -37.31 78.21 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.32 -0.855 . . . . 10.0 111.14 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 482' ' ' ALA . . . . . . . . . . . . . . . -98.01 17.18 18.93 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.125 -0.489 . . . . 10.0 111.76 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 483' ' ' LEU . . . . . 0.635 HD23 ' H ' ' A' ' 103' ' ' SER . 29.9 tp -81.38 -78.08 0.2 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.79 0.328 . . . . 10.0 110.547 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 484' ' ' GLY . . . . . . . . . . . . . . . -88.57 33.87 4.02 Favored Glycine 0 C--O 1.229 -0.168 0 C-N-CA 120.796 -0.716 . . . . 10.0 112.067 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 485' ' ' ILE . . . . . 0.534 HG13 ' HE3' ' A' ' 79' ' ' LYS . 12.9 tt -72.79 -31.11 35.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.797 0.332 . . . . 10.0 111.298 -178.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 486' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -81.61 -20.5 39.63 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.477 -0.329 . . . . 10.0 111.412 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 487' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -92.97 -7.89 44.63 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.48 -0.327 . . . . 10.0 111.599 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 488' ' ' TYR . . . . . 0.509 ' CZ ' ' HA ' ' A' ' 79' ' ' LYS . 7.0 t80 -63.57 104.02 0.6 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.921 0.391 . . . . 10.0 110.499 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 489' ' ' GLY . . . . . . . . . . . . . . . 90.18 8.88 66.07 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.783 -0.722 . . . . 10.0 112.104 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.929 0 CA-C-O 118.715 -1.047 . . . . 10.0 111.972 179.757 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.499 ' O ' ' HA ' ' A' ' 72' ' ' SER . . . . . . . . 0 N--CA 1.477 0.889 0 CA-C-O 120.681 0.276 . . . . 10.0 110.506 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 24.0 mmt -123.23 92.78 3.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.239 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.558 ' HB2' ' HB ' ' A' ' 71' ' ' VAL . 91.8 m-85 -96.34 121.09 37.75 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.734 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -87.13 120.11 28.06 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.796 0.332 . . . . 10.0 110.174 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.3 pt -110.23 0.13 9.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.064 0.459 . . . . 10.0 111.063 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.697 ' HA3' ' HG2' ' B' ' 108' ' ' GLN . . . 170.19 -178.64 42.86 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.583 -0.818 . . . . 10.0 111.964 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.449 ' HG2' ' HG2' ' A' ' 68' ' ' MET . 57.0 tttp -65.9 114.25 4.98 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.457 0.17 . . . . 10.0 110.92 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.449 ' HG2' ' HG2' ' A' ' 67' ' ' LYS . 71.5 mmm 69.15 18.78 8.15 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 123.917 0.761 . . . . 10.0 111.663 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -121.83 112.6 18.55 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.934 -0.395 . . . . 10.0 109.934 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -124.91 144.08 50.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.392 0.615 . . . . 10.0 111.671 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.558 ' HB ' ' HB2' ' A' ' 63' ' ' PHE . 48.0 t -104.0 107.22 21.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.177 -0.92 . . . . 10.0 109.037 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 61' ' ' ALA . 1.5 p -102.5 92.48 4.68 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.168 0.508 . . . . 10.0 112.059 -178.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.439 HG22 HG23 ' A' ' 82' ' ' ILE . 16.9 t -83.47 100.54 7.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.085 -0.507 . . . . 10.0 110.003 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.65 156.72 38.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.393 -0.367 . . . . 10.0 110.363 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.51 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 1.1 t70 -83.49 136.07 34.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.145 -0.479 . . . . 10.0 110.86 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.808 ' HE1' ' HG2' ' C' ' 477' ' ' GLN . 1.1 m-85 -135.24 98.73 4.05 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.075 -0.511 . . . . 10.0 110.672 179.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.546 ' HE3' ' HB3' ' C' ' 477' ' ' GLN . 84.3 mttt 59.91 42.3 16.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.632 -0.713 . . . . 10.0 111.004 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.32 51.82 3.99 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.634 -0.793 . . . . 10.0 111.556 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.525 ' HG3' ' HE2' ' C' ' 488' ' ' TYR . 0.0 OUTLIER -138.02 89.81 2.43 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.058 -0.349 . . . . 10.0 110.058 -179.626 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.3 t -95.49 91.55 2.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.641 -0.503 . . . . 10.0 109.641 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.734 HD13 ' HB3' ' A' ' 103' ' ' SER . 0.5 OUTLIER -157.14 174.06 16.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.9 -0.591 . . . . 10.0 111.181 -179.08 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.439 HG23 HG22 ' A' ' 73' ' ' VAL . 69.7 mt -88.65 88.87 3.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.267 -0.642 . . . . 10.0 109.267 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.488 ' HA ' ' HA ' ' A' ' 103' ' ' SER . 32.1 t70 -84.39 117.59 23.72 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.86 -0.609 . . . . 10.0 111.806 -178.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.422 HG12 HG13 ' A' ' 71' ' ' VAL . 58.4 mt -103.93 137.54 32.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.97 -0.559 . . . . 10.0 109.642 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.453 ' HD3' ' HD2' ' C' ' 479' ' ' PHE . 10.4 ttm180 -144.92 146.41 31.98 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.711 -0.477 . . . . 10.0 109.711 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -78.59 93.74 4.89 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.402 -0.592 . . . . 10.0 109.402 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 97' ' ' PRO . 16.4 m-85 -78.08 115.95 18.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.702 -0.681 . . . . 10.0 111.717 -178.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.417 ' CH2' ' HA3' ' A' ' 98' ' ' GLY . 35.1 m0 -99.19 -157.39 0.6 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.175 -0.676 . . . . 10.0 109.175 178.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 20.6 ttt -130.58 132.4 45.51 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.042 -0.355 . . . . 10.0 110.042 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.467 ' OD2' ' HB3' ' A' ' 94' ' ' GLU . 2.8 p30 -94.73 167.85 12.38 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 116.273 -0.421 . . . . 10.0 110.565 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -62.48 -14.92 42.28 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.124 2.549 . . . . 10.0 113.452 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.438 ' HA ' ' OE1' ' A' ' 92' ' ' GLU . 2.9 tp10 -83.7 -39.88 19.6 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.12 0.486 . . . . 10.0 110.044 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 123.75 19.19 2.81 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.787 -0.72 . . . . 10.0 112.518 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.467 ' HB3' ' OD2' ' A' ' 90' ' ' ASP . 21.5 tt0 -106.59 166.27 10.68 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.684 -0.487 . . . . 10.0 109.684 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 94.4 mmm -87.33 84.37 7.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.877 0.37 . . . . 10.0 110.484 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.657 ' HE2' ' HA ' ' A' ' 96' ' ' LYS . 0.3 OUTLIER -90.07 108.16 24.24 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.153 -0.476 . . . . 10.0 110.05 179.164 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.625 ' HD2' ' HE2' ' A' ' 96' ' ' LYS . 58.6 Cg_endo -73.95 152.72 46.73 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.251 1.967 . . . . 10.0 112.821 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.417 ' HA3' ' CH2' ' A' ' 88' ' ' TRP . . . -94.24 178.93 37.5 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 111.038 -0.825 . . . . 10.0 111.038 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -78.53 71.59 5.0 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.243 0.544 . . . . 10.0 110.345 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 24.7 ttmt -161.97 133.88 5.55 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.242 -0.89 . . . . 10.0 109.672 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 154.37 -169.47 32.74 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.958 -0.639 . . . . 10.0 111.652 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 20.4 tt -168.91 139.63 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.745 0.307 . . . . 10.0 110.42 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.734 ' HB3' HD13 ' A' ' 81' ' ' LEU . 0.7 OUTLIER -96.01 145.01 25.8 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.506 -0.315 . . . . 10.0 110.268 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 45.6 mt -121.93 117.56 26.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.461 -0.336 . . . . 10.0 110.176 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.673 ' HB3' ' HG3' ' C' ' 487' ' ' GLU . 2.7 p30 -78.61 164.24 56.84 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 109.969 -0.382 . . . . 10.0 109.969 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.545 ' HD2' ' HB2' ' A' ' 105' ' ' ASN . 1.7 Cg_endo -43.22 -45.68 9.66 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.732 2.954 . . . . 10.0 113.866 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -64.01 -42.56 97.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.493 0.187 . . . . 10.0 111.135 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -63.84 -43.6 95.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.991 0.424 . . . . 10.0 110.011 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.534 ' HZ2' ' HB2' ' B' ' 120' ' ' ASP . 62.6 t-105 -59.27 -41.83 89.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.651 -0.704 . . . . 10.0 110.867 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.5 m -66.81 -43.9 82.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.851 -0.613 . . . . 10.0 111.115 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -68.35 -38.95 81.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.36 -0.382 . . . . 10.0 111.038 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.2 tp -59.08 -44.31 91.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.316 -0.402 . . . . 10.0 110.958 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -64.65 -32.54 74.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.272 -0.422 . . . . 10.0 111.1 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -75.45 -33.32 60.87 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.034 0.445 . . . . 10.0 110.888 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -77.81 -8.47 58.06 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.411 0.522 . . . . 10.0 112.411 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 74.7 mt -54.68 -44.46 70.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.674 0.273 . . . . 10.0 111.291 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.31 -19.78 62.17 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.147 -0.479 . . . . 10.0 111.911 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.407 ' HB3' ' CE1' ' B' ' 63' ' ' PHE . 0.6 OUTLIER -101.26 -48.4 4.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.755 0.312 . . . . 10.0 110.718 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.653 HG23 HG21 ' B' ' 73' ' ' VAL . 87.6 mt -58.02 -51.43 70.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.893 -0.594 . . . . 10.0 110.931 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -60.04 -35.66 75.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.73 -0.668 . . . . 10.0 111.38 -178.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.461 ' HA ' ' CZ ' ' A' ' 124' ' ' ARG . 6.9 t70 -66.12 -38.24 87.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.879 0.371 . . . . 10.0 110.259 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.54 -38.29 83.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.128 -0.487 . . . . 10.0 110.1 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 119' ' ' ILE . 59.7 t -63.15 -39.56 85.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.879 -0.6 . . . . 10.0 110.1 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.461 ' CZ ' ' HA ' ' A' ' 121' ' ' ASP . 25.2 mtm105 -72.92 -30.36 63.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.95 -0.568 . . . . 10.0 110.873 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 35.2 mttp -70.98 -35.06 71.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.262 -0.427 . . . . 10.0 110.905 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 26.6 mt . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 116.325 -0.398 . . . . 10.0 110.795 179.88 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.17 0 CA-C-O 121.183 0.516 . . . . 10.0 110.735 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 20.4 mmm -103.45 102.22 12.13 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.079 -0.712 . . . . 10.0 109.079 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' PHE . . . . . 0.419 ' CE2' ' HA ' ' A' ' 119' ' ' ILE . 34.8 m-85 -94.6 114.93 26.97 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.882 -0.599 . . . . 10.0 111.443 -178.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -75.56 121.57 22.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.813 -0.631 . . . . 10.0 110.522 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 12.6 pt -116.05 13.23 7.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.248 -0.433 . . . . 10.0 110.856 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 167.7 -179.31 41.16 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.778 -0.646 . . . . 10.0 111.874 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . 0.507 ' O ' ' HD2' ' B' ' 69' ' ' ARG . 0.3 OUTLIER -69.55 111.22 5.23 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.895 0.378 . . . . 10.0 110.06 -179.758 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' MET . . . . . 0.459 ' HB2' ' O ' ' B' ' 67' ' ' LYS . 49.2 mtp 73.17 8.75 5.31 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.2 -0.909 . . . . 10.0 111.175 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' ARG . . . . . 0.507 ' HD2' ' O ' ' B' ' 67' ' ' LYS . 1.5 mpt_? -105.1 118.95 37.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.496 -0.32 . . . . 10.0 110.213 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -132.74 124.09 27.47 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.881 0.372 . . . . 10.0 111.725 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.457 HG12 HG23 ' B' ' 73' ' ' VAL . 46.7 t -76.4 105.32 5.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.716 -0.846 . . . . 10.0 108.716 178.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 5.2 m -84.21 87.77 7.19 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.949 -0.569 . . . . 10.0 111.665 -178.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.653 HG21 HG23 ' A' ' 119' ' ' ILE . 67.5 t -93.87 120.14 42.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.31 -0.626 . . . . 10.0 109.31 178.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . 0.647 HH12 ' HB2' ' B' ' 83' ' ' ASP . 0.1 OUTLIER -164.43 172.9 12.77 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.217 -0.447 . . . . 10.0 110.45 -179.375 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -94.11 118.29 31.32 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.047 -0.524 . . . . 10.0 109.91 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -108.36 92.69 4.16 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.307 -0.406 . . . . 10.0 110.306 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 93.5 mttt 60.72 33.44 20.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.357 -0.838 . . . . 10.0 111.824 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 102.78 -1.97 48.68 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.619 -0.801 . . . . 10.0 113.146 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -119.37 115.99 25.26 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 122.596 -0.355 . . . . 10.0 111.216 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . 0.486 ' O ' ' HD3' ' B' ' 106' ' ' PRO . 28.5 t -75.64 106.6 5.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.172 -0.677 . . . . 10.0 109.172 178.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 80.6 mt -107.68 127.85 54.03 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.188 0.518 . . . . 10.0 112.163 -178.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' ILE . . . . . . . . . . . . . 5.0 mp -92.47 95.62 5.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 107.503 -1.295 . . . . 10.0 107.503 177.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . 0.647 ' HB2' HH12 ' B' ' 74' ' ' ARG . 3.4 t70 -91.07 117.42 29.58 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 112.677 0.621 . . . . 10.0 112.677 -177.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 77.9 mt -100.16 98.9 7.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 107.953 -1.129 . . . . 10.0 107.953 177.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' ARG . . . . . 0.54 ' HG3' ' HA3' ' B' ' 101' ' ' GLY . 8.9 ttm-85 -147.64 166.35 27.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.227 -0.442 . . . . 10.0 111.238 -177.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.87 157.07 17.46 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.917 -0.771 . . . . 10.0 108.917 178.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -121.03 120.73 36.22 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.961 0.41 . . . . 10.0 110.513 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' TRP . . . . . . . . . . . . . 36.2 m95 -103.52 138.32 40.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.764 -0.653 . . . . 10.0 110.173 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' MET . . . . . 0.503 ' HA ' ' O ' ' B' ' 94' ' ' GLU . 58.1 ttm -91.21 132.28 36.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.756 0.312 . . . . 10.0 110.668 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' ASP . . . . . 0.514 ' HB2' ' HD2' ' B' ' 91' ' ' PRO . 8.7 p30 -91.97 173.14 5.52 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 116.298 -0.41 . . . . 10.0 110.144 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' PRO . . . . . 0.514 ' HD2' ' HB2' ' B' ' 90' ' ' ASP . 39.5 Cg_exo -59.45 -26.28 81.43 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.482 2.121 . . . . 10.0 112.489 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -71.36 -26.43 62.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.004 0.431 . . . . 10.0 110.147 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 104.85 16.71 16.29 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.986 -0.626 . . . . 10.0 112.643 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' GLU . . . . . 0.503 ' O ' ' HA ' ' B' ' 89' ' ' MET . 16.3 mt-10 -98.22 155.23 17.28 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.893 0.378 . . . . 10.0 110.749 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' MET . . . . . . . . . . . . . 98.8 mmm -101.62 100.46 10.86 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.66 -0.496 . . . . 10.0 109.66 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . 0.414 ' HA ' ' HD3' ' B' ' 97' ' ' PRO . 71.8 mmtt -97.75 140.14 21.77 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 116.164 -0.471 . . . . 10.0 110.895 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 97' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' B' ' 96' ' ' LYS . 38.2 Cg_exo -60.31 143.16 99.49 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 122.569 2.179 . . . . 10.0 111.337 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.47 168.62 21.24 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 116.1 -0.5 . . . . 10.0 112.923 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 99' ' ' ARG . . . . . 0.441 HH11 ' HD2' ' B' ' 99' ' ' ARG . 8.1 mmt180 -79.85 -3.76 49.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.076 0.465 . . . . 10.0 111.136 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . 0.403 ' HB2' ' H ' ' B' ' 101' ' ' GLY . 3.9 pttp -117.79 -160.35 0.78 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.984 -0.746 . . . . 10.0 108.984 178.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' GLY . . . . . 0.54 ' HA3' ' HG3' ' B' ' 85' ' ' ARG . . . 108.53 168.24 21.05 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.655 -0.783 . . . . 10.0 112.386 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 20.9 tt -144.82 139.99 23.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.942 0.401 . . . . 10.0 110.869 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 3.8 m -102.69 110.3 22.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.006 -0.543 . . . . 10.0 110.003 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 92.9 mt -104.06 135.18 46.05 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.053 0.454 . . . . 10.0 111.24 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' ASN . . . . . 0.554 ' ND2' ' HB3' ' B' ' 107' ' ' GLU . 34.1 p-10 -93.1 165.77 17.78 Favored Pre-proline 0 C--N 1.317 -0.83 0 N-CA-C 108.698 -0.853 . . . . 10.0 108.698 178.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' B' ' 80' ' ' VAL . 73.7 Cg_exo -50.39 -32.43 33.83 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.505 2.137 . . . . 10.0 112.51 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' GLU . . . . . 0.554 ' HB3' ' ND2' ' B' ' 105' ' ' ASN . 6.4 tt0 -63.29 -53.51 51.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.607 -0.724 . . . . 10.0 110.948 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' GLN . . . . . 0.697 ' HG2' ' HA3' ' A' ' 66' ' ' GLY . 76.3 mt-30 -75.01 -30.49 61.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.925 0.393 . . . . 10.0 110.307 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' TRP . . . . . . . . . . . . . 46.7 t-105 -59.55 -41.26 89.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.771 -0.649 . . . . 10.0 109.777 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' SER . . . . . 0.627 ' HA ' ' HE3' ' B' ' 113' ' ' LYS . 22.9 t -63.32 -49.32 74.44 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.609 -0.515 . . . . 10.0 109.609 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -58.6 -40.6 83.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.683 -0.689 . . . . 10.0 110.96 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . 0.545 ' O ' HG13 ' B' ' 116' ' ' ILE . 63.5 tp -58.28 -44.68 88.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.557 -0.292 . . . . 10.0 110.214 178.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' LYS . . . . . 0.627 ' HE3' ' HA ' ' B' ' 110' ' ' SER . 51.2 mtmt -62.98 -41.64 99.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.109 -0.496 . . . . 10.0 110.529 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -68.81 -35.52 77.09 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.72 -0.673 . . . . 10.0 111.41 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' GLN . . . . . 0.426 ' HA ' ' OE1' ' B' ' 115' ' ' GLN . 13.6 mm-40 -75.27 -14.75 60.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.254 -0.43 . . . . 10.0 111.398 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' ILE . . . . . 0.545 HG13 ' O ' ' B' ' 112' ' ' LEU . 56.3 mt -57.99 -37.76 63.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 120.705 0.288 . . . . 10.0 110.6 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 1.1 m -65.0 -7.26 10.96 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.066 -0.516 . . . . 10.0 111.706 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -116.7 -47.11 2.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.056 0.455 . . . . 10.0 110.424 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . 0.529 ' O ' HG23 ' B' ' 123' ' ' VAL . 65.9 mt -64.66 -49.33 80.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.809 -0.632 . . . . 10.0 111.821 -179.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . 0.534 ' HB2' ' HZ2' ' A' ' 109' ' ' TRP . 34.2 t70 -58.1 -40.03 80.12 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.922 0.391 . . . . 10.0 111.106 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -64.66 -36.99 86.06 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.829 -0.623 . . . . 10.0 110.513 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.42 -24.85 60.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.942 -0.572 . . . . 10.0 111.599 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . 0.529 HG23 ' O ' ' B' ' 119' ' ' ILE . 89.3 t -58.53 -37.63 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 121.04 0.448 . . . . 10.0 110.847 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -100.6 16.42 24.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.309 -0.405 . . . . 10.0 110.809 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -132.83 31.35 3.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.172 -0.467 . . . . 10.0 110.247 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 82.3 mt . . . . . 0 C--O 1.247 0.944 0 CA-C-O 118.607 -0.711 . . . . 10.0 110.32 179.826 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 465' ' ' TYR . . . . . . . . . . . . . 4.2 t80 . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 120.75 0.309 . . . . 10.0 110.811 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 466' ' ' GLY . . . . . . . . . . . . . . . -80.34 33.42 2.26 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 121.087 -0.577 . . . . 10.0 114.109 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 467' ' ' ALA . . . . . . . . . . . . . . . -85.03 -27.43 26.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.355 0.598 . . . . 10.0 110.136 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 468' ' ' LEU . . . . . . . . . . . . . 13.8 tp -85.88 72.67 10.47 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.599 -0.728 . . . . 10.0 110.054 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 469' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -139.59 -114.97 0.14 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.016 -0.538 . . . . 10.0 110.672 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 470' ' ' MET . . . . . . . . . . . . . 57.3 mmm -59.18 -31.09 68.68 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 111.825 0.305 . . . . 10.0 111.825 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 471' ' ' ALA . . . . . 0.431 ' O ' ' HB2' ' C' ' 475' ' ' PHE . . . -60.04 -48.3 82.28 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.266 -0.424 . . . . 10.0 110.804 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 472' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -78.96 -30.62 44.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 10.0 110.386 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 473' ' ' PHE . . . . . 0.457 ' O ' ' HG3' ' C' ' 477' ' ' GLN . 44.9 t80 -50.95 -59.85 3.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.233 -0.894 . . . . 10.0 111.199 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 474' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -74.71 -26.44 59.81 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.492 -0.322 . . . . 10.0 110.817 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 475' ' ' PHE . . . . . 0.431 ' HB2' ' O ' ' C' ' 471' ' ' ALA . 9.9 t80 -57.73 -47.35 82.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.887 0.375 . . . . 10.0 111.243 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 476' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -78.61 -33.54 47.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.371 -0.377 . . . . 10.0 111.062 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 477' ' ' GLN . . . . . 0.808 ' HG2' ' HE1' ' A' ' 76' ' ' PHE . 26.3 mt-30 -64.75 -56.27 14.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.436 -0.347 . . . . 10.0 110.829 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 478' ' ' MET . . . . . 0.526 ' HA ' ' OD2' ' C' ' 481' ' ' ASP . 21.2 ttt -59.27 -31.85 69.48 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.521 -0.763 . . . . 10.0 111.826 -178.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 479' ' ' PHE . . . . . 0.453 ' HD2' ' HD3' ' A' ' 85' ' ' ARG . 9.8 t80 -62.72 -37.3 85.98 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.517 -0.473 . . . . 10.0 110.525 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 480' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.81 -31.14 70.79 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.296 0.57 . . . . 10.0 109.841 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 481' ' ' ASP . . . . . 0.692 ' O ' ' HB ' ' C' ' 485' ' ' ILE . 61.5 m-20 -66.69 -31.99 73.01 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-N 115.397 -0.819 . . . . 10.0 109.594 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 482' ' ' ALA . . . . . . . . . . . . . . . -85.57 -36.68 20.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.795 -0.639 . . . . 10.0 111.174 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 483' ' ' LEU . . . . . . . . . . . . . 11.9 mt -65.68 -47.36 75.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.342 -0.39 . . . . 10.0 110.778 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 484' ' ' GLY . . . . . 0.451 ' HA2' ' HB2' ' C' ' 487' ' ' GLU . . . -110.19 37.83 3.58 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.423 -0.894 . . . . 10.0 113.203 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 485' ' ' ILE . . . . . 0.692 ' HB ' ' O ' ' C' ' 481' ' ' ASP . 6.9 tt -76.73 -39.22 31.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.185 0.517 . . . . 10.0 110.647 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 486' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -104.16 4.92 34.59 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.024 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 487' ' ' GLU . . . . . 0.673 ' HG3' ' HB3' ' A' ' 105' ' ' ASN . 14.6 tp10 -71.64 -22.74 61.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.676 -0.693 . . . . 10.0 110.751 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 488' ' ' TYR . . . . . 0.525 ' HE2' ' HG3' ' A' ' 79' ' ' LYS . 6.2 m-85 -78.8 58.6 2.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.754 0.787 . . . . 10.0 109.681 178.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 489' ' ' GLY . . . . . . . . . . . . . . . 149.39 35.55 0.04 OUTLIER Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 114.748 -1.114 . . . . 10.0 110.611 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.647 0 CA-C-O 118.82 -0.989 . . . . 10.0 111.31 -179.81 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.624 ' HB3' ' HB ' ' A' ' 73' ' ' VAL . . . . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 109.827 -0.434 . . . . 10.0 109.827 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.549 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 41.7 ttm -112.29 103.04 11.16 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.107 0.479 . . . . 10.0 111.316 -179.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.474 ' HB2' ' HB ' ' A' ' 71' ' ' VAL . 88.1 m-85 -89.42 173.95 8.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.903 -0.59 . . . . 10.0 109.577 179.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.426 ' HG2' ' H ' ' A' ' 66' ' ' GLY . 39.9 tt0 -127.42 126.55 42.6 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.615 0.245 . . . . 10.0 110.64 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.586 HD11 HG23 ' A' ' 84' ' ' ILE . 10.7 pt -117.39 15.44 7.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.321 -0.4 . . . . 10.0 110.885 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.426 ' H ' ' HG2' ' A' ' 64' ' ' GLN . . . 154.07 175.75 25.66 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.312 -0.947 . . . . 10.0 112.595 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.606 ' HG2' ' HG2' ' A' ' 68' ' ' MET . 42.0 tttp -60.12 113.48 2.37 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 122.698 0.399 . . . . 10.0 110.91 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.606 ' HG2' ' HG2' ' A' ' 67' ' ' LYS . 66.8 mmm 69.87 17.68 7.51 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 123.784 0.678 . . . . 10.0 111.644 179.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.482 ' HB3' HG13 ' A' ' 65' ' ' ILE . 5.9 mpt_? -119.94 107.29 12.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.088 0.471 . . . . 10.0 109.936 178.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.509 ' HB3' ' HG2' ' A' ' 62' ' ' MET . 63.8 m-85 -115.3 152.0 33.55 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.728 -0.669 . . . . 10.0 110.838 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.638 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 23.4 t -102.05 111.59 32.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.421 -0.809 . . . . 10.0 110.203 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.633 ' HB2' ' HB3' ' A' ' 83' ' ' ASP . 0.9 OUTLIER -85.14 87.75 7.41 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.027 0.441 . . . . 10.0 111.43 -179.486 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.684 HG22 HG22 ' A' ' 82' ' ' ILE . 16.5 t -86.98 108.21 17.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.589 -0.893 . . . . 10.0 108.589 178.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -153.77 -179.64 8.01 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.306 0.574 . . . . 10.0 111.998 -178.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.523 ' HB2' HG22 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -120.53 123.02 41.88 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.814 -1.085 . . . . 10.0 109.075 178.457 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.558 ' CE2' ' HB ' ' C' ' 480' ' ' THR . 0.5 OUTLIER -115.67 86.11 2.41 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.014 0.435 . . . . 10.0 110.929 179.296 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt 57.35 41.49 26.38 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.257 -0.883 . . . . 10.0 111.348 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 112.38 -24.5 13.81 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.511 -0.852 . . . . 10.0 112.346 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.893 ' HE3' ' HA ' ' C' ' 485' ' ' ILE . 1.7 mppt? -84.3 82.72 8.26 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.887 0.375 . . . . 10.0 110.554 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.523 HG22 ' HB2' ' A' ' 75' ' ' ASP . 2.8 t -90.37 103.37 14.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 108.958 -0.756 . . . . 10.0 108.958 178.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.741 ' HB3' ' HA ' ' A' ' 105' ' ' ASN . 0.2 OUTLIER -157.97 174.19 15.63 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.952 0.406 . . . . 10.0 111.369 -178.479 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.684 HG22 HG22 ' A' ' 73' ' ' VAL . 38.7 pt -92.64 172.39 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.993 -0.549 . . . . 10.0 110.194 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.638 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 4.1 t70 -151.01 147.49 27.2 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.617 0.246 . . . . 10.0 111.216 -178.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.586 HG23 HD11 ' A' ' 65' ' ' ILE . 60.7 mt -121.22 106.83 19.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.326 -0.62 . . . . 10.0 109.326 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.489 ' HD3' HD11 ' C' ' 483' ' ' LEU . 60.2 mtm180 -129.72 151.89 49.82 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.949 0.404 . . . . 10.0 111.451 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -83.11 97.73 8.95 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.382 -0.97 . . . . 10.0 108.382 178.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 97' ' ' PRO . 18.6 m-85 -81.32 142.68 32.84 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.434 -0.803 . . . . 10.0 112.693 -177.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 13.8 m0 -128.6 177.25 7.16 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.489 -0.93 . . . . 10.0 108.489 178.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 1.1 ttt -103.97 127.51 51.51 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 110.059 -0.349 . . . . 10.0 110.059 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.515 ' OD2' ' HB2' ' A' ' 94' ' ' GLU . 4.2 p30 -85.02 167.21 27.43 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.636 -0.256 . . . . 10.0 110.359 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -61.63 -19.25 64.23 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.904 2.403 . . . . 10.0 113.403 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -77.68 -46.79 20.88 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.077 0.465 . . . . 10.0 110.006 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 133.36 15.79 1.25 Allowed Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.982 -0.628 . . . . 10.0 112.5 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.515 ' HB2' ' OD2' ' A' ' 90' ' ' ASP . 23.9 mt-10 -106.94 179.18 4.34 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.858 0.361 . . . . 10.0 110.386 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 85.7 mmm -106.55 109.93 21.99 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.205 -0.452 . . . . 10.0 110.737 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.462 ' HA ' ' HD3' ' A' ' 97' ' ' PRO . 48.5 mmtt -125.37 128.67 24.66 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.828 -0.623 . . . . 10.0 109.577 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.485 ' HD2' ' CE2' ' C' ' 475' ' ' PHE . 4.6 Cg_endo -82.63 177.28 7.07 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.078 2.519 . . . . 10.0 113.129 -179.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -100.82 -169.27 28.59 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.794 -0.639 . . . . 10.0 111.884 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -80.09 55.98 2.29 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.839 0.352 . . . . 10.0 111.282 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -160.6 132.98 6.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.261 -0.427 . . . . 10.0 110.231 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.446 ' HA3' ' HG2' ' A' ' 85' ' ' ARG . . . 172.19 -170.95 43.91 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.066 -0.588 . . . . 10.0 111.754 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.471 ' HB ' ' N ' ' B' ' 101' ' ' GLY . 8.9 tt -165.85 127.56 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.945 0.402 . . . . 10.0 110.897 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.583 ' HA ' ' HA ' ' A' ' 83' ' ' ASP . 51.7 m -105.56 145.05 31.47 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.235 -0.654 . . . . 10.0 109.235 178.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.423 HD11 HD11 ' A' ' 82' ' ' ILE . 0.5 OUTLIER -131.59 129.68 41.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.028 0.442 . . . . 10.0 110.351 179.71 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.741 ' HA ' ' HB3' ' A' ' 81' ' ' LEU . 3.5 p30 -75.25 164.0 64.08 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.36 -0.837 . . . . 10.0 111.263 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -48.27 -38.37 33.52 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.619 2.88 . . . . 10.0 114.224 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -65.31 -42.22 93.23 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.042 -0.355 . . . . 10.0 110.042 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -65.48 -45.37 83.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.136 0.493 . . . . 10.0 109.801 178.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 56.2 t-105 -56.79 -42.43 79.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.281 -0.872 . . . . 10.0 110.462 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.4 m -65.49 -46.42 79.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.269 -0.423 . . . . 10.0 110.605 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -61.5 -42.74 99.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.494 . . . . 10.0 110.847 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.438 ' O ' HG13 ' A' ' 116' ' ' ILE . 53.8 tp -57.85 -45.75 85.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.901 -0.591 . . . . 10.0 111.314 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -59.0 -42.47 90.15 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.328 -0.396 . . . . 10.0 111.322 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -74.04 -16.99 61.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.184 -0.462 . . . . 10.0 111.758 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -93.14 -10.6 35.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.745 0.307 . . . . 10.0 110.989 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 112' ' ' LEU . 70.7 mt -56.71 -37.53 53.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.571 -0.286 . . . . 10.0 111.45 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.14 -23.58 64.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.904 0.383 . . . . 10.0 111.397 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -97.73 -44.4 6.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.138 0.494 . . . . 10.0 110.088 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.498 ' O ' HG23 ' A' ' 123' ' ' VAL . 67.1 mt -60.25 -52.43 61.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.876 -0.602 . . . . 10.0 111.2 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -61.51 -33.82 74.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.995 -0.548 . . . . 10.0 110.268 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -66.41 -35.62 80.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.533 -0.758 . . . . 10.0 110.259 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.52 -37.42 63.09 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.932 -0.576 . . . . 10.0 110.767 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 119' ' ' ILE . 99.4 t -61.78 -34.54 62.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 10.0 110.805 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 13.9 mtm105 -78.05 -13.72 59.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.131 -0.486 . . . . 10.0 111.417 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -95.37 -31.48 13.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.862 0.363 . . . . 10.0 111.139 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 75.4 mt . . . . . 0 C--N 1.325 -0.48 0 CA-C-N 116.473 -0.33 . . . . 10.0 110.518 179.709 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.18 0 CA-C-O 121.019 0.438 . . . . 10.0 111.021 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 97.3 mmm -108.12 89.89 3.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.991 -0.55 . . . . 10.0 109.621 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -98.49 133.03 43.43 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.161 -0.472 . . . . 10.0 110.669 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -92.17 132.37 36.69 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.814 0.34 . . . . 10.0 110.746 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' ILE . . . . . 0.407 HD13 HD13 ' A' ' 112' ' ' LEU . 30.5 pt -125.73 16.86 4.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.188 0.518 . . . . 10.0 110.174 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 167.78 165.28 24.92 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.041 -0.824 . . . . 10.0 111.041 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . 0.543 ' O ' ' HD2' ' B' ' 69' ' ' ARG . 15.6 mttp -64.07 116.6 6.07 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.944 0.372 . . . . 10.0 110.126 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' MET . . . . . . . . . . . . . 17.5 mmt 69.64 15.73 8.1 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.868 -0.605 . . . . 10.0 110.824 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' ARG . . . . . 0.543 ' HD2' ' O ' ' B' ' 67' ' ' LYS . 2.0 mpt_? -119.17 109.81 16.31 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.436 -0.579 . . . . 10.0 109.436 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' TYR . . . . . 0.451 ' HB2' ' HE2' ' B' ' 87' ' ' TYR . 88.5 m-85 -122.33 142.36 50.58 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.353 0.597 . . . . 10.0 112.078 -178.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 70.8 t -94.48 93.67 4.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 107.809 -1.182 . . . . 10.0 107.809 177.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 8.5 t -84.15 95.87 8.77 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.889 -0.596 . . . . 10.0 111.551 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.495 HG21 HG23 ' A' ' 119' ' ' ILE . 17.4 t -90.07 87.92 2.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.533 -0.914 . . . . 10.0 108.533 178.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' B' ' 74' ' ' ARG . 10.4 ptt-85 -118.09 172.97 7.05 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.146 -0.479 . . . . 10.0 111.207 -178.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -105.54 128.87 53.83 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.811 -0.631 . . . . 10.0 110.67 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -108.8 78.0 1.11 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.302 -0.408 . . . . 10.0 109.93 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 35.5 mttm 60.56 50.97 5.36 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.713 -0.676 . . . . 10.0 111.768 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.18 4.61 71.29 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.683 -0.77 . . . . 10.0 112.356 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -118.29 99.3 6.76 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.65 0.262 . . . . 10.0 110.373 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 41.7 t -67.46 116.88 7.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.653 -0.499 . . . . 10.0 109.653 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 95.9 mt -123.53 132.03 53.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.232 0.539 . . . . 10.0 111.818 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' ILE . . . . . 0.401 HD13 ' HB2' ' B' ' 109' ' ' TRP . 5.2 mp -92.63 87.72 2.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 107.834 -1.173 . . . . 10.0 107.834 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . 0.632 ' HA ' ' HA ' ' B' ' 103' ' ' SER . 34.1 t70 -85.39 94.79 9.06 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.745 -0.662 . . . . 10.0 112.014 -178.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 50.9 mt -87.43 99.62 8.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 107.272 -1.381 . . . . 10.0 107.272 177.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' ARG . . . . . 0.735 ' HG3' ' HA3' ' B' ' 101' ' ' GLY . 12.7 ttm-85 -138.33 154.97 48.98 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.28 0.562 . . . . 10.0 111.819 -177.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' GLU . . . . . 0.516 ' HG3' ' HA3' ' B' ' 98' ' ' GLY . 17.1 pt-20 -82.25 148.82 28.17 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.362 -0.835 . . . . 10.0 109.56 178.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' TYR . . . . . 0.451 ' HE2' ' HB2' ' B' ' 70' ' ' TYR . 62.8 m-85 -132.65 121.63 23.45 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.594 -0.521 . . . . 10.0 109.594 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' TRP . . . . . . . . . . . . . 23.7 m0 -99.19 143.44 29.46 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.225 -0.443 . . . . 10.0 110.469 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 42.6 ttm -84.62 120.18 26.07 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.314 -0.403 . . . . 10.0 110.061 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.52 163.65 53.29 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.963 -0.562 . . . . 10.0 110.856 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -57.83 -32.34 94.69 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.233 2.622 . . . . 10.0 113.44 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.44 -49.57 66.27 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.888 0.375 . . . . 10.0 110.465 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 136.68 24.73 0.47 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.718 -0.754 . . . . 10.0 112.669 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' GLU . . . . . 0.808 ' HB2' ' HE2' ' B' ' 96' ' ' LYS . 26.9 mt-10 -115.35 161.98 17.76 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.938 0.399 . . . . 10.0 110.606 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' MET . . . . . . . . . . . . . 96.9 mmm -101.55 106.24 17.3 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.871 -0.604 . . . . 10.0 109.387 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . 0.808 ' HE2' ' HB2' ' B' ' 94' ' ' GLU . 35.4 mmtt -98.91 136.25 20.67 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 116.127 -0.488 . . . . 10.0 110.233 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -58.21 139.16 89.46 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.756 2.304 . . . . 10.0 112.194 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . 0.516 ' HA3' ' HG3' ' B' ' 86' ' ' GLU . . . -82.62 -140.13 3.53 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 121.061 -0.59 . . . . 10.0 112.455 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 60.8 mtp85 -117.32 -27.57 6.38 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.945 0.402 . . . . 10.0 110.645 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . 0.441 ' HG2' HD23 ' C' ' 483' ' ' LEU . 4.3 mtmt -88.57 114.32 25.07 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.945 -0.571 . . . . 10.0 110.134 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' GLY . . . . . 0.735 ' HA3' ' HG3' ' B' ' 85' ' ' ARG . . . 166.01 156.81 9.63 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.522 -0.847 . . . . 10.0 112.727 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 18.8 tt -156.38 140.92 8.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.001 0.429 . . . . 10.0 110.402 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' SER . . . . . 0.632 ' HA ' ' HA ' ' B' ' 83' ' ' ASP . 3.4 m -88.56 108.23 19.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.209 -0.45 . . . . 10.0 110.29 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 68.5 mt -87.12 131.5 34.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.206 -0.452 . . . . 10.0 110.443 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -88.2 166.65 22.71 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 109.295 -0.631 . . . . 10.0 109.295 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -47.13 -32.44 13.65 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.005 2.47 . . . . 10.0 113.251 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -67.45 -56.12 10.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.291 -0.413 . . . . 10.0 110.46 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -63.33 -34.07 76.91 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.044 -0.525 . . . . 10.0 110.285 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' TRP . . . . . 0.401 ' HB2' HD13 ' B' ' 82' ' ' ILE . 52.0 t-105 -61.37 -43.06 99.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.857 -0.61 . . . . 10.0 109.908 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 1.6 t -66.29 -45.46 80.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.807 -0.633 . . . . 10.0 109.494 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -56.52 -47.97 78.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.51 -0.768 . . . . 10.0 111.014 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 56.4 tp -58.62 -43.8 89.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.257 -0.429 . . . . 10.0 110.753 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -63.13 -38.54 91.6 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.953 0.406 . . . . 10.0 111.193 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -80.72 -6.65 58.73 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.203 -0.453 . . . . 10.0 111.503 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 13.6 mm-40 -105.26 -6.01 20.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.664 0.269 . . . . 10.0 111.078 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' ILE . . . . . 0.464 ' O ' ' HB2' ' B' ' 120' ' ' ASP . 85.1 mt -52.49 -47.23 48.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 10.0 111.921 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.57 -40.94 72.63 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.227 0.454 . . . . 10.0 112.227 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -76.04 -47.36 25.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.358 -0.383 . . . . 10.0 111.537 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . 0.453 ' O ' HG23 ' B' ' 123' ' ' VAL . 70.5 mt -64.21 -42.35 95.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.729 0.299 . . . . 10.0 110.904 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' B' ' 116' ' ' ILE . 2.1 t70 -60.68 -37.37 81.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.118 0.485 . . . . 10.0 110.422 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -69.33 -31.44 69.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.695 -0.684 . . . . 10.0 110.55 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.04 -32.44 63.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.259 -0.428 . . . . 10.0 110.212 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . 0.453 HG23 ' O ' ' B' ' 119' ' ' ILE . 95.0 t -69.2 -41.79 81.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.987 -0.551 . . . . 10.0 110.769 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . 0.709 ' HG3' ' HG3' ' B' ' 125' ' ' LYS . 7.8 ptp180 -75.27 -31.52 60.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.509 -0.314 . . . . 10.0 111.095 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 125' ' ' LYS . . . . . 0.709 ' HG3' ' HG3' ' B' ' 124' ' ' ARG . 86.0 mttt -107.79 78.09 1.17 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.426 -0.352 . . . . 10.0 110.805 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 94.6 mt . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.911 -0.566 . . . . 10.0 110.006 179.622 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 465' ' ' TYR . . . . . . . . . . . . . 28.5 t80 . . . . . 0 N--CA 1.48 1.048 0 CA-C-O 120.653 0.263 . . . . 10.0 110.488 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 466' ' ' GLY . . . . . . . . . . . . . . . -54.52 -42.07 74.9 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 121.297 -0.477 . . . . 10.0 112.513 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 467' ' ' ALA . . . . . . . . . . . . . . . -63.38 -38.15 90.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.047 0.451 . . . . 10.0 110.947 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 468' ' ' LEU . . . . . . . . . . . . . 65.2 tp -68.99 -40.92 78.49 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.996 -0.547 . . . . 10.0 110.539 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 469' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -65.91 -36.3 83.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.041 0.448 . . . . 10.0 110.723 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 470' ' ' MET . . . . . 0.529 ' HA ' ' HD2' ' C' ' 473' ' ' PHE . 90.1 mmm -71.49 -21.93 61.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.167 -0.47 . . . . 10.0 110.625 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 471' ' ' ALA . . . . . . . . . . . . . . . -69.38 -26.01 64.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.337 -0.392 . . . . 10.0 110.982 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 472' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -68.72 -24.94 64.53 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.024 0.44 . . . . 10.0 110.077 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 473' ' ' PHE . . . . . 0.529 ' HD2' ' HA ' ' C' ' 470' ' ' MET . 63.4 m-85 -74.35 -3.95 33.42 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.899 -0.591 . . . . 10.0 110.392 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 474' ' ' GLU . . . . . 0.403 ' O ' ' HB3' ' C' ' 478' ' ' MET . 1.5 tm-20 -101.33 -51.34 3.52 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.949 -0.76 . . . . 10.0 108.949 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 475' ' ' PHE . . . . . 0.485 ' CE2' ' HD2' ' A' ' 97' ' ' PRO . 50.7 t80 -68.53 -63.74 1.0 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.67 -0.695 . . . . 10.0 111.158 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 476' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -81.62 49.86 1.4 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.104 0.478 . . . . 10.0 111.531 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 477' ' ' GLN . . . . . 0.468 HE21 ' HB3' ' C' ' 477' ' ' GLN . 0.6 OUTLIER -165.05 -46.78 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.94 -0.573 . . . . 10.0 110.204 179.602 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 478' ' ' MET . . . . . 0.403 ' HB3' ' O ' ' C' ' 474' ' ' GLU . 27.8 ttp -95.19 -50.86 4.87 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.185 -0.462 . . . . 10.0 110.454 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 479' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -63.14 -51.74 65.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 10.0 111.159 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 480' ' ' THR . . . . . 0.558 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 0.2 OUTLIER -65.38 -17.12 64.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.283 -0.417 . . . . 10.0 112.017 -179.719 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 481' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -86.15 -47.5 9.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.003 0.43 . . . . 10.0 109.864 179.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 482' ' ' ALA . . . . . . . . . . . . . . . -63.67 -22.85 67.12 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.505 -0.771 . . . . 10.0 111.257 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 483' ' ' LEU . . . . . 0.506 HD12 ' HA ' ' C' ' 480' ' ' THR . 29.6 mt -64.39 -23.98 67.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.318 -0.401 . . . . 10.0 111.291 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 484' ' ' GLY . . . . . 0.431 ' HA2' ' HG2' ' C' ' 487' ' ' GLU . . . -141.17 28.55 2.35 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.47 -0.871 . . . . 10.0 112.229 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 485' ' ' ILE . . . . . 0.893 ' HA ' ' HE3' ' A' ' 79' ' ' LYS . 12.9 tt -71.85 -39.96 68.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.835 0.35 . . . . 10.0 111.061 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 486' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -99.14 10.68 40.97 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.857 0.361 . . . . 10.0 110.752 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 487' ' ' GLU . . . . . 0.596 ' HB3' ' HB3' ' A' ' 105' ' ' ASN . 5.2 mm-40 -63.79 -30.0 71.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.075 -0.512 . . . . 10.0 111.689 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 488' ' ' TYR . . . . . 0.838 ' HE2' ' HA ' ' A' ' 79' ' ' LYS . 5.8 m-85 -73.36 -3.03 24.68 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.952 0.406 . . . . 10.0 111.001 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 489' ' ' GLY . . . . . . . . . . . . . . . -117.48 13.63 13.47 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 121.07 -0.586 . . . . 10.0 111.787 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.785 0 CA-C-O 118.702 -1.054 . . . . 10.0 112.177 -179.898 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 110.412 -0.218 . . . . 10.0 110.412 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 54.0 ttm -107.44 115.46 30.2 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.968 -0.382 . . . . 10.0 109.968 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -98.83 149.75 22.58 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.413 -0.358 . . . . 10.0 110.482 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -102.83 124.35 48.18 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.699 0.285 . . . . 10.0 111.239 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 37.1 pt -116.38 0.31 8.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.368 -0.378 . . . . 10.0 110.859 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.464 ' HA3' ' NE2' ' B' ' 108' ' ' GLN . . . 168.45 -179.02 41.71 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.509 -0.853 . . . . 10.0 112.522 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.591 ' HG2' ' HG2' ' A' ' 68' ' ' MET . 37.3 tttp -64.4 117.52 7.39 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.728 0.299 . . . . 10.0 110.92 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.591 ' HG2' ' HG2' ' A' ' 67' ' ' LYS . 39.9 mmm 65.3 7.95 4.58 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.434 -0.803 . . . . 10.0 112.033 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -113.54 112.11 23.01 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.733 -0.469 . . . . 10.0 109.733 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.556 ' HB2' ' CD1' ' A' ' 87' ' ' TYR . 98.1 m-85 -125.55 157.05 38.06 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.08 -0.509 . . . . 10.0 111.342 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 86.3 t -117.78 101.0 11.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.048 -0.978 . . . . 10.0 109.344 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.9 m -89.42 98.72 11.93 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.109 -0.496 . . . . 10.0 110.987 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.1 t -86.64 117.64 31.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.066 -0.516 . . . . 10.0 110.213 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.946 HH12 ' HB2' ' A' ' 83' ' ' ASP . 27.1 ptt-85 -136.62 173.2 11.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.234 -0.439 . . . . 10.0 110.141 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -113.33 153.08 29.07 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.755 0.312 . . . . 10.0 110.351 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.563 ' HD1' ' HG3' ' A' ' 77' ' ' LYS . 1.5 t80 -161.16 119.34 2.41 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.085 -0.507 . . . . 10.0 109.842 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.563 ' HG3' ' HD1' ' A' ' 76' ' ' PHE . 30.4 mtmt 66.34 25.21 10.45 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.504 0.502 . . . . 10.0 110.264 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.41 1.89 90.52 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.706 -0.759 . . . . 10.0 111.399 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -102.12 -175.86 2.96 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.988 -0.375 . . . . 10.0 109.988 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.628 HG21 HG13 ' B' ' 123' ' ' VAL . 42.5 t -119.61 137.0 54.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.039 0.447 . . . . 10.0 111.267 -178.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.481 HD22 ' HB1' ' C' ' 482' ' ' ALA . 73.6 mt -121.27 100.83 7.26 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.482 -0.781 . . . . 10.0 110.301 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.45 ' HB ' ' HB2' ' A' ' 104' ' ' LEU . 44.8 mt -89.17 95.49 5.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.303 -0.629 . . . . 10.0 109.303 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.946 ' HB2' HH12 ' A' ' 74' ' ' ARG . 0.8 OUTLIER -79.34 109.97 14.18 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.464 0.542 . . . . 10.0 112.464 -177.748 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 35.3 mt -109.27 90.88 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.395 -0.965 . . . . 10.0 108.395 177.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 1.004 ' HG3' ' HA3' ' A' ' 101' ' ' GLY . 1.4 ttm-85 -137.35 168.07 20.36 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.969 -0.56 . . . . 10.0 111.678 -177.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -91.64 129.77 37.56 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.413 -0.958 . . . . 10.0 108.413 178.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.586 ' HB3' ' HB3' ' A' ' 95' ' ' MET . 95.8 m-85 -114.02 118.6 34.55 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.9 0.381 . . . . 10.0 110.068 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 81.6 m95 -102.43 146.23 28.39 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.896 -0.593 . . . . 10.0 110.726 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 34.2 ttm -68.35 128.63 37.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.144 -0.48 . . . . 10.0 111.474 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.407 ' HB2' ' CD ' ' A' ' 91' ' ' PRO . 34.5 p30 -97.46 171.79 5.61 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 115.61 -0.723 . . . . 10.0 110.845 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.407 ' CD ' ' HB2' ' A' ' 90' ' ' ASP . 3.2 Cg_exo -78.39 32.0 0.45 Allowed 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.927 2.418 . . . . 10.0 111.711 178.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.479 ' HB2' ' HB2' ' C' ' 467' ' ' ALA . 19.3 tp10 -123.0 -44.4 2.18 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.976 -0.749 . . . . 10.0 108.976 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 126.93 18.49 2.12 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 114.871 -1.059 . . . . 10.0 110.973 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.524 ' HG2' ' H ' ' A' ' 95' ' ' MET . 16.7 tt0 -121.24 -177.68 3.58 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.806 -0.442 . . . . 10.0 109.806 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.586 ' HB3' ' HB3' ' A' ' 87' ' ' TYR . 61.0 mmm -117.57 115.16 24.56 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.791 -0.448 . . . . 10.0 109.791 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.439 ' HA ' ' HD3' ' A' ' 97' ' ' PRO . 9.3 mmpt? -95.36 139.58 22.05 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.138 -0.483 . . . . 10.0 110.572 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.664 ' HD2' ' HB2' ' C' ' 474' ' ' GLU . 11.7 Cg_exo -69.36 118.8 5.9 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.941 2.427 . . . . 10.0 112.622 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -70.14 168.87 47.22 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 121.173 -0.537 . . . . 10.0 111.827 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.481 ' HD3' ' HA ' ' A' ' 99' ' ' ARG . 9.4 mmt180 -81.24 56.53 2.89 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.873 0.368 . . . . 10.0 111.8 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 13.2 ttmt -167.29 108.38 0.62 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.779 -0.646 . . . . 10.0 109.901 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 1.004 ' HA3' ' HG3' ' A' ' 85' ' ' ARG . . . 170.44 175.98 39.58 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.017 -1.087 . . . . 10.0 112.929 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.421 HG22 HG22 ' B' ' 102' ' ' ILE . 13.9 tt -155.21 157.65 4.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.313 -0.625 . . . . 10.0 109.313 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.533 ' OG ' ' HA ' ' C' ' 482' ' ' ALA . 2.1 p -112.24 173.92 6.13 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 121.069 -0.252 . . . . 10.0 110.861 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.45 ' HB2' ' HB ' ' A' ' 82' ' ' ILE . 37.7 mt -136.7 149.95 48.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.412 -0.358 . . . . 10.0 110.301 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.514 ' HB3' ' HA ' ' C' ' 486' ' ' ASP . 11.9 p-10 -117.95 167.37 11.4 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 109.538 -0.541 . . . . 10.0 109.538 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.417 ' HD3' ' HB ' ' A' ' 80' ' ' VAL . 80.1 Cg_exo -47.27 -45.59 21.76 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.944 2.429 . . . . 10.0 113.389 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -56.48 -50.54 71.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.089 -0.505 . . . . 10.0 111.514 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.42 ' OE1' ' HD3' ' B' ' 69' ' ' ARG . 44.5 mt-30 -71.97 -36.75 69.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.432 -0.349 . . . . 10.0 110.701 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 69.0 t-105 -56.45 -45.21 80.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.916 -0.584 . . . . 10.0 111.029 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.0 t -61.6 -51.38 68.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.334 -0.393 . . . . 10.0 110.182 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -61.55 -37.23 83.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.082 -0.508 . . . . 10.0 111.508 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 66.5 tp -61.47 -45.11 95.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.921 0.391 . . . . 10.0 110.2 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -65.08 -36.26 83.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.267 0.556 . . . . 10.0 110.172 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -74.42 -9.21 58.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.476 -0.783 . . . . 10.0 111.48 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -112.01 1.71 16.52 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.706 -0.225 . . . . 10.0 111.53 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.5 mt -55.28 -53.29 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.659 -0.246 . . . . 10.0 111.344 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.85 -39.1 80.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 10.0 111.446 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.539 ' HB3' ' CE1' ' B' ' 63' ' ' PHE . 2.0 m-20 -67.19 -51.39 54.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.131 -0.486 . . . . 10.0 111.566 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.456 HG12 ' CD2' ' B' ' 63' ' ' PHE . 62.6 mt -65.33 -45.05 94.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.351 -0.386 . . . . 10.0 111.182 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -60.32 -42.09 94.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.103 -0.499 . . . . 10.0 111.612 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -66.33 -36.87 84.02 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 120.836 0.35 . . . . 10.0 110.195 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.13 -41.95 97.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.936 -0.575 . . . . 10.0 109.974 178.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 119' ' ' ILE . 97.3 t -65.52 -41.98 92.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.784 -0.644 . . . . 10.0 109.856 178.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 27.3 mtm105 -67.12 -22.62 65.79 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.746 -0.661 . . . . 10.0 111.144 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 35.6 mttp -78.63 -30.39 46.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 10.0 110.283 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 70.8 mt . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 115.993 -0.549 . . . . 10.0 110.679 179.993 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.162 0 CA-C-O 120.91 0.385 . . . . 10.0 110.756 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 86.5 mmm -95.09 84.64 4.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.058 0.456 . . . . 10.0 110.274 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' PHE . . . . . 0.539 ' CE1' ' HB3' ' A' ' 118' ' ' ASP . 97.9 m-85 -82.22 159.46 23.23 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.757 -0.656 . . . . 10.0 110.091 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -133.6 119.01 18.89 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.942 0.401 . . . . 10.0 110.972 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' ILE . . . . . 0.416 HD11 HG21 ' B' ' 84' ' ' ILE . 3.0 pt -97.02 95.05 4.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.137 -0.69 . . . . 10.0 109.137 178.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.82 -93.06 1.78 Allowed Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 110.74 -0.944 . . . . 10.0 110.74 -178.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . 0.499 ' O ' ' HD2' ' B' ' 69' ' ' ARG . 1.3 ttpm? -165.37 151.92 10.11 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.652 -0.499 . . . . 10.0 109.652 178.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' MET . . . . . 0.479 ' HB2' ' O ' ' B' ' 67' ' ' LYS . 1.2 mpt? 74.93 -50.76 0.67 Allowed 'General case' 0 N--CA 1.473 0.69 0 O-C-N 123.856 0.722 . . . . 10.0 111.67 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' ARG . . . . . 0.624 ' HD2' ' H ' ' B' ' 69' ' ' ARG . 1.6 mpt_? -75.7 110.51 10.17 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.752 0.311 . . . . 10.0 110.365 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -110.26 131.16 55.3 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.184 -0.462 . . . . 10.0 111.086 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 22.3 t -78.65 83.54 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.698 -0.853 . . . . 10.0 108.698 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 26.1 t -87.22 92.59 9.11 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.576 -0.738 . . . . 10.0 111.731 -178.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.725 HG13 HG12 ' B' ' 82' ' ' ILE . 3.8 t -86.0 73.69 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.657 -0.868 . . . . 10.0 108.657 177.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . 0.43 ' NH1' ' HB3' ' B' ' 83' ' ' ASP . 35.0 ptt-85 -102.29 144.05 31.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.484 0.659 . . . . 10.0 112.093 -177.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -82.71 126.22 32.12 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.974 -1.012 . . . . 10.0 108.939 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -118.27 100.97 7.84 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.644 0.259 . . . . 10.0 110.674 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 63.7 mttm 58.78 35.46 24.33 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.8 -0.636 . . . . 10.0 111.872 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.19 8.27 61.59 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.613 -0.803 . . . . 10.0 112.265 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . 0.403 ' HA ' ' HD3' ' B' ' 79' ' ' LYS . 42.0 mmtt -117.43 107.45 14.35 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-O 120.78 0.324 . . . . 10.0 110.681 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 21.9 t -74.42 105.26 3.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.529 -0.545 . . . . 10.0 109.529 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 98.5 mt -118.07 125.05 49.55 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.197 0.523 . . . . 10.0 111.364 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' ILE . . . . . 0.725 HG12 HG13 ' B' ' 73' ' ' VAL . 32.7 mt -85.87 82.84 2.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.16 -1.052 . . . . 10.0 108.16 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . 0.509 ' HA ' ' HA ' ' B' ' 103' ' ' SER . 35.1 t70 -93.65 100.71 12.9 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.395 -0.82 . . . . 10.0 111.086 -178.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . 0.416 HG21 HD11 ' B' ' 65' ' ' ILE . 36.0 mt -84.24 94.93 3.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 108.353 -0.98 . . . . 10.0 108.353 178.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' ARG . . . . . 0.402 ' HD3' ' O ' ' B' ' 98' ' ' GLY . 5.6 ttm-85 -106.0 151.0 25.18 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.831 -0.622 . . . . 10.0 111.686 -177.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' GLU . . . . . 0.533 ' HG2' ' HG3' ' B' ' 69' ' ' ARG . 55.9 mt-10 -83.56 116.07 22.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.716 -0.674 . . . . 10.0 110.24 178.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' TYR . . . . . 0.84 ' HB3' ' HB3' ' B' ' 95' ' ' MET . 48.7 m-85 -96.03 106.74 18.95 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.942 -0.572 . . . . 10.0 109.855 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' TRP . . . . . . . . . . . . . 76.8 m95 -104.52 139.42 39.44 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.898 -0.592 . . . . 10.0 110.335 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' MET . . . . . 0.487 ' HA ' ' O ' ' B' ' 94' ' ' GLU . 39.3 ttm -69.05 130.44 42.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.953 -0.567 . . . . 10.0 111.665 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' ASP . . . . . 0.455 ' HB2' ' HD2' ' B' ' 91' ' ' PRO . 49.0 p30 -90.35 173.88 5.23 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.477 -0.783 . . . . 10.0 109.724 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' B' ' 90' ' ' ASP . 37.7 Cg_exo -61.55 -20.32 68.21 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.228 1.952 . . . . 10.0 112.56 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -74.66 -44.0 52.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.281 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 124.48 20.86 2.32 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.925 -0.655 . . . . 10.0 112.165 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' GLU . . . . . 0.601 ' HB3' ' HE2' ' B' ' 96' ' ' LYS . 4.5 tt0 -114.77 161.9 17.57 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.182 -0.303 . . . . 10.0 110.182 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' MET . . . . . 0.84 ' HB3' ' HB3' ' B' ' 87' ' ' TYR . 8.2 mmt -93.31 113.96 26.28 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.824 -0.435 . . . . 10.0 109.824 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . 0.601 ' HE2' ' HB3' ' B' ' 94' ' ' GLU . 48.1 mmtt -105.97 126.05 31.62 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.042 -0.526 . . . . 10.0 111.119 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.98 118.36 5.53 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.591 2.194 . . . . 10.0 111.819 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . 0.402 ' O ' ' HD3' ' B' ' 85' ' ' ARG . . . -83.46 -157.84 25.16 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.767 -0.73 . . . . 10.0 112.712 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 99' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' B' ' 99' ' ' ARG . 52.6 mtt180 -86.17 -20.74 28.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.868 0.366 . . . . 10.0 110.448 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . 0.889 ' HE2' ' HA ' ' C' ' 481' ' ' ASP . 6.8 mtpm? -69.39 106.36 2.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.905 -0.588 . . . . 10.0 109.694 178.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . 161.83 157.11 8.7 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.727 -0.669 . . . . 10.0 111.464 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' ILE . . . . . 0.421 HG22 HG22 ' A' ' 102' ' ' ILE . 6.5 tp -133.63 134.99 56.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.946 0.403 . . . . 10.0 110.731 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' SER . . . . . 0.509 ' HA ' ' HA ' ' B' ' 83' ' ' ASP . 0.8 OUTLIER -97.21 108.49 21.23 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.826 -0.625 . . . . 10.0 110.481 179.817 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 80.4 mt -111.4 137.74 48.79 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.979 0.419 . . . . 10.0 110.835 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' ASN . . . . . 0.557 ' ND2' ' HB3' ' B' ' 107' ' ' GLU . 36.5 p-10 -85.95 168.25 20.33 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.325 -0.398 . . . . 10.0 109.932 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . 0.406 ' HD2' ' HB2' ' B' ' 105' ' ' ASN . 76.3 Cg_exo -52.63 -27.33 32.77 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.775 2.317 . . . . 10.0 112.526 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' GLU . . . . . 0.557 ' HB3' ' ND2' ' B' ' 105' ' ' ASN . 7.5 tt0 -66.38 -51.38 57.7 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.936 -0.574 . . . . 10.0 109.942 178.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' GLN . . . . . 0.464 ' NE2' ' HA3' ' A' ' 66' ' ' GLY . 0.2 OUTLIER -65.63 -33.21 75.37 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.979 -0.555 . . . . 10.0 110.355 179.53 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' TRP . . . . . . . . . . . . . 45.9 t-105 -57.8 -41.91 83.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.126 -0.488 . . . . 10.0 110.699 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 13.6 t -68.04 -53.31 26.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.315 -0.402 . . . . 10.0 110.736 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -59.33 -36.59 75.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.481 . . . . 10.0 111.303 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . 0.459 ' O ' HG13 ' B' ' 116' ' ' ILE . 64.2 tp -60.12 -48.0 83.55 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.162 -0.31 . . . . 10.0 110.162 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 113' ' ' LYS . . . . . 0.412 ' HB2' ' HE3' ' B' ' 113' ' ' LYS . 42.6 mtmt -62.9 -39.11 93.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.142 -0.481 . . . . 10.0 110.881 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -68.29 -30.66 69.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.938 -0.574 . . . . 10.0 111.429 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -85.39 -8.3 58.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.676 -0.238 . . . . 10.0 111.265 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' ILE . . . . . 0.459 HG13 ' O ' ' B' ' 112' ' ' LEU . 27.3 mt -57.22 -37.4 56.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.676 -0.238 . . . . 10.0 111.513 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.12 -29.42 67.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.945 0.402 . . . . 10.0 111.282 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -91.2 -42.81 10.22 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.168 -0.469 . . . . 10.0 110.68 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . 0.513 ' O ' HG23 ' B' ' 123' ' ' VAL . 82.8 mt -64.05 -47.14 91.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.893 -0.594 . . . . 10.0 111.206 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . 0.411 ' O ' ' HG2' ' B' ' 124' ' ' ARG . 23.9 t70 -60.01 -38.96 84.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.565 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -63.85 -42.66 97.53 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.641 -0.709 . . . . 10.0 110.249 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.63 -33.96 77.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.971 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . 0.628 HG13 HG21 ' A' ' 80' ' ' VAL . 71.3 t -60.4 -35.22 61.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-O 121.362 0.601 . . . . 10.0 110.708 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' B' ' 120' ' ' ASP . 7.3 ptt85 -102.99 21.22 16.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.803 -0.635 . . . . 10.0 110.613 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 17.4 ttmt -136.81 47.27 2.16 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.412 0.625 . . . . 10.0 109.821 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 58.5 mt . . . . . 0 C--O 1.245 0.856 0 CA-C-O 118.517 -0.754 . . . . 10.0 109.922 179.722 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 465' ' ' TYR . . . . . . . . . . . . . 11.1 p90 . . . . . 0 N--CA 1.476 0.869 0 CA-C-O 120.768 0.318 . . . . 10.0 110.896 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 466' ' ' GLY . . . . . . . . . . . . . . . 84.09 -2.9 87.14 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 121.068 -0.587 . . . . 10.0 114.062 178.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 467' ' ' ALA . . . . . 0.479 ' HB2' ' HB2' ' A' ' 92' ' ' GLU . . . -74.8 -32.76 62.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 117.401 0.601 . . . . 10.0 110.754 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 468' ' ' LEU . . . . . . . . . . . . . 69.9 tp -56.8 -35.84 69.2 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.596 -0.729 . . . . 10.0 111.785 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 469' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -64.65 -38.55 91.39 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.688 0.28 . . . . 10.0 111.281 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 470' ' ' MET . . . . . . . . . . . . . 1.2 tmm? -80.07 -25.8 39.92 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.941 0.4 . . . . 10.0 110.117 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 471' ' ' ALA . . . . . 0.476 ' HA ' ' HB3' ' C' ' 474' ' ' GLU . . . -59.36 -30.88 68.71 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.955 -0.566 . . . . 10.0 111.051 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 472' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -59.4 -34.97 73.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.745 -0.661 . . . . 10.0 110.978 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 473' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -96.44 -13.88 22.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.161 -0.472 . . . . 10.0 111.175 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 474' ' ' GLU . . . . . 0.664 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 0.0 OUTLIER -69.36 -39.27 78.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.932 0.396 . . . . 10.0 110.005 179.645 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 475' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -74.85 -21.62 59.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.896 -0.593 . . . . 10.0 111.214 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 476' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -63.51 -61.82 2.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.389 -0.369 . . . . 10.0 110.702 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 477' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -63.55 -27.93 69.59 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.991 0.424 . . . . 10.0 111.113 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 478' ' ' MET . . . . . 0.499 ' HG2' ' NH2' ' A' ' 74' ' ' ARG . 0.4 OUTLIER -77.81 -5.6 51.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.156 -0.475 . . . . 10.0 111.057 -179.788 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 479' ' ' PHE . . . . . 0.42 ' O ' ' HB2' ' C' ' 483' ' ' LEU . 86.1 t80 -113.44 -55.12 2.55 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.509 -0.314 . . . . 10.0 111.705 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 480' ' ' THR . . . . . . . . . . . . . 1.7 p -59.45 -51.99 67.54 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 112.287 0.477 . . . . 10.0 112.287 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 481' ' ' ASP . . . . . 0.889 ' HA ' ' HE2' ' B' ' 100' ' ' LYS . 5.3 t70 -61.96 -45.42 93.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.055 -0.521 . . . . 10.0 110.87 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 482' ' ' ALA . . . . . 0.533 ' HA ' ' OG ' ' A' ' 103' ' ' SER . . . -64.27 -47.28 80.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.889 -0.596 . . . . 10.0 112.263 -178.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 483' ' ' LEU . . . . . 0.42 ' HB2' ' O ' ' C' ' 479' ' ' PHE . 0.2 OUTLIER -57.78 -46.74 84.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.45 -0.341 . . . . 10.0 111.135 -179.152 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 484' ' ' GLY . . . . . . . . . . . . . . . -70.32 -22.61 77.61 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.769 -0.729 . . . . 10.0 112.612 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 485' ' ' ILE . . . . . . . . . . . . . 1.3 mm -76.6 -44.63 34.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.821 0.344 . . . . 10.0 111.401 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 486' ' ' ASP . . . . . 0.514 ' HA ' ' HB3' ' A' ' 105' ' ' ASN . 0.1 OUTLIER -78.76 -45.59 20.73 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.345 -0.388 . . . . 10.0 111.996 -178.771 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 487' ' ' GLU . . . . . 0.543 ' HA ' ' OE1' ' C' ' 487' ' ' GLU . 0.7 OUTLIER -64.91 -42.81 94.43 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.51 0.559 . . . . 10.0 112.51 -178.022 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 488' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -135.59 72.4 1.44 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.974 0.416 . . . . 10.0 110.686 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 489' ' ' GLY . . . . . 0.528 ' HA2' ' NH1' ' B' ' 69' ' ' ARG . . . -98.18 -30.35 7.08 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.915 -0.659 . . . . 10.0 112.075 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.773 -1.015 . . . . 10.0 112.1 -179.804 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 109.933 -0.395 . . . . 10.0 109.933 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 49.1 ttm -126.55 105.54 8.81 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.917 0.389 . . . . 10.0 110.618 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -96.37 126.47 41.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.004 -0.544 . . . . 10.0 110.407 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.443 ' HG2' ' H ' ' A' ' 66' ' ' GLY . 23.4 tt0 -85.74 131.48 34.32 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.009 -0.367 . . . . 10.0 110.009 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 26.9 pt -119.62 11.68 6.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.147 0.498 . . . . 10.0 110.807 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.783 ' HA3' ' HG2' ' B' ' 108' ' ' GLN . . . 161.39 174.71 31.6 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.401 -0.68 . . . . 10.0 111.401 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.56 ' HG2' ' HG2' ' A' ' 68' ' ' MET . 52.4 tttp -61.85 120.32 10.51 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.058 0.456 . . . . 10.0 110.873 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.56 ' HG2' ' HG2' ' A' ' 67' ' ' LYS . 36.1 mmm 66.19 12.7 8.72 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.079 -0.964 . . . . 10.0 111.964 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.787 ' HE ' ' HB3' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -114.81 113.0 23.66 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.718 -0.475 . . . . 10.0 109.718 179.128 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -126.73 134.27 50.69 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.116 0.484 . . . . 10.0 111.71 -177.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 38.7 t -93.82 105.16 16.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 108.912 -0.773 . . . . 10.0 108.912 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.404 ' HB2' ' HB3' ' A' ' 83' ' ' ASP . 1.2 m -80.8 82.99 6.65 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.502 -0.772 . . . . 10.0 111.3 -178.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.472 HG22 HG23 ' A' ' 82' ' ' ILE . 10.8 t -83.41 93.55 3.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.912 -0.773 . . . . 10.0 108.912 178.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -133.92 -175.37 3.82 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.816 -0.629 . . . . 10.0 111.029 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.429 ' HA ' ' O ' ' A' ' 79' ' ' LYS . 7.3 t0 -117.07 142.45 46.96 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.873 -0.603 . . . . 10.0 110.033 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.457 ' HD1' ' HA ' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -145.38 96.53 2.85 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.018 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.8 mttp 68.48 29.15 5.77 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.016 -0.538 . . . . 10.0 111.057 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 84.37 54.15 3.06 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.545 -0.836 . . . . 10.0 111.834 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.94 ' HD3' ' HB ' ' C' ' 485' ' ' ILE . 18.8 mttp -146.41 130.52 17.39 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.783 -0.209 . . . . 10.0 110.472 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.3 t -80.2 84.69 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.54 -0.911 . . . . 10.0 108.54 178.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 30.5 mt -83.7 104.84 14.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.892 -0.595 . . . . 10.0 112.126 -178.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.472 HG23 HG22 ' A' ' 73' ' ' VAL . 16.6 mt -97.25 64.07 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 106.704 -1.591 . . . . 10.0 106.704 176.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.886 ' HA ' ' HA ' ' A' ' 103' ' ' SER . 19.9 t70 -68.41 101.68 1.28 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.735 -1.12 . . . . 10.0 113.375 -176.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 63.0 mt -84.21 108.0 16.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 107.383 -1.34 . . . . 10.0 107.383 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.818 ' HD2' ' HB2' ' A' ' 97' ' ' PRO . 12.3 ttm180 -143.69 170.47 15.8 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.599 0.714 . . . . 10.0 112.335 -177.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.787 ' HB3' ' HE ' ' A' ' 69' ' ' ARG . 6.9 pt-20 -99.95 140.77 33.7 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.282 -0.872 . . . . 10.0 108.911 177.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -122.23 121.76 37.58 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.912 0.387 . . . . 10.0 110.462 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -114.49 153.57 29.76 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.763 -0.653 . . . . 10.0 109.943 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 2.3 ttm -83.02 122.14 27.93 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.836 -0.431 . . . . 10.0 109.836 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.47 170.76 13.66 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.824 -0.626 . . . . 10.0 110.726 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -54.19 -29.78 58.17 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 123.053 2.502 . . . . 10.0 113.458 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -73.75 -45.2 53.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.965 0.412 . . . . 10.0 110.608 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 124.51 30.18 1.01 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.63 -0.795 . . . . 10.0 112.0 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -116.33 167.76 10.74 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.78 0.324 . . . . 10.0 110.32 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 92.3 mmm -89.42 98.25 11.66 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.251 -0.648 . . . . 10.0 109.251 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -98.23 124.54 46.77 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.447 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.818 ' HB2' ' HD2' ' A' ' 85' ' ' ARG . 80.1 Cg_endo -78.02 146.86 23.34 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.727 2.284 . . . . 10.0 112.891 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.54 ' O ' ' HD3' ' A' ' 85' ' ' ARG . . . -85.08 -174.1 50.13 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.725 -0.75 . . . . 10.0 112.332 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -76.06 -26.92 56.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.98 0.419 . . . . 10.0 110.758 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -76.38 81.38 3.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.863 -0.608 . . . . 10.0 110.609 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.438 ' HA3' ' NE ' ' A' ' 85' ' ' ARG . . . -146.62 129.48 3.33 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.959 -0.564 . . . . 10.0 111.766 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.578 HG13 HD21 ' C' ' 483' ' ' LEU . 8.5 tt -127.29 113.86 33.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.201 0.524 . . . . 10.0 110.702 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.886 ' HA ' ' HA ' ' A' ' 83' ' ' ASP . 2.3 m -79.27 99.9 7.28 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.089 -0.505 . . . . 10.0 110.679 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.47 ' HB2' ' HB ' ' A' ' 82' ' ' ILE . 34.7 mt -76.53 171.66 14.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.153 0.501 . . . . 10.0 110.442 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -133.03 158.32 76.13 Favored Pre-proline 0 C--N 1.316 -0.87 0 N-CA-C 108.835 -0.802 . . . . 10.0 108.835 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -41.39 -45.3 5.91 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.825 3.017 . . . . 10.0 113.891 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -64.38 -49.69 70.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.709 0.29 . . . . 10.0 110.833 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.571 ' NE2' ' HD3' ' B' ' 69' ' ' ARG . 72.3 mt-30 -63.56 -40.74 97.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.266 -0.424 . . . . 10.0 110.586 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -59.47 -44.79 92.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.924 -0.58 . . . . 10.0 110.294 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.482 ' HA ' ' CE ' ' A' ' 113' ' ' LYS . 56.8 m -64.4 -41.02 96.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.226 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.47 ' O ' ' HG2' ' A' ' 115' ' ' GLN . 46.5 mt-30 -63.98 -42.02 97.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.254 -0.43 . . . . 10.0 110.395 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 22.9 tp -59.36 -40.99 88.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.992 -0.549 . . . . 10.0 110.543 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.482 ' CE ' ' HA ' ' A' ' 110' ' ' SER . 53.3 mtmt -63.95 -33.49 75.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.856 -0.611 . . . . 10.0 111.121 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -76.82 -15.4 59.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.324 -0.398 . . . . 10.0 111.115 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.47 ' HG2' ' O ' ' A' ' 111' ' ' GLN . 14.2 mm-40 -99.55 -5.18 29.61 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.547 -0.297 . . . . 10.0 110.879 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.467 HG12 ' HH2' ' B' ' 109' ' ' TRP . 56.7 mt -56.56 -39.73 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.396 -0.365 . . . . 10.0 111.489 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.14 -30.21 69.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.109 -0.496 . . . . 10.0 111.099 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.425 ' HB3' ' CE1' ' B' ' 63' ' ' PHE . 2.6 m-20 -90.04 -39.93 12.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.756 -0.656 . . . . 10.0 110.571 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.48 ' O ' HG23 ' A' ' 123' ' ' VAL . 92.8 mt -62.21 -51.22 75.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.323 -0.399 . . . . 10.0 110.628 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -62.05 -28.7 69.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.243 0.544 . . . . 10.0 110.329 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -63.64 -49.78 71.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.422 -0.808 . . . . 10.0 110.064 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.47 -34.18 77.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.778 -0.647 . . . . 10.0 110.969 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.66 ' HA ' HG11 ' B' ' 80' ' ' VAL . 72.5 t -61.44 -42.65 94.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.964 0.412 . . . . 10.0 110.678 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 24.1 mtm180 -75.03 -24.25 58.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.018 -0.537 . . . . 10.0 111.143 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -74.78 -46.34 37.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.021 0.439 . . . . 10.0 110.81 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 17.6 mt . . . . . 0 C--N 1.326 -0.452 0 CA-C-N 116.008 -0.542 . . . . 10.0 111.14 -179.724 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.163 0 CA-C-O 121.171 0.51 . . . . 10.0 110.471 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 86.5 mmm -109.14 111.01 22.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.7 -0.682 . . . . 10.0 109.914 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' PHE . . . . . 0.425 ' CE1' ' HB3' ' A' ' 118' ' ' ASP . 15.6 m-85 -107.87 157.65 17.99 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.268 -0.424 . . . . 10.0 110.462 -179.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -117.38 135.07 54.13 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.486 -0.325 . . . . 10.0 110.284 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 21.2 pt -126.84 29.13 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.176 -0.465 . . . . 10.0 111.113 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 149.97 -172.1 29.89 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.929 -0.653 . . . . 10.0 111.616 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . 0.479 ' O ' ' HB2' ' B' ' 68' ' ' MET . 43.3 mtmt -69.24 105.87 2.67 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.555 0.178 . . . . 10.0 110.735 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' MET . . . . . 0.479 ' HB2' ' O ' ' B' ' 67' ' ' LYS . 0.3 OUTLIER 76.01 -12.8 0.96 Allowed 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.71 0.633 . . . . 10.0 112.71 178.705 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' ARG . . . . . 0.571 ' HD3' ' NE2' ' A' ' 108' ' ' GLN . 0.7 OUTLIER -79.75 113.87 18.24 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.861 -0.422 . . . . 10.0 109.861 179.276 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -119.88 161.79 20.24 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.439 0.638 . . . . 10.0 112.15 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 95.2 t -119.84 114.5 44.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.0 -1.0 . . . . 10.0 108.361 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 4.9 t -104.04 106.59 17.15 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.0 0.428 . . . . 10.0 111.571 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.445 HG22 HG23 ' B' ' 82' ' ' ILE . 31.2 t -104.9 110.01 29.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.972 -0.751 . . . . 10.0 108.972 178.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 7.0 ptt-85 -151.73 163.02 40.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.941 0.4 . . . . 10.0 111.686 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -82.64 113.38 20.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.823 -0.626 . . . . 10.0 109.984 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -105.24 84.25 2.08 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.364 -0.38 . . . . 10.0 110.787 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 59.0 mttm 62.41 43.6 7.91 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.69 -0.686 . . . . 10.0 111.477 178.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 86.87 35.52 9.93 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.528 -0.844 . . . . 10.0 112.429 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 19.1 mmtm -150.84 115.71 5.26 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 122.196 0.198 . . . . 10.0 110.557 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . 0.66 HG11 ' HA ' ' A' ' 123' ' ' VAL . 28.4 t -75.82 90.21 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.692 -0.855 . . . . 10.0 108.692 178.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 45.6 mt -95.21 130.99 41.74 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.358 0.599 . . . . 10.0 111.98 -178.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' ILE . . . . . 0.445 HG23 HG22 ' B' ' 73' ' ' VAL . 3.1 mp -103.13 91.06 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 107.799 -1.185 . . . . 10.0 107.799 178.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . 0.532 ' HA ' ' HA ' ' B' ' 103' ' ' SER . 34.1 t70 -89.85 104.46 17.02 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.588 -0.733 . . . . 10.0 111.69 -178.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 54.3 mt -87.28 97.56 6.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 107.501 -1.296 . . . . 10.0 107.501 177.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' ARG . . . . . 0.556 ' HD3' ' O ' ' B' ' 98' ' ' GLY . 12.6 ttm180 -132.0 150.28 52.2 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.886 -0.597 . . . . 10.0 112.127 -176.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -83.55 128.49 34.56 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.85 -0.796 . . . . 10.0 108.85 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' TYR . . . . . 0.565 ' HB3' ' HB3' ' B' ' 95' ' ' MET . 4.8 m-85 -103.01 122.14 44.01 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.971 0.415 . . . . 10.0 110.546 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' TRP . . . . . . . . . . . . . 22.4 m0 -99.92 136.88 39.16 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.859 -0.609 . . . . 10.0 109.851 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 44.2 ttm -73.33 141.02 47.11 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.109 0.481 . . . . 10.0 110.864 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' ASP . . . . . 0.421 ' OD2' ' HB2' ' B' ' 92' ' ' GLU . 0.0 OUTLIER -103.37 165.45 13.53 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 115.605 -0.725 . . . . 10.0 110.238 179.776 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -55.09 -29.71 66.89 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.113 2.542 . . . . 10.0 113.815 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . 0.421 ' HB2' ' OD2' ' B' ' 90' ' ' ASP . 0.5 OUTLIER -70.75 -35.24 72.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.966 0.412 . . . . 10.0 110.384 179.585 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 119.52 20.26 3.95 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.639 -0.791 . . . . 10.0 112.966 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' GLU . . . . . 0.764 ' HB2' ' HE2' ' B' ' 96' ' ' LYS . 3.3 mt-10 -111.56 160.68 16.96 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.88 0.34 . . . . 10.0 110.366 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' MET . . . . . 0.565 ' HB3' ' HB3' ' B' ' 87' ' ' TYR . 84.6 mmm -98.11 111.2 23.6 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.73 -0.47 . . . . 10.0 109.73 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . 0.764 ' HE2' ' HB2' ' B' ' 94' ' ' GLU . 49.8 mmtt -100.66 135.98 19.99 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.231 -0.44 . . . . 10.0 111.01 -178.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -63.0 118.88 5.77 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.394 2.063 . . . . 10.0 111.845 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . 0.556 ' O ' ' HD3' ' B' ' 85' ' ' ARG . . . -68.57 167.95 43.67 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.741 -0.743 . . . . 10.0 112.039 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 5.4 mtm180 -82.26 47.97 1.21 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.192 0.52 . . . . 10.0 110.98 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -161.78 104.87 1.21 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.689 -0.687 . . . . 10.0 110.418 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' GLY . . . . . . . . . . . . . . . -173.93 161.13 31.37 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 110.805 -0.918 . . . . 10.0 110.805 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 7.5 tp -119.8 122.46 68.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.298 0.57 . . . . 10.0 111.244 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' SER . . . . . 0.532 ' HA ' ' HA ' ' B' ' 83' ' ' ASP . 0.8 OUTLIER -94.37 104.84 16.81 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.825 -0.625 . . . . 10.0 110.254 179.854 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 83.9 mt -98.27 163.62 12.64 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.231 -0.441 . . . . 10.0 110.628 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' ASN . . . . . 0.447 ' HB2' ' HD2' ' B' ' 106' ' ' PRO . 45.4 p30 -115.83 169.95 6.32 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 108.652 -0.87 . . . . 10.0 108.652 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . 0.53 ' HD3' ' O ' ' B' ' 80' ' ' VAL . 53.1 Cg_exo -53.61 -30.38 54.94 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.283 1.988 . . . . 10.0 112.445 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -65.02 -56.53 12.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.601 -0.727 . . . . 10.0 110.799 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' GLN . . . . . 0.783 ' HG2' ' HA3' ' A' ' 66' ' ' GLY . 19.9 mt-30 -72.49 -27.52 62.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.258 -0.428 . . . . 10.0 110.409 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' TRP . . . . . 0.467 ' HH2' HG12 ' A' ' 116' ' ' ILE . 34.9 t-105 -65.92 -36.78 84.33 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.962 -0.755 . . . . 10.0 108.962 177.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' SER . . . . . 0.497 ' O ' ' HG3' ' B' ' 114' ' ' GLU . 29.2 t -64.35 -51.16 64.75 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.322 -0.854 . . . . 10.0 109.437 178.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -62.22 -36.1 80.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.757 -0.656 . . . . 10.0 111.076 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . 0.471 ' O ' HG13 ' B' ' 116' ' ' ILE . 52.7 tp -59.25 -44.24 92.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.92 0.39 . . . . 10.0 110.069 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -66.38 -30.54 70.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.926 -0.579 . . . . 10.0 110.751 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . 0.497 ' HG3' ' O ' ' B' ' 110' ' ' SER . 43.3 mt-10 -79.75 -25.8 40.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.19 -0.459 . . . . 10.0 111.01 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -84.03 -10.44 57.87 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.337 -0.392 . . . . 10.0 111.217 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' ILE . . . . . 0.499 ' O ' ' HB2' ' B' ' 120' ' ' ASP . 73.0 mt -56.53 -43.29 77.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.375 -0.375 . . . . 10.0 111.787 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.23 -28.75 68.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.871 0.367 . . . . 10.0 111.695 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.79 -43.09 12.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.304 -0.407 . . . . 10.0 110.99 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 78.5 mt -67.26 -46.1 84.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.14 -0.482 . . . . 10.0 110.773 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . 0.499 ' HB2' ' O ' ' B' ' 116' ' ' ILE . 0.3 OUTLIER -55.88 -43.84 77.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.019 -0.537 . . . . 10.0 110.828 -179.916 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 121' ' ' ASP . . . . . 0.446 ' HA ' ' NE ' ' B' ' 124' ' ' ARG . 29.2 t70 -61.32 -37.52 83.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.525 -0.761 . . . . 10.0 111.242 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.49 -41.64 54.87 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.354 -0.385 . . . . 10.0 111.15 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 77.1 t -62.9 -42.5 96.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.197 -0.456 . . . . 10.0 111.441 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . 0.446 ' NE ' ' HA ' ' B' ' 121' ' ' ASP . 20.1 ptt180 -73.41 -6.77 48.37 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.801 0.297 . . . . 10.0 111.801 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 125' ' ' LYS . . . . . . . . . . . . . 63.7 mttt -90.51 -4.8 56.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.025 0.441 . . . . 10.0 110.734 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 49.8 tp . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.561 -0.733 . . . . 10.0 109.972 179.578 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 465' ' ' TYR . . . . . . . . . . . . . 25.5 t80 . . . . . 0 N--CA 1.478 0.925 0 CA-C-O 120.389 0.138 . . . . 10.0 110.965 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 466' ' ' GLY . . . . . 0.604 ' HA2' ' HB3' ' C' ' 469' ' ' ASP . . . -54.12 -30.21 46.35 Favored Glycine 0 CA--C 1.519 0.343 0 N-CA-C 114.245 0.458 . . . . 10.0 114.245 -178.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 467' ' ' ALA . . . . . . . . . . . . . . . -56.57 -47.59 79.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 117.209 0.505 . . . . 10.0 111.472 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 468' ' ' LEU . . . . . . . . . . . . . 28.9 tp -88.44 -31.93 18.55 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.005 0.431 . . . . 10.0 110.317 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 469' ' ' ASP . . . . . 0.604 ' HB3' ' HA2' ' C' ' 466' ' ' GLY . 1.6 t70 -56.48 -48.61 76.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.487 -0.779 . . . . 10.0 111.653 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 470' ' ' MET . . . . . . . . . . . . . 1.8 mmm -63.03 -35.69 81.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.338 -0.392 . . . . 10.0 110.625 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 471' ' ' ALA . . . . . . . . . . . . . . . -68.95 -38.65 79.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.101 0.477 . . . . 10.0 110.148 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 472' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -67.81 -45.0 75.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.843 -0.617 . . . . 10.0 110.039 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 473' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -60.39 -42.94 96.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.686 -0.688 . . . . 10.0 109.778 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 474' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -65.64 -33.72 76.55 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.831 -0.622 . . . . 10.0 110.448 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 475' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -63.07 -47.37 83.21 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.811 -0.44 . . . . 10.0 109.811 178.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 476' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -65.98 -43.23 88.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.898 -0.592 . . . . 10.0 110.277 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 477' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -61.32 -38.49 87.06 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.558 -0.747 . . . . 10.0 110.948 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 478' ' ' MET . . . . . . . . . . . . . 31.3 tpp -74.46 -19.69 60.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.006 0.432 . . . . 10.0 111.2 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 479' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -70.59 -47.71 58.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.198 -0.456 . . . . 10.0 109.814 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 480' ' ' THR . . . . . 0.679 ' HB ' ' OG ' ' A' ' 103' ' ' SER . 0.1 OUTLIER -87.78 -4.73 58.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.844 -0.616 . . . . 10.0 111.152 179.798 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 481' ' ' ASP . . . . . 0.459 ' O ' ' HD2' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -55.39 -37.53 67.71 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.872 -0.603 . . . . 10.0 112.022 -179.825 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 482' ' ' ALA . . . . . . . . . . . . . . . -99.02 16.91 21.08 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.111 0.412 . . . . 10.0 112.111 -178.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 483' ' ' LEU . . . . . 0.578 HD21 HG13 ' A' ' 102' ' ' ILE . 33.0 tp -87.15 -51.28 6.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.711 0.291 . . . . 10.0 111.518 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 484' ' ' GLY . . . . . . . . . . . . . . . -75.12 41.99 1.34 Allowed Glycine 0 CA--C 1.521 0.461 0 C-N-CA 121.391 -0.433 . . . . 10.0 113.858 -178.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 485' ' ' ILE . . . . . 0.94 ' HB ' ' HD3' ' A' ' 79' ' ' LYS . 6.3 tp -151.13 -16.05 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.784 0.326 . . . . 10.0 110.507 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 486' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -68.34 -35.38 77.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.949 0.404 . . . . 10.0 110.611 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 487' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -77.17 -2.87 36.64 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.355 -0.384 . . . . 10.0 110.964 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 488' ' ' TYR . . . . . 0.45 ' HB2' ' O ' ' C' ' 485' ' ' ILE . 0.3 OUTLIER -79.7 -21.63 44.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.387 -0.37 . . . . 10.0 111.12 -179.825 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 489' ' ' GLY . . . . . . . . . . . . . . . -171.98 170.8 43.74 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.717 -0.754 . . . . 10.0 112.271 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.873 0 CA-C-O 118.679 -1.067 . . . . 10.0 111.801 -179.756 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 110.282 -0.266 . . . . 10.0 110.282 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.657 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -111.88 122.73 48.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.805 0.336 . . . . 10.0 111.162 -179.53 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -117.95 144.13 45.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.106 -0.497 . . . . 10.0 110.122 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -84.2 125.25 32.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.928 0.394 . . . . 10.0 110.76 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.3 pt -115.88 16.36 7.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.198 -0.456 . . . . 10.0 110.478 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 154.75 176.24 26.77 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.594 -0.602 . . . . 10.0 111.594 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.829 ' HG2' ' HG2' ' A' ' 68' ' ' MET . 51.8 tttp -65.61 120.17 12.45 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.688 0.28 . . . . 10.0 110.731 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.829 ' HG2' ' HG2' ' A' ' 67' ' ' LYS . 59.7 mmm 66.18 24.67 10.77 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.54 -0.755 . . . . 10.0 112.05 178.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -132.18 119.81 21.39 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.201 -0.296 . . . . 10.0 110.201 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.414 ' HB2' ' CD1' ' A' ' 87' ' ' TYR . 26.9 m-85 -128.3 135.23 49.33 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.054 0.454 . . . . 10.0 111.751 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.657 ' O ' ' HA ' ' A' ' 62' ' ' MET . 41.4 t -90.05 107.33 18.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 108.696 -0.853 . . . . 10.0 108.696 178.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.566 ' HB2' ' HB3' ' A' ' 83' ' ' ASP . 3.8 m -94.9 90.35 5.97 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.943 0.401 . . . . 10.0 111.799 -178.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 45.5 t -78.11 111.08 14.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.886 -0.783 . . . . 10.0 108.886 178.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.1 ptt180 -138.08 -167.01 2.08 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.106 -0.497 . . . . 10.0 110.596 -178.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -126.76 139.62 52.99 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.257 -0.428 . . . . 10.0 110.127 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.465 ' HD2' ' HE3' ' A' ' 77' ' ' LYS . 2.3 t80 -148.03 112.85 5.42 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.226 -0.443 . . . . 10.0 110.125 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.575 ' HZ2' ' HB2' ' A' ' 77' ' ' LYS . 6.8 mtmp? 68.42 15.11 9.22 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.755 -0.657 . . . . 10.0 111.234 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 100.21 0.39 55.9 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.278 -0.963 . . . . 10.0 112.485 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.3 mtpt -109.38 132.51 54.06 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.214 -0.291 . . . . 10.0 110.214 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.498 ' O ' ' HD3' ' A' ' 106' ' ' PRO . 43.8 t -70.74 107.32 2.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.204 -0.665 . . . . 10.0 109.204 178.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.597 HD11 ' HB2' ' C' ' 486' ' ' ASP . 6.7 mt -97.21 113.54 25.15 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.235 0.54 . . . . 10.0 112.376 -178.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.41 HD11 HG21 ' B' ' 123' ' ' VAL . 70.4 mt -89.1 89.38 3.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 107.322 -1.362 . . . . 10.0 107.322 177.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.566 ' HB3' ' HB2' ' A' ' 72' ' ' SER . 3.5 t70 -79.2 101.9 8.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.499 -0.773 . . . . 10.0 112.655 -177.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.5 mt -94.34 81.25 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.537 -0.912 . . . . 10.0 108.537 178.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.761 ' HG3' ' HA3' ' A' ' 101' ' ' GLY . 4.9 ttm180 -117.07 155.19 29.68 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.675 -0.693 . . . . 10.0 110.961 -178.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.464 ' O ' ' HA ' ' A' ' 97' ' ' PRO . 61.5 mt-10 -72.0 139.22 48.49 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.518 -0.549 . . . . 10.0 109.518 178.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.696 ' HD2' ' HB3' ' A' ' 95' ' ' MET . 5.4 m-85 -118.29 111.58 18.95 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.956 0.408 . . . . 10.0 110.229 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -103.02 145.65 29.56 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.761 -0.654 . . . . 10.0 109.897 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 40.8 ttm -87.62 137.74 32.08 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.112 -0.329 . . . . 10.0 110.112 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.493 ' HB2' ' CD ' ' A' ' 91' ' ' PRO . 53.0 p-10 -99.35 177.57 1.53 Allowed Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.071 -0.513 . . . . 10.0 110.275 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.493 ' CD ' ' HB2' ' A' ' 90' ' ' ASP . 28.0 Cg_exo -63.95 -12.46 32.15 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.513 2.142 . . . . 10.0 113.018 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -88.16 -16.76 32.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.291 0.567 . . . . 10.0 110.073 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.11 14.75 55.65 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.637 -0.71 . . . . 10.0 111.745 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.437 ' HB2' ' HD3' ' A' ' 96' ' ' LYS . 6.0 mm-40 -94.51 157.73 15.86 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.052 0.453 . . . . 10.0 110.751 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.696 ' HB3' ' HD2' ' A' ' 87' ' ' TYR . 87.1 mmm -92.64 108.71 20.19 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.181 -0.674 . . . . 10.0 109.181 178.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.73 ' HE2' ' HG2' ' C' ' 474' ' ' GLU . 2.2 mmmm -108.62 128.91 24.68 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 116.154 -0.475 . . . . 10.0 111.099 -178.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 58.2 Cg_endo -72.06 139.14 32.21 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.348 2.032 . . . . 10.0 112.283 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -84.16 -169.36 45.31 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.433 -0.667 . . . . 10.0 111.433 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.58 ' HD3' ' HG3' ' C' ' 477' ' ' GLN . 0.0 OUTLIER -91.03 -7.72 51.09 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 117.3 0.55 . . . . 10.0 110.969 -179.856 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 21.2 ttmt -100.25 113.9 26.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.173 -0.467 . . . . 10.0 110.108 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.761 ' HA3' ' HG3' ' A' ' 85' ' ' ARG . . . -175.7 168.66 41.11 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.85 -0.691 . . . . 10.0 111.8 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.816 ' HA ' HD11 ' C' ' 485' ' ' ILE . 17.2 tt -139.58 121.53 16.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.332 0.587 . . . . 10.0 111.006 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 83' ' ' ASP . 0.9 OUTLIER -97.77 113.0 24.68 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.952 -0.567 . . . . 10.0 109.704 179.519 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.51 ' HB3' ' HB2' ' A' ' 108' ' ' GLN . 25.2 mt -111.68 133.64 53.79 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.011 -0.54 . . . . 10.0 110.379 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.73 ' HB2' ' HD2' ' A' ' 106' ' ' PRO . 14.5 p30 -91.55 172.82 6.03 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 109.32 -0.622 . . . . 10.0 109.32 178.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.73 ' HD2' ' HB2' ' A' ' 105' ' ' ASN . 70.6 Cg_exo -42.77 -37.91 6.22 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 123.505 2.803 . . . . 10.0 114.282 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.418 ' HB3' ' NE2' ' A' ' 108' ' ' GLN . 19.0 tt0 -57.03 -49.56 75.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.645 0.26 . . . . 10.0 111.02 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.695 ' NE2' ' HA3' ' C' ' 490' ' ' GLY . 1.0 OUTLIER -74.4 -33.54 63.04 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 110.032 -0.358 . . . . 10.0 110.032 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.497 ' CH2' HG12 ' B' ' 116' ' ' ILE . 69.1 t-105 -57.91 -53.66 55.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.878 -0.601 . . . . 10.0 110.911 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.7 m -61.95 -42.52 99.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.296 -0.411 . . . . 10.0 110.748 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -64.35 -41.47 96.73 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.306 -0.406 . . . . 10.0 110.731 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.565 ' O ' HG13 ' A' ' 116' ' ' ILE . 61.2 tp -61.91 -43.89 97.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 10.0 110.615 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.58 ' HA ' HD12 ' A' ' 116' ' ' ILE . 43.5 mtmt -61.71 -27.83 68.98 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.925 0.393 . . . . 10.0 110.735 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -77.15 -38.19 52.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.096 0.475 . . . . 10.0 110.312 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.444 ' O ' HG13 ' A' ' 119' ' ' ILE . 20.5 mm-40 -76.42 -18.88 58.6 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.74 -0.664 . . . . 10.0 111.541 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.58 HD12 ' HA ' ' A' ' 113' ' ' LYS . 44.4 mt -51.62 -39.61 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 112.072 0.397 . . . . 10.0 112.072 -179.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 18.1 m -65.31 -17.52 64.58 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.968 0.359 . . . . 10.0 111.968 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.08 -34.29 8.47 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.745 -0.465 . . . . 10.0 109.745 178.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.573 HG23 HG21 ' B' ' 73' ' ' VAL . 83.0 mt -64.68 -48.72 83.53 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-N 115.827 -0.624 . . . . 10.0 109.966 178.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.42 ' O ' ' HG3' ' A' ' 124' ' ' ARG . 16.6 t70 -58.31 -38.47 77.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.448 -0.796 . . . . 10.0 110.326 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -65.87 -41.58 91.44 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.217 -0.902 . . . . 10.0 110.561 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.23 -37.95 89.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.87 -0.605 . . . . 10.0 110.874 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 119' ' ' ILE . 95.6 t -62.41 -40.66 88.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 10.0 110.35 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 120' ' ' ASP . 12.1 mtt85 -68.92 -30.43 68.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.831 -0.622 . . . . 10.0 110.872 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 16.9 mttp -71.21 -25.52 62.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.089 0.471 . . . . 10.0 110.762 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 62.3 mt . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 116.064 -0.516 . . . . 10.0 110.522 179.783 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.264 0 CA-C-O 121.143 0.497 . . . . 10.0 110.566 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' MET . . . . . . . . . . . . . 88.0 mmm -119.12 99.29 6.63 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.562 -0.745 . . . . 10.0 110.088 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -101.54 139.22 37.49 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.922 -0.581 . . . . 10.0 110.33 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -93.52 139.62 30.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.049 0.452 . . . . 10.0 111.708 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' ILE . . . . . 0.435 ' O ' ' HB3' ' B' ' 69' ' ' ARG . 5.8 pt -138.0 94.33 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.507 -0.769 . . . . 10.0 109.529 178.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.64 -135.98 12.45 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.669 -0.777 . . . . 10.0 111.387 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . 0.603 ' O ' ' HA2' ' C' ' 489' ' ' GLY . 5.6 mptt -117.63 120.96 39.63 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.369 -0.234 . . . . 10.0 110.369 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' MET . . . . . . . . . . . . . 96.4 mmm 65.26 2.11 1.8 Allowed 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.817 0.673 . . . . 10.0 112.817 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' ARG . . . . . 0.548 ' CZ ' ' HA3' ' C' ' 489' ' ' GLY . 2.3 tpp180 -98.95 126.36 44.62 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.819 -0.438 . . . . 10.0 109.819 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -130.66 142.67 50.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.514 0.673 . . . . 10.0 112.3 -178.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.418 HG13 HG12 ' B' ' 84' ' ' ILE . 62.1 t -93.41 110.44 23.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.586 -0.894 . . . . 10.0 108.586 178.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 13.3 t -100.4 103.29 14.66 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.14 0.495 . . . . 10.0 111.919 -178.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.573 HG21 HG23 ' A' ' 119' ' ' ILE . 19.3 t -96.2 98.33 7.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 108.943 -0.762 . . . . 10.0 108.943 178.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . 0.458 ' NH1' ' HB3' ' B' ' 83' ' ' ASP . 19.6 ptt-85 -131.51 155.07 48.06 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.221 0.534 . . . . 10.0 111.966 -178.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -95.79 113.43 25.07 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.288 -0.869 . . . . 10.0 109.871 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -92.77 78.6 4.78 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.379 -0.373 . . . . 10.0 110.526 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 90.1 mttt 56.53 57.53 4.79 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.743 -0.662 . . . . 10.0 111.092 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.27 29.56 33.21 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.636 -0.792 . . . . 10.0 112.02 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -142.21 88.97 2.13 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.744 0.307 . . . . 10.0 110.252 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . . . . . . . . . 12.0 t -70.01 102.31 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.408 -0.589 . . . . 10.0 109.408 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 37.0 mt -117.98 132.34 56.4 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.014 0.435 . . . . 10.0 111.366 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' ILE . . . . . 0.525 HD13 ' HB2' ' B' ' 109' ' ' TRP . 4.1 mp -91.65 86.9 2.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 108.138 -1.06 . . . . 10.0 108.138 178.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . 0.596 ' HA ' ' HA ' ' B' ' 103' ' ' SER . 37.4 t70 -89.78 95.89 10.44 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.315 -0.857 . . . . 10.0 110.937 -178.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . 0.418 HG12 HG13 ' B' ' 71' ' ' VAL . 21.7 mt -78.67 116.41 22.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 108.217 -1.031 . . . . 10.0 108.217 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 20.3 ttm-85 -142.38 151.42 41.85 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.296 0.57 . . . . 10.0 112.163 -177.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' GLU . . . . . 0.49 ' HG3' ' HA3' ' B' ' 98' ' ' GLY . 5.0 pt-20 -89.8 162.88 15.29 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.669 -0.696 . . . . 10.0 109.373 178.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -111.79 129.81 56.01 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.056 0.455 . . . . 10.0 111.251 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' TRP . . . . . . . . . . . . . 24.3 m95 -117.03 145.89 43.41 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.394 -0.965 . . . . 10.0 108.394 178.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' MET . . . . . . . . . . . . . 30.1 ttm -108.65 137.71 46.15 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.549 -0.461 . . . . 10.0 110.469 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' ASP . . . . . 0.438 ' HB2' ' CD ' ' B' ' 91' ' ' PRO . 55.1 p30 -93.83 171.78 6.62 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.165 -0.471 . . . . 10.0 110.644 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' PRO . . . . . 0.438 ' CD ' ' HB2' ' B' ' 90' ' ' ASP . 24.7 Cg_exo -64.65 -13.3 38.21 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.619 2.213 . . . . 10.0 113.098 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -82.71 -41.64 19.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.893 0.378 . . . . 10.0 110.048 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 119.87 27.84 2.01 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 121.085 -0.579 . . . . 10.0 111.886 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' GLU . . . . . 0.712 ' HB3' ' HE2' ' B' ' 96' ' ' LYS . 0.0 OUTLIER -110.24 151.39 27.4 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.965 0.412 . . . . 10.0 110.341 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' MET . . . . . . . . . . . . . 82.4 mmm -90.01 112.05 23.34 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.854 -0.612 . . . . 10.0 109.99 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . 0.712 ' HE2' ' HB3' ' B' ' 94' ' ' GLU . 61.2 mmtt -111.17 140.5 22.92 Favored Pre-proline 0 C--N 1.318 -0.786 0 CA-C-N 116.444 -0.344 . . . . 10.0 110.522 -179.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -63.22 131.38 32.05 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 122.607 2.205 . . . . 10.0 111.843 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . 0.49 ' HA3' ' HG3' ' B' ' 86' ' ' GLU . . . -68.69 160.88 51.63 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 121.151 -0.547 . . . . 10.0 112.835 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -71.83 -23.5 61.55 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.878 0.371 . . . . 10.0 110.877 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . 0.735 ' HD2' HD12 ' C' ' 485' ' ' ILE . 29.5 mmtp -88.45 142.84 27.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.195 -0.457 . . . . 10.0 110.378 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' GLY . . . . . 0.695 ' HA2' ' HB ' ' A' ' 102' ' ' ILE . . . 138.98 163.47 9.52 Favored Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 111.503 -0.639 . . . . 10.0 111.503 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 20.0 tt -145.39 142.99 22.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.888 0.375 . . . . 10.0 110.97 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' SER . . . . . 0.596 ' HA ' ' HA ' ' B' ' 83' ' ' ASP . 0.8 OUTLIER -97.11 110.87 23.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.911 -0.586 . . . . 10.0 110.194 179.509 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' LEU . . . . . 0.414 HD22 ' HB3' ' B' ' 108' ' ' GLN . 94.8 mt -95.49 133.98 38.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.779 0.323 . . . . 10.0 110.914 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -88.54 168.85 14.91 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.471 -0.566 . . . . 10.0 109.471 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -45.69 -37.78 16.27 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.995 2.463 . . . . 10.0 113.836 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -68.14 -52.98 28.52 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.972 0.415 . . . . 10.0 110.314 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' GLN . . . . . 0.414 ' HB3' HD22 ' B' ' 104' ' ' LEU . 11.4 mt-30 -62.58 -34.69 77.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.738 -0.664 . . . . 10.0 110.854 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' TRP . . . . . 0.525 ' HB2' HD13 ' B' ' 82' ' ' ILE . 34.7 t-105 -59.4 -43.74 92.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.114 -0.493 . . . . 10.0 110.143 178.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' SER . . . . . 0.447 ' HA ' ' HE3' ' B' ' 113' ' ' LYS . 19.3 t -67.97 -46.93 69.98 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.974 -0.557 . . . . 10.0 110.012 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' GLN . . . . . 0.536 ' O ' ' HG2' ' B' ' 115' ' ' GLN . 21.7 mm-40 -58.22 -41.71 84.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.949 -0.569 . . . . 10.0 110.841 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . 0.504 ' O ' HG13 ' B' ' 116' ' ' ILE . 43.2 tp -57.79 -46.93 83.92 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.926 0.393 . . . . 10.0 110.09 178.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 113' ' ' LYS . . . . . 0.447 ' HE3' ' HA ' ' B' ' 110' ' ' SER . 48.6 mtmt -65.13 -33.91 77.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.902 -0.59 . . . . 10.0 110.882 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -74.4 -38.43 63.1 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.859 -0.61 . . . . 10.0 112.026 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' GLN . . . . . 0.536 ' HG2' ' O ' ' B' ' 111' ' ' GLN . 10.5 mm-40 -79.06 -5.37 53.84 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.8 0.296 . . . . 10.0 111.8 -179.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' ILE . . . . . 0.504 HG13 ' O ' ' B' ' 112' ' ' LEU . 25.7 mt -53.32 -41.26 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.784 -0.189 . . . . 10.0 111.396 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 117' ' ' SER . . . . . 0.431 ' O ' ' HB2' ' B' ' 121' ' ' ASP . 0.2 OUTLIER -57.26 -37.42 72.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.289 -0.414 . . . . 10.0 111.889 -179.372 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.09 -45.29 16.7 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.864 0.364 . . . . 10.0 110.918 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . 0.475 ' O ' HG23 ' B' ' 123' ' ' VAL . 71.1 mt -59.82 -52.48 60.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.839 -0.619 . . . . 10.0 110.988 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -61.08 -39.06 88.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.925 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 121' ' ' ASP . . . . . 0.431 ' HB2' ' O ' ' B' ' 117' ' ' SER . 10.6 t70 -58.54 -38.84 78.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.958 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -78.47 -38.55 40.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.268 -0.423 . . . . 10.0 111.054 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . 0.475 HG23 ' O ' ' B' ' 119' ' ' ILE . 89.1 t -66.93 -35.45 74.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.34 -0.391 . . . . 10.0 111.466 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . 0.462 ' HG3' ' HG3' ' B' ' 125' ' ' LYS . 15.5 ptp180 -81.7 -6.33 58.94 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 111.875 0.324 . . . . 10.0 111.875 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 125' ' ' LYS . . . . . 0.462 ' HG3' ' HG3' ' B' ' 124' ' ' ARG . 91.4 mttt -119.95 83.48 2.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.103 0.478 . . . . 10.0 111.131 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 36.7 tp . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.306 -0.854 . . . . 10.0 109.728 179.627 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 465' ' ' TYR . . . . . . . . . . . . . 21.9 t80 . . . . . 0 N--CA 1.48 1.037 0 CA-C-O 120.416 0.151 . . . . 10.0 110.921 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 466' ' ' GLY . . . . . 0.404 ' C ' ' H ' ' C' ' 468' ' ' LEU . . . -58.11 -43.33 95.28 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.937 -0.649 . . . . 10.0 112.391 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 467' ' ' ALA . . . . . . . . . . . . . . . -77.25 23.84 0.19 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.354 0.597 . . . . 10.0 111.719 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 468' ' ' LEU . . . . . 0.404 ' H ' ' C ' ' C' ' 466' ' ' GLY . 69.8 tp -141.39 -53.91 0.46 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.652 -0.704 . . . . 10.0 109.205 179.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 469' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -59.22 -41.21 88.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.531 -0.759 . . . . 10.0 110.89 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 470' ' ' MET . . . . . . . . . . . . . 26.8 ttm -103.49 19.08 20.43 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.055 -0.521 . . . . 10.0 110.5 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 471' ' ' ALA . . . . . . . . . . . . . . . -117.34 -54.58 2.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.908 0.385 . . . . 10.0 110.892 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 472' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -59.61 -35.82 75.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.901 -0.59 . . . . 10.0 110.931 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 473' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -95.77 15.11 21.08 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.107 -0.497 . . . . 10.0 110.918 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 474' ' ' GLU . . . . . 0.73 ' HG2' ' HE2' ' A' ' 96' ' ' LYS . 1.5 tp10 -111.75 -30.19 7.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.0 0.428 . . . . 10.0 110.72 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 475' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -58.5 -39.95 81.46 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.973 -0.558 . . . . 10.0 110.955 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 476' ' ' GLU . . . . . 0.51 ' OE1' ' HB3' ' C' ' 479' ' ' PHE . 43.9 mm-40 -78.85 8.9 4.77 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.833 0.679 . . . . 10.0 112.833 -178.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 477' ' ' GLN . . . . . 0.593 ' HB2' ' O ' ' C' ' 474' ' ' GLU . 1.4 mp0 -73.01 -21.51 60.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.096 0.474 . . . . 10.0 109.878 179.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 478' ' ' MET . . . . . . . . . . . . . 3.9 ptp -145.01 -4.12 0.74 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.744 -0.662 . . . . 10.0 111.645 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 479' ' ' PHE . . . . . 0.51 ' HB3' ' OE1' ' C' ' 476' ' ' GLU . 2.6 t80 -71.48 -83.27 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.788 -0.365 . . . . 10.0 111.328 -179.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 480' ' ' THR . . . . . . . . . . . . . 13.0 p -65.41 -18.9 65.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.22 0.533 . . . . 10.0 110.774 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 481' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -67.31 -20.56 65.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.306 -0.861 . . . . 10.0 110.876 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 482' ' ' ALA . . . . . . . . . . . . . . . -65.56 -19.71 66.03 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.93 -0.577 . . . . 10.0 111.306 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 483' ' ' LEU . . . . . . . . . . . . . 22.4 tp -70.52 -58.61 3.51 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.442 -0.577 . . . . 10.0 109.442 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 484' ' ' GLY . . . . . . . . . . . . . . . -82.53 57.15 5.03 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.864 -0.607 . . . . 10.0 112.457 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 485' ' ' ILE . . . . . 0.816 HD11 ' HA ' ' A' ' 102' ' ' ILE . 17.9 tt -168.47 -31.82 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.394 -0.595 . . . . 10.0 109.394 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 486' ' ' ASP . . . . . 0.597 ' HB2' HD11 ' A' ' 81' ' ' LEU . 8.0 t70 -89.34 -55.69 3.56 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.126 -0.488 . . . . 10.0 110.033 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 487' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -81.07 61.14 4.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.878 -0.601 . . . . 10.0 111.141 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 488' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -161.55 -52.73 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.567 -0.742 . . . . 10.0 109.745 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 489' ' ' GLY . . . . . 0.603 ' HA2' ' O ' ' B' ' 67' ' ' LYS . . . -87.64 -5.61 78.16 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.45 -0.796 . . . . 10.0 112.898 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 490' ' ' GLY . . . . . 0.695 ' HA3' ' NE2' ' A' ' 108' ' ' GLN . . . . . . . . 0 N--CA 1.444 -0.796 0 CA-C-O 118.512 -1.16 . . . . 10.0 112.412 179.988 . . . . . . . . 1 1 . 1 stop_ save_